Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5984741156019043,-2.549177132172141,0.0,0.0,0.0,59/87,21.25%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC61B;RPLP2;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26
prerank,protein targeting to ER (GO:0045047),-0.5684367744064553,-2.4264156014726366,0.0,0.0,0.0,69/99,24.73%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;EDEM1;RPS14;RPSA;SPCS2;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;SGTA;RPS4X;RPS27;RPL27A;RPS9;RPL30;SGTB;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPLP2;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;ZFAND2A;RPS27A;RPS3;RPL4;SEC63;SPCS1
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.5688463734534406,-2.3575218139720566,0.0,0.0,0.0,61/91,21.25%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;SIL1;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;SRP68;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;SEC62;RPLP2;RPL29;RPLP0;RPL10A;SSR2;RPS10;RPL35;RPS26
prerank,cytoplasmic translation (GO:0002181),-0.5583782903229345,-2.269418658860421,0.0,0.0004297040985163253,0.001,61/91,23.10%,RPL13;RPS8;EIF3M;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RWDD1;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;RPL31;RPL13A;RPL36A;RPL29;RPLP0;RPL10A;RPS10;RPL35;RPS26;TMA7;RPS27A;RPS3
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.908246486392717,2.1938060872304317,0.0,0.0,0.0,50/125,2.94%,KNL1;KIF11;CENPF;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF2C;NUSAP1;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;INCENP;TTK;BUB1B;SGO1;SKA1;PLK1;BIRC5;BUB1;ESPL1;CENPI;SPDL1;KIF18A;CDC20;WDR62;CENPN;AURKB;CENPQ;CKAP5;CENPU;SKA2;STMN1;XPO1;DSN1;ITGB3BP;PMF1;GPSM2;AURKA;NUP160
prerank,mitotic sister chromatid segregation (GO:0000070),0.9084619543177518,2.1668663014002614,0.0,0.0,0.0,41/98,2.82%,PRC1;KIF18B;CENPE;KIF14;CDCA8;NSL1;KIF23;CEP55;KIF2C;NUSAP1;NCAPG;CCNB1;NDC80;CDK1;CENPK;DLGAP5;KIFC1;SGO1;NCAPG2;PLK1;CDCA5;SPAG5;ESPL1;KNSTRN;SPDL1;NCAPH;SMC2;KIF18A;SMC4;KIF22;NCAPD3;NCAPD2;NCAPH2;HASPIN;PDS5A;DSN1;PSRC1;KMT5A;SMC1A;RB1;PDS5B
prerank,mitotic spindle organization (GO:0007052),0.900823132775439,2.1648651281734392,0.0,0.0,0.0,56/153,3.25%,KNL1;KIF11;PRC1;CENPF;TPX2;KIF4A;CENPE;NUF2;CDCA8;SPC25;NSL1;CENPM;KIF23;KIF2C;CENPH;CENPP;ZWILCH;CCNB1;KNTC1;NDC80;STIL;CENPK;CENPA;DLGAP5;KIFC1;INCENP;TTK;BUB1B;SGO1;SKA1;PLK1;BIRC5;BUB1;CENPI;SPDL1;KIF18A;CDC20;WDR62;CENPN;AURKB;CEP192;CENPQ;CKAP5;CENPU;SKA2;STMN1;XPO1;DSN1;ITGB3BP;SMC1A;PMF1;GPSM2;CCDC61;AURKA;NUP160;RHOA
prerank,sister chromatid segregation (GO:0000819),0.9501844485719021,2.1116324467505003,0.0,0.0,0.0,19/31,2.56%,TOP2A;KIF18B;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;DSN1;SMC1A;RB1
prerank,mitotic nuclear division (GO:0140014),0.892662724512574,2.1114273306227433,0.0,0.0,0.0,23/71,2.40%,KIF11;KIF18B;TPX2;CDCA8;NSL1;NUSAP1;NDC80;CENPK;KIFC1;SGO1;NCAPG2;PLK1;SPAG5;ESPL1;KNSTRN;KIF18A;SMC4;UBE2C;CEP192;DSN1;UBE2S;SMC1A;CCDC61
prerank,centromere complex assembly (GO:0034508),0.9366904463730669,2.1044334853922875,0.0,0.0,0.0,18/36,2.05%,KNL1;CENPF;MIS18BP1;CENPE;CENPM;CENPH;CENPP;CENPK;CENPA;DLGAP5;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,chromosome condensation (GO:0030261),0.9243618774013921,2.0751434728574165,0.0,0.0,0.0,17/36,2.56%,TOP2A;NUSAP1;NCAPG;CCNB1;CDK1;INCENP;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.4941228465172327,-2.0721484410453073,0.0,0.030938695093175428,0.082,72/110,26.40%,RPL13;RPS8;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;RPS4X;RPS27;RPL27A;RPS9;RPL30;RPL19;RPL28;EIF4A3;RPL31;RBM8A;SMG1;RPL13A;RPL36A;RPLP2;RPL29;RPLP0;DCP1A;RPL10A;RPS10;NCBP1;RPL35;RPS26;RPS27A;CASC3;RPS3;RPL4;MAGOH;EIF3E;UPF1;GSPT1;RPS25
prerank,chromatin remodeling at centromere (GO:0031055),0.9298535922517804,2.072141186714283,0.0,0.0,0.0,15/31,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;HELLS;OIP5;ITGB3BP
prerank,mitotic metaphase plate congression (GO:0007080),0.8946936074898795,2.0715393777946103,0.0,0.0,0.0,14/51,2.10%,CENPE;KIF14;NUF2;CDCA8;CEP55;KIF2C;CCNB1;NDC80;KIFC1;CDCA5;SPDL1;KIF18A;KIF22;PSRC1
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.9329393517593987,2.06608933183083,0.0,0.0,0.0,14/29,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,CENP-A containing chromatin organization (GO:0061641),0.9329393517593987,2.06608933183083,0.0,0.0,0.0,14/29,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.8805062856384237,2.062137151820938,0.0,0.0,0.0,18/56,3.25%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;AURKB;ANLN;CIT;STMN1;ROCK2;RHOA
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.9141091605108796,2.060473054282377,0.0,0.0,0.0,16/38,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;ASF1B;CENPI;HJURP;CENPN;ATRX;CENPQ;CENPU;OIP5;ITGB3BP
prerank,mitotic spindle assembly (GO:0090307),0.8989704435230587,2.0409814237634527,0.0,0.0,0.0,14/42,4.72%,KIF11;PRC1;TPX2;KIF4A;KIF23;KIFC1;RACGAP1;AURKB;CEP192;SMC1A;CCDC61;RHOA;CHEK2;SMC3
prerank,mitotic cytokinesis (GO:0000281),0.8868891843741719,2.036555679600013,0.0,0.0,0.0,15/47,1.85%,KIF4A;KIF23;CEP55;ECT2;NUSAP1;CKAP2;CENPA;INCENP;PLK1;RACGAP1;ESPL1;KIF20A;ANLN;CIT;STMN1
prerank,histone exchange (GO:0043486),0.9103721767235301,2.0343595832205787,0.0,0.0,0.0,14/37,2.05%,KNL1;MIS18BP1;CENPM;CENPH;CENPP;CENPK;CENPA;CENPI;HJURP;CENPN;CENPQ;CENPU;OIP5;ITGB3BP
prerank,positive regulation of cell cycle process (GO:0090068),0.8545377487080307,2.020019883995256,0.0,0.0,0.0,26/91,3.48%,KIF20B;KIF14;KIF23;ECT2;NUSAP1;E2F7;CCNB1;NDC80;E2F8;SPAG5;RACGAP1;CEP295;ATRX;AURKB;DBF4;GEN1;CIT;DDX11;PLK4;GPSM2;AURKA;PHIP;CSPP1;RHOA;RAD21;CDC6
prerank,response to cadmium ion (GO:0046686),-0.6042232282058801,-2.001142875634184,0.0,0.07763320713194945,0.22,15/26,20.86%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,regulation of cation channel activity (GO:2001257),-0.4686893602764924,-1.9876085950098554,0.0,0.07882000892785168,0.252,36/89,18.60%,CAMK2D;AHNAK;FGF14;LRRC7;MEF2C;GRIN2A;KCNAB1;CALM1;FKBP1A;GRIN2B;HOMER1;FGF13;SHISA6;CACNG7;NETO1;NEFL;CACNG4;MINK1;RELN;OPRM1;GRIA1;APP;SELENON;SHANK1;CACNG2;CACNB2;DLG4;PRRT1;GRIN1;CACNG3;CACNG8;CACNB1;GRIA2;STAC;NLGN1;PDE4D
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.8366365617023918,1.9846728351180016,0.0,0.0003213458015724431,0.005,30/83,8.32%,CENPF;TPX2;HMMR;KIF14;NEK2;CDK1;PLK1;ATAD5;GTSE1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;PCM1;DYRK3;HAUS7;NDE1;CNTRL;HAUS1;CDK2;CENPJ;CEP76
prerank,mitotic chromosome condensation (GO:0007076),0.920650918486239,1.9830612771610316,0.0,0.00030443286464757765,0.005,15/26,2.56%,NUSAP1;NCAPG;CCNB1;CDK1;NCAPG2;PLK1;CDCA5;NCAPH;SMC2;SMC4;NCAPD3;NCAPD2;NCAPH2;KMT5A;RB1
prerank,cellular response to cadmium ion (GO:0071276),-0.617642397709425,-1.9819972964795636,0.0,0.0754130692896151,0.276,15/24,20.86%,MAPK8;MAPK9;JUN;MAPK3;MAPK1;CHUK;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,DNA replication (GO:0006260),0.8322824694638193,1.9755894047142122,0.0,0.0007850018866983968,0.017,49/105,7.94%,BRCA1;EXO1;TICRR;CDK1;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;WDHD1;ORC1;PCLAF;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;RPAIN;TOPBP1;RBBP8;CDC6;RPA1;RAD1;DNA2;RFC2;BLM;MRE11;MCM3;POLD1;RPA2;MCM4;RFC1;RFC3;ORC2;CHEK1;RNASEH2A;ORC3;CDK2
prerank,negative regulation of cell cycle process (GO:0010948),0.8291328072383604,1.9724969058237551,0.0,0.0008263177754719965,0.017,22/61,7.13%,BRCA1;NEK2;E2F7;E2F8;RRM2;EZH2;ESPL1;RAD51;AURKB;E2F1;CBX5;TERF1;FBXO5;SUZ12;RBBP8;TFDP1;EED;WAPL;YAF2;RBBP4;RBBP7;CHEK1
prerank,replication fork processing (GO:0031297),0.8592711575707128,1.9658992367157335,0.0,0.001089237067667632,0.023,19/38,7.36%,EME1;RAD51;ATRX;ZGRF1;GEN1;DDX11;BRCA2;ZRANB3;MMS22L;RFWD3;FAM111A;RTEL1;PRIMPOL;DNA2;TONSL;BLM;MRE11;ETAA1;NUCKS1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.8199317702496984,1.9555454096676497,0.0,0.0017244892705502537,0.039,11/79,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,protein depolymerization (GO:0051261),0.8862762664413955,1.9543370046476745,0.0,0.0017214953655666594,0.039,7/27,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,DNA replication initiation (GO:0006270),0.8700292559286317,1.9537962992388194,0.0,0.001850951817057272,0.045,23/37,7.94%,POLE;DBF4;MCM5;POLA1;ORC1;PRIM2;POLA2;MCM8;CDC45;PRIM1;MCM10;MCM6;MCM7;MCM2;TOPBP1;CDC6;RPA1;MCM3;RPA2;MCM4;ORC2;ORC3;CDK2
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.8205535185908601,1.9537038154249966,0.0,0.0017750529991620667,0.047,11/78,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.8205535185908601,1.9537038154249966,0.0,0.0017750529991620667,0.047,11/78,2.92%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22;CTSE;ACTR1A
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.8595397469120994,1.9532441741666327,0.0,0.001711658249191993,0.047,20/40,7.36%,EME1;POLE;RAD51;ATRX;GEN1;DDX11;ZRANB3;TIPIN;MMS22L;RFWD3;TIMELESS;FAM111A;RTEL1;MSH3;PRIMPOL;TONSL;BLM;POLD1;ETAA1;NUCKS1
prerank,positive regulation of cytokinesis (GO:0032467),0.8890466234172104,1.9422667731520131,0.0,0.0025074470428115754,0.072,10/32,3.48%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6
prerank,positive regulation of cell division (GO:0051781),0.8720775614741961,1.9402469526818718,0.0,0.002644216881510389,0.079,11/38,3.52%,KIF20B;KIF14;KIF23;ECT2;RACGAP1;AURKB;CIT;CSPP1;RHOA;CDC6;FGFR2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.8883895568598095,1.93826738054521,0.0,0.002825473683871988,0.083,12/26,3.64%,CENPE;CCNB1;DLGAP5;PLK1;ESPL1;UBE2C;CDK5RAP2;FBXO5;ANAPC7;RB1;CDC6;CDC27
prerank,kinetochore organization (GO:0051383),0.9686206187616745,1.938236348286024,0.0,0.0027371776312509885,0.083,7/13,0.52%,CENPF;CENPE;NUF2;CENPH;NDC80;CENPA;DLGAP5
prerank,embryonic heart tube development (GO:0035050),-0.6988973674984986,-1.9269418171640462,0.0,0.13998804631665177,0.489,7/14,17.86%,ACVR1;RYR2;MEGF8;SOX17;NDRG4;CITED2;TBX2
prerank,regulation of mitotic nuclear division (GO:0007088),0.8245966644109127,1.9262812324186942,0.0011013215859030838,0.00448214793362083,0.134,11/55,3.97%,KIF20B;MKI67;NEK2;NUSAP1;CCNB1;BORA;CDK5RAP2;FBXO5;AURKA;PHIP;OBSL1
prerank,regulation of cell cycle process (GO:0010564),0.82015293647785,1.9253700023073201,0.0,0.0045447477650959805,0.142,20/104,2.75%,KIF11;PRC1;KIF20B;MKI67;NEK2;ECT2;PLK1;SPAG5;RACGAP1;BUB1;KNSTRN;BORA;RMI2;KIF20A;AURKB;DBF4;TIPIN;PLK4;FBXO5;AURKA
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.831800463637598,1.9209241612779897,0.0,0.005288433763020777,0.168,18/42,8.37%,RAD51AP1;POLQ;PARPBP;FIGNL1;RMI2;RAD51;TIMELESS;RTEL1;ARID2;KLHL15;RPA2;SPIDR;CHEK1;RIF1;SETD2;FUS;MRNIP;SMCHD1
prerank,regulation of cytokinesis (GO:0032465),0.8300378959684725,1.917742670934548,0.0,0.005853084242926642,0.183,17/78,3.48%,PRC1;KIF20B;KIF14;KIF23;ECT2;E2F7;E2F8;PLK1;RACGAP1;KIF20A;AURKB;CIT;PLK4;AURKA;CSPP1;RHOA;CDC6
prerank,microtubule depolymerization (GO:0007019),0.9289169171291844,1.9164936130490573,0.0,0.005985220643959326,0.193,7/17,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,negative regulation of protein transport (GO:0051224),-0.5958572711186095,-1.9149617883110361,0.0,0.14558374857733103,0.534,12/25,23.22%,APOE;SNX3;SERGEF;CYP51A1;PPM1F;RHBDF1;PKDCC;WWP2;RHBDF2;DRD2;DPH3;NDFIP1
prerank,interstrand cross-link repair (GO:0036297),0.8210473469042742,1.912067818184949,0.0011001100110011,0.006784503840717445,0.217,18/53,7.36%,NEIL3;EME1;RAD51AP1;FANCA;UBE2T;FANCD2;RAD51;RAD51AP2;MCM8;RFWD3;RNF168;FANCI;USP1;RPA1;ERCC4;RPA2;FANCL;NUCKS1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.8285702241988774,1.9101078149096566,0.0,0.0072461712618313535,0.235,21/57,8.17%,DTL;BRCA1;EME1;TICRR;CDK1;CLSPN;PLK1;FANCD2;TIPIN;RFWD3;TOPBP1;CHEK2;PRKDC;BLM;MRE11;RPA2;MDC1;CHEK1;CDK2;UIMC1;MRNIP
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.8046249671728555,1.9040979401493345,0.0,0.008531731031748365,0.271,9/80,1.09%,KIF11;KIF15;KIF4A;CENPE;KIF23;KIF2C;RACGAP1;KIF18A;KIF22
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.9713024536356528,1.9038396960160162,0.0,0.008404256399312745,0.273,6/10,0.77%,NEK2;ECT2;CCNB1;SPAG5;RACGAP1;KNSTRN
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.6996116455686622,-1.902260162388102,0.0,0.15500598753752537,0.582,8/13,13.93%,SHANK3;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;APP;ADCY8
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.8475938528437559,1.9006341113675618,0.0,0.009187866693938628,0.303,17/42,6.47%,DTL;POLK;POLE;POLA1;PCLAF;USP43;RFC4;CDKN2D;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,monoacylglycerol metabolic process (GO:0046462),-0.7108091606767644,-1.8930470300546562,0.0,0.15755816945598597,0.617,4/13,4.62%,PLA2G4A;ABHD6;ABHD12;ABHD16A
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.9533303207214066,1.8897592262294882,0.0,0.013086567560382085,0.402,4/12,0.39%,CENPE;NUF2;KIF2C;NDC80
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.9288436109090467,1.8855006701141415,0.0,0.014854940009053392,0.45,11/17,3.49%,KNL1;ZWILCH;CDK1;CENPA;TTK;SPDL1;AURKB;HASPIN;MTBP;RB1;CTCF
prerank,dendritic spine morphogenesis (GO:0060997),-0.6861598242077308,-1.8828551288762823,0.0034129692832764505,0.16619632364154494,0.658,8/15,13.64%,CTNND2;DOCK10;SHANK3;PAK3;DIP2A;EPHB2;SHANK1;DLG4
prerank,spindle assembly checkpoint signaling (GO:0071173),0.9020962151433264,1.8811617070586593,0.0,0.01620989338266342,0.491,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.9020962151433264,1.8811617070586593,0.0,0.01620989338266342,0.491,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.9020962151433264,1.8811617070586593,0.0,0.01620989338266342,0.491,8/20,0.93%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20
prerank,double-strand break repair via homologous recombination (GO:0000724),0.7954830740539048,1.879627394900168,0.0,0.016354205972883264,0.502,39/95,8.70%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;RAD54L;MCM5;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;CDC45;AUNIP;RFWD3;XRCC2;SMC6;MCM6;MCM7;MCM2;RAD21;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;MCM3;RPA2;MCM4;SPIDR;UBE2N;NUCKS1;NIPBL;RAD51C;PSMD14
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.46224026739990615,-1.877427804608906,0.0,0.16562023682814941,0.69,25/57,18.41%,DLGAP1;DLGAP4;LRRC7;MEF2C;GRIN2A;GRIN2B;SHISA6;CACNG7;NETO1;NEFL;CACNG4;MINK1;RELN;OPRM1;GRIA1;APP;SHANK1;CACNG2;DLG4;PRRT1;GRIN1;CACNG3;CACNG8;GRIA2;NLGN1
prerank,DNA recombination (GO:0006310),0.8405363651717527,1.8768461205064884,0.001148105625717566,0.01709971886384907,0.516,16/37,5.38%,EXO1;RAD51B;RAD54B;RAD51;RAD54L;GEN1;DMC1;XRCC2;RPAIN;RTEL1;RAD21;RPA1;MSH3;BLM;MRE11;RECQL
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.8920551957142749,1.8747984879784716,0.001277139208173691,0.018046780216308404,0.541,9/21,2.18%,CENPF;KNTC1;TTK;BUB1B;PLK1;BUB1;TRIP13;CDC20;FBXO5
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.9119503310581087,1.87443339939092,0.0,0.017968361039185178,0.548,4/16,4.49%,TOP2A;EME1;HFM1;ERCC4
prerank,DNA metabolic process (GO:0006259),0.7856632839341767,1.8739934570169272,0.0,0.017892957984259,0.552,88/270,7.64%,TOP2A;NEIL3;BRCA1;EXO1;TICRR;RAD51AP1;POLK;POLQ;UHRF1;CDK1;FANCA;POLE;RAD51B;BARD1;UBE2T;KPNA2;RMI2;RAD51;RAD54L;DBF4;MCM5;GEN1;POLA1;WDHD1;ORC1;RAD18;HELLS;HMGB2;PRIM2;TYMS;ZRANB3;POLA2;MCM8;TERF1;CDC45;RFC4;PRIM1;PDS5A;DMC1;SMC1A;TIMELESS;XRCC2;MCM10;MCM6;MCM7;MCM2;PDS5B;RPAIN;TOPBP1;RTEL1;EID3;POLH;RAD21;RBBP8;CDC6;RPA1;STN1;CHD1L;MSH3;PRIMPOL;UHRF2;SMARCAD1;RAD1;ERCC4;POLD3;DNA2;RFC2;PRKDC;BLM;MRE11;RECQL;MCM3;NSMCE4A;POLD1;RPA2;MCM4;ERCC3;RFC1;TCF7L2;FANCL;RFC3;ORC2;UBE2N;DNASE2;CHEK1;RIF1;RNASEH2A;ORC3
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.778647532230464,1.8702867298825288,0.0,0.019628944892815914,0.582,45/146,10.31%,CENPF;TPX2;HMMR;DTL;KIF14;NEK2;CCNB1;CDK1;PLK1;RAD51B;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;FBXO5;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;PSMC2;PSMD5;PCM1;FBXL7;HAUS7;NDE1;CDC25B;CNTRL;HAUS1;CDK2;CENPJ;CEP76;PSMB1;RAD51C;PSMD14;ALMS1;CDC25C;ODF2;PSMD1;SDCCAG8;CDC25A;NINL
prerank,spindle assembly (GO:0051225),0.8058578778598826,1.868949698843071,0.0,0.01998464842160051,0.589,19/67,8.30%,KIF11;TPX2;NEK2;KIFC1;CEP192;HAUS8;SMC1A;CCDC61;HAUS4;HAUS6;RHOA;CHEK2;TUBGCP5;SMC3;NUMA1;HAUS7;STAG1;HAUS1;GOLGA8B
prerank,regulation of chromosome segregation (GO:0051983),0.9048479295957754,1.8669919108766952,0.0013698630136986301,0.020868279820556418,0.606,10/16,4.91%,MKI67;KIF2C;BUB1;RMI2;AURKB;RAD18;SMC6;CDC6;SMC5;NUMA1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.6896220930782184,-1.8662047226845255,0.0,0.17497550891584765,0.74,6/14,6.74%,PTK2;STAT3;STAT6;SOCS2;PIK3R1;LYN
prerank,dendrite morphogenesis (GO:0048813),-0.534109431594736,-1.8630924136239806,0.0,0.17091480518486837,0.75,17/35,15.33%,CTNND2;DOCK10;SHANK3;PAK3;KLF7;TAOK2;DIP2A;EPHB2;BTBD3;TMEM106B;MINK1;CTNNA2;CHRNA7;MEF2A;SHANK1;DLG4;DVL1
prerank,establishment of mitotic spindle localization (GO:0040001),0.8689123215353928,1.8587834976897823,0.0,0.025822430483499893,0.683,12/28,6.65%,NUSAP1;NDC80;CENPA;PLK1;ESPL1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,regulation of exit from mitosis (GO:0007096),0.8213814266798087,1.8575364493402695,0.0,0.026471162421260797,0.698,12/38,6.46%,NEK2;KNTC1;BUB1B;CDCA5;CDC20;UBE2C;ANLN;UBE2S;ANAPC7;CDC27;ZW10;BUB3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.7690709164429044,1.8546127690933834,0.0,0.02842248210459712,0.722,52/185,9.80%,CENPF;TPX2;HMMR;CENPE;KIF14;NEK2;CCNB1;KNTC1;CDK1;BUB1B;PLK1;CDC20;UBE2C;CEP192;CEP152;CDK5RAP2;CKAP5;ANLN;E2F1;HAUS8;PLK4;CEP57;UBE2S;FBXO5;ANAPC7;HAUS4;HAUS6;AURKA;ACTR1A;CEP43;CDC6;PSMC2;CDC27;PSMD5;PCM1;ZW10;HAUS7;ERCC3;BUB3;NDE1;CNTRL;HAUS1;CDK2;CENPJ;CEP76;PSMB1;CUL3;PSMD14;ALMS1;ODF2;PSMD1;SDCCAG8
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.8377147952706855,1.8546013846591967,0.0,0.027940745119773437,0.722,12/32,8.17%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;TOPBP1;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,postreplication repair (GO:0006301),0.8211332509442263,1.8534345052833445,0.0,0.028480419327934815,0.736,17/45,6.77%,DTL;BRCA1;POLK;RAD18;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;UBE2N
prerank,DNA replication checkpoint signaling (GO:0000076),0.9111863462644646,1.853334514834736,0.0027137042062415195,0.028067711979966832,0.737,9/16,4.70%,TICRR;CLSPN;ORC1;TIPIN;CDC45;TIMELESS;TOPBP1;CDC6;DNA2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4922067673146533,-1.852715044505774,0.0,0.1778469433624038,0.788,22/46,18.41%,GRM7;GRIK1;MEF2C;CDH2;GRM3;SHANK3;OPHN1;SYT1;HOMER1;CACNG7;NRXN1;TSHZ3;CACNG4;DGKI;RELN;GRM5;CACNG2;ATP1A2;GRM1;CACNG3;CACNG8;NLGN1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.8159695882025781,1.8511631521774676,0.0011792452830188679,0.029280970205031877,0.756,17/36,10.06%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,glycerolipid catabolic process (GO:0046503),-0.6070526449525395,-1.8504082473286403,0.012396694214876033,0.1707357618104866,0.794,9/19,14.75%,GPCPD1;PLA2G4A;ABHD6;ABHD12;PNPLA6;ENPP6;ABHD2;GDPD3;GDPD1
prerank,regulation of nuclear division (GO:0051783),0.8939425883042224,1.8495908236393652,0.0,0.029983530709983868,0.768,6/20,3.97%,KIF20B;MKI67;NEK2;BORA;FBXO5;OBSL1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.8771449852117407,1.8493098066274936,0.0,0.02970870627126662,0.768,7/25,1.85%,KIF18B;KIF14;KIF2C;KIF24;KIF18A;CKAP5;STMN1
prerank,recombinational repair (GO:0000725),0.7866537394249165,1.84925060139563,0.0,0.02927707441403089,0.768,29/77,8.70%,BRCA1;RAD51AP1;POLQ;RAD51B;RAD54B;RAD51;GEN1;RAD51AP2;BRCA2;MMS22L;MCM8;AUNIP;RFWD3;XRCC2;SMC6;RBBP8;RPA1;SMC5;ERCC4;TONSL;BLM;MRE11;RECQL;RPA2;SPIDR;UBE2N;NUCKS1;RAD51C;PSMD14
prerank,regulation of G0 to G1 transition (GO:0070316),0.8129863275545945,1.8485044223873806,0.002333722287047841,0.029284201164075756,0.775,17/38,10.06%,BRCA1;RRM2;EZH2;RAD51;E2F1;CBX5;SUZ12;RBBP8;TFDP1;EED;YAF2;RBBP4;RBBP7;CHEK1;UXT;EPC1;APAF1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.7155513023175664,-1.8463198238786793,0.0,0.1689867907428412,0.801,7/12,17.83%,PARP8;PARP12;TIPARP;PARP6;PARP1;PARP16;PARP10
prerank,protein localization to kinetochore (GO:0034501),0.9248298331399788,1.843712025816941,0.0,0.032522387670442604,0.816,7/14,2.47%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.4167591002184065,-1.8421805491281502,0.0,0.16835806579869628,0.811,36/107,16.25%,NRG3;GRM7;GRIK1;DLGAP1;DLGAP4;MCTP1;SYN3;RIMS1;IQSEC2;MEF2C;CDH2;SLC8A3;GRM3;OPHN1;TMEM108;GRID2;CNTNAP4;SYT1;LGI1;HOMER1;BCR;GRIK4;CACNA1B;DGKI;RELN;CHRNA7;APP;GRM5;PSMC5;ATP1A2;DLG4;GRM1;LRP8;CPLX1;SLC4A8;SLC12A2
prerank,chloride transmembrane transport (GO:1902476),-0.466348769572789,-1.841092154401429,0.0,0.16222352823987748,0.815,20/48,16.25%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;GABRA5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;SLC1A1;SLC12A2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.895507186612162,1.8406845695650234,0.004329004329004329,0.03446231192997915,0.836,4/13,1.20%,CCNB1;NDC80;GEN1;CDK5RAP2
prerank,regulation of DNA recombination (GO:0000018),0.8329741231031278,1.8399967323464015,0.0011890606420927466,0.03466941971002072,0.841,14/32,7.48%,RAD51AP1;FIGNL1;KPNA2;RAD51;ZRANB3;RTEL1;MSH3;SMARCAD1;BLM;MRE11;RPA2;SPIDR;CHEK1;SETD2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.6383846889472609,-1.8395902587617259,0.003676470588235294,0.15766234014653538,0.819,11/18,27.90%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACSL1;ELOVL1;ACSBG1;TECR
prerank,apoptotic nuclear changes (GO:0030262),0.859053109996823,1.831630431483138,0.0,0.04213040200942222,0.892,2/24,1.44%,TOP2A;HMGB2
prerank,regulation of centriole replication (GO:0046599),0.8624056759817785,1.8315861083872846,0.005305039787798408,0.04157193090121086,0.892,10/18,9.17%,BRCA1;STIL;CEP295;CDK5RAP2;PLK4;TRIM37;CENPJ;CEP76;ALMS1;SPICE1
prerank,double-strand break repair (GO:0006302),0.7675101789193722,1.8305900202620569,0.0,0.04203891682713782,0.898,50/158,7.36%,BRCA1;EME1;RAD51AP1;POLQ;BRIP1;CDCA5;RAD51B;RAD54B;BARD1;TRIP13;KPNA2;RAD51;GEN1;POLA1;NSD2;RAD51AP2;HMGB2;BRCA2;MMS22L;MCM8;AUNIP;RFWD3;RNF168;XRCC2;SMC6;PAXIP1;BAZ1B;SETX;RAD21;RBBP8;RPA1;SMC5;CHEK2;SMARCAD1;ERCC4;DNA2;TDP2;TONSL;PRKDC;BLM;MRE11;RECQL;RPA2;SPIDR;MDC1;UBE2N;TENT4A;PRPF19;RIF1;NUCKS1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.8871662760421263,1.83038961566879,0.004098360655737705,0.04173470737212673,0.898,9/16,3.39%,SGO1;CDCA5;DSCC1;HASPIN;PDS5A;SMC1A;RB1;PDS5B;RAD21
prerank,ganglion development (GO:0061548),-0.6979416243893005,-1.8254784299234945,0.015197568389057751,0.17688862629358992,0.867,6/11,19.32%,NRP2;SEMA3A;CTNNB1;UNC5C;TUBB3;NRP1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.9166680379453386,1.8235860608841914,0.004418262150220913,0.04889791268637666,0.938,6/12,4.19%,TICRR;CLSPN;ORC1;TOPBP1;CDC6;CHEK2
prerank,regulation of DNA replication (GO:0006275),0.8027441321081294,1.8206431765768183,0.0011210762331838565,0.05209107256575466,0.947,19/49,7.64%,ESCO2;ATAD5;GLI2;DSCC1;TERF1;PDS5A;FBXO5;CDC6;STN1;WAPL;CCNA2;DNA2;SMC3;DHX9;BLM;FAF1;USP37;NUCKS1;ORC3
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.8091094912232786,1.8191015108757072,0.0,0.053362732131796826,0.95,14/43,8.17%,DTL;BRCA1;TICRR;CDK1;CLSPN;PLK1;ORC1;TOPBP1;CDC6;BLM;MRE11;CHEK1;UIMC1;MRNIP
prerank,DNA biosynthetic process (GO:0071897),0.8786476410181533,1.817630312282443,0.009641873278236915,0.05456916738019613,0.953,8/16,6.47%,POLE;POLA1;TYMS;CDKN2D;POLH;POLD3;POLD1;RFC3
prerank,regulation of spindle organization (GO:0090224),0.8814185352491903,1.8172572170496095,0.0,0.05430390919319813,0.955,6/18,4.91%,TPX2;BORA;PSRC1;GPSM2;TACC3;NUMA1
prerank,negative regulation of centrosome duplication (GO:0010826),0.9338106769463269,1.8168085566289964,0.0,0.054296399651583976,0.955,4/11,2.31%,BRCA1;CCNF;CDK5RAP2;TRIM37
prerank,protein localization to condensed chromosome (GO:1903083),0.9341436302394154,1.8166308715301946,0.0,0.05379328718322697,0.955,7/12,2.47%,KNL1;ZWILCH;CDK1;TTK;SPDL1;AURKB;MTBP
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.7594025975889215,1.8152827581208002,0.0,0.05468999499142436,0.959,47/129,10.31%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CEP192;CCNB2;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CENPJ;CEP76;DNM2;ALMS1;CDC25C;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.5903094464555474,-1.814568454785571,0.00425531914893617,0.19021568094322672,0.892,13/23,28.01%,ELOVL7;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;ACOT7;ACSL1;ELOVL1;ACSBG1;TECR;FAR2
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.8306497848369024,1.814417525585573,0.0011890606420927466,0.055030748437226495,0.964,14/32,6.37%,E2F7;RRM2;POLA1;ORC1;E2F1;TYMS;CDC45;FBXO5;RB1;CDK14;CDC6;TFDP1;CCNA1;CCNE1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.7666341382588364,1.8142852014406377,0.0,0.054636529539642376,0.966,34/95,11.81%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;CEP57;CEP89;HAUS4;HAUS6;SCLT1;ACTR1A;CEP43;CEP97;PCM1;C2CD3;HAUS7;NDE1;CEP83;CNTRL;HAUS1;CENPJ;CEP76;ALMS1;ODF2;SDCCAG8;NINL;NPHP1;AKAP9;CC2D2A
prerank,meiosis I (GO:0007127),0.8382404299515211,1.8095137618316484,0.00655307994757536,0.06017364086383574,0.979,3/23,1.03%,SGO1;MEIOC;MYBL1
prerank,DNA repair (GO:0006281),0.7571478059196424,1.8039564682688092,0.0,0.06706783921154474,0.988,81/284,7.56%,NEIL3;BRCA1;EME1;EXO1;TICRR;RAD51AP1;POLK;POLQ;CDK1;FANCA;BRIP1;POLE;CDCA5;RAD51B;BARD1;TRIP13;UBE2T;FANCD2;KPNA2;RMI2;RAD51;RAD54L;POLA1;NSD2;WDHD1;RAD18;RAD51AP2;BRCA2;ZRANB3;RFC4;PDS5A;CDKN2D;SMC1A;RFWD3;RNF168;TIMELESS;XRCC2;FAM111A;BAZ1B;SETX;PDS5B;FANCI;USP1;RPAIN;MGME1;TOPBP1;EID3;POLH;RAD21;RBBP8;RPA1;FTO;CHD1L;APEX2;MSH3;PRIMPOL;CHEK2;RAD1;ERCC4;POLD3;DNA2;TDP2;RFC2;PRKDC;BLM;MRE11;RECQL;NSMCE4A;POLD1;RPA2;ERCC3;FANCL;RFC3;MDC1;UBE2N;TENT4A;CHEK1;MLH1;NUCKS1;SETD2;RNASEH2A
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.742353212417854,-1.8039301563273669,0.0,0.20378287168038212,0.912,5/10,12.77%,LYN;FAS;MAPK3;MAPK1;MAP2K1
prerank,mitotic cell cycle phase transition (GO:0044772),0.751766409123893,1.8023781123855824,0.0,0.06838260009342091,0.99,70/204,10.31%,CCNF;NEK2;MELK;CCNB1;CDKN3;CDK1;POLE;PLK1;CCNE2;MASTL;BORA;UBE2C;CEP192;CCNB2;CEP152;DBF4;CDK5RAP2;CKAP5;WEE1;E2F1;HAUS8;PLK4;SPDYA;CEP57;UBE2S;CDKN2D;ANAPC7;CDKN2C;HAUS4;HAUS6;RB1;CDK14;AURKA;ACTR1A;CEP43;E2F3;CDC27;TACC3;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;EIF4E;HAUS7;CCNA1;CCNE1;USP37;NDE1;CDC25B;CUL5;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CENPJ;CEP76;CUL3;DNM2;ALMS1;CDC25C;CUL4B;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,translesion synthesis (GO:0019985),0.8017756360346286,1.80063890728722,0.0,0.07038897740256284,0.993,14/42,6.47%,DTL;POLK;PCLAF;USP43;RFC4;POLH;RPA1;PRIMPOL;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,cell cycle G2/M phase transition (GO:0044839),0.7538078544076311,1.8001290455030043,0.0,0.0703778605359388,0.994,47/130,10.31%,NEK2;MELK;CCNB1;CDK1;PLK1;MASTL;BORA;CEP192;CCNB2;CEP152;CDK5RAP2;CKAP5;WEE1;HAUS8;PLK4;CEP57;HAUS4;HAUS6;CDK14;AURKA;ACTR1A;CEP43;AJUBA;CHEK2;PCM1;KHDRBS1;FBXL7;CCNA2;HAUS7;NDE1;CDC25B;CNTRL;FBXL8;HAUS1;CCDC57;CDK2;CENPJ;CEP76;DNM2;ALMS1;CDC25C;ODF2;SKP2;SDCCAG8;FBXL17;CDC25A;NINL
prerank,keratan sulfate catabolic process (GO:0042340),-0.7100830731454236,-1.7989666015701775,0.0029411764705882353,0.20751402542196082,0.923,8/11,16.96%,GNS;FMOD;HEXB;PRELP;HEXA;OGN;LUM;GALNS
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6870421897215433,-1.7981599080888777,0.006600660066006601,0.20167445690366204,0.924,6/12,18.02%,PTK2;LYN;MAPK3;MAPK1;BST2;IL34
prerank,positive regulation of synaptic transmission (GO:0050806),-0.42868935603095926,-1.7981598061970612,0.0,0.19447179772853126,0.924,30/72,18.61%,RIMS1;SLC8A3;GRIN2A;SHANK3;SYT1;GRIN2B;STX4;LGI1;SLC24A2;SQSTM1;EPHB2;CACNG7;NRXN1;LGMN;TSHZ3;CACNG4;RELN;CHRNA7;DTNBP1;APP;NFATC4;CACNG2;ADRA1A;DLG4;ADCY8;CACNG3;CACNG8;PRKCZ;NLGN1;STX1B
prerank,chromosome organization (GO:0051276),0.7485369604428205,1.787491161310483,0.0,0.09056071440397588,0.999,10/99,2.16%,TOP2A;NUF2;CDCA8;CENPH;NDC80;PHF19;EZH2;HMGB2;NUP155;RFWD3
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.7772779330697827,1.7846503723409315,0.0022099447513812156,0.09426449556412209,1.0,14/56,3.71%,DTL;CCNB1;CDK1;DLGAP5;CDCA5;RAD51B;ESPL1;UBE2C;FBXO5;ANAPC7;RB1;HYAL1;CDC27;TFDP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.8561362795159173,1.7841757065875177,0.0012594458438287153,0.09419114598869252,1.0,10/23,6.65%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.8764598131405552,1.7776045717138094,0.005805515239477504,0.10585849240992339,1.0,8/15,6.57%,CENPE;PLK1;UBE2C;ANAPC7;CDC6;CDC27;TACC3;TPR
prerank,regulation of sister chromatid cohesion (GO:0007063),0.8901966044792703,1.7775060322662364,0.010263929618768328,0.10490681693546088,1.0,8/12,4.39%,CDCA5;BUB1;ESPL1;DDX11;RB1;RAD21;CTCF;WAPL
prerank,cellular response to radiation (GO:0071478),0.7854498201021048,1.7765805489368858,0.0011261261261261261,0.10539946944584296,1.0,9/40,6.29%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.8965472967223868,1.7749777380029828,0.0029455081001472753,0.10767355518492468,1.0,4/12,1.04%,CCNB1;CDK1;PLK1;CCNB2
prerank,DNA double-strand break processing (GO:0000729),0.84141807284338,1.772836380739747,0.006648936170212766,0.11060607723765786,1.0,8/18,6.77%,BRCA1;BARD1;RBBP8;SMARCAD1;DNA2;BLM;MRE11;UBE2N
prerank,protein localization to centrosome (GO:0071539),0.8440685019058175,1.7706535925912388,0.006587615283267457,0.11366554719714277,1.0,8/17,7.17%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83;NUDCD3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.6367904199826886,-1.76593119923795,0.006600660066006601,0.2636901426619492,0.97,6/14,18.02%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,regulation of double-strand break repair (GO:2000779),0.7732630893338653,1.7615706578939077,0.004705882352941176,0.1321686850053423,1.0,16/39,9.19%,RAD51AP1;FIGNL1;RAD51;DDX11;TIMELESS;DEK;RTEL1;RPA2;SLF1;SPIDR;PML;CHEK1;SETD2;UBR5;MRNIP;MGMT
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.834235292942848,1.7599131608903291,0.018156424581005588,0.13450617122960834,1.0,6/16,8.37%,POLQ;PARPBP;RMI2;KLHL15;RIF1;SMCHD1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.844602996143298,1.7596106971684515,0.00655307994757536,0.13390479551523704,1.0,6/21,2.18%,DTL;CCNB1;CDK1;RAD51B;ATAD5;FBXO5
prerank,nuclear membrane disassembly (GO:0051081),0.8702276319844223,1.7588278111767295,0.00141643059490085,0.13426436646802903,1.0,4/14,1.04%,CCNB1;CDK1;PLK1;CCNB2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.5568708064312555,-1.755054608859072,0.004651162790697674,0.28303176622275295,0.98,12/23,29.47%,GPX4;PTGS2;ASAH2;GSTM1;EPHX2;ELOVL6;ACOT7;HPGD;FADS1;GSTM2;ACSBG1;ALOX12
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6988550726336384,-1.753818294978786,0.005970149253731343,0.2770066678951692,0.981,7/10,25.25%,WDFY1;IFI35;LBP;PTPN22;NR1H3;TIRAP;NINJ1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.7531496161500728,1.7538089461487012,0.0,0.14453270031564597,1.0,20/63,9.32%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;RFWD3;AURKA;TFDP1;CNOT1;CHEK2;MDM4;PRKDC;CNOT6L;RPA2;PML;CDK2;CNOT6;CDC25C;PLAGL1
prerank,negative regulation of DNA recombination (GO:0045910),0.7547921167728117,1.753458448356056,0.01020408163265306,0.14395578799096606,1.0,13/43,8.37%,POLQ;PARPBP;RMI2;ATRX;ZRANB3;TERF1;RTEL1;MSH3;BLM;KLHL15;RIF1;POLR2A;SMCHD1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.7903880781742805,1.748930848606376,0.002364066193853428,0.15324222053392692,1.0,14/36,7.16%,BRIP1;CLSPN;E2F1;TIPIN;CDC45;TIMELESS;CDC6;CHEK2;INTS7;RAD1;DNA2;MAP3K20;CHEK1;PRPF19
prerank,establishment of spindle orientation (GO:0051294),0.8214990838893181,1.7476542560236366,0.003663003663003663,0.15484408143035241,1.0,12/28,9.48%,NDC80;CENPA;PLK1;SPDL1;SAPCD2;CDK5RAP2;GPSM2;NUMA1;ZW10;NDE1;LLGL2;MAP4
prerank,cellular potassium ion homeostasis (GO:0030007),-0.664164226177557,-1.7450905443878715,0.0034602076124567475,0.2916616568679558,0.987,6/13,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,intracellular protein transmembrane transport (GO:0065002),-0.46841354412258557,-1.7440627312049202,0.0,0.28594854555813654,0.988,32/42,38.87%,PEX1;DNAJC19;AKT2;HSPD1;AIFM1;HSPA5;PEX5;TIMM44;PEX6;TOMM70;SEC61B;SEC62;DNAJC15;PAM16;TIMM17A;PEX26;TIMM17B;SEC63;CHCHD4;SEC61A2;C2CD5;PEX10;ROMO1;GRPEL1;ZFAND2B;SEC61A1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.8195733177417418,1.7403037229249658,0.007594936708860759,0.17252891515798327,1.0,10/24,6.47%,POLK;POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.8435722034257624,1.7402234672114962,0.01856763925729443,0.1710863925028655,1.0,8/16,6.00%,RAD51;MCM6;MCM7;MCM2;RPA1;BLM;RECQL;MCM4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.7542730614790598,1.740029449312273,0.0,0.1700225333938769,1.0,16/54,9.32%,E2F7;CCNB1;E2F8;CDK1;GTSE1;E2F1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;CDC25C;PLAGL1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.7402962805367044,1.7393089699613562,0.0,0.17008500560082304,1.0,37/83,14.13%,CDKN3;RRM2;POLE;CCNE2;DBF4;POLA1;ORC1;E2F1;TYMS;SPDYA;CDC45;CDKN2D;FBXO5;CDKN2C;RB1;CDK14;CDC6;E2F3;TFDP1;KHDRBS1;EIF4E;CCNA1;CCNE1;USP37;CUL5;CDK2;CUL3;KLF11;CUL4B;CDC25A;CRLF3;PCNA;NASP;BRD4;DHFR;PLK2;CDKN1B
prerank,base-excision repair (GO:0006284),0.7663579293112532,1.7392385605279934,0.0067039106145251395,0.16873408975138168,1.0,13/48,6.47%,NEIL3;POLQ;POLE;RFC4;RPA1;APEX2;POLD3;DNA2;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.8514406181932475,1.7390316930125589,0.008264462809917356,0.1677722856379494,1.0,5/18,2.18%,DTL;CCNB1;CDK1;RAD51B;FBXO5
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.7871582257654417,1.7363481552936273,0.004739336492890996,0.17334228691709425,1.0,6/33,4.05%,KIF14;EZH2;FAM83D;E2F1;ATP2B4;DDRGK1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.7731679634302882,1.732276100693334,0.007050528789659225,0.18260891583262565,1.0,8/34,3.64%,NUSAP1;DLGAP5;ESPL1;ANAPC7;RB1;AURKA;PHIP;CDC27
prerank,protein localization to microtubule organizing center (GO:1905508),0.8510884363722618,1.7318473530829661,0.016506189821182942,0.18218857268849675,1.0,7/15,6.84%,STIL;SPAG5;CEP192;PCM1;CCDC14;C2CD3;CEP83
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5391282784468008,-1.7311775891604342,0.016666666666666666,0.3112574275958841,0.992,14/22,20.99%,AEBP1;APOE;CAMSAP2;MAP1B;PRUNE1;MAP1A;CHRNA7;ABL1;CAMSAP1;GPX1;PIK3CA;ARL2;PARK7;GBA2
prerank,response to ionizing radiation (GO:0010212),0.7405509985955483,1.7282226861770553,0.0010449320794148381,0.1906351034873699,1.0,16/70,6.29%,BRCA1;ECT2;TICRR;RAD51AP1;FIGNL1;FANCD2;RAD51;RFWD3;RNF168;PAXIP1;TOPBP1;INTS7;RAD1;BLM;NET1;SPIDR
prerank,regulation of chromosome organization (GO:0033044),0.8007909317726288,1.727097397265443,0.02099737532808399,0.1920903890808436,1.0,11/22,11.99%,PIF1;BUB1;RMI2;RB1;HNRNPD;WAPL;MAPT;YLPM1;HDAC8;TERF2;CENPV
prerank,positive regulation of viral genome replication (GO:0045070),0.776942172082922,1.726833858702254,0.014598540145985401,0.19126078356886442,1.0,1/29,0.01%,TOP2A
prerank,proton transmembrane transport (GO:1902600),-0.4852781209394942,-1.7249082748945348,0.015625,0.31979806737580696,0.995,10/36,15.03%,ATP6V0D1;ATP6V0A4;ATP1A1;ATP1A3;ATP5PO;ATP5MF;ATP6V0C;ATP1A2;ATP6V1H;ATP5F1B
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.7509813257501127,1.7236507995152908,0.001098901098901099,0.1979731341556679,1.0,12/50,6.37%,CCNF;CCNB1;CDKN3;CCNE2;CCNB2;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.9033732769279824,1.7220775812745137,0.0109375,0.2008368825208114,1.0,2/10,0.98%,BRCA1;ATRX
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.8543624480784673,1.721850976822369,0.01456953642384106,0.19983118203497782,1.0,6/15,6.74%,EME1;FANCD2;TIPIN;CHEK2;MRE11;MDC1
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.5511705283379646,-1.7197311770064454,0.008733624454148471,0.32566796177553947,0.996,7/21,18.02%,PTK2;MTUS1;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.6120526164561266,-1.7180042497942025,0.010169491525423728,0.32258002811863384,0.996,3/15,6.91%,PLTP;APOE;ABCA5
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.7424406228645157,1.7176924763301664,0.004343105320304018,0.20991886033250992,1.0,20/58,10.39%,BRCA1;POLQ;BARD1;POLA1;NSD2;HMGB2;RNF168;PAXIP1;SMC5;ERCC4;PRKDC;MRE11;MDC1;UBE2N;PRPF19;RIF1;UIMC1;PSMD14;HMGB1;HERC2
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.890761371437314,1.7163143482665573,0.01870503597122302,0.21205887895289127,1.0,6/10,7.36%,E2F7;E2F8;ATRX;DBF4;WIZ;STOML2
prerank,DNA conformation change (GO:0071103),0.8390503672832945,1.7158327655360808,0.02029769959404601,0.21161124885847493,1.0,4/17,6.08%,TOP2A;HMGB2;HAT1;ERCC3
prerank,homologous chromosome segregation (GO:0045143),0.8204962857031581,1.714767195583506,0.020356234096692113,0.2129700789218511,1.0,2/20,0.88%,SGO1;FANCD2
prerank,dopamine metabolic process (GO:0042417),-0.5798045254410491,-1.7139617728314618,0.004201680672268907,0.3255800106442642,0.997,9/18,23.84%,PRKN;TGFB2;MAOA;MAOB;MOXD1;GCH1;ATP7A;DRD2;COMT
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3987054162127127,-1.7138236602750878,0.0,0.31749623853452386,0.997,26/63,19.27%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;SLC25A3;GABRA5;GABRB2;SLC5A6;SLC5A5;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;SLC1A1;SLC12A2;SLC25A11;LRRC8A;SLC26A2
prerank,negative regulation of secretion by cell (GO:1903531),-0.4846170580517461,-1.7134311995733635,0.015748031496062992,0.3106330928174516,0.997,19/38,30.81%,GRM7;APOE;STXBP6;IL1RAPL1;SERGEF;CYP51A1;TNFRSF1B;SYT11;RHBDF1;SLC30A1;VAMP8;VAMP3;RHBDF2;DRD2;DPH3;TNFRSF1A;RSAD2;CHGA;HTR1B
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.8341723671955583,1.7127677311670855,0.014608233731739707,0.21714309030963316,1.0,11/18,11.29%,POLE;POLA1;RFC4;MCM7;GINS3;POLD3;MCM3;MCM4;RFC3;GINS1;PCNA
prerank,double-strand break repair via break-induced replication (GO:0000727),0.8754194469700712,1.7107954643699752,0.014367816091954023,0.2210596791715084,1.0,7/12,6.00%,MCM5;CDC45;MCM6;MCM7;MCM2;MCM3;MCM4
prerank,protein localization to chromosome (GO:0034502),0.7723235624192526,1.708408266024057,0.011641443538998836,0.22603369700706422,1.0,12/34,6.03%,CENPA;PLK1;ATRX;MCM8;HASPIN;RB1;RAD21;CTCF;RPA1;WAPL;RPA2;SLF1
prerank,cellular response to nitrogen compound (GO:1901699),0.8155158832050307,1.7062812273622838,0.021220159151193633,0.23048455888809916,1.0,9/20,8.98%,ATRX;DDX11;ATP2B4;TIMELESS;ROCK2;BLM;SPIDR;FMR1;RIOK3
prerank,male meiosis I (GO:0007141),0.8321398108913797,1.7057409157955177,0.018439716312056736,0.23030565348310203,1.0,3/16,6.02%,MEIOC;MYBL1;CCNA1
prerank,regulation of mitotic spindle organization (GO:0060236),0.7702584642014288,1.7055475637705322,0.00580046403712297,0.2290870688137402,1.0,12/35,10.89%,TPX2;PLK1;BORA;PSRC1;GPSM2;CEP97;TACC3;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,positive regulation of macrophage migration (GO:1905523),-0.5542215834543293,-1.7053719122197124,0.011627906976744186,0.3236405502971738,0.998,8/19,22.05%,PTK2;MAPK3;MAPK1;THBS1;CX3CL1;CMKLR1;IL34;P2RX4
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.8016315104395454,1.7049682765094507,0.012547051442910916,0.2289404859599703,1.0,5/23,1.42%,ZWILCH;BUB1B;BUB1;AURKB;WEE1
prerank,intracellular pH reduction (GO:0051452),-0.4924052671430946,-1.7035999037148042,0.012738853503184714,0.3207229542926135,0.998,18/33,32.34%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;GPR89B;GPR89A;ATP6V0C;ATP6V1H;TMEM9;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.7114048876508436,1.7030342460636987,0.0,0.23312177241346327,1.0,94/336,11.14%,TOP2A;DTL;BRCA1;EXO1;TICRR;RAD51AP1;POLK;POLQ;CDK1;FANCA;RAD51B;BARD1;UBE2T;MASTL;RMI2;RAD51;RAD54L;POLA1;WDHD1;RAD18;WDR76;PCLAF;DDX11;E2F1;CBX5;ZRANB3;MCM8;SPDYA;RFC4;PDS5A;SMC1A;RFWD3;RNF168;TIMELESS;XRCC2;SMC6;FAM111A;MCM10;BAZ1B;SETX;MCM7;PDS5B;RPAIN;TOPBP1;RTEL1;EID3;POLH;RBBP8;RPA1;SMC5;CHD1L;MSH3;CHEK2;RAD1;ERCC4;RFC2;PRKDC;BLM;MRE11;RECQL;NSMCE4A;POLD1;SLF1;ERCC3;NRDE2;SPIDR;FANCL;RFC3;PML;FMR1;ETAA1;CHEK1;RIF1;NIPBL;PHF1;UBR5;TRIM28;MRNIP;HTRA2;RAD51C;USP16;YAP1;MGMT;CUL4B;IKBKG;CBX1;MBD4;SUSD6;HERC2;MMS19;FBXO45;BOK;USP28;XPA
prerank,regulation of cell division (GO:0051302),0.7378827773290405,1.702275704581923,0.0010582010582010583,0.23371124631526388,1.0,15/72,7.85%,PRC1;KIF18B;PLK1;KIF20A;AURKB;PLK4;AURKA;CSPP1;FGFR2;BLM;AHCTF1;PRPF40A;SFRP2;SETD2;SH3GLB1
prerank,response to ethanol (GO:0045471),-0.6215488220328207,-1.6994537115358364,0.010714285714285714,0.32621536260388195,0.999,5/14,4.69%,GRIN3A;GRIN2A;GLRA1;GRIN2B;GOT2
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.8261418832105479,1.699348162116649,0.0286493860845839,0.24066813538150056,1.0,5/15,5.20%,EZH2;FAM83D;ATAD5;DDRGK1;DYRK3
prerank,response to hydroxyurea (GO:0072710),0.8520606506165487,1.6954696471123856,0.023148148148148147,0.25081498878159997,1.0,6/11,6.93%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,neuron maturation (GO:0042551),-0.5788993622257264,-1.6938266556465318,0.007782101167315175,0.335481708914382,1.0,13/18,22.34%,B4GALT5;B4GALT6;APP;SCARF1;CX3CL1;FARP2;ADGRB3;EPHA8;MTCH1;PICK1;LGI4;CLN5;ANKS1A
prerank,mitotic recombination (GO:0006312),0.8448384477204844,1.6925663037876568,0.01977401129943503,0.25807240818509597,1.0,7/15,4.06%,RAD54B;RAD51;GEN1;DMC1;SMC6;SMC5;MSH3
prerank,cellular response to hydroxyurea (GO:0072711),0.8676858990427609,1.6924687515463717,0.0192,0.2564842122932203,1.0,6/10,6.93%,ATRX;DDX11;TIMELESS;BLM;SPIDR;FMR1
prerank,establishment of spindle localization (GO:0051293),0.849748260627231,1.6917757110544414,0.01455604075691412,0.256829145112644,1.0,2/14,0.75%,NUSAP1;ESPL1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.5076017126928203,-1.6915513786031928,0.006666666666666667,0.3350164131632613,1.0,14/32,18.41%,LRRC7;MEF2C;GRIN2A;GRIN2B;EPHB2;NEFL;RELN;OPRM1;GRIA1;APP;DLG4;GRIN1;GRIA2;NLGN1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.6200986578261974,-1.6915025027189965,0.014336917562724014,0.32777081323349616,1.0,8/14,28.44%,ECE1;NOS3;ACE;ENPEP;AGTR1;EDN1;EDN3;ACE2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6444962165517294,-1.690693450953013,0.014388489208633094,0.3231740526458525,1.0,5/13,13.14%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.7153713020829529,1.6900568719072853,0.001037344398340249,0.26073000945630426,1.0,15/78,6.37%,CCNF;CCNB1;CDKN3;PLK1;CCNE2;CCNB2;SPDYA;PSRC1;CDKN2D;CDKN2C;CDC6;CCNA2;BLM;CCNA1;CCNE1
prerank,negative regulation of double-strand break repair (GO:2000780),0.7592838378459925,1.6883621133782847,0.01734820322180917,0.2640616496917261,1.0,8/30,8.37%,POLQ;PARPBP;RMI2;AUNIP;KLHL15;RIF1;UBR5;SMCHD1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5671690937503376,-1.6879770835544248,0.004032258064516129,0.3242117423305675,1.0,12/19,28.28%,MAPK8;SLCO1C1;MAP2K5;KLF4;CHRNA7;APP;KLF2;WFS1;PAX8;MAPK7;TMEM106A;EGF
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.7821040124773152,1.6877264594936334,0.02064516129032258,0.2640817843852419,1.0,10/24,9.69%,PHF19;EZH2;PPM1D;SUZ12;MPHOSPH8;EED;RBBP4;RBBP7;PHF1;EPC1
prerank,regulation of centrosome duplication (GO:0010824),0.7606263077871754,1.6844131524578112,0.016908212560386472,0.2730514716793837,1.0,8/30,9.17%,CCNF;STIL;CEP295;GEN1;CENPJ;CEP76;ALMS1;SPICE1
prerank,chloride transport (GO:0006821),-0.3902057924987802,-1.6817925978219879,0.025,0.33429224970290455,1.0,26/74,19.08%,GABRB1;ANO3;GABRB3;GABRA2;SLC6A1;GLRB;GLRA1;ANO6;ANO1;GABRA3;GLRA3;ANO10;GABRA5;CLIC5;GABRB2;ANO4;GABRG2;SLC12A9;GABRG1;SLC4A8;TTYH3;SLC1A1;SLC12A2;CLCN2;FXYD1;LRRC8A
prerank,regulation of DNA metabolic process (GO:0051052),0.7318508917871449,1.680686751203109,0.012485811577752554,0.28383148820565735,1.0,17/44,13.89%,TICRR;PIF1;KPNA2;USP1;POLH;HNRNPD;MPHOSPH8;SMARCAD1;YLPM1;GRHL2;UBE2N;NUCKS1;HDAC8;TERF2;STOX1;WDR70;SMG6
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5440057470947703,-1.6802451262603009,0.009615384615384616,0.3324878432679919,1.0,8/20,12.67%,ANO6;PDCD4;PLCG1;SFRP4;GSN;THBS1;PIAS4;RGCC
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.8643412799779556,1.6794688652875098,0.020802377414561663,0.28571658582309845,1.0,6/11,5.21%,ZRANB3;TIPIN;FBXO5;TIMELESS;MSH3;BLM
prerank,cell cycle checkpoint signaling (GO:0000075),0.8529254151070641,1.6769208795556436,0.028089887640449437,0.2923227352455968,1.0,4/12,1.42%,ZWILCH;BUB1B;BUB1;WEE1
prerank,negative regulation of cell division (GO:0051782),0.8777282143134709,1.6766989510244426,0.010174418604651164,0.2911921201920151,1.0,4/11,5.21%,E2F7;E2F8;AURKB;BLM
prerank,error-prone translesion synthesis (GO:0042276),0.797980316334503,1.675455427333147,0.022106631989596878,0.2935957647136216,1.0,9/21,6.47%,POLK;RFC4;POLH;RPA1;PRIMPOL;RFC2;RPA2;RFC1;RFC3
prerank,negative regulation of histone methylation (GO:0031061),0.8614571632220113,1.6742236742900416,0.026438569206842923,0.2957826810214862,1.0,3/10,7.89%,BRCA1;BCOR;PHF1
prerank,negative regulation of JNK cascade (GO:0046329),-0.48222249825484026,-1.6693823333245323,0.015151515151515152,0.3572778939899266,1.0,12/31,14.05%,MECOM;PRKN;ZMYND11;PDCD4;DUSP3;CYLD;DNAJA1;DACT1;PTPN22;HDAC3;PINK1;SH3RF2
prerank,negative regulation of histone acetylation (GO:0035067),0.8467428345126357,1.668245703633562,0.020802377414561663,0.31406730376194697,1.0,2/11,5.16%,BRCA1;CTBP1
prerank,cellular response to ionizing radiation (GO:0071479),0.7383476413527698,1.6674878526882448,0.013363028953229399,0.3145791771221891,1.0,12/47,7.58%,ECT2;RAD51AP1;FIGNL1;RAD51;INTS7;RAD1;BLM;NET1;SPIDR;MAP3K20;NUCKS1;NIPBL
prerank,regulation of DNA repair (GO:0006282),0.7412860619143756,1.6674204203041645,0.00909090909090909,0.31274212495512976,1.0,17/44,12.36%,BRCA1;RNF168;DEK;EYA4;USP1;POLH;DHX9;PML;UBE2N;UIMC1;UBR5;TRIM28;SMCHD1;AXIN2;EYA2;PCNA;TRIP12
prerank,maintenance of blood-brain barrier (GO:0035633),-0.48561573570418937,-1.6659657131663193,0.01282051282051282,0.3614472551750783,1.0,16/30,23.34%,OCLN;JAM2;PECAM1;ACTB;CLDN5;ESAM;F11R;CDH5;TJP1;CLDN12;SLC1A1;SLC12A2;GJB6;LAMA2;CLDN1;MFSD2A
prerank,DNA-dependent DNA replication (GO:0006261),0.7025052104990726,1.6646031834887924,0.001017293997965412,0.3199589407446041,1.0,42/128,8.70%,POLE;RAD51;DBF4;MCM5;POLA1;WDHD1;ORC1;PRIM2;POLA2;MCM8;CDC45;RFC4;PRIM1;MCM10;MCM6;MCM7;MCM2;RPAIN;MGME1;TOPBP1;GINS3;CDC6;PSMC2;RPA1;PSMD5;PRIMPOL;POLD3;DNA2;RFC2;BLM;RECQL;MCM3;POLD1;RPA2;MCM4;RFC1;RFC3;ORC2;ORC3;CDK2;PSMB1;PSMD14
prerank,placenta development (GO:0001890),0.8580214854119355,1.6643772453964194,0.022988505747126436,0.3185482028293418,1.0,2/12,0.44%,E2F7;E2F8
prerank,nucleosome assembly (GO:0006334),0.75228066576656,1.6621191898128727,0.031652989449003514,0.32458728046511354,1.0,9/31,7.08%,ASF1B;CHAF1B;ATRX;HMGB2;NAP1L1;ANP32B;HAT1;RBBP4;UBN1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.7362309199595426,1.6616907161734453,0.01583710407239819,0.3239912031389362,1.0,14/40,8.69%,ANKLE1;WDR76;KMT5A;RFWD3;FBXO5;USP1;POLH;MAPT;NSMCE4A;RPA2;UBE2N;FMR1;ETAA1;BCLAF1
prerank,microtubule nucleation (GO:0007020),0.7934765008758382,1.6607815354450393,0.02607561929595828,0.3250765910159737,1.0,7/20,11.54%,TPX2;TUBGCP5;NDE1;CCDC57;CENPJ;TPPP;AKAP9
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.7033337244523755,1.6584231179878113,0.008298755186721992,0.33147448088679193,1.0,22/84,9.60%,CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;PSMC2;CDC27;PSMD5;BUB3;CDK2;PSMB1;CUL3;PSMD14;PSMD1;SKP2
prerank,DNA geometric change (GO:0032392),0.774196997374448,1.658309290885907,0.026151930261519303,0.3297844701627415,1.0,13/24,11.46%,PIF1;DDX11;HMGB2;ZRANB3;RTEL1;DNA2;DHX9;BLM;MRE11;RECQL;HMGB3;HMGB1;ANXA1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.8096581616840484,1.658032413324038,0.02924791086350975,0.32846391423368926,1.0,6/14,10.61%,RAD51AP1;TIMELESS;ARID2;FUS;MRNIP;MMS19
prerank,negative regulation of protein secretion (GO:0050709),-0.4584992778449452,-1.6569686585551182,0.021897810218978103,0.3815123784864945,1.0,15/38,23.05%,PRKN;APOE;KCNB1;SERGEF;NR1H3;OPRM1;IRS1;CYP51A1;RHBDF1;RAB11FIP1;MIDN;ADRA2A;RHBDF2;DRD2;DPH3
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.80749498415263,1.6564247417782918,0.028532608695652172,0.3318182317129736,1.0,4/16,4.18%,BRCA1;PAXIP1;AUTS2;BCOR
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.787174838266864,1.654628686693709,0.029449423815621,0.33648070409903164,1.0,5/21,2.18%,PLK1;CDC20;UBE2C;UBE2S;FBXO5
prerank,DNA damage checkpoint signaling (GO:0000077),0.7634375368708133,1.6544900564269003,0.024844720496894408,0.33495964195969463,1.0,9/28,7.16%,BRIP1;CLSPN;E2F1;CHEK2;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.7377016234026672,1.6531955235914508,0.02539298669891173,0.33740633240545814,1.0,13/29,15.37%,MEIOC;E2F1;THRAP3;EIF4ENIF1;FMR1;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15;PABPC1;GDNF
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.8446911627866676,1.6509148122531714,0.03235294117647059,0.3436524626589483,1.0,4/12,2.03%,PLK1;CDC20;UBE2C;UBE2S
prerank,protein monoubiquitination (GO:0006513),0.7413700729843561,1.6508796434443982,0.02662037037037037,0.3416348242857494,1.0,11/36,9.70%,DTL;UHRF1;UBE2T;RAD18;FANCL;RNF40;CUL3;UBE2R2;KLHL22;LEO1;OBI1
prerank,positive regulation of histone methylation (GO:0031062),0.7798651912833211,1.6495501416352172,0.022813688212927757,0.3442857989321998,1.0,7/24,9.83%,BRCA1;PHF19;PAXIP1;AUTS2;RIF1;PHF1;KMT2A
prerank,positive regulation of DNA repair (GO:0045739),0.7263733254955191,1.649424109722397,0.013651877133105802,0.34275859247003676,1.0,16/46,11.29%,BRCA1;DDX11;RNF168;TIMELESS;EYA4;DHX9;SLF1;SPIDR;UBE2N;UIMC1;TRIM28;SMCHD1;MGMT;HMGB1;EYA2;PCNA
prerank,glycerophospholipid catabolic process (GO:0046475),-0.50602935622416,-1.6491791370059699,0.015228426395939087,0.3977468455600001,1.0,10/27,16.10%,GPCPD1;PLA2G4A;ABHD12;ABHD16A;PNPLA6;PNPLA8;ENPP6;GDPD3;GDPD1;PLA2G7
prerank,positive regulation of telomere capping (GO:1904355),0.791097425271844,1.6485267440218632,0.04281767955801105,0.3438465657600972,1.0,4/17,3.73%,NEK2;AURKB;RTEL1;HNRNPD
prerank,cell cycle G1/S phase transition (GO:0044843),0.7146231952439112,1.6483195059518179,0.00974025974025974,0.34248671538882525,1.0,21/61,10.72%,CDKN3;POLE;CCNE2;DBF4;E2F1;SPDYA;CDKN2D;CDKN2C;RB1;E2F3;KHDRBS1;CCNA2;EIF4E;CCNE1;USP37;CUL5;CDK2;CUL3;CUL4B;CDC25A;CRLF3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.7622347979607713,1.647773908864589,0.024360535931790498,0.3425184393187363,1.0,3/29,3.39%,TRIP13;FANCD2;RAD21
prerank,phagosome acidification (GO:0090383),-0.4985985921215519,-1.646085537190881,0.030303030303030304,0.4003592149885559,1.0,14/26,32.34%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;RAB38;ATP6V1G2;ATP6V1B2;RAB39A;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6420723557506294,-1.6444089939333184,0.018518518518518517,0.39799807467579934,1.0,5/11,18.02%,PRKN;ADCK1;OMA1;BNIP3;VAT1
prerank,hyaluronan metabolic process (GO:0030212),0.777246364192995,1.6428850790428724,0.03443877551020408,0.3575056607178054,1.0,4/23,3.28%,HMMR;HAS3;SPAM1;HYAL1
prerank,smooth muscle tissue development (GO:0048745),-0.6758545162060383,-1.6423678051013422,0.01791044776119403,0.3984337020137689,1.0,6/10,15.54%,PROX1;MYLK;NF1;PTCH1;ENG;STRA6
prerank,heme catabolic process (GO:0042167),-0.6044581794815183,-1.6419958226334284,0.03663003663003663,0.3859179791895432,1.0,3/14,8.13%,SLCO2B1;HMOX2;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.6044581794815183,-1.6419958226334284,0.03663003663003663,0.3859179791895432,1.0,3/14,8.13%,SLCO2B1;HMOX2;ABCG2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.7071874938227874,1.6419797050956761,0.005279831045406547,0.3586891729784314,1.0,19/72,9.32%,E2F7;CCNB1;E2F8;CDK1;GTSE1;ATRX;E2F1;PAXIP1;AURKA;TFDP1;CNOT1;CHEK2;MDM4;CNOT6L;PML;CNOT6;ING4;CDC25C;PLAGL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.8296249550421387,1.6419336017048913,0.023121387283236993,0.35269131383488744,1.0,5/12,3.64%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.8296249550421387,1.6419336017048913,0.023121387283236993,0.35269131383488744,1.0,5/12,3.64%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.8296249550421387,1.6419336017048913,0.023121387283236993,0.35269131383488744,1.0,5/12,3.64%,DLGAP5;ESPL1;ANAPC7;RB1;CDC27
prerank,signal transduction in response to DNA damage (GO:0042770),0.7239574120252701,1.6407020387115745,0.015712682379349047,0.35497390937563206,1.0,13/49,7.16%,E2F7;BRIP1;CLSPN;ATRX;E2F1;PAXIP1;CHEK2;MDM4;INTS7;RAD1;MAP3K20;CHEK1;PRPF19
prerank,hyaluronan catabolic process (GO:0030214),0.7993549831887306,1.6397992235109786,0.04423592493297587,0.3560962766083473,1.0,3/18,3.28%,HMMR;SPAM1;HYAL1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.5849227180968226,-1.6396108750489946,0.02734375,0.38756444992182437,1.0,6/15,8.46%,ACVR1;SMAD7;ACVR2A;FKBP1A;ACVR2B;DACT1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.4977201435886363,-1.6362762755549256,0.02702702702702703,0.3913547688061143,1.0,17/29,30.36%,ELOVL7;ACLY;HACD2;ACSL4;HACD1;ACSL5;ACSL6;ELOVL6;PPT1;CBR4;ACSL1;SCD;ELOVL1;FASN;ACSBG1;TECR;HSD17B8
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.5744920999380988,-1.6348900163614362,0.03816793893129771,0.3894505274811186,1.0,8/16,29.55%,BMPR2;PLCB3;ACE;PRCP;GSK3A;DRD2;ADM;GPR37L1
prerank,mitotic DNA replication (GO:1902969),0.8637156068586946,1.6347412015576381,0.025036818851251842,0.3726321788603211,1.0,8/10,10.52%,POLA1;CDC45;MCM6;MCM2;GINS3;MCM3;MCM4;GINS1
prerank,catecholamine metabolic process (GO:0006584),-0.5951305625709248,-1.6346605716504488,0.03296703296703297,0.3838417118746782,1.0,6/14,23.84%,PRKN;RNF180;DDC;ATP7A;DRD2;COMT
prerank,microtubule polymerization (GO:0046785),0.7525096640472111,1.633198649482514,0.03402187120291616,0.37599766934186657,1.0,12/29,15.27%,TPX2;CKAP5;TUBGCP5;MAPT;NDE1;CCDC57;CENPJ;TPPP;AKAP9;TUBGCP3;PIN1;HDGFL3
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.7206702624112356,1.63268202560991,0.0265282583621684,0.37560733549510417,1.0,15/37,11.29%,POLK;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA
prerank,regulation of catecholamine secretion (GO:0050433),-0.49100239084053554,-1.6326643776456364,0.012987012987012988,0.38367204696276397,1.0,12/29,22.18%,PRKN;KCNB1;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,DNA strand elongation (GO:0022616),0.7967845923166529,1.632409332189687,0.03485254691689008,0.3745547821592512,1.0,9/18,6.47%,POLA1;RFC4;MCM7;GINS3;POLD3;MRE11;MCM3;MCM4;RFC3
prerank,positive regulation of double-strand break repair (GO:2000781),0.7093534961346654,1.632275687033422,0.02224824355971897,0.3729644302291104,1.0,17/39,15.23%,RAD51AP1;DDX11;TIMELESS;ARID2;PRKDC;SLF1;SPIDR;RIF1;FUS;MRNIP;SMCHD1;MGMT;PARP9;MMS19;KMT5C;FOXM1;SHLD2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.8371932440036876,1.6315818281071717,0.02902757619738752,0.37353175769478375,1.0,3/12,5.21%,TICRR;TIPIN;BLM
prerank,regulation of cell cycle phase transition (GO:1901987),0.6898353951938082,1.630422218985879,0.007209062821833162,0.3755299929496947,1.0,18/91,6.71%,CCNB1;CDK1;BUB1B;PLK1;GTSE1;CDC20;UBE2C;DBF4;UBE2S;ATP2B4;FBXO5;ANAPC7;PSMC2;CDC27;PSMD5;ERCC3;BUB3;FBXW7
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.7149067241614566,1.6277042875584238,0.012074643249176729,0.38083475798151306,1.0,10/51,6.17%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,mitotic nuclear membrane organization (GO:0101024),0.7149067241614566,1.6277042875584238,0.012074643249176729,0.38083475798151306,1.0,10/51,6.17%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,negative regulation of histone modification (GO:0031057),0.8040109107092543,1.6274946758181883,0.056818181818181816,0.37938149160921786,1.0,2/14,5.16%,BRCA1;CTBP1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6013919196115296,-1.6263264222107474,0.04377104377104377,0.39601529719264544,1.0,7/13,25.58%,GLUL;GLS;NOS3;PRODH;GLUD1;NOS1;GLS2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.8431906872421111,1.6253282644667717,0.0256797583081571,0.3848706898480314,1.0,2/10,5.16%,BRCA1;CTBP1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.8584107727072923,1.625147766261346,0.0243161094224924,0.3795091513086622,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.8584107727072923,1.625147766261346,0.0243161094224924,0.3795091513086622,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,t-circle formation (GO:0090656),0.8584107727072923,1.625147766261346,0.0243161094224924,0.3795091513086622,1.0,4/10,5.21%,EXO1;TERF1;DNA2;BLM
prerank,regulation of integrin activation (GO:0033623),0.7961332397836833,1.6226265034620069,0.050546448087431695,0.38664355536785777,1.0,1/15,0.13%,KIF14
prerank,regulation of mitotic cell cycle (GO:0007346),0.6799703183561625,1.62218438496782,0.0,0.3861558503789937,1.0,38/171,10.87%,KIF20B;MKI67;NEK2;CCNB1;CDK1;DLGAP5;BUB1B;PLK1;CKS2;BORA;CDC20;UBE2C;UBE2S;FBXO5;ANAPC7;RB1;TTC28;PSMC2;CDC27;PSMD5;GBF1;OBSL1;EIF4E;ERCC3;BUB3;CDC25B;SCRIB;CCDC57;RNF40;PSMB1;BTG3;PSMD14;CDC25C;PSMD1;GAS1;HNRNPU;TAL1;PSMB9
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.827661737263926,1.6214475646097455,0.05192878338278932,0.38660597530150115,1.0,7/12,11.06%,BRCA1;RBM15;PCGF5;LRIF1;SMCHD1;HNRNPU;RBM15B
prerank,peptidyl-arginine modification (GO:0018195),-0.5607553505207643,-1.6200097297984597,0.010830324909747292,0.40933872851391523,1.0,6/15,20.20%,ART3;KRTCAP2;PRMT8;PRMT1;PARK7;PADI2
prerank,positive regulation of DNA replication (GO:0045740),0.8059302189576776,1.6193509099149936,0.039889958734525444,0.3922085539824929,1.0,6/16,5.70%,ATAD5;GLI2;STN1;DNA2;DHX9;FAF1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.7136157126734368,1.6187535439195007,0.02883506343713956,0.3923323070684897,1.0,15/39,11.29%,POLK;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA
prerank,tRNA modification (GO:0006400),-0.3934778380478583,-1.6186360967680722,0.0,0.4073338314174456,1.0,27/62,25.83%,TRMT9B;ANKRD16;DTWD2;MTO1;PUS10;AARS1;NSUN2;THUMPD3;TRMT61B;OSGEP;CDKAL1;QTRT2;TRMT1;TPRKB;TRUB1;METTL1;PUS3;THUMPD1;QTRT1;TRMT10A;LCMT2;TRMO;WDR6;DTWD1;WDR4;GTPBP3;ALKBH1
prerank,phosphatidylserine metabolic process (GO:0006658),-0.4771264819417521,-1.616266113300443,0.005813953488372093,0.4086738744007028,1.0,8/32,10.44%,PLA2G4A;PLAAT3;ABHD12;ABHD16A;PLA1A;OSBPL10;SLC27A1;SERINC1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.6029085001709058,-1.6160407453173755,0.023411371237458192,0.40329909304227873,1.0,10/13,27.33%,EDEM2;EDEM1;SAR1A;CD81;BCAP31;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.504485572868785,-1.6158880595684193,0.02262443438914027,0.3980042133057781,1.0,10/22,14.10%,CYRIB;TMSB4X;KANK3;KANK4;PFN1;SSH1;SLIT2;GSN;ARFGEF1;TMSB10
prerank,rRNA metabolic process (GO:0016072),-0.32554724884783814,-1.6157994006597065,0.0,0.3927858590663312,1.0,80/160,27.93%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RRP1B;RRP1;RPL19;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;RPL29;MDN1;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;EXOSC2;PIH1D1;EBNA1BP2;DDX54;RPL4;BYSL;DEDD2;IMP3;DDX47;BOP1;EXOSC3;NIFK;RPS25;EXOSC5;POP5;WDR18;PDCD11
prerank,RNA biosynthetic process (GO:0032774),0.7231099541133602,1.6150042877651005,0.053763440860215055,0.4035912184677159,1.0,11/31,11.88%,POLA1;PRIM2;TTF2;POLA2;PRIM1;NAT14;SETX;TAF12;POLR2A;TTF1;TAF4
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.7480747351696436,1.6131398435520596,0.05966277561608301,0.40829696749142813,1.0,8/19,9.13%,TYMS;ADK;ADA;POLD3;DCK;HPRT1;POLD1;CDA
prerank,phagosome maturation (GO:0090382),-0.4559806183408326,-1.611848658765411,0.018404907975460124,0.40100941371540183,1.0,19/35,32.34%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;RAB38;ATP6V1G2;MREG;ATP6V1B2;RAB14;RAB32;RAB39A;ATP6V1F;ATP6V0D2;RAB31;ATP6V0E1
prerank,cellular response to zinc ion (GO:0071294),-0.5817058794769345,-1.6092660081542969,0.03571428571428571,0.4030271262632297,1.0,11/15,22.05%,GLRA1;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;P2RX4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.7896985435235007,1.6089297293973346,0.04477611940298507,0.4214635889970233,1.0,1/16,0.19%,BRCA1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.7371734051728186,1.6055889293587795,0.04039167686658507,0.43158577412902377,1.0,5/28,5.53%,SKA3;SKA1;SKA2;STMN1;MAPT
prerank,regulation of DNA damage checkpoint (GO:2000001),0.8222860741256303,1.6053524579381035,0.04482225656877898,0.43039645207706334,1.0,5/10,7.13%,WDR76;RFWD3;RPA2;DDX39B;ETAA1
prerank,response to muramyl dipeptide (GO:0032495),-0.6027986478565275,-1.602453543289987,0.036585365853658534,0.4185782464520378,1.0,6/12,16.25%,TRIM41;NOD1;PTPN22;ARHGEF2;CHMP5;ERBIN
prerank,midbody abscission (GO:0061952),0.7808442980098675,1.6022479118316215,0.0445945945945946,0.4401123918082011,1.0,2/17,1.01%,CEP55;KIF20A
prerank,protein export from nucleus (GO:0006611),0.7307400094533184,1.6014720683049288,0.04625,0.4409280496289537,1.0,10/27,12.89%,ANKLE1;CCHCR1;RANBP17;XPO1;XPO4;CSE1L;TPR;SMURF1;NUP214;STRADA
prerank,actin filament polymerization (GO:0030041),0.726906480352695,1.6010511633973215,0.0364963503649635,0.44030585700665176,1.0,1/29,0.03%,DIAPH3
prerank,determination of bilateral symmetry (GO:0009855),0.7350645239103523,1.600556573153816,0.04187192118226601,0.4399194912060402,1.0,5/25,9.03%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,epithelial cell-cell adhesion (GO:0090136),0.7856268966984693,1.6003538369639552,0.06871345029239766,0.4385862099627797,1.0,3/11,4.54%,SERPINB8;PLEKHA7;KIT
prerank,positive regulation of chromosome organization (GO:2001252),0.7795362133085544,1.6002419335370035,0.06548431105047749,0.4368466639661955,1.0,6/15,6.69%,ATRX;DDX11;RTEL1;RAD21;MRE11;PML
prerank,negative regulation of viral life cycle (GO:1903901),-0.559486503833085,-1.5989681727204286,0.024390243902439025,0.4238372052245824,1.0,7/15,16.82%,MID2;LY6E;SNX3;IFITM3;GSN;BST2;IFITM2
prerank,glutamate receptor signaling pathway (GO:0007215),-0.4448758772182165,-1.5985176065489124,0.02,0.4194138161571186,1.0,15/37,14.10%,GRM7;GRIK1;GRIN3A;GRIN2A;GRM3;GRID2;KCNB1;CPEB4;GRIN2B;HOMER1;GRIK4;APP;GRM5;GRM1;GRIN1
prerank,nuclear membrane reassembly (GO:0031468),0.7018963444004417,1.596746982746997,0.012021857923497269,0.4472166872029282,1.0,10/54,6.17%,CCNB1;CDK1;CCNB2;NDC1;NUP155;LBR;NUP205;NUP160;NUP85;AHCTF1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.6703756146773147,1.5963167073705737,0.006166495375128468,0.44676511305423733,1.0,18/104,7.13%,CCNF;CCNB1;CDKN3;EZH2;INCENP;CCNE2;CCNB2;CDKN2D;CDKN2C;KSR1;RB1;RHOA;CDC6;CCNA2;BLM;CCNA1;CCNE1;ETAA1
prerank,transport across blood-brain barrier (GO:0150104),-0.3597964422002114,-1.5960414664696847,0.0,0.42162342923513524,1.0,29/83,16.25%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;LRP1;SLC7A5;SLC27A1;ABCC4;ABCG2;SLC5A6;SLC15A2;SLC5A5;SLC22A5;SLC16A1;ATP1A2;ABCC5;SLC2A3;SLC4A8;SLC1A1;SLC12A2
prerank,ERAD pathway (GO:0036503),-0.3803843590091284,-1.593007427667143,0.0,0.42564945471494053,1.0,39/83,24.45%,PRKN;UBE4A;ATXN3;HSP90B1;ERLEC1;OS9;TRIM25;ECPAS;RNF103;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;RHBDD2;SGTA;STUB1;YOD1;RCN3;SGTB;DNAJC18;POMT2;UBXN6;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;SYVN1;UBE2G2;UBXN8;GET4;SEL1L;UBE4B;TOR1A;FAM8A1;WFS1;RNF103-CHMP3
prerank,positive regulation of intracellular transport (GO:0032388),0.6991102230995186,1.5908488991542806,0.02579132473622509,0.4652090378976343,1.0,7/38,7.67%,KIF20B;SPAG5;NEDD4;PCM1;NUMA1;TPR;RAB29
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8167895623133244,1.5900346222840651,0.04838709677419355,0.46618812469176274,1.0,4/12,5.45%,EZH2;CYP26B1;CNOT1;ASXL1
prerank,regulation of multicellular organismal development (GO:2000026),0.7306366617368354,1.5887269400967658,0.0345679012345679,0.46877942856611804,1.0,5/25,8.94%,CDK1;RACGAP1;HPSE;NIPBL;CCSAP
prerank,positive regulation of DNA metabolic process (GO:0051054),0.6863661682130622,1.5858133486192358,0.017112299465240642,0.477716418729564,1.0,17/61,11.29%,BRCA1;RAD51;ATRX;RNF168;EYA4;RTEL1;FGFR4;DHX9;MRE11;PML;UBE2N;UIMC1;TRIM28;SMCHD1;HMGB1;EYA2;PCNA
prerank,receptor-mediated endocytosis (GO:0006898),-0.30976316837550016,-1.585397792533285,0.0,0.4437592300424796,1.0,45/132,19.62%,DNM3;SGIP1;CALCRL;LRP1B;MICALL1;CAV1;APOE;FNBP1L;TMEM108;INSR;HSP90B1;AP2A2;LRP1;ACKR3;RAMP1;DNM1;GPR107;DAB2;RAMP2;HSPH1;CD81;VLDLR;CAV2;SCARF1;AP2M1;PDLIM7;GRB2;ARHGAP27;IGF2R;CTSL;LDLRAP1;AP2S1;AP1S1;AP2A1;FCHO2;LRP6;CLTB;CUBN;LMBRD1;STAB1;PPT1;SORL1;GRK4;LRP3;SPARC
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.8077786863278597,1.5826616126903195,0.06086956521739131,0.4874888745483157,1.0,1/12,0.19%,BRCA1
prerank,mitotic cytokinetic process (GO:1902410),0.7604106906692447,1.582568505513866,0.05053191489361702,0.48557507157526963,1.0,3/20,3.25%,CEP55;KIF20A;RHOA
prerank,regulation of platelet activation (GO:0010543),-0.5079855783024971,-1.5820746043544993,0.03375527426160337,0.44938454622837304,1.0,8/21,8.02%,PLA2G4A;APOE;NOS3;TLR4;PLEK;THBD;LYN;PRKCQ
prerank,histone monoubiquitination (GO:0010390),0.7315122185919104,1.581806317178377,0.05583126550868486,0.48654049685221973,1.0,8/24,9.30%,UHRF1;RNF168;TRIM37;BCOR;RNF40;KDM2B;LEO1;CUL4B
prerank,regulation of telomere maintenance (GO:0032204),0.7133652022401858,1.5806523320856185,0.05289052890528905,0.4885365852727179,1.0,15/26,18.74%,PIF1;ATRX;RTEL1;HNRNPD;ERCC4;MRE11;YLPM1;PML;HDAC8;TERF2;SMG6;GNL3;TINF2;TERF2IP;RAD50
prerank,gas transport (GO:0015669),0.823230729935005,1.580484934984766,0.06875,0.48698545339135635,1.0,2/10,1.82%,RHAG;AQP1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.77037463081813,1.5802686701682647,0.06586021505376344,0.4856635561080069,1.0,2/17,1.68%,NEIL3;TERF1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.7429583893205293,1.5799711526871882,0.05821474773609314,0.4845114276480051,1.0,2/21,4.77%,TPX2;SPEF1
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.8154264211446596,1.5793113955027782,0.05370101596516691,0.48483167252343135,1.0,5/11,7.08%,ASF1B;ATRX;HAT1;RBBP4;UBN1
prerank,regulation of protein export from nucleus (GO:0046825),0.726602547565098,1.5772135627097579,0.07345360824742268,0.49049032063332343,1.0,9/23,9.92%,BARD1;GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD;RANGAP1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7249968260719427,1.5771690419429132,0.060759493670886074,0.48845385274761693,1.0,7/24,14.42%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,vascular transport (GO:0010232),-0.3655167965839859,-1.5762780954907372,0.0,0.4620645306268141,1.0,29/81,16.25%,SLC6A6;SLC16A12;SLC1A2;ATP8A1;SLC6A1;SLC13A3;SLC2A1;SLC44A1;SLC7A2;INSR;SLCO1C1;SLC22A8;SLCO2B1;LRP1;SLC7A5;SLC27A1;ABCC4;ABCG2;SLC5A6;SLC15A2;SLC5A5;SLC22A5;SLC16A1;ATP1A2;ABCC5;SLC2A3;SLC4A8;SLC1A1;SLC12A2
prerank,protein heterooligomerization (GO:0051291),-0.5435228198850127,-1.5754965983839384,0.03076923076923077,0.45907070544419715,1.0,7/17,14.10%,FARSB;KCNC2;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1
prerank,cellular response to fluid shear stress (GO:0071498),-0.586436627992274,-1.575442351054361,0.041666666666666664,0.45378823666449336,1.0,9/12,25.43%,MEF2C;MAP2K5;KLF4;HDAC3;SREBF2;KLF2;MTSS1;ASS1;MAPK7
prerank,positive regulation of B cell proliferation (GO:0030890),0.7147065939009521,1.5753605951000011,0.05103280680437424,0.4934555797837614,1.0,1/29,0.09%,TNFSF13B
prerank,regulation of muscle contraction (GO:0006937),-0.4855309328345291,-1.5748794832901434,0.020100502512562814,0.45020712264553286,1.0,9/26,16.91%,CHRM2;CAV1;ANXA6;TPM1;ATP1A2;ENO1;MYL9;PLCE1;SRI
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6076978439285083,-1.574666864721992,0.0380952380952381,0.4453756597563325,1.0,4/12,8.32%,UNC13B;RIMS1;SYT1;SYT7
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.6623548608106249,1.5735697965908337,0.0020161290322580645,0.4981410802889849,1.0,30/148,7.33%,TPX2;BRCA1;EXO1;CDK1;BRIP1;BARD1;RMI2;AURKB;RFC4;KMT5A;AURKA;TOPBP1;RBBP8;RPA1;CHEK2;MDM4;TAF3;RAD1;DNA2;RFC2;BLM;MRE11;RPA2;RFC3;RBBP4;RBBP7;PML;RRS1;CHEK1;TAF12
prerank,protein prenylation (GO:0018342),0.8229095116182871,1.5735630218890004,0.05660377358490566,0.49595885385696653,1.0,1/10,0.45%,AIPL1
prerank,regulation of chromatin organization (GO:1902275),0.7743258140459651,1.571599090785748,0.07692307692307693,0.5016076512092078,1.0,1/14,0.23%,MKI67
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.7402937934265479,1.5707463208721328,0.06624203821656051,0.5026005385293026,1.0,2/21,1.19%,BRCA1;SLC18A2
prerank,regulation of protein localization to nucleus (GO:1900180),0.6860515432692553,1.5703512955902408,0.03728813559322034,0.5020042862847821,1.0,11/43,11.68%,CDK1;PLK1;GTSE1;GSK3B;CTNNA1;TPR;WWTR1;YAP1;PARP9;EIF2AK3;ILRUN
prerank,DNA modification (GO:0006304),0.7325306235085555,1.569360944414368,0.0751592356687898,0.503540088942733,1.0,2/22,1.68%,NEIL3;TERF1
prerank,dendritic spine organization (GO:0097061),-0.477717816872299,-1.5692597277306635,0.021164021164021163,0.45592604164439127,1.0,11/26,13.64%,CTNND2;DOCK10;SHANK3;PAK3;INSR;DIP2A;EPHB2;LGMN;CHRNA7;SHANK1;DLG4
prerank,metal ion transport (GO:0030001),-0.34133883303446283,-1.5685812106489438,0.0,0.45272043298857917,1.0,27/86,16.92%,CACNA2D1;GRIN3A;RYR3;NIPA1;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;NIPA2;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;SLC30A1;ATP2B2;NIPAL3;PANX1;CACNG3;CACNG8
prerank,positive regulation of neuron migration (GO:2001224),0.803583328465295,1.56831993819386,0.05373134328358209,0.5051842171376977,1.0,1/11,0.10%,KIF20B
prerank,cellular response to inorganic substance (GO:0071241),0.730931580216682,1.5677564309434253,0.07722513089005235,0.5052612642701808,1.0,8/21,7.94%,ATRX;DDX11;AQP1;TIMELESS;BLM;SPIDR;FMR1;CDK2
prerank,positive regulation of DNA recombination (GO:0045911),0.7142583403113114,1.5675939821994496,0.05623471882640587,0.5036779216465014,1.0,9/27,12.70%,RAD51AP1;TIMELESS;PAXIP1;ARID2;RIF1;FUS;MRNIP;MMS19;KMT5C
prerank,negative regulation of chemokine production (GO:0032682),-0.586576035558055,-1.5664790922273575,0.047244094488188976,0.45452927620788214,1.0,5/14,17.26%,APOD;MAP2K5;KLF4;C1QTNF3;LGALS9
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.6096689011264917,-1.5657204319400135,0.05740181268882175,0.45193283637665305,1.0,9/11,33.91%,UQCRC2;UQCRB;UQCR10;UQCRQ;UQCRC1;CYC1;UQCRFS1;CYCS;UQCC3
prerank,regulation of cell cycle (GO:0051726),0.6577368907172519,1.564662121913341,0.0,0.5122993644299141,1.0,54/271,10.72%,CENPF;DTL;KIF20B;BRCA1;PRR11;CCNB1;CDKN3;DLGAP5;PLK1;BIRC5;BARD1;MASTL;CKS2;FIGNL1;CCNB2;TGM1;PCLAF;DDIAS;CDKN2D;FBXO5;CDKN2C;RB1;TTC28;RASSF1;FGFR2;LIN54;GBF1;UHRF2;CTBP1;LIN52;TCF7L2;RBBP4;PML;MAP3K20;MYBL2;CHEK1;FBXL8;LIN9;HTRA2;RNF40;LIN37;MFN2;IRF1;ING4;GRK5;PLAGL1;SKP2;CSNK2A2;FBXL17;CDC25A;CDC123;TGFBR1;HNRNPU;CRLF3
prerank,insulin receptor signaling pathway (GO:0008286),-0.3873526951478171,-1.5645514753856715,0.0,0.45034899320504307,1.0,26/69,14.75%,FOXO1;ATP6V0A1;GRB14;GRB10;ATP6V0D1;ATP6V1E1;INSR;ATP6V0B;PIK3R3;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;IGF2;NAMPT;GPLD1;BCAR3;IRS1;CAV2;GRB2;ATP6V0C;ATP6V1H;SHC1;GSK3A;APC
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.7408207241269991,1.5642435441525189,0.06510416666666667,0.5115399304591088,1.0,4/22,8.56%,FANCA;CBFB;LAG3;IRF1
prerank,positive regulation of telomere maintenance (GO:0032206),0.7013853264820532,1.5638479809591739,0.06107784431137724,0.5109059781506241,1.0,7/31,6.69%,NEK2;ATRX;AURKB;RTEL1;HNRNPD;MRE11;PML
prerank,response to light stimulus (GO:0009416),0.6767480458483288,1.5624041300686766,0.019693654266958426,0.514081226676135,1.0,9/55,6.08%,DTL;PCLAF;ZRANB3;CDKN2D;USP1;PRIMPOL;ERCC4;POLD1;ERCC3
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.59435092097426,-1.562341350361442,0.05723905723905724,0.4522187044693566,1.0,6/12,21.65%,PODXL;JAG1;PROM1;PTPRO;KLF15;BASP1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.7586487482763091,1.561755315562316,0.07582260371959942,0.5144800290872557,1.0,1/15,0.19%,BRCA1
prerank,positive regulation of cellular respiration (GO:1901857),-0.6213602061854341,-1.5588808680967523,0.038922155688622756,0.4584755903300271,1.0,7/11,24.97%,IFNAR1;PINK1;NUPR1;IL10RB;PARK7;ISCU;PRELID1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.69594322586437,1.5580699584986266,0.053738317757009345,0.5259841093551516,1.0,10/37,9.80%,SKA3;SKA1;SKA2;STMN1;GSK3B;MAPT;BICD2;TPPP;ROCK1;MARK2
prerank,DNA duplex unwinding (GO:0032508),0.6792993549824102,1.5573760169536695,0.04285714285714286,0.5263403220405438,1.0,15/50,6.08%,PIF1;RAD51;DDX11;MCM6;MCM7;MCM2;RTEL1;RPA1;CHD1L;DHX9;BLM;MRE11;RECQL;MCM4;ERCC3
prerank,regulation of dendritic spine development (GO:0060998),-0.5260742569790235,-1.5567907166534127,0.028225806451612902,0.4601068186048997,1.0,8/19,8.17%,GRIN3A;CPEB3;PSEN1;MEF2C;SHANK3;APOE;KIF1A;CAMK1
prerank,synaptonemal complex assembly (GO:0007130),0.774400550636676,1.556442373997632,0.07560627674750357,0.5253742074596003,1.0,2/15,3.39%,TRIP13;RAD21
prerank,synaptonemal complex organization (GO:0070193),0.774400550636676,1.556442373997632,0.07560627674750357,0.5253742074596003,1.0,2/15,3.39%,TRIP13;RAD21
prerank,histone H4-K5 acetylation (GO:0043981),0.7579238067829435,1.5563566311423733,0.07267833109017496,0.5213489450024075,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,histone H4-K8 acetylation (GO:0043982),0.7579238067829435,1.5563566311423733,0.07267833109017496,0.5213489450024075,1.0,2/15,2.62%,KANSL1;KANSL2
prerank,protein oxidation (GO:0018158),0.8010632298327636,1.5553476940151842,0.06349206349206349,0.5229714610078053,1.0,3/11,2.55%,LOXL3;LOXL2;LOX
prerank,positive regulation of endocytosis (GO:0045807),-0.40776385297979734,-1.5529703311315108,0.034482758620689655,0.4674083475010344,1.0,18/45,19.70%,SGIP1;APOE;VTN;ANO6;LRP1;BICD1;CLIP3;DAB2;B2M;HNRNPK;LDLRAP1;HIP1;CBLL1;CBL;PPT1;NLGN1;NCKAP1L;CD151
prerank,lymphocyte mediated immunity (GO:0002449),-0.6059588399647122,-1.5521663150568852,0.0457516339869281,0.46473176734696137,1.0,3/12,12.97%,JAG1;MSH2;GNL1
prerank,potassium ion homeostasis (GO:0055075),-0.4921370687987413,-1.5499504566007174,0.027777777777777776,0.4673748244862566,1.0,7/23,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;SLC12A9;ATP1A2;SLC12A2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5961616021314107,-1.549614446902487,0.03289473684210526,0.46351339418515625,1.0,5/12,17.56%,APOD;IFT20;CBLB;NDRG4;CBL
prerank,response to steroid hormone (GO:0048545),-0.44860755015118176,-1.548796503288421,0.012195121951219513,0.46160743546331295,1.0,18/31,25.79%,CAV1;PAQR8;TGFB2;AR;ATP1A1;ABHD2;NR1H3;ATP1A3;CATSPER2;THBS1;ATP1A2;TGFB3;WBP2;ABCA2;PAQR7;URI1;UBE3A;CATSPER3
prerank,mRNA stabilization (GO:0048255),0.6717596521005983,1.548557878262554,0.04983012457531144,0.5458332759294654,1.0,13/40,10.93%,MEIOC;E2F1;SYNCRIP;DHX9;THRAP3;EIF4ENIF1;YBX3;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15
prerank,positive regulation of protein kinase activity (GO:0045860),0.6464746033656995,1.5484180229725117,0.0030303030303030303,0.5441453095207373,1.0,23/148,9.97%,TPX2;CENPE;KIF14;ECT2;EZH2;INCENP;CLSPN;BORA;SPDYA;MAP4K4;RHOA;PRNP;STK3;NRK;EFNA1;ETAA1;CCN1;EPHA4;MRNIP;NOX4;AGT;MARK2;DDR2
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.5311598786320578,-1.5483183570007935,0.047058823529411764,0.4581947823815896,1.0,7/17,16.69%,PCSK5;PCSK6;FURIN;LMF1;NR1H3;HDAC9;NR1H2
prerank,negative regulation of protein depolymerization (GO:1901880),0.7196259292204676,1.5472241824640198,0.0675,0.5464326163694837,1.0,2/24,4.77%,TPX2;SPEF1
prerank,acylglycerol metabolic process (GO:0006639),-0.42586264820279907,-1.545646638652812,0.03418803418803419,0.46133032016712694,1.0,10/37,9.48%,CAV1;APOE;PLAAT3;DGKB;ABHD6;ABHD12;DGKG;LMF1;DGKI;ABHD2
prerank,regulation of spindle assembly (GO:0090169),0.720224907348022,1.5451137997943722,0.08084577114427861,0.5520035038322748,1.0,9/25,10.89%,PLK1;SPAG5;GPSM2;CEP97;NUMA1;TPR;CCSAP;HNRNPU;DRG1
prerank,cell proliferation in forebrain (GO:0021846),0.8055816554039629,1.5447766418018902,0.07350689127105667,0.5511572615109236,1.0,3/10,6.66%,KIF14;PCM1;AKNA
prerank,positive regulation of cellular protein localization (GO:1903829),0.6620623932359063,1.5447257077529106,0.02454642475987193,0.5491457735982364,1.0,16/69,11.13%,NDC80;CDK1;PLK1;GTSE1;CENPQ;RANGRF;GSK3B;DDRGK1;NUMA1;PDZK1;MAPT;WWTR1;YAP1;SNX33;PARP9;EIF2AK3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.6560968030440418,1.5437819772499113,0.0417558886509636,0.5505145436754684,1.0,23/60,16.13%,CCNB1;CDK1;MED26;PPM1D;CBFB;PAXIP1;MOV10;MED14;SRF;TCF7L2;MED30;ATF7IP;TRIM28;MED24;MED15;HEY2;MED1;CDK8;MED27;TNRC6C;NFKB1;TP53;PTEN
prerank,positive regulation of nuclear division (GO:0051785),0.7057297091790977,1.5404036589457293,0.07196029776674938,0.561135091108764,1.0,3/25,2.78%,NUSAP1;AURKA;PHIP
prerank,regulation of telomere capping (GO:1904353),0.7124310979848981,1.5399904376605624,0.07741935483870968,0.5604061127494372,1.0,4/23,3.73%,NEK2;AURKB;RTEL1;HNRNPD
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.7782986981947104,1.5386791654885121,0.0718232044198895,0.563192272066796,1.0,3/14,4.13%,BRCA1;PAXIP1;AUTS2
prerank,microtubule bundle formation (GO:0001578),0.6779686781053852,1.538506596147071,0.05869074492099323,0.5617056468961418,1.0,7/42,4.91%,PLK1;KIF20A;CDK5RAP2;PSRC1;SPAG16;SPEF1;NUMA1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6962008139698029,1.5372823147008297,0.06619385342789598,0.5640535162211199,1.0,4/32,4.77%,TPX2;STMN1;DYRK1A;SPEF1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.6725421767993066,1.5370570541173887,0.055745164960182024,0.5627416217888824,1.0,14/46,9.67%,ECT2;GTSE1;GSK3B;XPO4;ANP32B;NEDD4;KHDRBS1;DHX9;NRDE2;TCF7L2;TPR;UBR5;TRIM28;EMD
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7492181324097147,1.5362570341191797,0.10248901903367497,0.5634370583076486,1.0,7/15,9.67%,GTSE1;GSK3B;XPO4;ANP32B;TCF7L2;TPR;EMD
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7038157866931115,1.535477999544368,0.0678391959798995,0.5641938863658278,1.0,7/26,14.42%,BRCA1;HPSE;SULF2;SULF1;EIF2AK3;RORA;ARNT
prerank,mismatch repair (GO:0006298),0.7069707017607987,1.5336383951735684,0.06157635467980296,0.5688390562160154,1.0,14/27,17.28%,EXO1;RPA1;MSH3;POLD3;POLD1;RPA2;MLH1;SETD2;RNASEH2A;PCNA;MSH6;PMS1;MSH5;MCM9
prerank,peroxisomal membrane transport (GO:0015919),-0.45350560965590403,-1.5317459864657617,0.05,0.5027282682879511,1.0,12/27,22.31%,PEX1;FIS1;ABCD4;ALDH3A2;PEX3;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,regulation of secretion (GO:0051046),-0.5831533886537705,-1.5315220173815411,0.04529616724738676,0.4986084145490019,1.0,9/13,30.38%,MYO6;SGK1;GPLD1;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,protein autoubiquitination (GO:0051865),0.6672806256583932,1.5312100824959425,0.031149301825993556,0.5756407165786178,1.0,7/61,4.25%,BRCA1;UHRF1;UBE2T;RAD18;TRIM37;RNF220;UHRF2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.5073413934711483,-1.530691679503516,0.03389830508474576,0.49653768743119453,1.0,4/21,6.12%,PLA2G4A;PLAAT3;PLA1A;OSBPL10
prerank,negative regulation of mRNA processing (GO:0050686),0.7460547734933289,1.527975959581632,0.09749303621169916,0.5856487959999246,1.0,5/15,8.14%,BARD1;SRSF4;SRSF10;SRSF7;SAP18
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.7286095566684391,1.5277411512446182,0.07800511508951406,0.584278657064898,1.0,5/22,8.29%,SHCBP1;NAP1L1;SLC16A2;KDM2B;LRRK2
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.6718013071103051,1.5267721140833586,0.041988950276243095,0.5857221028771143,1.0,19/53,16.08%,BRCA1;ANKLE1;RNF168;EYA4;DHX9;NSMCE4A;UBE2N;FMR1;UIMC1;TRIM28;SMCHD1;BCLAF1;EYA2;PCNA;SPRED1;BRCC3;NSMCE1;FXR1;SPRED2
prerank,error-free translesion synthesis (GO:0070987),0.7214357185558633,1.5255382852367287,0.09383033419023136,0.5883506819672716,1.0,8/22,6.47%,RFC4;POLH;RPA1;RFC2;POLD1;RPA2;RFC1;RFC3
prerank,regulation of interleukin-4 production (GO:0032673),-0.4880667397620664,-1.5254394024272453,0.043478260869565216,0.5091828296611335,1.0,10/21,28.19%,LEF1;SLC7A5;PRKCQ;CEBPB;DDIT3;LGALS9;PRKCZ;CD86;SYK;FCER1G
prerank,positive regulation of chromatin organization (GO:1905269),0.7752037645948109,1.5239874616764828,0.09142053445850915,0.5919375354352148,1.0,9/12,18.29%,ATRX;TERF1;MIER1;UBE2N;TAL1;TERF2;TINF2;ACD;TERF2IP
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.5288575038138821,-1.5239142123639504,0.06072874493927125,0.5100137483190336,1.0,9/18,21.39%,CDH8;UNC13B;GRIK1;GRID2;GRIK4;SLC17A6;GRIA2;GRIK2;GRID1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3970058864057028,-1.5238018593890559,0.014084507042253521,0.5056887553332121,1.0,16/51,19.54%,PTK2;VEGFC;ANO6;GAS6;LGMN;MAPK3;MAPK1;THBS1;VEGFA;PLA2G7;CMKLR1;LGALS9;IL34;VEGFB;CREB3;VEGFD
prerank,glycerolipid metabolic process (GO:0046486),-0.5949147472039666,-1.5228480706063914,0.0660377358490566,0.5042878790550654,1.0,8/11,30.26%,DGKB;DGKG;PIP5K1A;DGKQ;GAL3ST1;PLA2G15;PGP;PNPLA3
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.5272742449208077,-1.5223249244295955,0.03937007874015748,0.5011145537030939,1.0,7/17,16.42%,PRKG1;MEF2C;PDCD4;SOD2;TPM1;TAFA5;TGFB3
prerank,response to UV (GO:0009411),0.6381158455713137,1.5216480234530643,0.021560574948665298,0.5987258105598121,1.0,26/95,14.28%,DTL;POLK;AURKB;PCLAF;ZRANB3;AQP1;CDKN2D;USP1;POLH;BMF;PRIMPOL;NEDD4;ERCC4;POLD1;ERCC3;FMR1;MAP3K4;CDC25A;USP28;XPA;PCNA;MSH6;USP47;YY1;SMPD1;RUVBL2
prerank,neuron remodeling (GO:0016322),-0.6323628685088994,-1.5212011289190148,0.03323262839879154,0.5001440327575153,1.0,8/10,26.80%,APP;SCARF1;CX3CL1;FARP2;ADGRB3;EPHA8;ANKS1A;C1QA
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7772273924186748,1.5206476238861513,0.09343065693430656,0.598122470684891,1.0,5/12,12.26%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7772273924186748,1.5206476238861513,0.09343065693430656,0.598122470684891,1.0,5/12,12.26%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2
prerank,telomere maintenance (GO:0000723),0.6690859098445908,1.5197698977628509,0.05005561735261402,0.5991596649373535,1.0,27/50,19.60%,RAD51;TERF1;SMC6;RTEL1;RPA1;SMC5;STN1;ERCC4;POLD3;DNA2;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;NSMCE2;TERF2;TEP1;TINF2;ATR;ACD;TERF2IP;RAD50;SP100;TERT
prerank,chromatin assembly (GO:0031497),0.6889389546090762,1.518902894214969,0.049255441008018326,0.6002044224264792,1.0,8/38,6.48%,CHAF1B;ATRX;HMGB2;NAP1L1;CTCF;LIN54;ANP32B;RBBP4
prerank,chemical synaptic transmission (GO:0007268),-0.3115261397612006,-1.5188450546167127,0.0,0.5029569281106719,1.0,82/284,17.59%,CDH8;GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;SYN3;RIMS1;GABRB3;SLC1A2;CHRM2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;KIF1B;ATXN3;CALM1;AMPH;APOE;APBA1;GLRB;GRID2;SYN2;SYT1;GLRA1;LIN7A;GRIN2B;PTCHD1;KCNQ3;BRSK1;HOMER1;SHISA6;GRIK4;RPS6KA2;CAMK4;GABRA3;HTR2C;RIC3;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;SNPH;GIPC1;CHRNA7;CHRFAM7A;GABRB2;HCRTR2;GRIA1;PRKAR1B;SLC17A6;GABRG2;MAPK1;SYNJ2BP;HTR4;CAMKK2;GRM5;CACNB2;DLG4;SDCBP;GRM1;GRIN1;TBC1D24;GABRG1;DVL1;CPLX1;DTNA;CHRM3;SLC1A1;LRP6;HTR2A;SNAP25;CACNB1;GRIA2;SYT10;SYPL1
prerank,histone H4-K16 acetylation (GO:0043984),0.7246678122362604,1.5155493025847446,0.08507853403141362,0.6110786423892524,1.0,5/19,9.83%,KANSL1;KANSL2;ING4;MSL3;KMT2A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.6190704349467111,-1.5148470547820476,0.06666666666666667,0.5117117707953328,1.0,8/10,33.48%,MAP2K5;KLF4;TLE5;MAPK7;IRAK3;PTPRC;SH2B3;SIGIRR
prerank,glucose import (GO:0046323),-0.5702716471564433,-1.5145828976306899,0.045774647887323945,0.5081404430705018,1.0,6/13,21.40%,SLC2A1;SLC27A1;SLC2A3;ZDHHC7;SLC2A10;SLC27A4
prerank,piRNA metabolic process (GO:0034587),0.7347957230530098,1.5137796110631991,0.08776595744680851,0.6154016711619218,1.0,3/19,6.24%,MYBL1;MAEL;EXD1
prerank,RNA stabilization (GO:0043489),0.668438551006313,1.5137102644077716,0.0668229777256741,0.6134222590074805,1.0,12/33,10.93%,MEIOC;E2F1;TENT2;PHAX;THRAP3;EIF4ENIF1;FUS;LARP1;AXIN2;HNRNPU;TENT5D;TAF15
prerank,negative regulation of DNA replication (GO:0008156),0.7621065978648335,1.513678295538701,0.09038737446197992,0.6113284525050813,1.0,4/13,4.39%,TERF1;PDS5A;CDC6;WAPL
prerank,regulation of microtubule depolymerization (GO:0031114),0.7011810852003999,1.5124299354718806,0.08470290771175727,0.6137452904093286,1.0,1/25,0.06%,TPX2
prerank,smoothened signaling pathway (GO:0007224),0.6882857580169434,1.5122041907361852,0.07467911318553092,0.6123549742145281,1.0,3/32,1.27%,STIL;GLI2;GLI3
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.4165135802980821,-1.5120521333411352,0.008,0.5110360565611675,1.0,22/43,34.35%,IGF1;GAS6;TLR4;CD34;LBP;PTPN22;SELENOS;CHRNA7;CX3CL1;SYT11;TRIM27;DICER1;LGALS9;ZC3H12A;CD274;NLRC3;IRAK3;CACTIN;TNFAIP3;NR1H4;RARA;PTPN6
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.6858006542544339,1.5118537106005803,0.06850961538461539,0.6114573835745362,1.0,9/33,7.94%,PIF1;RAD51;TERF1;RTEL1;RPA1;STN1;MRE11;RFC1;CDK2
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.4162155783345558,-1.5111211481684341,0.014184397163120567,0.5100512262704832,1.0,14/41,19.48%,IGF1;GAS6;TLR4;CD34;LBP;PTPN22;SELENOS;CHRNA7;CX3CL1;SYT11;TRIM27;DICER1;LGALS9;ZC3H12A
prerank,striated muscle tissue development (GO:0014706),-0.4385132600855086,-1.5109815604203047,0.024539877300613498,0.5061690087079609,1.0,7/29,11.42%,MEF2C;PGM5;CAV1;IGSF8;BMPR2;MYL6;SIX1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.4457294017621217,-1.5103268051727137,0.012345679012345678,0.5039836380288197,1.0,23/31,38.87%,PEX1;DNAJC19;HSPD1;AIFM1;PEX5;TIMM44;PEX6;TOMM70;DNAJC15;PAM16;TIMM17A;PEX26;TIMM17B;CHCHD4;PEX10;ROMO1;GRPEL1;PEX16;DNLZ;TOMM40L;PEX2;PEX14;TIMM50
prerank,negative regulation of T cell differentiation (GO:0045581),0.7731137992825557,1.5095756151458093,0.09767441860465116,0.6177315598635654,1.0,3/10,8.56%,GLI3;LAG3;IRF1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.4276848350268722,-1.5073430983671254,0.014285714285714285,0.5091516118420104,1.0,6/38,4.31%,CAMK2D;CTNNA3;CACNA2D1;CAV1;KCNJ3;BIN1
prerank,modulation by symbiont of host process (GO:0044003),-0.5993005126218575,-1.5068078616176641,0.05917159763313609,0.5067595114367104,1.0,8/10,32.34%,B2M;PGK1;ENO1;UBB;RPS27A;UBC;MRC1;UBA52
prerank,positive regulation of histone modification (GO:0031058),0.6737626682390042,1.506501026715105,0.08492822966507177,0.6272222417056922,1.0,8/33,7.79%,BRCA1;PAXIP1;CTBP1;ARRB1;UBE2N;FMR1;NIPBL;ZBTB7B
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.5514215779849443,-1.506237507166556,0.0777027027027027,0.5041042938594377,1.0,6/13,21.78%,TMSB4X;NOS3;PINK1;ENO1;PPARGC1A;NOS1
prerank,dopaminergic neuron differentiation (GO:0071542),0.7097211623090106,1.5061611472987573,0.09859154929577464,0.6262844093004669,1.0,3/19,10.18%,EN1;LMX1B;NR4A2
prerank,hemidesmosome assembly (GO:0031581),-0.5932364406617,-1.505199844107747,0.04285714285714286,0.5028254126138534,1.0,6/11,27.04%,ITGA6;LAMA3;ITGB4;CD151;PLEC;LAMC2
prerank,zinc ion homeostasis (GO:0055069),-0.45181111706184623,-1.5047010048306004,0.023529411764705882,0.5001755706730027,1.0,14/28,20.86%,PRKN;SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,Golgi inheritance (GO:0048313),0.7889231837249565,1.5045146587335645,0.0872093023255814,0.6302731532785661,1.0,2/11,3.74%,CDK1;GBF1
prerank,chromatin assembly or disassembly (GO:0006333),0.7603926150124096,1.5041401003414694,0.08187134502923976,0.6293893740731544,1.0,7/11,18.77%,CHAF1B;RBBP4;HDAC8;CHAF1A;TP53;SUV39H2;HIRIP3
prerank,retinoic acid metabolic process (GO:0042573),0.7617262320077367,1.5034906574641245,0.09325681492109039,0.6297817167767518,1.0,4/14,9.15%,ALDH8A1;CYP26B1;ALDH1A2;SCPEP1
prerank,long-term synaptic potentiation (GO:0060291),-0.4840237362828915,-1.5031430711847562,0.0423728813559322,0.5012040427776484,1.0,7/21,11.24%,SLC8A3;GRIN2A;GRIN2B;STX4;SLC24A2;TSHZ3;NFATC4
prerank,regulation of osteoblast proliferation (GO:0033688),0.7204734089938957,1.502992793773399,0.11424731182795698,0.6294490100772888,1.0,7/17,11.40%,HPSE;RHOA;FGFR2;CCN1;NPR3;PLXNB1;BMP2
prerank,tRNA methylation (GO:0030488),-0.4178386761021383,-1.5024758701401295,0.029197080291970802,0.4990855895450589,1.0,21/34,36.55%,MTO1;NSUN2;THUMPD3;TRMT61B;DALRD3;TRMT1;METTL1;TRMT10A;LCMT2;TRMO;WDR6;GTPBP3;TRMT44;TRMT1L;TRMT10C;METTL6;TYW3;TRMT12;BCDIN3D;TRMT112;HSD17B10
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.6319590353983717,1.4989003825677527,0.04838709677419355,0.6427341506726205,1.0,12/66,11.13%,ECT2;CDK1;PLK1;GTSE1;TPR;NMD3;WWTR1;UBR5;TRIM28;YAP1;PARP9;EIF2AK3
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6442453592618812,1.4983019758854996,0.03411513859275053,0.6428580143635576,1.0,10/66,3.71%,KIF14;E2F7;RBL1;WEE1;E2F1;CDKN2D;CDKN2C;RB1;HYAL1;TFDP1
prerank,protein heterotetramerization (GO:0051290),-0.5784816951677676,-1.4968873683238186,0.05787781350482315,0.5126231281074434,1.0,7/13,20.26%,FARSB;CPSF6;GRIN2B;FARSA;CPSF7;GRIN1;CBR4
prerank,neuromuscular process controlling balance (GO:0050885),-0.5800429917681527,-1.4967340169894718,0.05396825396825397,0.5090721643286847,1.0,4/12,12.24%,PCDH15;NRXN1;TPP1;SHANK1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5374327411477671,-1.4961511412087796,0.07092198581560284,0.5066825184505356,1.0,4/15,9.47%,ATP1B1;KCNJ3;ATP1A1;KCNN2
prerank,protein acetylation (GO:0006473),0.6814231396553353,1.494598219882532,0.08066429418742586,0.6546809943515518,1.0,4/30,5.53%,ESCO2;DSCC1;HAT1;MAPT
prerank,ceramide catabolic process (GO:0046514),-0.5687356590930215,-1.4945680844110205,0.02711864406779661,0.5075245258066835,1.0,6/14,13.78%,HEXB;ACER2;ASAH1;ACER3;HEXA;ASAH2
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.6406883660645815,1.4926348044290916,0.03488372093023256,0.6601281745947406,1.0,21/72,11.79%,POLK;ANKLE1;RFC4;RPA1;CHD1L;ERCC4;RNASE6;POLD3;DNA2;RFC2;MRE11;POLD1;RPA2;ERCC3;RFC1;RFC3;CUL4B;XPA;PCNA;RNASE1;ENPP1
prerank,positive regulation of organelle assembly (GO:1902117),0.6513955702157923,1.4922193272067468,0.07198228128460686,0.6594470181064043,1.0,15/44,11.29%,SPAG5;PLK4;GPSM2;ASAP1;CNOT1;CNOT6L;NUMA1;G3BP1;SH3GLB1;CNOT6;TAPT1;SDC1;ARHGAP35;CEP120;STX18
prerank,peroxisome organization (GO:0007031),-0.4502250649384115,-1.4916664482922313,0.035175879396984924,0.512784700313841,1.0,8/25,13.66%,PLAAT3;PEX1;FIS1;ABCD4;PEX3;LONP2;PEX6;ABCD2
prerank,regulation of dopamine secretion (GO:0014059),-0.4688946295896118,-1.4909273282081767,0.040229885057471264,0.5113945117877545,1.0,11/25,22.18%,PRKN;SYT1;SYT7;DTNBP1;KCNA2;SYT11;SYT12;SYT10;SYT6;SYT2;DRD2
prerank,pore complex assembly (GO:0046931),0.720417406374942,1.489361861923834,0.09530026109660575,0.6680722617583181,1.0,7/19,6.57%,PLEKHA7;NDC1;NUP205;TSPAN33;AFDN;AHCTF1;TPR
prerank,positive regulation of protein binding (GO:0032092),-0.38671960113593806,-1.4889404942642617,0.042105263157894736,0.5134236785718753,1.0,20/56,11.05%,PRKN;MARK3;PSEN1;EPB41;TIAM1;CAV1;APOE;CLDN5;VTN;HIPK2;FKBP1A;RALB;LRP1;NVL;PPP2CB;DACT1;B2M;DERL1;ABL1;APP
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.4147693507918529,-1.4888243222983901,0.035398230088495575,0.5098717944532642,1.0,13/36,14.72%,MECOM;PRKN;FOXO1;ZMYND11;IGBP1;DUSP3;CYLD;DACT1;PTPN22;HDAC3;PINK1;SH3RF2;DUSP1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.6795292164168745,1.4884428477266554,0.08466257668711656,0.6694132848366382,1.0,7/29,9.17%,BRCA1;CBFB;CNOT1;DDRGK1;VPS18;KANK2;YAP1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6766822181899823,1.4866547036849354,0.09952038369304557,0.6740335927828001,1.0,6/31,2.56%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,protein neddylation (GO:0045116),-0.5496326630114656,-1.4860444918290001,0.05574912891986063,0.5140953791976679,1.0,5/13,15.14%,DCUN1D3;RBX1;DCUN1D5;DCUN1D4;DCUN1D2
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6633858776277711,1.485222011261635,0.10520094562647754,0.677339683247408,1.0,5/33,5.42%,ECT2;AQP1;SETX;FXN;NET1
prerank,chordate embryonic development (GO:0043009),0.6443124132629937,1.484053381661916,0.062023939064200215,0.6796184541846538,1.0,9/55,8.21%,BRCA1;STIL;FGFR2;ALDH1A2;SULF2;ZNF568;GRHL2;SULF1;LMX1B
prerank,protein localization to chromatin (GO:0071168),0.7174400209228092,1.4828645442550774,0.11621621621621622,0.6820460305322645,1.0,7/18,8.17%,PLK1;MCM8;SGF29;RAD21;WAPL;NIPBL;MRNIP
prerank,liver development (GO:0001889),0.6793344805623778,1.4825658143098088,0.08633093525179857,0.6808387080554251,1.0,11/32,16.74%,E2F7;E2F8;AURKA;TGFBR3;PHF2;NPHP3;ANXA1;GFER;PKD2;PCK2;COBL
prerank,regulation of neuron migration (GO:2001222),0.6766758730798655,1.4821569343236682,0.10206561360874848,0.6802060002572659,1.0,6/26,10.71%,KIF20B;ULK4;PHACTR1;NIPBL;SRGAP2;PLXNB2
prerank,nucleosome organization (GO:0034728),0.652814934898653,1.481798447362045,0.0536480686695279,0.6794563172373587,1.0,19/55,13.54%,CHAF1B;ATRX;HMGB2;NAP1L1;SMARCC1;CTCF;LIN54;NFE2;ARID2;ANP32B;ARID1A;SETD2;SRCAP;SMARCA4;ANP32E;NASP;SPTY2D1;MCM3AP;CHAF1A
prerank,protein polymerization (GO:0051258),0.6404713134846822,1.4815508161936073,0.052689352360043906,0.67819001956197,1.0,12/56,12.54%,DIAPH3;UBE2C;CKAP5;UBE2S;UBE2K;DIAPH1;MAPT;CENPJ;TPPP;ARHGAP6;RAC1;TRIM6
prerank,catecholamine biosynthetic process (GO:0042423),-0.5742274710881821,-1.4801590793562853,0.07119741100323625,0.5285941966169846,1.0,4/11,19.18%,TGFB2;MOXD1;GCH1;DDC
prerank,vacuolar acidification (GO:0007035),-0.48960662757012346,-1.4799851292578072,0.03587443946188341,0.5252779862191653,1.0,15/21,33.44%,ATP6V0A1;DMXL2;ATP6V0D1;ATP6V0A4;GRN;ATP6V1H;PPT1;ATP6AP2;TMEM9;CLN5;TMEM199;CLN3;ATP6V0D2;ATP6V0E1;CLN6
prerank,negative regulation of organelle assembly (GO:1902116),0.6654374443245592,1.4795713789240756,0.08041958041958042,0.6833948979826595,1.0,11/35,12.59%,BRCA1;CDK5RAP2;TRIM37;CEP97;EVI5L;LRRK2;YAP1;TBC1D7;TMEM39A;SCFD1;SMAD4
prerank,nuclear migration (GO:0007097),0.7515005959113821,1.4768412823137673,0.1168091168091168,0.6913661744184264,1.0,8/13,15.61%,SYNE3;SYNE2;PCM1;CLMN;CEP120;FBXW11;DOCK7;SUN2
prerank,cellular response to light stimulus (GO:0071482),0.6288870563517567,1.4764238514495538,0.0536480686695279,0.6906195442059159,1.0,20/66,17.18%,POLK;AURKB;AQP1;BMF;NEDD4;ERCC4;POLD1;FMR1;CDC25A;USP28;PCNA;USP47;YY1;SMPD1;RUVBL2;INO80;TP53;METTL3;PTPRK;ATR
prerank,cilium assembly (GO:0060271),0.6198436501279317,1.4758954171688072,0.0,0.6903790190717247,1.0,67/297,10.82%,NEK2;CDK1;KIF24;PLK1;CEP192;CEP152;CDK5RAP2;CKAP5;HAUS8;PLK4;IFT80;CEP57;HYLS1;CEP89;BBS9;HAUS4;HAUS6;DZIP1L;SCLT1;ACTR1A;DNAAF3;ACTR3;CEP43;WDR35;PARVA;ASAP1;GBF1;CEP97;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;TNPO1;C2CD3;OCRL;HAUS7;TXNDC15;MKKS;WDR11;NDE1;CEP83;RILPL1;NUDCD3;RFX2;CNTRL;SSX2IP;HAUS1;CCDC57;CENPJ;CFAP52;SPATA6;CEP76;WDPCP;NPHP3;ALMS1;ODF2;SDCCAG8;RAB1A;NINL;RSPH9;NPHP1;TRAPPC14;TTC39C
prerank,regulation of multicellular organism growth (GO:0040014),-0.5219464696353642,-1.4754795587794192,0.08833922261484099,0.5351884972187774,1.0,5/15,16.35%,MBD5;IGF1;APP;PTCH1;PPIB
prerank,rRNA processing (GO:0006364),-0.2980823737933047,-1.4748184624986214,0.0,0.5333007013262758,1.0,82/172,27.09%,RPL13;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RSL1D1;RPL39;KRR1;RPL12;RPL27;RPL24;NSA2;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RRP1B;RRP1;RPL19;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;RPL29;MDN1;RIOK2;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;THUMPD1;NOP2;EXOSC2;PIH1D1;RRP15;EBNA1BP2;DDX54;RPL4;BYSL;IMP3;DDX47;BOP1;EXOSC3;RPS25;EXOSC5;POP5
prerank,determination of left/right symmetry (GO:0007368),0.6583374328410176,1.4745912125921263,0.07780320366132723,0.6932644113116821,1.0,5/37,9.03%,STIL;DNAH11;CFAP53;MKKS;NPHP3
prerank,regulation of chromatin binding (GO:0035561),0.7759690699815304,1.4743548228663397,0.11666666666666667,0.6918890621880441,1.0,4/10,10.38%,DDX11;BTAF1;WAPL;PARP9
prerank,neural tube development (GO:0021915),0.7162328500017106,1.4735593373049318,0.10425240054869685,0.6927011180382066,1.0,3/15,6.59%,STIL;ALDH1A2;GRHL2
prerank,protein targeting to peroxisome (GO:0006625),-0.42875473060206,-1.4733655608688094,0.03592814371257485,0.5343386147681839,1.0,17/29,34.36%,PEX1;FIS1;ALDH3A2;PEX3;LONP2;PEX5;PEX6;ABCD2;GDAP1;PXMP4;PEX26;PXMP2;HACL1;PEX11B;PEX10;ACBD5;PEX16
prerank,T cell differentiation in thymus (GO:0033077),0.7225502937384338,1.47009028159175,0.11267605633802817,0.7035012820282994,1.0,2/14,2.15%,GLI3;FADD
prerank,activation of protein kinase activity (GO:0032147),0.6190870565316864,1.4695302670296628,0.02774922918807811,0.7033110451987507,1.0,15/106,9.91%,TPX2;KIF14;ECT2;CLSPN;BORA;MAP4K4;STK3;NRK;IL18;TXN;TNFRSF10B;ANGPT1;OSBPL8;MARK2;MAPKAP1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.6634636443980875,1.468868852151793,0.09860788863109049,0.7035630888334701,1.0,11/35,11.29%,POLE;RFC4;RPA1;POLD3;RFC2;POLD1;RPA2;RFC1;RFC3;MBD4;PCNA
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.43818799645218887,-1.4687259209929466,0.050955414012738856,0.5443167685032015,1.0,12/29,15.19%,CYRIB;PRKN;SHANK3;KANK3;KANK4;PFN1;SSH1;TJP1;SLIT2;SHANK1;ARFGEF1;FKBP4
prerank,renal absorption (GO:0070293),-0.6073732079470775,-1.4685491168979394,0.07692307692307693,0.5408830783655421,1.0,8/10,38.37%,SGK1;SLC15A2;GSN;KLHL3;KCNQ1;MAGED2;HYAL2;HAS2
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.49987495684019967,-1.4677082454117485,0.04526748971193416,0.5395241888371405,1.0,5/17,12.97%,STAT3;JAG1;TLR4;MSH2;GNL1
prerank,nuclear transport (GO:0051169),0.7088411300865305,1.4661980721237688,0.12911725955204217,0.7116079181282686,1.0,7/16,17.31%,XPO1;NUP205;PSIP1;RBM15B;NXT1;NUP98;NXT2
prerank,protein-DNA complex assembly (GO:0065004),0.6180316837222446,1.4659815289904767,0.025510204081632654,0.7100841683841976,1.0,33/116,12.04%,CHAF1B;RAD51;ATRX;MCM5;ORC1;HMGB2;MCM8;DMC1;NAP1L1;MCM6;MCM7;MCM2;CDC6;PSMC2;RPA1;PSMD5;CHD1L;ANP32B;MCM3;RPA2;MCM4;ERCC3;ORC2;TCF4;ORC3;PSMB1;PSMD14;CUL4B;PSMD1;PSMB9;XPA;CENPV;SPTY2D1
prerank,myotube cell development (GO:0014904),-0.6028713300695354,-1.465870880179682,0.08211143695014662,0.5413418328202262,1.0,4/10,11.42%,IGF1;CAV2;SELENON;SIX1
prerank,membrane repolarization (GO:0086009),-0.5247284003989431,-1.4658422842744152,0.043478260869565216,0.5376021924367345,1.0,8/15,31.95%,ATP1B1;ATP1A1;ATP1B3;ATP1A2;KCNQ1;ATP1B2;KCNIP2;KCNE4
prerank,regulation of intracellular protein transport (GO:0033157),0.6562727728450599,1.4652650224684785,0.09963985594237695,0.710583286785745,1.0,4/32,7.67%,KIF20B;PCM1;TPR;RAB29
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.6301079915771861,1.465226446477437,0.07173913043478261,0.7084743677655568,1.0,22/59,16.13%,CCNB1;CDK1;MED26;PPM1D;CBFB;SETX;MOV10;MED14;TCF7L2;MED30;TRIM28;BCLAF1;MED24;MED15;TWIST1;MED1;CDK8;MED27;TNRC6C;NFKB1;TP53;PTEN
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6542142334288251,1.4641197387254343,0.10469314079422383,0.7102985759082575,1.0,6/31,6.77%,PLK1;CDC20;UBE2C;UBE2S;FBXW7;UBE2N
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.5700270551960916,-1.4639042402415485,0.06309148264984227,0.5396722886513144,1.0,6/12,16.82%,MID2;LY6E;SNX3;IFITM3;GSN;IFITM2
prerank,telomere maintenance via recombination (GO:0000722),0.7470133625496328,1.4629477205108157,0.1282051282051282,0.7125909040963885,1.0,4/11,4.49%,RAD51;SMC6;SMC5;ERCC4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.5850997174836109,-1.4626072609504384,0.0886426592797784,0.539911263560804,1.0,8/10,36.28%,OGT;SELENOS;ZNF692;DGKQ;PDK2;SIRT7;USP7;SDHAF3
prerank,regulation of AMPA receptor activity (GO:2000311),-0.436934620214899,-1.462524389866847,0.07960199004975124,0.5364366696346976,1.0,13/25,18.41%,MEF2C;SHANK3;SHISA6;CACNG7;CACNG4;MINK1;RELN;SHANK1;CACNG2;PRRT1;CACNG3;CACNG8;NLGN1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4059177945711761,-1.462345371836918,0.025974025974025976,0.5332922180463294,1.0,10/33,17.38%,PRKG1;APOD;MEF2C;PDCD4;SOD2;TPM1;OGN;TAFA5;TGFB3;NDRG4
prerank,nuclear pore complex assembly (GO:0051292),0.7722269853541988,1.4620977369955157,0.11208151382823872,0.7135487854722049,1.0,4/10,6.57%,NDC1;NUP205;AHCTF1;TPR
prerank,response to amyloid-beta (GO:1904645),-0.3852583995056413,-1.461894959061978,0.017699115044247787,0.5312428846800198,1.0,16/44,14.10%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;CASP4;VCAM1;LGMN;CACNA1B;CHRNA7;ATP1A3;APP;GRM5;MMP2;GRIN1
prerank,telomere capping (GO:0016233),0.7258937545295525,1.461852637076248,0.10821917808219178,0.71230405482184,1.0,11/16,18.74%,TERF1;STN1;PRKDC;MRE11;TERF2;TINF2;ACD;DCLRE1A;TERF2IP;DCLRE1C;RAD50
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6723353086079764,1.4617300857108706,0.10664993726474278,0.7105145037256929,1.0,6/26,11.37%,BRCA1;CNOT1;VPS18;SMARCA4;KANK2;HDAC1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.671420036961065,1.461067834074968,0.10754017305315204,0.7108263518067282,1.0,1/26,0.19%,BRCA1
prerank,negative regulation of transmembrane transport (GO:0034763),-0.5847205445492798,-1.4610235944331706,0.08169014084507042,0.5303129256905666,1.0,5/10,12.52%,AKT2;CTTNBP2NL;IRS2;INPP5K;THBS1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.6422386621662147,1.4598711326900278,0.07924107142857142,0.7128915466649709,1.0,13/45,14.33%,ZWILCH;BUB1B;BUB1;WEE1;ZW10;CHEK1;SCRIB;BTG3;GAS1;TOM1L2;PLK2;CDKN1B;SMAD3
prerank,organophosphate catabolic process (GO:0046434),0.7613970113079326,1.4584414856527255,0.12184249628528974,0.7160670298009713,1.0,2/11,6.97%,PON1;ENPP2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.4866437587903427,-1.4573165895622118,0.06611570247933884,0.5380587454254218,1.0,10/18,18.41%,SHANK3;CACNG7;NRXN1;TSHZ3;CACNG4;RELN;CACNG2;CACNG3;CACNG8;NLGN1
prerank,DNA methylation or demethylation (GO:0044728),0.6977298142718547,1.4571706019386186,0.11543450064850844,0.7163463208797187,1.0,5/19,8.10%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,DNA alkylation (GO:0006305),0.6977298142718547,1.4571706019386186,0.11543450064850844,0.7163463208797187,1.0,5/19,8.10%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP
prerank,response to nutrient levels (GO:0031667),-0.505660010107988,-1.4570701526311391,0.05172413793103448,0.535296718991737,1.0,5/17,10.95%,KCNB1;EIF4G1;ULK1;PRKAA1;MTOR
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.7082224500483507,1.455439637369889,0.13730569948186527,0.7207037179548441,1.0,10/19,18.35%,PIF1;TERF1;STN1;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,purine-containing compound salvage (GO:0043101),0.7241207076418732,1.4552421263589441,0.12051649928263988,0.7192123353699151,1.0,4/12,5.27%,ADK;ADA;DCK;HPRT1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.41470450485619165,-1.4549909425667245,0.05813953488372093,0.5384220811634624,1.0,8/30,21.17%,STAT3;TLR4;PIBF1;CD34;HSPD1;LGALS9;PRKCZ;CD274
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6547184036777881,1.4533569790617635,0.11294117647058824,0.7241440863871863,1.0,6/33,2.56%,E2F7;RBL1;WEE1;CDKN2D;CDKN2C;RB1
prerank,linoleic acid metabolic process (GO:0043651),-0.4919593783911304,-1.4529163422804963,0.08208955223880597,0.541280160096867,1.0,10/17,46.84%,PNPLA8;ACSL1;ELOVL1;FADS1;GSTM2;ALOX12;ELOVL2;ALOXE3;ALOX5;FADS2
prerank,telomere organization (GO:0032200),0.6417691323792984,1.4521644928263158,0.08928571428571429,0.7263433710566081,1.0,22/43,19.60%,TERF1;RTEL1;RPA1;STN1;ERCC4;POLD3;DNA2;PRKDC;BLM;MRE11;POLD1;RPA2;RIF1;PCNA;TERF2;TINF2;ATR;ACD;TERF2IP;RAD50;SP100;TERT
prerank,retrograde axonal transport (GO:0008090),-0.5163446444520849,-1.4519844892133216,0.08532423208191127,0.5406407775450498,1.0,6/16,10.40%,TMEM108;KIF1A;MAP1A;KIF5B;NEFL;ACTR10
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.6670562020574933,1.4511276964346003,0.10087173100871731,0.7279534082784618,1.0,8/27,14.72%,RRM2;TYMS;RRM1;CTPS1;GUK1;DTYMK;DUT;AK7
prerank,histone lysine methylation (GO:0034968),0.6400455628874183,1.4508561429282965,0.11852704257767549,0.7268001567366017,1.0,5/33,5.85%,EZH2;SETD6;PAXIP1;SETDB2;SETD3
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.49554295979793483,-1.4494732181203025,0.06097560975609756,0.5446527351557964,1.0,9/18,18.34%,EPHA5;RPS6KA5;CRTC1;RELN;CRTC3;ADCY8;LRP8;VEGFA;CRTC2
prerank,regulation of transposition (GO:0010528),0.7225002060349047,1.4491732484256177,0.13655761024182078,0.7309004725856413,1.0,1/13,1.03%,MYBL1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.6081420001663037,1.4485057303652893,0.0,0.7312267139889262,1.0,56/306,7.94%,BRCA1;EXO1;TICRR;CDK1;MRPL36;BRIP1;POLE;CLSPN;PIF1;BARD1;RMI2;DBF4;MCM5;POLA1;ORC1;PCLAF;E2F1;TYMS;TIPIN;POLA2;MCM8;CDC45;RFC4;NAP1L1;TIMELESS;FAM111A;MCM10;MCM6;MCM7;MCM2;PABPC4;TOPBP1;RBBP8;CDC6;AGO2;RPA1;LARGE1;RAD1;POLD3;DNA2;RFC2;SRBD1;BLM;MRE11;MRPL18;MCM3;POLD1;RPA2;MCM4;RFC3;ORC2;CHEK1;POLR2A;RNASEH2A;ORC3;CDK2
prerank,positive regulation of synapse assembly (GO:0051965),-0.41867803863024894,-1.4473864996152677,0.04736842105263158,0.5477257945294673,1.0,14/27,23.77%,PTPRD;SYNDIG1;GRID2;AGRN;EPHB2;IL1RAPL1;SEMA4D;NRXN1;LRRC4B;NLGN1;IL1RAP;BDNF;DLG5;SRPX2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.48569800103759375,-1.4457233619956156,0.08029197080291971,0.5496466322714207,1.0,11/18,18.61%,RIMS1;SHANK3;NRXN1;RELN;CHRNA7;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),-0.3391053049212397,-1.4453194264408384,0.0,0.5473499645712663,1.0,39/87,25.24%,IMMP2L;TTC19;COX16;UQCC1;NDUFS5;OXA1L;NDUFS1;OMA1;AIFM1;NDUFA9;COX19;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;UQCC2;NDUFA6;NDUFB9;DMAC2;ACAD9;PET100;COX20;SMIM20;COX17;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;COX14;TIMMDC1;NDUFA10;COA8;NDUFS6;NDUFA1;CHCHD4
prerank,indolalkylamine catabolic process (GO:0046218),0.7648785689720735,1.4451892881264066,0.12326656394453005,0.741595463432959,1.0,3/10,13.20%,ACMSD;KMO;IL4I1
prerank,regulation of myelination (GO:0031641),0.673597762473581,1.4451588019837713,0.11837237977805179,0.7395075432631564,1.0,1/25,0.13%,KIF14
prerank,DNA packaging (GO:0006323),0.7073780344800776,1.4439372453433177,0.11050477489768076,0.7417628416735496,1.0,6/16,15.81%,CHAF1B;HAT1;RBBP4;CHAF1A;KAT6A;TP53
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.7073042927869199,1.4432271013670679,0.1301460823373174,0.7423030803421078,1.0,5/17,6.79%,DHDDS;ALG14;ALG13;SRD5A3;MPDU1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.4871111918624122,-1.4427370399559682,0.06640625,0.5523927775813157,1.0,6/19,18.02%,PTK2;MAPK3;MAPK1;THBS1;CMKLR1;IL34
prerank,water transport (GO:0006833),0.7348689640155893,1.4423270886639625,0.12238805970149254,0.7435930982932349,1.0,2/12,5.71%,AQP1;PDPN
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.3430575090210185,-1.4417851865951623,0.011904761904761904,0.552140038636977,1.0,27/64,32.11%,PLA2G4A;SCP2;ACSL4;GPX4;PNPLA8;ACSL5;ACSL6;PTGS2;ASAH2;EPHX2;ELOVL6;GPX1;ACAD9;HPGD;SLC27A4;ACSL1;ELOVL1;AIG1;FADS1;GSTM2;HACL1;ACSBG1;ALOX12;CPT1A;PNPLA3;PLA2G4C;FAAH
prerank,exit from mitosis (GO:0010458),0.724095782513626,1.4405241052454787,0.12464183381088825,0.7483782153813857,1.0,2/12,2.03%,UBE2C;UBE2S
prerank,positive regulation of tissue remodeling (GO:0034105),0.7435284280533692,1.4396322997191966,0.12332838038632987,0.7494750830458976,1.0,3/10,9.38%,ROCK2;IL18;ROCK1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.7696616259162515,1.4393648876016314,0.13023255813953488,0.7483410021672652,1.0,4/10,12.59%,BRCA1;CHEK1;KMT2A;SMAD4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.7473602509911353,1.4383595177104502,0.12857142857142856,0.749919623248533,1.0,7/10,18.44%,RTEL1;RIF1;TERF2;ACD;DCLRE1A;TERF2IP;DCLRE1C
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.444691566679975,-1.4379164558873696,0.06432748538011696,0.5609572154081369,1.0,11/26,25.97%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1;TMEM106A
prerank,positive regulation of dephosphorylation (GO:0035306),0.6609558669637297,1.437744099627369,0.12192118226600986,0.7500652675150296,1.0,11/27,16.17%,CDCA2;PPP1R7;MTMR9;CALM2;BMP2;SMPD1;CAMTA1;PTPA;PIN1;SRC;ANKLE2
prerank,embryonic organ development (GO:0048568),0.6300744353250479,1.4376039427690674,0.06147091108671789,0.7483868813160721,1.0,22/61,16.85%,STIL;PBX4;GLI2;GLI3;FOXE1;PBX3;BMPR1A;TEAD1;FGFR2;KIT;ERCC3;KMT2A;TAL1;TEAD3;RBPJ;NES;HEY2;RARB;GDNF;SALL1;COBL;TEAD4
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.573355350622408,-1.437501169586673,0.08196721311475409,0.558679383340567,1.0,6/11,16.50%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,transepithelial transport (GO:0070633),-0.5075096198312467,-1.437056934961501,0.10175438596491228,0.5564933325229942,1.0,5/15,16.25%,SLC1A2;ABCG2;GPLD1;SLC1A1;SLC12A2
prerank,regulation of interleukin-10 production (GO:0032653),-0.37877174522283835,-1.4369916535505063,0.01680672268907563,0.5532585260578169,1.0,7/44,8.62%,STAT3;TRIB2;TLR4;PIBF1;CD34;TNFRSF21;HSPD1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.6148705698201016,1.436420877430861,0.06624605678233439,0.7505983257509191,1.0,18/73,10.06%,PHF19;EZH2;PPM1D;BAZ1B;DEK;SUZ12;CTCF;POLR1A;MPHOSPH8;EED;MYO1C;POLR1B;RBBP4;RBBP7;PHF1;PHF2;EPC1;TAF1D
prerank,fatty acid biosynthetic process (GO:0006633),-0.3526815842314342,-1.436238641868198,0.01694915254237288,0.5523374559977772,1.0,27/63,31.53%,ELOVL7;HACD3;ACLY;HACD2;GPX4;LIAS;HACD1;ABHD2;PTGS2;ASAH2;DEGS1;EPHX2;XBP1;ELOVL6;DECR2;ACOT7;CBR4;HPGD;SCD;ELOVL1;FADS1;ACSBG1;TECR;ALOX12;HSD17B8;OXSM;TECRL
prerank,negative regulation of viral transcription (GO:0032897),-0.5399867404343608,-1.4361101080695984,0.08992805755395683,0.5493337195432704,1.0,10/13,31.64%,MID2;IFITM3;TRIM27;TRIM14;TRIM21;TRIM11;TRIM32;ZFP36;HEXIM1;TRIM13
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.34209135789897616,-1.435472564645687,0.05172413793103448,0.5480435718161586,1.0,32/69,24.45%,UBE4A;HSP90B1;OS9;TRIM25;ECPAS;RNF103;EDEM2;EDEM1;UFD1;DERL1;SELENOS;HSPA5;UBXN4;RHBDD2;SGTA;STUB1;YOD1;SGTB;DNAJC18;DNAJB9;ERLIN2;SEC61B;AUP1;DNAJB12;SYVN1;UBE2G2;UBXN8;SEL1L;UBE4B;FAM8A1;WFS1;RNF103-CHMP3
prerank,regulation of protein acetylation (GO:1901983),0.7275019945772125,1.435168443337066,0.15029761904761904,0.7530573012512479,1.0,3/12,4.23%,CEP295;GSK3B;FAM161A
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5806344034054769,-1.4344742129159085,0.08408408408408409,0.547808398647459,1.0,4/10,23.39%,PFKP;HK1;PFKM;PFKL
prerank,tryptophan catabolic process (GO:0006569),0.744334217628273,1.4342802346983636,0.13392857142857142,0.7542328608284437,1.0,3/11,13.20%,ACMSD;KMO;IL4I1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.5191345329376108,-1.4328552111902102,0.09183673469387756,0.5492948415534045,1.0,7/15,21.78%,INPP5K;ATP1A2;TRIM27;SLC30A1;ADRA2A;PACSIN3;NOS1
prerank,protein K11-linked ubiquitination (GO:0070979),0.6578050997458977,1.4327718256424369,0.13228155339805825,0.7578236302097401,1.0,5/27,3.64%,UBE2T;UBE2C;UBE2S;ANAPC7;CDC27
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5953610499684663,-1.4326489493814072,0.07309941520467836,0.5466446363800107,1.0,8/10,34.92%,HSP90AB1;LAPTM4B;FURIN;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.593481680742959,-1.4324259857305108,0.08310991957104558,0.5442379344691002,1.0,5/10,16.43%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,aerobic electron transport chain (GO:0019646),-0.35079347541988903,-1.4321155749343493,0.0,0.541758865539951,1.0,33/68,25.19%,COX6C;COX4I1;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;NDUFA5;UQCRB;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFAF1;NDUFB6;NDUFA11;COX8A;NDUFB10;NDUFB11;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6547912330055169,1.431254268610179,0.118562874251497,0.7611617901905814,1.0,5/30,8.90%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.5744040078024897,-1.4306506964178278,0.08285714285714285,0.5429061456789517,1.0,2/10,2.43%,KCNAB1;CAV1
prerank,cellular response to alcohol (GO:0097306),0.6301008242763158,1.4305833086033564,0.10490307867730901,0.7615934845732399,1.0,9/42,11.56%,BRCA1;RAD51;GRAMD1C;BLM;CTNNA1;SPIDR;LARP1;AHR;KLF9
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.4287559591064356,-1.4293798572369607,0.07878787878787878,0.5432453340734251,1.0,16/29,30.56%,MCTP1;APOE;EPHB2;SHISA6;NETO1;RAB5A;APP;NSMF;DLG4;GRIK2;DRD2;SHISA9;SHISA7;CAMK2B;RAB3GAP1;CLN3
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.6680017337893115,1.4289198823962466,0.1437994722955145,0.7655351582500265,1.0,3/20,6.67%,BRCA1;PAXIP1;ARRB1
prerank,tRNA transport (GO:0051031),0.6289875817047889,1.4284258334397555,0.10867052023121387,0.7651773025681098,1.0,21/35,25.19%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35;NUP43;TOMM20;NUP93;NUP107;SSB;SEH1L
prerank,regulation of nervous system development (GO:0051960),0.6496127580079201,1.4282756171714364,0.0941860465116279,0.763526987910351,1.0,6/37,10.55%,KIF14;HMGB2;BHLHE41;NPHP3;YAP1;YTHDF2
prerank,spinal cord development (GO:0021510),0.721948835809866,1.428210733457164,0.13274336283185842,0.7616712478118356,1.0,2/12,1.21%,GLI2;LOXL3
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.5442625386317337,-1.427719494637474,0.10576923076923077,0.5450821185317434,1.0,6/12,21.96%,MAOA;HNMT;SMS;OAZ2;DDC;ATP7A
prerank,tRNA export from nucleus (GO:0006409),0.6343065138640966,1.4262917078928288,0.1154299175500589,0.7647617434340263,1.0,15/32,20.10%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.6343065138640966,1.4262917078928288,0.1154299175500589,0.7647617434340263,1.0,15/32,20.10%,NDC1;NUP155;NUP205;NUP160;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,renal system development (GO:0072001),0.6224347226137716,1.426199280735591,0.10099889012208657,0.7629922067909366,1.0,12/52,15.39%,CENPF;GLI2;SULF2;SULF1;NPHP3;AGT;C1GALT1;TGFBR1;TBX18;IFT27;ITGA8;GREB1L
prerank,embryonic axis specification (GO:0000578),0.6984833354494342,1.4260510859386195,0.13128491620111732,0.7613756611404879,1.0,1/15,0.41%,STIL
prerank,cellular response to UV (GO:0034644),0.5988322429366278,1.4260030479222585,0.06610703043022036,0.7594297683544025,1.0,26/76,17.18%,POLK;AURKB;AQP1;HYAL1;BMF;NEDD4;ERCC4;POLD1;FMR1;CHEK1;CUL4B;CDC25A;USP28;XPA;PCNA;PPID;USP47;YY1;SMPD1;RUVBL2;STK11;INO80;TP53;METTL3;PTPRK;ATR
prerank,nuclear export (GO:0051168),0.6007008246674251,1.425846872916057,0.059748427672955975,0.7578825963728365,1.0,22/80,12.89%,ANKLE1;CCHCR1;RANBP17;NUP155;XPO1;XPO4;SRSF4;PHAX;HNRNPA1;EIF4E;UPF3B;CSE1L;WASHC4;TPR;DDX39B;SRSF7;SMURF1;SRSF3;SRRM1;ATXN1;NUP214;STRADA
prerank,tRNA wobble base modification (GO:0002097),-0.5028123529191401,-1.4239695402817474,0.09385113268608414,0.5524570544764862,1.0,7/14,25.83%,ELP3;TRMT9B;MTO1;DPH3;ELP4;GTPBP3;ALKBH1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6792853671166768,1.4230717345959336,0.14412136536030343,0.7659668212667481,1.0,11/24,18.35%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TINF2;ACD;EXOSC10
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5014987008192305,-1.4229852703422385,0.06909090909090909,0.5522185966046731,1.0,11/15,32.41%,ENTPD1;CMPK1;ENTPD2;AK5;AK4;ENTPD5;CMPK2;AK1;NME2;ENTPD3;ENTPD6
prerank,response to muscle stretch (GO:0035994),-0.5061846818805599,-1.422352523715625,0.0763888888888889,0.5509729071552377,1.0,5/15,12.26%,PTK2;CDH2;RYR2;CTNNB1;GSN
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.40262843235265644,-1.4212732322356199,0.07432432432432433,0.5510351546479575,1.0,9/34,6.83%,PTK2;FLT1;TEK;PIK3R3;PDGFRB;PIK3R1;FGF2;PIK3R4;PIK3IP1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.5277912246907089,-1.4212340174395683,0.06896551724137931,0.5481487924872499,1.0,3/13,2.53%,PSEN1;TMSB4X;PER2
prerank,nucleotide biosynthetic process (GO:0009165),0.6855419087110473,1.4209676277152437,0.14127423822714683,0.7716758005845692,1.0,6/18,11.44%,RRM2;RRM1;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,spermatid development (GO:0007286),0.648665762654987,1.4202344295452816,0.11565420560747663,0.7721677830672365,1.0,4/32,7.18%,MEIOC;CEP57;MKKS;RFX2
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.4417868192345551,-1.4185965174069295,0.0625,0.5532201543898513,1.0,10/25,25.12%,HSP90AB1;INSR;TLR4;KLF4;KLF2;PTGS2;DDAH2;P2RX4;ASS1;EDN1
prerank,regulation of protein neddylation (GO:2000434),-0.5733644257185512,-1.4184883748487331,0.09785932721712538,0.550496057259478,1.0,7/10,30.05%,DCUN1D3;DCUN1D5;DCUN1D4;DCUN1D2;HIF1A;RPL11;COPS9
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6996933713173528,1.4181202879126333,0.13049645390070921,0.7778215484461496,1.0,5/13,15.75%,KPNA2;KPNA3;RANBP2;KPNA4;IPO5
prerank,regulation of B cell proliferation (GO:0030888),0.6198603308826348,1.4176594092223307,0.11864406779661017,0.7774110825856362,1.0,1/44,0.09%,TNFSF13B
prerank,regulation of catabolic process (GO:0009894),0.6543963076970755,1.4175985885293532,0.14111261872455902,0.7755489016549506,1.0,3/18,5.70%,FAM83D;CHEK2;FAF1
prerank,tryptophan metabolic process (GO:0006568),0.7375155211054358,1.4174349666939194,0.14497041420118342,0.7740098338922542,1.0,3/11,13.20%,ACMSD;KMO;IL4I1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.49595341350559163,-1.416705365087096,0.064,0.5527977956605404,1.0,3/16,1.04%,MCTP1;RIMS1;MEF2C
prerank,positive regulation of histone acetylation (GO:0035066),0.6665797884585845,1.4165402074649824,0.15,0.7753016345515515,1.0,3/23,6.67%,BRCA1;PAXIP1;ARRB1
prerank,cardiac muscle cell contraction (GO:0086003),-0.4731087061871824,-1.4158092844566574,0.07234042553191489,0.5523881408074782,1.0,7/19,18.25%,CAMK2D;CACNA2D1;SCN1A;ATP1A1;GSN;SCN1B;PIK3CA
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.38236451326153553,-1.4153019852053892,0.015037593984962405,0.5506564608552249,1.0,18/39,21.48%,PIP4K2A;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;EFR3A;SOCS5;ITPKB;PI4KA;SMG1;PIK3CD;TMEM150A;PIK3CA;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,signal peptide processing (GO:0006465),-0.5582561715707262,-1.4146151728407002,0.09064327485380116,0.5499747916037595,1.0,7/11,26.41%,PCSK5;FURIN;SPCS2;PARL;CLN5;SPCS1;SEC11A
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.5585613968246798,-1.4146023573789885,0.09798270893371758,0.5470364197821701,1.0,3/11,7.70%,ATP1B1;KCNJ3;ATP1A1
prerank,negative regulation of transposition (GO:0010529),0.6917886592670803,1.4139657618751724,0.1499312242090784,0.7825856349917997,1.0,4/16,13.45%,MYBL1;MOV10;TUT7;TUT4
prerank,mRNA methylation (GO:0080009),-0.49486739131913604,-1.4139611514548458,0.09302325581395349,0.546059696016179,1.0,8/15,16.73%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;CMTR1;CBLL1
prerank,nucleoside salvage (GO:0043174),0.7304784155625627,1.413925355158662,0.1458966565349544,0.7806134693232548,1.0,4/10,9.13%,TK1;DCK;HPRT1;CDA
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3856756643201935,-1.4139219968719006,0.04838709677419355,0.5432648348497567,1.0,11/41,17.53%,ATP1B1;KCNJ3;KCNJ6;ATP1A1;ATP1B3;ATP1A3;SLC12A9;KCNJ10;ATP1A2;SLC12A2;KCNK9
prerank,response to organonitrogen compound (GO:0010243),-0.3880352572513648,-1.413047954866322,0.04838709677419355,0.5429822837252004,1.0,14/38,23.09%,PRKN;GLRB;ERLEC1;GLRA1;GLRA3;DERL1;MTOR;RCN3;RRAGC;UBXN6;DNAJB12;SYVN1;DRD2;SEL1L
prerank,epiboly involved in wound healing (GO:0090505),0.6863875355514926,1.4122387773657317,0.1364256480218281,0.7849083412898527,1.0,9/16,15.76%,RHOA;PDPN;CCN1;TMEFF2;ARHGAP35;MRTFA;CD44;RHOC;LCP1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6154068795379277,1.4121733168588797,0.09513274336283185,0.7830049520743393,1.0,15/46,17.19%,KIF14;RHOA;ATRNL1;PARVA;ITGB7;LAMB1;EFNA1;TMEFF2;SRGAP2;RAC1;ITGA8;ITGAV;NTN4;FERMT3;ANTXR1
prerank,prostanoid metabolic process (GO:0006692),0.7082145505177203,1.4119495016488959,0.1466275659824047,0.7817675061295251,1.0,4/13,7.45%,PTGR1;PTGR2;HPGDS;PTGS1
prerank,odontogenesis (GO:0042476),0.6448832054690118,1.4111955719296383,0.11465721040189125,0.782414672486959,1.0,12/35,12.61%,GLI2;AQP1;FGFR2;BCOR;LAMB1;ANKRD11;AXIN2;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,sympathetic nervous system development (GO:0048485),-0.504162081224321,-1.4110768565077485,0.09187279151943463,0.5461041540028423,1.0,6/15,19.32%,NRP2;SEMA3A;NF1;CTNNB1;SOX4;NRP1
prerank,regulation of telomerase activity (GO:0051972),0.6152247568138243,1.4104591959575308,0.11744583808437856,0.7829988924106525,1.0,6/45,6.59%,NEK2;PIF1;AURKB;TERF1;ERCC4;GRHL2
prerank,regulation of embryonic development (GO:0045995),0.6249269523728113,1.4100801475993983,0.13652275379229872,0.7822680055476329,1.0,6/34,9.03%,CDK1;RACGAP1;NIPBL;WDPCP;CCSAP;NPHP3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.6207075882746445,1.4100675913954426,0.11383928571428571,0.7802434360603338,1.0,6/51,5.03%,NEK2;PIF1;AURKB;TERF1;STN1;HNRNPA1
prerank,actin polymerization or depolymerization (GO:0008154),0.6125398054858732,1.4096982381849053,0.10033076074972437,0.7795499382009704,1.0,10/50,14.59%,DIAPH3;DIAPH1;MICAL3;ABI1;ARHGAP6;TWF1;RAC1;SVIL;DSTN;CAPG
prerank,somite development (GO:0061053),0.7138701931087561,1.4093598048206073,0.14446002805049088,0.7787118424180887,1.0,4/11,9.89%,LOXL3;PPP2R3A;SFRP2;MEOX2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.6999734578256949,1.408884480065502,0.1361031518624642,0.7782521751850675,1.0,5/11,8.17%,MPHOSPH8;SETDB2;TPR;ATF7IP;TRIM28
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.38342961813206244,-1.4085907598150964,0.11224489795918367,0.5506781759269005,1.0,26/46,31.28%,FIS1;DNAJC19;HSPD1;AIFM1;TIMM44;PINK1;TOMM70;HK1;BCAP31;GDAP1;AIP;FBXO7;TOMM34;DNAJC15;PAM16;TIMM17A;TOMM7;TIMM17B;CHCHD4;TIMM9;TIMM13;TOMM22;TIMM8B;ROMO1;GRPEL1;TOMM5
prerank,covalent chromatin modification (GO:0016569),0.6986078761273342,1.4083913831846657,0.1731301939058172,0.7779250496869398,1.0,2/14,1.39%,AURKB;HELLS
prerank,vasoconstriction (GO:0042310),0.7344307153262142,1.4082140721884673,0.14180206794682423,0.7765245585254261,1.0,1/11,0.68%,KEL
prerank,epithelial cell differentiation (GO:0030855),0.5987463742122973,1.4080876239355324,0.0720250521920668,0.7750062463491493,1.0,12/88,11.46%,E2F7;E2F8;CDK1;SCUBE1;FGFR2;RAB10;GRHL2;SCRIB;FN3K;PCNA;HDAC1;ANXA1
prerank,ncRNA export from nucleus (GO:0097064),0.6215851475850086,1.407656025085322,0.11805555555555555,0.7745911434751324,1.0,16/36,20.10%,NDC1;NUP155;NUP205;NUP160;PHAX;NUP85;TPR;NOL6;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;NUP188;NUP35
prerank,tRNA wobble uridine modification (GO:0002098),-0.5125032101146714,-1.4072437952076544,0.09688581314878893,0.5520444362314108,1.0,7/14,25.81%,ELP3;TRMT9B;MTO1;TRMU;DPH3;ELP4;GTPBP3
prerank,acidic amino acid transport (GO:0015800),-0.5034497213709458,-1.4067746732729678,0.1078838174273859,0.5504041948311804,1.0,8/17,15.85%,SLC6A6;SLC1A2;SLC6A1;SLC25A13;SLC25A12;GIPC1;LRRC8D;SLC1A1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.6258015765842724,1.4060887271392262,0.10647639956092206,0.7782239346595899,1.0,7/47,6.71%,BRCA1;ACMSD;ATP2B4;ROCK2;GCK;ERFE;FBXW7
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.7187751283292659,1.4060484292483186,0.15597667638483964,0.7763448165325708,1.0,4/12,7.60%,GLI2;MYCBP2;NFIB;EPHA4
prerank,peptide biosynthetic process (GO:0043043),-0.2898823069071764,-1.405270021736642,0.0,0.5521033175060787,1.0,79/153,21.25%,EEF1A1;RPL13;FARSB;RPS8;PCSK5;RPS23;RPS29;RPL37A;RPS21;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;GGT5;MRRF;RPL8;FURIN;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;SARS1;RPL12;RPL27;RPL24;MRPS5;RPS12;RPS4X;RPS27;RPL27A;RPS9;WARS1;MRPS18A;MRPS15;RPL30;MRPS21;MRPS6;RPL19;RPL28;MRPL27;RPL31;RPL13A;RPL36A;RPLP2;RPL29;HBS1L;PCSK1;MRPL23;DHPS;MRPL9;TNIP1;RPLP0;RPL10A;RPS6KB2;RPS10;RPL35;RPS26
prerank,primary neural tube formation (GO:0014020),0.6286528379618881,1.4047919484115265,0.12911084043848964,0.7788909784983945,1.0,6/30,10.71%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,histone H2A monoubiquitination (GO:0035518),0.6766925246451935,1.4041216141499562,0.1503448275862069,0.7793134980945675,1.0,6/17,9.30%,RNF168;TRIM37;BCOR;PCGF5;KDM2B;CUL4B
prerank,bicarbonate transport (GO:0015701),0.653240812767204,1.4041186237315986,0.15272727272727274,0.7773143699132214,1.0,7/25,14.85%,RHAG;AQP1;SLC4A2;CYB5RL;SLC39A8;CA2;CYB5R1
prerank,nuclear pore organization (GO:0006999),0.6977415143825524,1.4036229420889852,0.1472972972972973,0.777077711107973,1.0,12/14,26.67%,NDC1;NUP205;AHCTF1;TPR;NUP133;NUP98;NUP35;NUP93;NUP107;SEH1L;RTN4;NUP153
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.5169892021939315,-1.4023044568070524,0.1134020618556701,0.5579542448427363,1.0,5/13,18.95%,GOT2;DLST;ADHFE1;GOT1;GPT2
prerank,female gamete generation (GO:0007292),0.6538702709312726,1.4014720075876987,0.14268440145102781,0.7828991087275663,1.0,10/29,19.55%,TRIP13;MCM8;DMC1;KMT2D;TOB2;USP9X;METTL3;MCM9;MARF1;FMN2
prerank,skeletal system morphogenesis (GO:0048705),0.6244389262372105,1.4014400295465186,0.13498312710911137,0.78101153070613,1.0,11/42,10.48%,RAB33B;CYP26B1;WWOX;FGFR2;HOXC4;PDGFRA;RFLNA;ANKRD11;DSCAML1;HOXB3;TGFBR1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.7327941300675976,1.4007373185269065,0.14558823529411766,0.7815998964675731,1.0,5/10,7.48%,KMT5A;SETD6;SETD3;EEF1AKMT2;SETD2
prerank,protein sumoylation (GO:0016925),0.615402539910569,1.4004039115447935,0.10898876404494381,0.780792699451259,1.0,30/49,25.24%,NDC1;NUP155;SAE1;NUP205;NUP160;NUP85;TPR;TRIM28;RANGAP1;NSMCE2;SUMO2;NUP214;TRPM4;RANBP2;NUP133;NUP42;NUP98;NUP210;EGR2;NUP188;NUP35;NUP43;PIAS1;UBA2;NUP93;UBE2I;NUP107;STX1A;SEH1L;EYA1
prerank,tube closure (GO:0060606),0.6264038930122563,1.3993623053694133,0.1292270531400966,0.7826066111213955,1.0,6/31,10.71%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;PLXNB2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.5784233017495255,-1.3993421169326132,0.07584269662921349,0.5630439111273606,1.0,6/10,32.66%,NR1H3;ABCD2;NR1H2;SLC45A3;MID1IP1;MLXIPL
prerank,kidney development (GO:0001822),0.5956412437911289,1.399298835919842,0.10086767895878525,0.7808536045326433,1.0,15/65,15.39%,CENPF;GLI2;SULF2;NIPBL;SULF1;KANK2;NPHP3;AGT;C1GALT1;TGFBR1;CTSH;IFT27;ITGA8;GDNF;GREB1L
prerank,telomere maintenance via telomerase (GO:0007004),0.6446832164664307,1.399135627614896,0.13927227101631118,0.7794049887179327,1.0,14/28,19.60%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,histone H4 acetylation (GO:0043967),0.6143588275599395,1.3990955116344161,0.1210762331838565,0.7775733314204096,1.0,21/47,18.78%,KANSL1;BRCA2;KANSL2;HAT1;ING4;MSL3;EP400;EPC1;KMT2A;JADE1;ACTL6B;RUVBL2;PER1;TRRAP;BRD8;PHF20;ZZZ3;KANSL3;NAA60;NAA40;JADE3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4205413086416829,-1.399062887084024,0.08653846153846154,0.561293889659944,1.0,14/26,18.61%,RIMS1;SLC8A3;SHANK3;TMEM108;NRXN1;RELN;CHRNA7;APP;SHANK1;DLG4;GRIN1;PRKCZ;NLGN1;STX1B
prerank,cellular protein catabolic process (GO:0044257),-0.3338384224721542,-1.3978970880322974,0.0,0.5617491296785844,1.0,23/59,21.46%,PRKN;ADAMTS12;UBE2G1;CTSC;CLPX;MALT1;AP2A2;CTSB;LGMN;CTSZ;BNIP3L;BNIP3;VLDLR;AP2M1;RAB12;CTSL;AP2S1;AP2A1;UBE2G2;CTSF;FAP;YME1L1;CTSS
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.44118389428866744,-1.3975182156573698,0.08450704225352113,0.5574465329232585,1.0,12/23,21.79%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.44118389428866744,-1.3975182156573698,0.08450704225352113,0.5574465329232585,1.0,12/23,21.79%,EP300;HSP90AB1;HIPK2;DAB2;GIPC1;THBS1;SDCBP;CITED2;SLC2A10;TGFB1I1;SNW1;CDKN1C
prerank,oogenesis (GO:0048477),0.693262738007622,1.395759095169328,0.14713896457765668,0.78776042122704,1.0,5/15,19.55%,TRIP13;KMT2D;METTL3;MARF1;FMN2
prerank,positive regulation of rRNA processing (GO:2000234),-0.5767636638774808,-1.395195140287975,0.11764705882352941,0.5616681512188911,1.0,9/10,39.98%,HEATR1;WDR75;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7;WDR43
prerank,regulation of coagulation (GO:0050818),-0.5553363295042606,-1.3950306931395722,0.09393939393939393,0.559304556427259,1.0,2/11,5.30%,CAV1;EPHB2
prerank,neural tube closure (GO:0001843),0.6224605624874728,1.3948811180703409,0.13110846245530394,0.7888773170653604,1.0,7/34,10.71%,STIL;MTHFD1L;MTHFR;GRHL2;SCRIB;KDM2B;PLXNB2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.4295287812052546,-1.3946560522529523,0.10160427807486631,0.5575484765162858,1.0,13/26,21.76%,SGIP1;ITSN2;FNBP1L;AP2A2;GPR107;AP2M1;AP2S1;AP2A1;FCHO2;CLTB;LMBRD1;FCHSD2;ITSN1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.533777902354498,-1.3942504499417536,0.10819672131147541,0.5559949756273292,1.0,6/12,30.21%,TLR4;GRIN1;RAB27A;ZNF205;SLC5A3;ADGRB1
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.6236834935729774,1.3930583951317357,0.1413427561837456,0.7934010668800022,1.0,6/33,6.39%,EZH2;FAM83D;HYAL1;TFDP1;DDRGK1;LSM11
prerank,nucleotide-excision repair (GO:0006289),0.5895797640297071,1.3930344313648706,0.06974358974358974,0.7915219861605786,1.0,18/101,7.46%,POLK;BRIP1;POLE;POLA1;BRCA2;RFC4;RPA1;CHD1L;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;PRPF19;POLR2A
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3708969703107376,-1.3927489749557855,0.06481481481481481,0.5573073507176902,1.0,8/39,4.32%,MAML3;STAT3;EP300;MAML2;JAG1;ZMIZ1;TGFB2;NOS3
prerank,diol metabolic process (GO:0034311),-0.4756727927364127,-1.3927380680833206,0.10548523206751055,0.554660381611092,1.0,8/19,16.50%,CALM1;NOS3;PLPP3;DEGS2;ASAH2;GCH1;PRKG2;PTS
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4244033975875968,-1.3923705795672168,0.09644670050761421,0.5531267404553912,1.0,12/27,26.82%,CAMK2D;AHNAK;CALM1;FKBP1A;SELENON;CACNB2;CACNB1;ADRA2A;PDE4D;NOS1;JPH2;JPH4
prerank,in utero embryonic development (GO:0001701),0.6595748509841324,1.3918905814025602,0.1596958174904943,0.7937920214464078,1.0,6/25,11.40%,STIL;FGFR2;ZNF568;LMX1B;TGFBR1;BMP2
prerank,fluid transport (GO:0042044),0.7188748507610006,1.3911633357963664,0.14074074074074075,0.7943163697417122,1.0,2/12,5.71%,AQP1;PDPN
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7313327834490574,1.388834012424957,0.1491628614916286,0.8005999098921829,1.0,4/10,9.73%,CBFB;ZBTB7B;SH3RF1;HMGB1
prerank,histone methylation (GO:0016571),0.6362748864008607,1.388201507753692,0.14441747572815533,0.8009359799598997,1.0,2/26,2.23%,EZH2;SETD6
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.6374987762742608,1.38804467429664,0.1432129514321295,0.7995101589920646,1.0,14/29,19.60%,PIF1;TERF1;RTEL1;RPA1;MRE11;RFC1;CDK2;TERF2;ANKRD28;TINF2;ACD;TERF2IP;RAD50;TERT
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.4053802660199912,-1.3879952627657963,0.06097560975609756,0.5635156075023803,1.0,15/30,23.75%,RASGRF1;IGF1;IRS2;LYN;TGM2;RELN;RASGEF1A;SHOC2;GRB2;SHC1;ERBIN;LRRC59;JAK2;MMD2;FGF10
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4580911027837605,-1.387921369570382,0.09387755102040816,0.5611400966500653,1.0,8/20,13.49%,CAMK2D;PSEN1;FIS1;PACS2;TGM2;BCL2;TMCO1;BCAP31
prerank,membrane depolarization (GO:0051899),-0.38803151547423786,-1.3873802947994942,0.06289308176100629,0.5600394902263056,1.0,20/32,37.86%,CAV1;SCN1A;CACNA1B;SCN9A;CACNG4;ABL1;CACNG2;SCN3A;SCN8A;SCN1B;P2RX4;P2RX7;CACNA1H;CACNB3;CACNA1I;YWHAH;SCN3B;CHRNA4;CACNA1A;KCNH2
prerank,central nervous system neuron differentiation (GO:0021953),-0.39006340785022564,-1.38697378174478,0.037267080745341616,0.5585094294308303,1.0,13/33,22.17%,SPOCK1;NTRK2;OPHN1;GRID2;PROX1;MDGA2;CTNNB1;SOX4;LRP6;TOX;GBA2;ATP7A;ZC4H2
prerank,B cell homeostasis (GO:0001782),-0.5603975916857433,-1.3863361082940127,0.11827956989247312,0.5577964579966919,1.0,3/10,6.74%,DOCK10;MEF2C;LYN
prerank,secretory granule organization (GO:0033363),-0.5600793454312625,-1.3845678613097798,0.13897280966767372,0.5607860398552773,1.0,5/10,14.60%,LYST;SRGN;DTNBP1;BLOC1S2;VPS33B
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5785303888537285,1.3840707691795815,0.09488272921108742,0.811968605277832,1.0,10/72,7.46%,SHCBP1;CEP57;SETX;FGFR4;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A
prerank,cellular response to amyloid-beta (GO:1904646),-0.37472377464379725,-1.3837976604490905,0.0472972972972973,0.5604224948406841,1.0,13/35,14.10%,CACNA2D1;PSEN1;GRIN2A;IGF1;TLR4;LRP1;CASP4;VCAM1;LGMN;ATP1A3;APP;GRM5;GRIN1
prerank,artery development (GO:0060840),-0.4435263174511612,-1.3837456485733695,0.07655502392344497,0.5579517849981651,1.0,13/23,19.32%,SMAD7;BMPR2;ACVRL1;ACVR2B;NF1;TBX1;VEGFA;ENG;STRA6;ROBO2;PDE2A;SLC2A10;NRP1
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.428940303102187,-1.3833860992392326,0.07317073170731707,0.556259913012689,1.0,7/25,14.10%,PRKN;TMTC2;TRPM7;CAV1;FAM20A;SELENON;GRIN1
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.4858425691564495,-1.3830669490210037,0.0989399293286219,0.5547499713877949,1.0,9/17,33.39%,SLC7A5;PRKCQ;CEBPB;LGALS9;PRKCZ;CD86;SYK;FCER1G;RARA
prerank,positive regulation of chemotaxis (GO:0050921),-0.3745620101029405,-1.3829011544956284,0.05555555555555555,0.5526388930863536,1.0,16/43,22.29%,TMSB4X;STX4;PDGFRB;NTRK3;STX3;FGF2;LGMN;MEGF8;MET;THBS1;PPM1F;VEGFA;SMOC2;NRP1;P2RX4;HSPB1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.6514445757603566,1.382703603737441,0.1527777777777778,0.8147493266153886,1.0,8/18,22.47%,AQP1;NR3C1;HNRNPU;ANXA1;KLF9;PCK2;UBE2L3;ZFP36L1
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.4757995834977258,-1.3826208677896938,0.1038961038961039,0.5511592752202547,1.0,8/19,22.21%,MAOB;NOX1;PRDX2;PRDX1;GPX1;PRDX3;PARK7;PRDX5
prerank,axonogenesis (GO:0007409),-0.2728211220266865,-1.3809739393994551,0.0,0.5533807508711149,1.0,90/237,19.33%,PTK2;ENAH;SH3KBP1;EPHA5;TNR;UNC5D;NRP2;NRXN3;RPS6KA5;HSP90AB1;SHANK3;SPG11;OPHN1;DCC;SEMA6A;PAK3;BSG;GRB10;ACTB;B4GALT5;CNTN6;FEZ1;S100A6;KLF7;NRCAM;LGI1;SEMA6D;MAP1B;TAOK2;SEMA7A;BRSK1;EPHB2;PIK3R1;IRS2;PLCG1;ULK1;B4GALT6;SEMA4D;NRXN1;MAP1A;PRKCQ;KIF5B;SEMA3A;PTPRO;SPTBN1;DAB1;LAMA3;RELN;KIF5C;MAPK3;CTNNA2;SIAH1;NOTCH3;GFRA1;FEZ2;GFRA2;VLDLR;APP;MAPK1;PDLIM7;SLIT2;GRB2;UNC5C;SLITRK1;PTPN11;CNTN2;EPHA8;NTNG1;SEMA3B;SHC1;DOK5;SCN1B;UNC5B;ROBO2;USP33;SEMA3C;SHTN1;APBB1;PIK3CD;PIK3CA;NEXN;TUBB3;BAIAP2;SLITRK4;SHC3;ROBO4;EFNB3;SEMA5B;NRP1;CYFIP1
prerank,inorganic ion transmembrane transport (GO:0098660),0.6930234605162995,1.3805350555724434,0.16715542521994134,0.8209346174761778,1.0,1/12,0.91%,RHAG
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.6169475518051677,1.3793826969224798,0.15714285714285714,0.8230708090306649,1.0,4/35,5.03%,NEK2;AURKB;RTEL1;HNRNPA1
prerank,regulation of histone acetylation (GO:0035065),0.6172302816192718,1.3792145363596355,0.14681107099879662,0.82170082518283,1.0,6/33,9.83%,BRCA1;PAXIP1;CTBP1;ARRB1;CHEK1;KMT2A
prerank,regulation of establishment of cell polarity (GO:2000114),0.6888421436877269,1.3786513282134893,0.16071428571428573,0.8217620234750239,1.0,2/16,3.09%,KIF20B;ROCK2
prerank,regulation of T cell differentiation (GO:0045580),0.6137634867408391,1.3778855919278494,0.15566037735849056,0.8224815852196844,1.0,2/33,2.36%,FANCA;CBFB
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.6328162793825459,1.3775532455232826,0.1608643457382953,0.8216824314206741,1.0,8/30,7.52%,DDIAS;CDKN2D;FBXO5;DYRK1A;RTEL1;DDX39B;SFRP2;YJU2
prerank,signal release from synapse (GO:0099643),-0.36241197712524514,-1.376349988713942,0.03759398496240601,0.5649072849164665,1.0,13/43,17.36%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;DVL1;CPLX1;SNAP25;SYT10
prerank,positive regulation of leukocyte activation (GO:0002696),-0.47669598203484187,-1.376272486262815,0.1148936170212766,0.5626723541545121,1.0,6/18,19.30%,TLR4;LBP;HSPD1;THBS1;NECTIN2;KARS1
prerank,transition metal ion homeostasis (GO:0055076),-0.41892207190335395,-1.3760056355673809,0.09302325581395349,0.5608505601531912,1.0,9/28,18.29%,PRKN;FBXL5;FTL;HMOX2;NEO1;B2M;IREB2;CUTC;COMMD1
prerank,mRNA modification (GO:0016556),-0.43590224748757783,-1.3759818829451018,0.07655502392344497,0.5584465157468059,1.0,10/22,16.73%,METTL16;NSUN2;TRMT61B;METTL14;PCIF1;ZC3H13;TRUB1;CMTR1;DKC1;CBLL1
prerank,histone modification (GO:0016570),0.5871780217575884,1.3757180799214728,0.062118126272912425,0.8264985324853811,1.0,20/109,10.23%,UHRF1;EZH2;INCENP;AURKB;SGF29;BAZ1B;EYA4;MIER1;CCNA2;TBL1XR1;UBE2N;MIDEAS;CDK2;RCOR1;MSL3;USP21;USP16;MIER3;MTA3;EYA2
prerank,negative regulation of cytokine production (GO:0001818),-0.2882002308670927,-1.375685131931753,0.0,0.5567819239175533,1.0,47/163,19.48%,APOD;LEF1;RPS6KA5;TMSB4X;TRIB2;MAP2K5;RNF135;GAS6;TLR4;PIBF1;TRIM25;KLF4;PDCD4;IKBKE;CD34;TNFRSF21;CYLD;UFD1;PTPN22;SELENOS;SARS1;SRGN;CHID1;IRF3;THBS1;RGCC;CX3CL1;SYT11;TRIM27;RNF125;ABCD2;HDAC7;HDAC9;TBK1;C1QTNF3;IFIH1;PPP1R11;SSC5D;DDIT3;CMKLR1;LGALS9;NLRC5;UBA7;SLC2A10;NCKAP1L;INHBA;ZC3H12A
prerank,cell differentiation in hindbrain (GO:0021533),-0.5434167889277723,-1.3748010444930172,0.11834319526627218,0.5567900363253129,1.0,3/11,4.85%,OPHN1;GRID2;PROX1
prerank,relaxation of muscle (GO:0090075),-0.5163181891817628,-1.3740743983520254,0.12631578947368421,0.5563967677035528,1.0,8/13,25.08%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.4259650505402599,-1.3734085418033632,0.08849557522123894,0.5559918714697549,1.0,3/23,7.30%,PLA2G4A;PLAAT3;PNPLA8
prerank,response to hydrogen peroxide (GO:0042542),0.6089324016960259,1.372640237587163,0.13318284424379231,0.8354251051987813,1.0,6/45,5.77%,ECT2;AQP1;SETX;FXN;NET1;STK24
prerank,neurotransmitter secretion (GO:0007269),-0.35875992974376625,-1.3720314885127205,0.0625,0.5575044773012594,1.0,13/44,17.36%,PCLO;SYN3;RIMS1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;DVL1;CPLX1;SNAP25;SYT10
prerank,positive regulation of protein processing (GO:0010954),-0.4538494156409057,-1.3714968034123407,0.11538461538461539,0.5564705441360197,1.0,6/19,18.88%,CCBE1;GSN;PLGRKT;ENO1;NKD2;CLEC3B
prerank,sodium ion transport (GO:0006814),-0.3223296172524295,-1.3706220939215206,0.022222222222222223,0.5564947104421814,1.0,22/85,16.25%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SGK1;SCN1A;FGF13;SCN9A;ATP1B3;NDUFA9;SLC5A6;SLC5A5;ATP1A2;SCN3A;SCN8A;SCN1B;SLC4A8;SLC6A11;SLC12A2
prerank,pre-replicative complex assembly (GO:0036388),0.588424365178601,1.3689415559216311,0.10991379310344827,0.8466060513802957,1.0,17/64,10.87%,MCM5;ORC1;MCM8;MCM6;MCM7;MCM2;CDC6;PSMC2;PSMD5;MCM3;MCM4;ORC2;ORC3;PSMB1;PSMD14;PSMD1;PSMB9
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.6776719832866377,1.368196772124045,0.17320703653585928,0.8472794261533613,1.0,5/18,9.38%,KIF20B;ROCK2;RIPOR2;LLGL2;ROCK1
prerank,regulation of glucose metabolic process (GO:0010906),-0.3957177920703994,-1.367892772706277,0.047619047619047616,0.5614973090078238,1.0,10/34,14.45%,PRKN;OGT;AKT2;IRS2;GPLD1;PDK1;SELENOS;IRS1;ZNF692;DGKQ
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4443643583716359,-1.367706769155252,0.10822510822510822,0.5596185857089606,1.0,13/20,30.22%,CDC73;MEIS2;CDK6;MEIS1;HOXA5;PRMT1;HOXA9;PTK2B;MAFB;HSPA9;ZFP36;HOXB8;CIB1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.6925594625723137,1.3671117870901306,0.17456021650879566,0.8492205498154953,1.0,7/15,12.61%,GLI2;ANKRD11;WNT6;EDA;HDAC1;BMP2;HDAC2
prerank,regulation of nervous system process (GO:0031644),-0.45298155653582306,-1.3662698647150628,0.09504132231404959,0.5610025730629803,1.0,8/18,11.05%,DLGAP1;DLGAP4;SLC8A3;TMEM108;NOS3;HTR2C;CHRNA7;APP
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.47856439335087747,-1.3660358215975956,0.10486891385767791,0.5592297135056973,1.0,10/16,32.98%,PINK1;NUPR1;COX7A2;UQCC2;ATP7A;AK4;PDE12;MLXIPL;PPIF;VCP
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.33231968527680383,-1.3655802018660648,0.03773584905660377,0.5580763771679991,1.0,33/69,25.19%,COX6C;COX4I1;COX5A;COX7B;NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;COX7C;NDUFS3;UQCRC2;NDUFB3;NDUFS4;NDUFA5;UQCRB;NDUFA6;NDUFA4;NDUFB9;UQCR10;UQCRQ;NDUFAF1;NDUFB6;NDUFA11;COX8A;NDUFB10;NDUFB11;NDUFA10;UQCRC1;COX5B;NDUFS6;NDUFA1
prerank,negative regulation of secretion (GO:0051048),-0.5592455314467437,-1.363213306987488,0.12912912912912913,0.5623793184025304,1.0,7/10,28.82%,NR1H3;VAMP8;VAMP3;PTGER3;CD74;EGF;ERBB3
prerank,lipoprotein catabolic process (GO:0042159),-0.5389336725904816,-1.363032534297535,0.12337662337662338,0.56044247322962,1.0,8/11,27.00%,APOE;LYPLA1;ABHD17C;CTSD;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.6045612480370485,1.3627359605762575,0.13105726872246695,0.8631801843583137,1.0,10/49,11.94%,KIF14;GSK3B;IAPP;PMEPA1;ANKRD27;SMAD6;RIOK3;HMGB1;PYDC1;AIDA
prerank,regulation of macrophage activation (GO:0043030),-0.393327594651012,-1.36251626939503,0.08571428571428572,0.5595286740212074,1.0,18/30,38.84%,TLR4;LBP;HSPD1;NR1H3;MYO18A;THBS1;KARS1;ZC3H12A;SHPK;SPHK1;MFHAS1;LRFN5;CD74;MIF;PJA2;TNIP2;FCGR2B;CEBPA
prerank,histone H2A ubiquitination (GO:0033522),0.6660905048506816,1.3623651850742553,0.176,0.8624681990993993,1.0,5/17,9.30%,RNF168;TRIM37;BCOR;KDM2B;CUL4B
prerank,regulation of phospholipase C activity (GO:1900274),-0.4990505742101351,-1.3597309654666023,0.12643678160919541,0.5647887436199074,1.0,8/15,10.85%,FLT1;PDGFRB;NTRK3;FGF2;BICD1;PLCG1;ESR1;ABL1
prerank,lipoxygenase pathway (GO:0019372),0.6662781681893224,1.3588426033944916,0.17851959361393324,0.8731326820658178,1.0,1/14,0.82%,PON1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.6950861923218599,1.3586292390166195,0.17664233576642335,0.8718549008061443,1.0,3/11,3.24%,FADD;TICAM1;COLEC12
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.407327570156372,-1.3577088987980905,0.11176470588235295,0.5676801232449035,1.0,13/30,27.90%,ELOVL7;HACD3;HACD2;ABCD4;HACD1;ACSL6;ABCD2;ELOVL6;SLC27A4;ACSL1;ELOVL1;ACSBG1;TECR
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5560012460777768,-1.3573023329577365,0.12944983818770225,0.5665133604274238,1.0,6/11,21.78%,CAMK2D;CACNA2D1;BIN1;CACNB2;CACNB1;NOS1
prerank,regulation of calcium ion transport (GO:0051924),-0.3528422359923805,-1.3571467757765656,0.053763440860215055,0.5646700887021691,1.0,18/54,22.05%,CACNA2D1;EPB41;SARAF;HOMER1;MYLK;CAMK2G;INPP5K;BCL2;CTNNB1;CACNB2;CRACR2A;SRI;ADRA2A;PLPP4;PACSIN3;NOS1;CD84;P2RX4
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.6491183842388599,1.3564693986876994,0.19035202086049544,0.8779383329750119,1.0,4/20,9.13%,ACMSD;GCK;ERFE;CDA
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6247447598312681,1.3559531073483302,0.1650485436893204,0.8777453885731445,1.0,8/28,11.74%,CDK5RAP2;CKAP5;PSRC1;NUMA1;MAPT;DRG1;AKAP9;RAC1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.6707258946825195,1.3556801873341784,0.15491009681881052,0.8766786508557979,1.0,8/14,19.60%,ATRX;BRCA2;TERF2;TINF2;ATR;ACD;TERF2IP;TERT
prerank,skeletal muscle tissue development (GO:0007519),-0.39232668037434454,-1.3554312123914225,0.08383233532934131,0.5670333018044525,1.0,7/32,11.42%,MEF2C;CAV1;IGSF8;MYL6;CAV2;SELENON;SIX1
prerank,nuclear membrane organization (GO:0071763),0.6520480174611053,1.3552791869328118,0.16944801026957637,0.8759895131527056,1.0,2/19,1.13%,PLK1;NEMP1
prerank,"wound healing, spreading of cells (GO:0044319)",0.6199499291531109,1.3551419350086882,0.17274939172749393,0.8744580089507182,1.0,12/24,15.76%,RHOA;PDPN;CCN1;ARHGAP24;TMEFF2;ARHGAP35;MRTFA;ADAM17;ITGA5;CD44;RHOC;LCP1
prerank,cardiac muscle contraction (GO:0060048),-0.3791743202155957,-1.3550289545917285,0.06164383561643835,0.5657782323093481,1.0,9/34,19.39%,CAMK2D;ATP1B1;RYR2;TPM1;GSN;ATP1A2;SCN1B;PIK3CA;KCNQ1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.3404098073309041,-1.3547793724437573,0.07317073170731707,0.5641281172375544,1.0,20/56,22.46%,HSP90B1;TAB2;TLR4;CTSB;SFTPA2;SFTPA1;TAB3;LGMN;NOD1;LBP;IRAK4;CTSL;CNPY3;UNC93B1;UBB;TIFA;CTSS;S100A1;RPS27A;UBC
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.5180341701449953,-1.3530305442518153,0.1411042944785276,0.5664648215631487,1.0,3/12,7.99%,PRKG1;MEF2C;TPM1
prerank,neural crest cell migration (GO:0001755),-0.3637158680554279,-1.3527874164757032,0.07142857142857142,0.5647905918095786,1.0,22/36,37.46%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;TBX1;SEMA3B;SEMA3C;SEMA5B;NRP1;SEMA6C;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;HTR2B;SEMA3E;SEMA4G;SEMA3F
prerank,genitalia development (GO:0048806),-0.5194391356813988,-1.3518280516952457,0.13354037267080746,0.5651799641786772,1.0,6/12,27.80%,DNAJC19;TBX3;PTPN11;STRA6;CHD7;FOXF2
prerank,regulation of trans-synaptic signaling (GO:0099177),-0.3970545875851639,-1.351432727255355,0.09433962264150944,0.5640674136731981,1.0,15/33,22.52%,NRG3;GRIK1;IQSEC2;GRID2;BCR;GRIK4;CACNA1B;RELN;PSMC5;LRP8;SLC4A8;NLGN1;GRIK2;GRID1;BDNF
prerank,acyl-CoA metabolic process (GO:0006637),-0.3804161992624495,-1.3507047875321287,0.078125,0.5638402559942183,1.0,14/35,27.84%,ACOT11;SUCLG2;ACBD6;DLST;ACACB;HMGCS2;ACSL6;DBI;ACSF2;ACOT7;ACOT13;MCEE;ACOT6;HMGCS1
prerank,regulation of mitochondrial translation (GO:0070129),-0.42321007880498623,-1.3504729645503943,0.08597285067873303,0.5622030162588354,1.0,17/21,44.18%,UQCC2;MTG2;TSFM;RPUSD4;ALKBH1;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;MTG1;SHMT2;RPUSD3;NGRN;MALSU1
prerank,positive regulation of cartilage development (GO:0061036),0.6377492663658848,1.3503779295030958,0.17896174863387979,0.8899576958680572,1.0,5/17,11.40%,BMP1;LOXL2;SOX6;TAPT1;BMP2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.48106451962457164,-1.3488337318558403,0.11313868613138686,0.5648791569855637,1.0,7/15,24.36%,VEGFC;NTRK3;SCG2;VEGFA;VEGFB;VEGFD;CXCL12
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.49054442533390374,-1.3487631652175485,0.11636363636363636,0.5627567282018054,1.0,11/14,43.89%,UQCC2;RPUSD4;FASTKD2;RMND1;COA3;MPV17L2;TRMT10C;C1QBP;FASTKD3;RPUSD3;NGRN
prerank,positive regulation of transporter activity (GO:0032411),0.6685472878195517,1.3485632608384488,0.1835883171070932,0.8946356585605558,1.0,5/13,17.52%,PON1;PDZK1;KMT2A;STK39;WNK3
prerank,cellular response to alkaloid (GO:0071312),0.6442629470262291,1.3483574879197298,0.1611185086551265,0.8933164623272225,1.0,5/17,9.40%,RAD51;CASP7;BLM;SPIDR;SLC8A1
prerank,histone ubiquitination (GO:0016574),0.6387775621949987,1.3481518069949503,0.19770408163265307,0.8919861841827744,1.0,4/21,9.09%,UHRF1;UBE2N;RNF40;LEO1
prerank,cellular response to interleukin-4 (GO:0071353),-0.5758140614638698,-1.347741323840071,0.13291139240506328,0.5635358612777628,1.0,4/10,21.08%,LEF1;STAT6;XBP1;SHPK
prerank,protein localization to Golgi apparatus (GO:0034067),0.6253744480761472,1.3475512878967284,0.17769607843137256,0.8922175700448922,1.0,7/27,12.33%,RAB33B;GBF1;OBSL1;BICD2;VPS13A;GAK;ZDHHC15
prerank,cellular zinc ion homeostasis (GO:0006882),-0.4114579692423524,-1.3473808730395103,0.07222222222222222,0.5621939575166792,1.0,13/26,20.86%,SLC39A10;SLC39A13;SLC39A7;SLC30A1;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.6121771948990481,1.3464946878894766,0.16953316953316952,0.8941518163044218,1.0,3/32,5.03%,NEK2;AURKB;HNRNPA1
prerank,positive regulation of B cell activation (GO:0050871),0.5808957689543919,1.3459413517556849,0.1545253863134658,0.8941952321888074,1.0,3/50,3.93%,TNFSF13B;PAXIP1;MMP14
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4914293113900873,-1.3457305410808553,0.11724137931034483,0.5645275214266849,1.0,8/14,19.13%,ETNK1;SLC27A1;CHKA;ETNK2;PCYT2;SELENOI;CHKB;LPIN1
prerank,inhibitory synapse assembly (GO:1904862),-0.5318879760530419,-1.3453027059375555,0.11730205278592376,0.5636651839886706,1.0,5/11,11.29%,GABRB3;GABRA2;FGF13;GABRB2;GABRG2
prerank,innate immune response in mucosa (GO:0002227),-0.5434491190928809,-1.3446357034950558,0.13496932515337423,0.5632342323579776,1.0,2/10,10.51%,DEFA6;RPL39
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.4933919592512659,-1.3444231248854062,0.11074918566775244,0.5616563109222616,1.0,9/15,22.29%,TMSB4X;FGF2;LGMN;FGF1;MET;THBS1;SMOC2;P2RX4;HSPB1
prerank,DNA methylation (GO:0006306),0.6276040534002323,1.3443536833427148,0.18734177215189873,0.8980032061033897,1.0,7/23,14.27%,ATRX;HELLS;PPM1D;GATAD2A;ATF7IP;METTL4;DNMT3A
prerank,regulation of B cell apoptotic process (GO:0002902),0.6864179234846749,1.3439808318362438,0.18115942028985507,0.8973282801952065,1.0,2/12,2.98%,AURKB;FNIP1
prerank,anterograde axonal transport (GO:0008089),0.6023481048292063,1.3431398630742513,0.1716937354988399,0.8983674151292108,1.0,2/37,3.22%,KIF4A;TRAK1
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.5580481973658051,-1.3431215762223077,0.14912280701754385,0.5629551748286522,1.0,9/10,43.86%,NAF1;DKC1;RPUSD4;GAR1;NOP10;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.6772203146020442,1.3428466867856772,0.17062937062937064,0.8974055180968634,1.0,4/13,6.79%,ALG14;ALG13;SRD5A3;MPDU1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.6257426384951434,1.3424919608771877,0.17271589486858574,0.8966784529929692,1.0,10/26,18.76%,RRM2;RRM1;LARGE1;TKT;ALG8;ST3GAL4;ST3GAL2;GK5;GK;GCNT1
prerank,aromatic amino acid family catabolic process (GO:0009074),0.6698517576282915,1.3418944568803461,0.18450704225352113,0.8968912958884397,1.0,3/15,13.20%,ACMSD;KMO;IL4I1
prerank,regulation of anoikis (GO:2000209),-0.4467814405818003,-1.341741262881722,0.12658227848101267,0.564690228761698,1.0,9/19,21.74%,PTK2;CAV1;SIK1;TLE1;BCL2;PIK3CA;TLE5;MYBBP1A;PTRH2
prerank,regulation of striated muscle contraction (GO:0006942),-0.4058711352057279,-1.3408966139777057,0.085,0.5647847679039136,1.0,9/27,22.05%,SMAD7;SLC8A3;CALM1;RYR2;ATP1A2;SRI;CALM3;NOS1;P2RX4
prerank,tetrahydrofolate metabolic process (GO:0046653),0.6998158279689808,1.3398846264169808,0.17496229260935142,0.9023259538754014,1.0,3/10,5.66%,TYMS;MTHFD1L;MTHFR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5399787898928001,-1.3397122517681699,0.13056379821958458,0.5638042077514201,1.0,5/10,15.62%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5399787898928001,-1.3397122517681699,0.13056379821958458,0.5638042077514201,1.0,5/10,15.62%,AP2A2;VLDLR;AP2M1;AP2S1;AP2A1
prerank,negative regulation of transferase activity (GO:0051348),0.6184879761551261,1.3394379011939652,0.1855921855921856,0.9020728769372839,1.0,12/28,15.81%,PIF1;TERF1;FBXO5;GSK3B;ERCC4;MAPT;HNRNPU;BAG5;EIF4A2;CDKN1B;SRC;TP53
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.36940377458931767,-1.339222287944119,0.0743801652892562,0.5629899096455921,1.0,19/39,24.35%,RPS15;RPS7;RPS6;RPS14;RPSA;RPS28;RPS5;RPS24;RPS19;RPS27;METTL17;SNU13;RIOK2;ERAL1;LTV1;NOB1;EMG1;SURF6;MRPS7
prerank,negative regulation of hemostasis (GO:1900047),-0.5051550883697801,-1.3390569101393908,0.14790996784565916,0.561357709284226,1.0,4/12,6.10%,APOE;VTN;THBD;CD34
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.3716044474804937,-1.3387065202283812,0.0975609756097561,0.5601609801270802,1.0,11/39,12.67%,KRIT1;TEK;ANO6;GAS6;PDCD4;CDH5;PLCG1;RAMP2;THBS1;SCG2;RGCC
prerank,engulfment of apoptotic cell (GO:0043652),0.6571804730785991,1.3384538638624932,0.19448275862068964,0.9036499778929106,1.0,1/15,0.66%,XKR5
prerank,V(D)J recombination (GO:0033151),0.6851544271883032,1.3379131878957085,0.18794835007173602,0.9036507439657209,1.0,4/11,15.42%,HMGB2;PRKDC;HMGB1;DCAF1
prerank,organelle assembly (GO:0070925),0.5591306693134047,1.3370964060903547,0.007,0.9045813451815219,1.0,68/385,10.88%,CENPF;CENPE;NEK2;CENPA;DLGAP5;KIF24;ANLN;HAUS8;PLK4;IFT80;HYLS1;CEP89;BBS9;CCDC61;HAUS4;HAUS6;DZIP1L;SCLT1;VPS37B;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;PATL1;EXOC4;KIF27;PCM1;TUBGCP5;OCRL;MAPT;HAUS7;TXNDC15;LSM3;EIF4ENIF1;MKKS;G3BP1;WDR11;CEP83;ATG7;VPS37A;RILPL1;NUDCD3;RFX2;SSX2IP;STAM;HAUS1;CCDC57;CENPJ;CFAP52;GOLGA8B;ZFYVE1;WDPCP;ATP2A2;NPHP3;LIMD1;RAB1A;RB1CC1;YTHDF2;CENPW;TRAPPC14;TTC39C;VTA1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6802956674041531,1.3370106369915165,0.1893491124260355,0.9028702150996523,1.0,3/12,9.13%,TK1;DCK;CDA
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.579631750849322,1.3369369334986032,0.1559432933478735,0.901170387680844,1.0,26/59,18.70%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;MARK2;CSNK2A2;CDC42BPG;TGFBR1;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3;WNK3;OXSR1;HIPK1
prerank,fibrinolysis (GO:0042730),0.6573246813194857,1.335889514406825,0.19480519480519481,0.903069842981282,1.0,4/13,18.50%,PLAU;SERPINE1;PLAUR;PLAT
prerank,neuron migration (GO:0001764),-0.3478810231398206,-1.3352769026984892,0.1016949152542373,0.5676758546391953,1.0,20/48,19.32%,ASTN2;MEF2C;SPOCK1;DNER;NTRK2;CDKL5;ELP3;ADGRL3;NRCAM;MAP1B;FGF13;SEMA3A;RELN;LRP12;VEGFA;DCX;DDIT4;GPM6A;TUBB2A;NRP1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6662643151867557,1.3351824513343882,0.20723226703755215,0.9037479650711585,1.0,3/13,7.79%,GLI3;CBFB;ZBTB7B
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.5385502899048213,-1.3349884409550818,0.13583815028901733,0.5664454916441871,1.0,2/11,8.02%,MALT1;PRKCQ
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6405020526801,1.334981319484424,0.19245773732119636,0.9025199963458885,1.0,10/21,15.93%,PNLDC1;CNOT1;CNOT6L;SAMD4A;TUT7;CNOT6;PAN3;TUT4;CNOT7;CNOT4
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.43187428538647166,-1.3342151754489568,0.1111111111111111,0.5665434479700481,1.0,13/20,31.66%,APOE;SREBF2;ARV1;FMO5;LDLRAP1;DGKQ;EPHX2;ABCA2;RAN;MBTPS1;ACADVL;MBTPS2;NR1H4
prerank,regulation of establishment of protein localization (GO:0070201),0.6581438042936368,1.3336902880171642,0.18273381294964028,0.9051262372192197,1.0,5/14,12.14%,CEP295;SPIDR;CENPJ;CEP120;SCFD1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.6429339227985352,1.3333138139567,0.18469656992084432,0.9044721483327179,1.0,1/20,0.19%,BRCA1
prerank,embryonic digestive tract development (GO:0048566),0.6573120645550103,1.333305594230277,0.18194070080862534,0.9025042743705145,1.0,7/18,13.79%,GLI2;GLI3;FGFR2;PDGFRA;NIPBL;RBPMS2;RARB
prerank,positive regulation of telomerase activity (GO:0051973),0.5966997052246966,1.3331889749776233,0.18607442977190877,0.9009998686310478,1.0,2/33,1.02%,NEK2;AURKB
prerank,axonal transport (GO:0098930),0.597238003545198,1.3325852275133498,0.17265353418308227,0.9011438334640263,1.0,1/36,0.11%,KIF4A
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.654210129771507,1.3324388105890492,0.2034383954154728,0.8997463936901948,1.0,4/12,7.94%,RFWD3;PRKDC;RPA2;CDK2
prerank,regulation of mitotic spindle assembly (GO:1901673),0.6383763196917828,1.3323932768328424,0.20157068062827224,0.8979373834493438,1.0,6/19,10.89%,PLK1;CEP97;TPR;CCSAP;HNRNPU;DRG1
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.49318853466291246,-1.3319924795856624,0.12937062937062938,0.570293168866196,1.0,5/14,13.11%,IGF1;GRN;TNFRSF1B;CX3CL1;SYT11
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4959524617729595,-1.3314544837362479,0.12781954887218044,0.5695263493566265,1.0,8/14,29.12%,ANO6;PDCD4;PLCG1;THBS1;RGCC;ECSCR;GPER1;CD40
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3364791139974389,-1.3313963214148676,0.06896551724137931,0.5675795201410015,1.0,34/54,36.42%,DCUN1D3;SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;CTNNB1;SPRY2;SOX4;SH3RF2;PIAS3;UBXN1;PRKCG;PARK7;MINAR1;RPS3;TRIM21;RPL11;U2AF2;COPS9;ADGRB1;TNFAIP3;SPOPL;VPS28;AKT1;BAG2;HSPA1A;SIRT7;ARRB2;CHP1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.6237619496684446,1.3313620525077046,0.18758085381630013,0.8996444963301854,1.0,1/21,0.46%,CDK1
prerank,relaxation of cardiac muscle (GO:0055119),-0.5007915751480685,-1.3307021149984763,0.148014440433213,0.5674031675259713,1.0,8/13,25.08%,CAMK2D;ATP1B1;ATP1A1;GSN;ATP1A2;PIK3CA;P2RX4;GSTM2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3759848450312977,-1.329702835578638,0.06015037593984962,0.5681373217905196,1.0,21/38,25.19%,NDUFS5;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFA4;NDUFB9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;NDUFA10;NDUFS6;NDUFA1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.6642762599165533,1.3293282837333114,0.18440779610194902,0.9048824922110705,1.0,1/11,0.73%,BARD1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.39373122570746477,-1.3288803778066218,0.11242603550295859,0.568338740668697,1.0,16/31,32.76%,KCNB1;SYT1;SYT7;SYT11;SYT12;SCAMP5;ADRA2A;SYT10;SYT6;SYT2;CACNA1H;RAB3GAP1;CACNA1I;SYT13;SYT3;CBARP
prerank,retinal metabolic process (GO:0042574),0.6612489264978882,1.3288330935414436,0.19460227272727273,0.9046927644788858,1.0,3/12,4.67%,ALDH8A1;ABCA4;RDH11
prerank,cytoskeleton organization (GO:0007010),0.5573034830108288,1.328639145187119,0.09257375381485249,0.9033420142491464,1.0,29/114,13.65%,DIAPH3;SYNE3;MAST2;PHIP;ARHGAP10;RHOA;OBSL1;PACSIN2;AJUBA;DIAPH1;MICAL3;CNN2;FGD4;ANK1;PRPF40A;PDZD8;FGD1;WDPCP;SH3D19;LIMD1;STRIP2;EPB41L3;FGD6;RND2;RAC1;DMTN;DES;LARP4;PRKCI
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6382785524469585,1.3283425358467695,0.21005154639175258,0.9024975071128706,1.0,9/21,13.63%,PAXIP1;SETX;MED14;SRF;MED30;BCLAF1;MED24;TWIST1;MED1
prerank,epithelial to mesenchymal transition (GO:0001837),0.5807981267234975,1.328300219479472,0.16345062429057888,0.9007076995941656,1.0,15/47,13.42%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;TGFBR3;AKNA;TRIM28;ROCK1;TGFBR1;LIMS1;BMP2;RBPJ;HEY2
prerank,sodium ion homeostasis (GO:0055078),-0.4289150912531167,-1.3278580904927044,0.13513513513513514,0.5689344092283991,1.0,6/21,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,regulation of synapse maturation (GO:0090128),0.7018414151660983,1.3272484404481408,0.17331288343558282,0.9025500232945644,1.0,2/10,4.55%,CDC20;ADGRL1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5925659401907849,1.3270776355594829,0.17889908256880735,0.9012242780562181,1.0,5/38,8.90%,BRCA1;FADD;GSK3B;SERPINE1;TNFRSF10B
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.5696196450930711,1.3263615096376322,0.15766738660907129,0.901722803756361,1.0,9/60,6.59%,NEK2;AURKB;DSCC1;RFC4;FGFR4;RFC2;HNRNPA1;RFC3;GRHL2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.4731469820405918,-1.3256315943511354,0.15,0.5728587098026888,1.0,5/15,9.37%,ABHD12;ABHD16A;GOT2;GGT5;PRODH
prerank,mesenchymal cell differentiation (GO:0048762),0.5852187119494143,1.3250073320759093,0.1767337807606264,0.9047756792236883,1.0,17/51,13.42%,FAM83D;LOXL3;LOXL2;TGFBR3L;ROCK2;GSK3B;FGFR2;TGFBR3;AKNA;TRIM28;ROCK1;FBXL17;TGFBR1;LIMS1;BMP2;RBPJ;HEY2
prerank,positive regulation of nervous system development (GO:0051962),-0.3561899042662805,-1.3244205494901726,0.06557377049180328,0.5742135868473656,1.0,23/42,27.95%,PTPRD;SYNDIG1;GRID2;EPHB2;NUMBL;IL1RAPL1;NUMB;NRXN1;TGM2;OPRM1;FAIM;LRRC4B;NLGN1;IL1RAP;SNW1;BDNF;DLG5;SRPX2;SERPINF1;TRIM32;GPER1;SOX11;EPHB3
prerank,negative regulation of translational initiation (GO:0045947),0.6692258885122115,1.3238405807532254,0.2032967032967033,0.9069646322351368,1.0,6/13,17.56%,AGO2;TPR;FMR1;LARP1;RBM4;PAIP2B
prerank,nucleus organization (GO:0006997),0.57678851184165,1.3232603634441544,0.16997792494481237,0.9071706013751863,1.0,7/47,7.63%,CEP55;NDC1;NUP155;NUP205;NUMA1;TPR;LEMD3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.5566763485907821,1.321769434385537,0.006,0.9105304109667622,1.0,100/417,15.02%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;CTCF;ZEB1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;SETDB2;MBD1;KHDRBS1;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;IKZF1;GZF1;SCML2;YAF2;TCF7L2;HOXA7;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;SFRP2;NIPBL;POU2F1;ZHX2;UIMC1;ATF7IP;SAP18;TRIM28;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;LIMD1;NONO;ARID4A;EPC1;MTA3;NR3C1;SFPQ;RUNX1T1;LIMS1;RBM15B;DKK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;ZHX3;ATXN1;FBXW11;RBPJ;SMAD4;HDAC2;ATF5;TWIST1;HEY2;USP47;BTRC;BCL7A;EIF4A2;FOXK2;CDKN1B;KDM5C;PCGF6;FOXM1;QARS1;PER1;YEATS2;RBAK
prerank,peptidyl-threonine modification (GO:0018210),0.5659478557080619,1.3216077703581068,0.16381156316916487,0.909146960859848,1.0,24/66,16.32%,CDK1;CIT;DYRK1A;ROCK2;GSK3B;NLK;GALNT1;PRKDC;DYRK3;WNK1;CHEK1;CDC42BPA;LRRK2;ROCK1;MARK2;CSNK2A2;CDC42BPG;TGFBR1;PRKCA;PDPK1;PRKD1;PRKD2;STK39;HIPK3
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.27877412505710164,-1.321493227732172,0.0,0.5798099857418146,1.0,77/168,21.25%,RPL13;AGO1;RPS8;NBDY;RPS23;RPS29;RPL37A;RPS21;RPL38;PARN;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;RPLP1;RPS13;RPL9;RPL37;RPL8;CSDE1;RPS14;RPSA;RPL10;ATM;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;RPL12;RPL27;RPL24;RPS12;DDX5;DCP1B;RPS4X;RPS27;RPL27A;RPS9;RPL30;EXOSC9;RPL19;RPL28;EIF4A3;RPL31;RBM8A;SMG1;MTPAP;RPL13A;RPL36A;DCPS;TENT4B;RPLP2;RPL29;TNKS1BP1;CNOT11;ZC3H12A;RPLP0;DCP1A;RPL10A;RPS10;NCBP1;RPL35;RPS26
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.6359278623705121,1.3214540676221107,0.17992177314211213,0.9077920108189569,1.0,9/20,15.48%,MOV10;AGO2;CNOT1;AJUBA;NRDE2;CNOT6;LIMD1;CNOT7;TNRC6C
prerank,regulation of phosphate metabolic process (GO:0019220),0.6437562704722647,1.3208055945738113,0.19101123595505617,0.9081075786963992,1.0,2/16,2.72%,BARD1;MCM7
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.3393190158288737,-1.3199398649983953,0.08064516129032258,0.5821789599132672,1.0,15/57,18.25%,GRM7;CHRM2;GABBR1;GNAI1;PSAP;GNAL;GPR37;OPRM1;HTR4;ADCY3;ADCY8;ADCY4;CHRM3;ADRA2A;PDE2A
prerank,lipid transport (GO:0006869),-0.2945102245018682,-1.3197036537113345,0.09090909090909091,0.5808384700708163,1.0,35/97,25.83%,CERT1;PLTP;ATP8A1;APOE;SLCO1C1;SLCO2B1;GOT2;SCP2;PEX3;ABCA5;SLC27A1;ABCC4;ATP8B1;CHKA;SLCO2A1;LBP;MTTP;SPNS2;GLTP;ABCD2;TNFAIP8L3;STARD5;PRELID3B;OSBP;SLC27A4;ACSL1;OSBPL2;PLEKHA8;ABCA2;MFSD2A;NPC2;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,signal transduction by p53 class mediator (GO:0072331),0.6066398271607363,1.3180572547087959,0.18399044205495818,0.9162024010568474,1.0,7/30,10.88%,E2F7;ATRX;PAXIP1;MDM4;HINT1;BOK;NDRG1
prerank,early endosome to late endosome transport (GO:0045022),-0.41706528286110833,-1.3170326732746276,0.1341991341991342,0.5857653644929728,1.0,5/20,12.93%,STX8;KIF16B;BECN1;RAB5A;HOOK1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.5916942261805314,1.3169969472995862,0.19086651053864168,0.9181204677012691,1.0,10/33,11.26%,TTF2;SETX;CSTF3;FIP1L1;SLBP;LSM11;WDR33;PCF11;SCAF8;CPSF4
prerank,positive regulation of macrophage activation (GO:0043032),-0.45578368290712784,-1.316908038050196,0.15162454873646208,0.5840598416381053,1.0,5/17,19.30%,TLR4;LBP;HSPD1;THBS1;KARS1
prerank,sulfate transport (GO:0008272),0.6744890298500311,1.3160191900287137,0.20488466757123475,0.9197833051089095,1.0,1/14,0.73%,RACGAP1
prerank,chromatin organization (GO:0006325),0.5481889959409684,1.3155764251955988,0.08417849898580122,0.9195019242771547,1.0,35/132,15.71%,PHF19;EZH2;ATRX;DDX11;HMGB2;LOXL2;SMARCC1;RB1;BAZ1B;CHD1L;SMARCAD1;SETDB2;TCF7L1;NUDT5;HMGN2;HP1BP3;RBBP4;ARID1A;NUCKS1;SETD2;PHF1;SMARCA4;HDAC8;HDAC1;HDAC2;MCM3AP;TADA2A;ACTL6B;KDM5C;RUVBL2;BAZ1A;SOX1;INO80;DR1;CHD1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.48057098738365706,-1.3153796194617973,0.16544117647058823,0.5859240752552535,1.0,6/15,13.87%,AKT2;PPM1K;IRS2;GPLD1;IRS1;LDLRAP1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.37742914498535673,-1.3148426947888154,0.10404624277456648,0.5853557991496257,1.0,12/32,26.78%,CAV1;AKAP6;CEMIP;PLCG1;TRPC3;TRPC1;CX3CL1;GRIN1;P2RX4;P2RX7;GPER1;THY1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.4855280704782806,-1.314413980140505,0.16194331983805668,0.5845587130191461,1.0,6/15,16.25%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.49947742797625344,-1.3139620013857563,0.13357400722021662,0.583671983670521,1.0,8/13,18.74%,ERLEC1;OS9;EDEM2;EDEM1;YOD1;BCAP31;SVIP;UBE2G2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.46959821949099156,-1.3136768986826777,0.15073529411764705,0.5823527751685731,1.0,8/15,22.29%,TMSB4X;FGF2;LGMN;MET;VEGFA;SMOC2;P2RX4;HSPB1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.5415649826223823,-1.3135453965119568,0.1305732484076433,0.5806823316733809,1.0,6/10,15.05%,GABRA2;GABRA3;GABRA5;GABRB2;GABRG2;GABRG1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.6029108481243488,1.31323474839873,0.18397997496871088,0.9258890674163721,1.0,4/28,8.17%,ECT2;TPR;UBR5;TRIM28
prerank,iron ion transport (GO:0006826),-0.3426627870671288,-1.3131638674684594,0.043478260869565216,0.5797650106187456,1.0,11/47,14.96%,ATP6V0A1;FTH1;ATP6V0D1;ATP6V1E1;SCARA5;ATP6V0B;ATP6V0A4;IREB2;ATP6V0C;ATP6V1H;MCOLN1
prerank,central nervous system myelination (GO:0022010),-0.5191986323170221,-1.3129003099382064,0.1572700296735905,0.578437446144761,1.0,4/11,13.78%,B4GALT5;B4GALT6;PLP1;TENM4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5009105628198669,-1.3128227317790735,0.17191977077363896,0.5766570538946431,1.0,9/12,20.27%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.6493545516978921,1.3120334145961734,0.2020497803806735,0.9282108313946472,1.0,6/13,16.10%,MOV10;ZC3HAV1;CNOT1;RC3H1;CNOT7;PNPT1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.5329976559991114,-1.3113625512710256,0.16304347826086957,0.5790080649499638,1.0,2/10,8.29%,PRKN;OXA1L
prerank,sprouting angiogenesis (GO:0002040),0.5703370756438556,1.311103400866821,0.16592920353982302,0.9296503562117778,1.0,12/51,14.41%,E2F7;E2F8;LOXL2;PARVA;SRF;ADGRA2;ROBO1;ANGPT1;NR4A1;RSPO3;EFNB2;MIA3
prerank,cellular protein-containing complex assembly (GO:0034622),0.550313933602844,1.3110150564662957,0.07114228456913828,0.9280147399547239,1.0,20/160,9.54%,CENPF;CENPE;CENPA;DLGAP5;ANLN;NDC1;NUP205;DNAAF3;DHX9;MAPT;EIF4H;MKKS;AHCTF1;TPR;TCF4;NCK1;DNAI4;ANGPT1;LONP1;PICALM
prerank,positive regulation of immune effector process (GO:0002699),-0.3881008931547078,-1.3109046877603727,0.11386138613861387,0.5782365462994211,1.0,7/27,17.26%,DDX60;LBP;RPS19;MYO18A;CD81;XBP1;LGALS9
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4524242832466112,-1.310887804201875,0.14864864864864866,0.5763359199857951,1.0,4/16,7.68%,KCNC2;APOE;NOS3;GUCY1A1
prerank,natural killer cell mediated immunity (GO:0002228),0.6473602294060675,1.3108573769525365,0.22052704576976423,0.9266744107566968,1.0,2/15,5.54%,ULBP1;RAET1E
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3995368231856842,-1.310741774611383,0.1270718232044199,0.5747768164476357,1.0,11/24,19.32%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MEGF8;SEMA3B;VEGFA;SEMA3C;SEMA5B;NRP1
prerank,neural crest cell development (GO:0014032),-0.3314484918146232,-1.3093507207227053,0.07920792079207921,0.5766082889856858,1.0,31/44,42.26%,CDH2;SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;TBX1;SEMA3B;SEMA3C;SEMA5B;NOLC1;KLHL12;SEMA6C;SOX11;SEMA3G;SEMA4C;SOX10;SOX8;SEMA4A;KBTBD8;HTR2B;SEMA3E;SEMA4G;SEMA3F;PDCD6;SNAI2;NRTN;SEMA4F;NRG1
prerank,response to estrogen (GO:0043627),0.5879483013651678,1.3087082471321485,0.1971326164874552,0.9325822413976952,1.0,1/31,0.19%,BRCA1
prerank,maintenance of protein location in nucleus (GO:0051457),0.6137944331568401,1.3083669217938227,0.2018111254851229,0.9318246134126124,1.0,9/20,19.16%,BARD1;TAF3;PML;RANGAP1;HNRNPU;MORC3;SUN2;SP100;SUN1
prerank,thyroid hormone generation (GO:0006590),0.6661455345593212,1.3078804580133327,0.20899854862119013,0.9315926961684237,1.0,2/10,8.46%,FOXE1;CPQ
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.40604188962009063,-1.3071345914634929,0.1452513966480447,0.5806792011830412,1.0,9/27,20.57%,RIMS1;SYT1;SYT7;SYT11;SYT12;ARL8B;SYT10;SYT6;SYT2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.42353483114555296,-1.3070651757171863,0.12796208530805686,0.5789498967731052,1.0,15/20,37.46%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;SEMA5B;SEMA6C;SEMA3G;SEMA4C;SEMA4A;SEMA3E;SEMA4G;SEMA3F
prerank,positive regulation of viral life cycle (GO:1903902),0.6067623029704555,1.3068644231539375,0.20332480818414322,0.9334122843762533,1.0,3/22,6.93%,KPNA2;VPS37B;FMR1
prerank,regulation of Golgi organization (GO:1903358),0.6288510334791287,1.3062143626571165,0.20164609053497942,0.9338455444016684,1.0,5/17,11.54%,RAB33B;USP6NL;ARMH3;STX18;AKAP9
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.4185175549760867,-1.306089906690564,0.13488372093023257,0.5795200056056661,1.0,12/24,26.82%,CAMK2D;CALM1;FKBP1A;AKAP6;SELENON;SRI;PDE4D;CALM3;NOS1;GSTM2;JPH2;JPH4
prerank,UV-damage excision repair (GO:0070914),0.6718362894657123,1.3059279562848802,0.21764705882352942,0.9330392457184155,1.0,5/12,15.19%,POLA1;POLD3;CUL4B;XPA;INO80
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.45421624386917675,-1.305799136289313,0.1773049645390071,0.5783845529336572,1.0,6/14,36.11%,PIBF1;THBS1;CMKLR1;IRAK3;C1QBP;JAK3
prerank,cardiolipin metabolic process (GO:0032048),-0.48454552620520186,-1.3053245895754912,0.16300940438871472,0.5776919284448293,1.0,4/13,7.30%,PLA2G4A;HADHB;SLC27A1;PNPLA8
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5596064172179773,1.3049582833961098,0.15074309978768577,0.9346344041174723,1.0,23/70,17.66%,KIF14;RB1;RHOA;ATRNL1;PARVA;ITGB7;LAMB1;GRHL2;EFNA1;RILPL1;TMEFF2;SRGAP2;YTHDF2;RAC1;ITGA8;ITGAV;NTN4;UNK;TBCD;METTL3;FERMT3;ANTXR1;ABI2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.41191321612137655,-1.3046442569927934,0.11864406779661017,0.5776124758233349,1.0,14/22,32.11%,RPL23;RPS15;RPS7;RPS20;RPL37;ATM;DDX5;UBB;CDK5RAP3;EEF1E1;HEXIM1;CHD5;HIC1;SPRED3
prerank,response to progesterone (GO:0032570),-0.4357835914573847,-1.304620234367635,0.1510204081632653,0.5757978749648365,1.0,10/18,25.79%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;THBS1;TGFB3;WBP2;UBE3A;CATSPER3
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5649360052045039,1.304255261514784,0.16630196936542668,0.9352405661436649,1.0,5/55,5.61%,HMMR;HPSE;SPAM1;HYAL1;GPC6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.5494188877748639,1.3039993095383067,0.09543147208121827,0.9342167750582232,1.0,27/144,10.34%,KIF20B;ECT2;GTSE1;E2F1;SAE1;MIEF2;GSK3B;XPO4;TFDP1;ANP32B;PCM1;PRNP;PDZK1;MYO1C;LEPROT;TCF7L2;TPR;FBXW7;RNF31;RAB29;SH3GLB1;UBR5;TRIM28;HTRA2;EMD;CSNK2A2;MIEF1
prerank,epithelial cell morphogenesis (GO:0003382),0.6373653514254102,1.3028557024807836,0.22029372496662217,0.9362866206397201,1.0,5/17,13.49%,COL22A1;COL18A1;GRHL2;RILPL1;COL15A1
prerank,endoderm development (GO:0007492),-0.49621834780286544,-1.3023904897617136,0.16095890410958905,0.5802041098807207,1.0,3/13,15.06%,KIF16B;DUSP1;SOX17
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.5273034020055306,-1.3022177000250503,0.18206521739130435,0.5768492443810808,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.5273034020055306,-1.3022177000250503,0.18206521739130435,0.5768492443810808,1.0,6/11,21.47%,CCT5;TCP1;CCT7;CCT2;DKC1;MEPCE
prerank,regulation of lipid kinase activity (GO:0043550),0.6682464471924399,1.3008772140440314,0.20287769784172663,0.9414146602866292,1.0,2/11,2.56%,RBL1;RB1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.4771124000602224,-1.3007719492550756,0.1554054054054054,0.5786090439325116,1.0,8/15,34.09%,NR1H3;NR1H2;PPARGC1A;SLC45A3;MID1IP1;MLXIPL;PPARG;NR4A3
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.5381834900045636,1.3005962888701583,0.1534446764091858,0.9404329266499819,1.0,11/87,7.46%,SHCBP1;CEP57;SETX;FGFR4;HYAL1;FGFR2;RBFOX2;HNRNPA1;FRS2;HNRNPH1;POLR2A
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.2942881498798967,-1.300562623527307,0.06,0.5774007201079688,1.0,30/75,23.34%,MEF2C;OPHN1;DCC;PAK3;ACTB;S100A6;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;MAP1A;BTBD3;TMEM106B;MINK1;CTNNA2;APP;MEF2A;SLITRK1;NTNG1;DVL1;SHTN1;APBB1;BAIAP2;SLITRK4;S100B;PLPPR4;DRD2;ZDHHC17;MFSD2A
prerank,receptor recycling (GO:0001881),-0.5201767973684922,-1.3003050215697354,0.18285714285714286,0.5764039759444181,1.0,6/10,29.68%,ARFGEF2;SORL1;NSG1;PHETA1;PLEKHJ1;REP15
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.5158510831717625,-1.3002408168646826,0.19469026548672566,0.5746777496451559,1.0,6/11,17.83%,PARP8;PARP12;TIPARP;PARP6;PARP16;PARP10
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.31528882462205604,-1.300073692329387,0.03636363636363636,0.5732690589212637,1.0,15/72,7.53%,PTK2;FLT1;TEK;NTRK2;INSR;IGF1;TGFB2;PDGFRB;BECN1;NTRK3;PIK3R1;FGF2;IRS2;LYN;SEMA4D
prerank,positive regulation of ERAD pathway (GO:1904294),-0.476134041513294,-1.2999448118247678,0.16216216216216217,0.5718802253854223,1.0,4/13,13.49%,ATXN3;CAV1;SGTA;BCAP31
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6177616365552867,1.2996610054201347,0.20107962213225372,0.9399928848692073,1.0,8/19,19.31%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6177616365552867,1.2996610054201347,0.20107962213225372,0.9399928848692073,1.0,8/19,19.31%,ATRX;TERF1;POLR2A;TERF2;TINF2;ACD;TERF2IP;POLR2B
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.36762770175499043,-1.2989247059593574,0.10457516339869281,0.5727738061527166,1.0,11/31,23.45%,PRKN;ATXN3;HSPA5;PACRG;STUB1;DNAJC18;TM7SF3;HSPB8;DNAJB12;UBE2W;BAG3
prerank,negative regulation of cilium assembly (GO:1902018),0.6657742113077036,1.2988642998516078,0.2116788321167883,0.9410285669399245,1.0,7/12,18.55%,CEP97;EVI5L;YAP1;TBC1D7;MAP4;ODF2L;LIMK2
prerank,organelle transport along microtubule (GO:0072384),0.5873691586692127,1.298543179159464,0.21342925659472423,0.9402521229896263,1.0,9/31,12.13%,ARHGAP21;TRAK1;MAPT;RHOT1;BICD2;NDE1;UXT;RAB1A;FBXW11
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5355996129877084,-1.2984824174141394,0.17183098591549295,0.5722031952116888,1.0,3/10,6.74%,STAT3;STAT6;LYN
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.5421406548279022,-1.298298706995252,0.1880597014925373,0.5709118918966901,1.0,5/10,13.64%,SHANK3;NETO1;RAB5A;APP;DLG4
prerank,defense response to protozoan (GO:0042832),-0.5182006952343066,-1.2981862002155786,0.14666666666666667,0.5694778166305824,1.0,10/12,43.13%,LYST;GBP4;GBP6;CD40;BATF;GBP7;MYD88;SLC11A1;GBP2;BATF2
prerank,negative regulation of cellular senescence (GO:2000773),0.6432590457189383,1.2971666693670367,0.21830985915492956,0.9433844083411608,1.0,6/13,15.01%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10
prerank,negative regulation of cell aging (GO:0090344),0.6348585229093922,1.2969140227178217,0.20600272851296045,0.9423923782069741,1.0,7/16,15.01%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;FOXM1;SLC30A10
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.5465834888657527,1.2966185475234884,0.13594232749742532,0.9416277104539654,1.0,22/88,16.20%,KIF14;CCNF;PSMC2;PSMD5;FBXL7;FBXW7;CUL5;FBXL8;PSMB1;PSMD14;CUL4B;PSMD1;SKP2;FBXL17;PSMB9;FBXW11;BTRC;FBXO27;PSMC6;FBXO17;FBXL14;AMN1
prerank,protein import into nucleus (GO:0006606),0.5528606126222891,1.2954656295311089,0.16720604099244876,0.9439041065371782,1.0,26/66,20.51%,KPNA2;RANBP17;NUP155;KPNA3;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;RANBP2;IPO11;NXT1;NUP133;KPNA4;IPO5;NXT2;FAM53B;IPO9;NUP188;NUP35;IPO4
prerank,fatty acid elongation (GO:0030497),-0.5022837725496665,-1.2953071154715967,0.16554054054054054,0.5753684166121282,1.0,7/13,27.90%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.610792962949627,1.2952159792026199,0.21878862793572312,0.9428874876351657,1.0,7/26,12.17%,CCNB1;EIF4E;CDC25B;CCDC57;CUL3;TAL1;PRKCA
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.44553449487195873,-1.2951911489462098,0.16312056737588654,0.5739186840034306,1.0,2/17,2.92%,PLA2G4A;PLAAT3
prerank,synaptic vesicle localization (GO:0097479),-0.47300155500727964,-1.294818053547891,0.13846153846153847,0.5730651292474179,1.0,7/13,18.48%,SPG11;SYNDIG1;KIF5B;KIF5C;SYNJ1;NLGN1;RAB27A
prerank,myelination (GO:0042552),-0.34563896203759625,-1.294590419063679,0.0859375,0.5718390393382579,1.0,21/46,24.19%,SLC8A3;MAL;B4GALT5;TNFRSF21;B4GALT6;PLP1;ACER3;NF1;ABCD2;ARHGEF10;SCN8A;DEGS1;CMTM8;GAL3ST1;ADGRG6;LGI4;PLLP;EIF2B2;PMP22;MARVELD1;GPC1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5683330035463375,1.2942934558518107,0.19471947194719472,0.9444044645276398,1.0,10/51,11.05%,KIF20B;MAP4K4;SNX1;NRK;ANKRD27;LRRK2;DNM2;SRGAP2;EPB41L3;PLXNB1
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.48689975459761725,-1.2938931245686354,0.1702127659574468,0.5720316449248993,1.0,9/13,20.27%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;IRS1;DYRK2;SORBS1
prerank,electron transport chain (GO:0022900),-0.4780055443886425,-1.2938360547275531,0.1752988047808765,0.570451362194048,1.0,9/15,30.25%,PDIA5;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;NDOR1;CYB561;UQCRFS1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6068926329027693,1.2937983355957747,0.2258469259723965,0.9442318551955625,1.0,3/22,3.50%,MASTL;ROCK2;GSK3B
prerank,receptor metabolic process (GO:0043112),-0.3142952247762397,-1.293409651177328,0.04,0.5698983559341056,1.0,16/53,12.14%,DNM3;KIF16B;CALCRL;CAV1;BECN1;LRP1;ACKR3;PIK3R4;RAMP1;DNM1;RAMP2;LGMN;CD81;AP2M1;GRB2;ARFGEF2
prerank,negative regulation of platelet activation (GO:0010544),-0.4534812608585001,-1.2930131483556835,0.12350597609561753,0.5693382193369515,1.0,4/16,5.31%,PRKG1;APOE;NOS3;THBD
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6024660286784294,1.292987024601853,0.20772946859903382,0.9451237282332152,1.0,13/30,18.65%,PIF1;TERF1;STN1;ERCC4;HNRNPA1;HNRNPU;TERF2;SRC;TP53;TINF2;ACD;EXOSC10;NIBAN2
prerank,neurogenesis (GO:0022008),0.5734045288219618,1.2924907498095448,0.19369369369369369,0.9450364249857326,1.0,7/43,6.30%,WDR62;CDK5RAP2;CIT;TRAK1;LPAR1;MAPT;CXCR4
prerank,proteoglycan biosynthetic process (GO:0030166),-0.35489026573835375,-1.290743526472764,0.09523809523809523,0.5735606462293762,1.0,12/31,19.05%,IGF1;BMPR2;CSGALNACT1;CHST9;FAM20B;NDST3;HS3ST3B1;EXTL3;CANT1;BMPR1B;B3GAT2;XYLT2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.41618643097969643,-1.290249449128322,0.11961722488038277,0.5729771100386561,1.0,6/23,19.48%,CARD16;IGF1;GAS6;CX3CL1;GIT1;ZC3H12A
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.543167625293685,1.2901621440301223,0.007,0.9516944854750827,1.0,122/497,15.60%,DEPDC1;CENPF;BRCA1;EZH2;BIRC5;LOXL3;GLI3;HMGB2;E2F1;CBX5;TYMS;RBM15;FOXE1;ATOH8;TERF1;BTAF1;PDS5A;ILF3;SYNCRIP;KMT5A;SFMBT1;TIMELESS;LOXL2;RB1;SP3;TWIST2;CDC6;CTCF;GSK3B;ZEB1;CNOT1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;SETDB2;WAPL;MBD1;KHDRBS1;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;IKZF1;EIF4ENIF1;GZF1;SCML2;YAF2;TCF7L2;SAMD4A;HOXA7;CAPRIN1;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;FMR1;SFRP2;NIPBL;POU2F1;ZHX2;UIMC1;ATF7IP;SAP18;LARP1;TRIM28;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;LIMD1;NONO;ARID4A;EPC1;MTA3;NR3C1;SFPQ;RUNX1T1;LIMS1;MRPL13;RBM15B;DKK3;EIF2AK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;ENPP1;ZHX3;ATXN1;FBXW11;RBPJ;SMAD4;HDAC2;ATF5;TWIST1;HEY2;RBM4;DHFR;USP47;BTRC;BCL7A;FOXK2;CDKN1B;KDM5C;PCGF6;FOXM1;QARS1;EPRS1;PER1;YEATS2;RBAK;CNOT7;KAT6A;FXR1;PASK
prerank,nucleic acid metabolic process (GO:0090304),0.5422159691868209,1.2889994215745801,0.18181818181818182,0.9539976167943407,1.0,23/69,19.31%,ANKLE1;KPNA2;TOPBP1;HNRNPD;RBFOX2;DNA2;HNRNPA1;DNASE2;HNRNPH1;POLR2A;HNRNPU;MMS19;HNRNPL;ENPP1;HNRNPH2;DXO;HNRNPA2B1;DDX1;METTL3;RAD50;XRN2;HNRNPR;POLR2B
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.35831240297154365,-1.2865726832239914,0.11428571428571428,0.5806318035188411,1.0,14/36,20.05%,FHIT;HSP90AB1;OPHN1;OGT;MAP1A;GIPC1;CCAR2;SDCBP;UBXN1;PRKCG;RYBP;AQP11;GABARAPL2;PARK7
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5087652515791569,-1.2862867832761942,0.17522658610271905,0.5796877054945371,1.0,5/11,14.68%,GIGYF1;IGF1;PIK3R1;IRS1;GIGYF2
prerank,regulation of axon regeneration (GO:0048679),0.6602573072098366,1.2852096445904637,0.22740963855421686,0.965692730104782,1.0,5/12,11.37%,RTN4R;STK24;EPHA4;CNTF;PTPRS
prerank,positive regulation of catabolic process (GO:0009896),0.5517050451559414,1.285093900825336,0.1810436634717785,0.9642194201337588,1.0,6/65,8.39%,DTL;BARD1;GSK3B;NEDD4;ATG7;SMURF1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5600154075374826,1.2839858340695618,0.2006651884700665,0.9663304097505618,1.0,9/48,12.40%,BRCA1;E2F1;CHEK2;PRKDC;PML;HTRA2;BOK;USP28;MSH6
prerank,regulation of intracellular transport (GO:0032386),0.5647824297830646,1.2825044245760457,0.2125,0.9697344512832371,1.0,9/38,15.76%,SPAG5;ATPSCKMT;NUMA1;LRRK2;GAS1;NUP214;SCFD1;RBM4;LCP1
prerank,ribosome assembly (GO:0042255),-0.32894008039702144,-1.281489149961992,0.0989010989010989,0.5902891795739081,1.0,29/47,34.10%,RPL3;RPS15;RPS14;RPSA;BRIX1;RPL10;RPS28;RPS5;RPS19;RPL24;TRAF7;RPS27;DHX29;MDN1;MTERF3;ERAL1;RPLP0;NOP2;MRPS7;BOP1;RPL11;MRPS11;MRPL22;DDX3X;RSL24D1;NLE1;MPV17L2;C1QBP;PWP2
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.35144312008463857,-1.281376007297968,0.1342281879194631,0.5888262360425869,1.0,13/34,16.13%,MEF2C;GRIN2A;GABRA2;GRID2;GLRA1;GRIN2B;GABRA3;GABRA5;GABRG2;GRIN1;GSK3A;GABRG1;INSYN2A
prerank,response to acidic pH (GO:0010447),-0.46374768085892154,-1.2812599078121618,0.1701388888888889,0.5873669064953032,1.0,7/13,36.63%,GPR4;LGMN;CTSS;SLC9A1;PKD2L1;CHP1;PKD1L3
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4724854666901913,-1.2806200866389745,0.17647058823529413,0.5873939583826029,1.0,5/14,13.66%,AKT2;IRS2;LONP2;IRS1;ABCD2
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.38849928227322533,-1.280195115828561,0.13440860215053763,0.5867302533741482,1.0,10/29,16.07%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;CD81;EPHA8;TNFAIP8L3
prerank,positive regulation of protein import (GO:1904591),0.5812151902894563,1.279784729267482,0.19852034525277434,0.9775083061267682,1.0,4/30,8.17%,ECT2;TPR;UBR5;TRIM28
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6022261296448191,1.2795285689584603,0.2416452442159383,0.9765541744252203,1.0,9/22,15.81%,PAXIP1;PSMC2;MED14;SRF;MED30;MED24;MED1;PSMC6;TP53
prerank,positive regulation of protein deacetylation (GO:0090312),0.6242774271529797,1.2794415971821143,0.21418439716312057,0.9749560721571889,1.0,4/14,7.79%,DYRK1A;CTBP1;NIPBL;ZBTB7B
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6170825250219387,1.2792118513248525,0.23190348525469168,0.9739245596030347,1.0,2/16,5.54%,ULBP1;RAET1E
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5119373798390033,-1.2789500641410338,0.18611111111111112,0.5882534350917377,1.0,4/10,21.45%,SLC2A1;SLC27A1;SLC27A4;ACSL1
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.2784801894063646,-1.2784547036670797,0.0625,0.5878199510035218,1.0,42/107,24.57%,PRKN;RASGRF1;RASGRF2;HSP90B1;ERLEC1;UFL1;ATF6;OS9;PIK3R1;UBA5;MAP3K5;CASP4;ATG10;DERL1;SELENOS;AIFM1;HSPA5;JUN;BCL2;PDIA4;THBS1;TMCO1;RCN3;BCAP31;CEBPB;TMTC3;NIBAN1;CREB3L1;SCAMP5;DDIT3;UBXN6;DNAJB9;DNAJB12;SYVN1;TMEM33;PIK3R2;ATP2A3;CDK5RAP3;SEL1L;WFS1;ERP44;MBTPS1
prerank,long-term memory (GO:0007616),-0.43290742848700425,-1.2783499582841953,0.14919354838709678,0.5863901841381542,1.0,7/19,12.24%,CPEB3;APOE;RASGRF1;SGK1;CAMK4;NFATC4;SHANK1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4911522230255599,-1.2772151221517527,0.16776315789473684,0.5877290445812878,1.0,5/13,25.12%,TLR4;NAMPT;SELENOS;JAK2;EDN1
prerank,respiratory electron transport chain (GO:0022904),-0.474870199233899,-1.2770652519137589,0.17549668874172186,0.5864087403787774,1.0,10/14,30.44%,SLC25A13;SLC25A12;GPD2;NDUFA5;PPARGC1A;ETFRF1;ETFDH;ETFB;UQCRFS1;SLC25A18
prerank,regulation of cellular metabolic process (GO:0031323),-0.3355735899192373,-1.2765905615217321,0.10619469026548672,0.585900281882277,1.0,11/45,13.47%,PRKN;KIF16B;TBC1D16;ACLY;RNF34;ACACB;PARL;SSH1;STUB1;PINK1;MPV17
prerank,regulation of adaptive immune response (GO:0002819),0.6050523700157795,1.2764308517319356,0.22631578947368422,0.9820691417125968,1.0,5/18,13.20%,FADD;IRF1;SAMSN1;AHR;IL4I1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.34102087081762456,-1.2748340005984709,0.10869565217391304,0.5888624877055616,1.0,13/37,17.02%,FHIT;HSP90AB1;OGT;HIPK2;RPL23;RPS7;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP
prerank,natural killer cell activation (GO:0030101),0.598530103697009,1.2745242892041901,0.23312101910828026,0.9870786124002441,1.0,5/23,12.73%,ULBP1;NFIL3;ELF4;SNX27;CASP8
prerank,response to ATP (GO:0033198),-0.44293138020387013,-1.2742033763161273,0.17194570135746606,0.5887695633566418,1.0,9/18,28.47%,RYR3;HSP90B1;TRPC3;SSH1;DGKQ;P2RX4;P2RX7;ABCC9;P2RY12
prerank,L-amino acid transport (GO:0015807),-0.3873561019195109,-1.2737856455239491,0.10112359550561797,0.5882736295027323,1.0,6/28,5.85%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC3A2;SLC7A5
prerank,regulation of protein dephosphorylation (GO:0035304),0.5683614044810595,1.2735273695526594,0.2062937062937063,0.9888665125875941,1.0,11/37,17.45%,CDCA2;PPP1R7;PPP1R8;CALM2;ENSA;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2;PPP6R2
prerank,regulation of microtubule-based movement (GO:0060632),-0.5011051061246832,-1.2717319906104818,0.21548821548821548,0.5921123770457383,1.0,9/11,45.29%,LAMP1;IGBP1;TTC21B;DYNLT2B;CFAP298;DRC1;HAP1;CCDC65;HDAC6
prerank,calcium import into the mitochondrion (GO:0036444),0.6473706768883104,1.2716692011196693,0.2413793103448276,0.9936810940914479,1.0,5/10,20.71%,MCU;MCUB;MICU1;MAIP1;MICU2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.5511946540516582,1.2706821751580724,0.22360953461975028,0.9953612613064843,1.0,17/41,20.10%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210;LACC1;NUP188;NUP35
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.4098439722923504,-1.2703311561642932,0.15348837209302327,0.5940863488144552,1.0,7/20,15.14%,PRKN;DCUN1D3;HSP90AB1;ZMIZ1;DCUN1D5;PINK1;DCUN1D2
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4965957721716602,-1.2700352527386116,0.20348837209302326,0.5931250123968962,1.0,6/12,19.75%,CAMK2D;CALM1;CAV1;SRI;PDE4D;CALM3
prerank,negative regulation of coagulation (GO:0050819),-0.46764322965154104,-1.2698265542227687,0.16783216783216784,0.5919377112295205,1.0,4/14,6.10%,APOE;VTN;THBD;CD34
prerank,regulation of intracellular signal transduction (GO:1902531),0.5334744401389248,1.269457208166881,0.019,0.9977527438952066,1.0,104/420,15.81%,TPX2;BRCA1;ECT2;EXO1;CDK1;BRIP1;FAM83D;BARD1;RACGAP1;RMI2;AURKB;ARHGAP22;ARHGAP11A;ARHGAP21;RFC4;KMT5A;MAP4K4;ULK4;AURKA;DEPDC1B;ARHGAP10;TOPBP1;ARHGAP28;RHOA;RBBP8;RPA1;CHEK2;MDM4;TAF3;RAD1;DNA2;WDR54;RFC2;ARHGAP18;BLM;MRE11;OCRL;NET1;MAPT;RHOT1;VRK2;STK3;RPA2;NRK;FGD4;RFC3;RBBP4;RBBP7;PML;ARHGAP36;RRS1;VAV2;CHEK1;TAF12;GNA13;FGD1;INPP5B;CDK2;ARHGAP24;LRRK2;SYDE2;ARHGAP19;RHOQ;IKBKG;CSNK2A2;MAPKAP1;SRGAP2;SRGAP3;PPP2R5C;MYO9B;ARHGAP6;ARHGAP35;TAF15;ARHGAP23;ARHGEF18;HDAC1;EZR;FAM13B;RAC1;TAF4;RRAS;PDPK1;TRIM6;SSRP1;HDAC2;DLG1;SPRED1;XIAP;PAK1IP1;ITFG2;PIP5K1C;STK11;PTPN13;ITGAV;PIN1;SLC15A4;TAOK1;PRKAG1;KAT6A;RHOC;PRKD2;NF2;PPP2R5B;TP53
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.6234359913431339,1.2691420872073742,0.23641304347826086,0.996985385980129,1.0,1/15,1.27%,GLI3
prerank,modification-dependent protein catabolic process (GO:0019941),0.5321105524908748,1.2677705422639192,0.09719438877755511,1.0,1.0,31/193,8.70%,DTL;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;FEM1C;PSMC2;CDC27;UBE2K;NEDD4;FBXL7;UBR4;KLHL15;SIAH2;SPSB2;RNF43;BUB3;ARRB1;ELOC;RC3H2;RNF40;SMURF1;CUL3;UBE2R2;PSMD14
prerank,positive regulation of coagulation (GO:0050820),0.6668582152459026,1.2668992339589547,0.22324159021406728,0.9996070786389386,1.0,4/10,14.11%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.6668582152459026,1.2668992339589547,0.22324159021406728,0.9996070786389386,1.0,4/10,14.11%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5272942544696219,-1.2647603815065918,0.2113564668769716,0.6034813468603104,1.0,5/10,22.18%,SMARCD3;CTNNB1;CX3CL1;VEGFA;DRD2
prerank,endochondral bone morphogenesis (GO:0060350),-0.49977744436479565,-1.2646729898525295,0.17575757575757575,0.602001975511162,1.0,3/11,7.11%,MEF2C;BMPR2;FOXC1
prerank,regulation of organelle assembly (GO:1902115),0.535013859895425,1.2645232820678252,0.19385593220338984,1.0,1.0,19/73,14.94%,STIL;CEP295;USP6NL;IFT140;TBC1D13;TBC1D2B;STAM;CENPJ;CEP76;ALMS1;SPICE1;NPRL3;SDCCAG8;TBC1D19;STX18;EZR;ATG3;PLK2;MTMR3
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.3835729448357441,-1.2640762881933918,0.18048780487804877,0.6018396539810698,1.0,6/26,9.74%,CAV1;WDFY1;IFI35;LBP;PTPN22;NR1H3
prerank,regulation of microtubule nucleation (GO:0010968),0.6740084639341496,1.263865512835403,0.23660714285714285,1.0,1.0,2/10,2.26%,CKAP5;RANGRF
prerank,aggrephagy (GO:0035973),-0.387574120530226,-1.2616496679294982,0.15151515151515152,0.6064987286922943,1.0,12/27,22.55%,PRKN;DYNC1LI2;SQSTM1;DYNC1I2;DYNC1LI1;DYNLL2;WDFY3;UBB;PARK7;RPS27A;UBC;WDR81
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5007706231175321,-1.2614926560675588,0.18885448916408668,0.6051593222901778,1.0,4/11,4.12%,ACVR1;SMAD7;TGFBR2;TGFB2
prerank,heart looping (GO:0001947),0.5569414841973782,1.2613682476998465,0.24018475750577367,1.0,1.0,5/40,9.03%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,regulation of membrane repolarization (GO:0060306),-0.486025953520257,-1.2593908913667804,0.20317460317460317,0.6090516953303167,1.0,3/13,3.48%,CACNA2D1;CAV1;AKAP6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6511766943655061,1.2576233490024182,0.2529411764705882,1.0,1.0,7/11,22.32%,PDPN;ENPP2;CORO1B;CD44;SRC;RREB1;ARPIN
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5917045218662071,1.2574524828216278,0.2374839537869063,1.0,1.0,8/22,16.89%,TGM1;FGFR2;CASK;KLF9;NOTCH2;PRKD1;MED1;PTPRK
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.5942338704931858,1.2571444162645236,0.2490118577075099,1.0,1.0,6/20,17.38%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4780985847930728,-1.2570009567196714,0.20677966101694914,0.6136464214969429,1.0,8/13,31.53%,ELOVL7;HACD3;HACD2;HACD1;ELOVL6;ELOVL1;TECR;TECRL
prerank,negative regulation of cellular metabolic process (GO:0031324),0.5552662576867003,1.256352250127948,0.2302325581395349,1.0,1.0,2/37,4.74%,BRCA1;WDR54
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4105446461814882,-1.2559922849446508,0.1606425702811245,0.6142674252673037,1.0,12/18,31.40%,GOT2;SLC25A13;SLC25A12;MTHFD1;SMS;GOT1;NIT2;ASS1;ASPG;ADI1;ASNS;NAT8L
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.44232852115308363,-1.2556574679653465,0.19591836734693877,0.6135598387239696,1.0,5/17,10.12%,TGFB2;TAOK2;LYN;MID1;STK25
prerank,respiratory system development (GO:0060541),0.5734074793808878,1.2553532523130628,0.24179829890643986,1.0,1.0,7/32,11.52%,GLI2;LOXL3;FGFR2;PDPN;SMCHD1;NPHP3;NKX2-1
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.5045254849407119,-1.2552970381742825,0.19122257053291536,0.6128609819563479,1.0,5/11,23.69%,UFD1;DERL1;POMT2;AUP1;TOR1A
prerank,cellular response to interleukin-15 (GO:0071350),-0.4742950033659023,-1.2549008015907146,0.19718309859154928,0.6104845408051492,1.0,6/13,28.89%,STAT3;GRB2;SHC1;IL15;JAK1;PLCB1
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4742950033659023,-1.2549008015907146,0.19718309859154928,0.6104845408051492,1.0,6/13,28.89%,STAT3;GRB2;SHC1;IL15;JAK1;PLCB1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.5692645284145241,1.2547245581720674,0.23980815347721823,1.0,1.0,9/32,16.17%,CDCA2;PPP1R7;CALM2;PPP1R15B;SMPD1;CAMTA1;PTPA;PIN1;ANKLE2
prerank,positive regulation of protein metabolic process (GO:0051247),0.5243634286172705,1.254662626127295,0.17520491803278687,1.0,1.0,14/110,9.87%,DTL;UHRF1;BARD1;ROCK2;GSK3B;NEDD4;IL18;SLC25A37;ATG7;CD80;SMURF1;ABCB10;AGT;RAB1A
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.4135258397580172,-1.2545352688878413,0.17757009345794392,0.6096670238419138,1.0,6/22,8.62%,CYRIB;STX7;MALT1;FBXO38;B2M;HSPD1
prerank,sulfur amino acid catabolic process (GO:0000098),-0.5054129549021004,-1.254532089771725,0.2484076433121019,0.6079875003602557,1.0,7/10,41.55%,TXN2;MTRR;CBS;CTH;ADO;MPST;BLMH
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5411893995200024,1.254469563139166,0.20257234726688103,1.0,1.0,6/63,12.29%,TNFSF13B;IL18;CD80;NCK1;ANXA1;NCK2
prerank,cilium organization (GO:0044782),0.5246035305763381,1.2530663757284426,0.089,1.0,1.0,41/210,10.82%,KIF24;MNS1;PLK4;IFT80;HYLS1;CEP89;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;OCRL;TXNDC15;MKKS;RTTN;WDR11;CEP83;RILPL1;NUDCD3;RFX2;SSX2IP;CCDC57;CENPJ;CFAP52;WDPCP;NPHP3;ODF2;RAB1A;TRAPPC14;TTC39C
prerank,peptidyl-lysine modification (GO:0018205),0.5279625494167385,1.2527810778589332,0.16288659793814433,1.0,1.0,46/99,25.24%,LOXL3;NDC1;NUP155;SAE1;LOXL2;LOX;NUP205;ATPSCKMT;NUP160;SENP1;NUP85;NDUFAB1;TPR;EEF1AKMT2;TRIM28;RANGAP1;VIPAS39;NSMCE2;SUMO2;NUP214;TRPM4;RANBP2;P3H4;NUP133;NUP42;PLOD2;NUP98;NUP210;EGR2;NUP188;NUP35;HDAC4;PLOD1;SIRT2;SIRT3;NUP43;PIAS1;UBA2;LOXL1;NUP93;UBE2I;NUP107;STX1A;EEF1AKMT1;SEH1L;EYA1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.41878318731638425,-1.252647639082948,0.1732283464566929,0.6111525566436694,1.0,5/19,19.48%,CARD16;IGF1;CX3CL1;GIT1;ZC3H12A
prerank,supramolecular fiber organization (GO:0097435),0.5289435824646316,1.2525517657944407,0.061,1.0,1.0,52/334,12.11%,KIF18B;KIF14;KIF2C;KIF24;FIGNL1;KIF18A;BMP1;SPTA1;LOXL3;CKAP5;KATNAL2;COL22A1;SHROOM3;STMN1;LOXL2;LOX;TRIOBP;TSPAN33;RHOA;COL4A6;CGNL1;IAPP;COL4A4;PCM1;TUBGCP5;TPM4;SIAH2;MAPT;MYO1C;COL18A1;COL5A2;CDC42EP2;FAT1;COL23A1;ADAMTS14;FBLN5;B4GALT7;CENPJ;CORO1B;TPPP;ADAMTS2;DDR2;SAMD14;FIGN;TLL2;TGFBR1;RND2;RAC1;COL4A5;CALB1;COL12A1;P3H1
prerank,phosphate ion homeostasis (GO:0055062),0.6443728665509667,1.2515828861133294,0.2549019607843137,1.0,1.0,2/10,11.79%,FGFR4;ENPP1
prerank,protein homooligomerization (GO:0051260),0.5283082319392903,1.2515091333159563,0.16615698267074414,1.0,1.0,24/114,16.10%,ECT2;POLQ;TK1;UPB1;ALDH1A2;BLM;HPRT1;TRPA1;ATL2;ATL3;FUS;USP16;APIP;TRPM2;ACACA;APPL2;MICU1;TRPM4;EHD1;GSDMD;VSTM5;SLC1A5;PKD2;PNPT1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.5387546243844301,1.2511723201734393,0.22742474916387959,1.0,1.0,19/50,20.10%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,regulation of gene silencing by RNA (GO:0060966),0.5387546243844301,1.2511723201734393,0.22742474916387959,1.0,1.0,19/50,20.10%,NDC1;NUP155;NUP205;NUP160;AGO2;NUP85;TPR;FMR1;POLR2A;PUM2;NUP214;RANBP2;NUP133;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,photoreceptor cell development (GO:0042461),-0.4680874134328298,-1.2503281246148534,0.19931271477663232,0.6154728325697009,1.0,6/14,23.34%,RORB;VEGFA;DCX;AHI1;RP1;MFSD2A
prerank,regulated exocytosis (GO:0045055),-0.25746498787270766,-1.250326414242171,0.0,0.6137912128085815,1.0,54/173,20.57%,CYRIB;PCLO;RIMS1;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;SYT1;APOOL;TGFB2;RAB27B;GAS6;PLEK;PSAP;ISLR;LYN;ABCC4;IGF2;SYT7;LHFPL2;ENDOD1;SCG3;SRGN;APP;TAGLN2;CHID1;THBS1;SYT11;SYT12;RAB11FIP2;RAB11FIP1;VEGFA;TMX3;HABP4;STEAP2;CPLX1;LAMP2;SCCPDH;TGFB3;SNAP25;SYT10;ACTN1;VEGFB;SYT6;TEX264;CLEC3B;VEGFD;SPARC;LGALS3BP;ITGB3;SYT2
prerank,selective autophagy (GO:0061912),-0.32220969087875484,-1.2499798392044061,0.1125,0.6130694921415152,1.0,23/56,22.55%,PRKN;DYNC1LI2;UFL1;BECN1;SQSTM1;UBA5;DYNC1I2;ULK1;DYNC1LI1;ATM;PEX5;DYNLL2;KLHL3;WDFY3;USP30;AUP1;ATG2B;TEX264;UBB;PARK7;RPS27A;UBC;WDR81
prerank,thymus development (GO:0048538),0.6243273758397462,1.2498207280950826,0.25673758865248225,1.0,1.0,3/13,10.48%,FOXE1;FADD;TGFBR1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.5426286967792989,1.2489139314308948,0.24862486248624863,1.0,1.0,11/48,10.06%,ATAD2;BAZ1B;DEK;POLR1A;MYO1C;POLR1B;ELOF1;ARID1A;CHEK1;PHF2;TAF1D
prerank,negative regulation of insulin secretion (GO:0046676),-0.43616276059018066,-1.2488292373821601,0.17557251908396945,0.6144348246078382,1.0,6/17,17.16%,PRKN;KCNB1;KLF7;IRS1;MIDN;ADRA2A
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.4332305990551929,-1.2486358897161098,0.1952191235059761,0.613351944457839,1.0,3/16,12.83%,CLDN5;CLDN11;CLDN12
prerank,polyamine metabolic process (GO:0006595),-0.4774319708891044,-1.248601134973029,0.20955882352941177,0.6117592727958365,1.0,8/13,38.18%,SAT1;SMS;OAZ2;DHPS;PAOX;HDAC10;ODC1;SRM
prerank,chromatin disassembly (GO:0031498),0.6254043412233651,1.2476614693933044,0.2483130904183536,1.0,1.0,5/14,8.78%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,nucleosome disassembly (GO:0006337),0.6254043412233651,1.2476614693933044,0.2483130904183536,1.0,1.0,5/14,8.78%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.32823769865234076,-1.2464616664769825,0.12931034482758622,0.6154752569239547,1.0,19/48,26.82%,CAMK2D;CALM1;FKBP1A;AKAP6;CEMIP;PLCG1;TRPC1;SELENON;CX3CL1;SRI;PDE4D;CALM3;NOS1;PTK2B;GSTM2;JPH2;GPER1;THY1;JPH4
prerank,positive regulation of protein ubiquitination (GO:0031398),0.5206518329128457,1.246417935370443,0.2063157894736842,1.0,1.0,11/80,9.24%,BRCA1;PLK1;PAXIP1;FANCI;MYCBP2;FBXW7;UBE2N;LRRK2;CUL3;ANGPT1;TBC1D7
prerank,regulation of isotype switching (GO:0045191),0.6305360381041226,1.2458540837398928,0.267425320056899,1.0,1.0,5/14,15.23%,PAXIP1;RIF1;KMT5C;SLC15A4;SHLD2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.5346938736711871,1.2458414050510302,0.20957446808510638,1.0,1.0,16/72,11.29%,POLK;RFC4;RPA1;ERCC4;POLD3;RFC2;POLD1;RPA2;ERCC3;RFC1;RFC3;PRPF19;POLR2A;CUL4B;XPA;PCNA
prerank,fatty acid oxidation (GO:0019395),-0.31139089250469926,-1.2457270588702343,0.13043478260869565,0.615585774680968,1.0,15/57,16.00%,ADIPOR2;HADHB;ACADM;CROT;SCP2;ABCD4;MECR;ALDH3A2;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;ADH5
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.4106040396864359,-1.245645408071075,0.20703125,0.6141381664950641,1.0,5/18,8.00%,FLT1;MEF2C;FGF2;PLCG1;IGF2
prerank,epithelium development (GO:0060429),0.5338232836520627,1.2456284048520099,0.1723076923076923,1.0,1.0,14/107,11.40%,STIL;CDK1;LOXL3;TIMELESS;FGFR2;ALDH1A2;PPP2R3A;GRHL2;FN3K;KANK2;MEOX2;ERRFI1;PCNA;BMP2
prerank,apoptotic DNA fragmentation (GO:0006309),0.6095690205109737,1.2450547568538117,0.2569906790945406,1.0,1.0,3/16,9.73%,HMGB2;DNASE2;HMGB1
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.4575916949424198,-1.2444710076496994,0.1873015873015873,0.6155476743003163,1.0,6/15,16.43%,NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,protein O-linked mannosylation (GO:0035269),0.592728022978619,1.2439435202245652,0.24570673712021135,1.0,1.0,6/18,11.98%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,presynapse assembly (GO:0099054),-0.44224288491161734,-1.243580788362809,0.17582417582417584,0.6161750514756817,1.0,7/16,19.55%,PCLO;PTPRD;LRRTM3;IL1RAPL1;DVL1;NLGN1;FZD1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.5246225220313364,1.2435678024575973,0.18491735537190082,1.0,1.0,12/98,9.87%,CCNB1;UHRF1;CDK1;ANXA2;XDH;ARRB1;FMR1;SCRIB;RAB29;ANGPT1;AGT;RAB1A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4498391181454408,-1.2431857922650449,0.208955223880597,0.6156654041295605,1.0,7/16,19.28%,PPP1R16B;FGF2;AGTR1;THBS1;VEGFA;GATA2;FGFBP1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.38337808785984967,-1.243117453698168,0.17708333333333334,0.6141873520162148,1.0,9/27,15.31%,PLAAT3;ETNK1;SLC27A1;PNPLA8;CHKA;ETNK2;PCYT2;SELENOI;CHKB
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.27769678418893945,-1.2423750843629238,0.043478260869565216,0.614454125211757,1.0,19/100,7.53%,PTK2;FLT1;TEK;NTRK2;PIP4K2A;PPP1R16B;INSR;IGF1;TGFB2;PDGFRB;BECN1;PIP4K2B;NTRK3;PIK3R1;FGF2;IRS2;LYN;PIK3IP1;SEMA4D
prerank,protein methylation (GO:0006479),0.5508349574266742,1.2422728913886343,0.24513172966781213,1.0,1.0,4/40,6.99%,EZH2;ATPSCKMT;SETD3;EEF1AKMT2
prerank,regulation of protein catabolic process (GO:0042176),0.524331713866992,1.2414845809313948,0.19131334022750776,1.0,1.0,9/99,6.95%,DTL;FAM83D;BARD1;GSK3B;CHEK2;MDM4;NEDD4;FAF1;ATG7
prerank,calcium ion transport (GO:0006816),-0.2815111962445493,-1.2414482502013537,0.05,0.6151956798716416,1.0,33/113,16.92%,CACNA2D1;GRIN3A;RYR3;PSEN1;SLC8A3;TRPM7;CALCRL;TRPC5;CAV1;RYR2;FKBP1A;ANO6;GAS6;SLC24A2;TRPC4AP;SLC3A2;CACNG7;TPT1;RAMP1;RAMP2;CACNA1B;TRPC3;TRPC1;CHRNA7;TRPM3;TMCO1;CACNB2;ATP2B2;MCOLN1;PANX1;CACNG3;CRACR2A;CACNG8
prerank,establishment of protein localization to organelle (GO:0072594),0.5279684026924706,1.2409804353381242,0.21845174973488865,1.0,1.0,20/72,17.48%,NEURL1B;RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;ZDHHC15;IPO11;NXT1;NUP133;IPO5;NXT2;FAM53B
prerank,motile cilium assembly (GO:0044458),0.6311581119325814,1.2406774226584938,0.24631268436578171,1.0,1.0,4/12,14.74%,DNAAF3;SPATA6;RSPH9;E2F4
prerank,regulation of hydrolase activity (GO:0051336),-0.29619157603952406,-1.2399613018532656,0.1016949152542373,0.617344570335812,1.0,17/71,12.12%,PRKG1;PTK2;EPHA5;CHN2;NTRK2;FGD5;CAV1;VAV3;RABGAP1;TDG;ARHGEF5;NF1;ARHGAP44;PLXNC1;RASIP1;RAB3GAP2;ARHGAP27
prerank,regulation of leukocyte activation (GO:0002694),-0.4496978630915811,-1.239458871274934,0.22145328719723184,0.6170956874315078,1.0,8/14,32.53%,LYN;MYO18A;SHPK;MFHAS1;GPER1;CD74;MIF;PJA2
prerank,protein complex oligomerization (GO:0051259),0.5144283778624015,1.2389144230713915,0.22302904564315354,1.0,1.0,19/85,16.71%,ECT2;POLQ;UPB1;BLM;ATL2;ATL3;STOML2;FUS;MCU;WDCP;BOK;MICU1;EHD1;GSDMD;VSTM5;PKD2;PNPT1;UGDH;LRRC8C
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.5960802460158637,1.2387305214422333,0.2396804260985353,1.0,1.0,7/16,16.30%,TERF1;RTEL1;ERCC4;TERF2;SMG6;HNRNPA2B1;TINF2
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.36341691406266763,-1.2384031793356303,0.16216216216216217,0.6181934638665597,1.0,10/28,13.93%,SHANK3;APOE;SQSTM1;EPHB2;LGMN;RELN;CHRNA7;ABL1;APP;ADCY8
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.575501763713445,1.2382661617969544,0.26424870466321243,1.0,1.0,6/22,17.38%,PLK1;IPO7;CDKN1B;IPO5;PTEN;TFAP4
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.42592056067545697,-1.2378856014401354,0.16731517509727625,0.617984054121066,1.0,10/17,19.75%,SMAD7;CALM1;EIF4G1;INPP5K;SPRY2;CADM4;DGKQ;PPEF2;DDIT4;CALM3
prerank,carboxylic acid catabolic process (GO:0046395),0.6230627819809346,1.2375615732374294,0.24963503649635035,1.0,1.0,1/12,0.82%,PON1
prerank,positive regulation of protein transport (GO:0051222),0.528401274778569,1.237556388013093,0.21147715196599362,1.0,1.0,12/67,13.76%,KIF20B;FRMD4A;PCM1;MYH10;BMP6;TPR;RAB29;EZR;SYTL4;ACHE;PPID;ADAM9
prerank,peptidyl-serine phosphorylation (GO:0018105),0.5199104593366762,1.2375189884792557,0.13266331658291458,1.0,1.0,51/153,18.82%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;NLK;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;MARK2;CSNK2A2;CAMK1D;TGFBR1;EIF2AK3;PRKCB;PRKCA;ULK2;PDPK1;CSNK1G2;MAPKAPK3;PRKCE;PRKD1;PRKCI;CAB39;PLK2;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;CSNK1A1;MAST4;CSNK1G1;SRPK2;PIKFYVE;MAST1;PKN2;MAPK14;HIPK1;RIPK1;CAMKV
prerank,diol biosynthetic process (GO:0034312),-0.4499804114099533,-1.2374294423468832,0.18505338078291814,0.6175922155925887,1.0,8/15,23.85%,ACER2;ASAH1;ACER3;QDPR;ASAH2;GCH1;ABCA2;SPHK1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.5389960225290847,1.237005735568068,0.24114285714285713,1.0,1.0,14/41,17.39%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,keratan sulfate metabolic process (GO:0042339),-0.3557704862661327,-1.2369280150482236,0.13580246913580246,0.6173363463339266,1.0,14/31,17.45%,GNS;FMOD;B4GALT5;HEXB;B3GNT2;ST3GAL6;B4GALT6;PRELP;HEXA;OGN;LUM;B4GALT4;GALNS;CHST2
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5953236030650793,1.235670457416834,0.2594142259414226,1.0,1.0,8/14,20.59%,ADK;LHPP;ADSL;PFAS;RFK;GART;PPAT;ADSS2
prerank,protein import into peroxisome matrix (GO:0016558),-0.478971605105012,-1.2350417874232518,0.21241830065359477,0.6207509860059048,1.0,4/12,10.97%,PEX5L;PEX1;PEX5;PEX6
prerank,cognition (GO:0050890),-0.3270504914452595,-1.234554997656343,0.140625,0.6203683594487008,1.0,18/42,27.66%,SHROOM4;PTCHD1;NF1;BBS4;SOBP;CHMP2B;CHRNA7;APP;GRM5;STRA6;CYFIP1;MFSD2A;CTNS;JAKMIP1;DOP1B;NSUN5;DGCR2;CHD7
prerank,granulocyte differentiation (GO:0030851),0.604526622951109,1.2341808630598325,0.25679347826086957,1.0,1.0,6/18,10.56%,E2F1;LBR;DEK;PML;CDK2;TAL1
prerank,protein autoprocessing (GO:0016540),0.6004190953884354,1.2337319661888626,0.2651413189771198,1.0,1.0,3/17,8.21%,FAM111A;FXN;HTRA2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.5408125003778205,1.2337190837253684,0.25278396436525613,1.0,1.0,3/46,6.33%,LMNB1;ANXA2;CNN2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6393608805956443,1.2332832212335372,0.27071823204419887,1.0,1.0,5/15,8.26%,RAB10;RTN3;LNPK;ATL2;ARL6IP1
prerank,cellular response to reactive oxygen species (GO:0034614),0.5280124530003759,1.232943734346586,0.249728555917481,1.0,1.0,10/59,11.46%,ECT2;AQP1;SETX;FXN;NET1;MAPT;PDGFRA;AGAP3;TRPM2;ANXA1
prerank,negative regulation of heart contraction (GO:0045822),-0.47543764585346476,-1.2321601598511263,0.22822822822822822,0.6247100203378578,1.0,7/11,40.77%,ATP1A2;SRI;PDE4D;ZC3H12A;PLN;SPX;PIK3CG
prerank,digestive tract development (GO:0048565),0.5598294972793463,1.2319772931987252,0.26346604215456676,1.0,1.0,6/33,7.58%,GLI2;GLI3;CLMP;FGFR2;KIT;NIPBL
prerank,heart morphogenesis (GO:0003007),-0.3115015657469859,-1.2305127515440193,0.11235955056179775,0.6274563548566661,1.0,15/50,15.06%,PTK2;ACVR1;INSR;RYR2;FKBP1A;ACVRL1;TGFB2;NOS3;TBX3;MEGF8;HEYL;TBX1;VEGFA;ENG;SOX17
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.42671547058161474,-1.2304489052995968,0.20522388059701493,0.6260149668261991,1.0,7/18,16.43%,PARN;NAF1;CCT5;TCP1;CCT7;CCT2;DKC1
prerank,peptidyl-lysine methylation (GO:0018022),0.5689185688720467,1.2303027059754938,0.25985221674876846,1.0,1.0,6/26,7.48%,KMT5A;SETD6;ATPSCKMT;SETD3;EEF1AKMT2;SETD2
prerank,positive regulation of programmed cell death (GO:0043068),0.5203324941537405,1.229819654180564,0.081,1.0,1.0,43/272,11.40%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;NET1;CCAR1;FAF1;STK3;ERCC3;FGD4;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;LRRK2;ING4;BCLAF1;KLF11;TNFRSF10B;DNM2;HMGB1;APAF1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,negative regulation of nuclear division (GO:0051784),0.6167505053023675,1.2283687849988805,0.24695121951219512,1.0,1.0,3/11,11.98%,FBXO5;CHEK1;TOM1L2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4526475700301559,-1.2276059733054763,0.2255892255892256,0.6317947053397781,1.0,7/13,27.33%,SAR1A;CD81;SAR1B;SORL1;SEC16B;TMEM30A;SEC16A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.5235288402374157,1.2275816582059824,0.22894168466522677,1.0,1.0,23/62,20.10%,NDC1;NUP155;NUP205;NUP160;AGO2;AJUBA;DHX9;NUP85;TPR;FMR1;POLR2A;LIMD1;PUM2;NUP214;RANBP2;NUP133;FXR1;NUP42;NUP98;NUP210;POLR2B;NUP188;NUP35
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.2968959587419688,-1.2268765081040478,0.08695652173913043,0.6320596510319214,1.0,24/71,22.46%,PRKN;CHFR;OTUD7A;ADAMTS12;CTSC;ATXN3;CLPX;MALT1;CTSB;VPS4B;LGMN;OMA1;CTSZ;STUB1;CTSL;NGLY1;CTSF;UBB;FAP;UBE2W;YME1L1;CTSS;RPS27A;UBC
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.5812041897868772,1.225660689034317,0.25823451910408435,1.0,1.0,6/18,11.40%,BHLHE41;FRS2;SOX6;CCN3;HDAC1;BMP2
prerank,amide biosynthetic process (GO:0043604),0.5426815577562071,1.225608011071188,0.26072234762979685,1.0,1.0,10/47,14.80%,RHD;SLC25A15;CERS6;CERS5;PAM;SLC25A2;ASMT;AGK;SMPD1;SPTLC2
prerank,positive regulation of response to stimulus (GO:0048584),0.5550660648784626,1.2252101340034454,0.26136363636363635,1.0,1.0,7/40,8.69%,ANKLE1;ECHDC3;DHX9;NSMCE4A;FMR1;CD80;BCLAF1
prerank,respiratory tube development (GO:0030323),0.5664321140373789,1.2251278135736612,0.2717258261933905,1.0,1.0,6/28,11.52%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;NKX2-1
prerank,regulation of acrosome reaction (GO:0060046),-0.49829650968304673,-1.2243755846707303,0.21766561514195584,0.6370379661424315,1.0,3/10,28.89%,GLRA1;CACNA1H;PLCB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.5700460386610329,1.224292294018766,0.26590330788804073,1.0,1.0,7/21,11.14%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.5700460386610329,1.224292294018766,0.26590330788804073,1.0,1.0,7/21,11.14%,RPA1;CHD1L;ERCC4;RPA2;ERCC3;CUL4B;XPA
prerank,polarized epithelial cell differentiation (GO:0030859),0.6109679664079896,1.2239449635702482,0.2411242603550296,1.0,1.0,6/13,16.26%,RHOA;RAB10;RAP2A;SCRIB;EZR;MSN
prerank,negative regulation of protein processing (GO:0010955),0.624824792483344,1.2238078470868072,0.264919941775837,1.0,1.0,4/12,9.98%,PRNP;SERPINE1;LRRK2;GAS1
prerank,vitamin D metabolic process (GO:0042359),-0.4662831278030585,-1.2233922350990412,0.2026578073089701,0.638056055319774,1.0,4/13,25.88%,LGMN;PIAS4;CUBN;CYP2R1
prerank,ribosome biogenesis (GO:0042254),-0.23399175358374205,-1.2233671315690657,0.0,0.6364798864393356,1.0,81/187,23.97%,GLUL;RPL13;HEATR3;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;RPS7;NVL;RPL18A;RPS6;RPL14;RPLP1;RPL9;RPL37;RPL8;RPS14;NAF1;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;DHX29;EXOSC9;RRP1B;RRP1;RPL19;METTL17;RPL28;RBIS;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;RPLP2;LTO1;RPL29;MDN1;RIOK2;LSG1;RPLP0;LTV1;RPL10A;RPL35;NOB1;NOLC1;EMG1;SURF6;EXOSC2;PIH1D1;EBNA1BP2;RAN;TSC1;DDX54;RPL4
prerank,regulation of cellular component organization (GO:0051128),0.5119752667739899,1.2231164980533218,0.19125127161749747,1.0,1.0,22/135,12.82%,KIF14;MKI67;HJURP;RAB33B;AURKA;ROCK2;STON1;PACSIN2;NEDD4;NET1;STON2;NCLN;ZFYVE16;ROCK1;PICALM;AGT;HNRNPU;BAG5;METTL4;SSRP1;ATF5;ITCH
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.4859736570173281,-1.2224266108853015,0.24829931972789115,0.6374291363627325,1.0,4/12,4.31%,CTNNA3;CAV1;RYR2;BIN1
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.6196829441697151,1.2221377395313493,0.2503576537911302,1.0,1.0,5/12,12.80%,DPYD;CTPS1;CDA;DPYSL4;DPYSL3
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.3524484844333585,-1.2220097387559135,0.16477272727272727,0.6368712633929617,1.0,8/29,19.72%,PLA2G4A;PLAAT3;PNPLA8;NR1H3;LPCAT2;DBI;NR1H2;PLA2G12A
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.565033390558237,1.221897280520739,0.26113861386138615,1.0,1.0,10/26,17.85%,CDK5RAP2;PSRC1;NUMA1;MAPT;DRG1;AKAP9;RAC1;STMN2;TRPV4;CLASP1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.35666091678472245,-1.2209026273479304,0.17058823529411765,0.6380997897113533,1.0,12/30,20.05%,FHIT;HSP90AB1;OGT;MAP1A;GIPC1;SGTA;CCAR2;SDCBP;UBXN1;RYBP;SVIP;PARK7
prerank,lung development (GO:0030324),0.5541316637887734,1.2200964972447823,0.27380952380952384,1.0,1.0,7/33,11.52%,GLI2;LOXL3;FGFR2;PDPN;NPHP3;ERRFI1;NKX2-1
prerank,regulation of glucose import (GO:0046324),-0.3679586987723671,-1.2192531882346769,0.21428571428571427,0.6407135807982819,1.0,12/30,14.61%,OCLN;GRB10;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;SELENOS;IRS1;PTPN11;GSK3A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.4834185238872018,-1.2187936444522451,0.23529411764705882,0.6405083351664642,1.0,7/11,45.57%,AKAP6;LRRC38;KCNIP2;LRRC55;NOS1AP;TREM2;RNF207
prerank,endothelial cell differentiation (GO:0045446),-0.47313841352016306,-1.2187845258927061,0.22847682119205298,0.6389453481240354,1.0,6/12,8.29%,JAG1;BMPR2;ACVRL1;PROX1;TIE1;ACVR2B
prerank,regulation of microtubule-based process (GO:0032886),0.546482395436148,1.2185191534513908,0.26395348837209304,1.0,1.0,15/36,17.85%,MACF1;AURKA;GSK3B;MEMO1;DIAPH1;MAPT;BICD2;TPPP;ROCK1;MARK2;ATF5;MAP6;TAOK1;EPHA3;CLASP1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.4793831759547609,-1.2179779649192295,0.23478260869565218,0.6391901911213737,1.0,2/10,0.92%,CPEB3;CDC73
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.5126856797302448,1.2178994580394489,0.15577889447236182,1.0,1.0,33/140,11.74%,ECT2;RACGAP1;ARHGAP22;ARHGAP11A;ARHGAP21;DEPDC1B;ARHGAP10;ARHGAP28;RHOA;CGNL1;ARHGAP18;OCRL;NET1;RHOT1;FGD4;ARHGAP36;VAV2;GNA13;FGD1;INPP5B;ARHGAP24;SYDE2;ARHGAP19;RHOQ;SRGAP2;SRGAP3;MYO9B;ARHGAP6;ARHGAP35;ARHGAP23;ARHGEF18;FAM13B;RAC1
prerank,protein import into peroxisome membrane (GO:0045046),-0.39243572887818756,-1.21779517490136,0.18090452261306533,0.6380945923476669,1.0,9/22,22.31%,FIS1;ALDH3A2;PEX3;PEX5;ABCD2;GDAP1;PXMP4;PEX26;PXMP2
prerank,cytoplasmic microtubule organization (GO:0031122),0.5263471507436627,1.2177937750023888,0.26731601731601734,1.0,1.0,15/54,18.55%,FIGNL1;KATNAL2;RHOA;PCM1;TUBGCP5;NUMA1;MAPT;TPPP;FIGN;EZR;DLG1;TUBGCP3;TRPV4;CLASP1;LIMK2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6048975162027885,1.2174617871126032,0.24495677233429394,1.0,1.0,3/13,9.92%,BARD1;TPR;RANGAP1
prerank,regulation of viral transcription (GO:0046782),-0.33043132318832136,-1.217084354196821,0.176,0.6382892751297895,1.0,23/39,31.64%,MID2;CCNT1;NELFB;IFITM3;TRIM27;TRIM14;POLR2K;POLR2H;POLR2F;POLR2C;TRIM21;TRIM11;TRIM32;TARBP2;POLR2E;ZFP36;NELFCD;MDFIC;HEXIM1;POLR2J;NELFE;POLR2D;TRIM13
prerank,regulation of actomyosin structure organization (GO:0110020),0.6070917501716926,1.2160438080679012,0.25894134477825465,1.0,1.0,5/13,15.84%,ROCK2;ALMS1;ROCK1;RAC1;FHOD1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.5108684313852561,1.2160168284550479,0.009,1.0,1.0,175/807,15.42%,DEPDC1;CENPF;BRCA1;E2F7;NR2E3;E2F8;UHRF1;EZH2;EN1;PLK1;BIRC5;AURKB;GLI2;LOXL3;TCFL5;GLI3;HMGB2;E2F1;CBX5;RBM15;FOXE1;ATOH8;BTAF1;ILF3;KMT5A;SFMBT1;TIMELESS;LOXL2;TRIM37;ZFP69;CBFB;RB1;SP3;ETV6;TWIST2;FNIP1;MIER1;WWOX;SP2;HDGF;CTCF;FGFR2;ZEB1;JAZF1;CNOT1;MPHOSPH8;EED;RBFOX2;DAP;BCOR;MDM4;TAF3;SETDB2;MBD1;KHDRBS1;HIVEP1;CUX1;FHL2;BHLHE41;NFIL3;CTBP1;ZNF568;MAEL;TBL1XR1;IKZF1;MCPH1;BMP6;GZF1;LCOR;SCML2;YAF2;TCF7L2;ORC2;HOXA7;TPR;PML;SCMH1;GATAD2A;PSPC1;MIDEAS;EFNA1;GLIS3;RIF1;SFRP2;NIPBL;POU2F1;ZBTB2;MXD1;ZBTB7B;ZHX2;UIMC1;FOXO3;ATF7IP;SAP18;TRIM28;KDM2B;LIN37;RCOR1;IRF1;ING4;BCLAF1;SMARCA4;ZFP90;KLF11;MIER3;KANK2;LIMD1;YAP1;NONO;VHL;ARID4A;UXT;EPC1;HMGB1;HDAC8;MTA3;NR4A2;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;RUNX1T1;LIMS1;KCNIP3;RBM15B;DKK3;SMURF2;L3MBTL2;HDAC1;BMP2;AHR;EZR;NKX2-1;ZHX3;ATXN1;FBXW11;RBPJ;SMAD4;HDAC2;SAP130;ATF5;ELK4;IRF2BP1;PPID;TWIST1;HEY2;USP9X;MED1;USP47;DLG1;BTRC;RARB;YY1;BCL7A;ZMYM5;FOXK2;CDKN1B;KDM5C;PCGF6;DNMT3A;FOXM1;SMAD3;FOXP4;QARS1;SOX1;PER1;YEATS2;RBAK;OTUD7B;DR1;CNOT7;KAT6A;DCAF1
prerank,cellular response to interleukin-12 (GO:0071349),0.5304834012445816,1.2155943435999421,0.27464008859357697,1.0,1.0,9/48,17.28%,LMNB1;ANXA2;CNN2;CAPZA1;HNRNPA2B1;LCP1;MSN;SIRPA;CD47
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3671826940118166,-1.2145465198056125,0.19626168224299065,0.643210802596911,1.0,13/26,32.33%,EPHA5;KLF7;STX4;ANO1;GPLD1;ADCY8;ADRA2A;EFNA5;PIM3;BAIAP3;ADCY5;NR1H4;CFTR
prerank,sphingosine biosynthetic process (GO:0046512),-0.49359313407561317,-1.214503255308717,0.2515527950310559,0.6401894250436194,1.0,6/11,23.85%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,sphingoid biosynthetic process (GO:0046520),-0.49359313407561317,-1.214503255308717,0.2515527950310559,0.6401894250436194,1.0,6/11,23.85%,ACER2;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.6135871810397868,1.214492457872542,0.2761087267525036,1.0,1.0,4/12,8.17%,MPHOSPH8;SETDB2;ATF7IP;TRIM28
prerank,determination of heart left/right asymmetry (GO:0061371),0.5387541778487067,1.2138975521150148,0.2682648401826484,1.0,1.0,5/43,9.03%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3749155080036804,-1.213209177561579,0.15104166666666666,0.6419863487539491,1.0,9/27,16.07%,PTK2;FLT1;TEK;PDGFRB;FGF2;PIK3R4;IRS1;EPHA8;TNFAIP8L3
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.3743953498420921,-1.2129470917131242,0.24285714285714285,0.6411521348669259,1.0,12/24,35.91%,TAPBP;SEC24B;B2M;ACE;BCAP31;SAR1B;TAP2;FCER1G;ABCB9;CALR;SEC13;CANX
prerank,positive regulation of glucose import (GO:0046326),-0.39815458304661044,-1.2123620450851844,0.19823788546255505,0.6410262858139929,1.0,9/21,13.58%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;IRS1;PTPN11
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6337938099961626,1.2117124161571868,0.29333333333333333,1.0,1.0,3/11,10.09%,E2F2;ADAMTS9;PIK3CB
prerank,histone H4 deacetylation (GO:0070933),0.627378215302593,1.2112071853606452,0.27811550151975684,1.0,1.0,5/10,12.61%,SMARCAD1;RCOR1;HDAC8;HDAC1;HDAC2
prerank,synapse assembly (GO:0007416),-0.29359198023105193,-1.2109265944557386,0.1016949152542373,0.6432638989526724,1.0,13/67,5.66%,DNM3;GABRB3;CDH2;DNER;GABRA2;SHANK3;SPOCK2;LRRTM3;GRID2;ADGRL3;NRCAM;SDK2;FGF13
prerank,synaptic vesicle exocytosis (GO:0016079),-0.322651782151205,-1.2108442693172603,0.14173228346456693,0.6419612356455835,1.0,14/40,18.61%,UNC13B;PCLO;RIMS1;SNAP47;SYT1;STX4;STX3;SYT7;SNPH;SNAP29;CPLX1;SNAP25;SYT10;STX1B
prerank,organelle disassembly (GO:1903008),0.5436554394669401,1.2102577398067313,0.28365384615384615,1.0,1.0,12/33,17.30%,CDK1;GBF1;DDRGK1;DYRK3;RB1CC1;ULK2;VRK1;ATG2A;GFM2;MCTS1;DENR;MTIF3
prerank,replicative senescence (GO:0090399),0.5964761630794665,1.2094649399917345,0.2867981790591806,1.0,1.0,6/12,19.60%,CHEK2;CHEK1;SERPINE1;TP53;ATR;TERT
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.5157948816467963,1.2093234842653826,0.26940133037694014,1.0,1.0,15/48,17.39%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;NUP133;PRKAG1;NUP42;PNPT1;NUP98;NUP210
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5689001435952971,1.2092834345540833,0.2655654383735705,1.0,1.0,8/24,12.40%,ZRANB3;RTEL1;MSH3;ERCC4;BLM;KMT2A;TERF2;MSH6
prerank,regulation of mononuclear cell migration (GO:0071675),-0.38496487314817973,-1.208971514803121,0.21393034825870647,0.6454217986460753,1.0,8/23,18.02%,PTK2;LYN;MAPK3;MAPK1;SLIT2;THBS1;CMKLR1;IL34
prerank,endocrine system development (GO:0035270),0.5790950685035382,1.208823365049088,0.2772151898734177,1.0,1.0,5/21,11.52%,GLI2;FOXE1;TGFBR1;DKK3;NKX2-1
prerank,L-serine metabolic process (GO:0006563),-0.4967505497158112,-1.2087283426377182,0.2520775623268698,0.6444980235486019,1.0,7/10,43.40%,SERINC3;PSAT1;CBS;PSPH;SHMT2;PHGDH;SHMT1
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.42542629665532555,-1.2083146251928591,0.22262773722627738,0.6440467154456446,1.0,3/18,4.31%,CAMK2D;CAV1;BIN1
prerank,positive regulation of protein catabolic process (GO:0045732),0.5059022671567361,1.2081919975526274,0.2450879007238883,1.0,1.0,19/84,17.02%,DTL;BARD1;GSK3B;NEDD4;FAF1;ATG7;SMURF1;SH3D19;SNX33;SMURF2;EZR;ITCH;ADAM9;PLK2;CDKN1B;NKD1;MSN;AMER1;WWP1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.394442808994289,-1.208027475548316,0.2,0.6432091906964464,1.0,7/21,10.95%,MEF2C;HSP90AB1;CALM1;PDGFRB;PLEK;GPLD1;MTOR
prerank,positive regulation of cell population proliferation (GO:0008284),0.5092966145670771,1.2079941644223904,0.057,1.0,1.0,71/423,13.37%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SAPCD2;E2F1;TIPIN;SPDYA;MATK;AQP1;HPSE;NAP1L1;FBXO5;BMPR1A;PHIP;FGFR4;HYAL1;CEP43;FGFR2;FXN;GAREM1;DDRGK1;LAMB1;DHX9;CNOT6L;CCAR1;BMP6;TCF7L2;RTKN2;IL18;TGFBR3;DERL2;CDC25B;PDGFRA;SFRP2;CCN1;SAAL1;POU3F2;WWTR1;CDK2;CNOT6;GRK5;CUL3;YAP1;MAP3K3;PIM1;AGT;DDR2;CDC123;S1PR2;TGFBR1;HNRNPU;RBPMS2;CRKL;CNTF;HDAC1;BMP2;STOX1;GLP2R;RBPJ;GJA1;ADAM17;KMT2D;TRPM4;HDAC2;IL31RA;CTSH;LRP5;NES
prerank,protein homotetramerization (GO:0051289),0.5346302709071797,1.2078448990770951,0.2816593886462882,1.0,1.0,11/49,12.51%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,positive regulation of protein acetylation (GO:1901985),0.6005977982225397,1.2076735561410754,0.26255380200860834,1.0,1.0,2/12,4.23%,CEP295;FAM161A
prerank,cellular response to increased oxygen levels (GO:0036295),-0.469038860775039,-1.2074537429317493,0.265625,0.643237151980481,1.0,4/11,7.95%,FOXO1;ATP6V0D1;CAV1;FAS
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.5484400296064885,1.206057656097281,0.2848180677540778,1.0,1.0,8/23,14.76%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;CAB39;RPTOR
prerank,intestinal lipid absorption (GO:0098856),0.6202272746410983,1.205304054764749,0.2772133526850508,1.0,1.0,3/11,20.16%,SOAT2;LDLR;UGCG
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.283543718430056,-1.2051527294431987,0.029411764705882353,0.647718276499455,1.0,18/76,17.16%,CHRM2;ANO1;HOMER1;HTR2C;GPR4;TGM2;ESR1;OPRM1;GNA14;AGTR1;GRM5;ADRA1A;GRM1;HTR2A;PTH1R;PLCE1;CMKLR1;ADRA2A
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.6103831868021832,1.2051400822862857,0.2867981790591806,1.0,1.0,5/12,13.46%,NEDD4;KHDRBS1;TPR;NUP214;RBM4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.46581606848239737,-1.2047592361196773,0.23717948717948717,0.6473415328140354,1.0,7/11,29.60%,ATF6;HSPA5;CEBPB;CREB3L1;DDIT3;ATF6B;MBTPS2
prerank,positive regulation of calcium ion transport (GO:0051928),-0.33699521376481656,-1.2034636806979977,0.16783216783216784,0.649176489938535,1.0,11/36,25.13%,CAV1;PDGFRB;MYLK;TRPC3;CACNB2;GRIN1;CRACR2A;P2RX4;WFS1;CXCL12;P2RX7
prerank,protein-containing complex subunit organization (GO:0043933),0.5038621621559806,1.20323914496611,0.20956256358087488,1.0,1.0,22/109,14.66%,KNTC1;FANCA;NDC1;KPNA3;NUP205;TEAD1;MDM4;ADD2;ZW10;TPR;PML;DARS1;YAP1;PICALM;IKBKG;KMT2A;CAPZA1;DMTN;PPID;EPRS1;CAPG;NUP133
prerank,regulation of protein kinase activity (GO:0045859),0.5010069506433147,1.2016806824331707,0.2198364008179959,1.0,1.0,12/106,10.11%,CENPE;ECT2;SPDYA;RB1;CEP43;TAB1;CCN1;WWTR1;MRNIP;GNAQ;DDR2;CEP85
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.43205629492264347,-1.20110271984595,0.20833333333333334,0.6539463561031108,1.0,8/16,39.61%,TRIB2;TNFRSF21;CD274;TYROBP;JAK3;FCGR2B;DLL1;AGER
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.5060627935531904,1.2004775811322272,0.112,1.0,1.0,52/314,11.24%,KIF14;CCNF;CCNB1;CDK1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;FBXO5;ANAPC7;RB1;AURKA;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SPSB3;KLHL15;SIAH2;SPSB2;TBL1XR1;FAF1;BUB3;ARRB1;PML;FBXW7;DERL2;CUL5;FBXL8;CDK2;AGAP3;PSMB1;SMURF1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;SMURF2;DCAF12
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5585517160935458,1.2004507466306593,0.2756892230576441,1.0,1.0,8/26,15.71%,ATP2B4;GSK3B;FHL2;PRNP;HOMER2;CAMTA1;LMCD1;STIMATE
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.48804514542497557,-1.1997029380585584,0.28353658536585363,0.6557854766807393,1.0,5/10,26.48%,DIP2A;PRKAA1;KLF15;PARK7;MYOCD
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.6227706743605592,1.198646583718445,0.28905109489051095,1.0,1.0,3/11,11.29%,ATL2;ARL6IP1;STX18
prerank,atrial septum morphogenesis (GO:0060413),-0.4744374233944605,-1.1985078771123967,0.21839080459770116,0.6572705130156945,1.0,4/10,12.73%,ACVR1;BMPR2;TGFB2;SOX4
prerank,negative regulation of cell development (GO:0010721),0.5522633390151646,1.1984327067810112,0.2889165628891656,1.0,1.0,6/25,11.97%,GSK3B;FBN1;PCM1;FBXW7;RFLNA;APPL2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.34377249168478047,-1.1981120392131308,0.1834319526627219,0.6567094769004498,1.0,20/33,34.94%,IGF1;PIK3C2B;PIK3R1;MYO16;NYAP2;NF1;IRS1;HTR2A;ERBB2;PIK3CD;PIK3CA;PIK3R2;EDN1;PIK3R5;ERBB3;PIK3C2A;C1QBP;AKT1;TYRO3;HTR2B
prerank,regulation of ERAD pathway (GO:1904292),-0.47665525622588795,-1.1980901151381802,0.2551928783382789,0.65524516360864,1.0,6/11,27.85%,ATXN3;UBXN1;AQP11;TMEM259;USP19;RNFT1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.4878992498502611,-1.1974662451238798,0.2774725274725275,0.6552765589459234,1.0,8/10,33.47%,SLC1A2;SLC25A13;SLC25A12;SLC1A1;ARL6IP5;SLC25A18;SLC1A6;PRAF2
prerank,protein modification by small protein conjugation (GO:0032446),0.4982561490544134,1.1972582729377934,0.097,1.0,1.0,73/361,14.66%,BRCA1;CCNF;UHRF1;PLK1;BARD1;UBE2T;UBE2C;RAD18;NDC1;NUP155;SAE1;UBE2S;RFWD3;RNF168;ANAPC7;TRIML2;NUP205;NUP160;BRAP;PDZRN3;CDC27;RNF220;UBE2K;DDRGK1;UHRF2;NEDD4;FBXL7;MYCBP2;PRKDC;SPSB2;NUP85;RNF43;TPR;ARRB1;ELOC;FBXW7;UBE2N;ATG7;CUL5;TRIM28;VPS18;RNF40;SMURF1;CUL3;UBE2R2;LEO1;VHL;CUL4B;FBXL17;RANGAP1;HERC2;FBXO45;TRIM63;ARRDC1;SMURF2;PCNA;NSMCE2;SUMO2;NUP214;FBXW11;TRPM4;TRIM6;RANBP2;ITCH;ATG3;USP9X;CRBN;BTRC;FBXO25;HLTF;TRIM5;BIRC6;NUP133
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.48418848110155577,-1.196779593884208,0.2631578947368421,0.6557827963062166,1.0,5/12,34.29%,TLR4;STRAP;SOX9;RBP4;NOD2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5042654286563641,1.1952956950574678,0.2474120082815735,1.0,1.0,20/87,14.38%,E2F7;RBL1;WEE1;CDKN2D;FBXO5;CDKN2C;RB1;AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;KANK2;PSMD1;PSMB9;JADE1;USP47;DLG1;PSMC6
prerank,organic hydroxy compound transport (GO:0015850),-0.32278892370851714,-1.1951680730588985,0.23076923076923078,0.658459284120876,1.0,12/36,31.66%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1;SLC16A1;STRA6;STARD5;OSBP;NPC2;SLC5A3;RBP4;NR1H4
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5133951026202728,1.1947441863679649,0.2625523012552301,1.0,1.0,17/74,15.37%,BRCA1;FADD;PHIP;EYA4;GSK3B;SIAH2;TCF7L2;SERPINE1;SH3RF1;TNFRSF10B;EYA2;TGFBR1;CASP8;BIRC6;ITGAV;SRC;GDNF
prerank,sodium ion transmembrane transport (GO:0035725),-0.2869198245111861,-1.1943886450699261,0.13636363636363635,0.658999814675666,1.0,19/84,16.25%,SLC6A6;SLC8A3;ATP1B1;SLC6A1;HCN1;ANO6;SLC24A2;SCN1A;ATP1A1;SCN9A;ATP1B3;ATP1A3;ATP1A2;SCN3A;SCN8A;SCN1B;SLC4A8;SLC6A11;SLC12A2
prerank,gene silencing by miRNA (GO:0035195),0.5336461314084715,1.193851706704458,0.28418549346016647,1.0,1.0,12/32,15.48%,ZC3H7A;MOV10;AGO2;CNOT1;AJUBA;CNOT6;LIMD1;PUM2;RBM4;CNOT7;ZC3H7B;TNRC6C
prerank,protein targeting to mitochondrion (GO:0006626),-0.31849926487794444,-1.1935685468388237,0.17647058823529413,0.6595498228771367,1.0,28/52,31.75%,IMMP2L;FIS1;DNAJC19;HSPD1;AIFM1;IMMP1L;TIMM44;TOMM70;BCAP31;GDAP1;AIP;FBXO7;TOMM34;DNAJC15;PAM16;TIMM17A;TOMM7;TIMM17B;CHCHD4;TIMM9;TIMM13;TOMM22;TIMM8B;NDUFA13;ROMO1;GRPEL1;TOMM5;TIMM29
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.583805613225964,1.1934450784254957,0.29461756373937675,1.0,1.0,3/15,7.25%,IQGAP2;ACTR3;ARPC5L
prerank,dendritic cell chemotaxis (GO:0002407),0.6020210110229147,1.1931165638759005,0.29667149059334297,1.0,1.0,4/14,12.51%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,response to amino acid (GO:0043200),-0.3452299859586708,-1.1929240016629277,0.1956521739130435,0.6598141327482556,1.0,11/31,16.81%,CPEB3;GLRB;CPEB4;GLRA1;SH3BP4;GLRA3;MTOR;NSMF;GRIN1;RRAGC;XBP1
prerank,embryonic digit morphogenesis (GO:0042733),0.5738983346549162,1.1923219868223425,0.2921646746347942,1.0,1.0,8/18,18.16%,GLI3;MAP3K20;WDPCP;HDAC1;HDAC2;TWIST1;SALL1;OSR1
prerank,fatty acid transport (GO:0015908),-0.40763427189226037,-1.1918769187664364,0.23921568627450981,0.6611554579505075,1.0,13/17,45.99%,APOE;GOT2;SLC27A1;SLC27A4;ACSL1;MFSD2A;FABP5;PPARG;SLC27A3;FABP3;SLC27A6;CD36;CPT1B
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.5919767890407078,1.1915346743695585,0.28257686676427524,1.0,1.0,5/12,18.13%,CBFB;ELF2;ELF1;RC3H1;RUNX1
prerank,regulation of cell population proliferation (GO:0042127),0.5017589628907281,1.1910733936807951,0.033,1.0,1.0,105/691,12.75%,PRC1;KIF20B;KIF14;SHCBP1;E2F7;CDKN3;UHRF1;EZH2;TTK;BIRC5;RAB33B;SAPCD2;TCFL5;HMGB2;TIPIN;SPDYA;MATK;CDKN2D;NAP1L1;FBXO5;TIMELESS;PPM1D;CDKN2C;KSR1;BMPR1A;PHIP;PDS5B;FGFR4;RHOA;CEP43;CDC6;CTCF;FGFR2;FXN;GAREM1;DDRGK1;RBFOX2;ALDH1A2;MDM4;ARID2;KIT;PRKDC;CNOT6L;CTBP1;CCAR1;PDPN;NMI;COL18A1;BMP6;PTPN2;TCF7L2;RTKN2;HP1BP3;RBBP4;PML;DERL2;CDC25B;PDGFRA;SFRP2;POU3F2;WWTR1;CLMN;CDK2;BTG3;SMAD6;CNOT6;IRF1;ING4;GRK5;CDCA7;CUL3;KLF11;AXIN2;KANK2;YAP1;VHL;ABI1;ELN;NPR3;NOX4;AGT;PPP2R5C;CDC123;S1PR2;TGFBR1;LIMS1;TRAPPC14;BOK;CRKL;CNTF;HDAC1;BMP2;STOX1;P3H1;GLP2R;PLPP1;NCK2;ADAM17;KMT2D;WNT9A;TRPM4;TES;HDAC2;ATF5;IL31RA
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.37578929314354037,-1.1909761729796418,0.21890547263681592,0.6620221804162602,1.0,10/26,13.58%,OCLN;INSR;IGF1;CREBL2;AKT2;PIK3R1;IRS2;CLIP3;IRS1;PTPN11
prerank,epithelial tube morphogenesis (GO:0060562),-0.3471938530987432,-1.1906842076280062,0.2054794520547945,0.6612136172524572,1.0,14/32,16.18%,ACVR1;MEF2C;PODXL;RYR2;ACVRL1;RHOB;PAK1;RASIP1;CTNNB1;MEGF8;SLIT2;MET;SOX17;MTSS1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.5439483992471438,1.1904747079079456,0.3018867924528302,1.0,1.0,8/28,15.23%,AUNIP;PRKDC;RIF1;MRNIP;SMCHD1;PARP9;KMT5C;SHLD2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5086972013511522,1.1896640645282206,0.27444444444444444,1.0,1.0,16/44,16.34%,MOV10;ROCK2;AGO2;ZC3HAV1;CNOT1;FTO;EIF4ENIF1;ROCK1;YTHDF2;MEX3D;RC3H1;PABPC1;CNOT7;TNRC6C;PNPT1;METTL3
prerank,regulation of filopodium assembly (GO:0051489),-0.3248436431614547,-1.18959025314664,0.192,0.6626807703022525,1.0,11/38,9.20%,PPP1R16B;ARAP1;FNBP1L;AGRN;GAP43;PIK3R1;PALM;MYO10;RAB5A;CAPZB;ARHGAP44
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.5658213877681855,1.1887836590230223,0.3033112582781457,1.0,1.0,3/20,9.54%,SAPCD2;RHOQ;PICALM
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.3223014169211885,-1.1884082618212024,0.17857142857142858,0.664208211362597,1.0,17/40,19.77%,SGIP1;INSR;VTN;BICD1;DAB2;B2M;HNRNPK;SFRP4;LDLRAP1;HIP1;VEGFA;PICK1;CBL;PPT1;AHI1;TBC1D5;DGKD
prerank,regulation of cellular respiration (GO:0043457),-0.4137697675270956,-1.1883578728597224,0.24031007751937986,0.6628652789286619,1.0,7/17,26.30%,IFNAR1;TRAP1;CBFA2T3;IL10RB;PRDM16;PRELID1;NOA1
prerank,protein mannosylation (GO:0035268),0.5500799479689662,1.188135068850874,0.29093198992443325,1.0,1.0,6/22,11.98%,POMT1;LARGE1;CRPPA;FKRP;RXYLT1;TMTC4
prerank,import into cell (GO:0098657),0.5254784179011145,1.1877959722510925,0.29050925925925924,1.0,1.0,4/41,8.05%,NEURL1B;TSPO2;SLC19A1;SLC16A2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.39131331872724595,-1.18779050350537,0.2222222222222222,0.6630550073215743,1.0,13/20,37.03%,ACLY;ACSL4;PPT1;CBR4;SCD;FASN;FAR2;HSD17B8;DGAT2;FITM2;GCDH;SCD5;PPT2
prerank,alpha-amino acid catabolic process (GO:1901606),0.5532688228121538,1.187021929550814,0.29518072289156627,1.0,1.0,5/29,13.20%,ACMSD;ACAT1;KMO;HOGA1;IL4I1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3282583886946031,-1.1865479844413802,0.183206106870229,0.6647708380764451,1.0,11/37,13.87%,PRKG1;MEF2C;IGF1;PDCD4;FGF2;SOD2;TPM1;JUN;MMP2;TAFA5;LDLRAP1
prerank,positive regulation of neuron differentiation (GO:0045666),0.5275270868544343,1.1863699078783245,0.3044982698961938,1.0,1.0,4/40,6.82%,ECT2;RHOA;ZEB1;TCF4
prerank,negative regulation of vascular permeability (GO:0043116),-0.45648550681931055,-1.186307428897782,0.25666666666666665,0.663908457811305,1.0,7/12,23.72%,PDE3A;CLDN5;RAMP2;SLIT2;VEGFA;PDE2A;SH3GL2
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5970362211386987,1.1862764825779821,0.3006993006993007,1.0,1.0,4/13,14.36%,DYRK1A;YJU2;TWIST1;CD44
prerank,cobalamin metabolic process (GO:0009235),-0.41070769895757986,-1.186135474177695,0.22916666666666666,0.6628629065112788,1.0,7/17,25.36%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,icosanoid biosynthetic process (GO:0046456),-0.486665640691224,-1.185703925877016,0.26869806094182824,0.6625103905152108,1.0,1/10,0.17%,PLA2G4A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.4250529552329934,-1.1855998103117031,0.2620689655172414,0.6612903579496655,1.0,10/14,22.66%,VEGFC;FOXC1;VEGFA;PIK3CD;VEGFB;PIK3CA;NRP1;VEGFD;NUS1;FLT4
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.44618918690811415,-1.185591906700691,0.25333333333333335,0.6598203212920544,1.0,5/12,14.55%,STAT3;SDK2;PROM1;RORB;VEGFA
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.58975597787488,1.184303916732278,0.28772919605077574,1.0,1.0,4/14,13.63%,LOXL3;LIMS1;DMTN;PRKD1
prerank,actin filament capping (GO:0051693),0.5768733696519572,1.1838296888945263,0.30040053404539385,1.0,1.0,8/18,15.60%,TRIOBP;ADD2;TWF1;CAPZA1;ADD3;SVIL;CAPG;ADD1
prerank,barbed-end actin filament capping (GO:0051016),0.5768733696519572,1.1838296888945263,0.30040053404539385,1.0,1.0,8/18,15.60%,TRIOBP;ADD2;TWF1;CAPZA1;ADD3;SVIL;CAPG;ADD1
prerank,peptidyl-serine modification (GO:0018209),0.4970570140974969,1.183705223449187,0.2,1.0,1.0,49/166,18.82%,CDK1;TTK;CLSPN;PLK1;MASTL;MAST2;DYRK1A;AURKA;ROCK2;GSK3B;GALNT1;PRKDC;DYRK3;VRK2;WNK1;CDK2;LRRK2;ROCK1;MARK2;CSNK2A2;CAMK1D;TGFBR1;EIF2AK3;PRKCB;PRKCA;ULK2;PDPK1;CSNK1G2;MAPKAPK3;PRKCE;PRKD1;PRKCI;CAB39;PLK2;MORC3;VRK1;PRKD2;STK39;HIPK3;ATR;CSNK1A1;MAST4;CSNK1G1;SRPK2;MAST1;PKN2;MAPK14;HIPK1;CAMKV
prerank,mitochondrion distribution (GO:0048311),0.6021943816471285,1.1836512284203728,0.28400597907324365,1.0,1.0,3/12,8.29%,TRAK1;MAPT;LRRK2
prerank,protein autophosphorylation (GO:0046777),0.4907370096787055,1.183263664371018,0.2209889001009082,1.0,1.0,38/157,15.60%,NEK2;MELK;AURKB;DYRK1A;STK17B;AURKA;FGFR4;GSK3B;FGFR2;STK10;CHEK2;KIT;VRK2;STK24;MUSK;PDGFRA;EPHA4;LRRK2;GRK5;MAP3K3;PIM1;MARK2;DDR2;EIF2AK3;ULK2;PDPK1;AAK1;SIK2;MAPKAPK3;MEX3B;PRKD1;VRK1;STK11;TAOK1;SRC;PRKD2;STK39;PASK
prerank,regulation of RNA export from nucleus (GO:0046831),0.6138451468143207,1.18326298004766,0.2962962962962963,1.0,1.0,5/11,7.48%,KHDRBS1;DHX9;NRDE2;TPR;SETD2
prerank,apical junction assembly (GO:0043297),0.5118818901554207,1.1832474836527784,0.28152173913043477,1.0,1.0,5/53,6.59%,ECT2;RHOA;AFDN;CTNNA1;GRHL2
prerank,positive regulation of cell communication (GO:0010647),-0.35559266749671203,-1.1828685258131557,0.21428571428571427,0.6656763456233623,1.0,12/28,26.99%,RIMS1;SYT1;LGI1;HOMER1;DLG4;GRIK2;KCTD13;CDKN2AIP;NMU;EDN1;SOX11;EDN3
prerank,pseudouridine synthesis (GO:0001522),-0.4472193488976216,-1.182689469136666,0.27960526315789475,0.6646385518764483,1.0,11/13,42.89%,PUS10;TRUB1;DKC1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.41829223255294445,-1.1826081421639012,0.25213675213675213,0.6633708426652297,1.0,8/17,29.71%,CAV1;KLF7;MAFG;CEBPB;AJAP1;SOX9;CD24;MAFF
prerank,ribosomal small subunit assembly (GO:0000028),-0.4147534813716387,-1.1823233523858296,0.2597864768683274,0.662615229843384,1.0,7/16,11.77%,RPS15;RPS14;RPSA;RPS28;RPS5;RPS19;RPS27
prerank,RNA export from nucleus (GO:0006405),0.49551082365596866,1.1819720456968683,0.26337448559670784,1.0,1.0,31/100,17.39%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;HNRNPA1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4329535787417983,-1.1816049500506884,0.2589928057553957,0.6630190686399156,1.0,11/15,31.97%,PKM;KLF4;FGF2;FGF1;TJP1;VEGFA;S100A1;JAK1;JMJD8;SMAD1;BMPER
prerank,regulation of viral life cycle (GO:1903900),0.5650223535943679,1.1814710456033473,0.30299089726918077,1.0,1.0,2/21,2.48%,KPNA2;TRIML2
prerank,regulation of oxidoreductase activity (GO:0051341),-0.438658183972926,-1.1812438666280354,0.21875,0.6623096113291892,1.0,6/13,34.29%,OXA1L;SZT2;ABL1;ATP7A;MT3;NOD2
prerank,bile acid and bile salt transport (GO:0015721),-0.36156981553889206,-1.1812416657074514,0.22535211267605634,0.6608448867284461,1.0,4/24,7.82%,SLCO1C1;SLCO2B1;ABCC4;ATP8B1
prerank,regulation of macrophage migration (GO:1905521),-0.4770004974402625,-1.1805884803744342,0.271523178807947,0.6610218003990517,1.0,8/10,45.66%,MTUS1;CD81;PTK2B;P2RY12;CD200R1;CX3CR1;EMILIN1;CSF1
prerank,axonemal dynein complex assembly (GO:0070286),0.5328424621414615,1.1801787579565342,0.3075030750307503,1.0,1.0,8/28,19.00%,DNAAF3;DNAH1;DNAI4;DNAAF5;LRRC49;SPAG1;ODAD1;DNAH8
prerank,leukotriene biosynthetic process (GO:0019370),-0.42959806354910846,-1.1800075655944622,0.246875,0.6609361265232295,1.0,2/14,7.68%,PLA2G4A;GGT5
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.3649120914364125,-1.1796859627961682,0.22727272727272727,0.6602942970038481,1.0,14/27,34.38%,GAS6;TLR4;PTPN22;SELENOS;CX3CL1;SYT11;C1QTNF3;NCKAP1L;ZC3H12A;NLRC3;IRAK3;TNFAIP3;PTPN6;CD200R1
prerank,C4-dicarboxylate transport (GO:0015740),-0.43799363480566333,-1.1792949091470077,0.25886524822695034,0.6598177263064084,1.0,6/14,18.10%,SLC1A2;SLC25A13;SLC25A12;LRRC8D;SLC1A1;SLC25A11
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5833173794566596,1.1778996785492322,0.29004329004329005,1.0,1.0,1/13,1.19%,GLI2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.49439155165123083,1.1777057871816536,0.2706611570247934,1.0,1.0,30/96,17.39%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.344920647614294,-1.176761284824177,0.22962962962962963,0.6646881617233976,1.0,12/35,12.67%,FLT1;KRIT1;MEF2C;CAV1;APOE;NF1;ATP5F1A;CAV2;SYNJ2BP;THBS1;SCG2;RGCC
prerank,cellular response to organic substance (GO:0071310),-0.2624296506591827,-1.1766100330089437,0.15,0.6635947661262573,1.0,45/116,24.63%,STAT3;ACVR1;LEF1;ACVR2A;MAPK8;TGFBR2;BMPR2;AKAP6;ACVRL1;MAP2K5;NFAT5;SOCS2;KLF4;IL1RAPL1;RAMP1;TIPARP;RAMP2;ACVR2B;INPP5K;CTNNB1;SLIT2;PTPN14;PTPN11;ASAH2;LDLRAP1;SHC1;TBK1;SLC1A1;ROBO2;DCPS;ADRA2A;ERBB2;PTPN9;BMPR1B;CLEC3B;PTPN12;PARK7;CERS1;NOS1;RACK1;SLIT3;SPHK1;URI1;ARL6IP5;PLK5
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5036862489886654,1.176023523620586,0.27958115183246074,1.0,1.0,6/72,5.70%,TPX2;STMN1;DYRK1A;IAPP;SPEF1;SSH2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.6020411597553089,1.175994830271051,0.2971768202080238,1.0,1.0,4/10,18.15%,WNK1;ADAM17;STK39;OXSR1
prerank,regulation of T cell cytokine production (GO:0002724),-0.4289691211536282,-1.1759714037463667,0.2491349480968858,0.6636920534368003,1.0,4/15,11.61%,SMAD7;MALT1;B2M;TNFRSF1B
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.46349640867783315,-1.1756008800540596,0.2898550724637681,0.6631822757572349,1.0,5/12,16.43%,CCT5;TCP1;CCT7;CCT2;DKC1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.5532717692618803,1.1752310708397367,0.31218274111675126,1.0,1.0,11/20,21.68%,ROCK2;RHOQ;LLGL2;ROCK1;DLG1;LCP1;FHOD1;NCKAP1;RAB13;FMNL2;IKBKB
prerank,cellular response to hormone stimulus (GO:0032870),-0.29249965417359747,-1.1751924271206875,0.0967741935483871,0.6627419725351746,1.0,22/69,17.16%,THRB;STAT3;MEF2C;CAV1;AR;SOCS2;CTSB;RAMP1;RAMP2;ATP1A1;INPP5K;ATP1A3;SLC5A5;SFR1;SLIT2;ATP1A2;NSMF;SERPINB9;CTSL;ROBO2;XBP1;ADRA2A
prerank,protein-DNA complex disassembly (GO:0032986),0.5783844954094773,1.1750348009447626,0.30779392338177014,1.0,1.0,5/16,8.78%,SMARCC1;NFE2;ARID2;ARID1A;SMARCA4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.40674453744689737,-1.1749387488308825,0.26506024096385544,0.6619493765777735,1.0,2/17,3.48%,KCNAB1;AKAP6
prerank,clathrin coat assembly (GO:0048268),-0.4283463585601945,-1.1745703362632733,0.27058823529411763,0.661335069716554,1.0,7/15,19.84%,SGIP1;NSG2;AP2S1;HIP1;FCHO2;CLTB;NSG1
prerank,response to interleukin-4 (GO:0070670),-0.497236725380606,-1.174397133336816,0.2848297213622291,0.6602779348778715,1.0,3/10,21.08%,LEF1;XBP1;SHPK
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.5621949428819736,1.1742427963464568,0.2892347600518807,1.0,1.0,7/18,18.13%,RB1;PDPN;DDR2;BMP2;SMAD3;CLASP1;RUNX1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.38540478876624384,-1.17422234810712,0.20866141732283464,0.6592809218400258,1.0,4/20,3.07%,CAMK2D;ATP1B1;CALM1;RYR2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.31440815457009563,-1.1737150432760177,0.1897810218978102,0.6590792222095043,1.0,14/39,20.19%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;LGMN;TGFA;GRB2;SPRY2;ARHGEF7;ERBB2;CBL;PTPN12;HBEGF
prerank,high-density lipoprotein particle assembly (GO:0034380),0.6051598516966318,1.1734798719022568,0.2926829268292683,1.0,1.0,1/10,1.05%,BMP1
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.33764868260092334,-1.1729379211781472,0.2119205298013245,0.659726731098073,1.0,16/32,26.57%,PSEN1;TMSB4X;INSR;IGF1;PFKFB3;PRKAA1;APP;PINK1;NUPR1;ENO1;PPARGC1A;P2RX7;HIF1A;ENTPD5;PRXL2C;BEND3
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.263923898844293,-1.1725730175580715,0.1320754716981132,0.6593666770458344,1.0,14/75,13.14%,CACNA2D1;SLC8A3;ATP1B1;SLC39A10;SLC6A1;KCNJ3;SLC24A2;KCNJ6;ATP1A1;ATP1B3;ATP1A3;SLC12A9;KCNJ10;ATP1A2
prerank,response to interferon-alpha (GO:0035455),-0.4115366377762381,-1.1721964573843908,0.25,0.6588649269866214,1.0,7/16,16.82%,IFNAR1;RO60;GAS6;IFITM3;ADAR;BST2;IFITM2
prerank,establishment of apical/basal cell polarity (GO:0035089),0.5757784995800159,1.1718953105214314,0.2958152958152958,1.0,1.0,5/14,16.26%,RHOA;RAP2A;SCRIB;EZR;MSN
prerank,phospholipid catabolic process (GO:0009395),-0.3597729688545213,-1.171766389324314,0.25961538461538464,0.6586145266393804,1.0,7/24,14.75%,GPCPD1;PLA2G4A;ABHD12;PNPLA6;ENPP6;GDPD3;GDPD1
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.29664067437984487,-1.1717611531338907,0.17857142857142858,0.6558251605661518,1.0,24/56,25.19%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;TIMMDC1;NDUFA10;NDUFS6;NDUFA1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.29664067437984487,-1.1717611531338907,0.17857142857142858,0.6558251605661518,1.0,24/56,25.19%,NDUFS5;OXA1L;NDUFS1;NDUFA9;NDUFB4;NDUFV3;NDUFC2;NDUFS3;NDUFB3;NDUFS4;NDUFA5;NDUFA6;NDUFB9;DMAC2;ACAD9;NDUFAF1;NDUFB6;NDUFA11;NDUFB10;NDUFB11;TIMMDC1;NDUFA10;NDUFS6;NDUFA1
prerank,ubiquinone biosynthetic process (GO:0006744),-0.41254907987165357,-1.1717592863770703,0.2427536231884058,0.6544393420403635,1.0,6/15,12.22%,COQ8B;COQ5;NDUFA9;COQ10A;COQ3;PDSS2
prerank,positive regulation of apoptotic process (GO:0043065),0.4973547362502648,1.171651797904933,0.137,1.0,1.0,44/293,11.40%,TOP2A;ECT2;MELK;BARD1;E2F1;STPG1;ITGB3BP;FADD;STK17B;BMF;IAPP;AIFM2;FAM162A;PRNP;NET1;CCAR1;FAF1;STK3;ERCC3;FGD4;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;ING4;BCLAF1;KLF11;TNFRSF10B;DNM2;HMGB1;APAF1;TGFBR1;BOK;IP6K2;ARHGEF18;QRICH1;BMP2
prerank,intraciliary retrograde transport (GO:0035721),0.5845888047052923,1.1710260813354418,0.3033381712626996,1.0,1.0,2/12,3.88%,WDR35;IFT140
prerank,pulmonary valve development (GO:0003177),-0.3966208265701097,-1.1695830248118266,0.23140495867768596,0.6587354745602021,1.0,9/18,16.19%,JAG1;BMPR2;TGFB2;NOS3;TNFRSF1B;SLIT2;HEYL;STRA6;ROBO2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.4881912815442138,1.1694153061715793,0.004,1.0,1.0,343/1645,15.86%,DEPDC1;CENPF;BRCA1;E2F7;NR2E3;E2F8;RRM2;MXD3;PHF19;ATAD2;EZH2;BRIP1;EN1;BIRC5;E2F2;ATRX;MYBL1;PBX4;POLA1;NSD2;GLI2;CDK5RAP2;LOXL3;ORC1;TCFL5;GLI3;LCORL;HMGB2;E2F1;BRCA2;CBX5;TYMS;RBM15;FOXE1;ATOH8;HAS3;CDC45;BTAF1;ZBTB8A;ILF3;NAT14;MED26;ATP2B4;PSRC1;KMT5A;SFMBT1;FBXO5;TIMELESS;DYRK1A;LOXL2;ZFP69;BRD9;CBFB;SMARCC1;ZNF32;RB1;PBX3;BAZ1B;SP3;CDK14;HOXC5;DEK;PHIP;ZFP41;ETV6;TWIST2;ELF2;TRAK1;TEAD1;SP2;ZSCAN29;RAD21;RBBP8;HDGF;CDC6;CTCF;E2F3;ZEB1;LIN54;TFDP1;HNRNPD;NFE2;TFCP2L1;NLK;MPHOSPH8;MED14;EED;RBFOX2;DAP;BCOR;AJUBA;CHEK2;RFXAP;MDM4;ZNF260;SETDB2;MBD1;NFIA;KHDRBS1;HIVEP1;KIT;CUX1;PCGF5;DHX9;WIZ;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;CTBP1;EPC2;BLM;SRSF10;TSHZ1;ELF4;NFIB;THRAP3;KLF13;ZNF568;MAEL;CCAR1;TBL1XR1;SP8;IKZF1;SETD3;NUP85;CCNA1;GZF1;LCOR;PCBD2;SCML2;HOXC4;YAF2;TCF7L2;PSIP1;MED30;SOX6;ELF1;CCNE1;HP1BP3;HOXA7;GMEB1;GRHL2;GON4L;ARRB1;PML;SCMH1;ELOC;GATAD2A;TCF4;PSPC1;MIDEAS;ARID1A;MYBL2;GLIS3;TASP1;RFX2;SFRP2;ELK1;NUCKS1;POLR2A;FUS;NIPBL;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;MAMSTR;SIM1;ZBTB7B;MYCBP;WWTR1;SRCAP;ZFX;PHF1;PHF2;LIN9;ZHX2;UIMC1;PRRX2;OLIG2;FOXO3;ATF7IP;CD80;SAP18;TRIM28;LMX1B;KDM2B;PLAGL2;SMAD6;ZNF23;BNC2;RCOR1;IRF1;ING4;HMGB3;BCLAF1;CREB5;MED24;SMARCA4;MSL3;USP21;USP16;ZFP90;KLF11;LIMD1;DNM2;ZBTB25;HOXB3;YAP1;NONO;NFYA;VHL;ARID4A;PLAGL1;ZIC5;PICALM;ZBTB20;UXT;EPC1;ZNHIT3;HMGB1;AGT;ERC1;KMT2A;HOXB6;MEOX2;MTA3;NR4A2;CARF;MYPOP;NR3C1;HINT1;PARP9;SFPQ;TGFBR1;TAL1;TADA1;MMS19;RUNX1T1;CRLF3;SLC39A8;TEAD3;LIMS1;ZBTB24;TAF15;RBM15B;POFUT1;DKK3;NCOA2;SMURF2;PRKCB;PCNA;ZNF585B;ZNF585A;CHD2;QRICH1;L3MBTL2;HDAC1;BMP2;AHR;NKX2-1;KLF9;HTATSF1;TBX18;ZHX3;ATXN1;SPTY2D1;FBXW11;RBPJ;NR4A1;METTL4;ZIC4;KMT2D;SMAD4;HDAC2;ZNF394;ATF5;IL31RA;ZNF496;ILF2;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;NCOA7;TADA2A;IRF2BP1;TWIST1;HEY2;DHFR;ACTL6B;MED1;USP47;BTRC;FOXL1;GPBP1L1;POU2F2;YY1;BCL7A;RLF;FOXK2;CDKN1B;KDM5C;CAMTA1;PCGF6;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;QARS1;ZFP91;JMJD1C;BAZ1A;SOX1;E2F4;PER1;YEATS2;RBAK;ZNF445;MED27;PRDM8;EFEMP1;HDGFL3;CNOT7;ATF1;KAT6A;TRRAP;MLF2;HOXB7;BICRA;CHD1;ZNF112;NFKB1;ZBTB7C;TP53;PKNOX2
prerank,striated muscle contraction (GO:0006941),-0.2940709996440726,-1.1690363403760546,0.1595744680851064,0.6587635794874581,1.0,24/53,39.75%,ATP1B1;RCSD1;RYR2;TPM1;ATP1A2;SCN1B;DTNA;STAC;PIK3CA;KCNQ1;NOS1;ALDOA;SCN4B;MYH14;STAC3;SCN3B;MYL4;CASQ2;TNNI1;GAA;KCNH2;STAC2;TTN;SCN5A
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3864123805956058,-1.1686275241390964,0.24180327868852458,0.6585237925767871,1.0,8/20,14.40%,CPEB3;PSEN1;SHANK3;APOE;CAMK1;RELN;SHANK1;LRP8
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.579551293604821,1.168398918229607,0.2913165266106443,1.0,1.0,4/14,8.14%,SRSF4;SRSF10;SRSF7;SAP18
prerank,regulation of protein import into nucleus (GO:0042306),0.5225817942528785,1.1680256292258249,0.288622754491018,1.0,1.0,4/36,8.17%,ECT2;TPR;UBR5;TRIM28
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.4278878373390018,-1.1678832801738124,0.22846441947565543,0.6589674843894346,1.0,9/15,23.09%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1;SEL1L
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3557403792478392,-1.1676079360836433,0.2342857142857143,0.658331902647678,1.0,11/26,23.85%,NOS3;ACER2;ASAH1;ACER3;CYB5R3;ASAH2;GCH1;DDAH2;NOS1;ABCA2;SPHK1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4895327860849466,1.1674010554580285,0.125,1.0,1.0,66/366,12.04%,ESCO2;PHF19;EZH2;ATRX;MYBL1;NSD2;TCFL5;E2F1;DSCC1;BRCA2;FBXO5;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;NFIA;CCNA2;SMC3;NFIL3;EIF4E;TCF7L1;SRSF10;CCAR1;GZF1;YAF2;SOX6;HP1BP3;USP37;GON4L;PML;PSPC1;MYBL2;NUCKS1;POLR2A;FUS;ORC3;MYCBP;WWTR1;PHF1;PRRX2;FOXO3;LMX1B;BNC2;MSL3;LIMD1;DNM2;NONO;NFYA;VHL;OBI1;ZNHIT3;ERC1;NR3C1;HINT1;SFPQ;TGFBR1;SLC39A8;POFUT1;NCOA2;BMP2;AHR;ATXN1;SPTY2D1
prerank,skeletal system development (GO:0001501),0.4855113977709664,1.1673658904508675,0.24974721941354905,1.0,1.0,25/148,12.35%,EN1;RAB33B;BMP1;GLI2;MATN3;HYAL1;WWOX;FGFR2;FBN1;MMP14;DDRGK1;SULF2;BMP6;SOX6;SLC10A7;PAPSS2;RFLNA;SULF1;ANKRD11;NPR3;TGFBR1;EIF2AK3;BMP2;P3H1;GJA1
prerank,mRNA transport (GO:0051028),0.4876753529599259,1.1673356789858855,0.26564102564102565,1.0,1.0,31/101,17.39%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;FMR1;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;DHX38;NUP98;NUP210
prerank,negative regulation of telomere maintenance (GO:0032205),0.5696179197529427,1.1671656530081846,0.30277777777777776,1.0,1.0,7/15,18.74%,TERF1;RTEL1;ERCC4;TERF2;SMG6;TERF2IP;RAD50
prerank,regulation of cell communication by electrical coupling (GO:0010649),-0.45153811583151504,-1.1671018532977733,0.253125,0.6582131868218938,1.0,3/13,2.43%,CAMK2D;CALM1;CAV1
prerank,positive regulation of secretion (GO:0051047),0.5973728975922419,1.1662404901221868,0.3298662704309064,1.0,1.0,1/11,1.82%,AQP1
prerank,negative regulation of response to wounding (GO:1903035),0.5629025134536146,1.1658975860658694,0.30257801899592945,1.0,1.0,5/19,11.37%,RTN4R;CASK;EPHA4;SERPINE1;PTPRS
prerank,mRNA export from nucleus (GO:0006406),0.4878735266742042,1.165851215936691,0.28234086242299794,1.0,1.0,31/102,17.39%,NDC1;NUP155;NUP205;NUP160;SRSF4;FIP1L1;EIF4E;UPF3B;NUP85;SLBP;TPR;DDX39B;SRSF7;WDR33;SRSF3;RBM15B;SRRM1;CPSF4;NUP214;RANBP2;MCM3AP;SMG6;NXT1;NUP133;HNRNPA2B1;NUP42;UPF2;IWS1;DHX38;NUP98;NUP210
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.46270678397881826,-1.1656838963101357,0.275,0.660323327806895,1.0,6/11,14.65%,MAP3K5;GSKIP;PRODH;PDK1;STK25;DIABLO
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.354604069184527,-1.1655723750212097,0.22164948453608246,0.6592198001363575,1.0,16/24,36.58%,ATF6;GCN1;HSPA5;KLF2;CEBPB;VEGFA;CREB3L1;DDIT3;MAPK7;HIF1A;ATF6B;MBTPS2;MT3;CHD6;NFE2L2;ATF3
prerank,heterochromatin assembly (GO:0031507),0.56372813764761,1.1655578306483891,0.3062015503875969,1.0,1.0,5/20,11.99%,HELLS;NRDE2;SMCHD1;HDAC1;CENPV
prerank,positive regulation of innate immune response (GO:0045089),0.5334881363885839,1.1653533561525895,0.3157262905162065,1.0,1.0,10/30,17.14%,FADD;UBE2K;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;TRIM6;SLC15A4;MAVS
prerank,regulation of peptidase activity (GO:0052547),-0.3831154715314217,-1.1642526868312544,0.22983870967741934,0.6611082424466512,1.0,6/19,13.28%,CST3;CAV1;PSMA3;FURIN;PINK1;RCN3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.332201930921369,-1.1641833787734421,0.21818181818181817,0.6599292130749352,1.0,17/32,34.91%,ADIPOR2;APOE;CREBL2;ASAH1;ASXL3;MTOR;PRKAG2;SORBS1;AVIL;MID1IP1;GPER1;MLXIPL;AKT1;FITM2;STAR;C3;PDK4
prerank,inositol lipid-mediated signaling (GO:0048017),-0.2885613097188398,-1.163395774111963,0.17204301075268819,0.6605948754930229,1.0,18/50,21.48%,OGT;ADAP2;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;IRS1;TNFAIP8L3;PI4KA;PLCE1;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5428228517388272,1.16299159262428,0.31025957972805934,1.0,1.0,6/27,9.97%,E2F1;AQP1;DHX9;PDGFRA;AGT;DDR2
prerank,negative regulation of cellular protein localization (GO:1903828),0.5217413580257056,1.1623418107252976,0.30723606168446027,1.0,1.0,12/34,16.77%,ROCK2;GSK3B;MAPT;LEPROT;CTNNA1;RIPOR2;PICALM;SNX33;ILRUN;OTUD7B;LZTFL1;UBXN2B
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4964785526117419,1.1622895917267213,0.28335056876938985,1.0,1.0,13/85,9.23%,UHRF1;RAB33B;HYAL1;FGFR2;LAMB1;PRKDC;MCC;BMP6;TCF7L2;TGFBR3;SFRP2;YAP1;ANGPT1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4510437598625561,-1.1610172781326964,0.3058103975535168,0.6651712906826472,1.0,9/12,48.96%,INPP5K;PPP1R3B;PPP1R3C;AKT1;RUBCNL;KHK;PPP1R3E;PPP1R3D;GCGR
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3181434950002945,-1.1609625277500397,0.2037037037037037,0.6639451054898102,1.0,9/41,6.47%,CACNA2D1;RYR3;SLC8A3;GRIN2A;RYR2;GRIN2B;SLC24A2;FGF2;HTR2C
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5980088329206663,1.160769553758845,0.327217125382263,1.0,1.0,4/11,18.72%,FADD;PRKCA;CASP8;RIPK1
prerank,response to alcohol (GO:0097305),-0.3615174586886676,-1.1607650423593976,0.2542372881355932,0.6630458023180547,1.0,6/27,4.69%,GRIN3A;GRIN2A;TGFBR2;GLRA1;GRIN2B;GOT2
prerank,positive regulation of cell cycle (GO:0045787),0.5056815018033772,1.1605882404119665,0.31170212765957445,1.0,1.0,12/62,12.38%,CCNB1;TGM1;SPDYA;PSRC1;FGFR2;EIF4E;CDC25B;CHEK1;CCDC57;TAL1;PRKCA;ADAM17
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3586775963522894,-1.1605382187084938,0.24390243902439024,0.6622596036936493,1.0,14/24,24.17%,PRKN;SELENOS;NR1H3;CREB3L1;UBXN1;NR1H2;XBP1;AQP11;SYVN1;CREB3;PARK7;BCL2L1;RACK1;WFS1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.34623319998434904,-1.1602047812525942,0.24293785310734464,0.6617760111978185,1.0,12/29,25.64%,APOE;CREBL2;SLC27A1;GPLD1;NR1H3;MTOR;NR1H2;SORBS1;SLC45A3;MFSD2A;CTDNEP1;MID1IP1
prerank,positive regulation of hormone secretion (GO:0046887),-0.39984650434120744,-1.159719951380951,0.26640926640926643,0.6615158391883226,1.0,11/17,46.52%,SNX4;C1QTNF3;VAMP8;EDN1;SOX11;EDN3;SPP1;GRP;VAMP7;RASL10B;NMB
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.39518011308596857,-1.1583776680745705,0.26907630522088355,0.6634490969549691,1.0,5/18,17.16%,PRKN;KCNB1;IRS1;MIDN;ADRA2A
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.36408984612706285,-1.1574838662206517,0.26540284360189575,0.6644678130483036,1.0,9/23,12.93%,KIF1B;MYO10;DYNC1I2;KIF1A;KIF5B;KIF5C;TUBA1A;TUBA1B;HOOK1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.4760942646042442,-1.1574762668401872,0.28851540616246496,0.6631347363591207,1.0,6/10,21.77%,AKT2;IRS2;GPLD1;IRS1;PTH1R;SLC45A3
prerank,nuclear envelope organization (GO:0006998),0.5540133126618975,1.1572500820570801,0.3358395989974937,1.0,1.0,6/20,15.61%,NEMP1;NUP155;LEMD3;EMD;TOR1B;SUN2
prerank,carbohydrate transport (GO:0008643),0.5900548867080554,1.1571803328118508,0.3285302593659942,1.0,1.0,1/11,1.82%,AQP1
prerank,nitrogen compound transport (GO:0071705),0.4812057476506796,1.1568718952578767,0.2558139534883721,1.0,1.0,11/141,7.76%,CENPF;RHAG;SLC18A2;NDC1;AQP1;ZG16;SLC6A2;PDPN;SLC38A4;SLC25A47;SLC16A10
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.38405310231679324,-1.156831107238253,0.28,0.6634596416662164,1.0,9/19,19.05%,CSGALNACT1;HS6ST3;NDST3;NDST1;HS3ST3B1;NDST2;EXTL3;NDST4;XYLT2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.516822864064237,1.156785009858335,0.32555425904317387,1.0,1.0,11/36,15.61%,NLK;KIT;LEPROT;CENPJ;VHL;OCIAD2;CRLF3;PIGU;ADIPOR1;OCIAD1;NF2
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.44262610892971777,-1.1563396133111246,0.2874617737003058,0.6634631281092064,1.0,5/12,19.45%,AKT2;IRS2;IRS1;ABCD2;PPARGC1A
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.38019212278179587,-1.1563146181531117,0.2616033755274262,0.6622130798226135,1.0,5/20,10.73%,IL1R1;MALT1;B2M;DENND1B;CD81
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.5702381662005294,1.1560795882879842,0.3141654978962132,1.0,1.0,4/14,15.23%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,mitochondrial fusion (GO:0008053),0.5451694212238738,1.1560554277304198,0.3195187165775401,1.0,1.0,8/18,20.46%,MIEF2;STOML2;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7
prerank,organelle organization (GO:0006996),0.48425304881212045,1.1553859266451998,0.14,1.0,1.0,67/388,13.65%,DIAPH3;KIF4A;CDCA8;CEP55;MNS1;ARHGAP21;USP6NL;SYNE3;MAST2;MTFR2;MIEF2;PHIP;ARHGAP10;GBF1;OBSL1;PACSIN2;AJUBA;FAM161A;LNPK;DIAPH1;TSPO2;NUMA1;DYRK3;COG1;ZW10;RHOT1;MICAL3;TMEM11;CNN2;FGD4;ATL2;ANK1;PRPF40A;ATL3;STOML2;RAB29;PDZD8;FGD1;VPS18;LRRK2;GOLGA8B;GOLGA5;ZFYVE16;WDPCP;SH3D19;LIMD1;ODF2;LONP1;STRIP2;RAB1A;PITPNB;YTHDF2;NIPSNAP2;FGD6;CENPW;EIF2AK3;BAG5;GAK;FANCG;GORASP2;DMTN;DES;PPID;PPRC1;LARP4;PRKD1;PRKCI
prerank,dendritic cell differentiation (GO:0097028),-0.3669335894333792,-1.1546126269254937,0.2926829268292683,0.6651646177251057,1.0,4/22,6.74%,TGFBR2;GAS6;CAMK4;LYN
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),-0.45718750599095925,-1.1540105278334656,0.3166144200626959,0.6654586151502037,1.0,3/11,9.42%,MERTK;GAS6;SELENOS
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.48086124454373547,1.153865754497903,0.3148535564853556,1.0,1.0,10/76,9.24%,BRCA1;SAE1;PAXIP1;FANCI;MYCBP2;FBXW7;LRRK2;CUL3;ANGPT1;TBC1D7
prerank,cellular response to peptide (GO:1901653),-0.2855427328044423,-1.153447094509867,0.15384615384615385,0.6654684139022826,1.0,20/56,14.10%,CACNA2D1;PSEN1;GRIN2A;CAV1;IGF1;TLR4;LRP1;RPL23;CASP4;TRIM41;VCAM1;LGMN;NOD1;PTPN22;ATP1A3;APP;ARHGEF2;GRM5;CHMP5;GRIN1
prerank,regulation of mast cell activation (GO:0033003),-0.48110264724514784,-1.152691046869184,0.2803738317757009,0.6660086297429022,1.0,9/10,49.97%,LYN;NECTIN2;CD84;CRLF2;MILR1;CD300LF;TSLP;PLSCR1;CD226
prerank,P-body assembly (GO:0033962),0.576212118394198,1.1523149198957188,0.33284457478005863,1.0,1.0,7/12,17.40%,PATL1;LSM3;EIF4ENIF1;LIMD1;RC3H1;LSM4;EDC3
prerank,actin crosslink formation (GO:0051764),0.5915974668817209,1.1520133960867383,0.3422913719943423,1.0,1.0,4/12,15.76%,GAS2L3;DPYSL3;BAIAP2L1;LCP1
prerank,protein polyubiquitination (GO:0000209),0.47887224326208166,1.1506008166760149,0.17317317317317318,1.0,1.0,57/297,15.04%,DTL;BRCA1;CCNF;BARD1;UBE2T;UBE2C;UBE2S;RNF168;ANAPC7;CBFB;TRIML2;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;SIAH2;FBXW7;FBXO30;UBE2N;PRPF19;FBXL8;RNF31;RC3H2;UBR5;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;PSMD1;SKP2;TPP2;FBXL17;UBOX5;PSMB9;SMURF2;FBXW11;TRIP12;TRIM6;ITCH;IRF2BP1;UBE2J1;BTRC;FBXO27;ZNRF2;SPOP;RC3H1;TRIM5;PSMC6;RNF114;UBE2QL1;ZNRF1;ZFP91;FBXO17;NPEPPS
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.40135976936610657,-1.1505455361872827,0.24334600760456274,0.6700186938361713,1.0,8/17,18.55%,HSP90B1;OS9;UFD1;DERL1;SELENOS;SEC61B;AUP1;SYVN1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.37328165200963465,-1.1505053658455608,0.26582278481012656,0.6688185620236493,1.0,4/22,3.48%,ATP1B1;CALM1;RYR2;AKAP6
prerank,embryonic eye morphogenesis (GO:0048048),0.5860506471479936,1.1501222561429925,0.3273542600896861,1.0,1.0,5/11,15.21%,MFAP2;FBN1;KDM2B;MFAP5;EFEMP1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.37638500531792,-1.1500730092831277,0.2459016393442623,0.668516859180203,1.0,4/21,3.48%,CAMK2D;CALM1;RYR2;AKAP6
prerank,myeloid cell development (GO:0061515),0.5525441235765036,1.1492709564199035,0.33026315789473687,1.0,1.0,8/18,17.23%,ANXA2;KIT;ABCB10;DMTN;MED1;SRC;ALAS2;FOXP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.3725316501774207,-1.1486412384371005,0.2809917355371901,0.6707484492864374,1.0,8/20,25.61%,ATP1B1;ATP1A1;ATP1B3;ATP1A3;ATP1A2;SLC12A2;NEDD4L;ATP6AP1
prerank,substrate-dependent cell migration (GO:0006929),-0.4186017830278743,-1.1483950556907017,0.26885245901639343,0.670041693236492,1.0,11/14,31.33%,OPHN1;VEGFC;SDCBP;EPHA8;ITGB1BP1;SHTN1;NRP1;ANKS1A;P2RY12;PTPRC;ITGA2
prerank,glycolipid metabolic process (GO:0006664),-0.29850399591062543,-1.1482365160518733,0.16326530612244897,0.6691233096207521,1.0,18/47,23.94%,HEXB;ST3GAL6;PSAP;ASAH1;ST6GALNAC3;ESYT1;B3GALNT1;HEXA;ST8SIA6;GBGT1;GLTP;CTSA;SCCPDH;GBA2;ST6GALNAC4;ABCA2;ESYT3;NEU1
prerank,regulation of actin filament-based process (GO:0032970),0.48532902991902616,1.1477505893973683,0.3169164882226981,1.0,1.0,13/70,12.63%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;CNN2;RHOQ;ROCK1;ARHGAP35;RND2;EZR;RAC1;DMTN
prerank,negative regulation of wound healing (GO:0061045),-0.35466998521339455,-1.1472396287611775,0.2824858757062147,0.6702330907048034,1.0,6/28,6.10%,PHLDB2;APOE;VTN;THBD;FGF2;CD34
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.557703871161953,1.146392079064126,0.3290229885057471,1.0,1.0,6/16,15.23%,PRKDC;RIF1;SMCHD1;PARP9;KMT5C;SHLD2
prerank,lysine catabolic process (GO:0006554),0.5755768504332358,1.1460664969531773,0.31754874651810583,1.0,1.0,1/12,1.41%,SLC25A21
prerank,lysine metabolic process (GO:0006553),0.5755768504332358,1.1460664969531773,0.31754874651810583,1.0,1.0,1/12,1.41%,SLC25A21
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3400983736225646,-1.1460577360107878,0.20212765957446807,0.671941944285848,1.0,8/30,13.05%,EP300;SAFB2;AR;PRMT2;KDM4C;DAB2;DDX5;HEYL
prerank,cardiac conduction system development (GO:0003161),0.538391634764315,1.1460231706871067,0.33551769331585846,1.0,1.0,7/24,13.42%,BMPR1A;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.40639658528939093,-1.1457701887448017,0.2465277777777778,0.6713602097307584,1.0,3/14,6.59%,PUM1;DDX60;ZDHHC5
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.47949363405007617,1.145246950695552,0.29258098223615464,1.0,1.0,23/88,16.41%,HAS3;FNIP1;HYAL1;GSK3B;BMF;TRABD2B;AJUBA;FAF1;SLF1;SPIDR;TPR;CDC42EP2;STAM;SH3GLB1;TPPP;SDC1;TAL1;STX18;PRKCA;SYNPO2;SMAD3;RHOC;SMPD3
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.39185464574804885,-1.1441693816926806,0.2527075812274368,0.6739651300454402,1.0,4/18,9.25%,OCLN;SLC2A1;CLIP3;INPP5K
prerank,nuclear body organization (GO:0030575),0.5728008610459132,1.143769169835336,0.3180473372781065,1.0,1.0,3/12,6.69%,DYRK3;SERBP1;PML
prerank,purine-containing compound catabolic process (GO:0072523),0.5785226526472231,1.1436143440080304,0.32531824611032534,1.0,1.0,3/13,9.05%,DPYD;XDH;ITPA
prerank,regulation of humoral immune response (GO:0002920),-0.31142903095009605,-1.1434923930941356,0.17757009345794392,0.6743186332176069,1.0,19/44,39.06%,VTN;CD81;C4B;C1QB;GATA6;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;FCGR2B;C7
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5308966933566552,1.1427042894046975,0.327455919395466,1.0,1.0,8/24,13.63%,CBFB;ROCK2;NUMA1;HOXA7;GRHL2;ROCK1;ERRFI1;MED1
prerank,regulation of neuroblast proliferation (GO:1902692),-0.41066627400453115,-1.1425332981932899,0.2641509433962264,0.6754006611474406,1.0,7/15,22.18%,NF1;SMARCD3;CTNNB1;CX3CL1;VEGFA;TAFA1;DRD2
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3101234151534972,-1.141879159100429,0.2,0.6756694101576857,1.0,10/39,14.55%,PTK2;PODXL;JAG1;MAP2K5;NEXMIF;KLF4;FXYD5;RGCC;PPM1F;VEGFA
prerank,monocyte chemotaxis (GO:0002548),-0.3352404445580511,-1.1417906656230523,0.24074074074074073,0.6746170068145539,1.0,5/32,13.08%,FLT1;PTPRO;RPS19;TNFRSF11A;CX3CL1
prerank,regulation of blood circulation (GO:1903522),-0.3159642297734472,-1.1416477892547063,0.23129251700680273,0.6736222024383317,1.0,13/34,22.36%,CAMK2D;ECE1;PER2;DMPK;TPM1;ACE;AGTR1;SRI;TBX2;FXYD1;KCNQ1;KCNJ12;S100A1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.4792138364822988,1.140985206964531,0.2638469284994965,1.0,1.0,18/175,11.47%,TNFSF13B;BRCA1;MAP3K14;HYAL1;PSMC2;PSMD5;ACTN4;DHX9;NPNT;YBX3;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.3444734722652023,-1.1404193644457064,0.2818181818181818,0.6754013926559473,1.0,9/25,19.32%,PSEN1;ITGA6;AR;APP;THBS1;SDCBP;PTH1R;NCKAP1L;NRP1
prerank,regulation of cell morphogenesis (GO:0022604),0.5156631980100309,1.14041258934426,0.35414165666266506,1.0,1.0,8/30,14.36%,MACF1;MOV10;PHIP;PDPN;PDZD8;SH3D19;LARP4;CD44
prerank,histone deacetylation (GO:0016575),0.5127905394700866,1.1402631520608228,0.31444444444444447,1.0,1.0,14/43,14.79%,MIER1;SMARCAD1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;HDAC8;MTA3;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,endodermal cell fate commitment (GO:0001711),-0.47046320654032775,-1.140065864862406,0.2955223880597015,0.6748219728839403,1.0,4/10,17.58%,CDC73;RTF1;SOX17;SOX2
prerank,cortical cytoskeleton organization (GO:0030865),0.5055612111812433,1.139935919410687,0.3340987370838117,1.0,1.0,20/41,22.89%,ROCK2;RHOA;RHOQ;LLGL2;ROCK1;EPB41L3;RND2;EZR;RAC1;DLG1;RHOC;LCP1;FHOD1;NCKAP1;RAB13;TRPV4;FMNL2;RND3;IKBKB;RHOH
prerank,eosinophil migration (GO:0072677),-0.4213599547937465,-1.1397408379498413,0.3181818181818182,0.6730758908381778,1.0,12/14,57.89%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.4213599547937465,-1.1397408379498413,0.3181818181818182,0.6730758908381778,1.0,12/14,57.89%,SCG2;CX3CL1;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,protein ubiquitination (GO:0016567),0.4741893112024584,1.1396802015875216,0.139,1.0,1.0,90/471,14.63%,DTL;BRCA1;CCNF;UHRF1;PLK1;BARD1;UBE2T;UBE2C;RAD18;UBE2S;RFWD3;RNF168;ANAPC7;TRIM37;CBFB;TRIML2;BRAP;PDZRN3;PSMC2;CDC27;RNF220;PSMD5;UBE2K;UHRF2;NEDD4;FBXL7;MYCBP2;PRKDC;SIAH2;SPSB2;RNF43;FANCL;ARRB1;ELOC;FBXW7;FBXO30;UBE2N;PRPF19;CUL5;FBXL8;RNF31;RC3H2;UBR5;VPS18;RNF40;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;SH3RF1;KLHL22;LEO1;VHL;CUL4B;PSMD1;SKP2;OBI1;TPP2;FBXL17;HERC2;FBXO45;UBOX5;PSMB9;TRIM63;ARRDC1;SMURF2;PCNA;FBXW11;TRIP12;TRIM6;ITCH;ATG3;IRF2BP1;UBE2J1;USP9X;CRBN;BTRC;FBXO27;ZNRF2;FBXO25;SPOP;RC3H1;HLTF;TRIM5;PSMC6;RNF114;UBE2QL1;ZNRF1;BIRC6
prerank,glutamate metabolic process (GO:0006536),-0.3818476231292587,-1.1396606939224667,0.29130434782608694,0.6719711036705815,1.0,9/19,25.58%,GLUL;GLS;GOT2;PRODH;GOT1;ALDH5A1;GLUD1;OAT;GLS2
prerank,positive regulation of hydrolase activity (GO:0051345),0.4734482633293796,1.1396030673420479,0.28600201409869086,1.0,1.0,24/137,13.07%,ECT2;EZH2;ARHGAP11A;HMGB2;USP6NL;MAP4K4;RHOA;GSK3B;RTN4R;EVI5L;NET1;AFDN;RSU1;TBC1D7;PICALM;MTMR9;SRGAP2;LIMS1;CALM2;PLXNB1;BMP2;DOCK11;SNX18;CTSH
prerank,pyroptosis (GO:0070269),0.5725101410760334,1.1395032205349533,0.32814710042432815,1.0,1.0,4/15,14.51%,DHX9;APIP;CASP8;GSDMD
prerank,embryonic heart tube morphogenesis (GO:0003143),0.501269300839667,1.1394823652766728,0.3412698412698413,1.0,1.0,5/44,9.03%,STIL;SETDB2;SRF;MKKS;NPHP3
prerank,response to histamine (GO:0034776),-0.4729907636263132,-1.1392019914825773,0.32507739938080493,0.6718754121916991,1.0,4/10,11.29%,GABRB1;GABRB3;GABRB2;GABRG2
prerank,negative regulation of anoikis (GO:2000811),-0.41534969501979296,-1.1390858890136148,0.32,0.6709190303176279,1.0,4/14,10.55%,PTK2;CAV1;TLE1;BCL2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.4581837535458843,-1.1390124516928681,0.2968299711815562,0.6698543591836905,1.0,5/10,32.82%,EP300;KAT2B;KAT7;CREBBP;ESCO1
prerank,epithelial cell migration (GO:0010631),0.508536107042201,1.1388472725394267,0.35219399538106233,1.0,1.0,7/37,9.38%,ANLN;LOXL2;RHOA;KIT;ADGRA2;KANK2;ROCK1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.476858537186212,1.1370856517825971,0.197,1.0,1.0,77/341,16.77%,DTL;KIF14;UHRF1;BUB1B;PLK1;CDC20;UBE2C;AURKB;UBE2S;RNF168;ANAPC7;AURKA;VPS37B;FEM1C;PSMC2;CDC27;PSMD5;UBE2K;NEDD4;FBXL7;UBR4;SPSB3;KLHL15;SIAH2;SPSB2;TBL1XR1;FAF1;RNF43;BUB3;ARRB1;PML;ELOC;FBXW7;VPS37A;RC3H2;AGAP3;RNF40;PSMB1;SMURF1;CUL3;UBE2R2;PSMD14;KCTD2;KLHL22;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;ARRDC1;SMURF2;ADRM1;FBXW11;TRIP12;ITCH;COPS3;USP9X;CRBN;BTRC;SPOP;RC3H1;PSMC6;RNF114;ZNRF1;BIRC6;ANAPC15;OTUD7B;ASB2;NTAN1;CNOT4;FBXL14;RAD23B;ANAPC5;SIAH3;UBXN2B
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.3261747700276097,-1.136900205097681,0.21794871794871795,0.6738516149574671,1.0,17/34,23.85%,FLT1;SEMA6A;VEGFC;FOXC1;RAMP2;SPRY2;VEGFA;ITGB1BP1;VEGFB;PIK3CA;NRP1;VEGFD;MT1G;HSPB1;NUS1;FLT4;SPHK1
prerank,regulation of macrophage differentiation (GO:0045649),0.5626396701214446,1.136185274304376,0.3547008547008547,1.0,1.0,4/15,12.73%,FADD;PTPN2;PRKCA;CASP8
prerank,negative regulation of translation (GO:0017148),0.48110103401811827,1.1356160273214764,0.30785123966942146,1.0,1.0,26/87,16.34%,TYMS;ILF3;SYNCRIP;ROCK2;AGO2;CNOT1;FTO;EIF4ENIF1;SAMD4A;CAPRIN1;TPR;FMR1;LARP1;CPEB2;ROCK1;YTHDF2;MRPL13;EIF2AK3;MEX3D;RBM4;DHFR;EPRS1;CNOT7;FXR1;UNK;METTL3
prerank,carnitine metabolic process (GO:0009437),-0.44127795530916525,-1.1354699662925996,0.3092105263157895,0.6762886473855333,1.0,4/12,11.12%,TMLHE;ACADM;CROT;BBOX1
prerank,platelet degranulation (GO:0002576),-0.26240184674147615,-1.1352969040043623,0.09090909090909091,0.6754195423399235,1.0,40/118,20.56%,CYRIB;VWF;TMSB4X;PECAM1;TIMP3;CALM1;VEGFC;IGF1;APOOL;TGFB2;RAB27B;GAS6;PLEK;PSAP;ISLR;LYN;ABCC4;IGF2;LHFPL2;ENDOD1;SCG3;SRGN;APP;TAGLN2;CHID1;THBS1;VEGFA;TMX3;HABP4;LAMP2;SCCPDH;TGFB3;ACTN1;VEGFB;TEX264;CLEC3B;VEGFD;SPARC;LGALS3BP;ITGB3
prerank,cartilage development (GO:0051216),0.4814781208651718,1.1352005594533696,0.33444444444444443,1.0,1.0,15/49,18.16%,HYAL1;DDRGK1;SULF2;WNT2B;NFIB;SOX6;SULF1;CCN3;BMP2;CD44;SNX19;ITGB8;TRPV4;RUNX1;OSR1
prerank,tetrapyrrole metabolic process (GO:0033013),-0.38819453474067517,-1.1350385654226687,0.2727272727272727,0.6747628754298867,1.0,7/18,25.36%,ABCD4;CUBN;LMBRD1;MTRR;MMAA;MTR;TCN2
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.3546545932003824,-1.1348398166071076,0.27040816326530615,0.6739097484321497,1.0,6/25,13.08%,AKAP6;CEMIP;PLCG1;TRPC1;CACNB2;CX3CL1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5322462933532892,1.1343725582519832,0.3393782383419689,1.0,1.0,5/21,14.64%,MASTL;GSK3B;PPP1R8;ENSA;PTPA
prerank,regulation of viral entry into host cell (GO:0046596),-0.33095142726196436,-1.1343406228183421,0.25,0.6739387931775817,1.0,11/30,17.26%,MID2;LY6E;SNX3;TRIM25;IFITM3;GSN;TRIM27;TRIM14;NECTIN2;IFITM2;LGALS9
prerank,regulation of lamellipodium organization (GO:1902743),0.5598287041859175,1.1340756097995457,0.3244005641748942,1.0,1.0,5/14,14.36%,PDPN;TWF1;RAC1;DMTN;CD44
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.5724806049362376,1.1337959157643889,0.34852941176470587,1.0,1.0,2/12,8.14%,IL18;CD80
prerank,positive regulation of protein maturation (GO:1903319),-0.45787439308809785,-1.133717887855297,0.3086816720257235,0.6743023936869036,1.0,3/11,15.02%,CCBE1;SOX4;NKD2
prerank,positive regulation of T cell differentiation (GO:0045582),0.5133934995906906,1.1333603214347352,0.34942528735632183,1.0,1.0,2/36,1.27%,GLI2;GLI3
prerank,diacylglycerol metabolic process (GO:0046339),-0.3421668856511563,-1.133173970098329,0.25773195876288657,0.6742365395452156,1.0,13/23,36.90%,DGKB;DGKG;DGKI;DGKQ;PLCE1;DGKD;PLA2G15;DGKK;PNPLA2;LIPE;DGAT2;ANG;DGKA
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5855580840156592,1.132608864371771,0.3288888888888889,1.0,1.0,3/10,7.95%,PDE3B;WNK1;SERPINE1
prerank,regulation of heart contraction (GO:0008016),-0.26442899646125595,-1.1321966040820672,0.1388888888888889,0.6752747307870676,1.0,30/90,22.36%,CAMK2D;RYR3;SMAD7;SLC8A3;ATP1B1;CALM1;RYR2;TGFB2;DMPK;ATP1A1;TPM1;ATP1B3;NPR1;TRPC1;ATP1A3;ATP1A2;ATP2B2;ATP2B3;GSK3A;SRI;TBX2;PDE4D;FXYD1;KCNQ1;CALM3;KCNJ12;NOS1;ATP2A3;P2RX4;S100A1
prerank,neurotransmitter transport (GO:0006836),-0.2702135974110519,-1.1311436835141147,0.23404255319148937,0.6766999528582394,1.0,21/73,16.78%,UNC13B;SYN3;RIMS1;GLUL;SLC1A2;GABRA2;GLS;APBA1;SYN2;SYT1;LIN7A;BRSK1;NRXN1;SNPH;SLC17A6;ATP1A2;DVL1;CPLX1;SLC1A1;SYNJ1;SNAP25
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.3691469700048494,-1.130935023738571,0.2413793103448276,0.6760140350617433,1.0,5/19,10.95%,CHD8;AR;ICE1;ZNF76;MTOR
prerank,membrane repolarization during action potential (GO:0086011),-0.42780403644723325,-1.1309242758050029,0.30201342281879195,0.6747674037196133,1.0,5/13,31.95%,ATP1B1;ATP1A1;KCNQ1;KCNIP2;KCNE4
prerank,regulation of proteolysis (GO:0030162),0.5009027323235825,1.130744997787619,0.3352017937219731,1.0,1.0,11/48,13.88%,PLK1;FADD;FGFR4;DNAJC1;FBXW11;HDAC2;CASP8;ITCH;PLAUR;BTRC;SPOP
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.559071512711666,1.1306175893500314,0.362339514978602,1.0,1.0,7/15,15.48%,AGO2;CNOT1;EIF4ENIF1;TENT4A;PABPC1;CNOT7;TNRC6C
prerank,regulation of mRNA stability (GO:0043488),0.4690662646279556,1.1300560678959939,0.30522088353413657,1.0,1.0,38/145,15.52%,MEIOC;E2F1;XPO1;ROCK2;PSMC2;PSMD5;HNRNPD;FTO;TNPO1;SERBP1;THRAP3;EIF4ENIF1;SAMD4A;FMR1;FUS;RC3H2;LARP1;PSMB1;PSMD14;AXIN2;PUM2;ROCK1;PSMD1;HNRNPU;YTHDF2;PSMB9;TENT5D;TAF15;EXOSC7;NUP214;PRKCA;MEX3D;RC3H1;PABPC1;PSMC6;ZC3H14;GDNF;FXR1
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.35890602831538637,-1.129913483465271,0.270935960591133,0.6760956254203554,1.0,8/24,25.83%,PLA2G4A;CDS2;SLC27A1;PNPLA8;SERAC1;PLA2G12A;PLA2G15;ABCA3
prerank,protein phosphorylation (GO:0006468),0.473469526537116,1.1297340185121083,0.163,1.0,1.0,106/479,15.60%,NEK2;MELK;CDK1;INCENP;TTK;CLSPN;PLK1;BIRC5;MASTL;AURKB;NEK3;CIT;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;MAP4K4;DYRK1A;STK17B;BAZ1B;BMPR1A;CDK14;AURKA;ROCK2;FGFR4;MAP4K2;GSK3B;FGFR2;STK10;NLK;CHEK2;MYLK3;KIT;CCNA2;PRKDC;CTBP1;DYRK3;VRK2;STK3;STK24;MUSK;NRK;MAP3K1;CCNE1;TGFBR3;WNK1;MAP3K20;CDC25B;PDGFRA;CHEK1;CDC42BPA;EPHA4;CDK2;LRRK2;GRK5;MAP3K3;ABI1;ROCK1;PIM1;ERC1;MARK2;CSNK2A2;DDR2;PXK;CDC42BPG;CAMK1D;TGFBR1;SRPK1;EIF2AK3;LMTK3;PRKCB;BMP2;PRKCA;ULK2;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MAPKAPK3;MEX3B;STRADA;BTK;CDK19;PRKCE;MAML1;PRKD1;PRKCI;CAB39;PLK2;PRDX4;NRBP1;MORC3;VRK1;CDK8;BIRC6;STK11;TAOK1;EFEMP1;PRKAG1;SRC;PRKD2;STK39;PASK
prerank,T cell differentiation (GO:0030217),0.5081698481160455,1.1291644646942542,0.31927023945267957,1.0,1.0,8/40,12.38%,GLI3;FADD;KIT;LEPR;PTPN2;ANXA1;LMBR1L;ADAM17
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.48018192894162953,1.1289396021729825,0.32368148914167527,1.0,1.0,28/101,16.94%,UHRF1;PLK1;FADD;FGFR4;LARP4B;HNRNPD;PRKDC;UPF3B;FAF1;SAMD4A;FMR1;ATG7;AGT;PLXNB2;METTL5;EZR;EIF3C;FBXW11;HDAC2;CASP8;LARP4;BTRC;FXR1;PASK;MSN;METTL3;AMER1;PYM1
prerank,negative regulation of phosphatase activity (GO:0010923),0.5170071219293887,1.1287543892622232,0.3460122699386503,1.0,1.0,2/25,3.50%,MASTL;GSK3B
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5835395036694428,1.1286761068702933,0.3358433734939759,1.0,1.0,3/11,18.13%,CBFB;HMGB1;RUNX1
prerank,embryonic organ morphogenesis (GO:0048562),0.5034722612333615,1.1285871484930006,0.3438556933483653,1.0,1.0,15/42,19.69%,FOXE1;MFAP2;FGFR2;FBN1;HOXC4;PDGFRA;NIPBL;DSCAML1;HOXB3;RBPMS2;MFAP5;EFEMP1;HOXA3;DYNC2I1;ALDH1A3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.30862389648332467,-1.1284529510853212,0.23529411764705882,0.6785123917982893,1.0,12/40,21.58%,APOE;CREBL2;TLR4;LARP6;MTOR;RGCC;GRIN1;CREB3L1;TGFB3;RAB27A;SORBS1;SUCO
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5561405293175569,1.1272446246812626,0.3469387755102041,1.0,1.0,7/13,19.30%,AGO2;CNOT1;EIF4ENIF1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),-0.269207438499951,-1.1269548975550303,0.19642857142857142,0.681006578120141,1.0,26/70,19.33%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,bicellular tight junction assembly (GO:0070830),0.4944556640503557,1.1268441548947723,0.3322222222222222,1.0,1.0,3/46,6.59%,ECT2;AFDN;GRHL2
prerank,retina homeostasis (GO:0001895),-0.35441447500893386,-1.1261957314306745,0.30434782608695654,0.6816672467214444,1.0,6/23,13.15%,ACTB;POTEF;B2M;WHRN;BBS4;PRDX1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.3939663313220588,-1.1259549340087152,0.313953488372093,0.679785517866182,1.0,6/16,15.60%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.3939663313220588,-1.1259549340087152,0.313953488372093,0.679785517866182,1.0,6/16,15.60%,APOD;PHLDB2;ACVRL1;DUSP22;THBS1;ITGB1BP1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.5015642956543066,1.1256560791456283,0.35023041474654376,1.0,1.0,11/40,14.33%,EZH2;LOXL2;PDPN;TCF7L2;WWTR1;AXIN2;TGFBR1;BMP2;SMAD4;TWIST1;SMAD3
prerank,regulation of transport (GO:0051049),-0.3107993514277541,-1.1252876238588025,0.2537313432835821,0.680247799107075,1.0,14/36,25.71%,PRKN;MYO6;EPB41;ACTB;ICA1;DNAJA1;WWC1;PINK1;RAB11A;NRP1;GAPVD1;MBTPS1;ARL6IP5;POFUT2
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.25379285794898104,-1.1251290813340198,0.15625,0.679465245312995,1.0,35/109,19.88%,PLA2G4A;PIP4K2A;INPP4B;PLAAT3;MTMR10;PIK3R3;PDGFRB;PIP4K2B;PLEK;PIK3C2B;PLCB3;PIK3R1;FGF2;PIK3R4;PLCG1;SLC27A1;RAB5A;MTMR4;RUFY1;INPP5K;PIP5K1A;BMX;INPP5D;SYNJ2;CDS1;PIK3R6;SYNJ1;PI4KA;IMPA1;INPP4A;PIK3CD;PIK3CA;PIP4P1;PLA2G12A;CDIPT
prerank,negative regulation of bone mineralization (GO:0030502),0.5682995068713306,1.1251071138497246,0.33861671469740634,1.0,1.0,4/13,12.51%,BCOR;RFLNA;ENPP1;TRPM4
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.42131081554925986,-1.124883868959059,0.28664495114006516,0.6787362203769136,1.0,4/13,17.36%,KCNB1;SYT1;SCAMP5;SYT10
prerank,mitochondrial transport (GO:0006839),-0.2906277888669955,-1.124745306524104,0.2236842105263158,0.6778645345874226,1.0,28/53,31.41%,FIS1;DNAJC19;SLC25A13;MTX2;OXA1L;SLC25A24;BCL2;BNIP3;TIMM44;TOMM70;BCAP31;GDAP1;SLC25A4;AIP;FBXO7;TOMM34;BCL2L1;TIMM17A;TOMM7;TIMM17B;TIMM9;TMEM14C;TMEM14A;TIMM13;TOMM22;TIMM8B;TOMM5;BAK1
prerank,protein localization to nucleus (GO:0034504),0.46967385324482286,1.1242164535759298,0.32619775739041795,1.0,1.0,27/102,17.75%,PLK1;RANBP17;NUP155;RPAIN;E2F3;TAF3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;PML;RRS1;HNRNPU;XPA;IPO7;APPL2;NUP214;IPO11;NXT1;MORC3;NUP133;TOR1B;IPO5;NXT2;FAM53B;PIKFYVE
prerank,ncRNA processing (GO:0034470),-0.2558928901041782,-1.1238723976879224,0.0,0.678796862619198,1.0,91/200,27.09%,RPL13;AGO1;AGO3;SRRT;RPL37A;RPL38;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;PUS10;RPS7;NVL;RPL18A;RPS6;RPL14;AARS1;RPLP1;RPL9;RPL37;RPL8;RPS14;INTS3;NOL8;RPL10;RPL18;RPL32;RPS28;SENP3;RPS24;RPL15;RPS19;HEATR1;UTP20;RPL39;SARS1;KRR1;RPL12;RPL27;RPL24;WDR75;EXOSC1;RPS27;RPL27A;RPS9;RPL30;ADAR;EXOSC9;RRP1B;RRP1;RPL19;DICER1;RPL28;RPL31;MPHOSPH10;LAS1L;SNU13;DKC1;DDX49;RPL13A;RPL36A;AGO4;RPLP2;RPL29;MDN1;INTS12;KARS1;RPLP0;RPL10A;RPL35;NOB1;NOLC1;EMG1;EXOSC2;PIH1D1;EBNA1BP2;DDX54;RPL4;BYSL;INTS1;IMP3;DDX47;INTS11;BOP1;EXOSC3;RPS25;EXOSC5;TARBP2;POP5
prerank,RNA polyadenylation (GO:0043631),0.5128974863643311,1.123828454602233,0.3370233702337023,1.0,1.0,11/26,16.10%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,mRNA polyadenylation (GO:0006378),0.5128974863643311,1.123828454602233,0.3370233702337023,1.0,1.0,11/26,16.10%,TENT2;CSTF3;FIP1L1;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;PABPC1;PNPT1
prerank,ribosomal subunit export from nucleus (GO:0000054),0.5550366516904953,1.12346514635958,0.3386861313868613,1.0,1.0,4/13,13.01%,XPO1;NMD3;RRS1;SDAD1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5220326635729914,1.1234624382701457,0.34591194968553457,1.0,1.0,10/22,18.35%,ERI2;ERI1;RRS1;RPP40;EXOSC7;ERI3;WDR12;NOL9;ABT1;EXOSC10
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.30780086238618115,-1.1234280396705902,0.22137404580152673,0.678598786026177,1.0,13/41,14.92%,SMAD7;MEF2C;JAG1;TGFBR2;FKBP1A;CPE;TGFB2;PROX1;TPM1;SOX4;HEYL;GSK3A;ENG
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5329558890724531,1.1231781888727141,0.34478203434610305,1.0,1.0,6/18,14.26%,ITGB7;ADD2;PODXL2;ROCK1;SLC39A8;ITGB1
prerank,positive regulation of transferase activity (GO:0051347),0.4672124146169919,1.1229334364461372,0.31079717457114026,1.0,1.0,18/142,7.60%,NEK2;PLK1;AURKB;DSCC1;RFC4;FGFR4;FGFR2;HNRNPD;KIT;RFC2;MRE11;MUSK;RFC3;GRHL2;FBXW7;UBE2N;PDGFRA;EPHA4
prerank,positive regulation of vasculature development (GO:1904018),0.4769041111970061,1.12268450049809,0.33264248704663213,1.0,1.0,20/94,14.26%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PRKD1;ITGB1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.5121801548605228,1.1225080543466055,0.3491271820448878,1.0,1.0,7/25,11.44%,ADK;ADA;DCK;HPRT1;PRPS1L1;PRPS1;ADSL
prerank,regulation of T cell chemotaxis (GO:0010819),0.569699330090881,1.1224501097964532,0.3509544787077827,1.0,1.0,4/11,18.15%,WNK1;ADAM17;STK39;OXSR1
prerank,cellular response to insulin stimulus (GO:0032869),-0.26101844685020326,-1.1224356576753642,0.2,0.6798060240242586,1.0,38/124,14.88%,TBC1D4;FOXO1;ATP6V0A1;GRB14;GRB10;ATP6V0D1;ATP6V1E1;INSR;ATP6V0B;PIK3R3;PKM;AKT2;PIK3R1;ATP6V0A4;FOXC2;IRS2;SLC27A1;IGF2;NAMPT;INPP5K;GPLD1;SELENOS;BCAR3;IRS1;HDAC5;CAV2;PARP1;GRB2;ATP6V0C;KAT2B;RAB12;GOT1;ATP6V1H;SHC1;GSK3A;HDAC9;APC;ZDHHC7
prerank,autonomic nervous system development (GO:0048483),-0.3770303704742626,-1.1219764630629845,0.30996309963099633,0.6796821054334977,1.0,9/17,33.25%,SEMA3A;NF1;SOX4;NRP1;KIF26A;EDNRB;SOX11;SOX10;SOX8
prerank,response to zinc ion (GO:0010043),-0.34585713503833027,-1.1218345168587103,0.30808080808080807,0.6787602809350771,1.0,12/25,22.05%,GLRA1;SLC30A4;MT2A;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;P2RX4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.4703228730678271,1.121538660890353,0.155,1.0,1.0,117/572,15.19%,E2F7;NR2E3;E2F8;UHRF1;EZH2;EN1;PLK1;ATRX;AURKB;GLI2;TCFL5;GLI3;E2F1;CBX5;FOXE1;KMT5A;LOXL2;TRIM37;ZFP69;CBFB;RB1;ETV6;FNIP1;MIER1;WWOX;SP2;HDGF;CTCF;FGFR2;ZEB1;JAZF1;CNOT1;EED;BCOR;MDM4;TAF3;NEDD4;HIVEP1;CUX1;FHL2;BHLHE41;NFIL3;SRF;CTBP1;NFIB;ZNF568;TBL1XR1;MCPH1;BMP6;GZF1;LCOR;TCF7L2;ORC2;HOXA7;TPR;GATAD2A;EFNA1;GLIS3;RIF1;NIPBL;ZBTB2;MXD1;ZBTB7B;ZHX2;FOXO3;KDM2B;LIN37;SMARCA4;ZFP90;KLF11;MIER3;KANK2;YAP1;VHL;UXT;EPC1;HMGB1;HDAC8;MTA3;NR4A2;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;KCNIP3;SMURF2;HDAC1;BMP2;EZR;NKX2-1;ATXN1;RBPJ;SMAD4;HDAC2;SAP130;ELK4;IRF2BP1;PPID;TWIST1;HEY2;USP9X;MED1;DLG1;RARB;YY1;ZMYM5;DNMT3A;FOXM1;SMAD3;FOXP4;SOX1;PER1;YEATS2;OTUD7B;DR1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.309431566383606,-1.1215244044098744,0.2413793103448276,0.6783324524782294,1.0,9/37,13.78%,PTPRD;FAT4;GRID2;IL1RAPL1;VCAM1;NECTIN3;CADM3;HMCN1;TENM4
prerank,regulation of protein localization to cell periphery (GO:1904375),0.5401296789593998,1.1212526028213197,0.33875338753387535,1.0,1.0,2/18,3.93%,PLK1;MMP14
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.36727155814581947,-1.1210927437954339,0.27111111111111114,0.6780746271832568,1.0,5/19,13.66%,ABHD5;AKT2;IRS2;IRS1;ABCD2
prerank,positive regulation of cellular process (GO:0048522),0.471957913187435,1.1209445690591022,0.153,1.0,1.0,79/565,12.75%,PRC1;KIF20B;KIF14;EZH2;TTK;BIRC5;SPAG5;ANKLE1;SAPCD2;TGM1;RAD18;TIPIN;SPDYA;MATK;NAP1L1;FBXO5;SMC6;ECHDC3;PHIP;FGFR4;CSPP1;COLEC12;HYAL1;CEP43;CDC6;FGFR2;SMC5;FXN;MMP14;GAREM1;DDRGK1;ACTN4;CNOT6L;NUMA1;SRF;MAPT;CCAR1;NSMCE4A;FAF1;PDPN;BMP6;RTKN2;DERL2;FMR1;CDC25B;PDGFRA;CHEK1;SFRP2;PPP3CA;EPHA4;POU3F2;WWTR1;CDK2;CNOT6;GRK5;CUL3;BCLAF1;AXIN2;KLHL22;TPPP;VHL;CAMK1D;CDC123;S1PR2;TGFBR1;TAL1;CRKL;CNTF;HDAC1;ACACA;RAC1;STOX1;PRKCA;GLP2R;ADAM17;KMT2D;TRPM4;HDAC2;IL31RA
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.3767466857655751,-1.1200311078029912,0.2924901185770751,0.6792781072132964,1.0,8/17,26.62%,KCNB1;SLC4A8;SCAMP5;SYT10;NLGN1;RAB27A;RAB3D;CACNA1H
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.42301503932606294,-1.1196979944451222,0.28716216216216217,0.6788827449825481,1.0,7/12,29.60%,SREBF2;DGKQ;CLCN2;ABCA2;RAN;MBTPS1;MBTPS2
prerank,regulation of cartilage development (GO:0061035),0.5359094166637786,1.1196819062802768,0.3468286099865047,1.0,1.0,4/18,11.40%,BMP1;SOX6;TAPT1;BMP2
prerank,gland development (GO:0048732),0.4872839005588051,1.1187943307095722,0.34968017057569295,1.0,1.0,20/59,19.03%,GLI2;FOXE1;FADD;FGFR2;TGFBR3;PHF2;ARHGAP35;TGFBR1;DKK3;EZR;ANXA1;NKX2-1;GFER;PKD2;MSN;SALL1;COBL;IGSF3;ZBTB1;WNT4
prerank,cellular response to interferon-beta (GO:0035458),0.5583964966661996,1.118678890368722,0.35422740524781343,1.0,1.0,5/14,16.10%,UBE2K;HTRA2;IRF1;TRIM6;PNPT1
prerank,cellular macromolecule catabolic process (GO:0044265),0.48962066559510603,1.1184967196415128,0.34758155230596177,1.0,1.0,16/49,18.75%,PABPC4;HNRNPD;CHEK2;RNASE6;SIAH2;RNASEH2A;ADAMTS9;HTRA2;PPP1R8;EXOSC7;STT3B;FBXO27;FBXO17;PNPT1;RIPK1;XRN2
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.3721891335442026,-1.118067684250003,0.3031496062992126,0.6803601772011348,1.0,8/20,18.64%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.3721891335442026,-1.118067684250003,0.3031496062992126,0.6803601772011348,1.0,8/20,18.64%,MCCC1;BCKDHA;HIBADH;ACAD8;BCAT1;ECHS1;BCKDK;MCCC2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.48880172865038124,1.1180088506454315,0.3477777777777778,1.0,1.0,14/52,11.08%,RBM15;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;THRAP3;MBNL3;RBM25;FMR1;SAP18;CELF2;HNRNPU;RBM15B;HNRNPL
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.560460762416908,1.1179299854053795,0.36639118457300274,1.0,1.0,6/15,13.27%,MTHFD1L;FGFR2;PDGFRA;NIPBL;TGFBR1;TWIST1
prerank,aortic valve morphogenesis (GO:0003180),0.5054584992542811,1.1178398258262563,0.3469387755102041,1.0,1.0,9/30,13.42%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;TWIST1;HEY2
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.46926609617485204,-1.1178297423094488,0.35327635327635326,0.6797826096636501,1.0,3/10,19.55%,CTNNB1;LRP6;FZD1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5811083737454545,1.1175036446028086,0.3648255813953488,1.0,1.0,7/11,24.88%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5811083737454545,1.1175036446028086,0.3648255813953488,1.0,1.0,7/11,24.88%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5811083737454545,1.1175036446028086,0.3648255813953488,1.0,1.0,7/11,24.88%,ACAT1;PPCDC;PANK4;PANK2;COASY;SLC25A16;DCAKD
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.41163797853002804,-1.1171592016981462,0.28668941979522183,0.6802593895686273,1.0,8/13,29.60%,NR1H3;NUPR1;NR1H2;AQP11;MANF;WFS1;USP19;MBTPS2
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.5450834411297293,1.1171509343687855,0.34806629834254144,1.0,1.0,6/15,20.21%,ADGRV1;KIT;MKKS;LHFPL5;KCNA1;PIEZO2
prerank,cristae formation (GO:0042407),-0.33362665080728093,-1.1166482744649409,0.2541436464088398,0.6803186179090726,1.0,14/27,25.82%,APOOL;ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;DNAJC11;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;ATP5ME
prerank,nucleoside phosphate catabolic process (GO:1901292),0.554550290781208,1.1163247474127813,0.3484224965706447,1.0,1.0,4/13,11.79%,SMPDL3A;ENPP3;ITPA;ENPP1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.46877651642933954,-1.1157843562013734,0.32848837209302323,0.6813308241126294,1.0,5/10,19.75%,CACNA2D1;CALM1;CACNB2;SRI;CALM3
prerank,artery morphogenesis (GO:0048844),-0.33543654369010667,-1.1155362487687899,0.29651162790697677,0.6807310942395838,1.0,14/30,21.14%,SMAD7;JAG1;BMPR2;TGFB2;PDGFRB;LRP1;NF1;TBX1;VEGFA;ENG;STRA6;TBX2;NRP1;HPGD
prerank,axoneme assembly (GO:0035082),0.5125248007827361,1.115197171024697,0.3661800486618005,1.0,1.0,7/31,16.49%,DNAAF3;SPAG16;SPEF1;DNAI4;RSPH9;TTLL3;SPAG1
prerank,smooth muscle contraction (GO:0006939),0.5555298551214287,1.1151296955577752,0.34812760055478503,1.0,1.0,6/14,16.37%,ROCK2;ROCK1;SLC8A1;BDKRB2;SMTN;TPCN2
prerank,regulation of synapse assembly (GO:0051963),-0.2870674278597664,-1.115004354521889,0.19,0.6808657611186375,1.0,18/46,23.78%,PTPRD;MEF2C;SYNDIG1;GRID2;EPHB2;IL1RAPL1;EIF4G1;NRXN1;APP;SLITRK1;LRRC4B;ROBO2;NLGN1;IL1RAP;BDNF;DLG5;SRPX2;SLIT1
prerank,inner dynein arm assembly (GO:0036159),0.5661840576664674,1.1143237642428818,0.3550387596899225,1.0,1.0,2/11,10.86%,DNAH1;DNAAF5
prerank,cellular senescence (GO:0090398),0.5202448845017361,1.1142577207522124,0.35629453681710216,1.0,1.0,9/27,19.52%,SMC6;SMC5;SRF;PML;NSMCE2;TERF2;KAT6A;MAPK14;PRKCD
prerank,response to laminar fluid shear stress (GO:0034616),-0.4468483836480978,-1.1141422166478034,0.3402985074626866,0.6817614884040332,1.0,5/10,11.66%,SMAD7;MAP2K5;KLF4;SREBF2;KLF2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.4857183668553106,1.113943780545625,0.34782608695652173,1.0,1.0,4/42,7.95%,HMGB2;AQP1;RNASE6;SERPINE1
prerank,import into nucleus (GO:0051170),0.4751885909632375,1.1133488823168376,0.3432203389830508,1.0,1.0,24/73,20.51%,RANBP17;NUP155;RPAIN;E2F3;HNRNPA1;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;GEMIN7;NXT2;FAM53B;IPO9;NUP188;SNRPB;IPO4
prerank,regulation of cell killing (GO:0031341),-0.38528380141087826,-1.1131469257804814,0.27238805970149255,0.683087554008055,1.0,3/16,10.17%,MAPK8;TGFB2;NOX1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5153202357418225,1.1130955408578698,0.3661800486618005,1.0,1.0,8/26,16.40%,ATPSCKMT;SETD3;SETD2;KMT2A;KMT2D;KMT5C;SETD4;SUV39H2
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.27929070729459826,-1.113012009090514,0.21212121212121213,0.682251254118803,1.0,16/50,16.67%,SMAD7;OGT;PRMT3;CAV1;PER2;UFL1;SQSTM1;PINX1;DNAJA1;ABL1;LIMK1;SPRY2;SOX4;SH3RF2;UBXN1;PRKCG
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.5176998725838058,1.1126460235352043,0.33676092544987146,1.0,1.0,7/22,16.17%,CDKN2D;CDKN2C;CDA;ROCK1;CDKN1B;TP53;ANKLE2
prerank,blood vessel diameter maintenance (GO:0097746),0.5130748315249452,1.1124931869668298,0.36964078794901506,1.0,1.0,7/34,9.77%,KEL;ROCK2;SCPEP1;ROCK1;BDKRB2;KCNMB2;AGT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.33080564114534583,-1.1118030956794693,0.25157232704402516,0.6827345218136911,1.0,9/29,21.11%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.33080564114534583,-1.1118030956794693,0.25157232704402516,0.6827345218136911,1.0,9/29,21.11%,CROT;ACOT11;ACLY;ACBD6;ACSL6;DBI;ACSF2;ACOT7;ACOT13
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.3420192858148338,-1.1117442609623092,0.28169014084507044,0.681685007024068,1.0,6/25,5.66%,CAMK2D;CTNNA3;CALM1;CAV1;RYR2;FGF13
prerank,digestive tract morphogenesis (GO:0048546),0.5562788190671539,1.111297414956949,0.37158469945355194,1.0,1.0,4/14,10.81%,FGFR2;PDGFRA;NIPBL;RBPMS2
prerank,negative regulation of chemotaxis (GO:0050922),-0.3152272545109486,-1.1112433851965189,0.28846153846153844,0.6817073957849453,1.0,13/31,19.19%,SEMA6A;SEMA6D;SEMA7A;DUSP3;SEMA4D;SEMA3A;SLIT2;ANGPT2;THBS1;SEMA3B;ROBO2;SEMA3C;SEMA5B
prerank,positive regulation of organelle organization (GO:0010638),0.4953697308513076,1.1110273129628274,0.3639661426844015,1.0,1.0,10/32,15.20%,GSK3B;ANXA2;LNPK;ATL3;SORBS3;HTRA2;STX18;ANXA1;ADRB2;UVRAG
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.5150722259231493,1.1110150681955597,0.3694029850746269,1.0,1.0,3/23,9.73%,HMGB2;DNASE2;HMGB1
prerank,dendritic cell migration (GO:0036336),0.5505765044052494,1.1107116484933002,0.3677685950413223,1.0,1.0,4/16,12.51%,CXCR4;HMGB1;TRPM2;TRPM4
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.5146514170225123,1.110705130393249,0.3480392156862745,1.0,1.0,12/29,21.08%,FADD;UBE2K;USP18;PTPN2;YTHDF2;TRIM6;CNOT7;IFNAR2;METTL3;MAVS;PTPN1;ISG15
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.35367078582466693,-1.1105327196334538,0.2857142857142857,0.6822130285625689,1.0,12/24,16.82%,INSR;IGF1;AKT2;IRS2;IGF2;EPM2AIP1;INPP5K;SELENOS;IRS1;PPP1R3B;GSK3A;DYRK2
prerank,positive regulation of behavior (GO:0048520),-0.4560540698203181,-1.1101776850736014,0.3373134328358209,0.6818725563298531,1.0,3/10,5.06%,SGIP1;MEF2C;CFAP20
prerank,positive regulation of cellular component organization (GO:0051130),0.463865652069389,1.1099941258077606,0.36934156378600824,1.0,1.0,20/107,10.56%,CDC20;HAS3;RB1;FNIP1;HYAL1;GSK3B;ASAP1;BMF;TRABD2B;AJUBA;ADGRL1;ABCB4;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;TPPP;TGFBR1;TAL1
prerank,regulation of cell-cell adhesion (GO:0022407),-0.3043577794892827,-1.1098086809213021,0.26865671641791045,0.6815663886939851,1.0,5/39,2.63%,PTK2;PTPRG;SMAD7;PODXL;JAG1
prerank,regulation of centrosome cycle (GO:0046605),0.5191101849362436,1.1097551949698456,0.3490445859872611,1.0,1.0,2/21,2.75%,GEN1;AURKA
prerank,secretion (GO:0046903),-0.3942046008478186,-1.1094945080773124,0.28832116788321166,0.681174148785117,1.0,4/14,10.61%,RIMS1;SLC22A6;NPR1;TPD52
prerank,actin nucleation (GO:0045010),0.5206705612656064,1.1092748561545984,0.3552278820375335,1.0,1.0,3/21,7.25%,IQGAP2;ACTR3;ARPC5L
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.36264198659243074,-1.1090131948308313,0.308,0.6810832459080537,1.0,6/17,19.32%,VTN;IGF1;PDGFRB;S100A11;CCN4;NRP1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5473777348245371,1.1089007853905257,0.3500738552437223,1.0,1.0,5/13,15.74%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,lipid phosphorylation (GO:0046834),-0.45076414677400933,-1.1088165412830142,0.34513274336283184,0.6803308855095022,1.0,6/10,24.52%,DGKB;DGKG;DGKI;DGKQ;DGKD;DGKK
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.4648694386558711,1.108813697185374,0.2672672672672673,1.0,1.0,61/260,15.41%,KIF24;PLK4;IFT80;HYLS1;CEP89;MAP4K4;BBS9;DZIP1L;SCLT1;ACTR3;WDR35;PARVA;ASAP1;GBF1;SPAG16;WDR90;IFT140;POC1B;FAM161A;EXOC4;KIF27;PCM1;KIT;SPEF1;OCRL;NTN1;TXNDC15;RAP2A;MKKS;WDR11;FGD4;CEP83;RILPL1;NUDCD3;RFX2;SSX2IP;FGD1;CCDC57;CENPJ;CFAP52;WDPCP;NPHP3;RAB1A;SRGAP2;S1PR2;FGD6;TRAPPC14;TTC39C;EZR;RAC1;CC2D2A;DMTN;EHD1;TTLL3;EXOC8;ARF4;ITGB1;CEP162;VSTM5;LZTFL1;EMP1
prerank,icosanoid metabolic process (GO:0006690),0.48621497918157347,1.1082294459975153,0.35689455388180763,1.0,1.0,12/40,20.68%,PON1;PTGR1;ABCC10;PTGS1;DAGLB;PON2;DPEP1;PTGIS;DPEP2;PON3;DAGLA;MAPKAPK2
prerank,peptidyl-lysine dimethylation (GO:0018027),0.5380798094683498,1.1075248610240895,0.35618279569892475,1.0,1.0,8/18,16.40%,SETD3;EEF1AKMT2;SETD2;KMT2A;KMT2D;ASH1L;SETD4;SUV39H2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.376971085915793,-1.1073189070795366,0.3021276595744681,0.6827676781489866,1.0,13/18,35.42%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8;COA5;COA3;SURF1;FASTKD3
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.46566123110325647,1.1069694939422998,0.359375,1.0,1.0,16/87,12.63%,IQGAP3;IQGAP2;ROCK2;RHOA;ARHGAP18;PDGFRA;RHOQ;ROCK1;ARHGAP35;TRPM2;TWF1;RND2;EZR;RAC1;NOTCH2;DMTN
prerank,contractile actin filament bundle assembly (GO:0030038),0.5542305014367801,1.1067080239153837,0.3736111111111111,1.0,1.0,6/15,15.31%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,stress fiber assembly (GO:0043149),0.5542305014367801,1.1067080239153837,0.3736111111111111,1.0,1.0,6/15,15.31%,RHOA;ARRB1;PHACTR1;CUL3;ITGB1;SRC
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.4655973340588469,1.106641912055301,0.35051546391752575,1.0,1.0,17/94,12.40%,BRCA1;E2F1;CHEK2;ITPR1;PRKDC;STK24;PML;CUL5;HTRA2;CUL3;TNFRSF10B;APAF1;HINT1;BOK;LGALS12;QRICH1;MSH6
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.308614847555547,-1.1058468704242237,0.296969696969697,0.6851631850842808,1.0,15/34,28.16%,PTPRB;PTPRZ1;DUSP3;DUSP22;PTPN22;PTPRO;PTPN11;DUSP1;PTPN9;PTPN12;PTPRT;PGP;PTPRF;DUSP8;DUSP6
prerank,regulation of monooxygenase activity (GO:0032768),-0.3477145997665476,-1.105822175864377,0.3170731707317073,0.684035304915818,1.0,5/23,5.48%,CALM1;CAV1;NOS3;LYPLA1;NOSTRIN
prerank,Fc-gamma receptor signaling pathway (GO:0038094),-0.265460309935887,-1.1055233591900908,0.24074074074074073,0.6836547601432952,1.0,26/71,19.33%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.49860506802439825,1.105481763982097,0.35878787878787877,1.0,1.0,4/29,6.77%,PLK1;FBXO5;FBXW7;UBE2N
prerank,collagen fibril organization (GO:0030199),0.4691546122632402,1.1052723744518846,0.3608786610878661,1.0,1.0,21/88,14.39%,BMP1;LOXL3;COL22A1;LOXL2;LOX;COL4A6;COL4A4;COL18A1;COL5A2;COL23A1;ADAMTS14;ADAMTS2;DDR2;TLL2;TGFBR1;COL4A5;COL12A1;P3H1;COL15A1;COL20A1;P3H4
prerank,positive regulation of ruffle assembly (GO:1900029),-0.41136342678913945,-1.1047228439354122,0.3381294964028777,0.6842729777161108,1.0,9/13,32.31%,FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RY12;DEF8;EPS8;HRAS
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.4297614619498258,-1.1046923271741367,0.3457142857142857,0.683161356680503,1.0,6/11,25.76%,PRKN;PINK1;FBXO7;PARK7;RACK1;HIF1A
prerank,tyrosine metabolic process (GO:0006570),0.5630668894139464,1.104268349869285,0.34890510948905107,1.0,1.0,4/11,22.10%,TYR;IL4I1;THAP4;GSTZ1
prerank,regulation of phosphorylation (GO:0042325),0.46209045456908926,1.1040954930414084,0.3377416073245168,1.0,1.0,29/120,16.67%,BARD1;NDC1;NUP155;CDKN2D;CDKN2C;NUP205;MCM7;PHIP;NUP160;FNIP1;GCK;NUP85;TPR;PML;ROCK1;PLXNB2;DSCAM;NUP214;KCTD20;RANBP2;CDKN1B;BTBD10;NUP133;PIN1;PRKAG1;NUP42;SESN2;ANKLE2;NUP98
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.25992672671452116,-1.1040696410241804,0.25,0.6834439988932288,1.0,26/78,17.95%,STX8;PRKCH;ACTB;STX7;STX4;AR;SQSTM1;LRP1;EPHB2;PIK3R1;STX3;CLIP3;ZDHHC5;NUMB;DAB2;KIF5B;SPTBN1;AP2M1;LDLRAP1;ZDHHC7;NKD2;ZDHHC8;VAMP8;STAC;PTPN9;DPP10
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.53511026299232,1.103861313403561,0.3567567567567568,1.0,1.0,7/16,16.24%,GBF1;DDRGK1;LRRK2;TAPT1;MIA3;VAPA;BCAP29
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.511175101161561,1.1032007395250043,0.3711843711843712,1.0,1.0,8/27,17.18%,KMT5A;DYRK1A;YJU2;TWIST1;SPRED1;CD44;SPRED2;ATR
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.4541666864667532,-1.1022019109556138,0.34627831715210355,0.6867882344327936,1.0,5/11,22.21%,PRDX2;PRDX1;GPX1;PRDX3;PRDX5
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.45172334899394395,-1.101619900202172,0.34818941504178275,0.6869958767497368,1.0,2/10,8.26%,TLR4;NAMPT
prerank,ether lipid biosynthetic process (GO:0008611),-0.45221846522275033,-1.1015042874509082,0.3562874251497006,0.6861520931466197,1.0,4/10,11.45%,PLA2G4A;CHPT1;DHRS7B;LPCAT2
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.3104822329548955,-1.101079739447125,0.28125,0.6859164526962953,1.0,12/34,22.05%,SMAD7;ATP1B1;CALM1;RYR2;ADRA1A;SRI;PDE4D;KCNQ1;ZC3H12A;CALM3;NOS1;P2RX4
prerank,positive regulation of heart contraction (GO:0045823),-0.36363679653437575,-1.1010701766679578,0.32489451476793246,0.6847606124732134,1.0,11/19,32.55%,RYR2;TGFB2;ATP1A2;ADRA1A;GSK3A;KCNQ1;EDN1;ADM;EDN3;CHGA;SCN3B
prerank,regulation of immune effector process (GO:0002697),-0.3019567417143235,-1.1003379029814206,0.29464285714285715,0.6854329397014924,1.0,18/41,39.06%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;FCGR2B;C7
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.45972824154956055,1.0997753456357802,0.3360488798370672,1.0,1.0,30/113,15.81%,TERF1;FNIP1;GSK3B;PSMC2;RPA1;ASAP1;BMF;TRABD2B;CHD1L;AJUBA;ERCC4;FAF1;RPA2;SLF1;ERCC3;SPIDR;CDC42EP2;SH3GLB1;TPPP;CUL4B;TAL1;XPA;PIEZO1;ABCA1;PSMC6;CAPG;SRC;RHOC;LCP1;TP53
prerank,response to copper ion (GO:0046688),0.5304631568245146,1.0995999680854558,0.36973684210526314,1.0,1.0,3/20,5.24%,AQP1;LOXL2;PRNP
prerank,histone H2A acetylation (GO:0043968),0.5569615034364577,1.0991322588924872,0.38493723849372385,1.0,1.0,10/16,23.72%,MSL3;EP400;EPC1;RUVBL2;TRRAP;BRD8;NAA40;MEAF6;ACTL6A;MORF4L2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.43285350952290375,-1.099086919468102,0.3411764705882353,0.6873394755696237,1.0,6/11,24.59%,SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5085153525899604,1.0990112138773527,0.34809348093480935,1.0,1.0,9/26,14.76%,MTBP;HYAL1;CDC6;TFDP1;LSM11;ANXA1;ADAM17;ADAMTS1;RPTOR
prerank,monocarboxylic acid transport (GO:0015718),-0.2786055904985567,-1.0989775729821072,0.2808988764044944,0.6864176438234978,1.0,13/51,17.60%,SLC16A12;SLCO1C1;SLCO2B1;SLC27A1;ABCC4;ATP8B1;SLCO2A1;ABCG2;SLC5A6;SLC16A1;SLC16A4;SLC6A11;STARD5
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5570376184367294,1.0986196694326205,0.3766617429837518,1.0,1.0,7/12,19.08%,ADA;HPRT1;PRPS1L1;PRPS1;ADSL;GART;PPAT
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3831193358427871,-1.0982654781640298,0.3090909090909091,0.6870691776704116,1.0,11/16,25.82%,ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,tight junction assembly (GO:0120192),0.4783363119000202,1.0982606909976798,0.3513215859030837,1.0,1.0,3/49,6.59%,ECT2;AFDN;GRHL2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.42307485815137563,-1.0970930947472899,0.33876221498371334,0.6886549853095341,1.0,2/13,3.89%,LAMP1;STX4
prerank,regulation of transmembrane transport (GO:0034762),-0.3124427253885569,-1.0962310321988753,0.28823529411764703,0.6896141065912099,1.0,8/31,12.01%,OCLN;SLC2A1;ACTB;KCNJ3;CTTNBP2NL;KCNJ6;BCL2;KCNJ10
prerank,fatty acid catabolic process (GO:0009062),-0.26978910680068313,-1.0959379181555404,0.24561403508771928,0.6891729112717009,1.0,25/67,26.46%,HADHB;ACADM;CROT;PCCB;SCP2;ABCD4;MECR;ALDH3A2;HADH;ABHD2;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2;NUDT7;LPIN1;SLC27A4;PECR;MCEE;AIG1;PLA2G15;MMAA;HACL1;ILVBL
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.40178730118792116,-1.0958770018609258,0.336734693877551,0.6881573690300031,1.0,7/14,21.77%,AKT2;IRS2;GPLD1;IRS1;NNMT;PPARGC1A;SLC45A3
prerank,neuron projection organization (GO:0106027),-0.3990171559327213,-1.0953267876633062,0.35737704918032787,0.6883440787009449,1.0,10/15,19.57%,PSEN1;INSR;LGMN;MAP1A;CHRNA7;ATP1A3;APP;ABCD2;PICK1;DCTN1
prerank,basement membrane organization (GO:0071711),0.5458510266529443,1.095290433401271,0.37518037518037517,1.0,1.0,4/14,15.47%,NID2;LAMB1;NID1;NTN4
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.29567920593160846,-1.0951548615760591,0.3010752688172043,0.6875755842682331,1.0,17/45,20.19%,PTK2;KIF16B;RPS6KA5;PIK3R1;PLCG1;TGFA;GRB2;PTPN11;SHC1;ERBIN;PLCE1;CBL;PIK3CA;BCAR1;SHC3;DGKD;HBEGF
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.5554758103584635,1.09503151599536,0.35336194563662376,1.0,1.0,5/11,9.37%,AJUBA;DHX9;FMR1;LIMD1;PUM2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.5633451816677925,1.0949192499852314,0.37168141592920356,1.0,1.0,4/12,10.31%,NIN;PCM1;BICD2;NINL
prerank,RNA transport (GO:0050658),0.46314475810939826,1.0947244342835853,0.375,1.0,1.0,18/71,16.54%,CKAP5;NUP155;SRSF4;HNRNPA1;EIF4E;UPF3B;SLBP;TPR;DDX39B;FMR1;SRSF7;SRSF3;SRRM1;NUP214;SIDT1;HNRNPA2B1;PNPT1;DHX38
prerank,positive regulation of ATPase activity (GO:0032781),0.48864098212967694,1.0947026618098528,0.3933102652825836,1.0,1.0,3/41,4.75%,UHRF1;MSH3;DHX9
prerank,negative regulation of immune system process (GO:0002683),0.5363044055337072,1.0944188390678762,0.3784860557768924,1.0,1.0,2/16,6.51%,FADD;HOXA7
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.4905292636642762,1.0940427950818024,0.3683602771362587,1.0,1.0,6/37,7.67%,IFT80;WDR35;IFT140;PCM1;TNPO1;SSX2IP
prerank,organic substance transport (GO:0071702),0.45809473627600866,1.0936967605270032,0.34384537131230924,1.0,1.0,8/121,7.09%,CENPF;SLC18A2;NDC1;ZG16;ABCA4;SLC6A2;SLC19A1;ABCA9
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5648516073226663,1.0933803481627573,0.37315634218289084,1.0,1.0,3/11,10.11%,DDX11;SMARCA4;NOL11
prerank,regulation of aerobic respiration (GO:1903715),-0.3930908174063895,-1.092842704362815,0.34782608695652173,0.6920496071321114,1.0,6/15,26.17%,CBFA2T3;PINK1;COX7A2;UQCC2;ATP7A;AK4
prerank,RNA destabilization (GO:0050779),0.5185268292889577,1.0927663623282826,0.3684210526315789,1.0,1.0,8/18,16.34%,ROCK2;FTO;ROCK1;YTHDF2;MEX3D;DXO;ZC3H18;METTL3
prerank,protein ADP-ribosylation (GO:0006471),-0.3174704933479778,-1.092421981495091,0.33513513513513515,0.6920046779303911,1.0,8/28,13.03%,PARP8;PARP12;TIPARP;ART3;PARP6;PARP1;SIRT5;PARP16
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.406787933075844,-1.092273741318271,0.3881578947368421,0.6912080959125743,1.0,4/12,24.76%,SCP2;ACSL1;ELOVL1;FADS1
prerank,regulation of apoptotic process (GO:0042981),0.4589313410405808,1.0918849233427133,0.209,1.0,1.0,103/676,13.98%,TOP2A;KIF14;ECT2;MELK;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;E2F1;STPG1;AQP1;ITGB3BP;FADD;MAP4K4;STK17B;SETX;PHIP;ARHGAP10;ANGPT4;STEAP3;GSK3B;BMF;FXN;DDRGK1;IAPP;ACTN4;ANP32B;AIFM2;FHL2;PRKDC;FAM162A;MRE11;NET1;SIAH2;CCAR1;FAF1;PDPN;STK3;ERCC3;ANXA5;RBM25;FGD4;TMEM219;MAP3K20;ATG7;VAV2;SFRP2;CALHM2;GNA13;SCRIB;FGD1;FOXO3;SAP18;HTRA2;ARL6IP1;SMAD6;ING4;GRK5;BCLAF1;KLF11;SH3RF1;TNFRSF10B;DNM2;MGMT;ANGPT1;VHL;PIM1;SKP2;HMGB1;APIP;AGT;ERC1;GAS1;APAF1;BOK;NDRG1;ANP32E;IP6K2;ARHGEF18;QRICH1;HDAC1;BMP2;ANXA1;CHM;HDAC2;NOTCH2;ATF5;CASP8;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;PPID;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;SMPD1
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5087024779475832,1.0918582687645981,0.3554140127388535,1.0,1.0,4/21,11.76%,CYP26B1;LPIN2;AGXT;HOGA1
prerank,connective tissue development (GO:0061448),0.48311148470580284,1.0918368755964387,0.3710247349823322,1.0,1.0,11/35,17.51%,HYAL1;DDRGK1;SULF2;SOX6;SULF1;PGRMC2;LRP5;CD44;SPTLC2;ITGB8;SH3PXD2B
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4903123379108093,1.0915989406417008,0.3873239436619718,1.0,1.0,10/33,15.81%,ATOH8;TEAD1;KLF5;SRF;FOXO3;SMARCA4;NR3C1;SMAD3;GNL3;TP53
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.4610667456921635,1.0915422196905937,0.37265135699373697,1.0,1.0,22/74,17.85%,EZH2;LOXL2;USF3;PDPN;EFNA1;SFRP2;WWTR1;AXIN2;TGFBR1;BMP2;NKX2-1;SMAD4;ADIPOR1;TWIST1;SPRED1;SMAD3;SFRP1;SPRED2;PTEN;EPHA3;SMAD2;CLASP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5627286388222199,1.0910202771339388,0.3804347826086957,1.0,1.0,4/10,16.26%,RHOA;RAP2A;EZR;MSN
prerank,regulation of stem cell population maintenance (GO:2000036),0.5311494637780421,1.0909935969042162,0.3751651254953765,1.0,1.0,2/18,3.90%,LOXL2;CNOT1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.42108079188777464,-1.090683032497593,0.3443708609271523,0.6938231550163798,1.0,7/12,26.42%,HSPA5;SGTA;SGTB;SEC61B;SEC62;SEC63;SEC61A2
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4838147958360828,1.090335551896968,0.3822843822843823,1.0,1.0,7/37,11.81%,PABPC4;HNRNPD;RNASE6;NUDT5;RNASEH2A;PPP1R8;EXOSC7
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2594828161366487,-1.0901997464009339,0.27419354838709675,0.6938155380762863,1.0,17/66,25.97%,STAT3;CARD16;IGF1;MALT1;TLR4;APP;CX3CL1;PANX1;LGALS9;TRIM16;GIT1;EGR1;ZC3H12A;HSPB1;JAK2;P2RX7;TMEM106A
prerank,neurotransmitter uptake (GO:0001504),-0.4109977841343239,-1.089860047274322,0.3624161073825503,0.6934938770008655,1.0,9/12,46.57%,GLUL;ATP1A2;SNAP25;SLC22A2;SLC1A6;SLC22A3;SLC29A2;SLC29A4;SLC38A1
prerank,cellular component assembly (GO:0022607),0.45846332961221736,1.0897356289252433,0.3226452905811623,1.0,1.0,53/253,16.36%,KNTC1;FANCA;TRIP13;CHAF1B;HAS3;KPNA3;RHOA;TEAD1;RAD21;PARVA;SPAG16;RTN3;MDM4;SPEF1;ADD2;ZW10;NLGN3;RBBP4;GRHL2;PML;QSOX1;ARL6IP1;DARS1;CORO1B;RHOQ;YAP1;PICALM;IKBKG;KMT2A;HAS1;RSPH9;YTHDF2;LIMS1;CAPZA1;EZR;RAC1;GORASP2;DMTN;DPYSL3;BAIAP2L1;TTLL3;PPID;CHAF1A;P3H4;EPRS1;CAPG;ADD1;LCP1;TP53;SYCP2;TINF2;NLGN2;NCKAP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.5317047470795515,1.089615686679081,0.3748290013679891,1.0,1.0,5/15,16.34%,USP18;PTPN2;YTHDF2;CNOT7;METTL3
prerank,gluconeogenesis (GO:0006094),-0.28738337874474806,-1.0895911345920783,0.29285714285714287,0.693113423517278,1.0,16/39,22.24%,PER2;GOT2;SLC25A13;SLC25A12;MDH1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1
prerank,peptide cross-linking (GO:0018149),0.5084036672777253,1.0891630251655873,0.3778054862842893,1.0,1.0,1/25,1.15%,TGM1
prerank,regulation of cellular component biogenesis (GO:0044087),0.481455701286919,1.0890869493139665,0.3617511520737327,1.0,1.0,8/39,12.04%,HJURP;ROCK2;NCLN;ROCK1;AGT;BAG5;EZR;SPTY2D1
prerank,regulation of kinase activity (GO:0043549),0.45792919997834686,1.0890099893389864,0.3671147880041365,1.0,1.0,11/89,7.60%,ECT2;RBL1;RB1;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;EPHA4
prerank,Golgi organization (GO:0007030),0.4629223030386068,1.0889579651639716,0.36168032786885246,1.0,1.0,28/112,18.48%,CDK1;ARHGAP21;USP6NL;GBF1;OBSL1;COG1;ZW10;ATL2;ATL3;RAB29;LRRK2;GOLGA8B;GOLGA5;RAB1A;BAG5;GAK;GORASP2;VTI1A;PRKD1;VRK1;BET1;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;TMED10;PI4K2B
prerank,plasma membrane invagination (GO:0099024),0.5007052338344002,1.0874470877930684,0.3827460510328068,1.0,1.0,5/29,13.43%,AURKB;RHOA;SNX33;SNX18;DOCK1
prerank,regulation of microtubule polymerization (GO:0031113),0.48281888955103064,1.08737044726962,0.39590443686006827,1.0,1.0,9/40,11.74%,CDK5RAP2;STMN1;PSRC1;DYRK1A;NUMA1;MAPT;DRG1;AKAP9;RAC1
prerank,negative regulation of gene expression (GO:0010629),0.4540442623891006,1.0873072702922502,0.312,1.0,1.0,71/302,16.34%,PHF19;EZH2;RBL1;HELLS;TYMS;ATOH8;ILF3;SYNCRIP;ATP2B4;PPM1D;RB1;BMPR1A;AURKA;MOV10;ROCK2;SUZ12;AGO2;CNOT1;DDRGK1;MPHOSPH8;EED;SETDB2;MAPT;XDH;EIF4ENIF1;SAMD4A;RBBP4;CAPRIN1;RBBP7;FBXW7;FMR1;SFRP2;PHF1;LARP1;ROBO1;YAP1;VHL;SLC24A3;PICALM;EPC1;LSM2;PARP9;YTHDF2;FLOT2;ATP2B1;MRPL13;EIF2AK3;CRKL;HDAC1;BMP2;TERF2;STOX1;CENPV;RBMS3;TRIM6;NOTCH2;DXO;PTBP2;HEY2;RBM4;DHFR;YY1;DNMT3A;EPRS1;CNOT7;TNRC6C;FXR1;NFKB1;SFRP1;PNPT1;METTL3
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5180737585577975,1.0860257947049028,0.36054421768707484,1.0,1.0,3/19,11.01%,CEP295;CENPJ;CEP120
prerank,positive regulation of response to wounding (GO:1903036),-0.3412682006217215,-1.0851360844936595,0.32,0.7031495741880717,1.0,10/24,22.63%,PTK2;OCLN;VTN;MYLK;GRN;SCARF1;ARFGEF1;ADRA2A;HBEGF;CLDN1
prerank,response to growth factor (GO:0070848),-0.2943334169638335,-1.085080813114482,0.2833333333333333,0.7021379174850922,1.0,20/41,25.43%,ACVR1;ACVR2A;TGFBR2;BMPR2;ACVRL1;MAP2K5;KLF4;ACVR2B;CTNNB1;SHC1;ERBB2;SOX2;BMPR1B;NOS1;RACK1;GATA6;SPHK1;URI1;PLK5;MAPK7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.4650806273755687,1.084254533432497,0.3893617021276596,1.0,1.0,17/68,13.14%,TTF2;SETX;POLR1A;CSTF3;FIP1L1;POLR1B;SLBP;ERCC3;LSM11;POLR2A;WDR33;PCF11;TAF1D;SCAF8;CPSF4;TTF1;POLR1G
prerank,dorsal/ventral pattern formation (GO:0009953),0.5113920975868176,1.0841449930638005,0.3680104031209363,1.0,1.0,5/20,11.94%,GLI2;BMPR1A;LMX1B;DSCAML1;AIDA
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.2613794907226473,-1.084036851873654,0.27450980392156865,0.7034610634047654,1.0,26/73,19.33%,PTK2;HSP90AB1;ELMO1;ACTB;WIPF1;VAV3;PIK3R1;PLD2;PLCG1;MYO10;LYN;PAK1;MAPK3;WIPF2;ABL1;LIMK1;WIPF3;MAPK1;GRB2;ELMO2;PLPP4;PIK3CA;ARPC5;BAIAP2;NCKAP1L;CYFIP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.4575754224044899,1.0837524319270957,0.3904179408766565,1.0,1.0,31/114,22.97%,TNFSF13B;MAP3K14;PSMC2;PSMD5;ACTN4;FOXO3;PSMB1;PSMD14;PSMD1;EDA;LIMS1;PSMB9;PYDC1;ADAM17;PSMC6;PLVAP;TP53;TNFRSF25;PSMB2;PSME4;PSMB7;RIPK1;PSMD11;TRAF6;PSME3;TRAF2;IKBKB;PSMD13;BIRC2;PSMB8;PSMD4
prerank,regulation of protein kinase A signaling (GO:0010738),0.5130706141526834,1.083054316527307,0.38603425559947296,1.0,1.0,7/20,17.31%,ADGRV1;IAPP;LRRK2;ADRB2;RAMP3;PRKAR2B;PRKAR2A
prerank,purine nucleotide catabolic process (GO:0006195),0.5439484980199619,1.0824752473474455,0.3765867418899859,1.0,1.0,6/13,24.40%,XDH;ITPA;HINT1;PNP;NT5E;GDA
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3233509395640073,-1.082054339276213,0.3023255813953488,0.7072660454070583,1.0,13/32,20.66%,EP300;FHIT;PPP1R13B;CDIP1;HIPK2;MSH2;DDX5;DYRK2;DDIT4;RRP8;SNW1;BCL3;MYBBP1A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.38340804309653,-1.081655693423093,0.34317343173431736,0.7071063641150946,1.0,4/13,15.20%,UPP2;NT5M;TDG;SMUG1
prerank,regulation of cytoskeleton organization (GO:0051493),0.44934903442038776,1.0807822053276361,0.38153846153846155,1.0,1.0,22/108,12.65%,IQGAP3;IQGAP2;ROCK2;RHOA;GSK3B;SPEF1;DIAPH1;ARHGAP18;MAPT;BICD2;SORBS3;RHOQ;TPPP;ROCK1;MARK2;ARHGAP35;PLXNB1;RND2;EZR;RAC1;DMTN;CLIC4
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.39028731049456655,-1.0804229676203163,0.3612167300380228,0.7088946346695826,1.0,2/15,4.12%,SMAD7;TGFB2
prerank,regulation of ATP metabolic process (GO:1903578),0.46292724997636375,1.0799113545471188,0.3930131004366812,1.0,1.0,15/54,17.39%,NDC1;NUP155;NUP205;NUP160;GCK;NUP85;TPR;NUP214;RANBP2;ATP5IF1;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,regulation of cell projection organization (GO:0031344),0.550667496164807,1.0797998794472328,0.3864942528735632,1.0,1.0,2/13,2.76%,MACF1;MOV10
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.44019253422747756,-1.0791183362072794,0.36176470588235293,0.7109700861484538,1.0,2/10,0.68%,DLGAP1;DLGAP4
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.4187861478436972,-1.0790022713158636,0.3519736842105263,0.7101496696409701,1.0,2/12,8.37%,STAT3;ESR1
prerank,positive regulation of dendrite extension (GO:1903861),-0.3638404917545066,-1.0785549225391784,0.32867132867132864,0.7100396821601522,1.0,3/17,3.34%,RIMS1;ITSN2;SYT1
prerank,cyclooxygenase pathway (GO:0019371),0.5632873074437872,1.0782040999539608,0.3918305597579425,1.0,1.0,3/10,7.45%,PTGES2;HPGDS;PTGS1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5556512017660411,1.0776118469393206,0.39263803680981596,1.0,1.0,3/10,7.60%,ANXA2;EFNA1;EPHA4
prerank,negative regulation of hippo signaling (GO:0035331),0.5472914405986513,1.0773809727395236,0.39970717423133234,1.0,1.0,7/12,22.83%,CIT;AJUBA;LIMD1;SHANK2;MAPK14;WWC2;VGLL4
prerank,cellular response to acid chemical (GO:0071229),-0.3183577142395276,-1.0773083468327636,0.3147208121827411,0.7120498336171404,1.0,10/27,16.81%,CPEB3;CPEB4;GLRA1;SH3BP4;MTOR;KLF2;NSMF;VEGFA;RRAGC;XBP1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.46784075063242775,1.0772637580820044,0.3875545851528384,1.0,1.0,19/52,17.40%,PNLDC1;CNOT1;PATL1;CNOT6L;LSM3;SAMD4A;RC3H2;TUT7;CNOT6;LSM2;PAN3;EXOSC7;TUT4;LSM7;RC3H1;CNOT7;LSM4;CNOT4;EDC3
prerank,regulation of stem cell proliferation (GO:0072091),0.5348407600249094,1.0767148957004324,0.37112010796221323,1.0,1.0,9/17,24.24%,HMGB2;YAP1;HNRNPU;GJA1;TERT;FBLN1;EIF2AK2;ZFP36L1;KDM1A
prerank,negative regulation of B cell proliferation (GO:0030889),-0.42598514437038815,-1.0766897804931752,0.3701492537313433,0.7124549940905367,1.0,3/11,9.05%,TNFRSF21;LYN;ATM
prerank,regulation of cilium movement (GO:0003352),0.5505838343173565,1.0766184389593196,0.3881278538812785,1.0,1.0,1/10,3.41%,DNAH11
prerank,cellular response to organic cyclic compound (GO:0071407),0.44947371859356344,1.076616467871838,0.3690596562184024,1.0,1.0,30/141,16.26%,BRCA1;RAD51;AQP1;ROCK2;CASP7;ABCB4;DIAPH1;BLM;LCOR;CTNNA1;SPIDR;IL18;LARP1;LRRK2;RIOK3;P2RY1;NR3C1;TRPM2;AHR;EZR;AKAP9;DMTN;RORA;MED1;RUVBL2;RAMP3;ADCY6;PKD2;SFRP1;MSN
prerank,microtubule anchoring at centrosome (GO:0034454),0.5665352624771987,1.0762510390564821,0.3893129770992366,1.0,1.0,3/10,10.31%,NIN;PCM1;NINL
prerank,nucleocytoplasmic transport (GO:0006913),0.4776758124034307,1.0759320978620612,0.3884484711211778,1.0,1.0,10/40,17.31%,XPO1;NUP205;PHAX;HNRNPA1;RBM15B;ATXN1;NXT1;NUP98;GEMIN7;NXT2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.3574696582129043,-1.075325957662579,0.344,0.7146754721821373,1.0,4/18,18.81%,LYN;GPLD1;CMKLR1;BCAR1
prerank,positive regulation of cellular component movement (GO:0051272),0.5043492567511525,1.0753175776730106,0.3811944091486658,1.0,1.0,8/24,14.68%,CCDC25;ACTN4;NTN1;PDPN;TGFBR1;ADAM17;TWIST1;STK11
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.36277841436770614,-1.0750674309146884,0.3497942386831276,0.7141877437386107,1.0,11/17,39.21%,TEK;NTRK3;ABL1;BAIAP2;NRP1;FES;BCAS3;HRAS;NTF3;HCK;HCLS1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.36378854526618076,-1.0750282180620632,0.36704119850187267,0.7130998712363628,1.0,11/17,25.82%,ATP5PF;ATP5F1A;ATP5PO;ATP5MF;ATP5MC3;ATP5PD;ATP5F1B;ATP5F1D;ATP5F1E;ATP5MG;ATP5ME
prerank,amino acid import (GO:0043090),-0.35277608540841565,-1.073805212082526,0.32589285714285715,0.7150832450571869,1.0,5/21,5.85%,SLC6A6;SLC6A1;SH3BP4;SFXN2;SLC7A5
prerank,apoptotic cell clearance (GO:0043277),0.47791311636814116,1.0737813875462627,0.39504716981132076,1.0,1.0,6/30,14.99%,XKR5;HMGB1;ANXA1;RAC1;TXNDC5;ITGAV
prerank,reverse cholesterol transport (GO:0043691),-0.40618325188991483,-1.0736266190282358,0.38205980066445183,0.7143972946945696,1.0,2/13,6.91%,APOE;ABCA5
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.38638854170723635,-1.0733890115516325,0.3645833333333333,0.7138078147482804,1.0,5/15,13.86%,GRM7;GRM3;HOMER1;GRM5;GRM1
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.4485731436681624,1.0729669746700974,0.287,1.0,1.0,92/476,14.33%,BRCA1;ATAD2;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;HAS3;ILF3;NAT14;PSRC1;DYRK1A;SMARCC1;SP3;PHIP;ELF2;TEAD1;CTCF;HNRNPD;NFE2;MED14;CHEK2;NFIL3;BLM;ELF4;NFIB;THRAP3;TBL1XR1;SETD3;NUP85;PCBD2;YAF2;MED30;ELF1;PML;TCF4;ARID1A;TASP1;ELK1;FOXO3;ATF7IP;CD80;TRIM28;IRF1;CREB5;MED24;SMARCA4;USP21;USP16;ZFP90;DNM2;YAP1;NFYA;VHL;PICALM;EPC1;AGT;KMT2A;PARP9;TGFBR1;TAL1;MMS19;CRLF3;TAF15;QRICH1;HDAC1;BMP2;AHR;NKX2-1;FBXW11;SMAD4;HDAC2;ATF5;IL31RA;ZNF496;ILF2;BRD4;RAI1;LRP5;RORA;HEY2;MED1;BTRC;RLF;FOXK2;FOXM1;SMAD3
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5654988932438061,1.0728368181260053,0.37327188940092165,1.0,1.0,3/10,13.95%,PRNP;SCRIB;RC3H1
prerank,regulation of DNA binding (GO:0051101),0.47766779072372967,1.0726013114286579,0.4043280182232346,1.0,1.0,3/44,1.44%,HJURP;HMGB2;E2F1
prerank,cilium movement (GO:0003341),0.4659448652374562,1.0724263892098982,0.38295454545454544,1.0,1.0,7/48,10.86%,DNAH11;CFAP53;SPEF1;DNAH1;DNAI4;RSPH9;DNAAF5
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.42350838937632795,-1.0717256187777686,0.39087947882736157,0.7169374159245713,1.0,1/11,0.28%,STAT3
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5419584846251821,1.071343823044584,0.3961136023916293,1.0,1.0,5/12,10.70%,ROCK2;PRNP;ROCK1;PICALM;FLOT2
prerank,positive regulation of isotype switching (GO:0045830),0.5285294483822562,1.070747638543502,0.40273972602739727,1.0,1.0,4/15,15.23%,PAXIP1;RIF1;KMT5C;SHLD2
prerank,positive regulation of RNA splicing (GO:0033120),0.48673535339273744,1.0705950244027527,0.3878787878787879,1.0,1.0,11/29,21.28%,DYRK1A;SETX;TRA2B;THRAP3;POLR2A;DAZAP1;NUP98;HNRNPLL;SLC38A2;TRA2A;RBMX
prerank,regulation of dendrite extension (GO:1903859),-0.3612421830317074,-1.0703497023843394,0.336996336996337,0.7193716382132725,1.0,3/18,3.34%,RIMS1;ITSN2;SYT1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5027352473738945,1.0701343262354568,0.36528497409326427,1.0,1.0,6/19,13.67%,PARD3B;SCRIB;MARK2;CLIC4;PRKCI;DLG1
prerank,intracellular lipid transport (GO:0032365),-0.35616247145701513,-1.069300105493559,0.3218884120171674,0.7207910347741869,1.0,9/21,25.64%,CERT1;ABCD4;ACACB;ARV1;ABCD2;PRKAG2;PLEKHA8;NPC2;MID1IP1
prerank,response to organophosphorus (GO:0046683),0.5138248062440309,1.069172281485852,0.3989071038251366,1.0,1.0,2/16,6.47%,TYMS;RFC3
prerank,heme biosynthetic process (GO:0006783),0.49549500206323605,1.0691427872804988,0.3762755102040816,1.0,1.0,7/22,16.86%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,cellular response to interleukin-7 (GO:0098761),-0.37366478001021436,-1.0690394477836116,0.33210332103321033,0.7191472790644611,1.0,4/17,10.43%,STAT3;SOCS2;IRS2;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.37366478001021436,-1.0690394477836116,0.33210332103321033,0.7191472790644611,1.0,4/17,10.43%,STAT3;SOCS2;IRS2;IRS1
prerank,cellular response to mechanical stimulus (GO:0071260),0.4659918298830287,1.0686751156827596,0.4108352144469526,1.0,1.0,11/46,12.73%,AQP1;FADD;MAP3K14;CASP8AP2;MAP3K1;CNN2;CHEK1;IRF1;TNFRSF10B;PIEZO1;CASP8
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3324399682820653,-1.068622859960109,0.36,0.71900341248485,1.0,5/24,7.11%,KRIT1;TEK;GAS6;CDH5;RAMP2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.44735837738951956,1.0685463906401034,0.347,1.0,1.0,72/327,16.23%,PHF19;EZH2;ATRX;MYBL1;NSD2;TCFL5;E2F1;BRCA2;RB1;SP3;LIN54;HNRNPD;NLK;AJUBA;CHEK2;ACTN4;NFIA;NFIL3;TCF7L1;SRSF10;CCAR1;GZF1;YAF2;SOX6;HP1BP3;GON4L;PML;PSPC1;MYBL2;POLR2A;FUS;MYCBP;WWTR1;PHF1;PRRX2;LMX1B;BNC2;MSL3;LIMD1;DNM2;NONO;NFYA;VHL;ZNHIT3;ERC1;NR3C1;HINT1;SFPQ;TGFBR1;SLC39A8;POFUT1;NCOA2;BMP2;AHR;ATXN1;SPTY2D1;KMT2D;ATF5;RORA;GPBP1L1;FOXK2;JMJD1C;SOX1;RBAK;PRDM8;EFEMP1;TRRAP;MLF2;HOXB7;TP53;DRAP1;RALY
prerank,negative regulation of metabolic process (GO:0009892),-0.2601149947158541,-1.0682456511390999,0.30864197530864196,0.7188161434664098,1.0,15/54,16.69%,LNPEP;MAP2K6;FIS1;NOVA2;ZNF423;ABHD6;TLR4;ACOT11;FOXC2;ACVR2B;NR1H3;ZDHHC7;CCDC3;DDIT3;NR1H2
prerank,mRNA destabilization (GO:0061157),0.46081629229526205,1.0678872842119211,0.3984018264840183,1.0,1.0,11/38,13.95%,MOV10;ROCK2;CNOT1;FTO;RC3H2;TUT7;ROCK1;YTHDF2;MEX3D;TUT4;RC3H1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.4458265521934795,1.0677432302276664,0.156,1.0,1.0,334/1667,15.86%,BRCA1;CKAP2;E2F7;CCNB1;NR2E3;E2F8;UHRF1;CDK1;MXD3;ATAD2;EZH2;BRIP1;EN1;PLK1;E2F2;ATRX;AURKB;MYBL1;PBX4;GLI2;TCFL5;GLI3;RBL1;LCORL;HMGB2;E2F1;CBX5;FOXE1;ATOH8;ZBTB8A;MED26;ATP2B4;KMT5A;FADD;PPM1D;LOXL2;TRIM37;ZFP69;BRD9;CBFB;SMARCC1;ZNF32;RB1;PBX3;BAZ1B;SP3;SETX;BMPR1A;HOXC5;DEK;MOV10;PHIP;ZFP41;ETV6;TWIST2;FNIP1;ELF2;MIER1;ACTR3;TRAK1;TEAD1;WWOX;SP2;ZSCAN29;RAD21;RBBP8;HDGF;AGO2;CTCF;E2F3;FGFR2;SENP1;ZEB1;JAZF1;TFDP1;BCL2L12;NFE2;TFCP2L1;CNOT1;GALR1;DDRGK1;MED14;EED;AUTS2;BCOR;RFXAP;MDM4;TAF3;ZNF260;RGMA;NFIA;HIVEP1;KIT;CUX1;PCGF5;SSBP3;DHX9;WIZ;FHL2;PRKDC;ZFP62;BHLHE41;NFIL3;KLF5;SRF;TCF7L1;CTBP1;EPC2;TSHZ1;ELF4;ASXL1;NFIB;THRAP3;KLF13;ZNF568;TBL1XR1;SP8;LPIN2;IKZF1;MCPH1;MLLT10;SETD3;BMP6;GZF1;LCOR;HOXC4;TCF7L2;PSIP1;MED30;SOX6;ELF1;IL18;ORC2;HOXA7;GMEB1;TPR;GRHL2;AKNA;ARRB1;ELOC;GATAD2A;TCF4;MIDEAS;ARID1A;EFNA1;MYBL2;GLIS3;RFX2;RIF1;SFRP2;ELK1;NUCKS1;PPP3CA;CCN1;FUS;NIPBL;POU2F1;ZBTB2;PROX2;POU3F2;MXD1;MAMSTR;FHL5;SIM1;ZBTB7B;WWTR1;SRCAP;ZFX;PHF2;LIN9;SERPINE1;ZHX2;PRRX2;OLIG2;FOXO3;SAP18;TRIM28;LMX1B;KDM2B;LIN37;PLAGL2;SMAD6;ZNF23;RCOR1;PELP1;IRF1;ZFP64;HMGB3;BCLAF1;CREB5;MED24;RHOQ;SMARCA4;USP16;ZFP90;KLF11;NCK1;MIER3;KANK2;ZBTB25;HOXB3;YAP1;NFYA;VHL;ARID4A;PLAGL1;ZIC5;MED15;ZBTB20;UXT;EPC1;HMGB1;IKBKG;KMT2A;HOXB6;HDAC8;MEOX2;MTA3;NR4A2;CARF;MYPOP;NR3C1;CXXC5;PARP9;SFPQ;HNRNPU;TAL1;TADA1;CRLF3;TEAD3;ZBTB24;KCNIP3;NCOA2;SMURF2;PRKCB;ZNF585B;ZNF585A;CHD2;HDAC1;BMP2;AHR;EZR;NKX2-1;KLF9;HTATSF1;TBX18;MRTFA;NFATC2IP;ZHX3;ATXN1;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;ZIC4;KMT2D;SMAD4;HDAC2;ZNF394;RPRD1A;SAP130;ATF5;ZNF496;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;IL4I1;NCOA7;TADA2A;IRF2BP1;PPID;TWIST1;MAML1;HEY2;USP9X;PPRC1;ACTL6B;PRKD1;MED1;DLG1;ARF4;FOXL1;RARB;POU2F2;YY1;ZMYM5;RLF;FOXK2;CAMTA1;PCGF6;DNMT3A;RUVBL2;FOXM1;SMAD3;ARNT;FOXP4;ZFP91;CDK8;JMJD1C;BAZ1A;SOX1;E2F4;PER1;YEATS2;RBAK;ZNF445;PIN1;MED27;OTUD7B;INO80;DR1;HDGFL3;GDNF;ATF1;KAT6A;DCAF1;TNRC6C;ZNF507;HOXB7;PRKD2;PKD2;CSRP3;CHD1;ZNF112;NFKB1;ZBTB7C;PPIL4;TP53;FHOD1;PKNOX2
prerank,regulation of activated T cell proliferation (GO:0046006),0.4926925700700848,1.0674100292789277,0.4175691937424789,1.0,1.0,6/30,13.95%,FADD;PRNP;IL18;SCRIB;HMGB1;RC3H1
prerank,anterior/posterior axis specification (GO:0009948),-0.38951006210320305,-1.067387256508207,0.3568904593639576,0.7197653128899664,1.0,3/15,16.63%,TASOR;TBX3;DDIT3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.2970490722181027,-1.0672065026751487,0.3836477987421384,0.7190855568869475,1.0,14/32,19.28%,RHOJ;MAP2K5;KLF4;FGF2;FOXC2;HDAC5;PTGS2;THBS1;HDAC7;VEGFA;HDAC9;ITGB1BP1;GATA2;FGFBP1
prerank,negative regulation by host of viral process (GO:0044793),-0.42830608312637597,-1.0669861104417595,0.39244186046511625,0.7184925355192019,1.0,1/10,0.22%,PRKN
prerank,transition metal ion transport (GO:0000041),-0.3030302958476152,-1.0664034430437157,0.375,0.7187512681255984,1.0,11/35,21.96%,FTH1;TRPC5;TRPC3;TRPC1;IREB2;SLC31A2;SLC30A1;ATOX1;CUTC;COX17;ATP7A
prerank,regulation of ion transport (GO:0043269),-0.25620733880039787,-1.0663002426237738,0.2558139534883721,0.7178587716182255,1.0,28/76,23.69%,PRKN;NKAIN2;SYT1;KCNJ3;KCNJ6;SIK1;ATP1A1;NKAIN4;SYT7;B2M;DTNBP1;KCNJ10;KCNA2;SYT11;SYT12;WWP2;VAMP3;SYT10;NKAIN3;SYT6;ITGB3;SYT2;KCNJ12;NOS1;P2RX4;DRD2;NEDD4L;TOR1A
prerank,response to estradiol (GO:0032355),-0.3073551309017189,-1.0660654910308964,0.3433734939759036,0.7173465286207891,1.0,7/31,11.74%,STAT3;SOCS2;CCDC62;STRN3;GGT5;ESR1;CTNNB1
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.3380441074369552,-1.065766071395556,0.33476394849785407,0.7169606106077719,1.0,6/22,9.74%,WDFY1;IFI35;LYN;LBP;PTPN22;NR1H3
prerank,cardiac muscle cell differentiation (GO:0055007),-0.34223594751378134,-1.0651727294216486,0.3783783783783784,0.7173067434017213,1.0,8/21,26.48%,ACVR1;MEF2C;SIK1;VEGFA;MYH11;KDM6B;CBY1;MYOCD
prerank,negative regulation of ossification (GO:0030279),0.49934786296325784,1.0651332839261392,0.3952020202020202,1.0,1.0,7/23,16.05%,BCOR;CHSY1;SMAD6;ENPP1;RBPJ;TRPM4;SFRP1
prerank,sterol transport (GO:0015918),-0.34997060309949773,-1.0650986876059558,0.3739130434782609,0.7163194347682146,1.0,6/19,23.34%,CAV1;ARV1;LDLRAP1;OSBP;OSBPL2;NPC2
prerank,regulation of steroid metabolic process (GO:0019218),-0.32503290809272173,-1.0646815978737145,0.39195979899497485,0.7162499493291427,1.0,7/23,16.41%,APOE;ASAH1;STUB1;ARV1;FMO5;DGKQ;EPHX2
prerank,protein modification process (GO:0036211),0.448887461827642,1.0641651809326198,0.4118268215417107,1.0,1.0,33/76,25.29%,TGM1;UBE2S;LOXL2;LOX;GGCX;PRKDC;ST8SIA2;PHKA2;B4GALT7;DUSP12;RPN2;SEPHS1;NAGPA;ATG3;ST3GAL1;UBL5;PLOD2;NTAQ1;PLAT;YES1;UBE2D3;ICMT;UBE2L3;NEDD8;PIGH;FBXO22;PARP4;USP25;UBE2I;FBXW2;RABGGTB;UBL4A;ADPRH
prerank,glycerophospholipid metabolic process (GO:0006650),-0.24630671020959574,-1.0634398191619696,0.3220338983050847,0.7180719185601525,1.0,26/75,19.47%,GPCPD1;PLA2G4A;PDGFRB;ABHD6;ABHD12;PNPLA6;PLA1A;PLEK;PLCB3;PLCG1;ENPP6;GPLD1;PIGV;SERINC1;GDPD3;PIGX;PIP5K1A;PIGQ;GDPD1;PIGB;PIGP;PLA2G7;SYNJ1;HDHD5;ACP6;PIGF
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4463550182582219,1.0632712673008993,0.4127310061601643,1.0,1.0,17/101,15.58%,EZH2;INCENP;SPDYA;ATP2B4;PSRC1;RHOA;KIT;ETAA1;LRRK2;ROBO1;CALM2;ADAM17;ADRB2;CAB39;RPTOR;SRC;PKD2
prerank,B cell receptor signaling pathway (GO:0050853),-0.3119776429607491,-1.063190701988263,0.327683615819209,0.7175480126717588,1.0,9/32,19.23%,MEF2C;VAV3;BCL2;BMX;RFTN1;PIK3CD;BCAR1;CD38;NCKAP1L
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5426392953878331,1.0630060654880205,0.40594059405940597,1.0,1.0,5/11,18.42%,DCK;ENPP3;ERH;SLC19A2;SLC25A19
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5109684127633278,1.0628138215466332,0.3887434554973822,1.0,1.0,6/20,15.56%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.4276060949945423,-1.062803494254179,0.4140127388535032,0.7174178489791625,1.0,2/11,4.12%,MEF2C;TGFB2
prerank,negative regulation of programmed cell death (GO:0043069),0.44421003436061673,1.0624321345907346,0.34734734734734735,1.0,1.0,60/355,16.32%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;MAP4K4;SETX;PHIP;ARHGAP10;ANGPT4;GSK3B;FXN;DDRGK1;AIFM2;FHL2;PRKDC;MRE11;SIAH2;PDPN;ANXA5;ARL6IP1;SMAD6;GRK5;SH3RF1;KANK2;MGMT;ANGPT1;VHL;PIM1;APIP;ERC1;HDAC1;ANXA1;HDAC2;NOTCH2;ATF5;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;CD44;BIRC6;SRC;GDNF;TNFAIP8;NFKB1;TP53;SFRP1;ANKLE2;HIPK3
prerank,neuropeptide signaling pathway (GO:0007218),-0.26072592243408244,-1.062349056949077,0.2857142857142857,0.7174355717593567,1.0,9/58,10.55%,SORCS3;SORCS1;GLRB;GLRA1;CPE;GLRA3;GPR37;OPRM1;HCRTR2
prerank,histone mRNA catabolic process (GO:0071044),0.5290012180480569,1.0622032203682779,0.3920220082530949,1.0,1.0,5/15,13.45%,TENT2;ERI1;TUT1;TUT7;TUT4
prerank,positive regulation of protein sumoylation (GO:0033235),0.5566257228157708,1.0621097152352155,0.3978819969742814,1.0,1.0,5/10,22.96%,SAE1;GNL3;HDAC4;PIAS1;UBA2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5407707699353563,1.0619724147470844,0.42074074074074075,1.0,1.0,2/10,6.30%,LOXL2;SOX6
prerank,protein import into mitochondrial matrix (GO:0030150),-0.36763782974869436,-1.0618750202551324,0.39344262295081966,0.7174800121694268,1.0,12/18,38.87%,DNAJC19;TIMM44;TOMM70;DNAJC15;PAM16;TIMM17A;TIMM17B;ROMO1;GRPEL1;DNLZ;TOMM40L;TIMM50
prerank,regulation of cation transmembrane transport (GO:1904062),0.48937601869318653,1.0618442155229117,0.42293464858199753,1.0,1.0,9/29,17.52%,ATP2B4;RANGRF;PDZK1;WNK1;SNTA1;KCNIP3;DLG1;DPP6;WNK3
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.4501959857603943,-1.0617885149442006,0.4190751445086705,0.7165726835015693,1.0,5/10,19.23%,TGFBR2;PRKCQ;CD81;LGALS9;NCKAP1L
prerank,ribosomal large subunit assembly (GO:0000027),-0.3253253090750957,-1.0615206795854266,0.3697916666666667,0.7161699389011342,1.0,14/24,31.65%,DHX30;RPL3;BRIX1;RPL10;RPL24;TRAF7;MDN1;RPLP0;NOP2;BOP1;RPL11;FASTKD2;RSL24D1;NLE1
prerank,regulation of DNA biosynthetic process (GO:2000278),-0.33216722584350533,-1.0614050428121273,0.3701657458563536,0.7153767128732158,1.0,9/27,12.67%,DACH1;BMPR2;ACVRL1;PDGFRB;FGF2;PINX1;ATM;NABP2;RGCC
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.4873060279195094,1.0613995180166749,0.3918918918918919,1.0,1.0,8/29,13.78%,RAB33B;COG1;GOLGA5;COPB2;COPZ1;VTI1A;GOSR1;TRAPPC10
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.5410341337823441,1.0611671633352193,0.4094955489614243,1.0,1.0,4/11,14.28%,FRS2;SOX6;BMP2;EFNB2
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),-0.32996336622617484,-1.0610562289261865,0.3230769230769231,0.7151074411259362,1.0,18/25,34.94%,LYST;VPS4B;LAPTM4B;CHMP2B;CHMP5;CHMP1A;LEPROTL1;UBXN6;CHMP2A;CHMP3;MVB12A;TMEM50B;CHMP7;DENND10;TMEM50A;VCP;CHMP4C;CHMP1B
prerank,transferrin transport (GO:0033572),-0.2965296763758423,-1.0609149517985839,0.38125,0.7142997131429523,1.0,16/33,32.34%,ATP6V0A1;ATP6V0D1;ATP6V1E1;ATP6V0B;ATP6V0A4;ATP6V0C;ATP6V1H;MCOLN1;ARHGAP1;ATP6V1G2;ATP6V1B2;ATP6AP1;REP15;ATP6V1F;ATP6V0D2;ATP6V0E1
prerank,regulation of complement activation (GO:0030449),-0.2967791719197236,-1.0607200541690618,0.35398230088495575,0.7136801527580401,1.0,17/40,39.06%,VTN;CD81;C4B;C1QB;C2;CR1L;C1QC;C1QA;CFHR2;PHB2;CR2;C1QBP;SERPING1;C3;C3AR1;C6;C7
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.41574008146943187,-1.0605815080944363,0.4041916167664671,0.7128797615404304,1.0,8/11,46.15%,LYN;TIRAP;MFHAS1;TNFAIP3;PJA2;TREM2;TLR6;TLR1
prerank,post-translational protein modification (GO:0043687),0.4426634607956427,1.0603957109350048,0.349,1.0,1.0,45/332,12.60%,DTL;ESCO2;CCNF;MATN3;DSCC1;F5;FEM1C;ASB15;PSMC2;PSMD5;FBN1;OBSL1;LAMB1;FBXL7;SPSB3;SPSB2;RBBP7;ELOC;FBXW7;FBXO30;CUL5;CCN1;FBXL8;QSOX1;KLHL5;PSMB1;FN3K;SUMF2;CUL3;PSMD14;KLHL22;VHL;CUL4B;PSMD1;SKP2;DCAF10;RAB1A;WSB2;PSMB9;STT3A;APLP2;CHM;FBXW11;STT3B;DCAF7
prerank,negative regulation of microtubule polymerization (GO:0031115),0.5334814380223332,1.0602980726490783,0.38808139534883723,1.0,1.0,2/12,2.25%,STMN1;DYRK1A
prerank,protein K63-linked ubiquitination (GO:0070534),0.46828971499041655,1.0602618182763537,0.41289592760180993,1.0,1.0,6/41,7.16%,UBE2T;UBE2S;RNF168;NEDD4;UBE2N;PRPF19
prerank,response to X-ray (GO:0010165),0.5264303851437039,1.0590041432911452,0.3958041958041958,1.0,1.0,5/14,14.14%,BLM;NUCKS1;NIPBL;ANXA1;BRCC3
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.3628579183208827,-1.058991739399041,0.36099585062240663,0.7155749968443523,1.0,8/17,24.08%,COX6C;COX4I1;COX5A;COX7B;COX7C;NDUFA4;COX8A;COX5B
prerank,histone H3 deacetylation (GO:0070932),0.535007567186531,1.0587321648810106,0.42178770949720673,1.0,1.0,7/15,14.79%,SMARCAD1;HDAC8;SFPQ;HDAC1;HDAC2;ELK4;PER1
prerank,heart development (GO:0007507),-0.23070219732283306,-1.0581026225174321,0.3076923076923077,0.7165589770871682,1.0,43/150,18.27%,PTK2;ACVR1;TEK;ECE1;TCF25;MEF2C;ADAP2;TGFBR2;PCSK5;INSR;TAB2;FKBP1A;BMPR2;ACVRL1;TGFB2;RBM20;NTRK3;POU6F1;FOXC2;MTHFD1;FOXC1;RAMP2;ERBB4;NF1;PDLIM2;MEF2A;MEGF8;PDLIM7;SOX4;KAT2B;CACYBP;TBX1;PTPN11;VEGFA;HDAC9;SOX17;STRA6;PLCE1;CRELD1;NDRG4;CITED2;TBX2;PDLIM1
prerank,mitochondrion disassembly (GO:0061726),-0.3033806952015715,-1.0575383917732142,0.3619631901840491,0.7167938883115699,1.0,14/34,19.95%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5345898481772726,1.0573719492470737,0.40955137481910275,1.0,1.0,4/13,10.25%,SRSF10;PRPF19;PRPF3;LSM2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.32180733372569237,-1.0572682502144044,0.3404255319148936,0.716325286825919,1.0,6/27,5.85%,SLC1A2;SLC7A2;SLC25A13;SLC25A12;SLC3A2;SLC7A5
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5227790499878041,1.0570881934620584,0.39591836734693875,1.0,1.0,3/15,9.13%,GSTO2;HNRNPA1;CPEB2
prerank,protein deubiquitination (GO:0016579),0.44447462778969576,1.0568093837552706,0.4014014014014014,1.0,1.0,60/242,19.01%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;PSMD5;MDM4;USP18;CCNA2;TAB1;ASXL1;SIAH2;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;PSMB9;USP28;SMURF2;ADRM1;SMAD4;ADRB2;USP9X;USP47;YY1;FOXK2;BRCC3;SMAD3;OTUD1;PSMC6;OTUD7B;INO80;TRRAP;TP53;TAF10;PTEN;RAD23B;USP48;PSMB2;WDR20;SMAD2;USP14;PSME4;PSMB7;RIPK1;USP46;USP20
prerank,cellular response to ATP (GO:0071318),-0.3841682129661189,-1.0567866298891966,0.35766423357664234,0.7165388117149384,1.0,6/14,28.47%,RYR3;HSP90B1;SSH1;P2RX4;P2RX7;P2RY12
prerank,positive regulation of JNK cascade (GO:0046330),-0.25537010574736535,-1.056473659591013,0.359375,0.7162242310390947,1.0,39/70,39.61%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ANKRD6;MAP3K5;DUSP22;SEMA3A;MINK1;APP;SDCBP;SH3RF2;TIRAP;GADD45B;FLT4;MAP3K11;WNT16;PTK2B;MAPK8IP1;MFHAS1;EDA2R;PLCB1;MBIP;GADD45G;DUSP19;TRAF1;HRAS;PJA2;CCL19;EDAR;NOD2;DUSP15;PYCARD;GADD45A;UNC5CL;FCGR2B;RASSF2;AGER
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3878600638960855,-1.05614170758212,0.373015873015873,0.7159472915078681,1.0,4/14,21.07%,CROT;SCP2;DECR2;AMACR
prerank,regulation of amyloid fibril formation (GO:1905906),-0.37246393719626697,-1.0557171521165019,0.35379061371841153,0.7159275785910716,1.0,6/15,13.21%,PSEN1;APOE;CHRNA7;APP;CRYAB;PFDN5
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.38082569694325924,-1.0556559931085545,0.347682119205298,0.7149832128206803,1.0,3/16,3.07%,CAMK2D;CALM1;RYR2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.39794048194384884,-1.0551594407360751,0.38513513513513514,0.7151084747236024,1.0,6/13,16.50%,CALM1;NOS3;QDPR;GCH1;PRKG2;PTS
prerank,protein modification by small protein removal (GO:0070646),0.44314463522889996,1.0550994324130523,0.398,1.0,1.0,62/252,19.01%,BRCA1;CDK1;CLSPN;BARD1;CDC20;USP1;RHOA;PSMC2;SENP1;PSMD5;MDM4;USP18;CCNA2;TAB1;ASXL1;SIAH2;RHOT1;CCNA1;USP37;STAM;UIMC1;PSMB1;PSMD14;USP21;USP16;PSMD1;SKP2;IKBKG;CDC25A;TGFBR1;PSMB9;USP28;SMURF2;ADRM1;SMAD4;COPS3;ADRB2;USP9X;USP47;YY1;FOXK2;BRCC3;SMAD3;OTUD1;PSMC6;OTUD7B;INO80;TRRAP;TP53;TAF10;PTEN;RAD23B;USP48;PSMB2;WDR20;SMAD2;USP14;PSME4;PSMB7;RIPK1;USP46;USP20
prerank,response to prostaglandin E (GO:0034695),0.5431338636735383,1.0550144498720109,0.40620384047267355,1.0,1.0,4/10,22.02%,TGFBR3;ADCY6;SFRP1;GNB1
prerank,vesicle organization (GO:0016050),-0.2771599468388591,-1.0549210573733867,0.3181818181818182,0.7145666646254842,1.0,15/46,14.60%,CAV1;FNBP1L;SQSTM1;CD34;LAPTM4B;DNM1;USP8;SAR1A;VPS11;CHMP2B;SRGN;CAV2;ARFGEF2;HOOK1;VPS33B
prerank,regulation of neuron death (GO:1901214),0.4456718203368737,1.0534635609262841,0.42679127725856697,1.0,1.0,10/82,9.77%,KIF14;GSK3B;PRNP;MAPT;RILPL1;RAB29;HTRA2;LRRK2;PICALM;IKBKG
prerank,positive regulation of DNA binding (GO:0043388),0.4747388869845748,1.0534391076168017,0.40799031476997577,1.0,1.0,11/31,20.26%,HMGB2;RB1;TXN;HMGB1;TRIM6;PLAUR;TWIST1;NGF;NIBAN2;SKI;TRAF6
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5180316811647552,1.053196985416032,0.4031413612565445,1.0,1.0,4/18,10.43%,STMN1;CUL3;RIPOR2;ARHGAP35
prerank,cellular response to amino acid starvation (GO:0034198),-0.24959951230168423,-1.0530469934019298,0.2923076923076923,0.7182832298031316,1.0,21/71,15.13%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;SZT2;MAPK3;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;RRAGC;DAPL1
prerank,heart contraction (GO:0060047),-0.27890874879756505,-1.052959690510461,0.4132231404958678,0.7174682353547626,1.0,9/41,19.39%,ATP1B1;RYR2;TPM1;ACE;ATP1A2;SCN1B;GPX1;PIK3CA;KCNQ1
prerank,eye morphogenesis (GO:0048592),0.501724328497945,1.052836769160843,0.408355795148248,1.0,1.0,11/19,19.69%,MFAP2;FBN1;COL5A2;NIPBL;MFAP5;NKD1;EFEMP1;AGTPBP1;SHROOM2;SKI;ALDH1A3
prerank,macrophage chemotaxis (GO:0048246),0.5423206974923895,1.0528259741426933,0.40789473684210525,1.0,1.0,1/10,4.99%,CKLF
prerank,positive regulation of kinase activity (GO:0033674),0.4387523641673196,1.0527691485737058,0.4198161389172625,1.0,1.0,12/107,8.17%,CENPE;SPDYA;FGFR4;FGFR2;KIT;MRE11;MAPT;MUSK;PDGFRA;CCN1;EPHA4;MRNIP
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.45942504822888075,1.0521670864045394,0.4336569579288026,1.0,1.0,1/55,0.19%,BRCA1
prerank,lipid modification (GO:0030258),-0.2842078731532761,-1.0519031055013108,0.34328358208955223,0.7190563389000606,1.0,11/37,21.13%,PLPPR1;DGKB;PLPP3;DGKG;DGKI;DGKQ;PLA2G7;EPHX2;PLPP4;DGKD;PLPPR4
prerank,phosphorylation (GO:0016310),0.4410173683724443,1.0515266385228956,0.36036036036036034,1.0,1.0,85/385,15.60%,NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;NEK3;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;MAP4K4;DYRK1A;STK17B;BMPR1A;CDK14;AURKA;ROCK2;MAP4K2;GSK3B;STK10;NLK;CHEK2;MYLK3;PRKDC;CTBP1;DYRK3;VRK2;STK3;STK24;NRK;MAP3K1;CCNE1;WNK1;MAP3K20;CDC25B;CHEK1;CDC42BPA;CDK2;LRRK2;GRK5;LIMD1;ROCK1;PIM1;MARK2;PXK;PIK3CB;CDC42BPG;TGFBR1;SRPK1;EIF2AK3;LMTK3;PRKCB;BMP2;DGKE;PRKCA;PDPK1;GRK3;AAK1;CSNK1G2;SIK2;MEX3B;STRADA;BTK;CDK19;AGK;PRKCE;MAML1;PRKD1;PANK2;PRKCI;PLK2;NRBP1;MORC3;VRK1;CDK8;BIRC6;STK11;TAOK1;PRKAG1;PRKD2;STK39;PASK
prerank,leukocyte tethering or rolling (GO:0050901),0.5032979187069472,1.0515110142142121,0.41486486486486485,1.0,1.0,6/17,18.76%,ITGB7;ADD2;PODXL2;ROCK1;ITGB1;GCNT1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.3813511195242034,-1.0511616290878658,0.3890909090909091,0.7197233020679642,1.0,4/14,26.60%,PTGS2;OSMR;PARK7;PTGER3
prerank,regulation of protein kinase C signaling (GO:0090036),0.532414441829973,1.0507776771436028,0.4229137199434229,1.0,1.0,2/14,2.62%,ADGRV1;ULK4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.24751803783903756,-1.0505814928760082,0.26666666666666666,0.7200057257581877,1.0,31/100,15.33%,PRKN;FHIT;COP1;SMAD7;HSP90AB1;NUB1;OGT;RNF180;TRIB2;UFL1;GNA12;RBX1;RNF144B;DAB2;CBFA2T3;MAP1A;SOCS5;ARAF;RNF19B;UBQLN4;GIPC1;STUB1;RNF217;ARIH2;CCAR2;SDCBP;SH3RF2;GSK3A;NKD2;ELOB;DVL1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.4967355735260975,1.0502115696328975,0.4013071895424837,1.0,1.0,1/21,0.82%,PON1
prerank,actomyosin structure organization (GO:0031032),0.4507906658150694,1.0498125469222799,0.4424686192468619,1.0,1.0,20/75,16.48%,CIT;ROCK2;RHOA;MYLK3;CSRP2;MYH10;ARRB1;EPB41L2;CDC42BPA;PHACTR1;CUL3;ROCK1;CDC42BPG;EPB41L3;TMOD3;ITGB1;FRMD6;SRC;CSRP3;TNNT3
prerank,regulation of metal ion transport (GO:0010959),-0.37928096616465873,-1.0494554172727912,0.3894736842105263,0.7216680322163456,1.0,4/16,10.55%,CACNA2D1;EPB41;CAMK2G;BCL2
prerank,regulation of feeding behavior (GO:0060259),-0.41924699486048744,-1.0493533719301789,0.40705128205128205,0.7208231492718744,1.0,3/11,5.06%,SGIP1;STAT3;CFAP20
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4777145628043856,1.049322823090765,0.4329411764705882,1.0,1.0,9/34,14.33%,E2F1;ASXL1;ANKRD26;WWTR1;YAP1;RUNX1T1;ENPP1;RORA;SMAD3
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.34305447515393966,-1.0492555542234234,0.35789473684210527,0.7200168190151363,1.0,5/22,17.16%,APOD;PRKAA1;ASXL3;CCDC3;ADRA2A
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.25921566928744816,-1.0489633556386018,0.4342105263157895,0.7196342534058427,1.0,21/54,23.02%,HEATR3;RPL35A;RPL3;NVL;RPL14;BRIX1;RPL10;RSL1D1;RPL24;TRAF7;NSA2;LAS1L;SNU13;LTO1;MDN1;RPLP0;RPL10A;NOP2;SURF6;RRP15;EBNA1BP2
prerank,regulation of cellular senescence (GO:2000772),0.48061818106244725,1.04847894703229,0.42326732673267325,1.0,1.0,9/28,19.60%,RBL1;FBXO5;MAP3K3;TERF2;TWIST1;SLC30A10;PNPT1;YPEL3;TERT
prerank,positive regulation of angiogenesis (GO:0045766),0.4424272975602777,1.047144725253217,0.42857142857142855,1.0,1.0,21/108,14.26%,BRCA1;VASH2;AQP1;ANGPT4;HYAL1;AGO2;ADAM12;ANXA3;SFRP2;HSPB6;SERPINE1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PRKD1;ITGA5;ITGB1
prerank,positive regulation of phagocytosis (GO:0050766),-0.2677655212022257,-1.0470003026424546,0.28865979381443296,0.7233241157795343,1.0,28/47,44.91%,MERTK;ANO6;GAS6;MYO18A;C4B;GATA2;RAB27A;NCKAP1L;C2;IL15;TUB;FCER1G;PTPRC;ABCA7;CALR;RAB31;LYAR;C3;PYCARD;SLC11A1;LMAN2;FCGR2B;CD300LF;CCL2;TREM2;IL2RG;AHSG;PLA2G5
prerank,embryonic limb morphogenesis (GO:0030326),0.4824950376511293,1.0468917389387296,0.4332129963898917,1.0,1.0,14/34,20.38%,GLI3;CYP26B1;AFF3;MAP3K20;NIPBL;WDPCP;CACNA1C;HDAC1;HDAC2;TWIST1;SALL1;OSR1;SKI;FBXW4
prerank,negative regulation of proteolysis (GO:0045861),0.4668045475730278,1.0468501680496323,0.4211136890951276,1.0,1.0,7/34,9.98%,DNAJC1;PRNP;EFNA1;EPHA4;LRRK2;ROCK1;GAS1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.4700824097115141,1.0466555184231359,0.42926239419588874,1.0,1.0,10/31,16.26%,RHOA;PARD3B;RAP2A;ANK1;SCRIB;MARK2;EZR;PRKCI;DLG1;MSN
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.544117203439093,1.0462649412938598,0.4227129337539432,1.0,1.0,5/10,20.56%,ADA;WNK1;PIEZO1;FERMT3;DPP4
prerank,blood vessel morphogenesis (GO:0048514),-0.2714045672422036,-1.0462608841352616,0.3670886075949367,0.7240059380551578,1.0,17/54,15.85%,FLT1;SMAD7;CDH2;CAV1;TGFBR2;PROX1;RAMP2;NF1;RASIP1;CUL7;CCBE1;TBX1;VEGFA;ENG;SOX17;STRA6;SLC1A1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4681885995624831,1.0459381213728909,0.39520958083832336,1.0,1.0,9/29,16.13%,USF3;EFNA1;SFRP2;NKX2-1;ADIPOR1;SPRED1;SFRP1;SPRED2;PTEN
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5359502044191704,1.045922720826083,0.41341653666146644,1.0,1.0,3/10,8.29%,TXN;PYCR1;LRRK2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.4946665522322702,1.0458741194249321,0.4193138500635324,1.0,1.0,2/22,2.26%,PPM1G;PPM1D
prerank,cell-substrate junction assembly (GO:0007044),-0.2971410879896918,-1.0453486585524119,0.40789473684210525,0.7252509966083662,1.0,12/33,20.27%,ITGA6;THSD1;TAOK2;BCR;LAMA3;ITGB4;PIP5K1A;ARHGEF7;ACTN1;CD151;PLEC;SORBS1
prerank,regulation of hemopoiesis (GO:1903706),0.5376208921173,1.045303055198858,0.4254062038404727,1.0,1.0,4/10,22.60%,CBFB;PRKCB;RUNX1;MYSM1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.2808939898882044,-1.045265174384323,0.3431372549019608,0.7243546889818734,1.0,12/45,13.69%,CAMK2D;TRIM25;MID1;VCAM1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;IFNGR1
prerank,organic acid transport (GO:0015849),-0.2248447806903019,-1.0449831121082114,0.3870967741935484,0.7239277226244709,1.0,26/94,23.57%,SLC6A6;SLC13A3;SLC7A2;SLCO1C1;SFXN5;SLCO2B1;GOT2;SLC3A2;SLC27A1;ABCC4;ATP8B1;SLC22A6;ABCG2;SLC5A6;SLC7A6;SLC16A1;LRRC8D;SLC38A5;STARD5;SLC25A11;SLC6A15;SLC27A4;ACSL1;SLC36A1;MFSD2A;SLC7A14
prerank,regulation of lipid storage (GO:0010883),0.4873398719877944,1.0449550351329313,0.41923076923076924,1.0,1.0,6/22,15.76%,FTO;PTPN2;FBXW7;ITGAV;NFKB1;LPL
prerank,anion transport (GO:0006820),-0.29354603026026305,-1.0441799400696317,0.3815789473684211,0.7246860948684835,1.0,8/33,14.40%,SLC13A3;SLCO2B1;SLC13A4;SLC22A6;ABCG2;SLC17A6;LRRC8B;LRRC8D
prerank,activin receptor signaling pathway (GO:0032924),-0.37847832317323254,-1.0439776324012642,0.4326530612244898,0.7241632816232906,1.0,3/15,8.29%,ACVR1;ACVR2A;ACVR2B
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.36528783788140173,-1.0439583403747308,0.39622641509433965,0.7231316995912193,1.0,8/16,27.66%,ABHD5;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1;PNPLA2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4309283951383056,-1.0435379685970076,0.4154727793696275,0.7231298871810661,1.0,1/10,0.01%,PRKG1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.46150405784075854,1.043533936419878,0.4332579185520362,1.0,1.0,16/44,20.64%,AQP1;CDKN2D;FNIP1;SIAH2;ARL6IP1;SH3RF1;CAST;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6;SNCA
prerank,lymphocyte proliferation (GO:0046651),0.4993623752668351,1.0434478658903743,0.4049159120310479,1.0,1.0,5/22,16.26%,HELLS;ELF4;CTPS1;LMBR1L;MSN
prerank,establishment of endothelial barrier (GO:0061028),-0.2950380649912073,-1.042937788878527,0.35294117647058826,0.7235229775430699,1.0,11/29,20.76%,PPP1R16B;PECAM1;RAP1A;F11R;TJP1;RAP2C;PDE2A;PDE4D;RAB1B;ROBO4;RAPGEF3
prerank,RNA processing (GO:0006396),0.4371389971618599,1.0429265688969374,0.435,1.0,1.0,55/176,17.95%,SYNCRIP;SETX;PABPC4;SNRNP25;TENT2;SRSF4;HNRNPD;CSTF3;LSM3;NRDE2;DDX39B;TENT4A;HNRNPH1;SRSF7;YJU2;RBMS2;FUS;DHX8;PPIG;CELF2;TUT1;TUT7;HNRNPUL1;TSEN34;PRPF3;NONO;SF3A2;SFPQ;HNRNPU;FASTKD5;SNRNP48;IVNS1ABP;HNRNPL;SRPK1;SRRM1;SNRNP35;ATXN1;RNGTT;SF3B3;TUT4;RBM4;WBP4;RBMS1;TSEN2;LUC7L3;KIN;HNRNPA2B1;LSM4;ZCCHC8;METTL3;NOL9;PRPF4;PRPF18;SRPK2;PDCD7
prerank,regulation of neuron differentiation (GO:0045664),0.4479539552668904,1.0409556973378011,0.4385593220338983,1.0,1.0,7/76,9.38%,ECT2;CDK5RAP2;RHOA;ZEB1;TCF4;LRRK2;ROCK1
prerank,negative regulation of stress fiber assembly (GO:0051497),0.4818755711381987,1.0405737142215263,0.4362089914945322,1.0,1.0,7/24,12.72%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,hemopoiesis (GO:0030097),0.4357979435955885,1.0405177218062232,0.45903361344537813,1.0,1.0,18/87,16.05%,MELK;ETV6;FGFR2;FUT10;KIT;WNT2B;RTKN2;TGFBR3;SFRP2;KMT2A;YTHDF2;TAL1;RRAS;NOTCH2;MFAP5;KAT6A;TP53;SFRP1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.4352508586096543,1.040444972438912,0.33,1.0,1.0,162/834,15.84%,BRCA1;CKAP2;E2F7;NR2E3;E2F8;UHRF1;ATAD2;DLGAP5;E2F2;ATRX;MYBL1;GLI2;GLI3;RBL1;HMGB2;E2F1;ATOH8;FADD;PAXIP1;SP3;SETX;BMPR1A;PHIP;ACTR3;TEAD1;WWOX;AGO2;E2F3;FGFR2;SENP1;TFDP1;BCL2L12;GALR1;DDRGK1;MED14;AUTS2;RFXAP;RGMA;NFIA;HIVEP1;PCGF5;SSBP3;DHX9;PRKDC;KLF5;SRF;ELF4;ASXL1;NFIB;THRAP3;TBL1XR1;LPIN2;MLLT10;SETD3;BMP6;HOXC4;TCF7L2;MED30;ELF1;IL18;HOXA7;GRHL2;AKNA;ARRB1;TCF4;MYBL2;GLIS3;SFRP2;ELK1;PPP3CA;CCN1;POU2F1;POU3F2;FHL5;WWTR1;SERPINE1;FOXO3;LMX1B;PELP1;IRF1;ZFP64;BCLAF1;MED24;RHOQ;SMARCA4;USP16;NCK1;LEO1;HOXB3;YAP1;PLAGL1;EPC1;HMGB1;IKBKG;KMT2A;HDAC8;MEOX2;NR4A2;NR3C1;SFPQ;HNRNPU;TAL1;CRLF3;NCOA2;HDAC1;BMP2;AHR;NKX2-1;MRTFA;NFATC2IP;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;KMT2D;SMAD4;HDAC2;ATF5;BRD4;TCF20;ELK4;LRP5;RORA;IL4I1;NCOA7;TWIST1;PLXND1;MAML1;HEY2;PPRC1;PRKD1;MED1;ARF4;RARB;POU2F2;YY1;RLF;FOXK2;RUVBL2;FOXM1;SMAD3;ARNT;CDK8;SOX1;E2F4;PER1;PIN1;INO80;DR1;GDNF;ATF1;KAT6A;ZNF507;HOXB7;PRKD2;PKD2;GNL3;CSRP3;NFKB1;TP53;FHOD1
prerank,autophagy of peroxisome (GO:0030242),-0.4111128302196386,-1.0403947957062043,0.4257142857142857,0.7286037417731135,1.0,5/12,17.35%,SQSTM1;PIK3R4;ATM;PEX5;USP30
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.35324181102864377,-1.0403004127961366,0.3949579831932773,0.727743327704001,1.0,7/20,17.18%,OGT;ASAH1;CYLD;STUB1;NUPR1;SDCBP;BIRC3
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.22264844862078,-1.0401779523944537,0.0,0.7269786864130681,1.0,51/172,19.88%,PLA2G4A;PLD1;PIP4K2A;INPP4B;SLC44A1;CHPT1;DGKB;ETNK1;PIK3R3;ABHD5;PIP4K2B;CDS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;PLD2;SLC27A1;AGPAT5;RAB5A;CHKA;ETNK2;DGKG;MTMR4;RUFY1;PCYT2;INPP5K;STARD7;LPCAT2;SELENOI;PIP5K1A;BMX;INPP5D;DGKQ;SYNJ2;CHKB;CDS1;SLC44A5;PIK3R6;SYNJ1;PI4KA;IMPA1;INPP4A;PIK3CD;PIK3CA;HDHD5;ACP6;LPIN1;PLA2G12A;DGKD;CDIPT
prerank,regulation of protein localization to membrane (GO:1905475),-0.3168485302687431,-1.0399427835472559,0.3942857142857143,0.7264654244861095,1.0,10/28,16.12%,PRKN;STX8;ACTB;STX7;AR;SPTBN1;GSN;LDLRAP1;ZDHHC7;VAMP8
prerank,RNA catabolic process (GO:0006401),0.45176068270729886,1.0396415114043163,0.4370786516853933,1.0,1.0,12/46,16.34%,PABPC4;HNRNPD;RNASE6;DNA2;RNASEH2A;PPP1R8;LSM2;YTHDF2;EXOSC7;DXO;PNPT1;METTL3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.47031659339487275,1.0396357953878825,0.4159713945172825,1.0,1.0,6/30,11.74%,RTN4R;LPAR1;NET1;ARRB1;ROBO1;RAC1
prerank,negative regulation of blood pressure (GO:0045776),-0.3833577486639228,-1.0395878413739688,0.37666666666666665,0.7262803389554701,1.0,5/13,22.18%,BMPR2;NOS3;PRCP;NOS1;DRD2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.5290692943296648,1.0394391657562203,0.43548387096774194,1.0,1.0,5/13,12.32%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,aortic valve development (GO:0003176),0.46794611664336905,1.0388773250406156,0.42452830188679247,1.0,1.0,10/34,13.42%,RB1;ROCK2;EFNA1;SMAD6;ROBO1;ROCK1;ELN;BMP2;TWIST1;HEY2
prerank,response to tumor necrosis factor (GO:0034612),0.4380571523230608,1.0387858411889395,0.4474505723204995,1.0,1.0,6/91,7.40%,BRCA1;HYAL1;DHX9;AFF3;NPNT;YBX3
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.30157687520023035,-1.0387205576347311,0.36619718309859156,0.7273805149793164,1.0,10/33,13.35%,EP300;SAFB2;UFL1;AR;UBA5;PRMT2;KDM4C;ESR1;DDX5;KCTD6
prerank,receptor internalization (GO:0031623),-0.28225565885116854,-1.0386756541281454,0.4083333333333333,0.7264279327489453,1.0,13/44,13.87%,DNM3;CALCRL;CAV1;LRP1;ACKR3;RAMP1;DNM1;RAMP2;RAB5A;CD81;AP2M1;GRB2;LDLRAP1
prerank,cellular response to ketone (GO:1901655),0.46598011298699027,1.0383015303173255,0.4114219114219114,1.0,1.0,12/35,17.74%,AQP1;ROCK2;LARP1;NR3C1;AHR;KLF9;ADCY6;SRC;SFRP1;PCK2;MSN;ADCY2
prerank,stress granule assembly (GO:0034063),-0.3439236197921064,-1.038250587139156,0.37551020408163266,0.7264413614009265,1.0,5/20,8.26%,DDX6;RPS23;UBAP2L;BICD1;CSDE1
prerank,myoblast differentiation (GO:0045445),-0.38672610829472703,-1.0380833806968826,0.44107744107744107,0.7257652258347884,1.0,7/14,11.68%,DDX17;JAG1;IGF1;PLEKHM3;HINFP;MBNL1;DDX5
prerank,calcium ion import (GO:0070509),0.4750073976603817,1.0380538654305669,0.43757575757575756,1.0,1.0,10/28,20.71%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;MICU1;MAIP1;TRPV4;CACNA1G;MICU2
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.31309729389421875,-1.0377011185164022,0.3686868686868687,0.7256498553534151,1.0,5/25,3.75%,MEF2C;GRIN2A;GRID2;GLRA1;GRIN2B
prerank,synaptic vesicle cycle (GO:0099504),-0.29798724782197755,-1.0376477446871348,0.3854748603351955,0.724727722885499,1.0,12/30,18.41%,PCLO;RIMS1;SYNDIG1;BRSK1;PLD2;RAB5A;SYT7;SLC17A6;CPLX1;SNAP25;SYT10;NLGN1
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.5185895634108681,1.0373329711558492,0.43103448275862066,1.0,1.0,2/13,6.95%,SAE1;ATG7
prerank,oligosaccharide biosynthetic process (GO:0009312),0.48830377802848907,1.037280301170493,0.41603053435114506,1.0,1.0,6/20,16.82%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,lipid oxidation (GO:0034440),-0.3942205950591825,-1.0371090446040006,0.40327868852459015,0.7249201420718278,1.0,3/12,19.45%,ADIPOR2;PLA2G7;PPARGC1A
prerank,transcription by RNA polymerase II (GO:0006366),0.4325044642945846,1.037069910191223,0.409,1.0,1.0,62/305,13.80%,NR2E3;E2F2;TRIP13;TCFL5;TTF2;MED26;PMF1;CBFB;SETX;DEK;TEAD1;E2F3;TFDP1;CSTF3;FIP1L1;TAF3;MBD1;INTS7;PHAX;KLF13;TBL1XR1;SLBP;ERCC3;ELOF1;LSM11;ELOC;GLIS3;TAF12;POLR2A;SETD2;POU2F1;ZBTB7B;WWTR1;NR2C2AP;WDR33;LEO1;YAP1;NFYA;PCF11;NR4A2;NR3C1;SCAF8;INTS8;TEAD3;TAF15;GTF2A1;CPSF4;HDAC1;ADRM1;TAF4;RBPJ;NR4A1;RNGTT;SSRP1;NOTCH2;RPRD1A;RORA;MAML1;DDX21;MED1;RARB;POU2F2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5296895307533056,1.0363495440079944,0.4337899543378995,1.0,1.0,5/10,15.81%,PSMC2;ATF7IP;HMGB1;PSMC6;TP53
prerank,axon development (GO:0061564),-0.23839724967485798,-1.036055549592298,0.48717948717948717,0.7263688275255326,1.0,21/78,14.12%,GRM7;DCC;PAK3;ACTB;S100A6;CAMSAP2;KLF7;NRCAM;MAP1B;TAOK2;BRSK1;EPHB2;GAP43;PLP1;MAP1A;CTNNA2;APP;RTN4RL1;SLITRK1;NREP;NTNG1
prerank,positive regulation of lipid localization (GO:1905954),-0.40462425367122734,-1.0360287522392189,0.39375,0.7254273272043483,1.0,3/11,8.09%,LRP1;IKBKE;VSTM2A
prerank,retinoid metabolic process (GO:0001523),0.44227840426207005,1.0357467752076106,0.4636752136752137,1.0,1.0,10/71,10.41%,ALDH8A1;CYP26B1;ABCA4;ALDH1A2;RDH11;GPC6;RDH12;ALDH1A1;SCPEP1;SDC1
prerank,mitochondrial fission (GO:0000266),-0.3638432096147537,-1.0352499875261203,0.3948339483394834,0.7262940403585472,1.0,4/16,7.00%,DNM3;PRKN;FIS1;DNM1
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.4610257034845223,1.0350395933963914,0.4583333333333333,1.0,1.0,22/42,23.90%,SMARCC1;SMARCAD1;RBBP4;ARID1A;SRCAP;SMARCA4;ANP32E;HDAC1;NASP;SPTY2D1;HDAC2;ACTL6B;INO80;MBD3;MBD2;ZNHIT1;ARID1B;CHD4;ACTL6A;SMARCC2;CECR2;SMARCB1
prerank,negative regulation of intracellular protein transport (GO:0090317),0.48877452817865963,1.034452666379247,0.4355263157894737,1.0,1.0,4/22,12.63%,BARD1;LRRK2;RANGAP1;DMTN
prerank,chondrocyte differentiation (GO:0002062),0.45853164999849294,1.0341859673295906,0.41325301204819276,1.0,1.0,12/32,20.04%,SULF2;WNT2B;NFIB;SOX6;SULF1;EIF2AK3;CCN3;BMP2;SNX19;RUNX1;OSR1;CREB3L2
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.4888540708211924,1.0340090665347728,0.4226267880364109,1.0,1.0,2/22,4.11%,VKORC1L1;ALDH1A2
prerank,rRNA 3'-end processing (GO:0031125),0.5320000334702939,1.0338611955104706,0.43558282208588955,1.0,1.0,5/10,18.35%,ERI2;ERI1;EXOSC7;ERI3;EXOSC10
prerank,histone acetylation (GO:0016573),0.4424197173499013,1.0331918808409635,0.45263157894736844,1.0,1.0,25/69,18.78%,BRCA2;SGF29;HAT1;TAF12;ING4;MSL3;EP400;EPC1;TADA1;TADA2A;JADE1;ACTL6B;RUVBL2;PER1;YEATS2;DR1;KAT6A;TRRAP;BRD8;TAF10;PHF20;ZZZ3;NAA60;NAA40;JADE3
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.47251109118260487,1.0329661241062105,0.4138785625774473,1.0,1.0,7/24,16.86%,HMBS;FXN;COX10;ABCB10;CPOX;ATP5IF1;ALAS2
prerank,quinone biosynthetic process (GO:1901663),-0.36906440584102684,-1.0327908001767274,0.41379310344827586,0.7313798702873664,1.0,5/14,12.22%,COQ8B;COQ5;COQ10A;COQ3;PDSS2
prerank,filopodium assembly (GO:0046847),0.5096551253870557,1.0326957777787868,0.43191196698762035,1.0,1.0,8/16,15.13%,SPEF1;FGD4;FGD1;SRGAP2;S1PR2;FGD6;EZR;VSTM5
prerank,regulation of protein-containing complex assembly (GO:0043254),0.4342336281601278,1.0326879960748585,0.44933469805527126,1.0,1.0,20/110,11.94%,HJURP;RB1;FNIP1;GSK3B;BMF;TRABD2B;IAPP;AJUBA;FAF1;SLF1;SPIDR;CDC42EP2;SH3GLB1;NCLN;ATF7IP;RIOK3;TPPP;TAL1;ABCA1;AIDA
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4609527746463452,1.032358428924609,0.43380614657210403,1.0,1.0,8/33,15.58%,KCNN4;PRNP;PTPN2;RAB29;IKBKG;EZR;RC3H1;PRKD2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.47096849121706624,1.032099747525873,0.4221954161640531,1.0,1.0,12/29,18.91%,ZC3H7A;DGCR8;AGO2;TUT7;PUM2;TUT4;SMAD3;HNRNPA2B1;ZC3H7B;METTL3;SMAD2;SPOUT1
prerank,brain development (GO:0007420),0.43045328084593304,1.0318849361333233,0.4566532258064516,1.0,1.0,19/136,13.37%,CENPF;PBX4;CDK5RAP2;PBX3;NFIB;MKKS;CXCR4;SOX6;GRHL2;NIPBL;DSCAML1;UTP3;PLXNB2;DHX37;NKX2-1;ATXN1;FBXW11;TMX2;NES
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.441859843028834,1.0317008613824332,0.46812957157784746,1.0,1.0,13/76,13.37%,SPAG5;PLK4;GPSM2;MYLK3;NUMA1;CDC42EP2;SORBS3;NCK1;NCK2;SYNPO2;BAIAP2L1;PRKCE;NES
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5023773503248292,1.0316258484729246,0.44176706827309237,1.0,1.0,5/18,10.34%,MIEF2;AURKA;MCU;DDHD1;MIEF1
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5380940790936658,1.031575267949207,0.44113263785394935,1.0,1.0,2/10,5.53%,TERF1;MAPT
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.5082130898971257,1.0311553505963118,0.4334705075445816,1.0,1.0,1/17,0.52%,DLGAP5
prerank,excitatory postsynaptic potential (GO:0060079),-0.33531518324903925,-1.0301717622451338,0.41700404858299595,0.7367227377786707,1.0,4/19,3.75%,MEF2C;GRIN2A;GRID2;GRIN2B
prerank,anion transmembrane transport (GO:0098656),-0.24622395002020603,-1.0299766492770677,0.38596491228070173,0.7360899023152568,1.0,22/67,19.08%,SLC16A12;SLC1A2;SLC13A3;SLC7A2;SLC13A4;SLC25A13;SFXN2;SLC25A12;SLC3A2;SLC7A5;SLC27A1;SLC5A6;LRRC8B;ABCC5;LRRC8D;SLC25A4;SLC35A2;SLC1A1;SLC38A5;SLC25A11;SLC25A38;LRRC8A
prerank,response to exogenous dsRNA (GO:0043330),0.488954793273893,1.029846716315887,0.4296875,1.0,1.0,3/18,4.75%,TICAM1;COLEC12;DHX9
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5017967939992121,1.02920484826859,0.4555112881806109,1.0,1.0,3/18,9.73%,FADD;IL18;HMGB1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.46452818495604997,1.0289524447189604,0.4168765743073048,1.0,1.0,2/26,4.03%,KNSTRN;GAREM1
prerank,positive regulation of proteolysis (GO:0045862),0.4525910351558075,1.0287604498193323,0.46564885496183206,1.0,1.0,12/55,13.76%,PLK1;FADD;FGFR4;SH3D19;SNX33;FBXW11;HDAC2;CASP8;ATP5IF1;CTSH;BTRC;ADAM9
prerank,phosphatidylinositol biosynthetic process (GO:0006661),-0.2171603435058026,-1.0286125606304701,0.3125,0.7382070163743412,1.0,43/119,21.48%,PIP4K2A;INPP4B;PIK3R3;PIP4K2B;SOCS2;PIK3C2B;PIK3R1;FGF2;PIK3R4;SLC27A1;EFR3A;RAB5A;DPM1;SOCS5;MTMR4;RUFY1;INPP5K;PIGV;PIP5K1A;ITPKB;PIGQ;BMX;INPP5D;SYNJ2;PIGB;PIGP;CDS1;PIK3R6;SYNJ1;PGAP2;PI4KA;SMG1;IMPA1;INPP4A;PIK3CD;TMEM150A;PIK3CA;PIGF;CDIPT;EFR3B;ITPKC;PIP4K2C;PIK3R2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.5072147728754649,1.028456420952669,0.45296671490593343,1.0,1.0,2/14,8.14%,IL18;CD80
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.45097815594482304,1.0281042302498014,0.44130925507900676,1.0,1.0,11/43,15.81%,ATOH8;TEAD1;KLF5;SRF;NFIB;FOXO3;SMARCA4;NR3C1;SMAD3;GNL3;TP53
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.426929129059813,1.0280387125624872,0.4521651560926485,1.0,1.0,33/138,16.92%,NR2E3;E2F2;MED26;TEAD1;E2F3;TAF3;TBL1XR1;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;NR4A2;NR3C1;TEAD3;TAF15;GTF2A1;HDAC1;TAF4;RBPJ;NR4A1;NOTCH2;RORA;MAML1;MED1;RARB;NRBP1;MED27;DR1;TAF10;TEAD4;CCN2
prerank,negative regulation of binding (GO:0051100),0.4408274505682359,1.0280299157690116,0.45881126173096975,1.0,1.0,22/81,19.67%,AURKB;DDX11;E2F1;BTAF1;AURKA;ARHGAP28;GSK3B;WAPL;LRRK2;ROCK1;PSME3IP1;ILRUN;MITD1;NES;PIN1;TFAP4;DNAJB2;SP100;STYX;ZFPM1;PRKCD;IFIT2
prerank,protein N-linked glycosylation (GO:0006487),0.43761398648249455,1.0278713698506379,0.4607329842931937,1.0,1.0,15/66,14.55%,ALG14;B4GALT1;ALG13;SRD5A3;MPDU1;B4GALT7;MAGT1;RPN2;SLC39A8;STT3A;STT3B;MAN1C1;ALG8;UBE2J1;ST3GAL1
prerank,positive regulation of histone deacetylation (GO:0031065),0.5183332157979862,1.0278548498972058,0.4316860465116279,1.0,1.0,5/12,15.58%,CTBP1;NIPBL;ZBTB7B;PRKD1;PRKD2
prerank,vesicle transport along microtubule (GO:0047496),0.48223831090575653,1.0274262278823172,0.4108040201005025,1.0,1.0,13/23,25.90%,TRAK1;NDE1;RAB1A;FBXW11;KIFAP3;FYCO1;DYNC1I1;DYNC1H1;KIF5A;KIF13A;HTT;PAFAH1B1;KIF1C
prerank,external encapsulating structure organization (GO:0045229),0.4319838174262042,1.0267481415702264,0.45991983967935873,1.0,1.0,46/205,14.99%,TGM1;MATN3;COL22A1;NID2;MMP24;MMP28;MMP25;MFAP2;LOX;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;SLC39A8;NID1;COL4A5;POSTN;ADAMTSL3;COL15A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;MFAP5;ITGA8;ITGAV
prerank,histone mRNA metabolic process (GO:0008334),0.4736232062586413,1.026608570137649,0.4304878048780488,1.0,1.0,6/27,8.22%,TENT2;SLBP;LSM11;ERI1;TUT1;TUT7
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.32613762524697865,-1.026172422217571,0.38317757009345793,0.7431753899781832,1.0,10/22,23.09%,OS9;RNF103;EDEM2;EDEM1;MAN1A2;SYVN1;UBB;RPS27A;UBC;SEL1L
prerank,ion homeostasis (GO:0050801),0.478997018876871,1.0261605653621058,0.45180722891566266,1.0,1.0,4/30,8.19%,RHAG;RANGRF;WNK1;SLC4A2
prerank,maturation of 5.8S rRNA (GO:0000460),0.50523657814918,1.0258560583843734,0.42649006622516555,1.0,1.0,7/17,21.16%,PRKDC;MPHOSPH6;MAK16;WDR12;NOL9;EXOSC10;URB1
prerank,positive regulation of heart rate (GO:0010460),-0.3514143289631028,-1.0257000168806227,0.39285714285714285,0.7431867433699382,1.0,9/17,26.99%,RYR2;TPM1;ADRA1A;PDE4D;KCNQ1;ADRA1B;EDN1;ADM;EDN3
prerank,RNA splicing (GO:0008380),0.43390781728017064,1.0254418634035753,0.4600409836065574,1.0,1.0,28/95,17.95%,SYNCRIP;SNRNP25;SRSF4;TRA2B;SRSF10;NRDE2;DDX39B;SRSF7;YJU2;FUS;DHX8;PPIG;PRPF3;NONO;SFPQ;SNRNP48;IVNS1ABP;SRPK1;SRRM1;SNRNP35;SF3B3;WBP4;LUC7L3;LSM4;PRPF4;PRPF18;SRPK2;PDCD7
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3167633992123281,-1.0251665849088016,0.398876404494382,0.7434015761538809,1.0,4/25,5.24%,STAT3;IFNAR1;STAT6;SOCS2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5121344396113405,1.0250455430351662,0.42796005706134094,1.0,1.0,2/13,5.47%,SRF;NFIB
prerank,hematopoietic stem cell proliferation (GO:0071425),0.509215448470878,1.024815038372355,0.43601190476190477,1.0,1.0,4/11,10.55%,ETV6;WNT2B;SFRP2;YTHDF2
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.5071399474005253,1.0247876172033248,0.4330935251798561,1.0,1.0,4/14,15.58%,KCNN4;RAB29;IKBKG;PRKD2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.46862629360493596,1.0245258655388856,0.44632086851628466,1.0,1.0,9/30,15.09%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;NPEPPS;UBL5
prerank,protein localization to vacuole (GO:0072665),-0.389771206865956,-1.0242804269878043,0.423841059602649,0.7443846121887765,1.0,7/13,23.17%,SH3BP4;SZT2;CD81;KPTN;MFSD1;LMBRD1;GLMP
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.34435022383516956,-1.0238664702958395,0.3702127659574468,0.7443477425451498,1.0,9/18,19.28%,RHOJ;FGF2;FOXC2;PTGS2;HDAC7;VEGFA;HDAC9;GATA2;FGFBP1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.49714460381529424,1.0235840349487608,0.42696629213483145,1.0,1.0,5/14,18.16%,ZEB1;XDH;SPRED1;SPRED2;OSR1
prerank,extracellular matrix organization (GO:0030198),0.42809878254601,1.0229988614991665,0.46,1.0,1.0,60/276,14.99%,BMP1;LOXL3;MATN3;COL22A1;HAS3;NID2;LOXL2;MMP24;MMP28;MMP25;MFAP2;LOX;SCUBE1;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;QSOX1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;HAS1;TLL2;TGFBR1;SLC39A8;NID1;COL4A5;COL12A1;P3H1;POSTN;ADAMTSL3;EXOC8;COL15A1;COL20A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;P3H4;MFAP5;CAPG;ITGA8;ITGAV
prerank,autophagy of mitochondrion (GO:0000422),-0.27778819419737333,-1.022932261704511,0.3618421052631579,0.745512195920227,1.0,14/38,19.95%,PRKN;FIS1;WDR45B;BECN1;SQSTM1;ULK1;BNIP3;PINK1;ATG9A;USP30;ATG2B;FBXO7;FUNDC1;GABARAPL2
prerank,positive regulation of developmental growth (GO:0048639),-0.2664691354026192,-1.0229296162419772,0.425531914893617,0.7444717980746074,1.0,8/49,4.79%,RUFY3;RIMS1;ITSN2;CDKL5;INSR;SYT1;AGRN;SEMA7A
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5397653605643824,1.022719601408656,0.44298245614035087,1.0,1.0,1/11,1.19%,SLC18A2
prerank,"phagocytosis, engulfment (GO:0006911)",0.4591824044735234,1.0221934851077827,0.45496535796766746,1.0,1.0,1/36,0.66%,XKR5
prerank,membrane lipid biosynthetic process (GO:0046467),-0.2546152909524346,-1.02155252588552,0.3888888888888889,0.7467112977673775,1.0,25/58,25.76%,CERT1;ELOVL7;SGMS2;HACD3;ACER2;PLPP3;HACD2;ALDH3A2;ACER3;HACD1;ST8SIA6;DEGS2;SPNS2;GBGT1;DEGS1;SCCPDH;ELOVL6;VAPB;CERS1;SPTSSA;SGPL1;ELOVL1;SPHK1;SPTSSB;KDSR
prerank,heterochromatin organization (GO:0070828),0.5066900700662988,1.021461377555468,0.4318181818181818,1.0,1.0,4/14,8.37%,LOXL2;SETDB2;HP1BP3;SMCHD1
prerank,cardiac muscle cell development (GO:0055013),0.48384495221816537,1.021304721423572,0.4421052631578947,1.0,1.0,7/20,15.70%,OBSL1;MYLK3;PDGFRA;SLC8A1;PDLIM5;HEY2;CSRP3
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.47558148763572633,1.0210510460360205,0.45103092783505155,1.0,1.0,5/23,15.51%,KIT;CENPJ;OCIAD2;CRLF3;OCIAD1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.489988605951946,1.0208398686047002,0.4436997319034853,1.0,1.0,4/18,14.41%,FGL1;WNK1;IL4I1;MIA3
prerank,regulation of cellular protein metabolic process (GO:0032268),0.44541491377963716,1.0207252730086818,0.44456886898096304,1.0,1.0,4/47,9.77%,UHRF1;EIF4E;FOXO3;AGT
prerank,protein-containing complex assembly (GO:0065003),0.4251293776280401,1.020679374319779,0.458,1.0,1.0,68/259,18.72%,KNTC1;FANCA;PLEKHA7;F5;KPNA3;FADD;TSPAN33;TEAD1;GSK3B;MDM4;FBXL7;DHX9;ADD2;TCF7L1;BLM;ZW10;AFDN;TCF7L2;PML;STOML2;LRRK2;MCU;DARS1;CUL3;SMARCA4;AXIN2;TRAPPC6B;LEO1;YAP1;PICALM;IKBKG;KMT2A;RAB1A;WDCP;RSPH9;CDC123;BOK;CAPZA1;HDAC1;F8;SCFD1;KMT2D;DMTN;CASP8;SEC24D;PPID;TRAPPC10;TLE4;GSDMD;EPRS1;CAPG;ANKRD28;TLE3;TRRAP;TP53;BET1;AMER1;FERMT3;TRAPPC9;TFAP4;SH3PXD2B;CSNK1A1;USO1;FANCC;BAD;TMED10;KIFAP3;RIPK1
prerank,regulation of biomineral tissue development (GO:0070167),0.46885818893266035,1.020523580810975,0.4416365824308063,1.0,1.0,8/26,15.97%,FBXO5;ROCK2;ROCK1;DDR2;ENPP1;TWIST1;HEY2;NOTUM
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.4245743045688105,-1.0196299615898181,0.4428969359331476,0.7501454456910993,1.0,2/10,1.79%,APOD;LRCH1
prerank,synaptic vesicle transport (GO:0048489),-0.39774187640924186,-1.0196154250653617,0.4275618374558304,0.7491223338270031,1.0,6/11,23.69%,SPG11;KIF5B;KIF5C;SYNJ1;RAB27A;TOR1A
prerank,cell-matrix adhesion (GO:0007160),0.42974671076893023,1.019602218726073,0.47196738022426094,1.0,1.0,21/95,16.89%,OTOA;NID2;HPSE;TRIP6;ITGB7;NPNT;SGCE;FBLN5;ADAMTS9;RAC1;MKLN1;ADAM9;ITGB1;CD44;ITGA8;ITGAV;SRC;RCC2;ITGB8;FERMT3;PTPRK
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.28708978386148865,-1.0190906870827405,0.4098360655737705,0.7493894021166119,1.0,13/35,19.32%,NRP2;SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;MET;FARP2;SEMA3B;SEMA3C;PLXNA4;SEMA5B;NRP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5068513839914845,1.0189328146292091,0.4429347826086957,1.0,1.0,3/16,7.29%,DDIAS;CDKN2D;SFRP2
prerank,regulation of response to oxidative stress (GO:1902882),-0.40704983505901954,-1.0187716057678247,0.42452830188679247,0.7490480801928551,1.0,4/11,12.40%,PRKN;MCTP1;SELENON;PINK1
prerank,detection of visible light (GO:0009584),0.4992339825906902,1.0187214921610164,0.4438356164383562,1.0,1.0,3/16,18.07%,ABCA4;GNAQ;CEP250
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.4958136369672968,1.0185004599882943,0.43714285714285717,1.0,1.0,5/14,14.72%,SMPDL3A;ENPP3;ITPA;ENPP1;AK7
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.4245639069654076,1.0184785381433454,0.425,1.0,1.0,213/1082,16.10%,BRCA1;CKAP2;E2F7;NR2E3;E2F8;UHRF1;ATAD2;E2F2;ATRX;MYBL1;PBX4;GLI2;CDK5RAP2;GLI3;RBL1;HMGB2;E2F1;BRCA2;FOXE1;ATOH8;HAS3;ILF3;NAT14;PSRC1;FADD;DYRK1A;SMARCC1;SP3;SETX;BMPR1A;PHIP;ELF2;ACTR3;TEAD1;WWOX;AGO2;CTCF;E2F3;FGFR2;SENP1;TFDP1;HNRNPD;BCL2L12;NFE2;GALR1;DDRGK1;MED14;AUTS2;CHEK2;RFXAP;RGMA;NFIA;HIVEP1;PCGF5;SSBP3;DHX9;PRKDC;NFIL3;KLF5;SRF;BLM;ELF4;ASXL1;NFIB;THRAP3;TBL1XR1;LPIN2;MLLT10;SETD3;NUP85;BMP6;PCBD2;HOXC4;YAF2;TCF7L2;MED30;ELOF1;ELF1;IL18;HOXA7;GRHL2;AKNA;ARRB1;PML;DDX39B;TCF4;ARID1A;MYBL2;GLIS3;TASP1;CHEK1;SFRP2;ELK1;PPP3CA;CCN1;POU2F1;POU3F2;FHL5;WWTR1;SERPINE1;FOXO3;ATF7IP;CD80;TRIM28;LMX1B;PELP1;IRF1;ZFP64;BCLAF1;CREB5;MED24;RHOQ;SMARCA4;USP21;USP16;ZFP90;NCK1;DNM2;HOXB3;YAP1;NFYA;VHL;PLAGL1;PICALM;EPC1;HMGB1;AGT;IKBKG;KMT2A;HDAC8;MEOX2;NR4A2;NR3C1;SCAF8;PARP9;SFPQ;TGFBR1;HNRNPU;TAL1;MMS19;CRLF3;TAF15;EIF2AK3;NCOA2;QRICH1;HDAC1;BMP2;AHR;NKX2-1;MRTFA;NFATC2IP;FBXW11;AKIRIN2;NCK2;SLC30A9;RBPJ;NR4A1;KMT2D;SMAD4;HDAC2;ATF5;IL31RA;ZNF496;ILF2;BRD4;TCF20;ELK4;RAI1;LRP5;RORA;IL4I1;NCOA7;TWIST1;MAML1;HEY2;PPRC1;PRKD1;MED1;ARF4;BTRC;RARB;POU2F2;YY1;RLF;FOXK2;RUVBL2;FOXM1;SMAD3;ARNT;CDK8;SOX1;E2F4;RPTOR;PER1;PIN1;INO80;DR1;GDNF;ATF1;KAT6A;ZNF507;HOXB7;PRKD2;PKD2;BICRA;CSRP3;NFKB1;TP53;FHOD1;CDCA4;BRD8;SFRP1;DRAP1
prerank,regulation of presynapse organization (GO:0099174),-0.35096233966789003,-1.0184635235388728,0.4061302681992337,0.7477672097293586,1.0,6/18,15.66%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,regulation of presynapse assembly (GO:1905606),-0.35096233966789003,-1.0184635235388728,0.4061302681992337,0.7477672097293586,1.0,6/18,15.66%,PTPRD;IL1RAPL1;EIF4G1;APP;SLITRK1;LRRC4B
prerank,motor neuron axon guidance (GO:0008045),0.5026085921569332,1.018395627588582,0.44022503516174405,1.0,1.0,4/15,11.74%,NTN1;NTN3;EPHA4;RAC1
prerank,cellular glucose homeostasis (GO:0001678),-0.2786510662202666,-1.0182500887452026,0.4444444444444444,0.7472921902231289,1.0,15/41,21.90%,UNC13B;FOXO1;KCNB1;GAS6;PIK3R1;PRKAA1;SOX4;HK1;ADCY8;LRRC8D;XBP1;LRRC8A;PPARGC1A;PIK3R2;RACK1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.5105709351089421,1.0179927350324596,0.43768115942028984,1.0,1.0,4/13,12.81%,ECHDC3;ERFE;ZBTB7B;GKAP1
prerank,regulation of cellular component movement (GO:0051270),0.4484585791681504,1.0173144811421393,0.46051167964404893,1.0,1.0,12/49,12.38%,ROCK2;RHOA;ACTN4;MEMO1;MYCBP2;DIAPH1;ARHGAP18;PDPN;TGFBR3;ROCK1;TGFBR1;ADAM17
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.48520935431625817,1.0173076845643954,0.46954314720812185,1.0,1.0,7/21,16.84%,BMPR1A;BMP6;WWTR1;TGFBR1;CCN3;SMAD4;VEPH1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.48320490458817794,1.017221416094796,0.43943298969072164,1.0,1.0,6/21,13.42%,ROCK2;BCOR;ROCK1;ENPP1;TRPM4;HEY2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.49723126248300187,1.0172021723939968,0.4256480218281037,1.0,1.0,6/19,12.32%,BMPR1A;FGFR2;TGFBR3;PIM1;TGFBR1;RBPJ
prerank,cellular calcium ion homeostasis (GO:0006874),-0.20863610698095353,-1.0170500006942245,0.5,0.7491222930252086,1.0,29/133,16.64%,CAMK2D;PSEN1;SLC8A3;ATP1B1;TRPC5;CAV1;RYR2;ANXA6;PACS2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;TRPC3;TRPC1;CHRNA7;BCL2;HCRTR2;CAV2;TMCO1;SLC30A1;ADCY8;ATP2B2;ATP2B3;SMDT1;HTR2A;PTH1R;RMDN3
prerank,macromolecule catabolic process (GO:0009057),-0.31537764802859836,-1.0169142143869068,0.39896373056994816,0.7484423722073998,1.0,8/26,10.95%,KIF16B;CLPX;BECN1;PIK3R4;LGMN;TPP1;SIAH1;MTOR
prerank,regulation of cell adhesion (GO:0030155),0.42946429696811467,1.016492341290225,0.4808080808080808,1.0,1.0,24/129,15.58%,KIF14;ROCK2;HYAL1;PDE3B;CXCR4;IL18;EFNA1;PLAU;PPP3CA;EPHA4;RIPOR2;RSU1;ANGPT1;ROCK1;YTHDF2;PLXNB2;PLXNB1;DSCAM;PRKCA;PLXND1;MIA3;ITGAV;SRC;PRKD2
prerank,"phototransduction, visible light (GO:0007603)",0.5063014194025794,1.0161129780557157,0.4401114206128134,1.0,1.0,2/14,8.66%,ABCA4;GNAQ
prerank,sphingolipid metabolic process (GO:0006665),-0.24215920958606096,-1.0146747670039686,0.3333333333333333,0.7526087241896742,1.0,39/108,23.94%,CERT1;ELOVL7;HEXB;SGMS2;HACD3;ACER2;PLPP3;HACD2;PSAP;ASAH1;ALDH3A2;ST6GALNAC3;ACER3;ESYT1;B3GALNT1;HACD1;HEXA;SERINC1;DEGS2;SPNS2;ARV1;GLTP;CTSA;ASAH2;DEGS1;GAL3ST1;ELOVL6;PPT1;VAPB;CERS1;GBA2;SPTSSA;SGPL1;ABCA2;ELOVL1;ESYT3;PLA2G15;SPHK1;NEU1
prerank,stabilization of membrane potential (GO:0030322),0.49418960969954634,1.0138541356681678,0.4528301886792453,1.0,1.0,4/16,12.52%,KCNN4;KCNK2;KCNK12;KCNK6
prerank,negative regulation of MAP kinase activity (GO:0043407),-0.27001532934875594,-1.0131021784344807,0.4153846153846154,0.7554737429446517,1.0,16/44,24.49%,APOE;PDCD4;LYN;DNAJA1;PTPN22;STK38;NF1;INPP5K;SPRY2;DUSP1;SORL1;UCHL1;CDK5RAP3;BMP7;CD300A;MAPK8IP1
prerank,cellular response to misfolded protein (GO:0071218),-0.3371961204858538,-1.0130108269802371,0.3991228070175439,0.7546274260462464,1.0,10/20,23.69%,ATXN3;UFD1;DERL1;STUB1;DNAJC18;POMT2;AUP1;DNAJB12;UBE2W;TOR1A
prerank,mesenchyme development (GO:0060485),0.50209465772648,1.0128435438792256,0.4535211267605634,1.0,1.0,5/15,15.58%,FGFR2;SFRP2;TGFBR1;BMP2;PKD2
prerank,secondary palate development (GO:0062009),-0.37023063901442854,-1.0126678080579372,0.42391304347826086,0.7543978385596235,1.0,3/14,4.12%,LEF1;TGFBR2;TGFB2
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.4028554735689477,-1.012532610885648,0.456973293768546,0.7537153122675851,1.0,7/11,30.23%,PARN;DKC1;TENT4B;EXOSC2;EXOSC3;EXOSC5;FBL
prerank,response to unfolded protein (GO:0006986),-0.25154499953133563,-1.0124172358351322,0.39316239316239315,0.7529560094312748,1.0,12/48,18.18%,PRKN;HSP90AB1;DNAJA1;HSPH1;HSPD1;DERL1;HSPA4L;HSPA5;PACRG;DDIT3;TM7SF3;HSPB8
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.27271182913237885,-1.011964846216739,0.41843971631205673,0.7529558509425897,1.0,11/35,18.01%,SGIP1;VTN;BICD1;B2M;HNRNPK;SMAP1;LDLRAP1;BMP2K;HIP1;CBL;PPT1
prerank,axonal transport of mitochondrion (GO:0019896),0.5171135130794513,1.0116950413364918,0.4603658536585366,1.0,1.0,2/11,5.53%,TRAK1;MAPT
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.5065169602089288,1.0114472261707037,0.4292168674698795,1.0,1.0,3/11,13.46%,ARRB1;GRK3;ADRB2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.44845914991719926,1.0113628567419748,0.47513812154696133,1.0,1.0,16/52,18.32%,E2F1;SAE1;TFDP1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;CSNK2A2;CASP8;NPEPPS;UBL5;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.4049325074499363,-1.0111163853201055,0.4476744186046512,0.7538828552625668,1.0,4/10,24.36%,GAS6;LYN;LGALS9;CXCL12
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.5002765340382528,1.0110819142199634,0.45080763582966227,1.0,1.0,6/12,20.59%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,actin filament-based transport (GO:0099515),0.4644167994062651,1.0109167961058823,0.4263157894736842,1.0,1.0,3/21,5.73%,SYNE2;ACTN4;MYO1C
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3411654609460891,-1.010876290998773,0.4,0.7534279723814503,1.0,8/18,23.09%,OS9;RNF103;EDEM2;SYVN1;UBB;RPS27A;UBC;SEL1L
prerank,mitochondrion localization (GO:0051646),0.48320727979673034,1.0104899140060057,0.4667590027700831,1.0,1.0,5/19,15.74%,TRAK1;LRRK2;MFN2;MARK2;MFN1
prerank,RNA 3'-end processing (GO:0031123),0.42726867439717237,1.0100223094333924,0.4616998950682057,1.0,1.0,17/69,13.45%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;DDX39B;TENT4A;SRSF7;TUT1;TUT7;WDR33;PCF11;SRSF3;SRRM1;CPSF4;RPRD1A;TUT4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.30782956149011625,-1.0100063539354536,0.41919191919191917,0.7545248352761693,1.0,11/27,21.40%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4769255444476727,1.009747345554133,0.4448669201520912,1.0,1.0,8/23,16.13%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;MTMR3;PTEN
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.38085898464549195,-1.0096925969101367,0.4230769230769231,0.7542715600799621,1.0,4/12,6.94%,HSP90AB1;B4GALT5;EPHB2;B4GALT6
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.4396403501049304,1.0096905742057902,0.47240618101545256,1.0,1.0,6/45,12.59%,TTK;BMPR1A;BMP6;TGFBR1;BMP2;SMAD4
prerank,inositol phosphate metabolic process (GO:0043647),-0.2603549911894153,-1.0096712367259348,0.46846846846846846,0.7532718757639031,1.0,17/46,20.66%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;FGF2;PLCG1;NUDT3;INPP1;ITPKB;INPP5D;SYNJ1;PLCE1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,positive regulation of cyclase activity (GO:0031281),-0.3717364427838785,-1.0093161683232315,0.4326241134751773,0.7530493496152693,1.0,4/14,9.92%,MAPK8;NOS3;NF1;MAPK3
prerank,steroid catabolic process (GO:0006706),-0.41448976040660374,-1.0091864521298692,0.42771084337349397,0.7523299438961958,1.0,4/10,34.54%,HSD17B11;SPP1;YWHAH;HSD11B1
prerank,regulation of wound healing (GO:0061041),-0.2745858382160399,-1.0091134661714034,0.42105263157894735,0.7514641729423441,1.0,7/42,5.67%,PTK2;OCLN;CAV1;VTN;EPHB2;MYLK;FGF2
prerank,megakaryocyte differentiation (GO:0030219),0.5188894179005418,1.009003896826021,0.45021645021645024,1.0,1.0,4/11,19.40%,KIT;TAL1;MED1;ZFPM1
prerank,cellular response to glucose stimulus (GO:0071333),-0.29079838469154623,-1.0087979638519076,0.41847826086956524,0.751207411799131,1.0,8/30,16.81%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;RAB11FIP2;ADCY8;XBP1
prerank,activation of GTPase activity (GO:0090630),0.4249778868594305,1.0087137980138878,0.4757481940144479,1.0,1.0,12/89,9.92%,ECT2;ARHGAP22;USP6NL;EVI5L;TBC1D25;TBC1D13;TBC1D2B;SCRIB;ARHGAP24;SYDE2;TBC1D7;RANGAP1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4246873682669378,1.008177115510053,0.47594142259414224,1.0,1.0,11/86,12.62%,KIF14;DENND4C;MFN2;KANK2;EPS8L1;MAPKAP1;MYO9B;CRKL;ARHGEF18;DENND1A;NOTCH2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4864093032400863,1.0080996154490887,0.44047619047619047,1.0,1.0,6/19,19.02%,MTHFD1L;MTHFR;SLC19A1;DHFR;GGH;MTHFS
prerank,ganglioside metabolic process (GO:0001573),-0.33777238221766454,-1.007128958426898,0.4262295081967213,0.7540485090521725,1.0,6/20,10.93%,ST8SIA4;HEXB;ST6GALNAC3;ST6GALNAC5;HEXA;ST8SIA6
prerank,mRNA splice site selection (GO:0006376),0.4602090429494572,1.0070807177321435,0.4544334975369458,1.0,1.0,10/30,19.68%,SETX;SRSF10;PSIP1;CELF2;SF3A2;LUC7L3;PRPF39;SFSWAP;LUC7L2;SF3A3
prerank,regulation of water loss via skin (GO:0033561),0.48907764976693213,1.0070729872029376,0.43724137931034485,1.0,1.0,1/15,1.85%,STMN1
prerank,establishment of skin barrier (GO:0061436),0.48907764976693213,1.0070729872029376,0.43724137931034485,1.0,1.0,1/15,1.85%,STMN1
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.3064232532379981,-1.0068175240307629,0.4166666666666667,0.7537068510636445,1.0,7/24,18.60%,PDE3A;PEX5L;GNAI1;PRKAR1B;UBE2B;PDE2A;PDE4D
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5029209213440352,1.0064823602706197,0.43216783216783217,1.0,1.0,5/14,17.31%,ATP2B4;PKIG;ADRB2;PRKAR2B;PRKAR2A
prerank,ncRNA metabolic process (GO:0034660),0.450404842430435,1.0063501448749015,0.4689655172413793,1.0,1.0,6/37,8.22%,DGCR8;AGO2;MAPT;MAEL;EXD1;TUT7
prerank,positive regulation of transport (GO:0051050),0.42125135879874415,1.0059766256063734,0.4848800834202294,1.0,1.0,10/85,11.46%,SPAG5;PON1;GSK3B;ANXA2;NUMA1;FMR1;KMT2A;CAMK1D;BOK;ANXA1
prerank,negative regulation of biosynthetic process (GO:0009890),0.4938309248067383,1.00507264043018,0.4491180461329715,1.0,1.0,1/16,1.19%,SLC18A2
prerank,ESCRT III complex disassembly (GO:1904903),-0.4118724977265424,-1.0044529114069922,0.4644808743169399,0.7574858926531376,1.0,6/10,27.23%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,ESCRT complex disassembly (GO:1904896),-0.4118724977265424,-1.0044529114069922,0.4644808743169399,0.7574858926531376,1.0,6/10,27.23%,VPS4B;CHMP2B;CHMP5;CHMP1A;CHMP2A;CHMP7
prerank,cellular component disassembly (GO:0022411),0.4341547326975942,1.0040551369268236,0.46711259754738016,1.0,1.0,11/53,17.51%,BMP1;SCUBE1;MMP14;DYRK3;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,sulfur compound catabolic process (GO:0044273),-0.27618140505810407,-1.003997206600036,0.464,0.7576290447416806,1.0,12/38,16.96%,GNS;FMOD;HEXB;GGT5;PRELP;TXN2;HEXA;OGN;LUM;IDS;NUDT7;GALNS
prerank,ceramide transport (GO:0035627),-0.390001165356777,-1.0036401580728218,0.440625,0.7575409225735215,1.0,6/12,23.08%,CERT1;PLTP;PSAP;GLTP;PLEKHA8;ABCA2
prerank,organophosphate ester transport (GO:0015748),-0.3096722708669874,-1.0033855608562936,0.4393939393939394,0.7570710800201448,1.0,11/24,25.83%,PLTP;SCP2;MTTP;TNFAIP8L3;PRELID3B;OSBPL2;NPC2;PITPNC1;PRELID3A;PRELID1;ABCA3
prerank,retinol metabolic process (GO:0042572),0.4970121366152017,1.0027327440066032,0.4581005586592179,1.0,1.0,2/14,5.88%,RDH11;RDH12
prerank,B cell mediated immunity (GO:0019724),-0.4010467143107977,-1.0027237808507163,0.4319526627218935,0.7576072839719684,1.0,4/10,38.41%,MSH2;CD74;FCER1G;FCGR2B
prerank,establishment of epithelial cell polarity (GO:0090162),0.47875421505503524,1.002656384130727,0.464524765729585,1.0,1.0,10/19,26.18%,RHOA;RAP2A;CYTH3;EZR;MSN;CLASP1;SIPA1L3;GOLPH3;CYTH1;CDC42
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.3535727440850066,-1.001729776086624,0.41365461847389556,0.7590548695926623,1.0,4/17,9.01%,CPEB3;CPSF6;CCNT1;CPSF7
prerank,ganglioside biosynthetic process (GO:0001574),-0.36176074496594507,-1.0012749229660038,0.43097643097643096,0.7591299898371892,1.0,6/15,10.93%,ST8SIA4;B4GALT5;B4GALT6;ST6GALNAC3;ST6GALNAC5;ST8SIA6
prerank,response to gamma radiation (GO:0010332),0.4711356465548658,1.0003861851070368,0.4585427135678392,1.0,1.0,3/24,9.17%,FANCD2;MAP3K20;YAP1
prerank,synapse organization (GO:0050808),-0.22807967348384597,-1.000353197003228,0.5,0.7602843798918848,1.0,17/125,4.75%,DNM3;UNC13B;CTNND2;PTPRD;PSEN1;CDH2;SLC8A3;DNER;SLC6A1;SHANK3;ARHGAP39;PAK3;SPOCK2;ADGRL3;NRCAM;AGRN;SDK2
prerank,glucose metabolic process (GO:0006006),-0.25689471888549303,-1.0000903171107154,0.4358974358974359,0.7598834071194914,1.0,22/58,25.05%,APOD;PER2;GOT2;SLC25A13;SLC25A12;IRS2;MDH1;OMA1;MDH2;PGK1;GOT1;ENO1;PGAM1;SLC25A11;CRTC2;PPARGC1A;GAPDH;ALDOC;TPI1;GALM;BRAT1;ALDOA
prerank,translation (GO:0006412),-0.25411755120516777,-1.0,1.0,0.7570787164567495,1.0,89/208,21.67%,EEF1A1;RPL13;FARSB;RPS8;RPS23;RPS29;RPL37A;RPS21;LARS2;RPL38;RPS11;RPL21;RPL35A;RPL17;RPL23;RPL3;RPS15;EIF4G1;EEF2;RPS7;RPS20;RPL18A;RPS6;RPS18;RPL14;AARS1;RPLP1;RPS13;RARS1;RPL9;RPL37;MRRF;RPL8;FARSA;RPS14;RPSA;RPL10;RPL18;RPL32;RPS28;RPS5;RPS24;RPL15;RPS19;RPL39;SARS1;RWDD1;RPL12;RPL27;RPL24;MRPS5;RPS12;RPS4X;RPS27;RPL27A;RPS9;N6AMT1;WARS1;MRPS18A;MRPS15;RPL30;EEF1B2;MRPS21;MRPS6;RPL19;RPL28;MRPL27;RPL31;RPL13A;RPL36A;TARS1;NARS1;RPLP2;RPL29;HBS1L;MRPL23;DHPS;KARS1;MRPL9;TNIP1;RPLP0;RPL10A;RPS6KB2;TSFM;RPS10;RPL35;RPS26;MRPL51;TMA7
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.34001275128643105,-1.0,1.0,0.7570787164567495,1.0,68/224,17.59%,GRM7;UNC13B;GRIK1;DLGAP1;GABRB1;GABRB3;SLC1A2;CHRM2;GRIN2A;GABRA2;SLC6A1;GRM3;SPG11;ATXN3;CALM1;AMPH;APBA1;GLRB;SYN2;SYT1;GLRA1;GRIN2B;PTCHD1;KCNQ3;HOMER1;GRIK4;RPS6KA2;CAMK4;GABRA3;HTR2C;PLP1;GLRA3;NRXN1;CACNA1B;CAMK1;PRKACB;MINK1;GABRA5;GIPC1;CHRNA7;CHRFAM7A;GABRB2;HCRTR2;GRIA1;PRKAR1B;GABRG2;MAPK1;SYNJ2BP;HTR4;CAMKK2;GRM5;CACNB2;DLG4;SDCBP;GRM1;GRIN1;GABRG1;CPLX1;DTNA;CHRM3;SLC1A1;LRP6;HTR2A;SNAP25;CACNB1;GRIA2;SYT10;SYPL1
prerank,central nervous system development (GO:0007417),-0.2114594041018908,-1.0,1.0,0.7570787164567495,1.0,82/250,22.75%,PRKN;STAT3;APOD;GRIK1;SPOCK1;CHD8;CDH2;SLC8A3;DNER;GRIN2A;EML1;MEIS2;SLC2A1;MAL;ELP3;CNTN6;TGFBR2;ADGRL3;SHROOM4;NRCAM;GRIN2B;DHX30;PTPRZ1;PROX1;POU6F1;SH3GL1;SNTG2;TBX3;CNTNAP2;ALDH3A2;MEIS1;COX7B;RNF103;TPP1;PBX1;NF1;RELN;NHEJ1;SZT2;MARCKS;TBC1D23;GSN;PBX2;GLIS2;SOX4;PTCH1;PTPN11;GRIN1;SYNJ2;ALDH5A1;DCX;ZFHX2;NDUFS4;ROBO2;SERPINI1;SYNJ1;IER3IP1;PTS;PCDH18;NDRG4;ADGRG1;SMARCA1;PPT1;DDIT4;AHI1;POU6F2;ATP6AP2;AATK;S100B;GBA2;EIF2B2;ADGRL2;NNAT;TAGLN3;CLN5;ZIC3;BPTF;ADAM22;RPS6KA6;CDK5RAP3;PAFAH1B2;TUBGCP2
prerank,prostanoid biosynthetic process (GO:0046457),-0.3545392098264908,-0.9997233004707667,0.4563758389261745,0.7567647157436828,1.0,4/15,12.36%,PLA2G4A;PTGDS;PNPLA8;PTGS2
prerank,amide transport (GO:0042886),-0.31076017022227836,-0.9996137771633694,0.4739583333333333,0.7560356378034773,1.0,10/26,20.04%,CERT1;PLTP;SLC27A1;ABCG2;SLC5A6;GLTP;AQP11;SLC38A5;TAP2;DISP1
prerank,response to amino acid starvation (GO:1990928),-0.23646780564670872,-0.9996023117496948,0.4838709677419355,0.7550583718378078,1.0,21/72,15.13%,ATP6V0D1;MAPK8;ATP6V1E1;ATP6V0B;MIOS;SESN3;WDR59;MAP3K5;FAS;RNF152;GCN1;SZT2;MAPK3;MTOR;MAPK1;ATP6V0C;KPTN;CEBPB;ATP6V1H;RRAGC;DAPL1
prerank,GTP metabolic process (GO:0046039),0.4866490571494758,0.9992934212490852,0.4630969609261939,1.0,1.0,5/15,15.74%,EFL1;LRRK2;RHOQ;GNAI3;MFN1
prerank,regulation of trophoblast cell migration (GO:1901163),0.49782731997090207,0.9992267919413327,0.45331529093369416,1.0,1.0,3/14,12.35%,AGO2;SMURF2;GJA1
prerank,positive regulation of cholesterol transport (GO:0032376),0.45764930299407586,0.9989339245736475,0.4608695652173913,1.0,1.0,2/27,4.57%,PON1;ABCB4
prerank,cellular response to oxygen levels (GO:0071453),-0.40898191432116004,-0.9987873823407798,0.48936170212765956,0.756054621379908,1.0,5/10,27.83%,ATP6V0D1;CPEB4;PICK1;ATP6AP1;TMEM199
prerank,regulation of Rho protein signal transduction (GO:0035023),0.43208479431773694,0.9984298707477346,0.47468354430379744,1.0,1.0,15/72,11.77%,STMN1;RTN4R;LPAR1;NET1;ARRB1;CUL3;RIPOR2;ROBO1;KANK2;EPS8L1;MYO9B;ARHGAP35;ARHGEF18;RAC1;ABCA1
prerank,toxin transport (GO:1901998),0.5159261741722239,0.9979893727430035,0.45671641791044776,1.0,1.0,3/10,17.19%,ANTXR2;RAB29;ANTXR1
prerank,cardiac myofibril assembly (GO:0055003),0.4792018754699072,0.997881536369492,0.47455295735900965,1.0,1.0,3/15,7.01%,OBSL1;MYLK3;PDGFRA
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.310798791689579,-0.9975074742112929,0.37089201877934275,0.7580781344083535,1.0,8/24,19.53%,NBL1;ANO6;LYN;LGMN;SLIT2;DUSP1;PLA2G7;CREB3
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.4752751514047453,0.997417525735412,0.4702702702702703,1.0,1.0,4/18,9.54%,ROCK2;EFNA1;EPHA4;PICALM
prerank,central nervous system neuron development (GO:0021954),-0.36045041102570685,-0.9971424554707038,0.4580152671755725,0.757956887901025,1.0,4/15,6.94%,HSP90AB1;NTRK2;B4GALT5;B4GALT6
prerank,negative regulation of MAPK cascade (GO:0043409),-0.23254086474880914,-0.9968321722647456,0.5476190476190477,0.7576693318269607,1.0,33/87,28.16%,FOXO1;SEMA6A;TIMP3;CAV1;APOE;TLR4;WNK2;EPHB2;IGBP1;DUSP3;LYN;STK38;NF1;INPP5K;LMO3;SYNJ2BP;SPRY2;DUSP1;ITGB1BP1;SORL1;PPEF2;TNIP1;UCHL1;PIK3R2;RPS6KA6;CDK5RAP3;BMP7;CD300A;P2RX7;GPER1;DAG1;IRAK3;DUSP6
prerank,ephrin receptor signaling pathway (GO:0048013),-0.2316664165705488,-0.9967488788228088,0.4864864864864865,0.7568650699050121,1.0,27/82,19.18%,PTK2;EPHA5;PSEN1;PAK3;TIAM1;ACTB;VAV3;GRIN2B;AP2A2;EPHB2;NCSTN;LYN;DNM1;PAK1;AP2M1;MMP2;PTPN11;SDCBP;AP2S1;EPHA8;GRIN1;AP2A1;ARHGEF7;PSEN2;ARPC5;GIT1;EFNB3
prerank,regulation of defense response to virus (GO:0050688),0.506162312161917,0.9965471272125512,0.4646892655367232,1.0,1.0,6/14,23.18%,DHX9;ILRUN;ITCH;RNF216;ELMOD2;PCBP2
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2637833165998664,-0.9950983568042197,0.4369747899159664,0.7598534408571863,1.0,8/46,8.37%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,positive regulation of cell migration (GO:0030335),0.41800599874192435,0.9950231766817711,0.504,1.0,1.0,48/253,15.61%,KIF20B;ARHGEF39;GTSE1;FBXO5;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;HYAL1;CEP43;AGO2;MMP14;DDRGK1;ACTN4;LAMB1;KIT;SPAG9;CCAR1;PDPN;MYO1C;ENPP2;PDGFRA;PLAU;PPP3CA;CCN1;NIPBL;DDR2;TGFBR1;GAB1;SMURF2;CRKL;BMP2;PRKCA;ADAM17;DMTN;CTSH;PRKCE;DOCK1;ADAM9;INSL3;ITGB1;MIA3;SEMA3D;SRC;ELP6;RHOC;SUN2
prerank,bone development (GO:0060348),0.4386134524449611,0.9948994976680864,0.47011494252873565,1.0,1.0,13/39,20.37%,CYP26B1;FGFR2;SULF2;SLC10A7;SULF1;P3H1;GJA1;LRP5;TP53;NOTUM;SH3PXD2B;SKI;RANBP3L
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4677037377162453,0.9944947745083713,0.48635235732009924,1.0,1.0,7/25,14.42%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,cellular response to osmotic stress (GO:0071470),0.4558230312089238,0.9944698310416705,0.46573604060913704,1.0,1.0,8/21,18.15%,AQP1;YBX3;CAB39;PKD2;STK39;WNK3;TRPV4;OXSR1
prerank,regulation of rRNA processing (GO:2000232),-0.352957784594079,-0.9944599562253009,0.4728682170542636,0.7603739069412612,1.0,10/16,35.75%,USP36;HEATR1;WDR75;KAT2B;BUD23;RIOK2;DIMT1;RIOK1;TRMT112;SIRT7
prerank,neuron cell-cell adhesion (GO:0007158),-0.36605218794537664,-0.9944334982134047,0.4664310954063604,0.759423943515259,1.0,4/14,7.62%,ASTN2;NRXN3;NCAM2;NRXN1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4363214602302717,0.9943369024097073,0.4882154882154882,1.0,1.0,16/50,19.35%,AQP1;CDKN2D;FNIP1;BCL2L12;SIAH2;ARL6IP1;SH3RF1;PLAUR;USP47;XIAP;CD44;SRC;NGF;LAMTOR5;DPEP1;DNAJB6
prerank,immunoglobulin mediated immune response (GO:0016064),-0.40299994073192824,-0.994193221276699,0.471976401179941,0.7589753515055447,1.0,4/10,38.41%,CD81;CD74;FCER1G;FCGR2B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.33728124813426347,-0.9939949961362098,0.44813278008298757,0.7584735916309583,1.0,8/19,20.38%,EP300;CDIP1;HIPK2;MSH2;DYRK2;DDIT4;SNW1;BCL3
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3518182982045664,-0.9938852892170486,0.4312977099236641,0.7577673465299101,1.0,6/15,22.18%,GNAL;BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3003221138173977,-0.993556005165292,0.4714285714285714,0.7575982525137446,1.0,5/27,5.66%,CAMK2D;CTNNA3;CAV1;RYR2;FGF13
prerank,calcium ion homeostasis (GO:0055074),-0.2219521850242459,-0.9934332147821247,0.5161290322580645,0.7568769644969049,1.0,21/95,16.64%,TMTC2;SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;FAM20A;CHRNA7;SELENON;TMCO1;SLC30A1;GRIN1;ATP2B2;ATP2B3;HTR2A;PTH1R;RMDN3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.49511483690843505,0.993253181535473,0.46589259796806964,1.0,1.0,5/13,17.14%,DHX9;AGPAT2;AGPAT1;AXL;MAVS
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.5190310940974802,0.9928017763043641,0.4673748103186646,1.0,1.0,1/10,2.44%,ADGRV1
prerank,actin cytoskeleton reorganization (GO:0031532),0.4302715775339758,0.9926394850938228,0.48936170212765956,1.0,1.0,27/63,22.87%,RHOA;PARVA;AUTS2;KIT;PDLIM4;RAP2A;NRK;CDC42BPA;PHACTR1;MCU;CDC42BPG;S1PR2;GAB1;EZR;ANXA1;DMTN;MKLN1;SIPA1L1;ANTXR1;TRPV4;PTPN1;SYDE1;WHAMM;FER;FLNA;CXADR;MYH9
prerank,B cell proliferation (GO:0042100),-0.3413241802584658,-0.9924583344931254,0.4115384615384615,0.7583156616459213,1.0,7/17,32.88%,MEF2C;HSPD1;BCL2;CD180;CD40;PTPRC;CR2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.4149255123859863,0.9923600531711895,0.5171026156941649,1.0,1.0,35/166,15.15%,NR2E3;E2F2;NAT14;MED26;TEAD1;E2F3;POLR1A;TAF3;TBL1XR1;POLR1B;ERCC3;TAF12;POLR2A;WWTR1;NR2C2AP;YAP1;TAF1D;NR4A2;NR3C1;TEAD3;TAF15;GTF2A1;HDAC1;TAF4;RBPJ;NR4A1;NOTCH2;POLR1G;RORA;MAML1;MED1;RARB;NRBP1;TFB1M;MED27
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.46076246317850683,0.9922190995618201,0.4580801944106926,1.0,1.0,9/25,19.65%,CEP97;EVI5L;ARHGAP24;YAP1;TBC1D7;ODF2L;LIMK2;PRKCD;PLXNB3
prerank,regulation of insulin secretion (GO:0050796),-0.22808073338332735,-0.9921547051051218,0.4782608695652174,0.7580430249763599,1.0,27/101,21.39%,PRKN;EPHA5;MYRIP;SLC2A1;KCNC2;PER2;RAP1A;KCNB1;IRS2;ACSL4;SYT7;HADH;KCNS3;IRS1;SOX4;MIDN;SNAP25;UQCC2;ADRA2A;PICK1;TM7SF3;LRRC8A;CACNA2D2;EFNA5;RAPGEF3;NNAT;GLUD1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.4801246690001362,0.991847505493149,0.47101449275362317,1.0,1.0,5/15,22.47%,NR3C1;HNRNPU;ANXA1;UBE2L3;ZFP36L1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.49410741573626105,0.9917336297049603,0.4896265560165975,1.0,1.0,4/14,18.15%,WNK1;ADAM17;STK39;OXSR1
prerank,actin filament bundle organization (GO:0061572),0.44579806598758775,0.9916644395006865,0.46581691772885286,1.0,1.0,13/33,22.65%,ADD2;RFLNA;CORO1B;EZR;DMTN;DPYSL3;BAIAP2L1;ADD1;LCP1;SHROOM2;SHROOM1;PLS1;MYO1B
prerank,extracellular structure organization (GO:0043062),0.41728280009040014,0.9914450526323022,0.5250501002004008,1.0,1.0,46/204,14.99%,MATN3;COL22A1;NID2;MMP24;MMP28;MMP25;MFAP2;LOX;COL4A6;FBN1;MMP14;ADAM12;COL4A4;ITGB7;LAMB1;COL18A1;COL5A2;NPNT;ADAMTS10;ADAMTS5;COL23A1;ADAMTS14;FBLN5;SERPINE1;ADAMTS9;ADAMTSL2;ELN;ADAMTS2;ADAMTS16;DDR2;TGFBR1;SLC39A8;NID1;COL4A5;POSTN;ADAMTSL3;COL15A1;BGN;ADAM19;ADAMTS1;ITGA5;ITGB1;CD44;MFAP5;ITGA8;ITGAV
prerank,fatty acid transmembrane transport (GO:1902001),-0.34744020513080276,-0.9910979544926477,0.48,0.7596337138806796,1.0,6/19,19.08%,SLC2A1;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2
prerank,positive regulation of protein polymerization (GO:0032273),0.4263608150283775,0.9909751641602499,0.5169851380042463,1.0,1.0,13/65,13.18%,CDK5RAP2;PSRC1;NUMA1;MAPT;CDC42EP2;NCK1;TPPP;DRG1;AKAP9;RAC1;NCK2;BAIAP2L1;PRKCE
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.31261637391563324,-0.990938731067385,0.4482758620689655,0.7590212416309622,1.0,11/20,19.32%,VTN;IGF1;PDGFRB;LRP1;S100A11;ACE;SLIT2;NDRG4;SORL1;CCN4;NRP1
prerank,regulation of mitochondrial fission (GO:0090140),0.4696427165916899,0.9904910922808244,0.4730238393977415,1.0,1.0,7/24,10.34%,MIEF2;AURKA;MAPT;LRRK2;MCU;DDHD1;MIEF1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.4330222203773607,0.9902646508331088,0.4928335170893054,1.0,1.0,6/49,4.45%,HMGB2;RBM15;CBFB;MOV10;NFE2;RAB7B
prerank,regulation of cell motility (GO:2000145),0.41873729603246274,0.9902477848279686,0.523469387755102,1.0,1.0,17/121,13.35%,KIF14;CCDC25;MACF1;ROCK2;RHOA;MEMO1;DIAPH1;ARHGAP18;NTN1;ENPP2;ROCK1;PLXNB2;PLXNB1;TBCCD1;RAC1;TWIST1;PLXND1
prerank,outer dynein arm assembly (GO:0036158),0.47765882925981296,0.990240201602059,0.4595744680851064,1.0,1.0,4/15,19.00%,DNAAF5;LRRC49;ODAD1;DNAH8
prerank,regulation of autophagosome maturation (GO:1901096),0.49806128323801474,0.9901012553953663,0.456490727532097,1.0,1.0,6/13,20.06%,TBC1D25;TMEM39A;ADRB2;UVRAG;CLEC16A;FYCO1
prerank,extracellular matrix assembly (GO:0085029),0.4584885075054761,0.9900046916550769,0.47299077733860345,1.0,1.0,5/23,10.16%,HAS3;LAMB1;QSOX1;FBLN5;HAS1
prerank,regulation of potassium ion transport (GO:0043266),-0.2886096383934934,-0.9896639179076308,0.43575418994413406,0.7610188439929674,1.0,13/31,34.06%,KCNIP4;KCNAB1;KIF5B;KCNN2;ADRA2A;DPP10;NOS1;DRD2;PTK2B;KCNIP1;KCNIP2;CASQ2;CACNA1D
prerank,organonitrogen compound catabolic process (GO:1901565),-0.2496874417913097,-0.9894133391180243,0.52,0.7606322054283902,1.0,20/57,23.67%,PLA2G4A;LNPEP;CLPX;RENBP;PNPLA8;TPP1;TXN2;SIAH1;ACE;MTOR;ENPEP;RIDA;PLA2G7;PPT1;BCKDK;NAGK;CLN5;SGPL1;PLA2G15;USE1
prerank,regulation of fat cell differentiation (GO:0045598),0.4210354290516086,0.989038508006424,0.5031446540880503,1.0,1.0,24/74,19.40%,E2F1;FTO;ASXL1;ANKRD26;SFRP2;WWTR1;TMEM64;YAP1;RUNX1T1;BMP2;ENPP1;TRPM4;LRP5;RORA;SMAD3;MEDAG;WDFY2;LPL;SFRP1;AAMDC;FRZB;SYAP1;ZFPM2;ZFPM1
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4317357847611082,0.9888627870755793,0.5127659574468085,1.0,1.0,23/73,21.07%,FADD;SENP1;DAP;ANP32B;CASP8AP2;FAM162A;MAPT;XDH;ROBO1;TNFRSF10B;APAF1;BOK;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;COL4A3;SNCA;TRAF2
prerank,positive regulation of binding (GO:0051099),0.42003888161439396,0.9887419192455492,0.508937960042061,1.0,1.0,15/84,11.40%,PON1;DDX11;HMGB2;STMN1;GSK3B;DHX9;ADD2;STK3;TCF7L2;NMD3;TXN;LRRK2;HMGB1;PARP9;BMP2
prerank,regulation of neuron projection arborization (GO:0150011),0.4818833060857463,0.9886455986627609,0.46518105849582175,1.0,1.0,3/15,11.16%,MACF1;MOV10;GRIP1
prerank,negative regulation of cation channel activity (GO:2001258),-0.3023588699656171,-0.988278782255559,0.4595959595959596,0.7623207747842573,1.0,5/26,7.79%,KCNAB1;CALM1;FKBP1A;EPHB2;GNB5
prerank,regulation of JUN kinase activity (GO:0043506),-0.27784485143130383,-0.9881588232417632,0.47368421052631576,0.7616053119812518,1.0,13/33,27.32%,PDCD4;MAP3K5;DNAJA1;PAK1;PTPN22;ARHGEF5;TNFRSF11A;PPEF2;RPS3;MAP3K11;MAPK8IP1;EDN1;DVL2
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.40030316872460914,-0.9881098812095059,0.4623955431754875,0.7607378810776179,1.0,2/10,8.23%,SLC44A1;HNMT
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3529828050661149,-0.9877675148234668,0.4635036496350365,0.7605139138829194,1.0,7/15,20.33%,LEF1;EP300;CCNT1;JUN;RRP1B;TAF11;SNW1
prerank,inorganic anion transport (GO:0015698),0.429370608079374,0.9877001318737868,0.503767491926803,1.0,1.0,8/53,13.29%,RACGAP1;ANO9;ENPP3;CLCN1;ENPP1;CLIC4;SLC25A30;CLIC1
prerank,cardiac muscle cell action potential (GO:0086001),-0.2917157447486089,-0.9875363006175282,0.4642857142857143,0.7600325925260963,1.0,6/30,14.97%,CACNA2D1;ATP1B1;SCN1A;ATP1A1;ATP1A2;SCN1B
prerank,sphingosine metabolic process (GO:0006670),-0.35631125777813344,-0.9872008851907709,0.4732510288065844,0.7598589705298608,1.0,7/17,23.85%,ACER2;PLPP3;ASAH1;ACER3;ASAH2;ABCA2;SPHK1
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.3787029255782317,-0.9869900860977298,0.4689655172413793,0.7593265085183399,1.0,6/13,19.32%,TGFBR2;CTNNB1;VEGFA;ENG;NOTCH4;NRP1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.39837865789636506,-0.9868654238162655,0.4695121951219512,0.7586403709609925,1.0,4/10,18.94%,APOD;LRP1;NDRG4;PTPN12
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4516991001652443,0.9866502556427089,0.47324613555291317,1.0,1.0,9/31,18.32%,E2F1;GSK3B;TFDP1;BOK;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.4946658356412912,0.9864514050127724,0.46628407460545196,1.0,1.0,5/12,19.90%,GSS;GCLM;BDH2;GCLC;HAGH
prerank,regulation of establishment of planar polarity (GO:0090175),0.4196042648237211,0.9863655552724175,0.508298755186722,1.0,1.0,15/88,11.74%,SAPCD2;VANGL1;RHOA;PSMC2;PSMD5;SPEF1;DAAM1;PSMB1;SMURF1;PSMD14;NPHP3;PSMD1;PSMB9;SMURF2;RAC1
prerank,cellular response to hexose stimulus (GO:0071331),-0.31209489630596143,-0.986103015429787,0.4377880184331797,0.7593739677456146,1.0,7/23,16.81%,UNC13B;KCNB1;GAS6;PRKAA1;SOX4;ADCY8;XBP1
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.2927536746395794,-0.9860096682832099,0.4816753926701571,0.7586718588318853,1.0,9/26,12.71%,FMOD;B4GALT5;B3GNT2;ST3GAL6;B4GALT6;PRELP;OGN;LUM;B4GALT4
prerank,estrogen metabolic process (GO:0008210),-0.3506382475433186,-0.9857567282213224,0.46923076923076923,0.7582407381311255,1.0,8/15,49.18%,HSD17B11;HSD17B7;HSD17B8;HSD17B10;HSD17B2;SULT1A1;HSD17B14;HSD17B1
prerank,positive regulation of locomotion (GO:0040017),-0.29754510839459564,-0.9857347766175518,0.43455497382198954,0.75732152127898,1.0,6/27,5.46%,SPOCK2;STX4;PDGFRB;AKT2;CFAP20;STX3
prerank,regulation of stress fiber assembly (GO:0051492),0.4208232600037657,0.9842917265696771,0.5145228215767634,1.0,1.0,23/74,17.85%,STMN1;ARHGAP28;ROCK2;RHOA;CGNL1;LPAR1;SORBS3;TMEFF2;ALMS1;ROCK1;ARHGAP6;TGFBR1;ARHGEF18;RAC1;WASF2;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47;CLASP1
prerank,regulation of blood coagulation (GO:0030193),-0.2882398966095798,-0.984242555566505,0.5077720207253886,0.7599677361498766,1.0,6/27,6.10%,CAV1;APOE;VTN;EPHB2;THBD;CD34
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2861758100441635,-0.9839630425269679,0.4864864864864865,0.7596662927535084,1.0,8/28,18.32%,PRKN;APOE;PDK1;ARV1;FMO5;DGKQ;EPHX2;BCKDK
prerank,myelination in peripheral nervous system (GO:0022011),-0.3751852635372707,-0.9839085424913554,0.47202797202797203,0.7588234128787985,1.0,6/13,25.68%,NF1;ARHGEF10;DICER1;ADGRG6;LGI4;PRX
prerank,fatty acid beta-oxidation (GO:0006635),-0.2559884895490016,-0.9831284536171566,0.49411764705882355,0.759692730130518,1.0,12/51,15.94%,HADHB;ACADM;CROT;SCP2;ABCD4;MECR;HADH;ACAD10;ECHS1;ABCD2;DECR1;ECHDC2
prerank,protein localization to cilium (GO:0061512),0.43908980066054437,0.9829823986105354,0.4803804994054697,1.0,1.0,4/32,7.67%,BBS9;WDR35;IFT140;RAB29
prerank,positive regulation of T cell migration (GO:2000406),0.4654281685815277,0.9829134323317654,0.48046875,1.0,1.0,5/20,18.15%,RHOA;WNK1;ADAM17;STK39;OXSR1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.25594953727219255,-0.9825693399008921,0.43564356435643564,0.7599533202794861,1.0,13/43,17.56%,SH3KBP1;STAM2;DUSP3;EPN1;TSG101;SOCS5;ZGPAT;TGFA;GRB2;SPRY2;CBLB;ARHGEF7;CBL
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4451925161884277,0.9820890176111209,0.4883720930232558,1.0,1.0,8/33,14.42%,HMGB2;RAB7B;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT
prerank,regulation of ruffle assembly (GO:1900027),-0.29594880542879803,-0.9820232627228163,0.4558139534883721,0.7603860037043237,1.0,12/23,32.31%,CAV1;FAM98A;PFN1;PLEKHM1;EPS8L2;NLGN1;P2RX4;ABI3;P2RY12;DEF8;EPS8;HRAS
prerank,regulation of organelle organization (GO:0033043),0.41803019971616906,0.9819744699938624,0.5284810126582279,1.0,1.0,18/80,12.65%,RAB33B;USP6NL;MIEF2;TBC1D25;SPEF1;DIAPH1;MAPT;RHOT1;ARMH3;ARL6IP1;MARK2;PLXNB1;STX18;EZR;AKAP9;STOX1;CENPV;CLIC4
prerank,negative regulation of RNA splicing (GO:0033119),0.4661379736507396,0.9819481225295901,0.46390374331550804,1.0,1.0,5/19,13.30%,SRSF4;SRSF10;SRSF7;SAP18;PTBP2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.33555791458515233,-0.9819437591694226,0.44363636363636366,0.7595923575689066,1.0,10/17,39.75%,RYR2;KCNQ1;NEDD4L;KCNJ8;PKP2;GPD1L;KCNE4;SCN3B;KCNH2;SCN5A
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3934525454699454,-0.9818430614184347,0.46788990825688076,0.7588727066533819,1.0,3/10,9.30%,RAP1A;CD34;TMEM100
prerank,regulation of stem cell differentiation (GO:2000736),0.41680297181361786,0.9814960093346824,0.5269151138716356,1.0,1.0,32/89,22.97%,CBFB;BMPR1A;PSMC2;PSMD5;PRKDC;PDGFRA;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;HNRNPU;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;GDNF;OCIAD1;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.407246931329926,-0.981480257870858,0.48441926345609065,0.7587583173892982,1.0,4/10,24.40%,CST3;TNFRSF1B;FAP;TNFRSF1A
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.2321328155132804,-0.9813018773898355,0.4642857142857143,0.7582395343647489,1.0,21/69,21.48%,OGT;IGF1;PDGFRB;PIK3C2B;KCNH1;PLCB3;PIK3R1;IRS2;MYO16;NYAP2;NF1;IRS1;HTR2A;PI4KA;PLCE1;ERBB2;PIK3CD;PIK3CA;EXOC1;PLCH1;PIK3R2
prerank,RNA metabolic process (GO:0016070),0.4095090688139941,0.980916398584312,0.5308392315470172,1.0,1.0,34/127,16.58%,SYNCRIP;SETX;PABPC4;TENT2;AGO2;HNRNPD;FTO;RBFOX2;RNASE6;DHX9;HNRNPA1;DDX39B;HNRNPH1;POLR2A;RBMS2;RNASEH2A;DHX8;CELF2;HNRNPUL1;PPP1R8;HNRNPU;HNRNPL;RNASE1;EXOSC7;ATXN1;HNRNPH2;RNGTT;RBM4;RBMS1;HNRNPA2B1;PNPT1;METTL3;NOL9;PRPF4
prerank,phospholipid transport (GO:0015914),-0.25303373292619746,-0.9800914963411701,0.5180722891566265,0.7601514394496989,1.0,21/52,25.83%,PLTP;ATP8A1;APOE;SCP2;ATP8B1;ATP8A2;ATP9B;MTTP;ATP9A;TNFAIP8L3;PRELID3B;OSBPL2;MFSD2A;NPC2;SCARB2;PITPNC1;TMEM30A;PRELID3A;ATP10B;PRELID1;ABCA3
prerank,regulation of glycolytic process (GO:0006110),0.41259703863755026,0.9798851526253454,0.5310199789695058,1.0,1.0,17/68,17.39%,NDC1;NUP155;NUP205;NUP160;PFKFB1;GCK;NUP85;TPR;ZBTB20;NUP214;RANBP2;ARNT;NUP133;PRKAG1;NUP42;NUP98;NUP210
prerank,response to nitric oxide (GO:0071731),0.4827123444428453,0.9791623429465369,0.48614958448753465,1.0,1.0,3/13,7.94%,AQP1;TXN;CDK2
prerank,sensory perception of taste (GO:0050909),-0.3948225781570879,-0.9790910068144929,0.45425867507886436,0.761440003016368,1.0,8/10,56.24%,PKD2L1;PKD1L3;ASIC1;CD36;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,negative regulation of cellular component organization (GO:0051129),0.42101165550221215,0.9790691502458949,0.502092050209205,1.0,1.0,13/74,13.63%,PON1;RTEL1;GSK3B;IAPP;BMP6;TMEFF2;RIOK3;DNM2;MTMR2;SNX33;TERF2;AIDA;PRKD1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.37949064014363143,-0.9789088098777808,0.47604790419161674,0.7608959585581639,1.0,4/12,13.93%,STX4;ANO1;GPLD1;ADCY8
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5002104638135458,0.9786501414512413,0.4774774774774775,1.0,1.0,3/11,6.25%,AGO2;NECAB1;SOAT1
prerank,serine family amino acid metabolic process (GO:0009069),-0.3572260925840283,-0.978606857664424,0.4716981132075472,0.7606325380341549,1.0,12/16,49.34%,MTHFD1;SARS1;CBS;THNSL2;SEPHS2;CTH;SEPSECS;PSPH;SHMT2;SHMT1;GLYAT;DAO
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.28853377391348656,-0.9777761380872274,0.48366013071895425,0.7615459262641328,1.0,4/29,5.24%,STAT3;IFNAR1;STAT6;SOCS2
prerank,T cell homeostasis (GO:0043029),0.5120747113486828,0.976952251726593,0.49922958397534667,1.0,1.0,1/10,2.15%,FADD
prerank,response to ketone (GO:1901654),-0.2998967841883457,-0.9768215249874848,0.485,0.7628521745740778,1.0,12/24,25.79%,CAV1;TGFB2;ABHD2;NR1H3;CATSPER2;SLIT2;THBS1;TGFB3;WBP2;SLIT3;UBE3A;CATSPER3
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.4273521201832273,0.9768170394903418,0.48924122310305773,1.0,1.0,12/43,13.63%,FBXO5;BMPR1A;BMP6;NPNT;CCN1;WWTR1;YAP1;DDR2;BMP2;ZHX3;LRP5;PRKD1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.43017526003537254,0.9764109223653015,0.4867052023121387,1.0,1.0,12/37,17.52%,PLK1;UBE2K;S1PR2;CALM2;STOX1;TRIM6;DMTN;CAB39;SPRED1;RPTOR;SPRED2;WNK3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.41959405634290287,0.9760584856992814,0.5232067510548524,1.0,1.0,30/70,24.76%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,tRNA processing (GO:0008033),-0.23846097263737648,-0.975166329772161,0.49056603773584906,0.7657165289978038,1.0,28/61,29.55%,TRMT9B;ANKRD16;DTWD2;CSTF2;AARS1;NSUN2;RTRAF;SARS1;CDKAL1;QTRT2;TRMT10B;TRMT1;TRUB1;TSEN15;METTL1;KARS1;PUS3;THUMPD1;QTRT1;TRMT10A;LCMT2;RTCB;DTWD1;WDR4;POP5;ELAC2;CLP1;PTCD1
prerank,cardiocyte differentiation (GO:0035051),-0.40280424510954976,-0.9750979198749917,0.4945652173913043,0.7649120656536621,1.0,6/10,26.48%,TGFB2;SIK1;KDM6B;GATA6;CBY1;MYOCD
prerank,mitochondrion transport along microtubule (GO:0047497),0.4770774657598182,0.9750954164817806,0.48497854077253216,1.0,1.0,3/13,9.59%,MAPT;RHOT1;UXT
prerank,pulmonary valve morphogenesis (GO:0003184),-0.3304316050949108,-0.974985857772533,0.4521072796934866,0.764174152270109,1.0,7/17,16.19%,JAG1;TGFB2;NOS3;SLIT2;HEYL;STRA6;ROBO2
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.37077928105097646,-0.9749348527834975,0.46153846153846156,0.7633607369322817,1.0,4/12,12.33%,OS9;RER1;HSPA5;KDELR3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4253970490769655,0.9748924786761042,0.5263713080168776,1.0,1.0,18/66,16.89%,BRCA2;ATOH8;FGFR2;CASK;NFIB;MCC;XDH;TGFBR3;FBXW7;SFRP2;SULF1;ROBO1;KLF9;ATP5IF1;MED1;SFRP1;TINF2;PTPRK
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.4672998486538653,0.9748382194669986,0.502086230876217,1.0,1.0,2/14,4.54%,TICAM1;KIT
prerank,regulation of extracellular matrix organization (GO:1903053),0.4775362808234019,0.9747971717234053,0.4871060171919771,1.0,1.0,6/15,18.13%,RB1;FGFR4;AGT;DDR2;RIC1;RUNX1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.39301508651203176,-0.9740993376292003,0.5073313782991202,0.7644527110728709,1.0,2/10,9.82%,RAP1A;KIDINS220
prerank,regulation of sensory perception of pain (GO:0051930),0.49293234502468375,0.9738450996901226,0.4817073170731707,1.0,1.0,2/11,11.20%,ATPSCKMT;CCN3
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2585603272995794,-0.973776217852758,0.4909090909090909,0.7642517782090853,1.0,8/48,8.37%,PLA2G4A;PLD1;DGKB;ABHD5;PLD2;SLC27A1;AGPAT5;DGKG
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3807909604519774,-0.9728922343587177,0.4793650793650794,0.7654961790087143,1.0,10/11,61.95%,PKD2L1;PKD1L3;LPO;RTP4;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.2943953405378991,-0.9728141451313442,0.4816753926701571,0.7647407498162332,1.0,9/27,14.61%,PSEN1;BRSK1;HOMER1;IL1RAPL1;CAMK2G;CTNNA2;NCS1;NTNG1;GSK3A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.28656766102043607,-0.9728061651864504,0.4632768361581921,0.763797166834079,1.0,9/29,11.84%,RPS8;RPS21;NOL10;RPS14;KRI1;RPS19;HEATR1;UTP20;NGDN
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.33501247253880784,-0.9727827698295506,0.4746376811594203,0.7628943107266861,1.0,4/17,10.95%,HSP90AB1;CALM1;PDGFRB;MTOR
prerank,response to axon injury (GO:0048678),-0.3207263579973283,-0.9726231965102354,0.46120689655172414,0.7622727069858822,1.0,11/18,32.77%,APOD;GAP43;RTN4RL1;NREP;P2RX4;MTR;FLRT3;MORN4;P2RY12;SARM1;TYROBP
prerank,histone H3 acetylation (GO:0043966),0.432640549077167,0.9725561046444806,0.5011261261261262,1.0,1.0,14/40,18.78%,BRCA2;SGF29;TAF12;ING4;TADA1;TADA2A;JADE1;PER1;YEATS2;DR1;KAT6A;TAF10;NAA60;JADE3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.39969855930959175,-0.9724467366638224,0.4786885245901639,0.7617504952767722,1.0,5/10,18.16%,NEXMIF;RGCC;PPM1F;VEGFA;NOTCH4
prerank,cellular component maintenance (GO:0043954),0.49886013864139556,0.9723716637613257,0.5079365079365079,1.0,1.0,3/12,9.29%,LNPK;PRNP;MTMR2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.36088096072633047,-0.9722535821259869,0.50814332247557,0.761216826861919,1.0,7/13,36.53%,PIK3R4;IRAK4;UNC93B1;PIK3AP1;EPG5;TNIP2;MYD88
prerank,regulation of cellular catabolic process (GO:0031329),-0.2522650914411427,-0.9721709337720856,0.5,0.7604595446187432,1.0,30/62,28.52%,PRKN;EP300;PIP4K2A;DRAM2;ACER2;PIP4K2B;PSAP;LONP2;MTMR4;ATM;DAPK2;ABL1;OSBPL7;NUPR1;RRAGC;FBXL2;USP33;DDIT3;USP10;RMC1;PIP4K2C;PIK3R2;HSPB1;SCARB2;RAB39B;SMCR8;RRAGD;GPR137;KEAP1;RRAGA
prerank,cellular protein modification process (GO:0006464),0.4062652398857505,0.9721041363102011,0.64,1.0,1.0,240/983,19.97%,DTL;CCNF;NEK2;MELK;CDK1;PLK1;BIRC5;AURKB;TGM1;MATN3;NEK3;F5;PLK4;MATK;HUNK;HASPIN;MAST2;ILF3;UBE2S;PPM1G;MAP4K4;DYRK1A;PPM1D;LOXL2;STK17B;LOX;TRIOBP;BMPR1A;CDK14;AURKA;ROCK2;FEM1C;ASB15;MAP4K2;GSK3B;PSMC2;ZC3HAV1;GGCX;LARGE1;PSMD5;FBN1;STK10;OBSL1;NLK;CHEK2;MYLK3;FUT10;LAMB1;FBXL7;PRKDC;ST8SIA2;LHPP;SPSB3;B3GNT8;CTBP1;DYRK3;TAB1;PPP2R3A;SPSB2;VRK2;SSH2;STK3;STK24;SETD3;NRK;MAP3K1;CCNE1;RBBP7;ELOC;FBXW7;FBXO30;WNK1;MAP3K20;ATG7;CDC25B;CHEK1;CUL5;PPP3CA;CCN1;CDC42BPA;FBXL8;ST3GAL3;PHKA2;QSOX1;KLHL5;CDK2;B4GALT7;PORCN;LRRK2;PSMB1;FN3K;SUMF2;GRK5;CUL3;PSMD14;KLHL22;DUSP12;VHL;MTMR2;CUL4B;ROCK1;PIM1;PSMD1;RPN2;SKP2;DCAF10;ST3GAL5;MARK2;RAB1A;PXK;UST;CDC42BPG;PPP2R5C;PARP9;TGFBR1;WSB2;PTPN21;PSMB9;PIGU;SRPK1;EIF2AK3;LMTK3;PRKCB;PTPRS;BMP2;ANXA1;STT3A;APLP2;CHM;P3H1;FBXW11;SEPHS1;PRKCA;NAGPA;PDPK1;GRK3;STT3B;AAK1;CSNK1G2;DCAF7;SIK2;PPP1CC;MEX3B;ATG3;STRADA;BTK;CDK19;PRKCE;COPS3;MAML1;PRKD1;PRKCI;ARF4;BTRC;FBXO27;PLK2;ST3GAL4;MACROD2;NRBP1;MORC3;PSMC6;MIA3;PIGT;VRK1;ST3GAL1;CDK8;BIRC6;PTPRA;STK11;PTPN13;FBXO17;PTPRU;MTMR3;UBL5;TAOK1;PRKAG1;ST3GAL2;CKAP4;PRKD2;STK39;PASK;ASB2;PRSS23;PPP2R5B;NOTUM;DAPP1;FBXL14;PPP2R1B;PTEN;PLOD2;FBXW10;HIPK3;UBLCP1;NTAQ1;GLRX;B3GALT2;PTPRK;GOLM1;RAB13;PTPRE;WNK3;CDKL4;CSNK1A1;PSMB2;SRPK2;MAST1;PKN2;METAP1;OXSR1;FNTB;PLAT;IGFBP3;LIMK2;PSME4;LTBP1;FBXO4;PSMB7;HIPK1;BRAF;OGFOD1;DUSP7;CLK3;STRADB;ASB3;PPM1A;CAND1;PRKCD;RAB3A;TESK2;DCAF8;PARP14;YES1;TYK2;UBE2D3;DAPK1;PTPN1;TRIB1;PRKAB1;PTPN5;PSMD11
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.36892455779836575,-0.9718734050895896,0.5124555160142349,0.7602339746604044,1.0,4/13,16.61%,BPNT2;TPST1;ABHD14B;TPST2
prerank,regulation of cilium assembly (GO:1902017),0.42152212219058716,0.9718447082255336,0.5168295331161781,1.0,1.0,14/62,12.87%,USP6NL;CEP97;IFT140;EVI5L;TBC1D13;TBC1D2B;YAP1;TBC1D7;SDCCAG8;TAPT1;ARHGAP35;CEP120;TBC1D19;ATG3
prerank,regulation of translational initiation (GO:0006446),0.4207058119919798,0.9714064006889723,0.5080213903743316,1.0,1.0,18/63,17.56%,AGO2;CTIF;KHDRBS1;EIF4H;TPR;FMR1;LARP1;NCK1;CDC123;YTHDF2;EIF2AK3;NCK2;RBM4;PPP1R15B;EIF4A2;DDX1;EIF3H;PAIP2B
prerank,primary miRNA processing (GO:0031053),0.5184891949721655,0.9712917408287977,0.5,1.0,1.0,5/10,17.82%,DGCR8;SMAD3;HNRNPA2B1;METTL3;SMAD2
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.42784209708176607,0.9705739083099816,0.47928994082840237,1.0,1.0,12/36,19.66%,FADD;UBE2K;CXCR4;AGPAT2;PARP9;ADAM17;TRIM6;AGPAT1;AXL;MAVS;RIPK1;PARP14
prerank,metallo-sulfur cluster assembly (GO:0031163),0.45733296872964174,0.9704532064030832,0.4777636594663278,1.0,1.0,10/22,24.54%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1;CIAPIN1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4119955552486539,0.9703431667665615,0.5479166666666667,1.0,1.0,29/84,19.96%,RBM15;SRSF4;TRA2B;RBFOX2;KHDRBS1;HNRNPA1;SRSF10;THRAP3;MBNL3;RBM25;FMR1;SRSF7;SAP18;CELF2;SRSF3;HNRNPU;RBM15B;HNRNPL;SRPK1;RBM4;DAZAP1;FXR1;NUP98;SFSWAP;SRPK2;CWC22;LARP7;KHDRBS3;TRA2A
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4934220609073942,0.9699608861280725,0.4936530324400564,1.0,1.0,4/13,12.59%,BMPR1A;BMP6;TGFBR1;SMAD4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.26209722067799557,-0.9694000331387628,0.5367647058823529,0.765055337489465,1.0,10/40,11.25%,PTK2;NUB1;HIPK2;UFL1;GNA12;RPL23;RPS7;ARAF;UBQLN4;SGTA
prerank,alanine transport (GO:0032328),-0.39714542329217273,-0.9692881597901571,0.49244712990936557,0.7643468681977771,1.0,1/10,0.34%,SLC6A6
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.39930667615978543,-0.9689375324212263,0.5174418604651163,0.7642377133755042,1.0,4/10,23.39%,PLA2G4A;PNPLA8;PLA2G7;PLA2G15
prerank,glycosphingolipid metabolic process (GO:0006687),-0.26498041191044663,-0.9687693045262039,0.46153846153846156,0.7637070309836995,1.0,12/42,13.32%,HEXB;PSAP;ASAH1;B4GALT6;ST6GALNAC3;ST8SIA1;ESYT1;B3GALNT1;ST6GALNAC5;HEXA;GLTP;CTSA
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.3367471150186292,-0.9687076459369353,0.5075187969924813,0.7629206693819776,1.0,6/16,11.73%,CAMK2D;IGF1;AKAP6;TRPC3;PARP1;MEF2A
prerank,response to leucine (GO:0043201),0.49400750442805696,0.9686868004045455,0.5203619909502263,1.0,1.0,5/10,16.25%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,cellular response to leucine (GO:0071233),0.49400750442805696,0.9686868004045455,0.5203619909502263,1.0,1.0,5/10,16.25%,KLHL22;SESN1;RPTOR;SESN2;LARS1
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.44252303753239525,0.9683528284250366,0.5071258907363421,1.0,1.0,10/31,19.63%,FGFR2;HOXC4;PDGFRA;DSCAML1;HOXB3;TGFBR1;TWIST1;OSR1;HOXA3;DYNC2I1
prerank,glucose transmembrane transport (GO:1904659),-0.3221075608768247,-0.9682619290674491,0.5278969957081545,0.7630093157689222,1.0,6/18,32.85%,SLC2A1;SLC2A3;SLC2A10;SLC2A9;SLC5A3;SLC45A1
prerank,protein targeting to lysosome (GO:0006622),0.4604978505474996,0.9673730759635427,0.5116279069767442,1.0,1.0,4/20,12.19%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,inner mitochondrial membrane organization (GO:0007007),-0.24806362171642948,-0.9671495298503441,0.5048543689320388,0.764608538799582,1.0,25/47,31.75%,APOOL;MTX2;ATP5PF;ATP5F1A;ATP5PO;GHITM;ATP5MF;ATP5MC3;DNAJC11;TOMM70;ATP5PD;ATP5F1B;MTX3;ATP5F1D;ATP5F1E;ATP5MG;MICOS13;TIMM9;ATP5ME;TIMM13;HSPA9;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,long-chain fatty acid transport (GO:0015909),-0.2910201892017439,-0.9668683165444921,0.5086705202312138,0.7643843036376705,1.0,12/30,30.26%,APOE;ABCD4;SLC27A1;ACACB;ABCD2;PRKAG2;SLC27A4;ACSL1;MFSD2A;MID1IP1;FABP5;CPT1A
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.44727445787339093,0.9664328215389129,0.49165596919127086,1.0,1.0,4/22,7.77%,VPS37B;NEDD4;VPS37A;STAM
prerank,carbohydrate biosynthetic process (GO:0016051),0.4523750452787809,0.9661671906882869,0.48427672955974843,1.0,1.0,6/21,16.82%,B4GALT1;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4232383678869881,0.9660598195060189,0.5191873589164786,1.0,1.0,14/45,18.91%,ZC3H7A;EIF4E;MATR3;FOXO3;LARP1;PUM2;PARP9;MEX3D;LARP4;RC3H1;PER1;ZC3H7B;METAP1;SPOUT1
prerank,limb morphogenesis (GO:0035108),0.4655339716926036,0.9658802564842042,0.5025839793281653,1.0,1.0,3/20,7.58%,GLI3;CYP26B1;NIPBL
prerank,carboxylic acid transport (GO:0046942),-0.24568788608391978,-0.965302071132682,0.5238095238095238,0.7668981449159701,1.0,16/55,24.50%,SLC6A6;SLC16A12;SLC13A3;SLC3A2;SLC7A5;PSAP;SLC7A6;SLC16A1;SLC16A4;SLC6A11;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;SLC16A13
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.31001025509056096,-0.9650374118216625,0.4688995215311005,0.7665962988819772,1.0,2/23,0.29%,CAMK2D;CACNA2D1
prerank,myeloid dendritic cell activation (GO:0001773),-0.36892306848211576,-0.9648719792472332,0.46206896551724136,0.7659982627799923,1.0,2/12,6.22%,TGFBR2;CAMK4
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.3303366781892141,-0.9647122544138779,0.4697508896797153,0.7653995915088823,1.0,2/17,2.43%,ADIPOR2;CAV1
prerank,response to cholesterol (GO:0070723),0.46537427058312103,0.9635768412603369,0.4986910994764398,1.0,1.0,3/17,10.48%,GRAMD1C;PMVK;TGFBR1
prerank,sulfur compound transport (GO:0072348),0.45143786355837145,0.9632559225934664,0.5059665871121718,1.0,1.0,1/27,0.73%,RACGAP1
prerank,organelle fusion (GO:0048284),0.45119461150933793,0.9631910238011532,0.49345549738219896,1.0,1.0,9/22,21.23%,MIEF2;VPS18;MFN2;MIEF1;CHCHD3;MFN1;MIGA2;SPG7;EEA1
prerank,negative regulation of cell adhesion (GO:0007162),-0.23137206896791968,-0.9624056972912516,0.5208333333333334,0.7697731736474807,1.0,19/72,17.76%,PTK2;SPOCK1;PODXL;SEMA6A;JAG1;ACVRL1;ACER2;NEXMIF;EPHB2;SEMA4D;PTPRO;PLXNC1;FZD4;CX3CL1;DUSP1;ITGB1BP1;CORO2B;CBLL1;PLXNA4
prerank,actin filament depolymerization (GO:0030042),0.48595239740493335,0.9621700037641933,0.512743628185907,1.0,1.0,5/11,23.16%,MICAL3;TWF1;DSTN;CFL2;MICAL2
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.46464297091063045,0.961058315281756,0.5006675567423231,1.0,1.0,2/17,2.10%,SPDYA;PSRC1
prerank,positive regulation of cell junction assembly (GO:1901890),-0.24867256267041166,-0.9610524775001377,0.5373134328358209,0.7722131622151707,1.0,26/56,28.44%,PTPRD;TEK;SYNDIG1;CAV1;GRID2;CLDN5;EPHB2;IL1RAPL1;CNTNAP2;NRXN1;ABL1;PPM1F;VEGFA;LRRC4B;NLGN1;NRP1;IL1RAP;BDNF;DLG5;SRPX2;TSC1;THY1;EPHA2;EPHB3;COL16A1;ACE2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5084497578077416,0.9606378884115926,0.5068078668683812,1.0,1.0,5/10,18.94%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),-0.21477917643711764,-0.9603390562210697,0.5,0.7729804487141176,1.0,31/107,20.86%,SLC8A3;ATP1B1;SLC39A10;CAV1;RYR2;SLC39A13;SLC24A2;DMPK;CDH5;TPT1;HTR2C;CHRNA7;TMCO1;SLC39A7;SLC30A1;ATP2B2;ATP2B3;HTR2A;PTH1R;RMDN3;MT2A;VAPB;SLC24A4;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,regulation of macrophage cytokine production (GO:0010935),-0.3580216785200338,-0.9601490275390158,0.49834983498349833,0.7724905409264707,1.0,6/13,27.98%,TGFB2;SEMA7A;TGFB3;CD74;LAPTM5;IRAK3
prerank,amyloid precursor protein metabolic process (GO:0042982),-0.3200981758531811,-0.9601407075143658,0.5086206896551724,0.7715741882576616,1.0,10/18,31.11%,PSEN1;APOE;NCSTN;LDLRAP1;PSEN2;NSG1;BACE1;PSENEN;CLN3;ADAM10
prerank,positive regulation of biomineral tissue development (GO:0070169),0.41989642810500466,0.9598958033652083,0.506896551724138,1.0,1.0,9/40,11.40%,FBXO5;ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;WNT6;ATP2B1;BMP2
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3181063283936762,-0.9597099965766052,0.5155038759689923,0.7716448928777772,1.0,7/18,28.89%,CHRM2;AGRN;OPRM1;CHRM3;RGS10;CDK5R1;PLCB1
prerank,positive regulation of glycolytic process (GO:0045821),-0.3131214603243329,-0.959440463258492,0.49065420560747663,0.7704227350525334,1.0,6/20,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3131214603243329,-0.959440463258492,0.49065420560747663,0.7704227350525334,1.0,6/20,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,cellular response to sterol (GO:0036315),0.48067812873550264,0.9593676406389496,0.5021216407355021,1.0,1.0,5/13,20.88%,GRAMD1C;RORA;INSIG2;GRAMD1B;INSIG1
prerank,neuron differentiation (GO:0030182),0.4008586474925168,0.9593092045189947,0.5953815261044176,1.0,1.0,17/165,10.48%,EN1;PBX4;GLI2;ATOH8;PBX3;MYEF2;TDP2;SRF;WNT2B;ERCC3;WNK1;POU3F2;OLIG2;LMX1B;WNT6;NR4A2;TGFBR1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.41503244255390154,0.959078790657914,0.5515409139213603,1.0,1.0,8/59,15.76%,ACMSD;CYP39A1;ALDH1A2;NDUFAB1;ACACA;HOGA1;ELOVL4;LPL
prerank,mRNA 3'-end processing (GO:0031124),0.40647117747832423,0.9589709105932868,0.5458333333333333,1.0,1.0,19/78,12.66%,TENT2;SRSF4;CSTF3;FIP1L1;UPF3B;SLBP;LSM11;DDX39B;SRSF7;TUT1;WDR33;LEO1;PAPOLB;PCF11;SCAF8;SRSF3;SRRM1;CPSF4;RPRD1A
prerank,regulation of protein ubiquitination (GO:0031396),0.39787400616042035,0.9586779956192925,0.5462962962962963,1.0,1.0,16/108,11.39%,BRCA1;PAXIP1;FANCI;MYCBP2;ARRB1;FBXW7;UBE2N;LRRK2;CUL3;ANGPT1;TBC1D7;HDAC8;SVBP;TGFBR1;IVNS1ABP;BAG5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.43438741671861125,0.9585915783495037,0.5146541617819461,1.0,1.0,16/38,22.29%,SAE1;LEPROT;FBXW7;RNF31;SH3GLB1;HTRA2;LRRK2;CSNK2A2;ATP5IF1;NPEPPS;UBL5;SIAH3;SREBF1;UBE2D3;UBE2L3;ATG13
prerank,purine nucleotide metabolic process (GO:0006163),0.4476080483808424,0.9582064109642084,0.5144291091593476,1.0,1.0,7/24,11.44%,HPRT1;XDH;GUK1;ITPA;PRPS1L1;PRPS1;ADSL
prerank,positive regulation of blood coagulation (GO:0030194),0.4608781030860794,0.9581468962569449,0.4966711051930759,1.0,1.0,4/17,14.11%,HPSE;SERPINE1;DMTN;ST3GAL4
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.401165644529761,0.9576763841256201,0.5945945945945946,1.0,1.0,72/241,19.96%,RBM15;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRRM1;CPSF4;SNRNP35;HNRNPH2;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;RBM19;HNRNPA2B1;PPWD1;LSM4;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;GEMIN7;CWC25;CWC22;PDCD7;BUD13;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;SNRPB;TRA2A
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4184467054278602,0.9573473024237015,0.5369565217391304,1.0,1.0,8/56,12.59%,TTK;BMPR1A;BMP6;PMEPA1;SMAD6;TGFBR1;BMP2;SMAD4
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.4517467072964922,0.9573139975397246,0.5293333333333333,1.0,1.0,8/20,20.26%,RB1;DDRGK1;TRIM6;TWIST1;LAMTOR5;NIBAN2;GTF2B;TRAF6
prerank,regulation of lymphocyte migration (GO:2000401),0.49592179953781357,0.9567909088609677,0.5208012326656395,1.0,1.0,3/10,16.26%,STK10;MIA3;MSN
prerank,folic acid metabolic process (GO:0046655),0.46612565532126865,0.9559465296122195,0.5020463847203275,1.0,1.0,4/18,13.52%,MTHFD1L;MTHFR;SLC19A1;DHFR
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.33195522119199017,-0.955940411404396,0.5101214574898786,0.7774276790450385,1.0,4/17,8.58%,TMSB4X;MAP2K5;KLF4;PTPN22
prerank,regulation of epidermal cell differentiation (GO:0045604),0.4549948909858189,0.9558388402749771,0.5221932114882507,1.0,1.0,4/21,10.55%,CBFB;ROCK2;ROCK1;ERRFI1
prerank,muscle tissue development (GO:0060537),-0.3569912885379303,-0.9556790363708485,0.5209790209790209,0.7770700825203076,1.0,5/13,15.54%,PGM5;NF1;PTCH1;ENG;STRA6
prerank,N-glycan processing (GO:0006491),-0.3216684717647987,-0.9554337277199838,0.5150214592274678,0.7767792933309,1.0,12/18,27.61%,ST8SIA4;MAN2A1;ST8SIA1;ST8SIA6;MAN1A2;MGAT4B;PRKCSH;GNPTAB;GANC;ST8SIA3;ST8SIA5;MAN2A2
prerank,cardiac ventricle development (GO:0003231),0.4541503624422735,0.9552883490158,0.47925033467202144,1.0,1.0,6/20,16.73%,MDM4;MATR3;HEY2;TMEM65;HECTD1;SALL1
prerank,RNA modification (GO:0009451),-0.24568611846649285,-0.9552534561529787,0.5454545454545454,0.7762977636070381,1.0,24/54,25.86%,TRMT9B;ANKRD16;DTWD2;PARN;AARS1;NSUN2;CDKAL1;QTRT2;ADAR;TRMT1;TRUB1;METTL1;ADARB1;MEPCE;PUS3;THUMPD1;QTRT1;NOP2;JMJD6;LCMT2;DTWD1;WDR4;ALKBH1;NSUN5
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4011782938956267,0.955134457779692,0.5819095477386935,1.0,1.0,63/152,24.85%,MACF1;DEPDC1B;FGFR2;PSMC2;RNF220;PSMD5;SULF2;TBL1XR1;ADGRA2;WNK1;SFRP2;SULF1;UBR5;LRRK2;PSMB1;PSMD14;SMARCA4;AXIN2;PSMD1;LRRK1;PSMB9;SMURF2;BMP2;RSPO3;CSNK1G2;TRPM4;USP47;XIAP;PSMC6;PIN1;NFKB1;SFRP1;SALL1;AMER1;FAM53B;PSMB2;CSNK1G1;PSME4;PSMB7;CAPRIN2;SKI;PPM1A;TERT;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;PSMD13;COL1A1;ZRANB1;GPRC5B;PSMB8;PSMD4;DISC1;PSMF1;GPC3;WLS;AXIN1;PSMA5;PSMC3;TGFB1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.4146343046252981,0.9550733262108033,0.5519828510182208,1.0,1.0,1/69,0.13%,KIF14
prerank,positive regulation of cell development (GO:0010720),-0.2714593297170893,-0.955072230438609,0.5240963855421686,0.7757289778478926,1.0,13/31,26.98%,PDE3A;NUMBL;NUMB;TGM2;OPRM1;FAIM;SNW1;SERPINF1;ATP6AP1;TRIM32;GPER1;NKX6-1;SOX11
prerank,response to reactive oxygen species (GO:0000302),-0.24405948792554816,-0.9547048226116647,0.6172839506172839,0.7756235986122633,1.0,22/54,23.88%,APOD;APOE;MAPK8;MAPK9;SOD2;TPM1;JUN;MAPK3;STK25;MAPK1;CAMKK2;MPV17;TXNRD2;CHUK;GLRX2;GPX1;PRDX3;PRDX5;ERCC6L2;RPS3;COA8;PDK2
prerank,regulation of interleukin-13 production (GO:0032656),-0.3571326194080865,-0.9544783390965835,0.48,0.7752846462138031,1.0,4/13,18.30%,LEF1;TNFRSF21;LGALS9;PRKCZ
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.2913554745642013,-0.9543909162715858,0.4935064935064935,0.7745982315004513,1.0,7/29,19.53%,JAM2;ANO6;GAS6;LGMN;PLA2G7;LGALS9;CREB3
prerank,regulation of cholesterol transport (GO:0032374),-0.3093658902306631,-0.9542764483216959,0.4649122807017544,0.7739625601476758,1.0,8/20,23.08%,OSBPL6;LRP1;ABCA5;NR1H3;ARV1;NR1H2;NUS1;ABCA2
prerank,organic anion transport (GO:0015711),0.40509815739029015,0.9540480256771362,0.5507399577167019,1.0,1.0,15/76,18.42%,RHAG;AQP1;SLCO4A1;SLC19A1;SLC16A2;SLC4A2;CYB5RL;SLC39A8;SLCO3A1;CA2;CYB5R1;SLC25A42;LRRC8C;SLC25A17;SLC25A19
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3998875804910519,0.9538869385496915,0.6036036036036037,1.0,1.0,39/199,16.13%,PON1;BRCA2;ATP2B4;SFMBT1;LOXL2;RB1;ROCK2;USF3;GSK3B;SRF;NFIB;MCC;CHSY1;HOXA7;GRHL2;EFNA1;SFRP2;ADAMTS5;SMAD6;ALDH1A1;ROBO1;ROCK1;NPR3;ATP2B1;BMP2;NKX2-1;TBX18;RBPJ;GJA1;ADAM17;ADIPOR1;HEY2;SPRED1;DOCK7;STK11;TLE3;SFRP1;SPRED2;PTEN
prerank,regulation of developmental growth (GO:0048638),-0.28717369041447915,-0.9537196804869522,0.5,0.7742705816609762,1.0,8/29,11.42%,MBD5;APOE;INSR;IGF1;NRCAM;ABL1;APP;SIX1
prerank,ether lipid metabolic process (GO:0046485),0.4848067972285266,0.953642987859893,0.5064935064935064,1.0,1.0,4/14,11.76%,AGMO;AGPS;PEDS1;TMEM86B
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4471069753123292,0.9535454969977502,0.5126582278481012,1.0,1.0,4/22,11.13%,DDX11;SMARCA4;NOL11;EIF2AK3
prerank,tRNA 5'-leader removal (GO:0001682),0.48479558701195585,0.9534342599242311,0.49368863955119213,1.0,1.0,5/13,19.60%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3390192250551012,-0.9528880979515707,0.5173745173745173,0.7752433515132774,1.0,5/16,19.48%,APOD;PDCD4;CHID1;ABCD2;ZC3H12A
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.29803767908367435,-0.952856633702013,0.5555555555555556,0.7744134399709589,1.0,5/24,6.47%,RYR3;RYR2;ANXA6;FGF2;HTR2C
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4309560945654742,0.952832731896763,0.508235294117647,1.0,1.0,10/32,20.01%,ACTR3;AUTS2;ENPP2;CORO1B;RAC1;WASF2;SRC;NCKAP1;ABI2;RREB1
prerank,mitochondrion organization (GO:0007005),-0.20153573458782242,-0.9527241206771546,0.5555555555555556,0.7737952558121399,1.0,61/165,23.13%,DNM3;PRKN;IMMP2L;SLC25A36;FIS1;DNAJC19;NOS3;ADCK1;MTX2;ESRRA;ALAS1;DNM1;OXA1L;HSPD1;NDUFS1;OMA1;AIFM1;CHCHD2;TFB2M;BNIP3L;BNIP3;TIMM44;CAV2;PARP1;MEF2A;SIRT5;PINK1;SUPV3L1;TOMM70;MPV17;BCAP31;GDAP1;COX7A2;SSBP1;ATP5F1B;SLC25A4;TFAM;MTX3;HIGD1A;USP30;PRDX3;ATP5F1D;AIP;FBXO7;PPARGC1A;PARK7;TOMM34;BCL2L1;GABPA;ATCAY;VPS13D;YME1L1;POLG2;TIMM17A;TOMM7;ATP7A;TIMM17B;WDR81;FMC1;SLIRP;RAB38
prerank,protein tetramerization (GO:0051262),0.41425408111512885,0.9526666334746955,0.5588547189819725,1.0,1.0,11/67,12.51%,TK1;UPB1;ALDH1A2;HPRT1;TRPA1;USP16;APIP;TRPM2;ACACA;APPL2;TRPM4
prerank,bile acid metabolic process (GO:0008206),-0.27719113882274016,-0.9524673623515097,0.4899328859060403,0.7735121275786985,1.0,8/27,21.61%,OSBPL6;CYP7B1;SCP2;OSBPL7;GBA2;AMACR;OSBP;OSBPL2
prerank,potassium ion transmembrane transport (GO:0071805),-0.20185205574025333,-0.9524260799845716,0.5789473684210527,0.7726993955362926,1.0,23/135,13.14%,ATP1B1;KCNAB1;KCNC2;HCN1;KCNB1;KCNJ3;SLC24A2;KCNQ3;KCNK13;KCNH1;KCNK10;KCNJ6;ATP1A1;ATP1B3;KCNN2;KCNS3;KCNH7;ATP1A3;SLC12A9;KCNJ10;KCNA6;KCNA2;ATP1A2
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.21211297693783612,-0.9523635787499842,0.5555555555555556,0.7719190220653103,1.0,20/112,13.69%,STAT3;PSEN1;IGF1;GAS6;TLR4;EPHB2;CD34;LBP;PTPN22;SELENOS;CHRNA7;APP;ARHGEF2;ARFGEF2;THBS1;CX3CL1;SYT11;TRIM27;PTPN11;IFNGR1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.4504796260689161,0.9515584076319941,0.49240506329113926,1.0,1.0,7/23,18.32%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.4504796260689161,0.9515584076319941,0.49240506329113926,1.0,1.0,7/23,18.32%,E2F1;TFDP1;CASP8;TP53;PPP3R1;YWHAQ;BAD
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.45460740392665044,0.9511412652482152,0.5013192612137203,1.0,1.0,5/19,10.09%,MYO1C;XDH;JCAD;ROBO1;PIK3CB
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.28795882115390264,-0.9507888425271546,0.5080213903743316,0.77463487525743,1.0,5/28,8.92%,CYRIB;SH3KBP1;PRKCQ;HSPD1;XRCC6
prerank,regulation of plasminogen activation (GO:0010755),-0.36672622789994097,-0.9504166157591903,0.49107142857142855,0.7745525193638013,1.0,6/12,24.46%,CTSZ;THBS1;PLGRKT;ENO1;CLEC3B;SERPINE2
prerank,negative regulation of apoptotic process (GO:0043066),0.39903384861574376,0.9503577589163126,0.645,1.0,1.0,72/444,16.32%,KIF14;STIL;CDK1;PLK1;BIRC5;BARD1;FIGNL1;AQP1;CDKN2D;MAP4K4;RB1;SETX;PHIP;ARHGAP10;FNIP1;ANGPT4;GSK3B;FXN;DDRGK1;FHL2;PRKDC;MRE11;SIAH2;PDPN;ANXA5;KDM2B;ARL6IP1;SMAD6;GRK5;SH3RF1;YAP1;MGMT;ANGPT1;VHL;PIM1;APIP;ERC1;CSNK2A2;NR4A2;SFPQ;CNTF;HDAC1;ANXA1;PRKCA;HDAC2;NOTCH2;ATF5;IL31RA;ITCH;TXNDC5;PLAUR;CTSH;MED1;PRKCI;USP47;ARF4;PLK2;XIAP;ITGA5;ITGB1;CD44;QARS1;BIRC6;SLC30A10;SRC;GDNF;TNFAIP8;NFKB1;TP53;SFRP1;ANKLE2;HIPK3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.4039692844430613,0.9500350499962043,0.5486910994764398,1.0,1.0,20/84,15.52%,TYMS;ILF3;SYNCRIP;CNOT1;RTN3;PRNP;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;ROCK1;MRPL13;EIF2AK3;RBM4;DHFR;EPRS1;PIN1;CNOT7;FXR1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.46187061313728955,0.9498952386111854,0.49728260869565216,1.0,1.0,7/16,23.32%,TRA2B;THRAP3;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,base conversion or substitution editing (GO:0016553),-0.3756366022920423,-0.949631000247512,0.501577287066246,0.7753985181015414,1.0,3/11,20.04%,ADAR;ADARB1;ADARB2
prerank,glycogen catabolic process (GO:0005980),0.46035448505308174,0.9485235099549149,0.5041322314049587,1.0,1.0,4/15,10.14%,AGL;PYGB;PHKA2;RB1CC1
prerank,T cell activation (GO:0042110),0.41285736327819256,0.9483906296927254,0.5690021231422505,1.0,1.0,15/69,16.26%,ADA;KIT;LEPR;PTPN2;PPP3CA;SCRIB;RAB29;CTPS1;NCK1;NCK2;LMBR1L;CASP8;CD44;LCP1;MSN
prerank,negative regulation of angiogenesis (GO:0016525),0.40576684534210156,0.9483001478996927,0.5726141078838174,1.0,1.0,12/84,10.09%,E2F2;ATP2B4;THBS2;ANGPT4;ROCK2;PDE3B;PML;SULF1;SERPINE1;ADAMTS9;ROCK1;PIK3CB
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.31480695123227104,-0.9476599412038459,0.5,0.7789712253597356,1.0,8/17,24.57%,APOE;PRKAA1;FGF1;SREBF2;ERLIN2;ABCA2;RAN;MBTPS1
prerank,neurotrophin signaling pathway (GO:0038179),-0.3090395546424501,-0.9474181069571341,0.5269709543568465,0.778583478708904,1.0,9/21,29.26%,NTRK2;RAP1A;KIDINS220;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,cellular defense response (GO:0006968),-0.2619166600976678,-0.9465576326287143,0.569620253164557,0.7796716395536845,1.0,8/40,23.69%,BECN1;LSP1;RAB23;LBP;CCR9;LGALS3BP;NCF2;PTK2B
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.36629616177147895,-0.9464747801313624,0.4948453608247423,0.778921701015471,1.0,10/13,51.57%,TBX3;SRA1;SOX9;SOX8;DLL1;EID2B;SOSTDC1;ANKRD2;PRICKLE1;NOTCH1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4957622031022874,0.9464685148966013,0.5370101596516691,1.0,1.0,2/11,11.74%,STMN1;RAC1
prerank,ncRNA 3'-end processing (GO:0043628),0.47652725985918987,0.946330046692395,0.5234806629834254,1.0,1.0,3/14,10.73%,INTS7;ERI1;INTS8
prerank,neuron projection development (GO:0031175),0.39708065221625394,0.94622543859977,0.6163141993957704,1.0,1.0,39/168,17.32%,KIF20B;VASH2;STMN1;MAP4K4;ADGRV1;RB1;GSK3B;LAMB1;NEDD4;MAPT;NRK;EPHA4;ANKRD27;LRRK2;DNM2;ROCK1;MAP4;HMGB1;MARK2;SVBP;SRGAP2;SAMD14;EPB41L3;PLXNB1;FRYL;MAPK8IP3;EHD1;BLOC1S5;DOCK7;TAOK1;VAPA;HDGFL3;GDNF;DBN1;PTEN;NCKAP1;STMN2;NGF;RAB13
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.27253250150877506,-0.9454183201629334,0.5324675324675324,0.7804813544041153,1.0,13/33,25.58%,GLUL;GLS;GOT2;PRODH;KYAT1;GOT1;ALDH5A1;DDAH2;GLUD1;NIT2;RIMKLA;OAT;GLS2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4494930092271019,0.9453186153630849,0.5128205128205128,1.0,1.0,7/19,13.42%,BMPR1A;MDM4;EFNA1;SMAD6;BMP2;SMAD4;HEY2
prerank,protein homotrimerization (GO:0070207),-0.3427470895111525,-0.94511825903186,0.5198675496688742,0.7793498609744189,1.0,2/14,3.00%,SLC1A2;SCARA5
prerank,protein trimerization (GO:0070206),-0.3427470895111525,-0.94511825903186,0.5198675496688742,0.7793498609744189,1.0,2/14,3.00%,SLC1A2;SCARA5
prerank,positive regulation of inflammatory response (GO:0050729),-0.21519622152427878,-0.9451047822161396,0.6470588235294118,0.7784715770407785,1.0,21/86,19.44%,SNX4;TLR4;PDCD4;GPR4;IFI35;LBP;RPS19;GRN;CD81;APP;AGTR1;OSMR;CX3CL1;NUPR1;PLA2G7;VAMP8;FEM1A;PDE2A;CCN4;KARS1;TNIP1
prerank,regulation of muscle cell differentiation (GO:0051147),0.4330223516983981,0.9450366173628112,0.525934861278649,1.0,1.0,5/31,6.12%,CDH15;FGFR2;SPAG9;SRF;CTNNA1
prerank,histone deubiquitination (GO:0016578),0.4652208760798303,0.9449681560094914,0.5124835742444153,1.0,1.0,6/18,16.08%,UIMC1;USP21;USP16;BRCC3;TRRAP;TAF10
prerank,regulation of cytoplasmic translation (GO:2000765),0.47850380792110203,0.944248128963413,0.5238095238095238,1.0,1.0,4/14,9.13%,DHX9;FMR1;YBX3;CPEB2
prerank,regulation of response to cytokine stimulus (GO:0060759),0.4501496352811825,0.9441050292506565,0.5142487046632125,1.0,1.0,6/19,18.13%,CBFB;DHX9;ELF1;PARP9;MAVS;RUNX1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.4475170781175238,0.9438028344650966,0.5182767624020888,1.0,1.0,9/20,23.17%,STOML2;MCU;MCUB;MICU1;PMPCA;MAIP1;SPG7;MICU2;LETM1
prerank,regulation of mRNA catabolic process (GO:0061013),0.39201662634894413,0.9434680381120405,0.5957446808510638,1.0,1.0,42/121,23.25%,XPO1;MOV10;PSMC2;ZC3HAV1;PSMD5;HNRNPD;CNOT1;TNPO1;SERBP1;SAMD4A;FMR1;RC3H2;PSMB1;PSMD14;PUM2;PSMD1;YTHDF2;PSMB9;EXOSC7;NUP214;PRKCA;RC3H1;PABPC1;PSMC6;ZC3H14;CNOT7;FXR1;PNPT1;PSMB2;PSME4;PSMB7;PRKCD;PSMD11;PSME3;MAPKAPK2;DIS3;PSMD13;ZFP36L1;PSMB8;PSMD4;YTHDF1;HSPA8
prerank,regulation of cellular component size (GO:0032535),0.4311282053674055,0.9432041273589916,0.5332512315270936,1.0,1.0,11/30,17.73%,HP1BP3;VAV2;RAB22A;PICALM;EZR;RAC1;RPTOR;PTEN;LARS1;MSN;LAMTOR5
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.43560713516317046,0.9425369438741644,0.5175757575757576,1.0,1.0,12/29,23.53%,FADD;WWOX;PML;HTRA2;AGT;SFRP1;PPP2R1B;TNFSF10;RIPK1;TRAF2;BID;BCL10
prerank,extracellular matrix disassembly (GO:0022617),0.4072801516480119,0.9425199860000641,0.5379464285714286,1.0,1.0,10/53,17.51%,BMP1;SCUBE1;MMP14;ADAMTS5;TLL2;EXOC8;CD44;CAPG;LCP1;SH3PXD2B
prerank,isotype switching (GO:0045190),0.49614799260118736,0.942409313632452,0.5375552282768777,1.0,1.0,2/10,12.40%,RNF168;MSH6
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4814104671309948,0.9421042599286606,0.5108695652173914,1.0,1.0,1/11,1.68%,TERF1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.42631456357771674,0.94204807814006,0.5118483412322274,1.0,1.0,7/35,10.43%,STMN1;ARHGAP24;MFN2;CUL3;RIPOR2;MAPKAP1;ARHGAP35
prerank,neurotransmitter biosynthetic process (GO:0042136),0.46695130403112417,0.9418807688346286,0.5082417582417582,1.0,1.0,6/14,26.18%,CHAT;ACHE;DAGLB;DAGLA;SLC6A4;ALDH9A1
prerank,receptor catabolic process (GO:0032801),-0.2994816967239145,-0.9418589282572205,0.5133689839572193,0.7850268677933149,1.0,10/24,15.62%,KIF16B;GPRASP1;BECN1;AP2A2;PIK3R4;LGMN;VLDLR;AP2M1;AP2S1;AP2A1
prerank,regulation of myoblast fusion (GO:1901739),0.4852770891503168,0.9417122439208994,0.5218023255813954,1.0,1.0,4/11,24.30%,RIPOR2;EHD1;MAPK14;EHD2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.4147457929077968,0.941611962912468,0.5575221238938053,1.0,1.0,10/50,13.71%,GLI3;FGFR2;TXNDC15;WDR11;TUBD1;FBXL17;GAS1;TEDC1;RORA;BTRC
prerank,macrophage activation (GO:0042116),-0.2640579045840832,-0.9412357511785894,0.5970149253731343,0.7855830342838319,1.0,9/34,14.32%,TLR4;IFI35;CD93;LBP;APP;CRTC3;CX3CL1;IFNGR1;SBNO2
prerank,regulation of GTPase activity (GO:0043087),0.3921635279085955,0.941129619870595,0.6082164328657315,1.0,1.0,26/177,11.05%,ECT2;EZH2;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;OCRL;NET1;AFDN;FGD4;WNK1;VAV2;EPHA4;FGD1;LRRK2;RSU1;CPEB2;TBC1D7;PICALM;SRGAP2;PLXNB2;FGD6;LIMS1;PLXNB1
prerank,negative regulation of locomotion (GO:0040013),-0.3579768696395276,-0.9407388194719384,0.536144578313253,0.7857925485453662,1.0,4/12,14.34%,FRMD5;DUSP3;SPOCK3;CCDC125
prerank,positive regulation of developmental process (GO:0051094),0.3938210628583129,0.9405546288823192,0.6132930513595166,1.0,1.0,28/164,12.70%,CDC20;BMP1;FBXO5;PAXIP1;BMPR1A;MIEF2;AURKA;AGO2;ADGRL1;NUMA1;SRF;SOX6;FMR1;ENPP2;RIF1;MCU;CORO1B;VHL;TAPT1;DDHD1;MIEF1;GRIP1;SMURF2;BMP2;ZDHHC15;GJA1;TRPM4;KMT5C
prerank,cellular metal ion homeostasis (GO:0006875),-0.20791218506380643,-0.9403465124001754,0.6428571428571429,0.7857882201355683,1.0,22/102,16.64%,SLC8A3;ATP1B1;CAV1;RYR2;SLC24A2;DMPK;CDH5;TPT1;HTR2C;ATP1A1;ATP1B3;CHRNA7;ATP1A3;TMCO1;ATP1A2;SLC30A1;ATP2B2;ATP2B3;SLC12A2;HTR2A;PTH1R;RMDN3
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3354917924165659,-0.9402729532126998,0.5291970802919708,0.7850469816342474,1.0,7/14,15.86%,PPP2R2B;PPTC7;PPP2CB;PPM1F;PPP2R2C;DUSP1;PPP5C
prerank,positive regulation of vasoconstriction (GO:0045907),-0.3526098989892106,-0.9402010429094456,0.5640138408304498,0.7843074589627905,1.0,4/13,24.72%,CAV1;ADRA1A;TBXA2R;ADRA1B
prerank,Rac protein signal transduction (GO:0016601),-0.3183596791646745,-0.9396957851219409,0.5611814345991561,0.7844916471031131,1.0,3/18,3.68%,ELMO1;TIAM1;HACD3
prerank,regulation of cell growth (GO:0001558),0.3941057034282958,0.9396919101611285,0.6217303822937625,1.0,1.0,39/204,16.05%,KIF14;RAB33B;PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;CEP43;FXN;MMP14;NET1;RBBP7;PML;DERL2;SFRP2;SMARCA4;KLHL22;CDA;AGT;TGFBR1;CRLF3;IP6K2;CCN3;NDRG3;ENPP1;GJA1;ADAM17;SMAD4;ITCH;JADE1;USP47;CDKN1B;SMAD3;STK11;RPTOR;INO80;TP53;SESN2;SFRP1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.45714859813297504,0.9395421018608368,0.5210674157303371,1.0,1.0,6/15,19.30%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.45714859813297504,0.9395421018608368,0.5210674157303371,1.0,1.0,6/15,19.30%,AGO2;CNOT1;PABPC1;CNOT7;TNRC6C;TNRC6B
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4800989192889881,0.9389550899307638,0.5252525252525253,1.0,1.0,3/12,10.09%,ATP2B4;XDH;PIK3CB
prerank,positive regulation of GTPase activity (GO:0043547),0.39127960929582106,0.9389351274633296,0.6158475426278837,1.0,1.0,24/188,11.05%,ECT2;EZH2;ARHGAP22;ARHGAP11A;USP6NL;MAP4K4;GSK3B;RTN4R;EVI5L;TBC1D25;NET1;TBC1D13;AFDN;TBC1D2B;SCRIB;ARHGAP24;SYDE2;RSU1;TBC1D7;PICALM;RANGAP1;SRGAP2;LIMS1;PLXNB1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.4442334601274867,0.9387134581418637,0.5233291298865069,1.0,1.0,3/24,7.29%,DDIAS;CDKN2D;SFRP2
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.31681784344657127,-0.9386600497560591,0.5498154981549815,0.7859853623148011,1.0,8/18,21.77%,PTPRZ1;TNFRSF21;NF1;TNFRSF1B;TENM4;DAAM2;IL34;SLC45A3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.42953775101787045,0.9382848587219158,0.5412054120541205,1.0,1.0,11/27,19.30%,AGO2;AJUBA;DHX9;EIF4ENIF1;FMR1;LIMD1;PUM2;FXR1;TP53;RIPK1;TNRC6B
prerank,positive regulation of translational initiation (GO:0045948),0.4414952311725879,0.9381048737032968,0.514018691588785,1.0,1.0,4/18,10.55%,KHDRBS1;LARP1;CDC123;YTHDF2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.44821104216052915,0.9375614246338602,0.5198902606310014,1.0,1.0,5/18,15.17%,GSK3B;POLR1A;CTNNA1;ILRUN;OTUD7B
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.373566686446,-0.93743475038985,0.5238095238095238,0.7877690399208356,1.0,8/11,50.13%,P2RX4;CDH13;TREM2;P2RX5;P2RX3;TRAT1;CCL4;NEUROD2
prerank,membrane fusion (GO:0061025),-0.26502935356153967,-0.9372256304494231,0.5971223021582733,0.7873248394557324,1.0,10/33,16.57%,DNM3;RIMS1;NAPG;DNM1;RABIF;SNAP29;NSFL1C;VPS33B;GCA;VAMP3
prerank,regulation of exocytosis (GO:0017157),-0.24489752335827356,-0.9368874246985034,0.5714285714285714,0.7872119747083958,1.0,8/46,7.80%,STXBP5L;CADPS;SYT1;STX4;STXBP6;RAB27B;IL1RAPL1;RAB5A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.3690651489077687,-0.9367272064955863,0.5689149560117303,0.7866726287982736,1.0,5/10,17.98%,ATP5F1A;ATP5PO;ATP5MC3;ATP5PD;ATP5F1D
prerank,regulation of brown fat cell differentiation (GO:0090335),0.45253492794986816,0.9365509068794337,0.5174337517433751,1.0,1.0,4/16,10.49%,FTO;ZBTB7B;PIM1;HNRNPU
prerank,type I interferon signaling pathway (GO:0060337),-0.2521502934371315,-0.9362612611214706,0.6086956521739131,0.7858972582708715,1.0,17/41,29.28%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;JAK1;SAMHD1;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.2521502934371315,-0.9362612611214706,0.6086956521739131,0.7858972582708715,1.0,17/41,29.28%,IFNAR1;IFI35;IFITM3;IRF2;IRF3;IRF9;ADAR;IFIT1;BST2;IFI27;IFITM2;EGR1;RNASEL;STAT2;JAK1;SAMHD1;RSAD2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.24332685952036404,-0.9360192913369433,0.6434782608695652,0.7855798154236465,1.0,21/45,39.61%,STAT3;MALT1;TLR4;APP;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A;TYROBP;CCL19;NOD2;USP50;PYCARD;MYD88;CASP1;FZD5;AGER
prerank,regulation of dendrite morphogenesis (GO:0048814),0.4133577396980805,0.9359736909316352,0.5317365269461077,1.0,1.0,6/32,6.53%,GSK3B;OBSL1;NEDD4;CUX1;RAP2A;CAPRIN1
prerank,Golgi localization (GO:0051645),0.490021310207897,0.935881584142754,0.5265423242467718,1.0,1.0,3/11,15.20%,ARHGAP21;TBCCD1;UVRAG
prerank,endocardial cushion development (GO:0003197),-0.3135536132305947,-0.9358018127267366,0.5630630630630631,0.785210000543303,1.0,9/21,17.86%,ACVR1;BMPR2;ACVRL1;TGFB2;NOS3;HEYL;ENG;CRELD1;TBX2
prerank,angiogenesis involved in wound healing (GO:0060055),0.4725135806121089,0.9357332942578792,0.5250737463126843,1.0,1.0,2/11,5.10%,HPSE;SRF
prerank,regulation of cellular response to heat (GO:1900034),0.3974256619584049,0.9356258438971966,0.5833333333333334,1.0,1.0,19/77,17.39%,NDC1;NUP155;NUP205;NUP160;GSK3B;RPA1;MAPT;NUP85;RPA2;TPR;BAG5;NUP214;RANBP2;NUP133;RPTOR;NUP42;NUP98;ATR;NUP210
prerank,organelle fission (GO:0048285),-0.29116906233835,-0.934891815237224,0.5287958115183246,0.7863791260816042,1.0,4/24,7.00%,DNM3;PRKN;FIS1;DNM1
prerank,membrane lipid catabolic process (GO:0046466),0.48793830963191975,0.9345899616671152,0.534711964549483,1.0,1.0,5/10,21.93%,ENPP2;SMPD2;NAGA;PDXDC1;SMPDL3B
prerank,protein deacetylation (GO:0006476),0.42043996814124496,0.9345617583143705,0.5510662177328844,1.0,1.0,9/41,12.61%,MIER1;TBL1XR1;MIDEAS;RCOR1;MSL3;MIER3;MTA3;HDAC1;HDAC2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3046353239031635,-0.9343311716996051,0.5405405405405406,0.7866488939222289,1.0,7/19,19.71%,BPNT2;TPST1;SLC35B3;ABHD14B;TPST2;SLC26A2;PAPSS1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.27982778712481193,-0.9342389145118951,0.5432098765432098,0.7859577044438419,1.0,14/32,32.75%,CALM1;AKAP6;CEMIP;PLCG1;TRPC1;CX3CL1;CALM3;GSTM2;JPH2;GPER1;THY1;P2RY6;GSTO1;APLNR
prerank,regulation of cholesterol efflux (GO:0010874),0.4231878867952314,0.9339345850034503,0.525934861278649,1.0,1.0,1/30,0.82%,PON1
prerank,anterior/posterior pattern specification (GO:0009952),0.4061156983271615,0.9338197844709425,0.5540983606557377,1.0,1.0,15/53,20.49%,HOXC5;BHLHE41;HOXC4;HOXA7;HOXB3;HOXB6;TGFBR1;BMP2;LRP5;HEY2;HOXB7;SMAD2;HOXA3;SKI;HOXA6
prerank,blood circulation (GO:0008015),0.40497592509070013,0.9337220222414135,0.550328227571116,1.0,1.0,8/49,9.89%,F5;ROCK2;MYOF;SCPEP1;ROCK1;ELN;BDKRB2;MEOX2
prerank,endoplasmic reticulum organization (GO:0007029),0.40007925810881084,0.9334864263580668,0.5663531870428422,1.0,1.0,21/72,19.46%,RAB10;RTN3;LNPK;PRNP;ATL2;ATL3;LRRK2;TRAM2;EMD;EIF2AK3;STX18;GAK;MIA3;TOR1B;VAPA;TMCC1;CYB5A;REEP2;TRAM1;CCDC47;DNM1L
prerank,regulation of Wnt signaling pathway (GO:0030111),0.39516427681057076,0.9329890571321288,0.5787847579814624,1.0,1.0,33/108,19.60%,CBFB;MACF1;CDK14;DEPDC1B;WWOX;FGFR2;TRABD2B;NLK;SULF2;TCF7L1;RNF43;HMGXB4;SFRP2;SULF1;LRRK2;GNAQ;SMARCA4;EMD;BMP2;RSPO3;BTRC;FOXL1;NKD1;NOTUM;SFRP1;TMEM237;SALL1;AMER1;FAM53B;RUNX1;FRZB;SKI;TERT
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.39200525562675154,0.9325180712549195,0.6626626626626627,1.0,1.0,77/264,19.96%,RBM15;COIL;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRPK1;SRRM1;CPSF4;SNRNP35;HNRNPH2;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;RBM19;HNRNPA2B1;PPWD1;LSM4;DDX1;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;GEMIN7;CWC25;SRPK2;CWC22;PDCD7;BUD13;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;TGS1;SNRPB;TRA2A
prerank,regulation of leukocyte migration (GO:0002685),0.4604597868650676,0.9321581851367563,0.5350993377483444,1.0,1.0,4/16,14.41%,HOXA7;ANXA1;RAC1;MIA3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.448573439588688,0.9319903146530228,0.5238095238095238,1.0,1.0,5/19,10.54%,CBFB;ROCK2;MYO1C;ROCK1;NPHP1
prerank,cellular response to superoxide (GO:0071451),-0.3720504526261372,-0.9318425884999495,0.5536723163841808,0.7904734798524441,1.0,6/10,21.96%,NOS3;SOD2;PRDX2;PRDX1;ADPRS;ATP7A
prerank,response to iron ion (GO:0010039),0.4788351406760248,0.9316526290660945,0.539039039039039,1.0,1.0,5/12,23.19%,FXN;BMP6;ACO1;SNCA;SLC11A2
prerank,phospholipid metabolic process (GO:0006644),-0.22372986426751568,-0.9315412364355645,0.6909090909090909,0.790270323033826,1.0,21/71,24.76%,PLA2G4A;PLPPR1;PIP4K2A;PLAAT3;ABHD12;PIP4K2B;PLPP3;AGPAT5;GPX4;PCYT2;PIP5K1A;TNFAIP8L3;PIP4P1;PLBD2;ACP6;PLPPR4;AGPAT4;ABCA2;PLA2G15;PGP;FADS1
prerank,mammary gland development (GO:0030879),0.44596626765954805,0.9314066545228279,0.5366795366795367,1.0,1.0,3/21,10.43%,GLI2;ZBTB7B;ARHGAP35
prerank,endocytic recycling (GO:0032456),-0.249451940293624,-0.9313879233179,0.5760869565217391,0.7896730814447944,1.0,10/50,8.24%,VPS35L;MICALL1;VPS53;STX6;SNX4;ANKRD50;SNX3;EHD4;CCDC93;ENTR1
prerank,negative regulation of synaptic transmission (GO:0050805),0.4407283752234576,0.9313127608986939,0.530209617755857,1.0,1.0,9/23,19.94%,GRIK3;LRRK2;MTMR2;ACHE;PLK2;PTEN;SHANK2;STXBP1;ARF1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4650110217741321,0.9312574286065716,0.523121387283237,1.0,1.0,4/13,18.32%,BMF;RHOT1;VDAC2;BAD
prerank,amino acid import across plasma membrane (GO:0089718),-0.29083511200701173,-0.9312230774265867,0.5808080808080808,0.7891415781351979,1.0,5/24,5.85%,SLC6A6;SLC1A2;SLC7A2;SLC3A2;SLC7A5
prerank,epidermal cell differentiation (GO:0009913),0.413351002305369,0.9308363584898118,0.5556858147713951,1.0,1.0,8/41,13.76%,TGM1;ERCC3;HDAC1;ANXA1;HDAC2;CLIC4;MED1;ADAM9
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.42122424269984327,0.9306322487669993,0.542719614921781,1.0,1.0,8/31,13.27%,TWIST2;CRIM1;SMAD6;TMEM64;LIMD1;TRPM4;LRP5;TWIST1
prerank,atrial septum development (GO:0003283),0.4641236435556261,0.9305184112586461,0.5072674418604651,1.0,1.0,4/13,13.42%,MDM4;NPHP3;NOTCH2;HEY2
prerank,aorta morphogenesis (GO:0035909),-0.3320294246252487,-0.9296426599394881,0.5488721804511278,0.7919124988371271,1.0,6/17,5.50%,JAG1;ACVRL1;PDGFRB;PROX1;LRP1;MYLK
prerank,regulation of synapse organization (GO:0050807),0.43232160652238816,0.9295388124046641,0.533498759305211,1.0,1.0,3/26,7.60%,ARHGAP22;NEDD4;EPHA4
prerank,regulation of platelet aggregation (GO:0090330),-0.32529042547956416,-0.9295230938294322,0.5409252669039146,0.7912979075328263,1.0,4/17,8.02%,PRKG1;F11R;LYN;PRKCQ
prerank,"transcription, DNA-templated (GO:0006351)",0.3895485665850553,0.9291941558357794,0.6486486486486487,1.0,1.0,34/207,12.60%,TRIP13;TCFL5;E2F1;TTF2;NAT14;PMF1;CBFB;SETX;DEK;TFDP1;TAF3;MBD1;KLF13;ERCC3;ELOC;GLIS3;TAF12;POLR2A;ZBTB7B;FOXO3;GTF3C4;LEO1;NFYA;EPC1;NR4A2;MMS19;IVNS1ABP;DRG1;TAF15;GTF2A1;TTF1;TAF4;RNGTT;SSRP1
prerank,negative regulation of interferon-beta production (GO:0032688),0.47792931725142485,0.9288120986746099,0.5453194650817236,1.0,1.0,5/10,24.04%,PTPRS;YY1;SIRPA;RELB;REL
prerank,ventricular septum morphogenesis (GO:0060412),-0.28105299014959206,-0.9286954308113486,0.5627906976744186,0.7923218598783124,1.0,11/27,17.41%,ACVR1;SMAD7;TGFBR2;BMPR2;TGFB2;PROX1;SLIT2;SOX4;HEYL;ROBO2;CITED2
prerank,primary alcohol metabolic process (GO:0034308),-0.2861095540114237,-0.9286451160635912,0.5226130653266332,0.7915431108656181,1.0,7/25,14.75%,IGF1;RDH10;GPD2;ALDH3A2;GDPD3;DHRS3;GDPD1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2590579761303553,-0.9285687212016378,0.6029411764705882,0.7908262589254311,1.0,7/39,7.76%,CAMK2D;FGF14;HECW1;WNK2;FGF13;NETO1;FXYD5
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.36542178040857853,-0.9281770343614606,0.5364431486880467,0.7908008752379697,1.0,3/11,12.80%,NOVA2;PCBP1;IGF2BP2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4477373706093438,0.9279153197499045,0.5406451612903226,1.0,1.0,1/19,1.41%,SLC25A21
prerank,embryonic skeletal system development (GO:0048706),0.42238135697353485,0.9278078308024746,0.5387323943661971,1.0,1.0,11/35,19.63%,SULF2;HOXC4;PDGFRA;SULF1;DSCAML1;HOXB3;WNT9A;OSR1;HOXA3;XYLT1;DYNC2I1
prerank,generation of neurons (GO:0048699),0.38797345376770725,0.9275757762972383,0.6312625250501002,1.0,1.0,22/190,10.71%,EN1;RACGAP1;CIT;HMGB2;ATOH8;ARTN;MYEF2;AUTS2;BHLHE41;WNT2B;MAPT;POU3F2;OLIG2;LMX1B;SH3RF1;YAP1;WNT6;MARK2;SDCCAG8;NR4A2;YTHDF2;PLXNB2
prerank,T cell mediated immunity (GO:0002456),-0.35320326812586705,-0.9270718587610931,0.5186440677966102,0.7922524146091194,1.0,2/13,12.97%,JAG1;GNL1
prerank,regulation of sodium ion transport (GO:0002028),0.42174376168020755,0.9269949496237517,0.5565927654609102,1.0,1.0,10/34,17.52%,ATP2B4;RANGRF;NEDD4;WNK1;SNTA1;DLG1;NKAIN1;PER1;CNKSR3;WNK3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.42593038129832206,0.9268379413932184,0.535931790499391,1.0,1.0,6/28,11.12%,MMP14;DLK1;ARRB1;FBXW7;YTHDF2;ARRDC1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.26015569733259497,-0.926669592444181,0.6455696202531646,0.7923202217146845,1.0,15/34,34.29%,STX4;EPHB2;SLC7A5;PTPN22;VAMP3;XBP1;DNAJB9;CD86;LAPTM5;PHB2;PTPRC;RBP4;SPHK2;CLCF1;NOD2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.32981497003154425,-0.9263594548526671,0.549618320610687,0.7921059133059296,1.0,10/15,36.35%,PRKN;IGF1;GHITM;GPX1;BCL2L1;PRELID1;HGF;PPIF;AKT1;PSMD10
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.38008034059877316,-0.926355890351869,0.5416666666666666,0.7912226928074743,1.0,7/10,38.13%,ACADM;ETFDH;ETFB;ACADS;ACADVL;GCDH;ETFA
prerank,protein alkylation (GO:0008213),-0.2894921350338029,-0.9261632451178292,0.5502183406113537,0.7907499605562596,1.0,8/22,26.39%,PRMT3;FAM98A;PRMT2;METTL21A;PRMT8;PRMT1;METTL22;GSPT1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.44467390244299465,0.9261268166414112,0.5340453938584779,1.0,1.0,3/17,11.44%,PRNP;PTPN2;EZR
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.45407671793282534,0.9261229652157583,0.5281899109792285,1.0,1.0,2/13,7.97%,LARGE1;CHST3
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.46186722476581127,0.9259477842355358,0.529839883551674,1.0,1.0,3/13,8.29%,TXN;PYCR1;LRRK2
prerank,protein import (GO:0017038),0.39571008416714715,0.9255502087300828,0.5867507886435331,1.0,1.0,28/84,22.01%,RANBP17;NUP155;RPAIN;E2F3;TNPO1;NUP85;EIF4ENIF1;CSE1L;TPR;SNX33;IPO7;APPL2;NUP214;IPO11;NXT1;NUP133;IPO5;NXT2;SLC25A17;FAM53B;IPO9;NUP188;PEX12;IPO4;HSPA4;RAB8B;PEX13;APPL1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.39616963601403116,0.9254701226847326,0.5559071729957806,1.0,1.0,21/63,21.25%,FADD;PHIP;WWOX;BCL2L12;SIAH2;TCF7L2;PML;SH3RF1;TNFRSF10B;AGT;TGFBR1;CASP8;BIRC6;ITGAV;SRC;TNFSF10;RIPK1;SP100;PSME3;TRAF2;FEM1B
prerank,camera-type eye development (GO:0043010),0.42067434358741207,0.9253294048230103,0.5251533742331288,1.0,1.0,8/25,22.58%,FBN1;CACNA1C;NES;EFEMP1;SHROOM2;SKI;ALDH1A3;CEP290
prerank,proteasomal protein catabolic process (GO:0010498),0.38952617215920576,0.9252384964240996,0.6308926780341023,1.0,1.0,65/201,23.18%,KIF14;FEM1C;PSMC2;PSMD5;UBE2K;NEDD4;SPSB3;SIAH2;SPSB2;TBL1XR1;FAF1;ARRB1;PML;FBXW7;PRPF19;AGAP3;PSMB1;SMURF1;CUL3;PSMD14;KCTD2;KLHL22;CUL4B;PSMD1;SKP2;FBXL17;ARMC8;PPP2R5C;FBXO45;PSMB9;SMURF2;FBXW11;ITCH;CRBN;BTRC;SPOP;PSMC6;ZNRF1;RAD23B;SIAH3;UBXN2B;WWP1;PSMB2;PLAA;HECTD3;PSME4;PSMB7;CCDC47;UBE2D3;PSMD11;ZSWIM8;HECW2;PSME3;FEM1B;CLOCK;PSMD13;PCNP;GID4;SIRT2;BIRC2;RNF216;PSMB8;PSMD4;DDB1;PCBP2
prerank,regulation of gene expression (GO:0010468),0.38636702787959026,0.9250479686714402,0.794,1.0,1.0,164/903,15.54%,BRCA1;PHF19;EZH2;TCF19;ATRX;MYBL1;NSD2;ERMAP;TCFL5;RBL1;E2F1;BRCA2;ATOH8;ZC3H7A;MED26;ATP2B4;TRIML2;RB1;SP3;BMPR1A;AURKA;MOV10;TICAM1;ROCK2;FGFR4;AGO2;CTCF;GSK3B;LIN54;HNRNPD;TRA2B;NLK;DDRGK1;AJUBA;CHEK2;SETDB2;NFIA;UBAP2;NFIL3;TCF7L1;SRSF10;MAPT;CCAR1;AFF3;XDH;MBNL3;BMP6;MUSK;AFDN;GZF1;YAF2;SOX6;HP1BP3;GON4L;PML;FBXW7;PSPC1;MYBL2;HNRNPH1;SFRP2;YBX3;CIAO3;POLR2A;FUS;MATR3;ZBTB7B;MYCBP;WWTR1;PHF1;CDK2;PRRX2;UBR5;LARP1;LMX1B;BNC2;ZFP64;MSL3;ROBO1;LIMD1;DNM2;YAP1;NONO;NFYA;ANGPT1;VHL;PUM2;SLC24A3;ROCK1;SLC8A1;WNT6;PICALM;ZNHIT3;ERC1;PIK3CB;NR3C1;HINT1;PARP9;SFPQ;TGFBR1;YTHDF2;FLOT2;SLC39A8;LIMS1;POFUT1;HNRNPL;EIF2AK3;NCOA2;CRKL;CPSF4;CNTF;HDAC1;BMP2;AHR;EZR;NKX2-1;TERF2;STOX1;ATXN1;ZUP1;SPTY2D1;RBMS3;HNRNPH2;FUBP1;RBPJ;GJA1;METTL4;KMT2D;TRIM6;TOB2;NOTCH2;ATF5;CASP8;C1QTNF1;CTSH;RORA;TWIST1;PTBP2;HEY2;LARP4;MED1;GPBP1L1;YY1;RC3H1;ADAM19;FOXK2;TRIM5;SMAD3;RAMP3;JMJD1C;SOX1;PER1;RBAK;PIN1;PRDM8;EFEMP1;CNOT7;PRKAG1;ZC3H7B;GDNF;TRRAP;MLF2;TNRC6C;ZNF507;HOXB7
prerank,negative regulation of gluconeogenesis (GO:0045721),0.47543780510226635,0.9243356774558517,0.5029498525073747,1.0,1.0,2/11,4.84%,GCK;ERFE
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4072275465326543,0.9243243825538805,0.5569476082004556,1.0,1.0,13/42,16.25%,CARS2;SARS2;VARS1;DARS2;DARS1;IARS2;PPA1;TARS2;PARS2;RARS2;QARS1;EPRS1;LARS1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.43292468317605454,0.924258977781352,0.5298804780876494,1.0,1.0,2/19,9.03%,CFAP53;NPHP3
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3685669722000865,-0.9242036126229792,0.5489614243323442,0.7942856506980421,1.0,2/11,4.31%,CAV1;BIN1
prerank,regulation of protein metabolic process (GO:0051246),0.3998651950699522,0.9238280947827581,0.5505107832009081,1.0,1.0,4/44,5.70%,FAM83D;ROCK2;CHEK2;FAF1
prerank,B cell activation involved in immune response (GO:0002312),0.4680202445548669,0.9236238563282477,0.5536723163841808,1.0,1.0,2/13,12.40%,RNF168;MSH6
prerank,myelin maintenance (GO:0043217),0.4779078344862507,0.923611545158209,0.5166163141993958,1.0,1.0,4/10,21.72%,CXCR4;EPB41L3;PTEN;SOD1
prerank,cellular response to virus (GO:0098586),0.4164042424032469,0.9231266964851859,0.5515970515970516,1.0,1.0,4/30,8.98%,VWCE;GBF1;FMR1;RIOK3
prerank,regulation of hippo signaling (GO:0035330),0.4532530482891747,0.9228564856513761,0.5445816186556928,1.0,1.0,6/17,18.33%,CIT;AJUBA;LIMD1;NF2;SHANK2;MAPK14
prerank,neuron projection extension (GO:1990138),-0.27141682438939474,-0.9226975759347885,0.5373134328358209,0.7968021363615675,1.0,12/32,19.33%,NRP2;HSP90AB1;SPG11;TMEM108;MAP1B;ULK1;SEMA3A;CTNNB1;CDKL3;SEMA5B;NRP1;CYFIP1
prerank,cAMP metabolic process (GO:0046058),-0.34985155169154214,-0.9226164948499921,0.5597269624573379,0.7961000602389493,1.0,7/13,29.92%,ADCY3;ADCY8;ADCY4;PDE4D;PTHLH;EPHA2;ADCY5
prerank,regulation of cell development (GO:0060284),0.4158123843405171,0.9225672808297806,0.5600461893764435,1.0,1.0,8/36,14.59%,HMGB2;BHLHE41;ADGRA2;YAP1;YTHDF2;NOTCH2;HEY2;DOCK7
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.39022782089292324,0.9224212235257635,0.6016597510373444,1.0,1.0,22/88,18.62%,TYMS;ILF3;SYNCRIP;CNOT1;DNAJC1;EIF4ENIF1;SAMD4A;CAPRIN1;FMR1;LARP1;MRPL13;EIF2AK3;RBM4;DHFR;EPRS1;CNOT7;FXR1;NFKB1;PAIP2B;RIC1;PLAT;PUS7
prerank,miRNA metabolic process (GO:0010586),0.43535193158452345,0.9221699717061815,0.5325520833333334,1.0,1.0,4/20,13.45%,DGCR8;AGO2;TUT7;TUT4
prerank,regulation of protein localization (GO:0032880),0.40176913113998414,0.9221123977064208,0.5605726872246696,1.0,1.0,12/58,14.21%,BORA;TRIML2;DZIP1L;AFDN;TPR;FBXW7;WDPCP;PICALM;AAK1;TRIM6;DLG1;TRIM5
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3284578462337785,-0.9217595748072815,0.5502008032128514,0.7969955950450228,1.0,5/18,4.32%,ACVR1;TGFBR2;ACVRL1;TGFB2;NOS3
prerank,T cell proliferation (GO:0042098),0.4650804479302949,0.9212487460245821,0.5398860398860399,1.0,1.0,3/13,16.26%,CTPS1;LMBR1L;MSN
prerank,actin filament organization (GO:0007015),0.38662715964196304,0.9208527586338315,0.6251256281407035,1.0,1.0,34/151,17.66%,SPTA1;GAS2L3;SHROOM3;TRIOBP;RHOA;CGNL1;TPM4;MYO1C;CDC42EP2;FAT1;RFLNA;MCU;CORO1B;ABI1;SAMD14;RND2;RAC1;DMTN;DPYSL3;BAIAP2L1;SVIL;DLG1;TMOD3;DSTN;CAPG;MPRIP;RHOC;LCP1;FHOD1;DBN1;COBL;SHROOM2;TRPV4;ABI2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.2786259945570204,-0.9205748294847417,0.5663265306122449,0.7986881815419692,1.0,11/28,21.40%,GRB14;PIP4K2A;GRB10;PIP4K2B;PRKCQ;INPP5K;IRS1;GSK3A;PRKCZ;PIP4K2C;SLC27A4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4626058215822498,0.9205746703655655,0.5597122302158274,1.0,1.0,4/13,18.54%,TICAM1;IL18;AXL;ZBTB1
prerank,regulation of osteoblast differentiation (GO:0045667),0.3912529885135036,0.9205723085331553,0.5947643979057592,1.0,1.0,20/82,13.63%,FBXO5;BMPR1A;TWIST2;FGFR2;BMP6;NPNT;CRIM1;CCN1;WWTR1;SMAD6;TMEM64;LIMD1;YAP1;DDR2;BMP2;ZHX3;TRPM4;LRP5;TWIST1;PRKD1
prerank,stem cell differentiation (GO:0048863),0.4117284173265287,0.9204161858992015,0.5632183908045977,1.0,1.0,13/39,20.56%,SETD6;FGFR2;KIT;SETD2;FBXL17;METTL5;LMBR1L;TP53;SFRP1;MLLT3;OSR1;PSMD11;EEF1AKMT4-ECE2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.4488803442820366,0.9201165399495121,0.5450762829403606,1.0,1.0,3/15,9.97%,FGFR4;PDPN;DDR2
prerank,chromatin remodeling (GO:0006338),0.3881761792155968,0.9200832875272554,0.6095820591233435,1.0,1.0,36/100,23.33%,ATRX;SMARCC1;RB1;BAZ1B;CHD1L;SMARCAD1;NUDT5;RBBP4;ARID1A;SRCAP;SMARCA4;HDAC1;HDAC2;TADA2A;ACTL6B;KDM5C;RUVBL2;BAZ1A;INO80;DR1;SUV39H2;MBD3;ZBTB1;KDM4B;MBD2;ARID1B;NPM3;HDAC4;CHD4;CBX3;DAXX;MYSM1;KAT2A;ACTL6A;SMARCC2;CECR2
prerank,protein destabilization (GO:0031648),0.42062965786261486,0.9199706362788865,0.5529131985731273,1.0,1.0,6/32,13.71%,PLK1;PRNP;CUL3;FBXW11;CTSH;BTRC
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.31763270565731305,-0.9199156727236497,0.5423728813559322,0.799197943905577,1.0,7/17,19.85%,EMC2;EMC3;SGTA;EMC1;EMC9;GET4;MMGT1
prerank,protein deneddylation (GO:0000338),-0.3766535991948331,-0.9196848599414387,0.553623188405797,0.7987907623565211,1.0,7/10,30.62%,COPS8;COPS7A;COPS2;COPS4;TOR1A;COPS6;GPS1
prerank,cell chemotaxis (GO:0060326),0.39799193474019645,0.9196740720472819,0.581270182992465,1.0,1.0,9/60,12.37%,HMGB2;PARVA;LPAR1;KIT;CXCR4;PDGFRA;CORO1B;CCN3;NR4A1
prerank,regulation of interleukin-1 production (GO:0032652),0.45185091622986384,0.9194233104315157,0.5521978021978022,1.0,1.0,6/15,20.44%,HMGB1;ANXA1;SIRPA;FOXP1;TMED10;CEACAM1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.2661609218762824,-0.9193060088507845,0.6311475409836066,0.798655676686416,1.0,7/33,12.52%,PTPRG;KRIT1;APOE;ACVRL1;SYNJ2BP;SLIT2;THBS1
prerank,cellular response to drug (GO:0035690),-0.28947003575706,-0.9189667052786525,0.5377358490566038,0.7984617529065705,1.0,7/25,20.45%,MEF2C;GAS6;ACER2;GPLD1;PPM1F;KCNQ1;CERS1
prerank,carboxylic acid metabolic process (GO:0019752),0.41328185377482285,0.9185382411999864,0.5357561547479485,1.0,1.0,2/33,3.54%,PON1;GSTO2
prerank,cellular response to dsRNA (GO:0071359),0.4509504424603782,0.9184818750656726,0.5363511659807956,1.0,1.0,3/15,8.98%,COLEC12;DHX9;RIOK3
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.3555594771150903,-0.9182603092750046,0.5484848484848485,0.7991734007838657,1.0,4/11,17.93%,MEF2C;LYN;LGALS9;PIK3CD
prerank,vasodilation (GO:0042311),-0.34594575441895936,-0.9182421391636078,0.5494880546075085,0.7983188356249743,1.0,5/13,26.13%,NOS3;SOD2;KLF2;NOS1;GPER1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.3445371719995997,-0.918201812510174,0.5691318327974276,0.7975232014640252,1.0,5/13,7.83%,HSP90AB1;STX4;STX3;RIC3;MAP1A
prerank,regulation of dendrite development (GO:0050773),-0.2534103958011334,-0.917084127213832,0.5878378378378378,0.7992572202189024,1.0,12/37,16.20%,HECW1;DCC;CDKL5;TNIK;CAMSAP2;SEMA4D;VLDLR;NSMF;ADGRB3;RTN4IP1;LRP8;CSMD3
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.3639100634813571,-0.9168353046693732,0.5522388059701493,0.7988701935728011,1.0,3/11,20.05%,PRKN;PINK1;PARK7
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.4743151309540551,0.9157993434788595,0.5672333848531684,1.0,1.0,2/10,14.27%,PCGF5;DNMT3A
prerank,cellular response to organonitrogen compound (GO:0071417),0.37584533361384154,0.9157432645225345,0.6156217882836588,1.0,1.0,20/99,16.83%,BRCA1;AQP1;DIAPH1;CTNNA1;LARP1;P2RY1;TRPM2;AHR;EZR;AKAP9;DMTN;SLC38A9;GLRA2;RPTOR;PKD2;IPO5;SESN2;SFRP1;LARS1;LAMTOR3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3488844867796879,-0.9157084783545473,0.5638297872340425,0.8003487561053684,1.0,4/13,9.48%,NR3C2;AR;ESR1;ABHD2
prerank,alpha-amino acid metabolic process (GO:1901605),-0.23994645071162451,-0.9156804945095028,0.6086956521739131,0.7995259968015255,1.0,16/45,23.55%,GLUL;GLS;GOT2;SLC25A13;SLC25A12;MTHFD1;KYAT1;GOT1;MTRR;GPT2;DDAH2;GLUD1;ATP7A;ASS1;RIMKLA;OAT
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3925795267025141,0.9156071776825332,0.5903361344537815,1.0,1.0,30/73,24.76%,CBFB;PSMC2;PSMD5;PRKDC;PSMB1;PSMD14;YAP1;PSMD1;KMT2A;YTHDF2;TAL1;PSMB9;ITCH;PSMC6;METTL3;PSMB2;RUNX1;PSME4;PUS7;PSMB7;PSMD11;PSME3;EIF2AK2;LDB1;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,bone morphogenesis (GO:0060349),0.4564545984898368,0.9152835243412935,0.5369318181818182,1.0,1.0,2/14,3.52%,CYP26B1;FGFR2
prerank,response to sterol (GO:0036314),0.4784340850068737,0.9148905196176066,0.5545851528384279,1.0,1.0,5/11,20.88%,PMVK;TGFBR1;RORA;SMAD2;INSIG1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.44544460065459834,0.9145098625432081,0.5410071942446043,1.0,1.0,3/15,12.06%,LARGE1;CHST3;GNPDA2
prerank,skeletal muscle organ development (GO:0060538),-0.27484927902978123,-0.9142531047376314,0.5631578947368421,0.8018250115007798,1.0,8/26,21.65%,MEF2C;CAV1;IGSF8;MYL6;SIX1;STRA6;DISP1;BASP1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.39775550328291975,0.9137032648958737,0.5936473165388828,1.0,1.0,15/57,19.46%,MIEF2;AURKA;GSK3B;BMF;FAM162A;HTRA2;MCU;DDHD1;MIEF1;BOK;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,cellular response to exogenous dsRNA (GO:0071360),0.46076640208548214,0.9135076616565256,0.5545977011494253,1.0,1.0,2/12,4.75%,COLEC12;DHX9
prerank,microtubule anchoring (GO:0034453),0.46411966235390634,0.9134946480750138,0.543661971830986,1.0,1.0,2/12,6.63%,PCM1;BICD2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.2527486752934233,-0.9131787603056752,0.6564885496183206,0.8033426728293096,1.0,8/37,15.59%,STAT3;APOD;TLR4;PDCD4;PLD3;CHID1;ABCD2;IL17D
prerank,morphogenesis of an epithelium (GO:0002009),0.427743731052017,0.912657769025052,0.5558252427184466,1.0,1.0,4/25,11.71%,TIMELESS;FGFR2;KDM2B;TBX18
prerank,cellular response to copper ion (GO:0071280),0.4566258354360412,0.9125767435114994,0.5712290502793296,1.0,1.0,2/16,5.24%,AQP1;PRNP
prerank,mesonephros development (GO:0001823),-0.3673443091210773,-0.912432876235078,0.5903614457831325,0.8040306119808278,1.0,4/11,24.26%,FGF1;BMP7;FGF10;PAX8
prerank,negative regulation of cell communication (GO:0010648),-0.2994244675144278,-0.9115001002723289,0.6052631578947368,0.8052277872776186,1.0,5/21,13.50%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,regulation of vasoconstriction (GO:0019229),-0.26827947955295495,-0.9111686647876198,0.5802469135802469,0.8050216835516512,1.0,8/27,15.76%,ECE1;CAV1;PER2;BMPR2;ACE;AGTR1;ADRA1A;CHRM3
prerank,negative regulation of cell projection organization (GO:0031345),0.39700170150148156,0.9109433798857649,0.5674778761061947,1.0,1.0,17/48,18.56%,RTN4R;LPAR1;PRNP;EPHA4;RAB29;DENND5A;PTPRS;BAG5;GAK;HDAC2;DPYSL3;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3639270869738112,-0.9107380763243725,0.5579937304075235,0.8050680235940173,1.0,3/10,8.58%,PDCD4;DNAJA1;PTPN22
prerank,negative regulation of viral genome replication (GO:0045071),0.39906895757026123,0.9101764753607757,0.5572082379862701,1.0,1.0,4/40,4.06%,ILF3;FAM111A;ZC3HAV1;MPHOSPH8
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.35560386477571726,-0.9098596601685194,0.5613496932515337,0.8062112992582952,1.0,9/12,42.27%,SERINC3;MTHFD1;PSAT1;CBS;SEPHS2;CTH;PSPH;GGT1;PHGDH
prerank,regulation of microglial cell activation (GO:1903978),-0.32557504077417854,-0.909654846804999,0.6040955631399317,0.8058021416334612,1.0,5/15,29.51%,GRN;CX3CL1;SYT11;SPHK1;PTPRC
prerank,negative regulation of myotube differentiation (GO:0010832),0.4571116939038531,0.909596291889936,0.5518731988472623,1.0,1.0,3/12,11.37%,BHLHE41;CCN3;HDAC1
prerank,positive regulation of catalytic activity (GO:0043085),-0.25739742219360595,-0.9092203571471192,0.5971223021582733,0.8059955558491338,1.0,10/37,10.85%,PSEN1;CAV1;MAPK8;STX4;NCSTN;MSH2;IGF2;NHEJ1;MAPK3;ABL1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.35365556088336947,-0.9087527150526638,0.5591054313099042,0.8060949312324162,1.0,3/12,5.39%,MAP2K5;TLR4;KLF4
prerank,positive regulation of protein modification process (GO:0031401),0.3761316467274313,0.908661612841181,0.6763527054108216,1.0,1.0,37/203,15.52%,CDCA2;CEP295;DYRK1A;FNIP1;ROCK2;TRABD2B;FAM161A;LEPR;MUSK;RAP2A;ARRB1;UBE2N;EFNA1;FMR1;ATG7;TXN;CCN1;PPP1R7;LRRK2;AXIN2;ANGPT1;RB1CC1;P2RY1;CALM2;CRKL;BMP2;RAC1;ADAM17;PLAUR;SLCO3A1;SMPD1;CAMTA1;PTPA;WDFY2;PIN1;TAOK1;FXR1
prerank,regulation of tau-protein kinase activity (GO:1902947),0.46668800879008165,0.9083074034635016,0.5515695067264574,1.0,1.0,1/10,2.56%,RB1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.4299376055030583,0.9081744540748057,0.536745406824147,1.0,1.0,4/17,11.74%,MCU;RIPOR2;CAMK1D;RAC1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.263582823690184,-0.9076925148216269,0.6438356164383562,0.8074621616368185,1.0,12/34,20.57%,RIMS1;SYT1;RAB5A;SYT7;DTNBP1;SYT11;SYT12;PREPL;SYT10;SYT6;RAB27A;SYT2
prerank,neutrophil activation (GO:0042119),-0.36187179181905993,-0.9074161568921914,0.6109324758842444,0.8072327780793228,1.0,5/12,32.77%,KMT2E;IL15;SYK;FCER1G;TYROBP
prerank,protein acylation (GO:0043543),-0.25324342617407464,-0.9072717555778319,0.6412213740458015,0.8066511713607375,1.0,11/38,15.69%,FOXO1;EP300;GLUL;ZDHHC5;ZDHHC1;ZDHHC13;KAT2B;ING5;ZDHHC7;NAA80;ZDHHC8
prerank,vasculogenesis (GO:0001570),-0.25642964056203577,-0.9071798602817807,0.5878787878787879,0.8060093068031425,1.0,9/32,15.06%,CAV1;TGFBR2;PDGFRB;RAMP2;RASIP1;CUL7;VEGFA;ENG;SOX17
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.39422531450380915,0.9071008135179017,0.5922330097087378,1.0,1.0,10/57,14.06%,MRPL36;XPO1;RRS1;CUL4B;MRTO4;DHX37;RPS17;NOM1;SDAD1;PAK1IP1
prerank,negative regulation of cell activation (GO:0050866),-0.32481155776230514,-0.9069288591455623,0.5901060070671378,0.8056630616598243,1.0,3/14,5.31%,APOE;NOS3;THBD
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.42253605476804956,0.9068423880670797,0.5733333333333334,1.0,1.0,12/27,25.57%,CSTF3;RNASE6;PCF11;RPP30;POP1;RNASE1;KHNYN;LACTB2;TRIR;RNASEH1;TOE1;NUDT16
prerank,protein-containing complex disassembly (GO:0032984),-0.22443791287564105,-0.9064091730529644,0.6447368421052632,0.8059053862901115,1.0,14/54,16.15%,CAV1;TECPR1;SNX14;RPL23;TSG101;FZD2;SNAP29;CTNNB1;VPS33B;APC;DVL1;LAMP2;VAMP8;LRP6
prerank,positive regulation of ion transport (GO:0043270),-0.2347163635192227,-0.9062957827912828,0.5909090909090909,0.8052757006089638,1.0,19/48,34.06%,ANO6;SNX4;MYLK;KIF5B;CACNB2;SCN1B;VAMP8;CRACR2A;ADRA2A;P2RX4;DRD2;WFS1;P2RX7;SCN4B;RAB3B;PKP2;GPD1L;SCN3B;CACNA1D
prerank,regulation of autophagosome assembly (GO:2000785),-0.254473010197109,-0.9062538405122115,0.6204819277108434,0.804497024909936,1.0,10/33,13.17%,PIP4K2A;FEZ1;PIP4K2B;RALB;RAB5A;IFT20;FEZ2;RAB3GAP2;PINK1;NUPR1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.31190803859428845,-0.9061780266544807,0.604982206405694,0.8038016127197938,1.0,5/16,11.68%,DDX17;AR;SAFB;ESR1;DDX5
prerank,protein localization to organelle (GO:0033365),0.37852323169416563,0.906090905606531,0.6458752515090543,1.0,1.0,25/133,16.27%,RAB33B;CNTLN;BBS9;WDR35;RPA1;GBF1;IFT140;OBSL1;PACSIN2;DDRGK1;DHX9;PRNP;RPA2;BICD2;LRRK2;TRAM2;EMD;XPA;GAK;EHD1;TOR1B;VAPA;CSRP3;DDX1;CYB5A
prerank,sarcomere organization (GO:0045214),0.4158313407355022,0.9057269276271646,0.577639751552795,1.0,1.0,4/27,16.48%,MYLK3;CSRP2;CSRP3;TNNT3
prerank,negative regulation of cell population proliferation (GO:0008285),0.3824471992003953,0.9056967874830412,0.733,1.0,1.0,68/351,17.38%,E2F7;CDKN3;E2F1;CDKN2D;PPM1D;CDKN2C;PDS5B;CDC6;CTCF;E2F3;TFDP1;ALDH1A2;MDM4;ARID2;CTBP1;MCC;PDPN;NMI;COL18A1;PTPN2;RBBP4;TGFBR3;PML;SFRP2;CLMN;B4GALT7;SLC16A2;KDM2B;MFN2;BTG3;SMAD6;IRF1;ING4;KLF11;AXIN2;KANK2;VHL;ABI1;EMD;NOX4;PPP2R5C;PLXNB1;CCN3;BMP2;APPL2;P3H1;PLPP1;NCK2;WNT9A;TES;ATF5;CDKN1B;ADAMTS1;MORC3;STK11;PTPRU;CNOT7;PKD2;NF2;ZBTB7C;TP53;SFRP1;PTEN;TINF2;PTPRK;NGF;SLURP1;TFAP4
prerank,protein K48-linked ubiquitination (GO:0070936),0.39596932938509694,0.9045418039613642,0.6006674082313682,1.0,1.0,7/54,9.60%,UBE2T;UBE2C;UBE2K;UBR5;CUL3;UBE2R2;SKP2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.38307489346169527,0.9040684301288714,0.6370143149284253,1.0,1.0,28/122,16.94%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;SAMD4A;NMD3;SLC25A37;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;FXR1;PRKD2;PASK;NFKB1;METTL3;PYM1
prerank,regulation of actin nucleation (GO:0051125),0.4546729953816603,0.904017926061789,0.5604075691411936,1.0,1.0,5/12,22.32%,ARFIP1;CORO1B;ARF1;WHAMM;ARPIN
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3245407817004308,-0.9038996273250398,0.5698529411764706,0.8078566704205608,1.0,7/15,26.13%,NR1H3;GRN;ZC3H12A;CD84;CD300A;LRFN5;GPER1
prerank,lipoprotein localization (GO:0044872),0.47120163479667726,0.9037007046867697,0.559593023255814,1.0,1.0,5/11,19.43%,PRKCB;MIA3;UNC119;ZDHHC3;UNC119B
prerank,glutathione biosynthetic process (GO:0006750),0.46313778341822387,0.9036319418429393,0.5766961651917404,1.0,1.0,4/11,19.90%,GSS;GCLM;GCLC;HAGH
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.41404856992654804,0.9034159207119457,0.5671462829736211,1.0,1.0,15/31,22.03%,CAPRIN1;EFNA1;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;DBN1;PTEN;SIPA1L1;ABI2;TANC2;CAPRIN2;CDK5;NGEF
prerank,protein deacylation (GO:0035601),-0.2864621554630499,-0.9032563285971911,0.6390243902439025,0.8083358528542023,1.0,10/23,27.00%,LYPLA1;ABHD17C;HDAC5;HDAC3;SIRT5;HDAC7;PPT1;LYPLAL1;LYPLA2;ABHD17B
prerank,positive regulation of stress fiber assembly (GO:0051496),0.39638434452117083,0.9031781534478304,0.5625,1.0,1.0,13/44,17.28%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47
prerank,polyol metabolic process (GO:0019751),-0.23624213458570512,-0.9025897031092874,0.6818181818181818,0.808884235995486,1.0,16/46,20.66%,INPP4B;CALM1;IPPK;PPIP5K2;PLCB3;PLCG1;NUDT3;INPP1;ITPKB;INPP5D;SYNJ1;PLCE1;IMPA1;INPP4A;ITPKC;PLCH1
prerank,gastrulation (GO:0007369),0.4437035794451596,0.9024134104768234,0.5558620689655173,1.0,1.0,5/15,17.82%,MKKS;NPHP3;LRP5;UGDH;SMAD2
prerank,myofibril assembly (GO:0030239),0.3952962165073099,0.9024016610442749,0.5699774266365688,1.0,1.0,10/42,22.27%,OBSL1;MYLK3;CSRP2;PDGFRA;TMOD3;CSRP3;TNNT3;TMOD1;LMOD1;TMOD2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.2867770215169253,-0.9018553729706126,0.6190476190476191,0.809560675400252,1.0,9/23,24.55%,OTUD7A;ATXN3;USP8;MINDY1;YOD1;USP33;OTUB1;MINDY2;USP34
prerank,cilium-dependent cell motility (GO:0060285),0.42324747579333566,0.9017963818045586,0.5335917312661499,1.0,1.0,3/22,10.32%,DNAH2;DNAH1;RSPH9
prerank,regulation of neurogenesis (GO:0050767),0.3954048349909146,0.9017472666462876,0.5984427141268076,1.0,1.0,9/55,14.59%,HMGB2;NAP1L1;PCM1;BHLHE41;YAP1;YTHDF2;APPL2;HEY2;DOCK7
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4052479797745989,0.9015727394507519,0.5815028901734104,1.0,1.0,9/38,15.14%,DHX9;NMI;BMP6;RIOK3;PUM2;POLR3D;PRKCA;AKIRIN2;SLC15A4
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.4710757629733967,0.900248034024502,0.5686567164179105,1.0,1.0,5/11,18.94%,ING4;FOXM1;TP53;TFAP4;SP100
prerank,cardiac atrium morphogenesis (GO:0003209),-0.31065070328628225,-0.9001584095809475,0.5531914893617021,0.8124763948908332,1.0,3/16,4.85%,BMPR2;TGFB2;PROX1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.4219783456651255,0.8998240199050185,0.5749674054758801,1.0,1.0,4/19,11.74%,MCU;RIPOR2;CAMK1D;RAC1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.2477217409600924,-0.8997060065194508,0.6283185840707964,0.8125856488316178,1.0,10/44,12.01%,ATP1B1;GABBR1;ANO6;AKAP6;KCNJ3;WNK2;KCNJ6;ATP1B3;KCNN2;KCNJ10
prerank,regulation of receptor binding (GO:1900120),-0.3596941213440154,-0.8994266244000504,0.5876923076923077,0.8122530029410775,1.0,5/10,26.03%,ADAM15;B2M;ATP2A3;BDNF;PTPRF
prerank,Golgi to endosome transport (GO:0006895),0.4424047658653372,0.899194083498026,0.575208913649025,1.0,1.0,3/16,8.09%,AP4M1;GBF1;VPS13A
prerank,purine ribonucleotide catabolic process (GO:0009154),0.42408168006735736,0.8991318493729367,0.5776636713735558,1.0,1.0,5/21,13.58%,HPRT1;XDH;ACAT1;HINT1;NUDT4
prerank,apoptotic process (GO:0006915),0.37774237472854016,0.8990700746435455,0.708,1.0,1.0,36/203,16.42%,MELK;ESPL1;CIT;FADD;MCM2;BMF;CASP7;MAGI3;IAPP;DAP;AIFM2;FAM162A;STK3;ERCC3;CXCR4;CHEK1;IRF1;ING4;BCLAF1;TNFRSF10B;PLAGL1;IKBKG;APAF1;BOK;AHR;NOTCH2;CASP8;PRKCE;JADE1;STK11;FXR1;BCL2L13;RFK;AKAP1;NCKAP1;TNFRSF25
prerank,homocysteine metabolic process (GO:0050667),0.4611952050237662,0.8985101457080156,0.5611510791366906,1.0,1.0,3/11,18.07%,MTHFR;NOX4;DPEP1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.44581485116060765,0.8984182089243214,0.5633187772925764,1.0,1.0,7/13,21.72%,SCAP;DKK3;BMP2;NFKB1;ERLIN1;BMP5;SOD1
prerank,positive regulation of cell differentiation (GO:0045597),0.376424706166892,0.8982095599283043,0.7167167167167167,1.0,1.0,46/237,16.05%,ECT2;EZH2;CDH15;FBXO5;LOXL2;BMPR1A;RHOA;ZEB1;SPAG9;SRF;PDPN;BMP6;CTNNA1;SOX6;IL18;TCF4;NPNT;SFRP2;CCN1;WWTR1;RIPOR2;AXIN2;TMEM64;YAP1;VHL;AGT;DDR2;TGFBR1;BMP2;ZHX3;RRAS;GJA1;TRPM4;SMAD4;LRP5;TWIST1;RBM4;PRKD1;BLOC1S5;SMAD3;MEDAG;WDFY2;GDNF;NFKB1;LPL;SFRP1
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.4235272942638332,0.8976972101023022,0.5605263157894737,1.0,1.0,5/17,13.42%,BMPR1A;BMP2;RBPJ;NOTCH2;HEY2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.43723076018196927,0.897489071362291,0.5636856368563685,1.0,1.0,6/17,24.24%,CCNE1;HNRNPU;GJA1;TERT;FERMT2;KDM1A
prerank,RNA interference (GO:0016246),0.44044514536015267,0.8972158307983488,0.568,1.0,1.0,3/17,6.10%,AGO2;DHX9;NRDE2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.42562794618163324,0.8971598796051372,0.5636132315521628,1.0,1.0,5/21,11.13%,TXNDC12;LRRK2;NCK1;BOK;EIF2AK3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.30228108427109485,-0.8967334265525831,0.6210045662100456,0.8173661318644438,1.0,3/18,6.15%,POLDIP3;THOC2;DDX19B
prerank,negative regulation of signal transduction (GO:0009968),0.3747761957440773,0.8967098562688084,0.7291875626880642,1.0,1.0,39/249,11.79%,EZH2;GLI3;RB1;BRAP;CYP26B1;WWOX;TRABD2B;CNOT1;MMP14;NLK;NEDD4;DLK1;SULF2;NTN1;ASXL1;SIAH2;XDH;LEPROT;RNF43;PTPN2;HMGXB4;ARRB1;FBXW7;SFRP2;SULF1;LRRK2;NCK1;KANK2;MTMR2;AGT;CSNK2A2;PIK3CB;NR4A2;YTHDF2;DKK3;ARRDC1;PRKCB;BMP2;ENPP1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.43783208984630473,0.8967096805667945,0.5727762803234502,1.0,1.0,6/16,19.66%,LEPROT;PTPN2;VHL;ADIPOR1;NF2;PARP14
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.3076241771255944,-0.8965829967370486,0.5984251968503937,0.8168270917489048,1.0,6/18,12.77%,SNX3;DAB2;VPS11;MAPK3;MAPK1;MAP2K1
prerank,sterol metabolic process (GO:0016125),0.3866833930113561,0.8965113580309729,0.6016949152542372,1.0,1.0,12/60,15.92%,LBR;CYP39A1;CYP26B1;PMVK;SOAT1;SCAP;TM7SF2;ABCA1;SOAT2;FDXR;STARD3;DHCR7
prerank,positive regulation of cell motility (GO:2000147),0.376523134984969,0.8963484725400581,0.7017017017017017,1.0,1.0,23/205,7.41%,ARHGEF39;GTSE1;CCDC25;MAP4K4;SYNE2;TWIST2;TRIP6;ROCK2;CEP43;MMP14;DDRGK1;ACTN4;LAMB1;KIT;SPAG9;NTN1;CCAR1;PDPN;MYO1C;PDGFRA;PLAU;PPP3CA;CCN1
prerank,regulation of JNK cascade (GO:0046328),-0.20551586411370174,-0.896343244852447,0.72,0.8164744748308381,1.0,21/101,14.05%,MECOM;PRKN;TNFRSF19;SH3RF3;HIPK2;TPD52L1;TAOK2;ZMYND11;ANKRD6;MAP3K5;DUSP3;CYLD;DUSP22;DACT1;SEMA3A;MINK1;APP;HDAC3;PINK1;SDCBP;SH3RF2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.4621268687622642,0.8960924441553924,0.5747663551401869,1.0,1.0,3/10,19.95%,TICAM1;MIA3;CD68
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3818358903530463,0.8956975012031567,0.6150583244962884,1.0,1.0,5/66,9.14%,EZH2;KIT;LRRK2;ROBO1;MAP3K4
prerank,positive regulation of reproductive process (GO:2000243),-0.26435222634866096,-0.8954655615403111,0.6344827586206897,0.8174492868073764,1.0,13/31,33.32%,PDE3A;GLRA1;CFAP69;LHFPL2;VEGFA;PGAM4;INHBA;TACR3;PRDM9;CACNA1H;PLCB1;INHBB;C1QBP
prerank,negative regulation of cell differentiation (GO:0045596),0.3731313065953903,0.8954089336635717,0.7079556898288016,1.0,1.0,42/181,16.13%,E2F1;ADGRV1;RB1;TWIST2;SUZ12;USF3;ANP32B;ASXL1;ANKRD26;XDH;COL5A2;EFNA1;SFRP2;CRIM1;WWTR1;SMAD6;TMEM64;NPHP3;LIMD1;LEO1;YAP1;TGFBR1;HNRNPU;YTHDF2;RUNX1T1;NKX2-1;ABCA1;ENPP1;WNT9A;TRPM4;ADIPOR1;LRP5;RORA;TWIST1;MED1;SPRED1;SMAD3;ITGAV;EFEMP1;SFRP1;SPRED2;PTEN
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.36518827383641134,-0.8952124776396893,0.5911764705882353,0.8170693011916171,1.0,2/10,1.56%,CAMK2D;HECW1
prerank,positive regulation of vacuole organization (GO:0044090),-0.3626218572237666,-0.8949462927388322,0.5823529411764706,0.8167084093366795,1.0,5/10,11.86%,PIP4K2A;PIP4K2B;RALB;GRN;RAB3GAP2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.25572866810880157,-0.8943885522306164,0.6506849315068494,0.8170661323877754,1.0,8/32,13.10%,FIS1;SOD2;HSPD1;ERBB4;NDUFS1;BCL2;BNIP3;CCAR2
prerank,triglyceride biosynthetic process (GO:0019432),0.4395133770153108,0.8933940666962941,0.5746367239101717,1.0,1.0,8/18,27.07%,LPIN2;AGMO;PCK2;GK;LPIN3;GPAM;LPGAT1;DGAT1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.24043304952016537,-0.8927435558276231,0.7068965517241379,0.8195141400901413,1.0,10/46,12.53%,SEMA6A;TIMP3;TLR4;WNK2;EPHB2;DUSP3;LYN;LMO3;SYNJ2BP;SPRY2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.4336725006132678,0.8926065663128593,0.5880829015544041,1.0,1.0,3/21,9.97%,GCK;GPI;TKT
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.31264060776338853,-0.8924550501275466,0.6181102362204725,0.8192994433195998,1.0,6/17,10.34%,NTRK2;APOE;IGF1;BIN1;RTN1;CHRNA7
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.46517448793401445,0.8924440652549376,0.5855072463768116,1.0,1.0,5/11,20.85%,RSPO3;NKD1;SFRP1;MLLT3;CSNK1E
prerank,establishment of protein localization to membrane (GO:0090150),0.37693807551745856,0.8915606521796562,0.610752688172043,1.0,1.0,22/66,23.25%,SYNE3;VPS37B;RAB10;MYO1C;AFDN;VPS37A;ZDHHC18;CHM;ZDHHC15;GORASP2;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;BRAF;ZDHHC24;ICMT;VPS37C;ZDHHC2;ZDHHC14;BID
prerank,activation of protein kinase B activity (GO:0032148),-0.2745727239785459,-0.8914795721474633,0.6145251396648045,0.8204872020755108,1.0,10/29,17.16%,INSR;IGF1;GAS6;RICTOR;NTRK3;MTOR;FGF1;PINK1;ITGB1BP1;ADRA2A
prerank,regulation of T cell mediated immunity (GO:0002709),0.4730529237764237,0.8911636138051747,0.5749613601236476,1.0,1.0,3/10,18.54%,HMGB1;TRPM4;ZBTB1
prerank,melanocyte differentiation (GO:0030318),0.45814124354989477,0.8907411315287298,0.5797317436661699,1.0,1.0,3/11,11.79%,LRMDA;KIT;ENPP1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.30628520397123454,-0.8904235570847372,0.6239669421487604,0.8218052233491523,1.0,8/16,33.01%,EP300;NAA25;KAT2B;NAA80;NAA30;CREBBP;NAA16;NAA10
prerank,maintenance of protein localization in organelle (GO:0072595),0.4262317626129315,0.8903410643981092,0.5860215053763441,1.0,1.0,5/19,14.24%,TAF3;PML;TAPT1;HNRNPU;MORC3
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.45045550282836777,0.8898611164625205,0.5877192982456141,1.0,1.0,4/12,17.23%,SMARCA4;HDAC1;SFRP1;FOXP1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37094211555357043,0.8897410116526826,0.699497487437186,1.0,1.0,49/182,19.66%,RBL1;ATOH8;ATP2B4;RB1;BMPR1A;AURKA;MOV10;ROCK2;AGO2;DDRGK1;SETDB2;WDR54;MAPT;XDH;FBXW7;SFRP2;ROBO1;YAP1;VHL;MTMR2;SLC24A3;PICALM;PARP9;FLOT2;CRKL;HDAC1;BMP2;TERF2;STOX1;RBMS3;TRIM6;NOTCH2;HEY2;YY1;CNOT7;TNRC6C;NFKB1;SFRP1;ITGB8;LDLR;FOXP1;ANKRD13D;RUNX1;RBL2;WNT4;HAVCR2;TNRC6B;TERT;PARP14
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.276609666711233,-0.8897325086407362,0.6334841628959276,0.8223409948600015,1.0,10/23,18.55%,HSP90B1;OS9;UFD1;DERL1;SURF4;SELENOS;PREB;SEC61B;AUP1;SYVN1
prerank,regulation of angiogenesis (GO:0045765),0.37423689960381046,0.8896058573996198,0.7107107107107107,1.0,1.0,31/192,14.26%,BRCA1;VASH2;AQP1;ATP2B4;THBS2;ANGPT4;ROCK2;HYAL1;AGO2;ADAM12;PDE3B;ADGRA2;ANXA3;PML;SFRP2;HSPB6;SULF1;SERPINE1;ROCK1;GAB1;PRKCB;RRAS;PRKCA;PDPK1;CTSH;TWIST1;PLXND1;PRKD1;SPRED1;ADAMTS1;ITGB1
prerank,negative regulation of transport (GO:0051051),-0.2328744344987273,-0.8892744248528349,0.6705882352941176,0.8224128067895324,1.0,17/51,24.60%,PRKN;MCTP1;SNX3;CTTNBP2NL;NR1H3;CRYAB;SYT11;PPM1F;SCAMP5;BST2;WWP2;NR1H2;ITGB3;PACSIN3;RACK1;NDFIP1;ARL6IP5
prerank,regulation of fibroblast proliferation (GO:0048145),0.39297302881004625,0.8888474047764857,0.5746606334841629,1.0,1.0,11/45,16.05%,E2F1;AQP1;DHX9;PDGFRA;B4GALT7;EMD;AGT;DDR2;MORC3;TP53;SFRP1
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.29393762835832826,-0.8884112047268711,0.6217228464419475,0.8233728849735285,1.0,4/19,10.35%,APOE;RIC3;CHRNA7;CHRFAM7A
prerank,ureteric bud development (GO:0001657),0.431233743830689,0.8878729603361448,0.5906593406593407,1.0,1.0,6/17,18.16%,FGFR2;NPNT;BMP2;PKD2;SALL1;OSR1
prerank,negative regulation of axon extension (GO:0030517),-0.25066184455767976,-0.8874522445476567,0.6626506024096386,0.8245555269894488,1.0,10/30,19.19%,SEMA6A;SEMA6D;SEMA7A;SEMA4D;SEMA3A;SEMA3B;SEMA3C;CDKL3;MAG;SEMA5B
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4480912816502324,0.887412996851445,0.5811001410437235,1.0,1.0,4/12,20.95%,ACTN4;DMTN;RCC2;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4480912816502324,0.887412996851445,0.5811001410437235,1.0,1.0,4/12,20.95%,ACTN4;DMTN;RCC2;FBLN1
prerank,glycolytic process (GO:0006096),0.40890947497812447,0.8872294583151266,0.5771084337349398,1.0,1.0,4/28,8.43%,PFKFB1;GCK;GPI;PGM1
prerank,stress-activated MAPK cascade (GO:0051403),-0.21421468399278543,-0.8869032567875488,0.7340425531914894,0.8248816988769156,1.0,24/61,23.35%,MAPK10;TNFRSF19;MAPK8;TAB2;CUL1;TAOK2;MAP3K5;TAB3;MAPK9;NOD1;MINK1;MAPK3;MAPK1;CHUK;MAP2K7;LGALS9;MAP3K13;UBB;GPS2;MAP3K12;RPS27A;UBC;MAP2K4;MAP3K11
prerank,regulation of tube diameter (GO:0035296),0.4535004213637431,0.8866818423400535,0.5807365439093485,1.0,1.0,6/13,19.15%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,vascular process in circulatory system (GO:0003018),0.4535004213637431,0.8866818423400535,0.5807365439093485,1.0,1.0,6/13,19.15%,ROCK2;SCPEP1;ROCK1;ADCY6;GCLM;GCLC
prerank,cellular response to calcium ion (GO:0071277),0.37546740682841734,0.886663194852379,0.6289640591966174,1.0,1.0,2/67,2.44%,ECT2;ADGRV1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.37778396617357685,0.886505535129353,0.621196222455404,1.0,1.0,11/62,12.62%,MAP4K4;RTN4R;LPAR1;AUTS2;NET1;ARRB1;ROBO1;PIK3CB;CRKL;RAC1;NOTCH2
prerank,response to interferon-beta (GO:0035456),0.4184412478329635,0.8862625513303065,0.5843137254901961,1.0,1.0,6/22,16.33%,UBE2K;HTRA2;IRF1;TRIM6;PNPT1;IFNAR2
prerank,proteolysis (GO:0006508),0.3717902304806335,0.8860771083624376,0.749,1.0,1.0,27/252,10.44%,KEL;BMP1;VASH2;CTSE;FAM111A;MMP24;MMP25;ADGRV1;SENP1;TRABD2B;CASP7;MMP14;LVRN;NLN;CPXM1;TASP1;PLAU;CAPN15;TMPRSS5;SPPL2B;ADAMTS9;HTRA2;CPQ;VHL;LONP1;SVBP;TRHDE
prerank,iron-sulfur cluster assembly (GO:0016226),0.4126407792441151,0.8858366465518661,0.5714285714285714,1.0,1.0,9/24,22.54%,FXN;NUBP2;CIAO3;MMS19;ISCA2;NUBP1;LYRM4;CIAO2A;NFS1
prerank,dicarboxylic acid transport (GO:0006835),-0.2685324115074313,-0.8848436741706028,0.6467065868263473,0.8284532355382696,1.0,6/28,10.33%,SLC1A2;SLC13A3;SLC25A13;SLC25A12;SLC22A6;GIPC1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.36115025379452226,-0.8842835571879966,0.5902578796561605,0.8287385183708993,1.0,2/10,1.56%,CAMK2D;HECW1
prerank,carbohydrate derivative transport (GO:1901264),-0.2992498765830121,-0.8840453164178907,0.6199095022624435,0.8283666976011104,1.0,4/18,10.93%,PLTP;LBP;SLC15A2;VLDLR
prerank,regulation of MAPK cascade (GO:0043408),0.36909960239449613,0.8840406940606524,0.7006048387096774,1.0,1.0,25/157,14.21%,FAM83D;MAP4K4;KSR1;ULK4;ROCK2;FGFR2;LPAR1;IAPP;KIT;WDR54;VRK2;STK3;NRK;TGFBR3;JCAD;CCN1;ROCK1;HMGB1;APIP;BMP2;RRAS;ROR1;ADRB2;SPRED1;TRIM5
prerank,hexose transmembrane transport (GO:0008645),-0.28582094351960674,-0.8839274557161411,0.6355140186915887,0.8277740479267821,1.0,7/21,32.85%,SLC2A1;SLC2A3;SLC2A10;SLC45A3;SLC2A9;SLC5A3;SLC45A1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.4133344521714173,0.8839099391925936,0.5797665369649806,1.0,1.0,4/22,9.54%,ROCK2;EFNA1;EPHA4;PICALM
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.32851514867150505,-0.8837192519423147,0.6013289036544851,0.8273104257533201,1.0,5/14,31.78%,ATP1B1;ATP1B3;LRRC38;ATP1B2;KCNIP2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.3450384467145555,-0.8825781247182631,0.5975609756097561,0.8288362786595478,1.0,8/13,27.23%,NAMPT;PTGS2;PARP16;PARP10;NAXD;NNMT;NUDT12;NAXE
prerank,regulation of exosomal secretion (GO:1903541),-0.2909768054998666,-0.8823502223219554,0.6098654708520179,0.8284353770580883,1.0,5/19,15.43%,PRKN;VPS4B;TSG101;SDCBP;ATP9A
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4388576043713957,0.881907641988737,0.6035767511177347,1.0,1.0,3/11,7.13%,ELOF1;ARID1A;CHEK1
prerank,proteasome assembly (GO:0043248),0.4561238657801096,0.8818766826733273,0.5823699421965318,1.0,1.0,5/11,22.97%,PSMD5;ADRM1;PSMD11;PSMD13;PSMD4
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3666206210387645,0.8818751193214741,0.6743486973947895,1.0,1.0,34/158,18.72%,ECT2;FADD;TRIML2;TICAM1;MAP3K14;MIER1;RHOA;LPAR1;UBE2N;RNF31;TNFRSF10B;MAP3K3;IKBKG;CXXC5;PRKCB;GJA1;TRIM6;CASP8;BRD4;ROR1;DDX21;PRKD1;PLK2;TRIM5;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,Rho protein signal transduction (GO:0007266),0.37966874013840923,0.8817134929312296,0.6130099228224918,1.0,1.0,10/53,10.40%,ROCK2;RHOA;NTN1;PDPN;CDC42EP2;GNA13;ROCK1;EPS8L1;MYO9B;ARHGAP6
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.2761570711742478,-0.881665871103715,0.6530612244897959,0.8290185184494794,1.0,8/23,17.56%,CAV1;TSG101;DUSP22;SOCS5;ZGPAT;SRCIN1;CBLB;CBL
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.33482676801961997,-0.8815250197754105,0.6070175438596491,0.8284569558344091,1.0,1/13,0.28%,STAT3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4147462795727541,0.8814519798114806,0.5866666666666667,1.0,1.0,2/20,3.88%,STMN1;ADA
prerank,regulation of calcium-mediated signaling (GO:0050848),0.4058602115237838,0.8812209569918423,0.5818639798488665,1.0,1.0,3/25,8.29%,ITPR1;MAPT;LRRK2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.35775864230016563,-0.8800317570961559,0.603399433427762,0.8308275031800835,1.0,2/10,3.95%,SMAD7;MALT1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.3209876170155195,-0.8799694289721404,0.6490566037735849,0.8292395745650908,1.0,8/15,29.33%,AP3D1;DTNBP1;BLOC1S2;AP3B2;AP3M1;AP3S1;AP3M2;BLOC1S6
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.3209876170155195,-0.8799694289721404,0.6490566037735849,0.8292395745650908,1.0,8/15,29.33%,AP3D1;DTNBP1;BLOC1S2;AP3B2;AP3M1;AP3S1;AP3M2;BLOC1S6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.2793944276869577,-0.879436007175945,0.5978835978835979,0.8294957941789224,1.0,6/23,11.05%,PSEN1;INSR;IGF1;PFKFB3;PRKAA1;APP
prerank,synaptic vesicle recycling (GO:0036465),-0.2514419091865975,-0.8785045699183643,0.6424581005586593,0.8305645322953121,1.0,12/31,20.57%,OPHN1;AMPH;SYT1;PLD2;RAB5A;SYT7;TBC1D24;SYNJ2;FCHO2;SYNJ1;NLGN1;SYT2
prerank,mucosal immune response (GO:0002385),-0.3082090892050673,-0.8784450233926163,0.6360153256704981,0.8298374304271873,1.0,2/15,10.51%,DEFA6;RPL39
prerank,vasculature development (GO:0001944),-0.3050985436778416,-0.8782197761425664,0.6174242424242424,0.8294694758664574,1.0,8/16,18.25%,BMPR2;ACVRL1;PDGFRB;CDH5;ACVR2B;STRA6;NOTCH4;PIK3CA
prerank,neuromuscular process (GO:0050905),-0.31763179242688755,-0.8780766736479476,0.6030534351145038,0.8289298674472962,1.0,7/16,19.57%,UBA5;NRXN1;TPP1;SHANK1;GCH1;STRA6;DCTN1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.28447372649453173,-0.8777304977005455,0.6407766990291263,0.8287802383743528,1.0,15/22,41.85%,AHNAK;GNB5;CACNB2;SRI;CACNB1;STAC;DRD2;CACNB3;STAC3;CBARP;HPCA;STAC2;GPR35;NOS1AP;DMD
prerank,spliceosomal snRNP assembly (GO:0000387),0.3951349307070268,0.877579639947692,0.590221187427241,1.0,1.0,9/38,19.76%,COIL;SRSF10;PRPF19;PRPF3;LSM2;LSM4;GEMIN7;TGS1;SNRPB
prerank,regulation of immunoglobulin production (GO:0002637),-0.274040940980615,-0.8775739898010309,0.6330275229357798,0.8282264907465062,1.0,10/23,33.99%,STX4;EPHB2;VAMP3;XBP1;DNAJB9;CD86;PHB2;PTPRC;RBP4;CLCF1
prerank,metal ion homeostasis (GO:0055065),-0.23777600599113075,-0.8771030835210655,0.6865671641791045,0.8283684993266281,1.0,7/40,16.25%,TMTC2;CAV1;FAM20A;SELENON;SLC12A9;GRIN1;SLC12A2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.36695358920882065,0.8767966929321281,0.6811740890688259,1.0,1.0,51/129,24.85%,FGFR2;PSMC2;RNF220;PSMD5;TBL1XR1;ADGRA2;WNK1;SFRP2;UBR5;LRRK2;PSMB1;PSMD14;AXIN2;PSMD1;LRRK1;PSMB9;SMURF2;CSNK1G2;TRPM4;USP47;XIAP;PSMC6;PIN1;NFKB1;SFRP1;AMER1;FAM53B;PSMB2;CSNK1G1;PSME4;PSMB7;CAPRIN2;PPM1A;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;PSMD13;COL1A1;GPRC5B;PSMB8;PSMD4;PSMF1;GPC3;WLS;AXIN1;PSMA5;PSMC3;TGFB1
prerank,visual perception (GO:0007601),0.3659837267052161,0.8763721242134644,0.6443514644351465,1.0,1.0,7/84,8.41%,GPR179;ADGRV1;EYA4;CRYBA1;RDH12;COL18A1;TYR
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.3018325796952217,-0.8759300162297197,0.631336405529954,0.8299776703923523,1.0,5/18,17.18%,PUM1;DDX60;UFD1;RNF125;BIRC3
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.45853718414735556,0.8757477280381504,0.6192592592592593,1.0,1.0,2/10,5.33%,UPB1;DPYD
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.41952952422088313,0.8757189352805171,0.5754583921015515,1.0,1.0,5/14,20.32%,ACTN4;WNK1;GLRX;WNK3;ANK3
prerank,sensory perception of smell (GO:0007608),-0.34181998097900246,-0.8756336259882002,0.5913621262458472,0.8297356259499185,1.0,5/11,22.18%,BBS4;ADCY3;SYT10;SLC24A4;DRD2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.332004672375368,-0.8750097003933133,0.6607773851590106,0.8301176578445759,1.0,5/14,11.93%,PRKG1;MEF2C;LRP1;TPM1;SLIT2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.3757759305295077,0.8748910718843026,0.6399572649572649,1.0,1.0,23/65,19.37%,FBN1;PEG10;PMEPA1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;SMURF2;NKX2-1;PDPK1;ADAM17;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;LTBP1;SKI;PPM1A
prerank,chemical homeostasis (GO:0048878),-0.21008507760683084,-0.8747858169969098,0.7619047619047619,0.8297242026131718,1.0,28/61,33.80%,ADCK1;ABHD5;SLC4A7;WNK2;TLCD2;IRS2;PNPLA8;NR1D2;NR1H3;KLHL3;SLC4A8;TLCD3A;AQP11;TENT4B;USF2;USF1;NEDD4L;EIF5A2;ABHD8;PNPLA2;CLN8;DDX3X;PNPLA3;TLCD1;VGF;ANGPTL3;FITM2;PPARG
prerank,negative regulation of macrophage activation (GO:0043031),-0.3124735283648389,-0.8742018371015038,0.6274509803921569,0.8300913594600291,1.0,7/16,29.51%,NR1H3;GRN;CX3CL1;SYT11;ZC3H12A;LRFN5;PTPRC
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4069059311266395,0.8740295777046798,0.5883870967741935,1.0,1.0,7/20,19.90%,GSS;PTDSS2;PLOD2;GCLM;MTHFS;GCLC;HAGH
prerank,acetyl-CoA metabolic process (GO:0006084),0.4406269482077392,0.8735763158389224,0.6054794520547945,1.0,1.0,5/15,13.71%,PMVK;ACAT1;ACSS1;ACACA;MVK
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.43228345452096,0.8735308416391147,0.6044568245125348,1.0,1.0,5/16,12.32%,BMPR1A;FGFR2;TGFBR3;PIM1;RBPJ
prerank,positive regulation of neutrophil migration (GO:1902624),0.4137935720295958,0.8732441596020807,0.5845347313237221,1.0,1.0,4/18,11.74%,MCU;RIPOR2;CAMK1D;RAC1
prerank,aorta development (GO:0035904),-0.32573099163977864,-0.8727186812270846,0.6423611111111112,0.832289289602106,1.0,7/14,18.25%,JAG1;PDGFRB;LRP1;TBX1;ROBO2;TBX2;PDE2A
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.3542355722240856,-0.8727144276788852,0.60828025477707,0.831444444132274,1.0,5/10,18.74%,ERLEC1;OS9;YOD1;SVIP;UBE2G2
prerank,cytosolic calcium ion transport (GO:0060401),0.39665041241601223,0.8725664036830383,0.6007237635705669,1.0,1.0,10/28,18.17%,MCU;ATP2A2;SLC8A1;MCUB;CACNA1C;ATP2B1;MICU1;ITPR3;MAIP1;JPH1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.2646731276592752,-0.8725340680452122,0.5961538461538461,0.8309563375198458,1.0,13/26,33.69%,CALM1;FKBP1A;GNB5;ATP1A2;SRI;ADRA2A;CALM3;DRD2;GSTM2;GSTO1;CBARP;CASQ2;PLN
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3639933516561981,0.872054030957664,0.795,1.0,1.0,61/348,15.81%,CENPE;TTK;PLK1;SPDYA;ATP2B4;BMPR1A;FNIP1;ANGPT4;ROCK2;UBE2K;DDRGK1;SH2D3C;PRNP;MRE11;LEPR;BMP6;MUSK;RAP2A;ARRB1;EFNA1;FMR1;ENPP2;TXN;SFRP2;CCN1;CD80;MRNIP;LRRK2;AXIN2;ANGPT1;AGT;DDR2;RB1CC1;P2RY1;S1PR2;TGFBR1;CALM2;CRKL;BMP2;AKAP9;RAC1;STOX1;ADAM17;TRIM6;SMAD4;PLAUR;SLCO3A1;PRKD1;CAB39;ITGA5;RAMP3;CD44;DOCK7;RPTOR;WDFY2;PIN1;PRKAG1;SRC;FXR1;PRKD2;TP53
prerank,regulation of autophagy of mitochondrion (GO:1903146),-0.2906508718694437,-0.8711929460263871,0.6294820717131474,0.832967568948255,1.0,8/19,20.05%,PRKN;USP36;SREBF2;CAMKK2;PINK1;GSK3A;FBXO7;PARK7
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4164331503218129,0.8709047090217471,0.5971502590673575,1.0,1.0,10/21,22.79%,MACF1;ROCK2;RHOA;ROCK1;PTPRA;EPHA3;CLASP1;LDB1;VCL;SLK
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.341422341849328,-0.8707538101125757,0.61875,0.833020857595189,1.0,4/11,20.20%,NBL1;SLIT2;DUSP1;PADI2
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3258514808737378,-0.87066577614255,0.6327868852459017,0.8323679387150055,1.0,9/13,34.40%,ANO6;CLIP3;ACSL5;ACSL1;P2RX7;SLC26A6;C2CD5;NR4A3;C3
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3729201000333738,0.8706417716476629,0.6313559322033898,1.0,1.0,10/65,10.87%,AURKB;AURKA;PSMC2;PSMD5;FBXL7;CHEK1;PSMB1;PSMD14;PSMD1;PSMB9
prerank,intracellular protein transport (GO:0006886),0.3611071077559227,0.8705665805685964,0.797,1.0,1.0,82/304,20.51%,ANKLE1;CCHCR1;RANBP17;USP6NL;NUP155;XPO1;RANGRF;STX11;RPAIN;TRAK1;E2F3;XPO4;ARFIP1;AP4M1;FUT10;EVI5L;TBC1D25;SNX1;TNPO1;MYO1C;NUP85;TBC1D13;EIF4ENIF1;CSE1L;WDR11;TPR;VPS26C;TBC1D2B;RAB22A;RAB29;STXBP2;STAM;SMURF1;STX2;SRPRA;RAB1A;SNX27;VIPAS39;COPB2;HERC2;COPZ1;AP3B1;IPO7;APPL2;NUP214;SCFD1;EHD1;STRADA;IFT27;IPO11;ARF4;NXT1;NUP133;ARL4A;MAIP1;IPO5;STX12;NUP42;ARF3;TBC1D9;STXBP1;VPS26A;TMED3;NXT2;FAM53B;ACD;RIC1;USO1;ARL5A;TMED10;EGR2;TBC1D12;STRADB;TBC1D10A;IPO9;BCS1L;NUP188;KIF13B;ARF1;EIF2D;RANBP3L;IPO4
prerank,positive regulation of viral process (GO:0048524),0.372058264416271,0.8703627967376032,0.6248624862486248,1.0,1.0,13/60,19.31%,KPNA2;DHX9;POLR2A;LARP1;TMEM39A;SRPK1;PPID;PABPC1;CNOT7;AXL;SRPK2;PKN2;POLR2B
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.40893801710664746,0.8702375018661783,0.5795601552393272,1.0,1.0,3/23,4.84%,PFKFB1;GCK;ERFE
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.27578907211770354,-0.8699689764236315,0.6355140186915887,0.8329835828766387,1.0,11/22,41.63%,APOE;CREBL2;MTOR;SORBS1;MLXIPL;ANGPTL3;AKT1;PPARG;CREB1;PPARA;EEF1A2
prerank,ureteric bud morphogenesis (GO:0060675),0.43527978541494466,0.869783715046886,0.6008522727272727,1.0,1.0,5/16,16.73%,NPNT;BMP2;GDNF;PKD2;SALL1
prerank,positive regulation of cell killing (GO:0031343),-0.31796100726852927,-0.8697781317564522,0.6488294314381271,0.8325540951200822,1.0,4/13,27.32%,MAPK8;NOX1;SYK;DVL2
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.41025743300770834,0.8696635792440356,0.6069142125480154,1.0,1.0,5/20,15.58%,SPDYA;PSRC1;STOX1;ADAM17;PKD2
prerank,wound healing (GO:0042060),0.3729991619215343,0.8688092582923024,0.6380236305048335,1.0,1.0,14/62,15.83%,HPSE;MACF1;FUT10;SRF;MYOF;PDGFRA;PPP3CA;CORO1B;TGFBR1;SYTL4;SMPD1;SMAD3;MIA3;DYSF
prerank,neutral amino acid transport (GO:0015804),-0.25750140199543653,-0.868344433246697,0.6556603773584906,0.8346775034277965,1.0,9/28,24.23%,SLC6A6;SLC3A2;SLC7A5;SLC1A1;SLC38A5;SLC6A15;SLC36A1;SLC6A7;CTNS
prerank,negative regulation of endopeptidase activity (GO:0010951),0.38294677603841987,0.8674960779905514,0.6147902869757175,1.0,1.0,4/47,9.77%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.4268578920880917,0.8668453693256573,0.5991501416430595,1.0,1.0,5/13,17.77%,RRS1;RPP40;TSR1;NOL9;ABT1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.44940728918967565,0.8667124361475722,0.6284875183553598,1.0,1.0,4/10,14.94%,MTMR1;MTMR2;MTMR9;MTMR3
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.20736036482454429,-0.8666492593999147,0.796875,0.8373689573808286,1.0,23/65,26.13%,SH3KBP1;ARAP1;STAM2;DUSP3;EPN1;TSG101;TGFA;BCAR3;GRB2;SPRY2;RHBDF1;HIP1;ARHGEF7;CBL;AFAP1L2;PTPN12;DGKD;HBEGF;RHBDF2;SH3GL2;MVB12A;SHKBP1;GPER1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.40424881800675083,0.8665084273445074,0.5940959409594095,1.0,1.0,5/24,10.34%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1
prerank,cardiac muscle tissue development (GO:0048738),0.3769603082617037,0.8663711133373626,0.6237288135593221,1.0,1.0,14/50,21.17%,BMPR1A;ADAMTS9;BMP2;TBX18;GJA1;SMAD4;NOTCH2;MAML1;HEY2;CSRP3;ZFPM1;NDUFV2;CACNA1G;BMP5
prerank,regulation of myotube differentiation (GO:0010830),0.4039870053168012,0.8663093758332789,0.6111817026683609,1.0,1.0,6/24,13.41%,MMP14;BHLHE41;CCN3;HDAC1;PIEZO1;MAML1
prerank,negative regulation of protein binding (GO:0032091),0.3729650154045636,0.8662330117582024,0.6542155816435432,1.0,1.0,17/71,19.67%,AURKB;DDX11;AURKA;GSK3B;LRRK2;ATP2A2;ROCK1;PSME3IP1;MITD1;NES;ADRB2;PIN1;DNAJB2;STYX;ZFPM1;PRKCD;IFIT2
prerank,sensory perception (GO:0007600),-0.23172407081347063,-0.8659239078405041,0.6915887850467289,0.838111260028294,1.0,9/45,13.63%,PCDH15;GNAL;SCN9A;WHRN;BBS4;OPRM1;CHRNA7;KCNA2;TMEM150C
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3303384515642386,-0.8651895866652636,0.6518771331058021,0.8387719515719883,1.0,5/13,23.69%,CAV1;BIN1;NOS1;NEDD4L;PTK2B
prerank,leukotriene metabolic process (GO:0006691),0.4152282811196714,0.8648256642864208,0.6059379217273954,1.0,1.0,6/19,20.68%,PTGR1;ABCC10;MGST3;DPEP1;DPEP2;MAPKAPK2
prerank,negative regulation of cellular process (GO:0048523),0.3650135655257245,0.864483955307383,0.858,1.0,1.0,113/521,18.96%,E2F7;CDKN3;MYBL1;RAD18;PSRC1;CDKN2D;FBXO5;PPM1D;CDKN2C;TXNDC12;RB1;PDS5B;HYAL1;SUZ12;CDC6;CTCF;ALDH1A2;MDM4;ARID2;ANP32B;SPEF1;CASK;PDE3B;CTBP1;BLM;PDPN;NMI;COL18A1;PTPN2;RBBP4;TGFBR3;RBBP7;PML;SFRP2;CCN1;CLMN;HTRA2;BTG3;SMAD6;IRF1;ING4;SMARCA4;RIPOR2;KLF11;AXIN2;NCK1;KANK2;CDA;ANGPT1;VHL;ABI1;NOX4;SRGAP2;PIP4P2;PPP2R5C;TMEM98;PLXNB2;CRLF3;PLXNB1;IP6K2;EIF2AK3;CCN3;DSCAM;BMP2;NDRG3;ENPP1;APPL2;P3H1;PLPP1;NCK2;GJA1;NR4A1;WNT9A;TES;SMAD4;ATF5;ORC6;PLXND1;JADE1;PRKD1;CDKN1B;ADAMTS1;FOXM1;SMAD3;MIA3;STK11;PTPRU;CNOT7;PKD2;NF2;ZBTB7C;TP53;DYSF;SESN2;SFRP1;PTEN;PTPRK;CCN2;NGF;SIRPA;SLURP1;TFAP4;DNAJB2;CHMP4B;IGFBP3;DCBLD2;SIPA1;FRZB;NIBAN2;PLXNA2;ADNP2;SP100;CAPRIN2
prerank,keratinocyte differentiation (GO:0030216),0.3942752699897115,0.8643331476574658,0.6002460024600246,1.0,1.0,5/29,13.76%,TGM1;ANXA1;CLIC4;MED1;ADAM9
prerank,phosphate ion transmembrane transport (GO:0035435),0.43483779259138244,0.8642661214667463,0.5920114122681883,1.0,1.0,4/12,21.67%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,endothelial cell migration (GO:0043542),0.38798017473150714,0.8639144538940771,0.6100702576112412,1.0,1.0,10/37,17.76%,LOXL2;RHOA;ADGRA2;CORO1B;LGALS12;CCN3;NR4A1;PLXND1;RAB13;PLEKHG5
prerank,negative regulation of cell cycle (GO:0045786),0.37007638216357785,0.8630134432275879,0.6716259298618491,1.0,1.0,16/73,17.38%,PLK1;RB1;SCRIB;HTRA2;BTG3;GAS1;BMP2;IPO7;NR4A1;CDKN1B;SMAD3;IPO5;PTEN;PTPRK;ANGEL2;TFAP4
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.36663005834268536,0.8629935406353195,0.6736401673640168,1.0,1.0,15/86,13.18%,CDK5RAP2;PSRC1;RB1;MYLK3;NUMA1;MAPT;CDC42EP2;NCK1;DRG1;AKAP9;RAC1;NCK2;SYNPO2;BAIAP2L1;PRKCE
prerank,nucleoside catabolic process (GO:0009164),0.44526270488534625,0.8628435844755118,0.6107871720116618,1.0,1.0,2/11,5.33%,UPB1;DPYD
prerank,bile acid biosynthetic process (GO:0006699),-0.26045702496411094,-0.8627526663076386,0.6514285714285715,0.8428010904559834,1.0,7/24,21.61%,OSBPL6;CYP7B1;SCP2;OSBPL7;AMACR;OSBP;OSBPL2
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.38732934114885786,0.8626018468784443,0.6103286384976526,1.0,1.0,10/35,15.31%,RBFOX2;NEDD4;ARID1A;PMEPA1;UBR5;YAP1;NR3C1;PLPP1;MED1;SRC
prerank,positive regulation of cellular senescence (GO:2000774),-0.34938815542360335,-0.8625037859656592,0.6374622356495468,0.8424876748763112,1.0,4/10,28.96%,B2M;HMGA2;ABI3;EEF1E1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.38050270615844844,0.862443927209687,0.6164229471316085,1.0,1.0,9/39,15.96%,MAP4K4;RHOA;ACTN4;CASK;HOXA7;DMTN;NF2;TBCD;RCC2
prerank,entry into host (GO:0044409),-0.3249662362647938,-0.862006658099521,0.6472602739726028,0.8426523414577778,1.0,6/13,17.56%,CTNND1;CTNNB1;GRB2;MET;CBLL1;CBL
prerank,positive regulation of RNA metabolic process (GO:0051254),0.37609784176819583,0.8618855770974302,0.6355353075170843,1.0,1.0,12/45,18.72%,DYRK1A;SETX;NMD3;POLR2A;DXO;NFKB1;TP53;ZC3H18;PNPT1;HNRNPLL;SLC38A2;RIPK1
prerank,protein dephosphorylation (GO:0006470),0.36140320059526054,0.8614713159241231,0.6975806451612904,1.0,1.0,39/135,19.92%,PPM1G;PPM1D;EYA4;LHPP;TAB1;PPP2R3A;SSH2;PTPN2;PPP3CA;NCK1;DUSP12;MTMR2;EYA2;PPP2R5C;PTPN21;PTPRS;FBXW11;RPRD1A;PPP1CC;PPP2R2D;BTRC;PPP1R15B;PTPRA;STK11;PTPN13;PTPRU;MTMR3;PPP2R5B;DAPP1;PPP2R1B;PTEN;UBLCP1;PTPRK;PTPRE;RPRD1B;DUSP7;PPM1A;PTPN1;PTPN5
prerank,regulation of TOR signaling (GO:0032006),0.3700469897184366,0.8612658061561204,0.6477516059957173,1.0,1.0,13/67,17.73%,FAM83D;TNFAIP8L1;FNIP1;DEPDC5;DYRK3;TBC1D7;NPRL3;SLC38A9;ITFG2;RPTOR;LARS1;LAMTOR3;LAMTOR5
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4062850581856182,0.8612373121923933,0.6346396965865992,1.0,1.0,5/24,15.51%,KIT;CENPJ;OCIAD2;CRLF3;OCIAD1
prerank,glucan catabolic process (GO:0009251),0.42287149249058087,0.8611790269989933,0.6019417475728155,1.0,1.0,3/15,7.72%,AGL;PYGB;PHKA2
prerank,neural crest cell differentiation (GO:0014033),-0.29592166631188077,-0.8607425180609132,0.6302521008403361,0.8443377675189944,1.0,2/18,1.12%,MEF2C;CDH2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.34642300397951453,-0.8605711035773503,0.6448598130841121,0.8429297155910578,1.0,7/11,43.28%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,cellular response to interleukin-2 (GO:0071352),-0.34642300397951453,-0.8605711035773503,0.6448598130841121,0.8429297155910578,1.0,7/11,43.28%,SHC1;PTK2B;SYK;JAK1;JAK3;IL2RA;IL2RG
prerank,negative regulation of neuron projection development (GO:0010977),0.3689939360899819,0.8600543971406119,0.6489707475622969,1.0,1.0,18/56,18.56%,RHOA;RTN4R;LPAR1;EFNA1;EPHA4;RAB29;DENND5A;PTPRS;BAG5;GAK;HDAC2;DPYSL3;EFNB2;ADCY6;PTEN;STMN2;TRPV4;MYLIP
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.42121577067940386,0.859804042893218,0.6221264367816092,1.0,1.0,3/13,7.13%,ELOF1;ARID1A;CHEK1
prerank,regulation of postsynapse organization (GO:0099175),0.4015571823223417,0.8596024742575492,0.6253041362530414,1.0,1.0,9/28,18.66%,ARHGAP22;EPHA4;LRRK2;LZTS3;PDLIM5;ZDHHC15;SIPA1L1;ABI2;TANC2
prerank,actin filament bundle assembly (GO:0051017),0.3847902557301116,0.8593172764116673,0.6252873563218391,1.0,1.0,12/33,22.65%,ADD2;CORO1B;EZR;DMTN;DPYSL3;BAIAP2L1;ADD1;LCP1;SHROOM2;SHROOM1;PLS1;MYO1B
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.31223148323549366,-0.8591975350396471,0.6178571428571429,0.8448155495985289,1.0,2/15,10.55%,PRKN;BCL2
prerank,endothelial cell proliferation (GO:0001935),0.4100368614737536,0.858959219198643,0.6091644204851752,1.0,1.0,2/17,3.05%,LOXL2;ANGPT4
prerank,nucleotide metabolic process (GO:0009117),0.3928541072072533,0.8587924779123418,0.6096938775510204,1.0,1.0,12/23,26.49%,DCK;NUDT5;ENPP3;GUK1;AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;CTPS2;AK8
prerank,regulation of cellular response to stress (GO:0080135),0.3594935801014965,0.8586755179579241,0.7210953346855984,1.0,1.0,14/115,6.57%,NDC1;NUP155;NUP205;NUP160;ROCK2;GSK3B;RPA1;AJUBA;AIFM2;DYRK3;MAPT;NUP85;RPA2;TPR
prerank,neuron projection morphogenesis (GO:0048812),0.3589678909015264,0.8585298266776971,0.7161616161616161,1.0,1.0,15/137,11.05%,KIF20B;MAP4K4;ALCAM;FGFR2;RAB10;NRK;ANKRD27;LRRK2;DSCAML1;DNM2;FARP1;ROCK1;SRGAP2;EPB41L3;PLXNB1
prerank,glycogen metabolic process (GO:0005977),0.4016988579858136,0.8584852271264696,0.6161490683229813,1.0,1.0,6/27,12.42%,GSK3B;AGL;PYGB;PHKA2;PGM1;GYG1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.4429181988103185,0.8580944893713006,0.6343283582089553,1.0,1.0,4/11,15.61%,LEPROT;VHL;ADIPOR1;NF2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.38741409408771543,0.8574391693248896,0.6133960047003525,1.0,1.0,4/35,8.07%,PCDHGB4;CDH18;CDH24;PCDHGC3
prerank,negative regulation of T cell proliferation (GO:0042130),0.39900056772036546,0.8570554270239401,0.6357947434292867,1.0,1.0,5/28,13.95%,PRNP;SCRIB;CD80;IL4I1;RC3H1
prerank,phasic smooth muscle contraction (GO:0014821),-0.34823900946666375,-0.8566046376692066,0.659375,0.849059022141349,1.0,6/10,34.94%,DRD2;EDNRB;EDN1;PTGER3;EDN3;HTR2B
prerank,tRNA 5'-end processing (GO:0099116),0.4322494049885416,0.8564726891954249,0.6205479452054794,1.0,1.0,5/15,19.60%,RPP40;RPP30;POP1;PRORP;RPP21
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.3959392414359285,0.8560759236383086,0.6295399515738499,1.0,1.0,7/27,12.72%,STMN1;ARHGAP28;CGNL1;TMEFF2;ARHGAP6;ARHGEF18;WASF2
prerank,negative regulation of cell growth (GO:0030308),0.3605724696387753,0.8560420490268007,0.7057026476578412,1.0,1.0,32/121,18.96%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RTN4R;RBBP7;PML;SFRP2;SMARCA4;CDA;CRLF3;IP6K2;CCN3;PTPRS;NDRG3;ENPP1;ULK2;GJA1;SMAD4;JADE1;CDKN1B;SMAD3;STK11;TP53;SESN2;SFRP1;DNAJB2;DCBLD2;SIPA1;FRZB;CAPRIN2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3816507620808277,0.8558405821252957,0.6146682188591386,1.0,1.0,10/32,16.13%,MAP4K4;CASK;HOXA7;SERPINE1;ARHGAP6;DMTN;SRC;NF2;RCC2;PTEN
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.27722586876363475,-0.8558356711511733,0.6831275720164609,0.84978731209599,1.0,5/18,10.73%,CTSC;APOE;DACT1;VPS11;CD81
prerank,autophagy of nucleus (GO:0044804),0.4083077718983748,0.8552859938498835,0.6119610570236439,1.0,1.0,5/16,14.52%,ATG7;RB1CC1;ULK2;ATG3;ATG2A
prerank,protein palmitoylation (GO:0018345),-0.25310486545641875,-0.8551639771771208,0.6939890710382514,0.8502331309852931,1.0,12/30,23.28%,GLUL;CLIP3;ZDHHC5;ZDHHC1;ZDHHC13;ZDHHC7;ZDHHC8;GOLGA7;ZDHHC16;ZDHHC20;ZDHHC4;ZDHHC17
prerank,mesonephric tubule development (GO:0072164),0.41435798551072955,0.8550215283715462,0.6079779917469051,1.0,1.0,5/15,18.16%,FGFR2;NPNT;PKD2;SALL1;OSR1
prerank,regulation of mitochondrion organization (GO:0010821),0.3764773354508977,0.8548598320389135,0.6322869955156951,1.0,1.0,10/47,11.83%,MIEF2;GSK3B;IAPP;MAPT;RHOT1;FBXW7;HTRA2;LRRK2;CSNK2A2;STOX1
prerank,cAMP-mediated signaling (GO:0019933),-0.2678435816671727,-0.854825909254865,0.6716417910447762,0.8500373753892546,1.0,12/24,27.45%,EPHA5;PDE3A;AKAP6;CAP1;DGKQ;ADGRG6;PDE2A;PDE4D;RAPGEF3;MAPK7;SOX9;ADCYAP1
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.42230067229019397,0.8545232941357831,0.5869565217391305,1.0,1.0,2/18,6.71%,FBN1;FBXW7
prerank,regulation of vasculature development (GO:1901342),0.3948634797368468,0.8541692946103896,0.6145320197044335,1.0,1.0,6/26,20.26%,VASH2;ADGRA2;PLXND1;SFRP1;SP100;EGLN1
prerank,negative regulation of signaling (GO:0023057),-0.2628808306273247,-0.8539942566001906,0.6616161616161617,0.850919067815115,1.0,5/25,13.50%,ACVR1;GLRA1;SOCS5;OPRM1;HHIP
prerank,positive regulation of epithelial cell migration (GO:0010634),0.36229888833120405,0.8539061273788175,0.6815352697095436,1.0,1.0,23/92,15.58%,ATOH8;MAP4K4;ANGPT4;ROCK2;HYAL1;GPI;ANXA3;ENPP2;ANGPT1;AGT;PIK3CB;RAC1;RRAS;PRKCA;CTSH;PRKCE;DOCK1;PRKD1;ADAM9;INSL3;AAMP;SRC;PRKD2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.27630229856717775,-0.8529944977892988,0.6740088105726872,0.8521101026234494,1.0,7/21,19.55%,CAV1;FZD2;CTNNB1;APC;DVL1;LRP6;FZD1
prerank,limb development (GO:0060173),0.4029305026105049,0.8528342071016312,0.6227327690447401,1.0,1.0,3/28,6.89%,GLI3;LNPK;MAP3K20
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.28169468546239035,-0.8527853393932117,0.6666666666666666,0.8516709476104147,1.0,5/20,11.05%,HSP90AB1;TXNIP;ANO6;ENTPD1;APP
prerank,mRNA processing (GO:0006397),0.3576589154753,0.8526612396932698,0.813,1.0,1.0,79/287,19.96%,RBM15;PPIL1;SYNCRIP;SNRNP25;SRSF4;HNRNPD;TRA2B;CSTF3;FIP1L1;DHX9;HNRNPA1;SRSF10;UPF3B;CCAR1;LSM3;RAVER2;ERCC3;DDX39B;PSPC1;PRPF40A;HNRNPH1;PRPF19;SRSF7;POLR2A;FUS;DHX8;HNRNPUL1;WDR33;PRPF3;NONO;SF3A2;PCF11;LSM2;SRSF3;SFPQ;HNRNPU;SNRNP48;RBM15B;HNRNPL;SRRM1;CPSF4;SNRNP35;HNRNPH2;RNGTT;RPRD1A;SF3B3;SNRNP27;RBM4;LSM7;WBP4;PABPC1;AQR;UBL5;KIN;RBM19;HNRNPA2B1;PPWD1;LSM4;ZCCHC8;RALY;METTL3;DHX38;PRPF4;RBM10;PRPF18;GEMIN7;CWC25;CWC22;PDCD7;BUD13;RPRD1B;CDC5L;DNAJC8;HNRNPR;POLR2B;SF3A3;SNRPB;ERCC2;TRA2A
prerank,autophagosome maturation (GO:0097352),-0.23559261688909272,-0.8522035293953457,0.6983240223463687,0.85198572344271,1.0,18/32,34.31%,CALM1;TECPR1;SNX14;TSG101;SNAP29;VPS33B;LAMP2;VAMP8;GABARAPL2;CHMP3;MAP1LC3A;VPS33A;MAP1LC3B;CLN3;EPG5;ATG14;VCP;GABARAP
prerank,glial cell differentiation (GO:0010001),-0.25551393038721715,-0.8520254827760368,0.7257142857142858,0.8515304313661322,1.0,18/28,33.25%,STAT3;CDH2;SLC8A3;PTPRZ1;RELN;SOX4;ADGRG6;PICK1;SOX2;FGF10;GPC1;SOX11;SOX9;ERBB3;GPR157;SOX10;METRN;SOX8
prerank,carboxylic acid transmembrane transport (GO:1905039),0.37877006538387353,0.8518229512033281,0.6263345195729537,1.0,1.0,6/40,13.09%,SLC25A21;SLC38A7;SLC38A4;SLC19A1;SLC38A9;SLC25A30
prerank,mesoderm development (GO:0007498),-0.29010911758871855,-0.8517065233822763,0.6428571428571429,0.8513225697127598,1.0,6/18,14.55%,FOXC2;TBX3;TIE1;TBX1;BMX;VEGFA
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.28914740597342475,-0.8515994406379052,0.6454183266932271,0.85068584518217,1.0,8/17,26.13%,AR;ATP1A1;ABHD2;ATP1A3;ATP1A2;BMP7;URI1;GPER1
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.34216963956399904,-0.8512766180262266,0.649390243902439,0.84966709955407,1.0,2/10,5.39%,MAP2K5;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.34216963956399904,-0.8512766180262266,0.649390243902439,0.84966709955407,1.0,2/10,5.39%,MAP2K5;KLF4
prerank,muscle cell differentiation (GO:0042692),-0.24769614517205776,-0.8509775095218979,0.695906432748538,0.8494295129671049,1.0,6/32,13.44%,MEF2C;SYNE1;SPEG;NEBL;MRTFB;TBX1
prerank,establishment of vesicle localization (GO:0051650),-0.28777855815073333,-0.8508954452611244,0.6923076923076923,0.8487563051475265,1.0,7/18,18.48%,SPG11;KIF5B;KIF5C;SYT11;SYNJ1;RAB11A;RAB27A
prerank,neuron apoptotic process (GO:0051402),0.41504910721095206,0.8508594452077488,0.6085271317829457,1.0,1.0,2/19,5.17%,CIT;FAM162A
prerank,cellular response to nutrient levels (GO:0031669),-0.21055791445914995,-0.8507669942813747,0.7733333333333333,0.8481678185348276,1.0,16/62,16.81%,FOXO1;KCNB1;BMPR2;WDR45B;RALB;EIF4G1;ULK1;PRKAA1;VPS41;MTOR;SREBF2;KLF10;RRAGC;LAMP2;USP33;XBP1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3542458333337475,0.8506684541450503,0.7655935613682092,1.0,1.0,49/186,18.64%,GLI3;WWOX;GSK3B;PSMC2;PSMD5;TRABD2B;BICC1;NLK;SIAH2;MCC;STK3;RNF43;TCF7L2;HMGXB4;SFRP2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;EMD;PSMB9;DKK3;HDAC1;BMP2;RBMS3;LZTS2;LMBR1L;JADE1;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;TLE3;NOTUM;SFRP1;AMER1;MLLT3;CSNK1A1;PSMB2;PSME4;FRZB;PSMB7
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.2066572443798467,-0.8505986029193,0.8,0.847614498392066,1.0,30/91,23.32%,FTH1;SLC39A10;ATP6V0D1;SCARA5;SLC39A13;CUL1;FBXL5;FTL;HMOX2;ABCG2;APP;COX19;IREB2;SLC31A2;GLRX3;SLC39A7;SLC30A1;MT2A;ATOX1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ATP7A;NDFIP1;ISCU
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.36171997346899704,0.8502285597557165,0.6882416396979504,1.0,1.0,23/59,24.70%,TICAM1;MAP3K14;ROCK2;TAB1;RNF31;ROCK1;IKBKG;ERC1;PRDX4;RIPK1;RELB;TRAF6;TANK;TRAF2;IKBKB;BIRC2;TLR7;DAB2IP;NFKBIL1;BCL10;RIPK2;REL;RELA
prerank,negative regulation of immune effector process (GO:0002698),0.4231489352398167,0.8500766535396462,0.6059322033898306,1.0,1.0,6/13,22.01%,ENPP3;RC3H1;CD47;HAVCR2;FER;APPL1
prerank,regulation of B cell differentiation (GO:0045577),0.4056804174185355,0.8498462170608819,0.6347469220246238,1.0,1.0,4/17,16.05%,MMP14;BTK;IL4I1;SFRP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.38257434029627213,0.8491249931848185,0.6171224732461356,1.0,1.0,5/31,15.23%,PAXIP1;GPI;RIF1;KMT5C;SHLD2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.35099885178405527,-0.8486459107599433,0.6646706586826348,0.850601810665824,1.0,6/10,35.74%,GIPC1;ATP7A;CTNS;OPN3;CDH3;MFSD12
prerank,regulation of amyloid-beta formation (GO:1902003),0.37887564826535813,0.8485717986656903,0.6287069988137604,1.0,1.0,7/34,9.54%,ROCK2;RTN3;PRNP;EFNA1;EPHA4;ROCK1;PICALM
prerank,response to peptide (GO:1901652),-0.25011432745562606,-0.8485141474398585,0.7134146341463414,0.8499996709664196,1.0,7/33,12.35%,STAT3;GNAI1;STAT6;CACNA1B;CHRNA7;IRS1;MMP2
prerank,regulation of phospholipase activity (GO:0010517),0.444019477143731,0.8484614447076119,0.6332842415316642,1.0,1.0,2/10,12.27%,FGFR2;PDPK1
prerank,ketone body metabolic process (GO:1902224),0.4432140050552634,0.84831510278472,0.6275362318840579,1.0,1.0,3/10,18.80%,ACAT1;AACS;BDH2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.3673250581086127,-0.8482776591190763,0.6748466257668712,0.8496207750806457,1.0,4/10,17.16%,FKBP1A;BIN1;ATP1A2;ADRA2A
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.39938555387085095,0.8481786687954866,0.6207759699624531,1.0,1.0,6/25,12.67%,SRSF4;TRA2B;SRSF10;PRPF3;SRRM1;SF3B3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.3820749478040249,0.8481244906039475,0.6472684085510689,1.0,1.0,2/35,3.50%,MASTL;GSK3B
prerank,regulation of cell migration (GO:0030334),0.35657752910724655,0.8480638839399601,0.854,1.0,1.0,71/382,16.13%,KIF14;ARHGEF39;GTSE1;MAP4K4;SYNE2;ULK4;MACF1;TWIST2;TRIP6;ROCK2;RHOA;CEP43;MMP14;DDRGK1;ACTN4;ARID2;LAMB1;KIT;SPAG9;CCAR1;PDPN;MYO1C;STK24;RAP2A;AFDN;ENPP2;PDGFRA;PLAU;SFRP2;PPP3CA;CCN1;PHACTR1;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;ROCK1;SRGAP2;SRGAP3;TGFBR1;PLXNB2;PLXNB1;BMP2;ANXA1;NKX2-1;TBCCD1;RAC1;APPL2;PRKCA;ADAM17;CLIC4;DPYSL3;CTSH;PLXND1;ADAM9;ITGB1;MIA3;NKD1;PTPRU;SEMA3D;SRC;ELP6;RHOC;SUN2;NF2;LMO4;RCC2;SFRP1;PTEN
prerank,negative regulation of glycolytic process (GO:0045820),0.4451969450963013,0.8479053068235282,0.6201201201201201,1.0,1.0,1/10,2.99%,PFKFB1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4451969450963013,0.8479053068235282,0.6201201201201201,1.0,1.0,1/10,2.99%,PFKFB1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.25913964686186375,-0.847014535269867,0.6842105263157895,0.8511680388321367,1.0,11/27,22.46%,MAPK8;CUL1;TAOK2;MAP3K5;MAPK3;MAPK1;CHUK;MAP2K7;UBB;RPS27A;UBC
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.365369765432904,0.8469867970135452,0.6373507057546145,1.0,1.0,14/51,17.28%,ROCK2;RHOA;LPAR1;SORBS3;TGFBR1;RAC1;SYNPO2;ARHGEF10L;RHOC;NF2;FHOD1;SFRP1;CCN2;CD47
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.25038898349843747,-0.8461913084932662,0.7241379310344828,0.8518663825791633,1.0,4/27,8.62%,CYRIB;NFAT5;PRKCQ;HSPD1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36148124179842844,0.8460423204908138,0.6991701244813278,1.0,1.0,15/80,12.80%,ANLN;ACTR3;AUTS2;FMR1;CDC42EP2;RHOQ;RIPOR2;EPS8L1;TAPT1;ARHGAP35;CEP120;RAC1;DOCK11;WASF2;DPYSL3
prerank,regulation of cell size (GO:0008361),0.3922382800366158,0.8460040229330268,0.6414602346805737,1.0,1.0,9/23,17.73%,RHOA;VAV2;EZR;RAC1;RPTOR;PTEN;LARS1;MSN;LAMTOR5
prerank,cell projection organization (GO:0030030),0.38523090327044285,0.8453248714078538,0.6450471698113207,1.0,1.0,8/30,16.36%,PARVA;PACSIN2;RHOQ;NPHP1;RAC1;ITGB1;CAPG;NCKAP1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.33431553872637965,-0.8451621129346882,0.6161290322580645,0.8530230560918654,1.0,1/12,0.75%,IL1R1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.3000590643944421,-0.8445697308339611,0.6535433070866141,0.8533484406099587,1.0,3/15,19.18%,SAT1;MOXD1;DDC
prerank,positive regulation of translation (GO:0045727),0.35853683332057823,0.844393099361953,0.7054582904222451,1.0,1.0,22/94,16.94%,LARP4B;AGO2;HNRNPD;KHDRBS1;DHX9;PRKDC;UPF3B;SAMD4A;FMR1;YBX3;LARP1;USP16;CDC123;YTHDF2;PLXNB2;METTL5;EIF3C;LARP4;FXR1;PASK;METTL3;PYM1
prerank,stem cell development (GO:0048864),-0.3003351307290377,-0.8443710884709065,0.6496062992125984,0.8529158277482961,1.0,14/16,50.12%,CDH2;NOLC1;KLHL12;SOX11;PTPRC;SOX8;KBTBD8;PDCD6;SNAI2;NRG1;SHH;WNT7A;PEF1;CYP26C1
prerank,regulation of protein processing (GO:0070613),0.4090481740529325,0.844153706961858,0.62002567394095,1.0,1.0,3/21,9.98%,PRNP;LRRK2;GAS1
prerank,sensory perception of sound (GO:0007605),0.36048270802641796,0.8441316285839219,0.7042842215256009,1.0,1.0,9/88,13.17%,BIRC5;ADGRV1;KIT;MKKS;NIPBL;RIPOR2;LHFPL5;HOMER2;ROR1
prerank,regulation of dephosphorylation (GO:0035303),0.4145366758066258,0.8441301727716819,0.6167832167832168,1.0,1.0,6/15,15.31%,MTMR1;MTMR2;MTMR9;SMG6;MTMR3;SRC
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3684397974112903,0.8440164612963057,0.6559734513274337,1.0,1.0,10/48,13.43%,TRIOBP;OBSL1;CUX1;PRKDC;CAPRIN1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,endomembrane system organization (GO:0010256),0.35522690743572555,0.843622784825969,0.7893681043129388,1.0,1.0,47/178,20.48%,ARHGAP21;USP6NL;NUP155;GBF1;OBSL1;LNPK;COG1;ZW10;WASHC4;ATL2;MYOF;ATL3;RAB22A;LEMD3;RAB29;VPS18;LRRK2;GOLGA8B;GOLGA5;RAB1A;SNX33;EIF2AK3;BAG5;GAK;GORASP2;EXOC8;PRKD1;MIA3;TOR1B;VAPA;SYP;SUN2;TMCC1;DYSF;TMED3;UBXN2B;CSNK1A1;COG4;CLASP1;TMED10;PI4K2B;SUN1;LYSMD3;DNM1L;ANK3;ATP8B2;TRAPPC8
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.3157303702461771,-0.8432553149201591,0.6957928802588996,0.8541910837424289,1.0,3/13,13.91%,GLUL;GOT2;GOT1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3564638061065875,0.8430575484903406,0.72165991902834,1.0,1.0,24/113,20.01%,TGM1;HMGB2;VASH2;HYAL1;FGFR2;LAMB1;BMP6;TCF7L2;YAP1;TGFBR1;BMP2;PRKCA;NR4A1;NOTCH2;PRKD1;ARNT;PRKD2;SFRP1;NRAS;OSR1;BAD;PLXNB3;RREB1;SEMA5A
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2753719261879157,-0.8427584692009501,0.6923076923076923,0.8542534313141121,1.0,8/18,25.76%,PRKN;TRAP1;SOD2;PINK1;PARK7;HSPB1;MAPK7;HIF1A
prerank,erythrocyte development (GO:0048821),0.4384821624025167,0.8425283360666856,0.6246290801186943,1.0,1.0,4/10,16.86%,ABCB10;DMTN;MED1;ALAS2
prerank,peptidyl-proline modification (GO:0018208),0.3918794240500809,0.8424500218435775,0.6243781094527363,1.0,1.0,6/25,15.56%,PPIL1;FKBP5;PPIG;PPID;PIN1;PPWD1
prerank,response to glucocorticoid (GO:0051384),0.3888481586927294,0.8420653857277274,0.6448362720403022,1.0,1.0,7/26,22.47%,NR3C1;HNRNPU;ANXA1;ADAM9;PDCD7;UBE2L3;ZFP36L1
prerank,phosphate ion transport (GO:0006817),0.4088217136795712,0.8420086109587511,0.6296296296296297,1.0,1.0,4/16,21.67%,SLC20A2;SLC25A30;SLC37A2;SLC37A3
prerank,negative regulation of neuron death (GO:1901215),0.36077612972578205,0.8420013419091297,0.7184265010351967,1.0,1.0,12/93,15.37%,KIF14;GSK3B;HTRA2;KDM2B;LRRK2;IKBKG;CNTF;NENF;PRKCI;BTBD10;SLC30A10;GDNF
prerank,erythrocyte differentiation (GO:0030218),0.36908277363058006,0.8419778526300578,0.6386740331491713,1.0,1.0,11/44,13.63%,KIT;TSPO2;DYRK3;IKZF1;PTPN2;TGFBR3;ABCB10;TAL1;DMTN;ATP5IF1;MED1
prerank,positive regulation of cell aging (GO:0090343),-0.333012021241593,-0.8417122997673223,0.6752411575562701,0.8555097465420016,1.0,4/11,28.96%,B2M;HMGA2;ABI3;EEF1E1
prerank,neuromuscular synaptic transmission (GO:0007274),0.4025298023088911,0.8416404152683301,0.6188579017264276,1.0,1.0,4/18,13.15%,CHAT;ERC1;CHRNB1;ERC2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.41238733725513027,0.8416165309153589,0.644718792866941,1.0,1.0,6/14,23.84%,ZNHIT3;DDX18;WDR12;NOL9;URB1;RPL7
prerank,eye photoreceptor cell development (GO:0042462),-0.3059201862055221,-0.8416128326876535,0.6704980842911877,0.8548666909591819,1.0,5/15,26.78%,BBS4;RORB;VEGFA;RP1;THY1
prerank,cellular response to fatty acid (GO:0071398),-0.319579646591861,-0.8416003323480606,0.6590909090909091,0.854062073775719,1.0,8/12,42.61%,IRS1;ZC3H12A;NR1H4;DGAT2;PDK4;PDK3;KCNK4;PID1
prerank,regulation of endopeptidase activity (GO:0052548),0.36555040934039384,0.841438868701989,0.6558441558441559,1.0,1.0,7/59,11.37%,SERPINB8;SERPINA9;SERPINE1;PICALM;AGT;PSMB9;HDAC1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.37892595747360736,0.8414367631085655,0.6133004926108374,1.0,1.0,6/25,12.59%,BMPR1A;NUMA1;CCN1;SULF1;RBPJ;SMAD4
prerank,lipid homeostasis (GO:0055088),-0.21663041711521985,-0.8414190990593987,0.7971014492753623,0.8536011129617744,1.0,27/57,33.80%,APOE;ADCK1;ABHD5;TLCD2;IRS2;PRKAA1;PNPLA8;NR1D2;NR1H3;RCN3;TLCD3A;XBP1;USF2;USF1;ABCA2;ABHD8;PNPLA2;CLN8;ORMDL1;DDX3X;PNPLA3;TLCD1;DGAT2;MLXIPL;ANGPTL3;FITM2;PPARG
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.22536775448745067,-0.8413855060398485,0.7681159420289855,0.852822751374687,1.0,14/37,23.10%,NACC2;CAV1;FIS1;BECN1;RPS7;SIAH1;BCL2;NUPR1;BCAP31;DDIT3;UBB;BCL2L1;RACK1;RPS3
prerank,sodium-independent organic anion transport (GO:0043252),0.434955012531936,0.8413294023766313,0.6231671554252199,1.0,1.0,3/10,13.34%,SLCO4A1;SLC16A2;SLCO3A1
prerank,response to purine-containing compound (GO:0014074),-0.28751942474976416,-0.8410037650301344,0.6744186046511628,0.8526768635010726,1.0,9/17,32.59%,RYR2;TRPC3;DGKQ;NDUFS4;P2RX4;P2RX7;ABCC9;P2RY6;VGF
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.39873936912890606,0.8405279157785442,0.6263157894736842,1.0,1.0,6/21,18.13%,CBFB;ELF2;ELF1;PRKCB;FOXP1;RUNX1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.2706559644718612,-0.840485859249479,0.6796875,0.8528054675188727,1.0,2/20,1.56%,CAMK2D;HECW1
prerank,negative regulation of TOR signaling (GO:0032007),0.3749161237848784,0.8402760073897602,0.6459054209919262,1.0,1.0,9/36,15.98%,TNFAIP8L1;FNIP1;DEPDC5;TBC1D7;NPRL3;SESN1;ITFG2;STK11;SESN2
prerank,cation transmembrane transport (GO:0098655),0.36768574035200524,0.8402619929452457,0.6415730337078651,1.0,1.0,11/44,19.06%,RHAG;SLC6A5;TRPM2;TRPM4;PKD2;SLC36A4;SLC7A1;SLC6A9;SLC25A29;SLC25A19;TRPM6
prerank,xenobiotic transport (GO:0042908),-0.2850719485652319,-0.8401611993532591,0.7109375,0.8527116616353643,1.0,4/17,14.08%,SLC7A5;ABCG2;SLC15A2;ABCC5
prerank,acute-phase response (GO:0006953),-0.31707440352020216,-0.8401242147979445,0.6646341463414634,0.8519622176634086,1.0,3/12,20.74%,LBP;CEBPB;IL22
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.40953748582463323,0.8400450062002461,0.6239193083573487,1.0,1.0,1/15,2.25%,DYRK1A
prerank,regulation of cell-matrix adhesion (GO:0001952),0.36526366823102085,0.8399185310692121,0.6791845493562232,1.0,1.0,10/64,10.09%,MAP4K4;MACF1;ROCK2;RHOA;GSK3B;CASK;HOXA7;PLAU;ROCK1;PIK3CB
prerank,nucleotide-sugar metabolic process (GO:0009225),0.4280708914412198,0.8396257623460998,0.6448326055312955,1.0,1.0,1/12,2.53%,GMDS
prerank,negative regulation of protein catabolic process (GO:0042177),-0.231258803878463,-0.8395159368910281,0.7540983606557377,0.8523112024744199,1.0,5/40,4.87%,SNRNP70;CST3;TIMP3;BANP;SNX3
prerank,lung epithelium development (GO:0060428),0.4338679900095999,0.8394944612927995,0.651017214397496,1.0,1.0,2/10,10.55%,GRHL2;ERRFI1
prerank,positive regulation of cilium assembly (GO:0045724),0.39854977104974454,0.8390026745778073,0.6258148631029987,1.0,1.0,3/18,11.01%,TAPT1;ARHGAP35;CEP120
prerank,positive regulation of phospholipase activity (GO:0010518),0.3903833149663814,0.838933604970157,0.6474358974358975,1.0,1.0,6/22,13.69%,FGFR2;KIT;PDGFRA;GNA13;PDPK1;ARF4
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3883878425832767,0.838823233612466,0.635593220338983,1.0,1.0,1/26,1.19%,SLC18A2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.38581486047530195,0.838709265113856,0.6548223350253807,1.0,1.0,9/25,21.49%,STOML2;CD80;ANXA1;PRKD2;RUNX1;PDE4B;TRAF6;TRAF2;PNP
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.29245538699910545,-0.838183262133936,0.7163120567375887,0.8539652784514439,1.0,5/15,11.22%,SMAD7;RPL23;RPS7;ABL1;LIMK1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.36116833273581234,0.8381096372966834,0.6547231270358306,1.0,1.0,22/55,24.76%,AURKA;PSMC2;PSMD5;FBXL7;PSMB1;PSMD14;PSMD1;PSMB9;ATF5;USP47;PSMC6;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,regulation of p38MAPK cascade (GO:1900744),0.37763021079951486,0.83810359179158,0.642691415313225,1.0,1.0,8/35,14.79%,ULK4;XDH;MAP3K4;RELL1;BMP2;EZR;DLG1;PER1
prerank,muscle cell migration (GO:0014812),0.42414134987203395,0.8378812805512741,0.6110304789550073,1.0,1.0,4/10,18.50%,ROCK1;CCN3;AAMP;PLAT
prerank,negative regulation of growth (GO:0045926),0.3551610493791638,0.8378214287347647,0.7267144319344934,1.0,1.0,32/121,18.96%,PSRC1;CDKN2D;CDKN2C;RB1;HYAL1;RBBP7;PML;SFRP2;ING4;SMARCA4;CDA;CRLF3;IP6K2;CCN3;NDRG3;ENPP1;GJA1;SMAD4;NOTCH2;JADE1;CDKN1B;SMAD3;STK11;TP53;SESN2;SFRP1;PNPT1;DNAJB2;DCBLD2;SIPA1;FRZB;CAPRIN2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.20020770098530544,-0.8374821779762701,0.9130434782608695,0.8544214664101786,1.0,29/93,24.90%,TNFRSF19;SH3RF3;HIPK2;TPD52L1;TGFB2;TAOK2;ANKRD6;MAP3K5;MID1;DUSP22;SEMA3A;MINK1;STK25;APP;SDCBP;SH3RF2;VEGFA;ZC3H12A;PRMT1;TIRAP;GADD45B;FLT4;MAP3K11;WNT16;PTK2B;SPHK1;MAPK8IP1;ARL6IP5;MFHAS1
prerank,glycogen biosynthetic process (GO:0005978),-0.3277833471702594,-0.8374588958530635,0.6938110749185668,0.852816909817148,1.0,2/12,2.88%,PER2;GBE1
prerank,glucan biosynthetic process (GO:0009250),-0.3277833471702594,-0.8374588958530635,0.6938110749185668,0.852816909817148,1.0,2/12,2.88%,PER2;GBE1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3918340293342245,0.8374189899781274,0.6398996235884568,1.0,1.0,6/24,17.66%,ACTR3;AUTS2;RAC1;WASF2;NCKAP1;ABI2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3297859985144691,-0.8372153448254042,0.6608187134502924,0.8515964500073567,1.0,7/11,33.22%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3297859985144691,-0.8372153448254042,0.6608187134502924,0.8515964500073567,1.0,7/11,33.22%,CALM1;FKBP1A;SRI;CALM3;GSTM2;GSTO1;CASQ2
prerank,positive regulation of T cell proliferation (GO:0042102),0.36551059626783294,0.8367654171498881,0.6936353829557713,1.0,1.0,7/55,12.29%,FADD;IL18;CD80;NCK1;HMGB1;ANXA1;NCK2
prerank,regulation of interleukin-2 production (GO:0032663),0.35722668101715616,0.8367458479111568,0.6433408577878104,1.0,1.0,13/43,21.49%,PRNP;STOML2;CD80;EZR;ANXA1;HOMER2;PRKD2;RUNX1;HAVCR2;PDE4B;TRAF6;TRAF2;PNP
prerank,regulation of store-operated calcium entry (GO:2001256),-0.3453878507537033,-0.8364826207358235,0.6788990825688074,0.8521471085085887,1.0,2/10,5.11%,SARAF;HOMER1
prerank,histone H2B ubiquitination (GO:0033523),-0.3425952195048819,-0.8362290414704262,0.6616766467065869,0.851785188424515,1.0,2/10,3.25%,CDC73;UBE2E1
prerank,copper ion homeostasis (GO:0055070),-0.2909298083820562,-0.8358729000776264,0.6798245614035088,0.8516239420172204,1.0,8/17,21.96%,APP;COX19;SLC31A2;MT2A;ATOX1;CUTC;COMMD1;ATP7A
prerank,cellular polysaccharide catabolic process (GO:0044247),0.4074593325930507,0.8357786731094372,0.6142270861833106,1.0,1.0,3/16,7.72%,AGL;PYGB;PHKA2
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3834105294862499,0.8352737342512057,0.6455847255369929,1.0,1.0,6/29,11.14%,RPA1;CHD1L;RPA2;ERCC3;CUL4B;XPA
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3611742368226207,0.8352317525827376,0.6843783209351754,1.0,1.0,10/62,12.97%,DDIAS;CDKN2D;TXNDC12;RTKN2;SFRP2;YBX3;HTRA2;LRRK2;BAG5;PLAUR
prerank,regulation of viral genome replication (GO:0045069),0.3570771315224921,0.8351285043649738,0.6742919389978214,1.0,1.0,13/56,17.96%,ILF3;FAM111A;ZC3HAV1;LARP1;TMEM39A;SRPK1;TRIM6;PPID;PABPC1;CNOT7;MAVS;SRPK2;PKN2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.378751859195848,0.8342195249180923,0.6488095238095238,1.0,1.0,15/34,26.18%,TRIOBP;LIMS1;CRKL;RAC1;DMTN;DOCK1;DOCK5;RREB1;FERMT2;FLNA;S100A10;CRK;MYADM;P4HB;CDC42
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.3613489308613051,0.8338724817664743,0.6915789473684211,1.0,1.0,24/67,18.33%,ROCK2;RHOA;VAV2;SULF1;NCK1;ABI1;ROCK1;CYBB;PIK3CB;SH2D2A;RAC1;NCK2;MAPKAPK3;WASF2;DOCK1;PRKD1;ITGAV;AAMP;SRC;PRKD2;NCKAP1;AXL;SHB;MAPK14
prerank,negative regulation of peptidase activity (GO:0010466),0.36626007647977765,0.8331323224481577,0.6570796460176991,1.0,1.0,4/47,9.77%,SERPINB8;SERPINA9;SERPINE1;AGT
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.43849844063156096,0.8325338345641734,0.6458036984352774,1.0,1.0,2/12,12.02%,SOAT1;SOAT2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.40122982163864784,0.8313415462893471,0.6536388140161725,1.0,1.0,4/18,8.29%,GSK3B;FMR1;VPS18;LRRK2
prerank,reticulophagy (GO:0061709),0.4199394519006849,0.8311786599921287,0.6340740740740741,1.0,1.0,4/12,14.52%,DDRGK1;RB1CC1;ULK2;ATG2A
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2712003579207707,-0.8309983428109656,0.7448559670781894,0.8598275816283208,1.0,5/21,17.58%,GRIN2B;DELE1;GRIN1;BIRC3;SOX2
prerank,phospholipid biosynthetic process (GO:0008654),0.3807900913751917,0.830771065531533,0.661271676300578,1.0,1.0,5/36,13.23%,DHDDS;LPCAT1;SRD5A3;AGK;AGPAT3
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3481852039536059,0.8306402276669693,0.7782258064516129,1.0,1.0,45/161,18.64%,GLI3;GSK3B;PSMC2;PSMD5;BICC1;SIAH2;MCC;STK3;TCF7L2;SFRP2;WWTR1;PSMB1;CUL3;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;EMD;PSMB9;DKK3;HDAC1;BMP2;TBX18;RBMS3;LZTS2;LMBR1L;JADE1;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;TLE3;NOTUM;SFRP1;AMER1;MLLT3;CSNK1A1;PSMB2;PSME4;FRZB;PSMB7
prerank,regulation of protein binding (GO:0043393),0.35013038447668426,0.8305517456832308,0.7454361054766734,1.0,1.0,13/114,9.80%,PLK1;AURKB;DDX11;AURKA;GSK3B;ADD2;STK3;TCF7L2;NMD3;LRRK2;ROCK1;PSME3IP1;MARK2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.28938542980603643,-0.8302613807062645,0.7012448132780082,0.8603665773828925,1.0,3/18,11.93%,MTUS1;LYN;SLIT2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.4034664341447094,0.8298183622192442,0.6251655629139072,1.0,1.0,1/17,1.64%,ATOH8
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.35089078538714014,0.829266212915356,0.6923890063424947,1.0,1.0,23/72,22.61%,FADD;CBFB;USP18;VRK2;PTPN2;ELF1;RNF31;SPPL2B;AGPAT2;IKBKG;CASP8;AGPAT1;IFNAR2;AXL;RUNX1;HIPK1;RIPK1;PTPN1;TRAF2;TAX1BP1;IKBKB;BIRC2;PIAS1
prerank,sensory perception of light stimulus (GO:0050953),0.3466503961502758,0.8290458668043589,0.7265135699373695,1.0,1.0,7/87,8.41%,GPR179;ADGRV1;EYA4;CRYBA1;RDH12;COL18A1;TYR
prerank,triglyceride catabolic process (GO:0019433),0.3984108350334392,0.8288774545951716,0.6335877862595419,1.0,1.0,2/19,15.76%,FABP12;LPL
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.39022838383855046,0.8286607767900174,0.6433041301627034,1.0,1.0,7/25,19.46%,BMF;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,prostaglandin metabolic process (GO:0006693),0.3770910734935834,0.8284354581442055,0.6461159062885327,1.0,1.0,7/26,18.38%,PTGR1;PTGR2;HPGDS;PTGS1;DAGLB;PLAA;PTGIS
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.4190306718496557,0.8282905977032378,0.644793152639087,1.0,1.0,4/13,23.12%,NEDD4;NIBAN2;PTPN1;DAB2IP
prerank,acylglycerol catabolic process (GO:0046464),-0.24399788612550202,-0.8281043880067821,0.7597402597402597,0.8635890572356647,1.0,4/30,9.48%,ABHD6;ABHD12;ABHD16A;ABHD2
prerank,calcium ion import across plasma membrane (GO:0098703),0.4148111464305021,0.8276516977002107,0.643646408839779,1.0,1.0,3/14,10.65%,ATP2B4;SLC8A1;TRPM2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3457313276210813,0.8275709353889108,0.8276553106212425,1.0,1.0,78/248,21.76%,GLI3;CDK14;GSK3B;FGFR2;PSMC2;RNF220;PSMD5;BICC1;SIAH2;MCC;TBL1XR1;ADGRA2;STK3;TCF7L2;WNK1;SFRP2;WWTR1;UBR5;LRRK2;PSMB1;CUL3;GNAQ;PSMD14;AXIN2;TMEM64;NPHP3;LIMD1;PSMD1;LRRK1;EMD;PSMB9;DKK3;SMURF2;HDAC1;BMP2;RBMS3;LZTS2;LMBR1L;CSNK1G2;TRPM4;JADE1;USP47;BTRC;XIAP;RUVBL2;TLE4;PSMC6;STK11;NKD1;PTPRU;PIN1;TLE3;NFKB1;NOTUM;SFRP1;AMER1;MLLT3;FAM53B;CSNK1A1;PSMB2;CSNK1G1;PSME4;FRZB;PSMB7;CAPRIN2;TMEM131L;PPM1A;PSMD11;SEMA5A;LGR4;ZEB2;PSME3;CSNK1E;FRMD8;LATS1;PSMD13;COL1A1;STK4
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.3262148622606472,-0.8273385508221318,0.6677018633540373,0.864159637754176,1.0,7/11,31.75%,TOMM70;TIMM9;TIMM13;TIMM8B;NDUFA13;ROMO1;TIMM29
prerank,epidermis development (GO:0008544),0.3593184306694698,0.8273355529761407,0.6625971143174251,1.0,1.0,9/56,16.92%,FGFR2;GRHL2;SVEP1;ATP2A2;FLOT2;HDAC1;HDAC2;EMP1;CCN2
prerank,apical protein localization (GO:0045176),0.41530648752152766,0.8272271269456412,0.6381381381381381,1.0,1.0,1/10,1.69%,SHROOM3
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.2815792728789979,-0.827215854813881,0.6977611940298507,0.8635218427757677,1.0,5/16,20.56%,MEF2C;BOC;BTG1;LRRC8A;HIF1AN
prerank,regulation of axon extension (GO:0030516),0.36634440599436935,0.8271772616890003,0.6620847651775487,1.0,1.0,7/37,11.37%,MACF1;GSK3B;RTN4R;NTN1;MAPT;DNM2;PTPRS
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3507628283925145,0.8271081329169386,0.698093220338983,1.0,1.0,18/75,19.79%,PLK1;RB1;PKIG;SLC8A1;AGT;PIK3CB;IPO7;LRP5;SMPD1;CDKN1B;IPO5;PTEN;PRKAR2B;PRKAR2A;TFAP4;DUSP7;PRKCD;PTPN1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.34889285810358434,0.827096572016298,0.734020618556701,1.0,1.0,23/95,16.66%,HAS3;CHST15;HYAL1;B4GALT1;GPC6;CHSY1;SLC10A7;ST3GAL3;SLC35D2;B4GALT7;CHST3;ANGPT1;HAS1;UST;SDC1;HS2ST1;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;HSPG2;UGDH
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.35192464655937944,0.8270715073256135,0.72,1.0,1.0,4/78,4.05%,PLK1;CDC20;GSK3B;DDRGK1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.3787489407190864,0.8264688460333508,0.6654804270462633,1.0,1.0,8/30,17.34%,CHST15;HYAL1;CHSY1;CHST3;DSE;BGN;UGDH;ARSB
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.40710865688934783,0.8263400838038175,0.6433566433566433,1.0,1.0,5/16,16.73%,NPNT;BMP2;GDNF;PKD2;SALL1
prerank,regulation of immune response (GO:0050776),0.3434116859337401,0.8260757004691729,0.7454545454545455,1.0,1.0,14/135,14.26%,ULBP1;FGL1;COLEC12;ITGB7;RAET1E;LAG3;SPPL2B;IRF1;AHR;APPL2;CASP8;IL4I1;XIAP;ITGB1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.40661617734494704,0.8259944889689589,0.640495867768595,1.0,1.0,4/17,14.36%,DYRK1A;YJU2;TWIST1;CD44
prerank,embryonic hemopoiesis (GO:0035162),0.4220104346803371,0.8254701072074004,0.6637806637806638,1.0,1.0,3/12,10.56%,KIT;KMT2A;TAL1
prerank,Notch signaling pathway (GO:0007219),0.3588587310844241,0.8252881756346164,0.6958874458874459,1.0,1.0,11/59,13.42%,DLGAP5;GMDS;POFUT1;BMP2;RBPJ;ADAM17;NOTCH2;ITCH;PLXND1;MAML1;HEY2
prerank,sulfur amino acid metabolic process (GO:0000096),0.3876894264529738,0.8248561202175123,0.6532846715328468,1.0,1.0,3/24,9.68%,AHCY;MTHFR;NOX4
prerank,calcium ion import into cytosol (GO:1902656),0.4077748879693431,0.8246759451021146,0.6415094339622641,1.0,1.0,3/15,10.65%,ATP2B4;SLC8A1;TRPM2
prerank,regulation of steroid biosynthetic process (GO:0050810),0.42119040447378636,0.8244691595998743,0.6519174041297935,1.0,1.0,4/11,21.17%,FGFR4;BMP2;WNT4;BMP5
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.27001899637203564,-0.8241812703753765,0.7549019607843137,0.8682651954686086,1.0,6/21,20.02%,GUCY1A1;NPR1;ADCY3;ADCY8;ADCY4;AMPD2
prerank,peptidyl-glutamic acid modification (GO:0018200),0.39130233926849706,0.8232658412880773,0.649746192893401,1.0,1.0,5/24,13.19%,VKORC1L1;GGCX;TTLL4;TTLL11;TTLL3
prerank,microvillus organization (GO:0032528),0.4046732719355651,0.8232450966719718,0.6319648093841642,1.0,1.0,3/13,11.44%,MAP4K4;RAP2A;EZR
prerank,phospholipid dephosphorylation (GO:0046839),0.36842660032056146,0.8226719561600655,0.666283084004603,1.0,1.0,10/37,16.13%,OCRL;INPP5B;MTMR1;MTMR2;MTMR9;PIP4P2;PLPP1;PLPP5;MTMR3;PTEN
prerank,response to calcium ion (GO:0051592),0.34287744172215334,0.8225089467918887,0.7512794268167861,1.0,1.0,18/102,15.99%,ECT2;ADGRV1;NEDD4;PPP3CA;KCNMB2;KCNMB3;CARF;TRPM2;CALM2;ITPR3;DMTN;CLIC4;ADAM9;SMPD1;KCNMB4;PKD2;ADD1;STIM1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.40916248646424086,0.8222711063851638,0.6535859269282814,1.0,1.0,7/15,25.57%,RPP40;RPP30;POP1;KHNYN;LACTB2;RNASEH1;NUDT16
prerank,activation of protein kinase A activity (GO:0034199),-0.2929347919766834,-0.8220321603703706,0.7378277153558053,0.8712527627281436,1.0,5/16,14.86%,PRKACB;PRKAR1B;ADCY3;ADCY8;ADCY4
prerank,sulfation (GO:0051923),0.4295040803515381,0.8220194778428797,0.6506746626686657,1.0,1.0,11/11,57.08%,UST;SULT4A1;SULT2A1;CHST4;SULT1C2;SULT1C4;SULT6B1;SULT1A1;SULT2B1;HS3ST5;CHST5
prerank,protein localization to cell surface (GO:0034394),0.37833426098101763,0.8219652051923428,0.639751552795031,1.0,1.0,8/26,16.89%,FBLN5;SMURF1;ANGPT1;PIGU;MESD;PTPRU;UNC50;PTPRK
prerank,positive regulation of cellular catabolic process (GO:0031331),0.34824278314476564,0.8218298390752178,0.7728643216080402,1.0,1.0,36/132,16.76%,TRIML2;MOV10;TICAM1;PFKFB1;GSK3B;ZC3HAV1;CNOT1;FAF1;TPCN1;SH3GLB1;FOXO3;LRRK2;SH3D19;ROCK1;ZBTB20;HMGB1;PIK3CB;SNX33;EZR;DAGLB;TRIM6;ITCH;DXO;TWIST1;PRKD1;ADAM9;PLK2;RC3H1;TRIM5;ARNT;STK11;CNOT7;ZC3H18;PNPT1;MSN;AMER1
prerank,lymphocyte chemotaxis (GO:0048247),-0.23670419294649622,-0.8213259029243649,0.7579617834394905,0.8716629643002614,1.0,16/34,41.87%,CYP7B1;GAS6;CX3CL1;SLC12A2;PIK3CD;CCL13;CXCL16;GPR183;CCL19;ADAM8;CH25H;CCL15;HSD3B7;PIK3CG;CCL2;CXCL10
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.41652189171533105,0.8212152581295153,0.6594202898550725,1.0,1.0,3/12,14.03%,UST;DSE;BGN
prerank,outflow tract septum morphogenesis (GO:0003148),0.38422077426042933,0.8211448171435655,0.6586901763224181,1.0,1.0,6/24,12.59%,BMPR1A;FGFR2;PARVA;SMAD6;ROBO1;SMAD4
prerank,cellular response to decreased oxygen levels (GO:0036294),0.34896835965112927,0.8208479425324122,0.7110874200426439,1.0,1.0,24/65,23.38%,AQP1;ANGPT4;MDM4;FAM162A;HP1BP3;CPEB2;NDRG1;RORA;TWIST1;NPEPPS;TP53;SFRP1;SUV39H2;BAD;PTGIS;TBL2;FMN2;TERT;EGLN1;SIRT2;EGLN3;ZFP36L1;KCND2;NOP53
prerank,sphingoid metabolic process (GO:0046519),-0.323650638961778,-0.8206599398779806,0.6941580756013745,0.8720707452627141,1.0,8/12,38.54%,PLPP3;DEGS2;ASAH2;SPHK1;KDSR;SPHK2;SGPP1;PLPP2
prerank,amino sugar metabolic process (GO:0006040),-0.3293165403622659,-0.819875045124889,0.7151335311572701,0.8727462122505973,1.0,2/10,3.56%,CSGALNACT1;ST6GAL1
prerank,lipid catabolic process (GO:0016042),-0.274702738917446,-0.8198353960209089,0.708171206225681,0.8719714201907949,1.0,2/18,4.80%,PLAAT3;PLA1A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.39334592869633006,0.8197365560071767,0.6541049798115747,1.0,1.0,7/17,22.29%,ROCK2;ROCK1;S1PR2;ADD1;ZDHHC21;IKBKB;VCL
prerank,negative regulation of receptor internalization (GO:0002091),0.40658059850527467,0.8185232056070274,0.6622807017543859,1.0,1.0,6/12,27.33%,WDR54;MTMR2;ANKRD13D;RIN3;LRPAP1;ATXN2
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.375360474081288,0.8183557834301737,0.6715328467153284,1.0,1.0,6/31,12.59%,BMPR1A;FGFR2;TGFBR3;TGFBR1;RBPJ;SMAD4
prerank,regulation of translation (GO:0006417),0.34466584924507265,0.818272515568923,0.8190954773869347,1.0,1.0,42/173,19.10%,TYMS;ILF3;SYNCRIP;LARP4B;CTIF;HNRNPD;CNOT1;DHX9;PRKDC;EIF4E;UPF3B;EIF4ENIF1;EIF4H;SAMD4A;CAPRIN1;FMR1;FOXO3;LARP1;PLXNB2;METTL5;MRPL13;EIF2AK3;EIF3C;RBM4;DHFR;LARP4;EIF4A2;MTRF1;EPRS1;CNOT7;FXR1;PASK;DDX1;METTL3;PYM1;NSUN3;EIF3H;PAIP2B;METAP1;PUS7;OGFOD1;ETF1
prerank,regulation of T cell activation (GO:0050863),-0.22445356347351927,-0.8181199103278998,0.7796610169491526,0.8741831558268831,1.0,7/42,11.61%,CYRIB;DUSP3;PRKCQ;PTPN22;HSPD1;ABL1;TNFRSF1B
prerank,peptide metabolic process (GO:0006518),0.3494814765937513,0.8175127668116358,0.7132196162046909,1.0,1.0,8/75,10.44%,RHD;DNPEP;LVRN;NLN;CPXM1;HPGDS;CPQ;TRHDE
prerank,positive regulation of macroautophagy (GO:0016239),-0.22030825539493215,-0.8174618363114132,0.8476190476190476,0.8745723036811469,1.0,18/48,24.64%,PIP4K2A;SESN3;EPM2A;PIP4K2B;RALB;BNIP3L;BNIP3;RAB3GAP2;IRGM;PINK1;SLC25A4;TBK1;HSPB8;PIP4K2C;VPS13D;PAFAH1B2;BAG3;SMCR8
prerank,regulation of necroptotic process (GO:0060544),-0.2616769058675471,-0.8174582468437405,0.6977777777777778,0.8737523232206947,1.0,7/23,17.18%,OGT;CYLD;ARHGEF2;STUB1;SDCBP;SLC25A4;BIRC3
prerank,non-motile cilium assembly (GO:1905515),0.3812473912619252,0.8166764954378838,0.6666666666666666,1.0,1.0,3/30,5.29%,CEP89;PCM1;C2CD3
prerank,cellular response to chemical stress (GO:0062197),0.34025148563138563,0.8164565534410521,0.7264344262295082,1.0,1.0,27/96,19.13%,VKORC1L1;SETX;SRXN1;VRK2;ATG7;PYCR1;FOXO3;HTRA2;LRRK2;SOD3;STX2;CPEB2;LONP1;NOX4;CYBB;STOX1;PRKD1;GPX8;PKD2;SESN2;PNPT1;RAD52;CCS;TRPV4;FANCC;ADNP2;PYROXD1
prerank,response to chemokine (GO:1990868),0.4107657748216713,0.8159345412698499,0.6183098591549295,1.0,1.0,5/13,18.15%,RHOA;WNK1;RIPOR2;STK39;OXSR1
prerank,glycine transport (GO:0015816),0.419755042417681,0.8158224729349836,0.650887573964497,1.0,1.0,3/10,17.82%,SLC6A5;SLC6A17;SLC6A9
prerank,Ras protein signal transduction (GO:0007265),0.34265799746731856,0.8157272828100895,0.7823886639676113,1.0,1.0,35/137,18.33%,KSR1;GPSM2;RB1;BRAP;ROCK2;RASSF1;RHOA;CCNA2;NTN1;PDPN;RAP2A;G3BP1;CDC42EP2;GNA13;CDK2;TRIM28;ROCK1;EPS8L1;MYO9B;ARHGAP6;USP28;CRKL;RAC1;RRAS;PRKD1;PLK2;TP53;NCKAP1;RRAS2;ABI2;PLEKHG5;KRAS;NRAS;ARHGAP29;MAPK14
prerank,cellular response to unfolded protein (GO:0034620),-0.24631953821722113,-0.8155882429932003,0.7384615384615385,0.8762607437437515,1.0,6/26,18.18%,PRKN;HSPD1;HSPA5;PACRG;TM7SF3;HSPB8
prerank,regulation of smooth muscle contraction (GO:0006940),0.38159109958032117,0.8147577693142666,0.6821026282853567,1.0,1.0,6/20,16.78%,SRF;SETD3;ATP2B1;ADRB2;KCNB2;ZDHHC21
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3907825008718358,0.8146151315129423,0.6528150134048257,1.0,1.0,3/16,20.26%,RHOA;ST3GAL4;TRAF6
prerank,snRNA 3'-end processing (GO:0034472),0.39376592372605934,0.8146146473429147,0.6653333333333333,1.0,1.0,4/19,11.81%,INTS7;TUT1;INTS8;EXOSC7
prerank,eye development (GO:0001654),0.3550205330486274,0.8145097985203961,0.6983783783783784,1.0,1.0,12/54,19.28%,PBX4;PBX3;FBN1;COL5A2;NIPBL;CACNA1C;MAB21L2;EFEMP1;SHROOM2;SH3PXD2B;HIPK1;SKI
prerank,regulation of inclusion body assembly (GO:0090083),0.41580348515493526,0.8141479669399333,0.6379821958456974,1.0,1.0,5/11,24.09%,BAG5;DNAJB2;DNAJB6;SACS;SNCAIP
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.393864490697517,0.8139395943250534,0.6724367509986684,1.0,1.0,4/16,12.80%,UPB1;DPYD;DPYSL4;DPYSL3
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.26153420208366013,-0.8132185766741722,0.7364016736401674,0.8797068326864276,1.0,7/23,18.36%,HSP90AB1;NR1H3;IFNGR2;IRGM;IFNGR1;NR1H2;NLRC5
prerank,positive regulation of bone mineralization (GO:0030501),0.35575738335308776,0.8130658310768655,0.6515151515151515,1.0,1.0,7/35,11.40%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,glycoprotein metabolic process (GO:0009100),0.347874933253043,0.8123474135793021,0.6974972796517954,1.0,1.0,12/53,15.44%,HPSE;LARGE1;ST8SIA2;B4GALT7;ADAMTS9;GANAB;STT3B;MAN1C1;FBXO27;ST3GAL4;FBXO17;ST3GAL2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.33729299383246436,0.8123405423429552,0.885,1.0,1.0,54/348,14.34%,BRCA1;E2F1;MED26;MOV10;TICAM1;ROCK2;FGFR4;AGO2;CTCF;GSK3B;ANXA2;DDRGK1;MPHOSPH8;SETDB2;BMP6;MUSK;AFDN;ARRB1;FMR1;SCRIB;RAB29;ZBTB7B;UBR5;ATF7IP;TRIM28;ROBO1;YAP1;ANGPT1;SLC24A3;ROCK1;WNT6;PIK3CB;TGFBR1;LIMS1;EIF2AK3;CNTF;BMP2;EZR;NKX2-1;TERF2;STOX1;RBMS3;FUBP1;RBPJ;GJA1;ITCH;C1QTNF1;CTSH;TWIST1;HEY2;MED1;ADAM19;SMAD3;RAMP3
prerank,mitochondrial gene expression (GO:0140053),-0.21205174799887497,-0.8123050929840451,0.84,0.8804567868195772,1.0,26/42,34.46%,LARS2;TFB2M;MRPS18A;MRPS15;MRPS21;MRPS6;TFAM;MRPL23;MRPL51;MRPL47;MRPS14;MRPS7;NOA1;MRPL16;MRPS11;MRPS16;FASTKD2;MRPL12;TEFM;QRSL1;POLRMT;GATC;TWNK;MRPS12;MRPL57;MRPS34
prerank,superoxide anion generation (GO:0042554),0.4017088858896516,0.8107984448148283,0.6685314685314685,1.0,1.0,2/13,9.82%,NOX4;CYBB
prerank,response to retinoic acid (GO:0032526),0.3490223650263145,0.8104404943714095,0.6970021413276232,1.0,1.0,8/59,13.07%,AQP1;CDKN2D;SETX;ASXL1;HTRA2;WNT6;WNT9A;CTSH
prerank,regulation of protein transport (GO:0051223),0.37655066671124515,0.8104038421852108,0.6695979899497487,1.0,1.0,7/27,15.76%,ARFIP1;DNAJC1;STXBP5;LLGL2;P3H1;SCFD1;LCP1
prerank,response to organic cyclic compound (GO:0014070),0.3507479380923843,0.8097277234658125,0.7019650655021834,1.0,1.0,8/52,13.52%,CDKN2D;FGFR4;ABCB4;IL18;LRRK2;TRPM2;ANXA1;DHFR
prerank,negative regulation of protein modification process (GO:0031400),0.3446042734706348,0.8089657874166863,0.7282377919320594,1.0,1.0,27/79,21.59%,ATP2B4;GSK3B;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;PPP1R8;TPPP;SNTA1;CRKL;P3H1;ENSA;PPP1R15B;PTPA;PTPN13;PTEN;TINF2;SIRPA;TERF2IP;IGFBP3;DNAJC10;XRCC1;PNKP;FBLN1;FKBP8
prerank,microvillus assembly (GO:0030033),0.3951263488704474,0.8086006206492047,0.6738816738816739,1.0,1.0,3/14,11.44%,MAP4K4;RAP2A;EZR
prerank,regulation of protein targeting to membrane (GO:0090313),0.3713177581337114,0.8075363034913862,0.6742788461538461,1.0,1.0,6/28,12.63%,MIEF2;PRNP;PDZK1;MYO1C;MIEF1;DMTN
prerank,regulation of bone mineralization (GO:0030500),0.3513925034128966,0.8074776974486235,0.709211986681465,1.0,1.0,12/55,13.27%,ADGRV1;BMPR1A;BCOR;BMP6;CCN1;SLC8A1;DDR2;ATP2B1;BMP2;ENPP1;TRPM4;TWIST1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.2853866993145908,-0.8072855549977369,0.7416974169741697,0.8884656167153084,1.0,7/15,30.56%,SYN3;CNTNAP4;ADRA1A;NLGN1;DRD2;BAIAP3;CLN3
prerank,antibacterial humoral response (GO:0019731),0.3986533220077024,0.80723988232381,0.6778975741239892,1.0,1.0,1/16,4.49%,RNASE6
prerank,protein glycosylation (GO:0006486),0.3383945253484051,0.8071944143911801,0.7808080808080808,1.0,1.0,24/125,16.82%,POMT1;TRAK1;LARGE1;B4GALT1;FUT10;GALNT1;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;MAGT1;RPN2;ST3GAL5;SLC39A8;POFUT1;STT3A;STT3B;MAN1C1;ALG8;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2;B3GALT2
prerank,hepaticobiliary system development (GO:0061008),0.3836900189916673,0.8064161602651346,0.6609947643979057,1.0,1.0,7/20,19.03%,TGFBR3;NIPBL;PHF2;GFER;PKD2;COBL;WNT4
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3472499990542652,0.8062958452004279,0.7257383966244726,1.0,1.0,8/70,12.25%,PON1;CHAT;LPCAT1;LPIN2;ENPP2;CSNK2A2;TMEM86B;ACHE
prerank,regulation of cellular localization (GO:0060341),0.35520839583746383,0.8061072538511994,0.670045045045045,1.0,1.0,7/46,13.72%,SPAG5;NUMA1;STXBP2;LRRK2;MAD1L1;LRP5;GOSR1
prerank,response to molecule of bacterial origin (GO:0002237),-0.2039580867548006,-0.8056038048980799,0.8769230769230769,0.8905384127438617,1.0,15/69,17.67%,CYRIB;IFNAR1;TAB2;NOS3;TLR4;LIAS;GGT5;LBP;PTPN22;TNFRSF11A;C4B;GCH1;ERBIN;LGALS9;PRDX3
prerank,cGMP biosynthetic process (GO:0006182),-0.32560654670764433,-0.8043710094846529,0.6952662721893491,0.8917949138615812,1.0,2/10,9.96%,GUCY1A1;NPR1
prerank,lipoprotein transport (GO:0042953),0.42482152594688927,0.8042752066297061,0.6340740740740741,1.0,1.0,4/10,19.43%,PRKCB;MIA3;UNC119;UNC119B
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.38334446352803064,0.8042285808501971,0.6731517509727627,1.0,1.0,5/21,16.66%,CHST15;CHSY1;CHST3;BGN;UGDH
prerank,T cell receptor signaling pathway (GO:0050852),0.3358045043590847,0.8041647217039267,0.7945619335347432,1.0,1.0,45/138,24.98%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RNF31;RC3H2;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;PDPK1;BTRC;RC3H1;PSMC6;PRKD2;NFKB1;PSMB2;PSME4;PSMB7;PDE4B;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;EIF2B5;PSMB8;FYN;PSMD4;BCL10;RIPK2;PSMF1;PSMA5;RELA;PSMC3;SPPL3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3835586979617008,0.804004174704932,0.671957671957672,1.0,1.0,6/17,19.94%,ARFIP1;CORO1B;WASF2;NCKAP1;ABI2;ARF1
prerank,positive regulation of gene expression (GO:0010628),0.3347972923532732,0.8037077520374846,0.923,1.0,1.0,81/442,17.07%,BRCA1;E2F1;MED26;DYRK1A;BAZ1B;SETX;DEK;MOV10;TICAM1;ROCK2;FGFR4;LARP4B;AGO2;CTCF;GSK3B;POLR1A;HNRNPD;DDRGK1;PRKDC;UPF3B;MYO1C;BMP6;MUSK;POLR1B;AFDN;SAMD4A;TENT4A;FMR1;POLR2A;ZBTB7B;PHF2;UBR5;AGPAT2;ROBO1;YAP1;ANGPT1;SLC24A3;ROCK1;WNT6;AGT;TAF1D;PIK3CB;TGFBR1;PLXNB2;LIMS1;METTL5;EIF2AK3;CNTF;BMP2;EZR;NKX2-1;TERF2;STOX1;EIF3C;RBMS3;FUBP1;RBPJ;GJA1;C1QTNF1;CTSH;POLR1G;TWIST1;HEY2;DDX21;LARP4;MED1;ADAM19;SMAD3;RAMP3;AGPAT1;PRKAG1;TNRC6C;FXR1;PASK;TP53;MSN;METTL3;ITGB8;PYM1;NGF;HNRNPLL
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.386516259469224,0.8033555841308573,0.6722797927461139,1.0,1.0,5/19,16.05%,MAP4K4;ROCK1;LIMS1;RAC1;SFRP1
prerank,gliogenesis (GO:0042063),0.40195256637922777,0.8027531825680727,0.6784203102961918,1.0,1.0,4/15,16.34%,MMP24;NFIB;ANXA1;METTL3
prerank,positive regulation of bone resorption (GO:0045780),-0.3272384265428281,-0.8027357326204088,0.7435158501440923,0.8937829049173553,1.0,7/11,36.57%,TNFRSF11A;PLEKHM1;ATP6AP1;SYK;DEF8;SPP1;ADAM8
prerank,membrane raft organization (GO:0031579),0.39312853680065823,0.8026185320711208,0.6695035460992907,1.0,1.0,5/15,24.99%,ANXA2;FLOT2;FA2H;S100A10;MYADM
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.35449047087935476,0.80219919991179,0.6794425087108014,1.0,1.0,6/39,12.13%,TRAK1;ACTN4;MYO1C;NDE1;RAB1A;FBXW11
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3375330966644924,0.8021981787041925,0.7888324873096447,1.0,1.0,42/124,24.76%,VANGL1;MOV10;RHOA;AGO2;PSMC2;PSMD5;NLK;DAAM1;TCF7L2;SFRP2;PPP3CA;PSMB1;SMURF1;PSMD14;PSMD1;PSMB9;SMURF2;RAC1;PSMC6;TNRC6C;SFRP1;PPP3R1;PSMB2;PSME4;FRZB;PSMB7;WNT4;TNRC6B;PSMD11;ARHGEF19;PSME3;PSMD13;GNB1;CELSR1;PSMB8;GNAO1;PSMD4;PSMF1;AP2B1;PPP3CB;PSMA5;PSMC3
prerank,regulation of neuroinflammatory response (GO:0150077),-0.27283307985722927,-0.8014443237155592,0.7458333333333333,0.8952767553427026,1.0,4/19,13.17%,IGF1;TNFRSF1B;PTGS2;NUPR1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.37207025311215497,0.8010159758245522,0.6786600496277916,1.0,1.0,9/26,23.17%,IRF1;FLOT2;APPL2;LGR4;SMPDL3B;APPL1;BIRC2;GPR108;NFKBIL1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3721886252304832,0.8008547770272259,0.6817102137767221,1.0,1.0,5/33,9.89%,ATP2B4;ANGPT4;RHOA;HMGB1;MEOX2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4091406573076494,0.8007560414119315,0.6696035242290749,1.0,1.0,1/12,6.37%,IL18
prerank,ethanol metabolic process (GO:0006067),0.4135006778457727,0.8007033178062344,0.7090643274853801,1.0,1.0,2/12,9.50%,ALDH1A1;ACSS1
prerank,membrane depolarization during action potential (GO:0086010),-0.23741943874347893,-0.8006332387571943,0.7794871794871795,0.8957491174998357,1.0,12/26,34.06%,SCN1A;SCN9A;ATP1A2;SCN3A;SCN8A;SCN1B;SCN4B;CACNA1H;CACNA1I;YWHAH;SCN3B;CACNA1D
prerank,positive regulation of mRNA processing (GO:0050685),0.37837309521521617,0.8001360062667794,0.6563307493540051,1.0,1.0,8/21,23.32%,TRA2B;THRAP3;LEO1;DAZAP1;NUP98;TRA2A;RBMX;NCL
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3782782525818289,0.7994247511891428,0.6624525916561315,1.0,1.0,3/21,13.20%,FGL1;SAMSN1;IL4I1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.360134460383421,0.7993693614764185,0.6921296296296297,1.0,1.0,5/36,7.41%,MOV10;AGO2;NLK;TCF7L2;PPP3CA
prerank,zymogen activation (GO:0031638),0.3574068142057277,0.799278778149814,0.7034883720930233,1.0,1.0,8/39,19.09%,FADD;MMP14;PLAU;CASP8;CTSH;BAD;PLAT;TBC1D10A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4010281433388314,0.7990357663136292,0.6705710102489019,1.0,1.0,1/13,2.15%,FADD
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.41230284852556714,0.7990339371946173,0.6707882534775889,1.0,1.0,3/11,10.23%,LEPROT;PICALM;SNX33
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2870937593977252,-0.7989943241357315,0.7602739726027398,0.8977568646818199,1.0,7/15,24.59%,SIK1;SLC27A1;GPLD1;NR1H3;NR1H2;MFSD2A;CTDNEP1
prerank,cellular response to hypoxia (GO:0071456),0.3312415855275385,0.7986313265508296,0.7769929364278506,1.0,1.0,48/126,24.76%,AQP1;ANGPT4;PSMC2;PSMD5;MDM4;FAM162A;HP1BP3;ELOC;PSMB1;PSMD14;LIMD1;CPEB2;VHL;PSMD1;PSMB9;NDRG1;STOX1;RORA;TWIST1;PSMC6;ARNT;NPEPPS;TP53;SFRP1;SUV39H2;PSMB2;BAD;PTGIS;PSME4;PSMB7;TBL2;FMN2;TERT;PSMD11;EGLN1;PSME3;PSMD13;SIRT2;EGLN3;ZFP36L1;PSMB8;PSMD4;KCND2;NOP53;PSMF1;PSMA5;HIF3A;PSMC3
prerank,snRNA processing (GO:0016180),0.3949724960713161,0.798498797538132,0.6635006784260515,1.0,1.0,3/16,10.73%,INTS7;TUT1;INTS8
prerank,regulation of cell junction assembly (GO:1901888),0.359563476280896,0.7980863040277723,0.6837708830548926,1.0,1.0,5/27,12.31%,CBFB;ROCK2;MYO1C;ROCK1;PDLIM5
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.39783326584916984,0.7979315181004412,0.6578581363004172,1.0,1.0,3/14,11.67%,UPB1;DPYD;ERH
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.37611351712579805,0.7978426001433041,0.6705128205128205,1.0,1.0,7/23,17.82%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;SMAD3;SMAD2
prerank,mitochondrial translational termination (GO:0070126),0.3365684963527508,0.7974733067215788,0.7364102564102564,1.0,1.0,23/88,22.00%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,protein transport (GO:0015031),0.3321041761060889,0.7974534297151717,0.908,1.0,1.0,52/332,16.65%,CENPF;NEURL1B;NDC1;USP6NL;STX11;ZG16;MACF1;STEAP3;ARFIP1;AP4M1;RAB10;EVI5L;TBC1D25;SNX1;TBC1D13;WDR11;VPS26C;TBC1D2B;RAB22A;SLC10A7;RAB29;STXBP2;STX2;DNM2;RAB1A;SVBP;SNX27;VIPAS39;COPB2;SNX33;HERC2;COPZ1;ARRDC1;PRKCB;AP3B1;ABCA1;SCFD1;EHD1;IFT27;TOM1;ARF4;ARRDC2;RAMP3;MIA3;ARL4A;UNC119;STX12;ARF3;TBC1D9;STXBP1;VPS26A;TMED3
prerank,regulation of gastrulation (GO:0010470),-0.2906524345175155,-0.7973919504962311,0.743859649122807,0.8997221075559908,1.0,4/14,27.77%,PHLDB2;TENM4;RACK1;DAG1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.33517223449562483,0.7972146389151804,0.8117408906882592,1.0,1.0,32/166,16.96%,ATAD5;GLI2;FGFR4;LARP4B;GCK;HNRNPD;STN1;DNA2;DHX9;PRKDC;UPF3B;FAF1;PTPN2;SAMD4A;NMD3;SLC25A37;FMR1;ABCB10;PLXNB2;METTL5;PCNA;EIF3C;LARP4;SMAD3;ARNT;FXR1;PRKD2;PKD2;PASK;METTL3;PYM1;LDLR
prerank,spliceosomal complex assembly (GO:0000245),0.3512511869299797,0.7971883338624617,0.7241379310344828,1.0,1.0,11/46,17.77%,SETX;SRSF10;DDX39B;PRPF19;CELF2;SF3A2;SRPK1;LUC7L3;DDX1;SRPK2;LUC7L2
prerank,macrophage migration (GO:1905517),0.3993900940090429,0.7967496651966978,0.6761768901569187,1.0,1.0,1/13,4.99%,CKLF
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3222109461265391,-0.7965759524943661,0.7241379310344828,0.9003502100515121,1.0,3/11,9.04%,PRKN;DAB2;VPS11
prerank,positive regulation of nervous system process (GO:0031646),-0.2650359953448502,-0.7964823366913768,0.7322175732217573,0.8996658732314191,1.0,5/18,15.09%,UNC13B;RIMS1;TNFRSF1B;TENM4;DICER1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3780427422706768,0.7964436833493692,0.6825192802056556,1.0,1.0,5/19,15.71%,ADGRL1;PRNP;TRPM2;DMTN;STIMATE
prerank,membrane assembly (GO:0071709),0.35290798893306796,0.7962635930682933,0.676923076923077,1.0,1.0,12/34,20.32%,ANXA2;NLGN3;STX2;PICALM;FLOT2;GAK;PTEN;NLGN2;UBXN2B;CHMP4B;UGCG;ANK3
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2965638534469738,-0.7960597934797118,0.7185430463576159,0.8994752878066673,1.0,2/14,4.30%,CARD16;GAS6
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3416815089406679,0.7960578380254903,0.6924754634678298,1.0,1.0,20/50,24.76%,PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.3803847064413168,0.7957621838000506,0.6628643852978454,1.0,1.0,7/21,19.53%,HPSE;SULF2;SULF1;HS2ST1;UGDH;XYLT1;GLCE
prerank,zinc ion transport (GO:0006829),0.37876492031402464,0.7955017579810278,0.6709021601016518,1.0,1.0,6/21,15.01%,SLC39A11;TRPM2;SLC39A8;SLC30A9;SLC39A6;SLC30A10
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3710398584188476,0.7948256751763826,0.6805369127516778,1.0,1.0,7/20,20.59%,LHPP;HPRT1;ADSL;PFAS;GART;PPAT;ADSS2
prerank,regulation of primary metabolic process (GO:0080090),0.33214538800107496,0.7946468956079203,0.7933130699088146,1.0,1.0,32/126,20.43%,ZFP69;ROCK2;FGFR4;PSMC2;PSMD5;PMVK;TBL1XR1;PSMB1;NQO1;PSMD14;NFYA;PSMD1;PSMB9;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;MED1;MVK;PSMC6;AZIN1;DHCR7;LDLR;PSMB2;SREBF1;PSME4;PSMB7;TGS1;PRKAB1;PSMD11;PSME3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.33914997958312304,0.794540754598737,0.7484076433121019,1.0,1.0,29/72,24.76%,MAP3K14;PSMC2;PSMD5;PSMB1;PSMD14;TNFRSF10B;PSMD1;PSMB9;FBXW11;BTRC;PSMC6;ZFP91;PSMB2;PSME4;PSMB7;RELB;PSMD11;TRAF6;PSME3;TRAF2;PSMD13;BIRC2;PSMB8;PSMD4;PSMF1;REL;PSMA5;RELA;PSMC3
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.2774330811524973,-0.7939882917782567,0.7132616487455197,0.9021020527030117,1.0,1/17,0.17%,PLA2G4A
prerank,cellular response to oxidative stress (GO:0034599),0.3286700916112605,0.7935826645081538,0.7831813576494427,1.0,1.0,35/118,20.92%,VKORC1L1;SETX;SRXN1;MAPT;VRK2;PDGFRA;PYCR1;FOXO3;AGAP3;HTRA2;LRRK2;SOD3;STX2;CPEB2;LONP1;NOX4;CYBB;PRKD1;ARNT;GPX8;PKD2;TP53;SESN2;PNPT1;RAD52;PTPRK;CCS;FANCC;ADNP2;PYROXD1;PRKCD;DAPK1;TXNRD1;SNCA;FER
prerank,protein O-linked glycosylation (GO:0006493),0.334482022736141,0.7935694705738113,0.756951596292482,1.0,1.0,16/96,16.23%,POMT1;TRAK1;LARGE1;CRPPA;GALNT1;B3GNT8;FKRP;ST3GAL3;C1GALT1;POFUT1;RXYLT1;TMTC4;ST3GAL4;ST3GAL1;ST3GAL2;PLOD2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.3549684708303692,0.7934584154250602,0.7023945267958951,1.0,1.0,2/40,4.49%,HMGB2;RNASE6
prerank,polyol biosynthetic process (GO:0046173),-0.2843385986806186,-0.7934263562937438,0.7925925925925926,0.9021729914651802,1.0,5/16,13.40%,IPPK;PPIP5K2;FGF2;ACER3;ITPKB
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.23843668341877527,-0.7933051292226109,0.8,0.9015392595695343,1.0,10/27,22.46%,TAB2;TLR4;TAB3;HSPD1;IRAK4;TNIP1;UBB;TIRAP;RPS27A;UBC
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.38745538134324276,0.7932619256225751,0.7016348773841962,1.0,1.0,4/14,14.41%,RAB1A;SCAP;SEC24D;MIA3
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.2525931784583928,-0.7930206691574717,0.8095238095238095,0.9011792835048421,1.0,9/22,19.75%,CALM1;TAOK2;ACE;RAP2C;PDGFD;NBN;VEGFA;TNKS1BP1;CALM3
prerank,leukocyte cell-cell adhesion (GO:0007159),-0.24610679436647287,-0.7929685825010994,0.8232323232323232,0.9004259161253219,1.0,4/24,7.53%,PECAM1;F11R;VCAM1;SEMA4D
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3515870046374306,0.7916145500371671,0.6993087557603687,1.0,1.0,13/35,23.50%,HMGB2;PRKDC;FOXO3;ABCB10;TAL1;MED1;ARNT;MAPK14;ZFPM1;LDB1;ZFP36L1;STAT5B;ANKRD54
prerank,regulation of RNA splicing (GO:0043484),0.3350334275423582,0.7916080797106397,0.744136460554371,1.0,1.0,22/69,19.49%,DYRK1A;SETX;TRA2B;KHDRBS1;SRSF10;MBNL3;HNRNPH1;POLR2A;FUS;SRSF3;HNRNPL;SRPK1;HNRNPH2;METTL4;PTBP2;HNRNPLL;SRPK2;CWC22;SLC38A2;LARP7;CLK3;KHDRBS3
prerank,regulation of cellular protein catabolic process (GO:1903362),0.38223118492122865,0.7916020136649431,0.6855263157894737,1.0,1.0,9/18,25.95%,FAF1;EZR;MSN;AMER1;RIC1;VGLL4;DAB2IP;HSP90AA1;RDX
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.3944796804924452,0.7910715809814465,0.6864406779661016,1.0,1.0,3/13,16.00%,ADGRV1;GNAI3;GABBR2
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.2824764789476896,-0.7910687232560661,0.803030303030303,0.9028139123397634,1.0,6/17,18.02%,BIN1;PTPRZ1;TNFRSF1B;TENM4;DICER1;IL34
prerank,regulation of interleukin-6 production (GO:0032675),-0.17333814657821447,-0.7909669901646901,0.9393939393939394,0.9021595577252256,1.0,21/96,20.17%,STAT3;GAS6;TLR4;LBP;PTPN22;HSPD1;SELENOS;APP;ARHGEF2;CX3CL1;SYT11;PTPN11;IL17D;C1QTNF3;IFIH1;XBP1;LGALS9;AFAP1L2;NCKAP1L;ZC3H12A;TIRAP
prerank,regulation of innate immune response (GO:0045088),0.34046453053609615,0.7899507505747757,0.7287581699346405,1.0,1.0,20/57,24.20%,USP18;DHX9;NMI;IRF1;RIOK3;PARP9;POLR3D;APPL2;AKIRIN2;CASP8;XIAP;SLC15A4;IFNAR2;PTPN1;APPL1;POLR3C;BIRC2;POLR3G;ABCE1;FGR
prerank,mRNA metabolic process (GO:0016071),0.3359271633653877,0.7898443073305802,0.7647668393782383,1.0,1.0,24/90,19.76%,SRSF4;CSTF3;LSM3;SLBP;LSM11;SRSF7;PRPF3;NONO;SF3A2;PCF11;LSM2;SFPQ;YTHDF2;DXO;KIN;HNRNPA2B1;TP53;PNPT1;HIPK3;METTL3;PRPF18;HNRNPR;SF3A3;SNRPB
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.32838989552343495,0.7897131950137156,0.8388721047331319,1.0,1.0,43/173,20.78%,SPTA1;F5;RANGRF;ACTR1A;SPTB;GBF1;COG1;ZW10;ATL2;ANK1;DCTN5;ATL3;RAB29;CUL3;TRAPPC6B;RAB1A;COPB2;COPZ1;CAPZA1;F8;SCFD1;SEC24D;VTI1A;ARF4;GOSR1;NRBP1;MIA3;VAPA;BET1;BCAP29;TMED3;USO1;COG4;COG8;TMED10;BET1L;PROS1;COG5;CNIH4;DYNC1I1;ANK3;TRAPPC8;WHAMM
prerank,glutathione derivative metabolic process (GO:1901685),0.3797465811342149,0.7896840652727946,0.7154046997389034,1.0,1.0,6/20,22.10%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.3797465811342149,0.7896840652727946,0.7154046997389034,1.0,1.0,6/20,22.10%,GSTO2;HPGDS;GSTT1;MGST3;GSTM5;GSTZ1
prerank,global genome nucleotide-excision repair (GO:0070911),0.3605015932980267,0.7894923775549033,0.6723926380368098,1.0,1.0,11/26,23.15%,CHD1L;ERCC4;ERCC3;CUL4B;XPA;RAD23B;ERCC2;RNF111;GTF2H1;DDB2;DDB1
prerank,negative regulation of cyclase activity (GO:0031280),0.39057381318330053,0.7891902907994901,0.6946778711484594,1.0,1.0,3/14,16.00%,ADGRV1;GNAI3;GABBR2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3459017732803895,0.7891127364902487,0.7191629955947136,1.0,1.0,23/47,28.15%,TRIOBP;ACTN4;PDPN;LIMS1;CRKL;RAC1;DMTN;DOCK1;RCC2;DOCK5;RREB1;FERMT2;FBLN1;FLNA;S100A10;CRK;MYADM;P4HB;CDC42;CORO1C;KANK1;MYOC;CARMIL1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.23907731232131052,-0.7889395916720879,0.8228571428571428,0.9047443755456315,1.0,4/26,6.47%,RYR3;RYR2;FGF2;HTR2C
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.37684432609178214,0.7888841370368858,0.6865284974093264,1.0,1.0,6/20,19.60%,ZC3H7A;AGO2;PUM2;ZC3H7B;SPOUT1;TERT
prerank,regulation of MAP kinase activity (GO:0043405),0.3305159076703492,0.7887480626137295,0.760577915376677,1.0,1.0,7/92,10.09%,EZH2;KSR1;KIT;LRRK2;ROBO1;AGT;PIK3CB
prerank,protein localization to phagophore assembly site (GO:0034497),-0.31164033969122246,-0.7885887254527619,0.7201166180758017,0.9044852342196279,1.0,2/11,4.47%,WDR45B;PACS2
prerank,protein localization to synapse (GO:0035418),-0.3021602345606556,-0.7878651075619006,0.7423312883435583,0.9049121868937171,1.0,5/12,18.41%,PCLO;NRXN1;SHANK1;DLG4;NLGN1
prerank,lysosome organization (GO:0007040),-0.21805220468883957,-0.7875635198415001,0.8424242424242424,0.9046135460880587,1.0,16/36,26.92%,ZKSCAN3;CLVS1;TPP1;TMEM106B;ACP2;GRN;MTOR;HOOK1;HPS4;CLN5;TFEB;MBTPS1;ATP10B;GNPTAB;VPS33A;AKTIP
prerank,negative regulation of developmental process (GO:0051093),0.333638003397208,0.7874961553075592,0.7536842105263157,1.0,1.0,13/69,14.32%,SFMBT1;LOXL2;ROCK2;SUZ12;ANP32B;NFIB;MAPT;ROCK1;PTPRS;BMP2;HEY2;RC3H1;FOXM1
prerank,cGMP metabolic process (GO:0046068),-0.3010307873099287,-0.7866917465257315,0.7389937106918238,0.9052226114177968,1.0,3/12,18.25%,GUCY1A1;NPR1;PDE2A
prerank,protein kinase A signaling (GO:0010737),0.4051916319860315,0.7866494804263877,0.6858407079646017,1.0,1.0,5/12,25.95%,EZR;LCP1;RAB13;PRKACA;RDX
prerank,mitochondrial translational elongation (GO:0070125),0.33241667323318597,0.7863735936023334,0.7587628865979381,1.0,1.0,22/88,22.00%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.39151370941811775,0.786097506630579,0.7120115774240231,1.0,1.0,3/14,11.46%,IL18;CD80;ANXA1
prerank,regulation of lamellipodium assembly (GO:0010591),0.35447680109217555,0.7860056277793178,0.7154566744730679,1.0,1.0,11/34,22.30%,ACTR3;AUTS2;TWF1;RAC1;DMTN;WASF2;NCKAP1;ABI2;PLXNB3;FER;ARPC2
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3635362292214289,0.7852520776902946,0.6924939467312349,1.0,1.0,4/25,10.90%,HAS3;B3GNT8;HAS1;HS2ST1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.28852708274802885,-0.7852490334847496,0.7406143344709898,0.906854525616285,1.0,8/13,36.42%,IGF1;RAMP1;SLC2A10;ABCA2;PLCB1;CCL19;GOLGA2;CHP1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.40790434454731866,0.7841917698180065,0.6821589205397302,1.0,1.0,1/10,4.76%,GALNT1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.24555983538556403,-0.7841358946509837,0.7912087912087912,0.907760630861264,1.0,11/24,25.50%,NUB1;CTSC;APOE;PINK1;RHBDF1;GPX1;UBB;PSME2;PTK2B;PSME1;UBE3A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.33408231965129237,0.7837489354652194,0.7824310520939735,1.0,1.0,28/108,21.07%,FADD;SENP1;DAP;ANP32B;CASP8AP2;FAM162A;MAPT;XDH;HTRA2;ROBO1;TNFRSF10B;HMGB1;APAF1;BOK;UACA;EIF2AK3;CASP8;SMAD3;BCL2L13;NGF;TNFSF10;BAD;RIPK1;DAPK1;COL4A3;PRR7;SNCA;TRAF2
prerank,rRNA methylation (GO:0031167),0.3740545103507022,0.7837071934334412,0.6744487678339819,1.0,1.0,7/22,17.45%,MRM1;MRM3;METTL15;METTL5;TFB1M;MRM2;NSUN3
prerank,cellular response to growth factor stimulus (GO:0071363),0.32271960208174993,0.7837002505567463,0.8112449799196787,1.0,1.0,30/151,14.36%,KNSTRN;SETX;BMPR1A;HYAL1;WWOX;GAREM1;ACAP2;MAPT;BMP6;SOX6;HTRA2;CORO1B;EMD;GAS1;HAS1;NR3C1;TGFBR1;LIMS1;CRKL;BMP2;ANXA1;APPL2;PDPK1;NR4A1;SMAD4;EHD1;PRKD1;MED1;SMAD3;CD44
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.36855848714187245,0.7834037924013398,0.683377308707124,1.0,1.0,6/21,17.23%,KCNN4;RAB29;IKBKG;PRKCB;PRKD2;FOXP1
prerank,protein localization to cell junction (GO:1902414),0.36871327319454417,0.783253752586864,0.6768447837150128,1.0,1.0,5/22,16.32%,CGNL1;MPP4;ARHGEF18;TJP2;NLGN2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.28254069950467037,-0.78322157940577,0.7301038062283737,0.9083587547816406,1.0,4/14,17.26%,TGFBR2;PTPN22;CD81;LGALS9
prerank,regulation of mRNA metabolic process (GO:1903311),0.4029130683237769,0.7830454888131728,0.7009063444108762,1.0,1.0,4/11,17.75%,DHX9;SRPK1;IWS1;SRPK2
prerank,protein localization to cell-cell junction (GO:0150105),0.3835998082394534,0.7830191410520817,0.7044534412955465,1.0,1.0,4/15,12.74%,CGNL1;SCRIB;ARHGEF18;TJP2
prerank,regulation of signal transduction (GO:0009966),0.3279616777081658,0.7828009326899803,0.842685370741483,1.0,1.0,46/190,20.16%,RGS12;CBFB;NCAM1;BRAP;FGFR2;TCF7L1;GIT2;PRNP;PTPN2;WDR11;ELF1;NUCKS1;WWTR1;SULF1;NCLN;CD80;LRRK2;GRK5;NCK1;RGS3;LLGL2;RIC8B;FBXL17;GAS1;POFUT1;NCK2;GRK3;RSPO3;SIK2;RORA;PRKD1;FOXL1;TRIM5;SRC;GDNF;ZDHHC3;TMEM237;VEPH1;RUNX1;IGFBP3;ZIC1;SP100;USP20;PTPN1;SEMA5A;UGCG
prerank,phospholipid translocation (GO:0045332),0.359691483438632,0.7827557660414629,0.7158273381294964,1.0,1.0,3/28,4.57%,PLSCR2;ABCA4;ABCB4
prerank,regulation of neuron apoptotic process (GO:0043523),0.3342584811691433,0.782523022456542,0.7847579814624099,1.0,1.0,1/96,0.13%,KIF14
prerank,calcium ion transport into cytosol (GO:0060402),0.3720149577453441,0.7818192971088723,0.7142857142857143,1.0,1.0,8/21,18.17%,ATP2B4;SLC8A1;CACNA1C;TRPM2;ITPR3;GRIN2D;TRPV4;JPH1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3320846748568135,0.7817903933355006,0.7533960292580982,1.0,1.0,16/79,14.10%,ATP2B4;BMPR1A;NEDD4;CASK;SULF2;CRIM1;LEMD3;SULF1;SMAD6;SMURF1;AGT;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.327416362164515,0.781754000975885,0.8166160081053698,1.0,1.0,25/124,15.58%,MNS1;STMN1;RB1;GSK3B;FAM161A;LAMB1;NEDD4;MAPT;CORO1B;WDPCP;ODF2;ROCK1;MAP4;HMGB1;SAMD14;FRYL;RAC1;EHD1;BLOC1S5;PLEKHA1;DOCK7;VAPA;HDGFL3;GDNF;PKD2
prerank,negative regulation of TORC1 signaling (GO:1904262),0.38920017708523025,0.781328762919273,0.6758321273516642,1.0,1.0,5/13,15.98%,DEPDC5;SESN1;ITFG2;STK11;SESN2
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3461677101209735,0.7805531601216659,0.7342657342657343,1.0,1.0,4/36,7.10%,MACF1;RAB10;AFDN;RILPL1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.27745084647354246,-0.7804310985848053,0.7516129032258064,0.9119208919945091,1.0,6/15,21.15%,APOE;FURIN;GPLD1;TNFRSF1B;ADRA2A;PACSIN3
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3250338903373271,0.7801384864362383,0.8528528528528528,1.0,1.0,40/208,18.72%,ECT2;FADD;TRIML2;TICAM1;MAP3K14;MIER1;RHOA;LPAR1;TRIM59;UBE2N;RNF31;TNFRSF10B;RIOK3;MAP3K3;IKBKG;CXXC5;PRKCB;PDPK1;GJA1;TRIM6;CASP8;BRD4;RORA;ROR1;DDX21;PRKD1;PLK2;TRIM5;PER1;OTUD7B;VAPA;RHOC;DDX1;MAVS;TNFSF10;LAMTOR5;PLEKHG5;TERF2IP;ANKRD17;RIPK1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.383507170045811,0.7800798874875189,0.7,1.0,1.0,1/16,2.15%,FADD
prerank,microtubule-based transport (GO:0099111),-0.288790449108674,-0.7800640534411583,0.7661016949152543,0.9116443737864841,1.0,9/13,48.65%,DYNC1I2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,tRNA aminoacylation (GO:0043039),0.34771082370330236,0.7795609818284323,0.7132947976878613,1.0,1.0,10/37,16.25%,SARS2;VARS1;DARS2;DARS1;IARS2;PPA1;RARS2;QARS1;EPRS1;LARS1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.35217251145941214,0.7794024316460882,0.7217194570135747,1.0,1.0,9/39,16.73%,GLI2;NPNT;SFRP2;BMP2;NKX2-1;LRP5;GDNF;PKD2;SALL1
prerank,positive regulation of cation channel activity (GO:2001259),-0.21394432787831905,-0.7794014711309176,0.8529411764705882,0.9118257662361945,1.0,5/40,5.30%,TMSB4X;SHANK3;CALM1;AKAP6;EPHB2
prerank,regulation of protein localization to centrosome (GO:1904779),0.41184878801655156,0.7792874095781867,0.6953937592867756,1.0,1.0,3/10,18.07%,GSK3B;UBXN2B;CEP250
prerank,iron ion transmembrane transport (GO:0034755),0.4078711680225902,0.7792867349207142,0.6917293233082706,1.0,1.0,3/10,17.00%,SLC25A37;SLC39A8;SLC25A28
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.38195265199936956,0.7791492866243104,0.7011019283746557,1.0,1.0,5/16,18.51%,LEPROT;STAM;VTA1;CHMP4A;CHMP4B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.36993138100375944,0.7787436926598527,0.6775032509752926,1.0,1.0,6/19,15.08%,RTN3;PRNP;ROCK1;PICALM;FLOT2;PIN1
prerank,regulation of phagocytosis (GO:0050764),-0.2004324433921441,-0.7786717099083383,0.8526315789473684,0.9121475559942513,1.0,23/53,38.41%,MERTK;GAS6;SNX3;TGM2;SYT7;SYT11;GATA2;RAB27A;RACK1;SPHK1;IL15;SYK;TUB;FCER1G;PTPRC;ABCA7;CALR;LYAR;HCK;PYCARD;SLC11A1;LMAN2;FCGR2B
prerank,regulation of focal adhesion assembly (GO:0051893),0.33828474863714314,0.7784774230592331,0.7326839826839827,1.0,1.0,16/54,17.85%,MAP4K4;MACF1;ROCK2;RHOA;ROCK1;ARHGAP6;LIMS1;RAC1;DMTN;PTPRA;SRC;RCC2;SFRP1;PTEN;EPHA3;CLASP1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3799491820556046,0.7782813758002664,0.6821282401091405,1.0,1.0,7/18,26.13%,ADAMTS9;STT3B;FBXO27;FBXO17;NAGA;DERA;OGA
prerank,positive regulation of type 2 immune response (GO:0002830),-0.2860000698189803,-0.7778017527109614,0.7376543209876543,0.9127057233989936,1.0,8/14,34.29%,DENND1B;CD81;PRKCZ;CD86;CD74;RSAD2;RARA;NOD2
prerank,membrane lipid metabolic process (GO:0006643),-0.2489642912715315,-0.7776664089331353,0.740909090909091,0.9120585893863976,1.0,10/22,32.48%,ST3GAL6;SERINC1;B4GALT4;ARV1;GAL3ST1;ST6GALNAC4;SPHK1;TECR;SPHK2;CERKL
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.26962956285019773,-0.7775158062438953,0.7536231884057971,0.9114820261897317,1.0,9/17,30.22%,PODXL;TGFB2;FOXC2;NCKAP1L;RET;SYK;SKAP1;P2RY12;CIB1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.3138030367291482,-0.7773880840443229,0.7407407407407407,0.9108466528220477,1.0,5/10,19.85%,EMC2;EMC3;EMC1;EMC9;MMGT1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.35942990259232027,0.7772641903909684,0.6805555555555556,1.0,1.0,3/22,11.44%,PRNP;PTPN2;EZR
prerank,carbohydrate catabolic process (GO:0016052),0.3454314407765896,0.7769266127951547,0.7209567198177677,1.0,1.0,4/38,8.43%,PFKFB1;GCK;GPI;PGM1
prerank,adherens junction organization (GO:0034332),0.34167554254102184,0.776584541811386,0.74,1.0,1.0,6/48,6.12%,CDH15;CDH18;CDH24;CDH4;AFDN;CTNNA1
prerank,negative regulation of kinase activity (GO:0033673),0.3317753384178127,0.7761586094812095,0.7543103448275862,1.0,1.0,13/62,14.56%,RB1;CEP43;TAB1;MAPT;WWTR1;GNAQ;CEP85;HNRNPU;PYDC1;PDPK1;SPRED1;CDKN1B;QARS1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.266722980424573,-0.7757321902178393,0.7768924302788844,0.9126757651718063,1.0,7/16,23.15%,DDX17;SLU7;DDX5;PUF60;SRSF6;SRSF9;SCNM1
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3232642411320566,0.7756961364405334,0.8483935742971888,1.0,1.0,36/170,19.18%,TCF19;TRIML2;ROCK2;CTCF;HNRNPD;UBAP2;AFF3;YBX3;CIAO3;CDK2;ZFP64;MTMR1;MTMR2;SLC8A1;MTMR9;AHR;STOX1;ZUP1;FUBP1;TRIM6;TOB2;MKLN1;TRIM5;MTMR3;ZNF445;PIN1;GDNF;ZNF507;PRDM10;LDLR;SIRPA;FOXP1;MARF1;NPAT;ADNP2;ZNF462
prerank,neuromuscular junction development (GO:0007528),0.36265341223739145,0.7755153778643408,0.7044025157232704,1.0,1.0,4/24,8.29%,PDZRN3;NEDD4;MUSK;LRRK2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.30420896876617165,-0.7752792238697316,0.7508650519031141,0.9124933617302374,1.0,4/12,20.43%,ATF6;PIK3R1;XBP1;TMEM33
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.38631962341697745,0.7751945522409455,0.7057971014492753,1.0,1.0,4/13,19.09%,FADD;CASP8;BAD;TBC1D10A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.36345798825071574,0.7749975506465692,0.7187878787878788,1.0,1.0,3/26,6.51%,FBN1;PTPN2;HOXA7
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.40736501927493474,0.7747406084951471,0.7088989441930619,1.0,1.0,1/10,4.54%,KIT
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.35825337555421577,0.7747343416475065,0.7099143206854345,1.0,1.0,8/28,16.13%,PSMC2;DDRGK1;FBXW7;FMR1;SMURF1;ATP5IF1;PSMC6;PTEN
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.36229149842199104,0.7746683741813809,0.7111959287531806,1.0,1.0,7/25,17.91%,WDR54;MTMR2;PICALM;RAC1;ITGAV;UNC119;ANKRD13D
prerank,neuron projection regeneration (GO:0031102),-0.3116251402436874,-0.7743429459846783,0.778125,0.913065434226543,1.0,5/10,28.30%,GAP43;RTN4RL1;NREP;MTR;OMG
prerank,regulation of histone deacetylation (GO:0031063),0.3865713101731836,0.7738783817466433,0.6903409090909091,1.0,1.0,3/13,7.79%,CTBP1;NIPBL;ZBTB7B
prerank,endothelial tube morphogenesis (GO:0061154),0.4014079533773811,0.7736257500922756,0.6962616822429907,1.0,1.0,3/10,15.58%,RHOA;RBPJ;PRKD2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.35466345966742663,0.7735537679617722,0.705237515225335,1.0,1.0,2/27,2.26%,ATP2B4;RANGRF
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.36981000857683133,0.7733949701802678,0.7089136490250696,1.0,1.0,4/15,12.17%,ROCK2;ROCK1;AGT;PRKCA
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.35878609918681625,0.7733916227983846,0.7080200501253133,1.0,1.0,3/24,6.12%,CDH15;SPAG9;CTNNA1
prerank,transcription by RNA polymerase III (GO:0006383),-0.2285185730058129,-0.7731174855068867,0.842391304347826,0.9141999824675762,1.0,9/27,23.79%,RO60;SNAPC3;ICE1;POLR3K;GTF3C3;POLR3H;POLR2K;TBP;GTF3C1
prerank,regulation of receptor internalization (GO:0002090),0.3407148530467433,0.7727271782361156,0.7191539365452408,1.0,1.0,6/35,12.99%,WDR54;ARRB1;FMR1;ANGPT1;MTMR2;MKLN1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.3153082567526526,-0.7726267333712574,0.7687861271676301,0.9141358755944179,1.0,4/10,22.18%,CALM1;GNB5;CALM3;DRD2
prerank,sterol homeostasis (GO:0055092),0.33566259375367635,0.7723864071755913,0.7624076029567054,1.0,1.0,12/65,16.96%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;SOAT2;EHD1;LRP5;RORA;LPL;RALY;LDLR
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.32627978375328076,0.7722166950098375,0.7770897832817337,1.0,1.0,11/86,12.59%,TTK;BMPR1A;NUMA1;BMP6;CCN1;SULF1;TGFBR1;BMP2;RBPJ;ADAM17;SMAD4
prerank,calcium-mediated signaling (GO:0019722),0.3265199609268886,0.7721450857652384,0.7977178423236515,1.0,1.0,19/93,16.37%,ADGRL1;PRNP;CXCR4;PPP3CA;LRRK2;MCU;ATP2A2;SLC8A1;SAMD14;CACNA1C;TRPM2;EIF2AK3;PDPK1;TRPM4;DMTN;BTK;NUDT4;STIMATE;TPCN2
prerank,cholesterol homeostasis (GO:0042632),0.3359469942607188,0.7720714107276903,0.7653276955602537,1.0,1.0,12/64,16.96%,CYP39A1;FGFR4;SOAT1;IL18;ABCA1;SOAT2;EHD1;LRP5;RORA;LPL;RALY;LDLR
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3969743800312948,0.7715388504350338,0.6931137724550899,1.0,1.0,2/12,10.49%,RNF168;HNRNPU
prerank,secondary alcohol biosynthetic process (GO:1902653),0.35335130881696525,0.771420478032419,0.6994082840236686,1.0,1.0,7/30,18.28%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.20922745069044563,-0.7712814328566816,0.8521739130434782,0.9155024046205557,1.0,12/41,25.08%,PLA2G4A;SCP2;GPX4;PNPLA8;DEGS1;GPX1;DECR2;ACSL1;SCD;ELOVL1;FADS1;GSTM2
prerank,protein hydroxylation (GO:0018126),0.36879664695398584,0.7709627373648632,0.7047756874095513,1.0,1.0,7/15,22.16%,VIPAS39;P3H1;P3H4;PLOD2;OGFOD1;PLOD1;EGLN3
prerank,sodium ion import across plasma membrane (GO:0098719),0.37773214028617613,0.7707598551500515,0.702557200538358,1.0,1.0,3/17,12.51%,SLC9A5;SLC8A1;TRPM4
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4002134999209273,0.7704672616718155,0.7274096385542169,1.0,1.0,1/11,2.67%,BMPR1A
prerank,negative regulation of cell death (GO:0060548),0.32529989639536055,0.77032698532997,0.7892561983471075,1.0,1.0,26/88,22.78%,RAD18;TXNDC12;GSK3B;SPEF1;CCN1;HTRA2;LRRK2;NCK1;KANK2;IKBKG;SRGAP2;CCN3;NENF;PRKD1;BTBD10;CCN2;CHMP4A;CHMP4B;ADNP2;SNCA;FERMT2;INPP5A;TRAF2;CDK5;ATG5;FYN
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.36383307658680797,0.7699734437115838,0.7010050251256281,1.0,1.0,3/23,8.02%,FGFR2;TGFBR3;ADAMTS9
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.3519396512134037,0.7697245645584316,0.71125,1.0,1.0,6/23,20.56%,MCU;RIPOR2;CAMK1D;RAC1;DNM1L;DPP4
prerank,endothelial cell development (GO:0001885),0.3579049823574932,0.769459920688952,0.7033792240300375,1.0,1.0,5/25,16.26%,COL22A1;COL18A1;EZR;COL15A1;MSN
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.39989561322049755,0.7692328549751702,0.7168674698795181,1.0,1.0,1/11,2.79%,TICAM1
prerank,mitochondrial translation (GO:0032543),0.3245271705058898,0.7691440234994529,0.7912423625254582,1.0,1.0,21/104,18.10%,MRPL36;MRPL18;IARS2;RARS2;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MTIF3;MRPL42;MRPL37;MRPL2;MRPL20
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3275015726403728,0.7686751420877089,0.7692307692307693,1.0,1.0,19/80,16.94%,ROCK2;LARP4B;HNRNPD;PRKDC;UPF3B;SAMD4A;EFNA1;FMR1;EPHA4;PICALM;PLXNB2;METTL5;EIF3C;LARP4;FXR1;PASK;METTL3;SMPD3;PYM1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3704044212816758,0.7686059238753881,0.7038567493112947,1.0,1.0,6/16,20.59%,LHPP;ADSL;PFAS;GART;PPAT;ADSS2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.24428374357838561,-0.768603584549323,0.8358974358974359,0.9187840675489503,1.0,8/23,27.32%,MAP3K5;PAK1;ARHGEF5;TNFRSF11A;RPS3;MAP3K11;EDN1;DVL2
prerank,organic cation transport (GO:0015695),0.36864868012361157,0.7683360202117104,0.6941489361702128,1.0,1.0,9/20,26.65%,PDZK1;SLC22A18;SLC25A42;SLC25A29;SLC25A19;SEC14L1;SLC22A4;SLC47A1;RALBP1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.40639243321268936,0.7682196070254788,0.7342342342342343,1.0,1.0,1/10,3.48%,AGO2
prerank,regulation of fibrinolysis (GO:0051917),-0.2887585286583315,-0.7679273507054315,0.7697368421052632,0.9189896614078206,1.0,4/13,22.72%,THBD;THBS1;FAP;USF1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.3618490406515543,0.7678495357453671,0.714824120603015,1.0,1.0,7/23,18.65%,MMP14;MYLK3;PIEZO1;MAML1;EFNB2;MAPK14;NIBAN2
prerank,myotube differentiation (GO:0014902),0.37152454567909,0.7678053205842835,0.7008310249307479,1.0,1.0,3/17,7.57%,MYEF2;ADAM12;ADAMTS5
prerank,defense response to tumor cell (GO:0002357),-0.32357596815315903,-0.7671201008432152,0.7436619718309859,0.9192980104433188,1.0,5/10,27.36%,KLF4;PRDX2;ABI3;PLK5;LAPTM5
prerank,cytoplasmic translational initiation (GO:0002183),0.3677092295104529,0.7671120388081795,0.7137203166226913,1.0,1.0,9/17,23.41%,EIF4H;RBM4;EIF4A2;MCTS1;DENR;EIF3I;EIF2D;EIF5;EIF4B
prerank,lipid droplet organization (GO:0034389),0.36024504986756367,0.7669543075543994,0.7159383033419023,1.0,1.0,4/22,14.91%,TSPO2;ZFYVE1;PPID;FAF2
prerank,hippo signaling (GO:0035329),0.3567433701122474,0.766303457461697,0.7123287671232876,1.0,1.0,11/26,22.68%,TEAD1;STK3;WWTR1;YAP1;TEAD3;TJP2;TEAD4;AMOTL1;LATS1;STK4;DCHS1
prerank,cholesterol biosynthetic process (GO:0006695),0.3503703066407421,0.7656777131778927,0.7122641509433962,1.0,1.0,7/31,18.28%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.3863779045797932,0.7651742606067706,0.7244444444444444,1.0,1.0,4/13,24.85%,MAPT;PRKCD;SOD1;TGFB1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.39727098429308116,0.7650805207149692,0.7224806201550388,1.0,1.0,1/10,5.24%,PRNP
prerank,cellular response to interferon-gamma (GO:0071346),-0.18741732926110152,-0.7649410325273522,0.96875,0.9216649445157843,1.0,19/88,17.26%,CAMK2D;TLR4;TRIM25;MID1;VCAM1;TRIM8;B2M;IRF2;CAMK2G;IFNGR2;IRF3;IRF9;CX3CL1;IFNGR1;GBP3;GBP4;RPL13A;MT2A;LGALS9
prerank,regulation of axonogenesis (GO:0050770),0.3375697740141668,0.7645159448385289,0.7445414847161572,1.0,1.0,18/51,19.80%,RHOA;GSK3B;RTN4R;EPHA4;ROBO1;MARK2;ARHGAP35;PLXNB2;PLXNB1;PLXND1;MAP6;PTEN;SIPA1L1;NGF;PLXNA2;AMIGO1;PLXNB3;KIF13B
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.35576819867192816,0.7644128945853845,0.7175208581644815,1.0,1.0,6/28,17.01%,FADD;CASP8AP2;TNFRSF10B;CASP8;ZDHHC3;NGF
prerank,intermediate filament organization (GO:0045109),-0.2583511335325114,-0.7642139771850871,0.8214285714285714,0.9219188353641835,1.0,8/17,36.72%,NEFL;GFAP;KLHL24;PKP2;BFSP1;DSP;TCHH;BFSP2
prerank,response to UV-B (GO:0010224),0.3870516194741581,0.7639194007699494,0.7157434402332361,1.0,1.0,2/12,14.68%,HYAL1;STK11
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.3610132195025344,0.7636171202343752,0.7129750982961992,1.0,1.0,4/21,16.05%,TXNDC15;TUBD1;TEDC1;SFRP1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.3907818496834378,0.7631294594235463,0.7366136034732272,1.0,1.0,4/12,20.06%,SETX;ADRB2;UVRAG;FYCO1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.34736603962873713,0.7628965477048802,0.7121951219512195,1.0,1.0,10/29,15.43%,TCF7L1;TCF7L2;SMARCA4;AXIN2;LEO1;HDAC1;KMT2D;TLE4;TLE3;TRRAP
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.19077124967521772,-0.7628334566028285,0.9142857142857143,0.9231617929655606,1.0,13/51,25.97%,STAT3;MALT1;TLR4;APP;S100A13;PANX1;LGALS9;TRIM16;EGR1;HSPB1;JAK2;P2RX7;TMEM106A
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3569756488157595,0.7615041650692835,0.6993630573248407,1.0,1.0,4/22,11.40%,XDH;MAP3K4;RELL1;BMP2
prerank,regulation of adenylate cyclase activity (GO:0045761),0.35889141127472574,0.76122767995769,0.722860791826309,1.0,1.0,5/22,16.00%,ADGRV1;CACNA1C;GNAI3;STIM1;GABBR2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.37460955063943163,0.7598069625845031,0.7472826086956522,1.0,1.0,5/17,12.35%,SLC8A1;GJD3;GJC1;CACNA1C;GJA1
prerank,pinocytosis (GO:0006907),0.40179647966276677,0.7596952914823247,0.7236255572065379,1.0,1.0,3/10,20.68%,SNX33;MAPKAPK3;MAPKAPK2
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.3864055021689578,0.7595313603146479,0.7039764359351989,1.0,1.0,3/12,12.81%,ERFE;ZBTB7B;GKAP1
prerank,cellular response to cAMP (GO:0071320),0.34269917655133986,0.7593974223892638,0.7303506650544136,1.0,1.0,6/30,15.58%,AQP1;AHR;EZR;AKAP9;DMTN;PKD2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3306247284544092,0.7593323498341065,0.7221597300337458,1.0,1.0,2/42,6.75%,RBM15;WNK1
prerank,renal filtration (GO:0097205),0.3892554480104066,0.7589668852531458,0.7321981424148607,1.0,1.0,2/10,7.87%,SULF2;SULF1
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.3930169678768325,0.7588620517127083,0.6858407079646017,1.0,1.0,2/11,12.59%,ATP2B4;SMAD4
prerank,glial cell development (GO:0021782),-0.23722858874419633,-0.7588617930120145,0.8177570093457944,0.9282137873581234,1.0,12/25,30.76%,CDK6;NF1;APP;SOX4;NRROS;PICK1;CSPG5;EIF2B2;NSUN5;SOX11;SOX10;MT3
prerank,dermatan sulfate metabolic process (GO:0030205),0.38070815624452237,0.7588577472049644,0.7307692307692307,1.0,1.0,3/13,14.03%,UST;DSE;BGN
prerank,negative regulation of protein metabolic process (GO:0051248),0.3348641957838801,0.7588034074866493,0.7668845315904139,1.0,1.0,12/48,16.96%,IAPP;MDM4;PRNP;ROCK1;FLOT2;SF3B3;PFDN4;ITGAV;PIN1;AZIN1;NFKB1;LDLR
prerank,negative regulation of viral process (GO:0048525),0.32695920345712515,0.758755096564001,0.7564935064935064,1.0,1.0,13/57,21.33%,ILF3;FAM111A;ZC3HAV1;PML;TRIM28;SRPK1;TRIM6;TRIM5;MAVS;SRPK2;LARP7;ISG15;EIF2AK2
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3174431364952713,0.7587407801806828,0.93,1.0,1.0,46/308,15.37%,EZH2;BMP1;FBXO5;LOXL2;PAXIP1;MFAP2;BMPR1A;AGO2;NUMA1;PDPN;LEPR;CXCR4;SOX6;IL18;RIF1;ZBTB7B;WWTR1;SERPINE1;MFN2;AGPAT2;AXIN2;ALMS1;ROCK1;AGT;TAPT1;TGFBR1;SMURF2;BMP2;ABCA1;APPL2;ACHE;GJA1;TRPM4;SMAD4;KMT5C;ADIPOR1;TWIST1;ADRB2;MED1;CPT2;ACADL;SMAD3;AGPAT1;SHLD2;RBM19;GDNF
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.33919565303367155,0.7585388314165774,0.7416762342135477,1.0,1.0,7/38,16.13%,PHLPP2;XDH;PIK3CB;PPP2R5C;PLEKHA1;PPP2R5B;PTEN
prerank,action potential (GO:0001508),-0.19980435456269852,-0.7583268495168349,0.90625,0.9282121839635923,1.0,18/44,32.55%,KCNB1;AKAP6;SCN1A;SCN9A;GNA14;KCNA2;SCN3A;SCN8A;SRI;KCNQ1;GPER1;CACNA1H;MYH14;CLN3;CACNA1I;YWHAH;KCNE4;SCN3B
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.30059967889281014,-0.7582345413969659,0.8051948051948052,0.9274941509570583,1.0,2/12,3.22%,RYR2;ANXA6
prerank,canonical Wnt signaling pathway (GO:0060070),0.3239564497813414,0.7578460730792597,0.7684887459807074,1.0,1.0,17/68,19.03%,GSK3B;TCF7L1;WNT2B;TCF7L2;SFRP2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;LRP5;SFRP1;PTEN;AMER1;CSNK1A1;FRZB;WNT4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3279012819691433,0.7578090719839974,0.7553072625698324,1.0,1.0,16/47,20.01%,SFRP2;ZBTB7B;TMEM64;PIM1;HNRNPU;BMP2;TRPM4;LRP5;MEDAG;WDFY2;LPL;SFRP1;AAMDC;FRZB;SYAP1;RREB1
prerank,positive regulation of protein depolymerization (GO:1901881),0.3927191003548179,0.7575673688058201,0.7232415902140673,1.0,1.0,5/11,23.09%,NES;STMN2;TRPV4;SEMA5A;CFL2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.22924371086823425,-0.7575555040437804,0.8553459119496856,0.9276313890279851,1.0,4/30,7.70%,CACNA2D1;RYR2;SCN1A;ATP1A1
prerank,cell-cell junction organization (GO:0045216),0.32650138607327406,0.7573916329942837,0.7875647668393783,1.0,1.0,14/79,14.33%,CDH15;SDK1;CDH18;CDH24;CDH4;AFDN;CTNNA1;GJC1;TLN1;LIMS1;TJP2;TLN2;PRKCI;SMAD3
prerank,negative regulation of phosphorylation (GO:0042326),0.3212713606557778,0.7571857158630056,0.7926701570680629,1.0,1.0,20/85,18.54%,CDKN2D;CDKN2C;PFKFB1;PRKDC;PRNP;MAPT;XDH;WWTR1;LRRK2;ROCK1;HNRNPU;CRKL;PPP1R15B;CDKN1B;PTPN13;PTEN;ANKLE2;SIRPA;TERF2IP;IGFBP3
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.38333325567182797,0.7570354001870838,0.7077826725403817,1.0,1.0,2/13,10.49%,RNF168;HNRNPU
prerank,neuron development (GO:0048666),0.31606651838362987,0.7569599653064659,0.8561368209255533,1.0,1.0,30/141,17.32%,PBX4;GLI2;STMN1;RB1;PBX3;GSK3B;LAMB1;NEDD4;TDP2;SRF;MAPT;WNK1;POU3F2;ROCK1;MAP4;HMGB1;SAMD14;FRYL;EHD1;ACTL6B;BLOC1S5;DOCK7;VAPA;HDGFL3;GDNF;UNK;TBCD;UGDH;STMN2;RAB13
prerank,positive regulation of autophagy (GO:0010508),0.32490508592000966,0.7566446162689007,0.809375,1.0,1.0,19/81,14.68%,TRIML2;TICAM1;GSK3B;TPCN1;SH3GLB1;FOXO3;LARP1;LRRK2;ROCK1;HMGB1;IKBKG;SESN1;PIK3CB;TRIM6;GNAI3;PRKD1;PLK2;TRIM5;STK11
prerank,BMP signaling pathway (GO:0030509),0.3236575796681947,0.7561138969736485,0.7857900318133616,1.0,1.0,12/62,14.33%,BMPR1A;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;BMP2;SMAD4;USP9X;SMAD3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.36209016819741213,0.7560516304730761,0.6983695652173914,1.0,1.0,5/17,14.41%,SRF;ROBO1;NR4A1;EFNB2;MIA3
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3827313415705597,0.7559027033240544,0.7116212338593975,1.0,1.0,3/11,12.74%,AFDN;RAB1A;TJP2
prerank,endosome organization (GO:0007032),-0.2020188485212548,-0.7555884517424377,0.8861788617886179,0.9296283620992211,1.0,18/41,27.78%,SNX3;SQSTM1;LAPTM4B;DNM1;USP8;VPS11;CHMP2B;ARFGEF2;HOOK1;VPS33B;RAB27A;ALS2CL;PLEKHF1;TMEM9;SNX10;PI4K2A;AKTIP;PHETA1
prerank,sulfur compound biosynthetic process (GO:0044272),0.3169234419196842,0.7547719888857669,0.8181818181818182,1.0,1.0,27/104,19.90%,CHST15;GSTO2;B4GALT1;GSS;MAT2B;CHSY1;HPGDS;SLC10A7;PAPSS2;ST3GAL3;SLC35D2;CHST3;ANGPT1;UST;DSE;BGN;ST3GAL4;ST3GAL1;ST3GAL2;UGDH;GSTT1;MGST3;GCLM;GSTM5;GCLC;GLCE;HAGH
prerank,ncRNA transcription (GO:0098781),-0.28270933678629667,-0.7547263688606326,0.7752808988764045,0.9300532556962129,1.0,8/13,36.74%,SNAPC3;SPIN1;GTF3C1;NIFK;RPAP2;GTF3A;SIRT7;ANG
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.35179995672175296,0.7547110394765856,0.6945500633713562,1.0,1.0,9/22,23.15%,CHD1L;ERCC3;CUL4B;XPA;RAD23B;ERCC2;GTF2H1;DDB2;DDB1
prerank,endodermal cell differentiation (GO:0035987),0.33986955567168486,0.7542417018590614,0.740072202166065,1.0,1.0,7/31,14.99%,MMP14;LAMB1;SETD2;LEO1;COL12A1;ITGA5;ITGAV
prerank,heart trabecula morphogenesis (GO:0061384),0.35447565835974265,0.7541102406926791,0.7174770039421814,1.0,1.0,4/18,12.32%,BMPR1A;TGFBR3;TGFBR1;RBPJ
prerank,cholesterol efflux (GO:0033344),0.3550327349878292,0.7534562470731879,0.7212681638044914,1.0,1.0,4/20,15.89%,SOAT1;ABCA1;SOAT2;STX12
prerank,visual system development (GO:0150063),0.3422028978558803,0.7532661655465973,0.761297798377752,1.0,1.0,2/37,2.57%,PBX4;PBX3
prerank,ameboidal-type cell migration (GO:0001667),-0.19581765253158698,-0.7531817054783176,0.8941176470588236,0.9313677615809468,1.0,14/51,19.19%,SEMA6A;ANXA6;SEMA6D;SEMA7A;SEMA4D;SEMA3A;ERBB4;AMOT;MEGF8;TBX1;SEMA3B;SEMA3C;PDLIM1;SEMA5B
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.24105099137683472,-0.7531649515513096,0.819327731092437,0.9305526531059962,1.0,5/22,11.61%,TIMP3;APOE;FURIN;GPLD1;TNFRSF1B
prerank,membrane organization (GO:0061024),0.31504423643501567,0.7530084780114984,0.9047141424272819,1.0,1.0,39/227,17.62%,CEP55;KIF20A;NEMP1;NUP155;STX11;ACTR3;PACSIN2;OCRL;STON2;MYOF;ARRB1;LEMD3;STAM;SH3GLB1;MFN2;DNM2;PICALM;EMD;FNBP1;STX18;GAK;CHRNB1;AAK1;MITD1;ADRB2;PRKCI;PIP5K1C;TOR1B;VAPA;SYP;SUN2;SNAP23;TMCC1;DYSF;EPS15L1;UBXN2B;LDLR;EPS15;USO1
prerank,regulation of astrocyte differentiation (GO:0048710),0.38426156063561545,0.7529219734619945,0.7253731343283583,1.0,1.0,2/12,11.40%,EPHA4;BMP2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.36809851073030764,0.7527894067101674,0.7116212338593975,1.0,1.0,2/14,7.87%,SULF2;SULF1
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.2617273548996694,-0.7525173386086838,0.7928571428571428,0.930590690359535,1.0,5/17,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,negative regulation of receptor binding (GO:1900121),-0.3052047566334945,-0.7523893479375006,0.796923076923077,0.9299398972570445,1.0,4/10,26.03%,ADAM15;B2M;ATP2A3;PTPRF
prerank,positive regulation of axonogenesis (GO:0050772),0.33390679510637605,0.7522284590821624,0.7447744774477447,1.0,1.0,15/43,20.63%,MACF1;RHOA;NTN1;MAPT;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;DBN1;NGF;PLXNA2;AMIGO1;PLXNB3;GOLGA4
prerank,protein localization to membrane (GO:0072657),0.3144136919025624,0.7522178616986553,0.8800403225806451,1.0,1.0,39/187,17.64%,NDC1;SYNE3;NUP155;TSPAN33;ROCK2;AP4M1;RAB10;ITGB7;PDZK1;DENND4C;RAP2A;ANK1;SCRIB;RAB29;SH3GLB1;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;ZDHHC15;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;TM9SF2;ZDHHC3;NLGN2;STXBP1;DPP6;RAB13;SH3PXD2B;WNK3;TM9SF4
prerank,modified amino acid transport (GO:0072337),0.37107658294799467,0.7520226748353279,0.7187928669410151,1.0,1.0,2/15,6.14%,PDPN;SLC19A1
prerank,translational termination (GO:0006415),0.3178538237151155,0.7518681856102319,0.8155737704918032,1.0,1.0,24/95,22.00%,MRPL36;MRPL18;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;MTRF1;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;ETF1;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.2969447175635774,-0.7516491128935686,0.79,0.9292753857575131,1.0,2/12,3.48%,IGF1;AKAP6
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.2969447175635774,-0.7516491128935686,0.79,0.9292753857575131,1.0,2/12,3.48%,IGF1;AKAP6
prerank,ruffle organization (GO:0031529),-0.2614369684336504,-0.7513940926542902,0.7705479452054794,0.9287799963350605,1.0,9/16,31.87%,PLEK;TPM1;INPP5K;PIP5K1A;CYFIP1;ARFIP2;AIF1L;ARF6;CSF1R
prerank,negative regulation of T cell activation (GO:0050868),0.3410908109711199,0.7512731462270311,0.7407407407407407,1.0,1.0,7/35,20.44%,FGL1;CD80;RIPOR2;IL4I1;HAVCR2;SDC4;CEACAM1
prerank,regulation of execution phase of apoptosis (GO:1900117),0.3875086977307317,0.7509131412434967,0.7251461988304093,1.0,1.0,4/11,22.01%,BOK;TP53;PTGIS;SIRT2
prerank,positive regulation of cytokine production (GO:0001819),0.31175102984846154,0.7502798850116777,0.9359359359359359,1.0,1.0,73/292,24.97%,BRCA1;HPSE;FADD;TICAM1;ROCK2;RAB7B;DHX9;PRKDC;SULF2;MRE11;G3BP1;IL18;STOML2;SCRIB;ZBTB7B;SULF1;SERPINE1;CD80;AGPAT2;IRF1;HMGB1;AGT;RAB1A;POLR3D;EIF2AK3;ANXA1;ADAM17;TRIM6;RORA;TWIST1;POU2F2;ARNT;AGPAT1;SETD4;PRKD2;NFKB1;LPL;MAVS;FOXP1;LAMTOR5;LACC1;RUNX1;MAPK14;TMED10;RIPK1;HAVCR2;ZFPM1;PDE4B;TRAF6;IL16;TRAF2;ISG15;EIF2AK2;PNP;SOD1;APPL1;POLR3C;KAT2A;IL6R;POLR3G;TLR7;BCL10;RIPK2;IL6ST;CRCP;MBP;FGR;PAEP;F3;RELA;TGFB1;CD200;DHX33
prerank,icosanoid secretion (GO:0032309),-0.287122341506897,-0.7501889466953678,0.7954545454545454,0.9296103828249938,1.0,3/12,10.67%,ABCC4;PNPLA8;ACE
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3183514042535901,0.7497908220498485,0.8049792531120332,1.0,1.0,12/85,11.74%,VANGL1;RHOA;PSMC2;PSMD5;DAAM1;PSMB1;SMURF1;PSMD14;PSMD1;PSMB9;SMURF2;RAC1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.32055589046739996,0.7493705769147656,0.7798066595059077,1.0,1.0,22/61,24.76%,FGFR4;PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PANK2;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3480692630634629,0.7492581986497456,0.7376847290640394,1.0,1.0,7/27,16.55%,SGF29;MSL3;RUVBL2;KAT6A;TRRAP;BRD8;PHF20
prerank,T cell migration (GO:0072678),-0.2851324046422394,-0.7491935213187974,0.8184818481848185,0.930107204812156,1.0,9/13,49.03%,S1PR1;SLC12A2;PIK3CD;CXCL16;GPR183;PIK3CG;CXCL10;MYO1G;ZAP70
prerank,cellular amino acid catabolic process (GO:0009063),0.3209460945250229,0.7491138613447255,0.8055842812823164,1.0,1.0,8/87,13.20%,ACMSD;SLC25A21;ACAT1;AMT;KMO;ABAT;HOGA1;IL4I1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.3462777603570443,0.7490491739141298,0.7271604938271605,1.0,1.0,2/29,5.54%,FADD;RAET1E
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.2836896117002706,-0.748899337938772,0.7891373801916933,0.9297306743812633,1.0,3/12,9.08%,ATP1B1;WNK2;ATP1B3
prerank,necroptotic process (GO:0070266),0.3673368271277217,0.7488597386729211,0.7306122448979592,1.0,1.0,2/16,7.44%,TICAM1;IPMK
prerank,regulation of pseudopodium assembly (GO:0031272),-0.30664200166129096,-0.7486798465054649,0.7970149253731343,0.9283617135870759,1.0,3/10,14.75%,CDC42EP4;CDC42EP5;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.30664200166129096,-0.7486798465054649,0.7970149253731343,0.9283617135870759,1.0,3/10,14.75%,CDC42EP4;CDC42EP5;APC
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3199938878498047,0.7483998446925068,0.7928870292887029,1.0,1.0,20/80,19.73%,AQP1;CDKN2D;FNIP1;SIAH2;HTRA2;ARL6IP1;SH3RF1;HMGB1;UACA;USP47;XIAP;CD44;SRC;NGF;TNFSF10;LAMTOR5;DPEP1;BAD;DNAJB6;DAPK1
prerank,amino acid transport (GO:0006865),0.32413553789305527,0.7483888834172253,0.764638346727899,1.0,1.0,14/49,20.60%,SLC38A7;PDPN;SLC38A4;SLC25A47;SLC16A10;SLC38A9;SLC1A5;SLC6A17;SLC36A4;SLC7A1;SLC25A29;SLC38A2;SLC25A44;SLC7A11
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.234008463620212,-0.7477017146719008,0.845,0.9289191541455857,1.0,10/23,22.46%,RBX1;PARP1;XPC;COPS8;COPS7A;UBB;COPS2;COPS4;RPS27A;UBC
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.33845769129000813,0.7471883497380191,0.7317961165048543,1.0,1.0,6/33,7.95%,ADA;PDE3B;EFNA1;PLAU;SFRP2;SERPINE1
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.25814903375690695,-0.7469453226501965,0.8127090301003345,0.9291327569895916,1.0,5/16,23.88%,PRKN;PDK1;BCKDK;SCARB2;PDK2
prerank,snRNA metabolic process (GO:0016073),0.3686309565656056,0.746857897524589,0.7194950911640954,1.0,1.0,5/17,19.90%,INTS7;TUT1;INTS8;ZCCHC8;INTS4
prerank,response to metal ion (GO:0010038),0.3176458843233038,0.7462250267054528,0.7622601279317697,1.0,1.0,10/67,13.76%,LOXL2;FXN;NEDD4;PAM;MAPT;PPP3CA;NDRG1;CALM2;ITPR3;ADAM9
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.3011150909364503,-0.7460858397149475,0.7833827893175074,0.9294729030320137,1.0,6/10,44.46%,LGALS9;PTPRC;ARRB2;CX3CR1;FCGR2B;LILRB1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.3522244824804602,0.7456204604080716,0.7281045751633987,1.0,1.0,5/19,18.54%,MMP14;PRKDC;BTK;AXL;ZBTB1
prerank,negative regulation of neurogenesis (GO:0050768),0.3354447867931189,0.7451412039784617,0.764018691588785,1.0,1.0,3/34,4.44%,RHOA;RTN4R;PCM1
prerank,hexose biosynthetic process (GO:0019319),0.3297635062769517,0.7448079162607583,0.7574712643678161,1.0,1.0,5/42,8.43%,PFKFB1;CHST15;GPI;SORD;PGM1
prerank,skeletal muscle contraction (GO:0003009),-0.2530573297115331,-0.7447070984846255,0.803347280334728,0.9305840019516961,1.0,9/19,48.13%,RCSD1;STAC;MYH14;STAC3;TNNI1;STAC2;TNNC1;CCDC78;TCAP
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.2649927744136701,-0.7442484533902325,0.8063380281690141,0.930325401327043,1.0,5/16,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,microglial cell activation (GO:0001774),-0.23547061337827102,-0.7442360961404231,0.8878504672897196,0.9295212647060935,1.0,13/21,42.24%,GRN;APP;CX3CL1;IFNGR1;JAK2;C1QA;TYROBP;ITGB2;CX3CR1;ITGAM;AGER;AIF1;TREM2
prerank,regulation of protein sumoylation (GO:0033233),0.3579544663172399,0.7442085999001483,0.7397820163487738,1.0,1.0,1/17,1.87%,SAE1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3721675486951112,0.7438418281072584,0.73224043715847,1.0,1.0,3/14,11.26%,FIP1L1;TUT1;CPSF4
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.3580133116809574,0.743834976244652,0.7480314960629921,1.0,1.0,3/17,11.39%,HTRA2;SFPQ;BAG5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.29581285364483967,-0.7434193579712904,0.7791044776119403,0.9298171944799694,1.0,6/11,22.71%,FAS;GSN;ST18;LGALS9;PARK7;PIH1D1
prerank,cellular copper ion homeostasis (GO:0006878),-0.2794858663608752,-0.743415725810895,0.8481481481481481,0.9290012306956384,1.0,6/14,21.96%,APP;COX19;SLC31A2;MT2A;ATOX1;ATP7A
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3369351388734085,0.7433439327855217,0.7403381642512077,1.0,1.0,5/26,11.39%,TXN;PYCR1;HTRA2;LRRK2;BAG5
prerank,cellular response to estradiol stimulus (GO:0071392),0.36517866562719703,0.7431163414856496,0.7513297872340425,1.0,1.0,4/18,16.05%,LCOR;RUVBL2;RAMP3;SFRP1
prerank,lamellipodium assembly (GO:0030032),0.34203090607544895,0.7430232510582894,0.7582017010935601,1.0,1.0,6/26,14.26%,KIT;SPEF1;SRGAP2;RAC1;DMTN;ITGB1
prerank,renal water homeostasis (GO:0003091),0.3452551876067758,0.7425283607360182,0.7283018867924528,1.0,1.0,9/23,24.36%,AQP1;ADCY6;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;AQP4;MYO5B;PRKACA
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.30919199626077704,0.7422696185731887,0.8710976837865055,1.0,1.0,28/163,15.73%,ERMAP;THEMIS;PSMC2;PSMD5;KHDRBS1;EIF2B1;WNK1;UBE2N;STOML2;RNF31;RC3H2;PSMB1;PSMD14;NCK1;PSMD1;IKBKG;PIK3CB;PSMB9;PRKCB;FBXW11;PDPK1;BTK;BTRC;RC3H1;PSMC6;PLEKHA1;PRKD2;NFKB1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),-0.30186036780267345,-0.742209829450853,0.7960339943342776,0.9298173050546761,1.0,7/10,32.75%,PDE3A;UBE2B;PDE2A;PDE4D;PDE11A;MGRN1;APLNR
prerank,negative regulation of innate immune response (GO:0045824),0.3374764662713626,0.7421719186812203,0.7505938242280285,1.0,1.0,9/34,22.38%,USP18;NMI;PTPN2;YTHDF2;CNOT7;METTL3;SUSD4;ISG15;FAM3A
prerank,cellular response to purine-containing compound (GO:0071415),0.3796969037957204,0.7420145000254813,0.7242424242424242,1.0,1.0,3/10,10.65%,SLC8A1;P2RY1;TRPM2
prerank,muscle contraction (GO:0006936),0.3090374698174918,0.7418874713241308,0.8515151515151516,1.0,1.0,20/126,16.48%,ROCK2;TPM4;MYOF;SORBS3;ROCK1;SLC8A1;BDKRB2;EMD;GJC1;MYH2;TLN1;SNTA1;SMTN;CLCN1;CHRNB1;DES;TMOD3;DYSF;TPCN2;TNNT3
prerank,response to fatty acid (GO:0070542),-0.2551080234611474,-0.7418681418911854,0.8541666666666666,0.9295042954940725,1.0,12/17,44.77%,FOXO1;IRS1;PPP5C;SCD;SOX9;NR1H4;PDK4;PDK3;KCNK4;PID1;GLDC;CD36
prerank,macrophage activation involved in immune response (GO:0002281),-0.2799074422259517,-0.741720163550364,0.801948051948052,0.9288866427567144,1.0,4/13,14.32%,IFI35;LBP;GRN;SBNO2
prerank,positive regulation of growth (GO:0045927),0.3167833242051725,0.7416079207342323,0.781183932346723,1.0,1.0,13/64,16.05%,HYAL1;CEP43;FXN;MMP14;DERL2;SFRP2;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;SFRP1
prerank,protein processing (GO:0016485),0.3138617607430417,0.7412946037090381,0.8266666666666667,1.0,1.0,7/102,8.21%,KEL;FAM111A;FXN;MMP14;CPXM1;STOML2;HTRA2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3212643776020574,0.7411470955967182,0.7982646420824295,1.0,1.0,11/52,14.34%,ATP2B4;RANGRF;GPSM2;NUMA1;EPB41L2;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3
prerank,negative regulation of lipid storage (GO:0010888),0.3452785170655545,0.7407448759232191,0.7415584415584415,1.0,1.0,4/19,14.99%,PTPN2;OSBPL8;ABCA1;ITGAV
prerank,Golgi to lysosome transport (GO:0090160),0.3817997142149848,0.7404516457160393,0.7242380261248186,1.0,1.0,2/11,11.82%,AP4M1;GAK
prerank,detection of calcium ion (GO:0005513),0.36400457470960546,0.7403416708225391,0.7496382054992764,1.0,1.0,5/13,15.99%,KCNMB2;KCNMB3;CALM2;KCNMB4;STIM1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.31328655517432386,0.7400683332297339,0.7885416666666667,1.0,1.0,15/77,15.31%,RB1;PHIP;FXN;SIAH2;TCF7L2;RTKN2;SH3RF1;CSNK2A2;NR4A2;TGFBR1;PLAUR;QARS1;BIRC6;ITGAV;SRC
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3139582231152666,0.7398602097578593,0.879154078549849,1.0,1.0,30/151,18.76%,RHD;SLC25A15;CERS6;CERS5;GSTO2;LARGE1;PAM;CHAT;LPCAT1;LPIN2;SLC25A2;HPGDS;CSNK2A2;ACHE;PLPP1;CSNK1G2;PRKD1;ELOVL4;ST3GAL4;SPTLC2;TYW1;VAPA;ST3GAL2;PRKD2;ALAS2;GSTT1;MGST3;FA2H;GCNT1;GSTM5
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3538763353446608,0.7397223116848001,0.7291941875825627,1.0,1.0,3/20,13.18%,TICAM1;IL18;PRKCE
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3403460375394811,0.739689910319854,0.7425149700598802,1.0,1.0,5/33,14.20%,E2F2;ADAMTS9;PIK3CB;PDPK1;ITGA5
prerank,small GTPase mediated signal transduction (GO:0007264),0.31071126693478385,0.7392331339928636,0.8350515463917526,1.0,1.0,25/103,18.33%,KSR1;RB1;BRAP;RASSF1;RRAD;CCNA2;ARHGAP18;NTN1;SIAH2;G3BP1;CDK2;TRIM28;USP28;CRKL;ARHGEF18;RAC1;RRAS;PRKD1;PLK2;TP53;TNK2;RRAS2;KRAS;NRAS;MAPK14
prerank,ventricular septum development (GO:0003281),0.32924017684272566,0.7391385129628287,0.7523584905660378,1.0,1.0,12/37,19.40%,BMPR1A;MDM4;TGFBR3;MATR3;ROBO1;TGFBR1;SMAD4;HEY2;HECTD1;SALL1;ZFPM2;ZFPM1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.32812092724401665,0.7388057783746971,0.7395348837209302,1.0,1.0,7/36,13.52%,ATP2B4;NOSIP;DNM2;NPR3;PIK3CB;TERF2;DHFR
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.26906502439606,-0.7384890827175455,0.8156996587030717,0.9323175667579626,1.0,7/15,29.26%,NTRK2;GRB2;DDIT4;BCAR1;BDNF;ZFYVE27;SOS1
prerank,nervous system development (GO:0007399),0.30945301273716663,0.7383255134857003,0.969,1.0,1.0,68/429,17.02%,ECT2;STIL;WDR62;NAV2;CDK5RAP2;ARTN;SDK1;DYRK1A;ADGRV1;TRAK1;TEAD1;LPAR1;OBSL1;RBFOX2;ALDH1A2;FUT10;NINJ2;ST8SIA2;GSS;BTD;ADGRA2;CXCR4;SOX6;NLGN3;GRHL2;CRIM1;RAB29;POU3F2;WWTR1;WDPCP;ROBO1;DSCAML1;YAP1;FARP1;ZIC5;FBXL17;APAF1;TGFBR1;PRPS1;DPYSL4;DSCAM;ATXN1;MPZ;ACHE;ZIC4;DAGLB;NOTCH2;SH3GL3;LY6H;PLXND1;NES;ACTL6B;SMPD1;MAB21L2;CAPG;UNC119;GDNF;PKD2;PTEN;ANKLE2;NLGN2;NCKAP1;SHANK2;JRKL;ARNT2;AXL;NGF;WWP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),-0.21866126027339033,-0.73826322083475,0.8987341772151899,0.9318106851382162,1.0,6/31,15.53%,SCP2;LIAS;MOCS2;CYP51A1;MOCS1;GCH1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.3259943042028244,0.7381694115115154,0.7763157894736842,1.0,1.0,10/47,16.79%,MAP4K4;ULK4;RAP2A;TGFBR3;MAPK8IP3;FOXM1;QARS1;PER1;TAOK1;KLHDC10
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.36931106489644305,0.7381125487501079,0.7343511450381679,1.0,1.0,3/11,13.95%,RC3H2;ANXA1;RC3H1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.343552766564215,0.737974166186997,0.7668329177057357,1.0,1.0,6/25,20.26%,RB1;TRIM6;TWIST1;HEY2;NIBAN2;TRAF6
prerank,regulation of keratinocyte migration (GO:0051547),0.3682741392637012,0.7376424109806256,0.7554585152838428,1.0,1.0,3/12,16.13%,MAP4K4;ADAM9;PTEN
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3092999325087161,0.7369943375718275,0.8187372708757638,1.0,1.0,41/102,24.70%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;RHOQ;CPEB2;NR4A2;ENPP1;PDPK1;NR4A1;PRKCI;EPRS1;SLC30A10;ADCY6;SRC;NFKB1;PCK2;CYSLTR2;PRKAR2B;PRKAR2A;RAB13;ADCY2;INSIG2;SLC2A4;SYAP1;PRKCD;CEACAM1;INSIG1;FER;RAB8B;VAMP2;ZFP36L1;PRKAR1A;SLC25A33;RAB8A;LPIN3;RPS6KB1;PRKACA;RELA
prerank,energy reserve metabolic process (GO:0006112),0.35390606868756036,0.7368652363878598,0.743421052631579,1.0,1.0,2/19,5.84%,GSK3B;LEPR
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.2112106965806407,-0.7367425706083736,0.8860759493670886,0.9329689955716128,1.0,16/33,34.87%,ARAP1;TGFA;BCAR3;HIP1;ADRA2A;CBL;AFAP1L2;DGKD;HBEGF;SHKBP1;GPER1;EGF;NEU3;AKT1;PDE6H;DOK1
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.24223730212836525,-0.7364692095452894,0.8584905660377359,0.932506311143639,1.0,4/23,17.26%,LAMP1;NECTIN2;PIK3R6;LGALS9
prerank,MAPK cascade (GO:0000165),0.3073726844343162,0.7363270399853235,0.9319319319319319,1.0,1.0,46/295,15.73%,CDK1;SPTA1;ARTN;MAP4K4;KSR1;SETX;NCAM1;BRAP;FGFR4;SPTB;FGFR2;PSMC2;PSMD5;RASA3;KIT;FRS2;NRK;IL18;MAP3K20;PDGFRA;LRRK2;PSMB1;CUL3;PSMD14;ANGPT1;MAP3K3;PSMD1;IKBKG;PIK3CB;PSMB9;FBXW11;IL31RA;PPP1CC;CTSH;DLG1;BTRC;SPRED1;PSMC6;RGL3;PTPRA;ITGAV;TAOK1;PLVAP;RASAL3;GDNF;NFKB1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.3366292314717366,0.7362517940842774,0.7300613496932515,1.0,1.0,4/26,9.54%,ROCK2;EFNA1;EPHA4;PICALM
prerank,negative regulation of protein polymerization (GO:0032272),0.33477497642466764,0.7359145066523539,0.7261761158021713,1.0,1.0,3/27,5.70%,STMN1;DYRK1A;SSH2
prerank,regulation of Rac protein signal transduction (GO:0035020),0.368099130247772,0.7352430593353363,0.7385892116182573,1.0,1.0,3/16,10.09%,AUTS2;ARHGAP24;PIK3CB
prerank,regulation of vesicle-mediated transport (GO:0060627),0.30843971405073267,0.7349093229159942,0.8257261410788381,1.0,1.0,10/91,9.98%,RAB33B;STON1;RAB10;PACSIN2;STXBP5;STON2;LRRK2;ZFYVE16;PICALM;GAS1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3280615877830463,0.7346795301751348,0.7569124423963134,1.0,1.0,10/41,15.31%,PRNP;FBXW7;EFNA1;EPHA4;NOX4;AGT;DOCK3;ADAM17;UNC119;SRC
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.37291985688614215,0.7341902393217008,0.7528089887640449,1.0,1.0,3/13,11.26%,FIP1L1;TUT1;CPSF4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.3146142232128894,0.7341265364576878,0.7728260869565218,1.0,1.0,20/53,24.76%,PSMC2;PSMD5;PSMB1;NQO1;PSMD14;PSMD1;PSMB9;PSMC6;AZIN1;PSMB2;PSME4;PSMB7;PSMD11;PSME3;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.34570671719868246,0.7339728665784491,0.7551282051282051,1.0,1.0,4/21,14.18%,BMPR1A;MFN2;GJA1;ADAMTS1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3552011553559192,0.7334831817138806,0.7584345479082322,1.0,1.0,3/16,11.37%,SRF;ROCK1;HDAC1
prerank,regulation of tissue remodeling (GO:0034103),0.35175821060333023,0.7334337232794607,0.7450722733245729,1.0,1.0,3/18,9.97%,LEPR;IL18;DDR2
prerank,lamellipodium organization (GO:0097581),0.3351865585777052,0.7331805035170375,0.7720763723150358,1.0,1.0,6/29,14.26%,KIT;SPEF1;SNX1;RAC1;DMTN;ITGB1
prerank,gene expression (GO:0010467),0.3075458902491449,0.7330475990888115,0.955,1.0,1.0,59/348,14.25%,MRPL36;NDC1;E2F1;NUP155;SYNCRIP;SETX;NUP205;PABPC4;TSPAN33;NUP160;AGO2;SRSF4;HNRNPD;FIP1L1;SRBD1;EIF4E;UPF3B;MRPL18;NUP85;SLBP;TPR;DDX39B;HNRNPH1;TASP1;SRSF7;POLR2A;RBMS2;DHX8;CELF2;HNRNPUL1;DARS1;WDR33;NOX4;EPC1;NR4A2;SRSF3;HNRNPU;MMS19;DRG1;MRPL13;RBM15B;HNRNPL;SRRM1;CPSF4;ATXN1;MRPL55;NUP214;ASMT;RNGTT;RPS17;RANBP2;MCM3AP;MRPS33;TSPAN5;MRPS18B;RBM4;SMG6;NXT1;RBMS1
prerank,cardiac cell development (GO:0055006),-0.29220014188043,-0.7326961334770048,0.81875,0.9364692212225125,1.0,3/11,16.93%,JAG1;VEGFA;MYH11
prerank,positive regulation of lymphocyte migration (GO:2000403),0.3659634110258533,0.7325967435568909,0.7360114777618364,1.0,1.0,1/12,3.25%,RHOA
prerank,regulation of lipid metabolic process (GO:0019216),0.3089667882750208,0.7321606509967364,0.8338493292053664,1.0,1.0,14/88,13.71%,ZFP69;FGFR4;PMVK;TBL1XR1;NFYA;NCOA2;TM7SF2;ACACA;PLPP1;ADIPOR1;RORA;MED1;PANK2;MVK
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.36545709490184847,0.7320645056936002,0.7676767676767676,1.0,1.0,3/13,20.26%,RHOA;ZDHHC21;TRAF6
prerank,vesicle transport along actin filament (GO:0030050),0.341375928729986,0.7320310970061135,0.7356475300400535,1.0,1.0,2/19,5.73%,ACTN4;MYO1C
prerank,sensory perception of pain (GO:0019233),-0.23558857578590017,-0.7318345769783129,0.8884120171673819,0.9367398309308435,1.0,14/21,45.71%,SCN9A;OPRM1;KCNA2;NIPSNAP1;P2RX4;P2RX7;OPRK1;CHRNA4;CCR2;CCL2;KCNK4;OPRL1;CHRNB2;ALOXE3
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.3505519967950895,0.7315820662600534,0.7547683923705722,1.0,1.0,4/16,13.52%,NPR3;PIK3CB;TERF2;DHFR
prerank,positive regulation of keratinocyte migration (GO:0051549),0.3740827021679834,0.7315436675133633,0.78,1.0,1.0,1/10,2.18%,MAP4K4
prerank,regulation of protein secretion (GO:0050708),0.30701743533936826,0.7314891816480071,0.8558375634517766,1.0,1.0,20/119,13.76%,GCK;ARFIP1;ITPR1;FRMD4A;DNAJC1;STXBP5;MYH10;BMP6;LLGL2;CACNA1C;RAPGEF4;EZR;SYTL4;P3H1;ITPR3;PRKCA;ACHE;PPID;ENSA;ADAM9
prerank,PERK-mediated unfolded protein response (GO:0036499),0.38413293074151966,0.731268470868108,0.7351598173515982,1.0,1.0,2/10,11.33%,EIF2AK3;QRICH1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.38053073386777186,0.7302607913842497,0.7394468704512372,1.0,1.0,4/10,16.99%,LMBR1L;TP53;SFRP1;MLLT3
prerank,defense response to bacterium (GO:0042742),0.3064451797299636,0.7300590576422581,0.8398760330578512,1.0,1.0,7/105,9.87%,HMGB2;AQP1;COLEC12;RNASE6;ANXA3;SERPINE1;RAB1A
prerank,cellular response to pH (GO:0071467),0.35929374140521997,0.730048730734597,0.74,1.0,1.0,1/17,3.28%,HYAL1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.34868970691162726,0.7292442279102652,0.7486772486772487,1.0,1.0,4/19,16.66%,SLC35D1;UAP1;GNPDA2;UGDH
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.35775641744441616,0.7292072197302256,0.7516778523489933,1.0,1.0,5/15,18.87%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,sensory perception of mechanical stimulus (GO:0050954),0.311192134384828,0.7289811073812272,0.8056133056133056,1.0,1.0,7/85,13.17%,BIRC5;ADGRV1;NIPBL;RIPOR2;LHFPL5;HOMER2;ROR1
prerank,positive regulation of ossification (GO:0045778),0.31887041268362726,0.7288424656639978,0.7627314814814815,1.0,1.0,7/39,11.40%,ADGRV1;BMPR1A;BMP6;CCN1;SLC8A1;ATP2B1;BMP2
prerank,proteoglycan metabolic process (GO:0006029),0.33569813832696205,0.7281812195887924,0.7487980769230769,1.0,1.0,4/26,7.96%,HPSE;SULF2;SULF1;B4GALT7
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.3821914177245331,0.7280215770958884,0.7548005908419497,1.0,1.0,5/10,26.74%,PTPN2;NF2;PARP14;PPP2CA;PPP2R1A
prerank,mesoderm formation (GO:0001707),-0.2547833794259482,-0.7279798844090971,0.8333333333333334,0.9409063517103422,1.0,7/17,31.33%,BMPR2;ITGB4;ITGB3;HMGA2;KDM6B;SNAI1;ITGA2
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.3694084814287407,0.7277666722181487,0.7541478129713424,1.0,1.0,3/11,19.18%,BMPR1A;HEY2;ZFPM2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.33203286593027603,0.7274976893437592,0.7717391304347826,1.0,1.0,9/29,17.40%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,regulation of histone modification (GO:0031056),0.36509962591417083,0.7274736121432879,0.7600574712643678,1.0,1.0,2/13,6.77%,MTHFR;UBE2N
prerank,skin development (GO:0043588),0.3138190601065543,0.7273410904403079,0.8139784946236559,1.0,1.0,8/65,13.76%,TGM1;STMN1;COL5A2;ERRFI1;ANXA1;CLIC4;MED1;ADAM9
prerank,cellular response to retinoic acid (GO:0071300),0.3240539664820707,0.7268023325716174,0.7655719139297849,1.0,1.0,5/42,12.50%,AQP1;SETX;HTRA2;WNT6;WNT9A
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.37832634534902676,0.7259258009846301,0.750733137829912,1.0,1.0,2/10,12.38%,FBXW7;ADAM17
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3336828221102035,0.7250335006836187,0.7697929354445798,1.0,1.0,5/25,14.99%,PARVA;ITGB7;ITGA5;ITGB1;ITGAV
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.30766733579479344,0.7249676422004506,0.7966280295047419,1.0,1.0,13/75,15.58%,HMGB2;VASH2;JCAD;HMGB1;TGFBR1;BMP2;PRKCA;PDPK1;NR4A1;ADAM17;PRKD1;ARNT;PRKD2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.332055422494295,0.7249330082148286,0.7544757033248082,1.0,1.0,6/22,15.56%,ROCK2;ROCK1;AGT;PRKCA;SMAD4;LMCD1
prerank,amyloid-beta metabolic process (GO:0050435),0.3532076073656332,0.7249120754838525,0.7542372881355932,1.0,1.0,1/16,2.25%,DYRK1A
prerank,monocyte differentiation (GO:0030224),-0.2884352771234067,-0.7246932376437185,0.8017241379310345,0.94414584526007,1.0,6/10,33.80%,PIR;VEGFA;MT1G;PDE1B;CSF1R;PPARG
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3090458281696578,0.7245450364498977,0.8583078491335372,1.0,1.0,33/118,20.80%,VASH2;PHIP;GSK3B;FGFR2;NEDD4;MAPT;ADGRA2;RAP2A;EPHA4;PDZD8;LRRK2;SH3D19;MARK2;ARHGAP35;LZTS3;PDLIM5;ZDHHC15;PLXND1;LARP4;RC3H1;GDNF;SFRP1;SIPA1L1;ABI2;CLASP1;TANC2;SP100;KIF13B;FMNL2;HECW2;EGLN1;CEACAM1;FERMT2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.303208780128652,0.724481568439939,0.9196787148594378,1.0,1.0,35/190,16.40%,CIT;ATP2B4;TNFAIP8L1;FNIP1;CGNL1;DEPDC5;AJUBA;ITPR1;PDE3B;PHLPP2;NMI;XDH;RTKN2;TRIM59;RIOK3;LIMD1;TBC1D7;NPRL3;PIK3CB;PPP2R5C;UACA;CCN3;ADIPOR1;CASP8;PLAUR;RORA;TWIST1;SPRED1;PLEKHA1;PER1;OTUD7B;SRC;PPP2R5B;PTEN;SHANK2
prerank,nucleotide catabolic process (GO:0009166),0.35588857920533984,0.7244134117671133,0.7427785419532325,1.0,1.0,6/16,25.62%,XDH;ITPA;PNP;NT5E;GDA;DERA
prerank,mitochondrial genome maintenance (GO:0000002),0.3805621483752817,0.7240145344839671,0.7756024096385542,1.0,1.0,2/11,9.40%,MGME1;LONP1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.361082141448656,0.7240084124333783,0.7619718309859155,1.0,1.0,3/14,14.05%,DYRK1A;ADAM17;ADAM19
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.3490191303005673,0.7239917971373636,0.748378728923476,1.0,1.0,4/19,14.93%,BMP6;AFDN;ADAM19;PTPRU
prerank,regulation of TORC1 signaling (GO:1903432),0.32186137075006116,0.7234958241160413,0.7726737338044759,1.0,1.0,10/33,17.73%,DEPDC5;DYRK3;KLHL22;SESN1;ITFG2;STK11;CLEC16A;SESN2;LARS1;LAMTOR5
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3552116858356025,0.7234469606217299,0.7667121418826739,1.0,1.0,4/15,18.33%,RIPOR2;EHD1;ADAM9;MAPK14
prerank,regulation of chemotaxis (GO:0050920),0.3283817507486234,0.7233553514542235,0.7634803921568627,1.0,1.0,5/30,7.01%,MYCBP2;ADGRA2;PTPN2;CXCR4;PDGFRA
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.3647249414970746,0.723176089608615,0.7503649635036497,1.0,1.0,2/12,7.48%,RAB10;SCRIB
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.3587466180921316,0.7231542907260634,0.7568306010928961,1.0,1.0,5/14,18.87%,TSEN34;CPSF4;TSEN2;DDX1;ZBTB8OS
prerank,sterol biosynthetic process (GO:0016126),0.3276281114879962,0.7229041914680694,0.7625145518044237,1.0,1.0,7/33,18.28%,LBR;PMVK;TM7SF2;ACAT2;MVK;DHCR7;INSIG2
prerank,atrioventricular valve development (GO:0003171),0.3546817112308156,0.722096279723429,0.7428977272727273,1.0,1.0,3/14,11.40%,BMPR1A;MDM4;BMP2
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.1733910775784855,-0.7219679912747705,0.9636363636363636,0.9466098838015009,1.0,13/69,17.26%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;ARFGEF2;THBS1;PTPN11;IFNGR1;IFIH1;LGALS9
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.3351483696494956,0.7219381970811488,0.7384230287859824,1.0,1.0,8/23,24.74%,BMF;AGK;MAIP1;BAD;HSPA4;TIMM10B;HSP90AA1;BAX
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.25084170020839136,-0.7216423365374822,0.8156862745098039,0.9461602619516787,1.0,4/18,19.48%,ESR1;DDX5;MAP2K1;ZC3H12A
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3026121514006843,0.7215295283559575,0.988,1.0,1.0,66/532,16.42%,TNFSF13B;LMNB1;BIRC5;IL1RL1;NCAM1;MAP3K14;PLP2;PSMC2;ANXA2;ZEB1;PSMD5;ACTN4;KIT;TAB1;LEPR;CNN2;IL18;PML;UBE2N;POU2F1;FOXO3;CD80;PSMB1;IRF1;PSMD14;SMARCA4;YAP1;MAP3K3;PIM1;PSMD1;IKBKG;EDA;PIK3CB;SDC1;LIMS1;PSMB9;IP6K2;CAPZA1;CRKL;CNTF;ANXA1;PYDC1;APPL2;FBXW11;ADAM17;SMAD4;ADIPOR1;IL31RA;RORA;TWIST1;BTRC;CDKN1B;TRIM5;ITGB1;CD44;PSMC6;HNRNPA2B1;PLVAP;SRC;IL1RL2;NFKB1;LCP1;TP53;MSN;IFNAR2;TNFRSF25
prerank,peptidyl-tyrosine modification (GO:0018212),0.316052949572992,0.721505245182183,0.8140043763676149,1.0,1.0,13/56,17.66%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,pre-miRNA processing (GO:0031054),0.3575570575345406,0.7213814231745397,0.7561643835616438,1.0,1.0,3/14,13.45%,AGO2;TUT7;TUT4
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.35068537478708267,0.7211496967494345,0.7416777629826897,1.0,1.0,4/18,16.15%,FXN;AGT;GDNF;RFK
prerank,regulation of receptor recycling (GO:0001919),0.34939416898912273,0.721058976492002,0.7578659370725034,1.0,1.0,3/16,7.67%,ANXA2;SCRIB;RAB29
prerank,cGMP-mediated signaling (GO:0019934),0.35842168735677754,0.7210169953941638,0.7535816618911175,1.0,1.0,1/13,1.82%,AQP1
prerank,prostaglandin biosynthetic process (GO:0001516),0.3486190530535151,0.720931015309014,0.7493224932249323,1.0,1.0,4/18,12.44%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,translational elongation (GO:0006414),0.3031439408642757,0.7203791181606977,0.8432377049180327,1.0,1.0,24/101,22.00%,MRPL36;MRPL18;EEFSEC;MRPL13;MRPL55;DAP3;MRPL1;MRPS33;MRPS18B;MRPL46;GFM2;MRPS10;MRPS24;MRPL45;MRPL42;MRPL37;MRPL2;MRPL20;LTN1;MRPS23;MRPS22;MRPL43;MRPL50;PTCD3
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3043047541969045,0.7202625046796635,0.8109820485744457,1.0,1.0,21/73,21.76%,ATP2B4;FNIP1;SH2D3C;TXN;SFRP2;AKAP9;STOX1;TRIM6;PRKD1;RAMP3;CD44;DOCK7;RPTOR;PRKD2;NGF;TERF2IP;BRAF;CAPRIN2;SNCA;LATS1;STK4
prerank,transport along microtubule (GO:0010970),0.3645121271131948,0.7198266762180602,0.7808417997097242,1.0,1.0,1/13,1.67%,ARHGAP21
prerank,diterpenoid metabolic process (GO:0016101),0.3096702367551235,0.719755801839891,0.789647577092511,1.0,1.0,6/55,10.41%,ABCA4;RDH11;GPC6;RDH12;ALDH1A1;SDC1
prerank,negative regulation of lyase activity (GO:0051350),0.35038190328715924,0.7196485672159084,0.7583892617449665,1.0,1.0,3/16,16.00%,ADGRV1;GNAI3;GABBR2
prerank,DNA dealkylation (GO:0035510),0.36333354643915355,0.7195822618945753,0.7797356828193832,1.0,1.0,2/10,9.19%,FTO;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.36333354643915355,0.7195822618945753,0.7797356828193832,1.0,1.0,2/10,9.19%,FTO;MGMT
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3186678955180058,0.7192684253051634,0.7791762013729977,1.0,1.0,8/35,18.30%,AQP1;KSR1;AHR;PDE7B;NUDT4;IRAG1;ADCY2;PDE7A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.32600730362493974,0.7190417165298092,0.7950236966824644,1.0,1.0,9/31,17.40%,PATL1;LSM3;CNOT6;LSM2;EXOSC7;LSM7;CNOT7;LSM4;EDC3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.3545497103916637,0.7187106198505927,0.7705146036161336,1.0,1.0,5/13,25.09%,FBN1;BMP2;LTBP1;DAND5;FSTL1
prerank,negative regulation of catalytic activity (GO:0043086),0.33467106163511945,0.7186420142457789,0.7493702770780857,1.0,1.0,6/24,19.44%,NOSIP;PARP9;ATP5IF1;NES;TP53;CAND1
prerank,ATP transport (GO:0015867),0.37332427053926864,0.718354360445433,0.7409733124018838,1.0,1.0,4/10,19.33%,SLC25A42;CD47;SLC25A17;SLC25A5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.29715361669653895,-0.7181663501603417,0.8164383561643835,0.9495520716977816,1.0,5/10,34.40%,ANO6;NCKAP1L;CD300A;RAB31;C3
prerank,regulation of cytoplasmic transport (GO:1903649),-0.28574384825390625,-0.7180283816067226,0.8376811594202899,0.9489023390890314,1.0,8/11,35.96%,MAPK3;MAPK1;MAP2K1;ATP9A;CHMP3;DENND10;DNAJC13;USP7
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2997712053560334,0.7167415810092448,0.9054325955734407,1.0,1.0,20/159,12.03%,CDH15;SDK1;MMP24;PCDHGB4;CDH18;CDH24;ALCAM;OBSL1;ADGRL1;CDH4;GPC6;PCDHGC3;ROBO1;DSCAML1;FGFRL1;PLXNB2;DSCAM;PTPRS;EMB;MPZ
prerank,coenzyme A metabolic process (GO:0015936),0.36403876640253885,0.7163753355981788,0.7666666666666667,1.0,1.0,5/14,19.08%,ACAT1;PPCDC;PANK4;PANK2;COASY
prerank,cell projection assembly (GO:0030031),0.33670393788541253,0.7163294574493715,0.7700865265760197,1.0,1.0,5/22,16.36%,PARVA;RHOQ;RAC1;CAPG;NCKAP1
prerank,glycerol metabolic process (GO:0006071),-0.2934111386880699,-0.7156802320390072,0.8233438485804416,0.9509002682863554,1.0,6/10,34.55%,COQ3;GOT1;TPI1;PGP;ANGPTL3;TKFC
prerank,negative regulation of phagocytosis (GO:0050765),0.35234200898331214,0.7153708513116248,0.7674731182795699,1.0,1.0,5/17,17.28%,HMGB1;PIP4P2;DYSF;SIRPA;CD47
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.31243728841270646,0.7150187735323038,0.8076502732240437,1.0,1.0,5/50,6.32%,TRIP6;RHOA;ACTN4;NMI;RTKN2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.32998711050630875,0.7148018423591046,0.7757125154894672,1.0,1.0,5/25,9.86%,PML;EFNA1;EPHA4;PSME3IP1;CSNK2A2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3353471332340934,0.7144583184914503,0.7705128205128206,1.0,1.0,7/24,19.79%,NEDD4;PRKCB;ITGA5;ARNT;PRKD2;NIBAN2;PTPN1
prerank,myoblast fusion (GO:0007520),0.3634190270758665,0.7144008921457985,0.748159057437408,1.0,1.0,2/12,7.57%,ADAM12;ADAMTS5
prerank,striated muscle cell differentiation (GO:0051146),0.3515802546695212,0.7130057650643037,0.7823613086770982,1.0,1.0,3/16,11.40%,MYEF2;SDC1;BMP2
prerank,cAMP biosynthetic process (GO:0006171),-0.29625987626142525,-0.7128841691499972,0.8148148148148148,0.9534316533394217,1.0,3/10,14.86%,ADCY3;ADCY8;ADCY4
prerank,positive regulation of exosomal secretion (GO:1903543),0.3421870519768114,0.7126094805565563,0.7722908093278463,1.0,1.0,5/15,21.87%,STAM;SDC1;SMPD3;SDC4;PDCD6IP
prerank,regulation of interleukin-17 production (GO:0032660),0.3237746744848145,0.712090352032843,0.7730582524271845,1.0,1.0,3/31,7.79%,PRNP;IL18;ZBTB7B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3283095446101243,0.7115667694692902,0.7885783718104495,1.0,1.0,10/30,19.66%,PTPN2;SFRP2;SAMSN1;DMTN;NF2;SFRP1;MVP;SH3BP5;PRKCD;PARP14
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.32607576179517694,0.7114959453143587,0.766546329723225,1.0,1.0,9/29,22.18%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.36258499449459025,0.7114513269959485,0.7718023255813954,1.0,1.0,4/13,13.42%,SFRP2;RBPJ;SMAD4;HEY2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.25796058139839545,-0.7113824754870512,0.8603773584905661,0.9543611891804744,1.0,3/15,10.71%,PRKCH;FOXC1;SFRP4
prerank,early endosome to Golgi transport (GO:0034498),-0.2825045470467217,-0.7111451955783039,0.84,0.9537978677043046,1.0,6/11,25.49%,STX5;SURF4;SNX2;SNX8;RBSN;RAB6A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.31410900256670493,0.71084992061944,0.8017917133258678,1.0,1.0,6/42,12.15%,MAP4K4;GSK3B;ROCK1;LIMS1;RAC1;RRAS
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.27207916328160003,-0.7099979499785543,0.8471337579617835,0.9542826733985423,1.0,1/12,0.38%,DOCK10
prerank,programmed necrotic cell death (GO:0097300),0.34524744644676075,0.7099749530122134,0.7612732095490716,1.0,1.0,2/18,7.44%,TICAM1;IPMK
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.29984491346754216,0.7099179217686294,0.8941532258064516,1.0,1.0,17/142,12.83%,ATP2B4;LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;SLC8A1;BDKRB2;HMGB1;P2RY1;CACNA1C;TRPC7;ATP2B1;CALB1;ITPR3;TRPM4;C1QTNF1
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.3432166106939636,0.7095021135635942,0.7844474761255116,1.0,1.0,3/16,9.75%,LARGE1;ST8SIA2;ST3GAL5
prerank,termination of RNA polymerase I transcription (GO:0006363),0.32334144892998207,0.708984087872833,0.7847058823529411,1.0,1.0,6/30,13.14%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,adipose tissue development (GO:0060612),0.3657484146362577,0.708589158447792,0.7800891530460624,1.0,1.0,4/11,17.51%,PGRMC2;LRP5;SPTLC2;SH3PXD2B
prerank,defense response to symbiont (GO:0140546),0.30119546337400893,0.7083937860364528,0.8357289527720739,1.0,1.0,15/92,17.14%,FADD;MOV10;MAP3K14;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;IFNAR2;MAVS
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.35047587690430987,0.7080813055646686,0.783448275862069,1.0,1.0,5/16,24.22%,PHIP;BMP2;IGFBP3;BMP5;IGFBP2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.31780707721629653,0.7079211837754543,0.7940119760479042,1.0,1.0,7/33,22.47%,FADD;PRKCA;CASP8;RUNX1;RIPK1;TRAF6;ZFP36L1
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.20416263584200153,-0.7075051052378518,0.8982035928143712,0.9554618096295824,1.0,15/31,31.56%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;CDK7;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,7-methylguanosine RNA capping (GO:0009452),-0.20416263584200153,-0.7075051052378518,0.8982035928143712,0.9554618096295824,1.0,15/31,31.56%,CCNH;GTF2H5;CMTR1;POLR2K;POLR2H;NCBP1;POLR2F;GTF2H2;POLR2C;RAMAC;CDK7;POLR2E;POLR2J;GTF2H4;POLR2D
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3228470098277636,0.706496927547055,0.7808383233532934,1.0,1.0,9/30,22.18%,FADD;TICAM1;IKBKG;CASP8;RIPK1;UBE2D3;TANK;IKBKB;BIRC2
prerank,fat cell differentiation (GO:0045444),0.30397242891462994,0.7064629324459675,0.8185792349726776,1.0,1.0,10/57,13.63%,BBS9;CTBP1;MKKS;TCF7L2;SMAD6;OSBPL8;NR4A2;NR4A1;ATF5;MED1
prerank,striated muscle cell development (GO:0055002),0.3519888729634308,0.706409633041728,0.7884344146685472,1.0,1.0,5/14,22.27%,SDC1;TMOD3;TMOD1;LMOD1;TMOD2
prerank,negative regulation of defense response to virus (GO:0050687),0.3708486547729609,0.7063804078400745,0.7960122699386503,1.0,1.0,2/10,12.82%,ILRUN;ITCH
prerank,cellular response to metal ion (GO:0071248),0.2971314675301012,0.7063263161662351,0.8953252032520326,1.0,1.0,15/123,15.60%,ECT2;AQP1;ADGRV1;PRNP;BMP6;LRRK2;CARF;TRPM2;DMTN;CLIC4;SMPD1;GLRA2;CDKN1B;PKD2;ADD1
prerank,mesenchymal cell development (GO:0014031),-0.24326328046686768,-0.7063258008990358,0.8739837398373984,0.9558394664465694,1.0,8/18,33.74%,CDH2;FOXC1;HEYL;NOLC1;KLHL12;SOX11;SOX8;KBTBD8
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.33356447574775144,0.7056858475490221,0.78239608801956,1.0,1.0,6/26,19.60%,EYA4;HTRA2;EYA2;GDNF;PPP2R1B;TERT
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.3388608487915388,0.7054730005832177,0.7730398899587345,1.0,1.0,3/17,13.93%,CASK;SULF1;XIAP
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.21771259821930053,-0.7054081917013838,0.8932038834951457,0.956021182013551,1.0,12/25,34.87%,ARAP1;BCAR3;HIP1;CBL;AFAP1L2;DGKD;SHKBP1;GPER1;NEU3;AKT1;PDE6H;DOK1
prerank,TOR signaling (GO:0031929),0.3272382413968762,0.7052282681372409,0.7784810126582279,1.0,1.0,5/26,14.76%,FNIP1;LARP1;NPRL3;MAPKAP1;RPTOR
prerank,COPII-coated vesicle budding (GO:0090114),0.30211896364429064,0.7051290037858177,0.8433476394849786,1.0,1.0,16/68,18.42%,F5;CUL3;TRAPPC6B;RAB1A;SCAP;F8;SCFD1;SEC24D;TRAPPC10;MIA3;ANKRD28;VAPA;BET1;TRAPPC9;USO1;TMED10
prerank,UV protection (GO:0009650),0.3733603619521463,0.7048351153972239,0.7931570762052877,1.0,1.0,4/10,23.75%,XPA;SDF4;ERCC2;ERCC5
prerank,regulation of protein localization to cell surface (GO:2000008),0.31726345614543344,0.7048081354017303,0.7859690844233056,1.0,1.0,5/33,10.23%,RANGRF;GBF1;LEPROT;PICALM;SNX33
prerank,presynapse organization (GO:0099172),-0.28914823228260556,-0.7045358168642981,0.8254437869822485,0.9562085404180043,1.0,4/10,19.55%,LRRTM3;DVL1;NLGN1;FZD1
prerank,copper ion transport (GO:0006825),0.36013406610956267,0.7044890498008087,0.7784256559766763,1.0,1.0,1/11,3.07%,STEAP3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.33086992119024283,0.7044503662460286,0.7928176795580111,1.0,1.0,3/18,12.26%,PRNP;EZR;HOMER2
prerank,monovalent inorganic cation homeostasis (GO:0055067),-0.22602916993344746,-0.70325070449283,0.8963730569948186,0.9567780296419084,1.0,8/23,37.86%,ATP6V0A4;SLC12A9;SLC12A2;PDK2;SLC9A1;PDK4;SLC12A5;KCNH2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.23991844651516955,-0.7031318395878046,0.8676470588235294,0.9560752636795031,1.0,1/17,0.29%,CACNA2D1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.34521167961842786,0.7026168840035072,0.7811594202898551,1.0,1.0,3/13,10.49%,ZBTB7B;PIM1;HNRNPU
prerank,positive regulation of MAPK cascade (GO:0043410),0.2909200395521381,0.702437974961961,0.946,1.0,1.0,32/245,15.58%,EZH2;KSR1;ROCK2;FGFR4;FGFR2;LPAR1;GAREM1;IAPP;KIT;ARRB1;FBXW7;JCAD;PDGFRA;NPNT;LRRK2;ROBO1;ANGPT1;ROCK1;HMGB1;P2RY1;CRKL;BMP2;PRKCA;NOTCH2;ROR1;ADRB2;TRIM5;RAMP3;CD44;SLC30A10;TAOK1;PRKD2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.32470675673044697,0.7017096797928528,0.7878787878787878,1.0,1.0,3/24,7.08%,LEPR;COX10;COQ10B
prerank,positive regulation of interleukin-13 production (GO:0032736),0.36532593919280965,0.701706436824137,0.7735562310030395,1.0,1.0,1/10,6.37%,IL18
prerank,ERBB2 signaling pathway (GO:0038128),0.3183973166654465,0.7015892118001216,0.7966706302021404,1.0,1.0,5/31,15.31%,MATK;CUL5;GAB1;PRKCA;SRC
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.3408038126189183,0.7014547622821141,0.7768361581920904,1.0,1.0,6/15,23.23%,PIK3CB;AAK1;UNC119;TNK2;SNAP91;SCYL2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.3534863852205441,0.7006817489271143,0.7972602739726027,1.0,1.0,5/14,20.13%,RFLNA;TGFBR1;WNT9A;EFEMP1;CHADL
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3172323623737088,0.6996557974478861,0.791907514450867,1.0,1.0,5/36,9.88%,ATP2B4;ANGPT4;ADAMTS9;HMGB1;SVBP
prerank,negative regulation of blood coagulation (GO:0030195),0.3085986799697302,0.6994418212826498,0.7811791383219955,1.0,1.0,6/38,12.97%,PDGFRA;PLAU;SERPINE1;F8;C1QTNF1;PLAUR
prerank,negative regulation of autophagosome assembly (GO:1902902),0.3522712807856092,0.6991518526455112,0.7972027972027972,1.0,1.0,6/13,21.41%,LRRK2;TMEM39A;SCFD1;CHMP4A;CHMP4B;SEC22B
prerank,negative regulation of autophagy (GO:0010507),0.30413969109878736,0.6985249622537539,0.8192904656319291,1.0,1.0,9/54,9.56%,BMF;DAP;EIF4E;LEPR;ATG7;QSOX1;LRRK2;KLHL22;MTMR9
prerank,pancreas development (GO:0031016),0.3591892682582559,0.6984926760703892,0.7844574780058651,1.0,1.0,2/12,9.03%,TCF7L2;NPHP3
prerank,triglyceride homeostasis (GO:0070328),-0.22076390499010456,-0.6982363839382286,0.9567567567567568,0.9605182770641792,1.0,11/26,33.47%,APOE;PNPLA8;NR1H3;C1QTNF3;XBP1;NR1H4;DGAT2;MTLN;MLXIPL;ANGPTL3;FITM2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.31876333388180766,0.6978977419868317,0.7978339350180506,1.0,1.0,6/27,18.24%,CHST15;CHSY1;CHST3;BGN;UGDH;XYLT1
prerank,protein stabilization (GO:0050821),0.2921783630786089,0.6978706037175021,0.9197592778335005,1.0,1.0,28/168,16.18%,GTSE1;MCM8;PARVA;NLK;CHEK2;MDM4;WIZ;TSPAN1;STK3;FBXW7;EFNA1;EPHA4;NCLN;ATF7IP;GNAQ;VHL;MTMR9;FLOT2;BAG5;SUGT1;P3H1;AAK1;USP9X;MORC3;PIN1;STX12;PTEN;CDC37L1
prerank,positive regulation of protein localization to membrane (GO:1905477),0.295966297140652,0.6976776998516734,0.8663265306122448,1.0,1.0,22/98,18.32%,E2F1;ATP2B4;RANGRF;MIEF2;TFDP1;PRNP;PDZK1;MYO1C;MIEF1;PDPK1;CASP8;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;TP53;PPP3R1;EPHA3;WNK3;YWHAQ;BAD
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.32392675635018453,0.697628832738148,0.7926380368098159,1.0,1.0,5/26,12.38%,GPRC5A;FBXW7;ERRFI1;NCK2;ADAM17
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.24468381098640535,-0.6967189948922489,0.8837209302325582,0.9612265460686588,1.0,9/16,41.77%,GSK3A;GPER1;MRAP2;CHGA;PDE6H;C3;ACP3;GRP;NECAB2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.26133747906918164,-0.6965561752639368,0.8591549295774648,0.960564768421084,1.0,6/13,30.56%,SHISA6;GRIK2;SHISA9;SHISA7;RAB3GAP1;CLN3
prerank,negative regulation of cellular component movement (GO:0051271),-0.25034834021489166,-0.6964180393800028,0.8763250883392226,0.9598863509102044,1.0,4/15,17.87%,FRMD5;SPOCK3;CCDC125;ACTN1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),-0.22910986848970838,-0.695710539746972,0.9111111111111111,0.9598442202796654,1.0,7/21,21.90%,SMAD7;CAV1;INPP5K;PPM1F;DDIT4;PDE4D;RACK1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.3433149985982178,0.6941420304628734,0.7784011220196353,1.0,1.0,2/14,8.29%,TXNDC12;LRRK2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.2973786407331291,0.6941144776609399,0.8446601941747572,1.0,1.0,24/67,24.76%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;IKBKG;CYBB;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,arachidonic acid secretion (GO:0050482),0.36413157328331297,0.6940720589557299,0.8121301775147929,1.0,1.0,2/10,11.46%,BDKRB2;ANXA1
prerank,arachidonate transport (GO:1903963),0.36413157328331297,0.6940720589557299,0.8121301775147929,1.0,1.0,2/10,11.46%,BDKRB2;ANXA1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.3611046205567272,0.6939183217009954,0.7993874425727412,1.0,1.0,2/10,10.09%,XDH;PIK3CB
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.2375767110353972,-0.6937425280518529,0.8760330578512396,0.9611097643080034,1.0,5/16,19.32%,PDGFRB;ABL1;PDGFD;BCAR1;NRP1
prerank,epithelial structure maintenance (GO:0010669),-0.2825194150430825,-0.6935720688172299,0.8357348703170029,0.9604592306765208,1.0,6/11,49.40%,STRAP;RBP4;NOD2;MUC13;PIWIL4;MUC6
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3593934078685993,0.6934000810663283,0.796711509715994,1.0,1.0,2/10,13.16%,FGFR2;LRP5
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.26080194180459293,-0.6930798149368349,0.85625,0.9601848829826289,1.0,6/13,28.37%,SUFU;GOPC;GET4;MDFI;YWHAB;KEAP1
prerank,endoderm formation (GO:0001706),0.30717289545578874,0.6929246584513176,0.8071005917159764,1.0,1.0,6/35,14.99%,MMP14;LAMB1;SETD2;COL12A1;ITGA5;ITGAV
prerank,positive regulation of protein secretion (GO:0050714),0.29794141537627,0.6928948462656704,0.8292422625400213,1.0,1.0,16/69,19.46%,GCK;FRMD4A;MYH10;BMP6;TCF7L2;MCU;EZR;SYTL4;ACHE;PPID;ADAM9;AACS;NLGN2;BAD;TMED10;DNM1L
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.31220470444426657,0.6925943733326885,0.796037296037296,1.0,1.0,3/39,5.30%,RANGRF;NEDD4;PDZK1
prerank,regulation of endothelial cell proliferation (GO:0001936),0.2969376744550211,0.692001349231275,0.8712357217030114,1.0,1.0,14/88,15.58%,HMGB2;VASH2;ATOH8;XDH;SULF1;ANGPT1;TGFBR1;BMP2;PRKCA;NR4A1;ATP5IF1;PRKD1;ARNT;PRKD2
prerank,regulation of pH (GO:0006885),-0.2745863911733176,-0.6918737556664333,0.8704819277108434,0.9606029589661657,1.0,5/11,34.91%,ATP6V0A4;PDK2;ATP6AP1;SLC9A1;PDK4
prerank,intracellular sterol transport (GO:0032366),0.34554324222793886,0.6918653956292025,0.7844827586206896,1.0,1.0,3/13,15.88%,TSPO2;ABCA1;RELCH
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.3557735949903359,0.6917318234901955,0.8119533527696793,1.0,1.0,2/11,13.16%,FGFR2;LRP5
prerank,negative regulation of response to stimulus (GO:0048585),0.3009734875269268,0.6916914720584437,0.8535791757049892,1.0,1.0,9/60,15.01%,RBL1;FBXO5;BRAP;CASK;MAP3K3;TERF2;APPL2;TWIST1;SLC30A10
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.3465899222394269,0.6911762488972764,0.7970027247956403,1.0,1.0,4/15,15.76%,IL18;AGT;NFKB1;LPL
prerank,cell-cell junction assembly (GO:0007043),0.29601288936001,0.6899217258228322,0.853475935828877,1.0,1.0,17/63,18.61%,CDH18;CDH24;RHOA;CTNNA1;GJD3;GJC1;TLN1;EPB41L3;PRKCA;GJA1;TLN2;PIP5K1C;RHOC;TBCD;TRPV4;PKN2;CDH11
prerank,neuron fate commitment (GO:0048663),0.3468107497443673,0.6898757544041679,0.8002915451895044,1.0,1.0,2/14,10.48%,POU3F2;TGFBR1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.34429278341931513,0.6894898296901959,0.7906666666666666,1.0,1.0,4/15,16.05%,SPEF1;NPHP3;RSPO3;SFRP1
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.29245624730517716,0.6894070636605588,0.8442796610169492,1.0,1.0,28/74,24.76%,PSMC2;PSMD5;ELOC;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;RBPJ;PSMC6;ARNT;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;SIRT2;EGLN3;PSMB8;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.28715663568838856,0.6889879557652432,0.982,1.0,1.0,67/390,17.05%,SHCBP1;CEP57;STMN1;STYK1;SETX;PHIP;ROCK2;FGFR4;ACTR3;RHOA;COL4A6;GSK3B;FGFR2;RBFOX2;KIT;SULF2;HNRNPA1;FRS2;MUSK;PTPN2;EFNA1;PDGFRA;VAV2;HNRNPH1;POLR2A;EPHA4;SULF1;RHOQ;NCK1;ANGPT1;ABI1;ROCK1;FGFRL1;BDKRB2;CYBB;DDR2;PIK3CB;CLNK;SH2D2A;GAB1;EIF2AK3;EFNB1;RAC1;ANKS1B;NCK2;MAPKAPK3;WASF2;IL31RA;POLR1G;ROR1;DOCK1;ADRB2;PRKD1;SPRED1;EFNB2;ITGAV;AAMP;ARPC1B;SRC;PRKD2;SPRED2;NCKAP1;TNK2;AXL;SIPA1L1;NGF;EPHA3
prerank,protein maturation (GO:0051604),0.2926566474094018,0.6889678683259934,0.8876288659793814,1.0,1.0,6/95,7.11%,KEL;TSPAN33;MMP14;CPXM1;NDUFAB1;TASP1
prerank,cell junction maintenance (GO:0034331),-0.24585091040419715,-0.6887549744967313,0.8875968992248062,0.9628378998398529,1.0,8/14,41.68%,DCTN1;CLDN1;CHCHD10;CSF1R;CBLN2;F2R;CBLN1;PRTN3
prerank,negative regulation of inflammatory response (GO:0050728),-0.136480173853345,-0.6887389589358639,1.0,0.9620305201456704,1.0,22/182,11.67%,TEK;CALCRL;APOE;IGF1;KLF4;CDH5;PLCG1;RAMP1;LYN;RAMP2;GGT5;FURIN;OTULIN;PRKACB;SELENOS;NR1H3;RPS19;GRN;TNFAIP6;PRKAR1B;TNFRSF1B;HTR4
prerank,aromatic amino acid family metabolic process (GO:0009072),0.36051979424345354,0.6884957991592856,0.8047337278106509,1.0,1.0,3/10,17.15%,ASRGL1;IL4I1;THAP4
prerank,histone H3-K4 methylation (GO:0051568),0.3174453941381318,0.6884749502006426,0.808641975308642,1.0,1.0,4/26,15.57%,PAXIP1;KMT2A;KMT2D;SETD4
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3106360433161425,0.6883193153042227,0.8112058465286236,1.0,1.0,2/30,4.02%,MACF1;RAB10
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.28942723170580303,0.6878474315820309,0.8709677419354839,1.0,1.0,23/93,18.96%,ATP2B4;FNIP1;SH2D3C;TXN;SFRP2;NCK1;AKAP9;STOX1;NCK2;TRIM6;DMTN;PRKD1;RAMP3;CD44;DOCK7;RPTOR;PRKD2;PTEN;CNKSR3;NGF;TERF2IP;BRAF;CAPRIN2
prerank,intracellular cholesterol transport (GO:0032367),0.34146987585496685,0.6876588877855587,0.7963483146067416,1.0,1.0,4/15,16.96%,TSPO2;ABCA1;RELCH;LDLR
prerank,pharyngeal system development (GO:0060037),0.3382430574372659,0.6875947313688412,0.7997179125528914,1.0,1.0,2/15,10.48%,BMPR1A;TGFBR1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.32106817589408765,0.6872553126393778,0.7990074441687345,1.0,1.0,5/24,15.21%,LOXL2;SOX6;TGFBR1;WNT9A;EFEMP1
prerank,SNARE complex assembly (GO:0035493),-0.2790962344113933,-0.68711572506884,0.8463768115942029,0.9627799929240182,1.0,4/10,20.68%,STXBP6;VAMP8;VAMP3;VAMP1
prerank,regulation of cell aging (GO:0090342),-0.28099507414834013,-0.6870302890920813,0.8753894080996885,0.9620490309393321,1.0,2/11,10.42%,NEK6;RSL1D1
prerank,lipoprotein biosynthetic process (GO:0042158),0.34873421670413307,0.6865755120546551,0.7972350230414746,1.0,1.0,2/11,7.97%,ATG7;PORCN
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.29817489371605566,0.685993678223635,0.8340659340659341,1.0,1.0,11/51,14.10%,BMPR1A;FBN1;CRIM1;LEMD3;SMAD6;SMURF1;RBPMS2;SMURF2;BMP2;SMAD4;HTRA3
prerank,regulation of actin filament-based movement (GO:1903115),0.3515341156256976,0.6850481397603508,0.794435857805255,1.0,1.0,1/10,5.71%,PDPN
prerank,regulation of calcium ion import (GO:0090279),-0.2207015891626834,-0.6849074340939577,0.888,0.9633804290613495,1.0,6/21,18.20%,PDGFRB;CTNNB1;TRIM27;SLC30A1;PLPP4;PSEN2
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3349004475442646,0.6848661396283487,0.8155467720685112,1.0,1.0,5/16,19.10%,TBC1D25;MTRF1;CLEC16A;OGFOD1;ETF1
prerank,regulation of membrane depolarization (GO:0003254),0.33683971929442785,0.6847885922794309,0.801641586867305,1.0,1.0,2/18,8.29%,RANGRF;LRRK2
prerank,positive regulation of receptor internalization (GO:0002092),0.3227027537458981,0.6846460869222509,0.8012820512820513,1.0,1.0,3/22,9.23%,ARRB1;FMR1;ANGPT1
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.22164937070915053,-0.6843042771839563,0.8923766816143498,0.9631228405751444,1.0,12/23,33.39%,GAS6;TLR4;DDIT3;LGALS9;INHBA;ZC3H12A;CD274;LAPTM5;NR1H4;INHA;C1QBP;RARA
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.3110910297012931,0.6839993652251021,0.8137847642079806,1.0,1.0,7/30,14.33%,TGFBR3L;TGFBR3;DKK3;SMURF2;SMAD4;XIAP;SMAD3
prerank,regulation of viral release from host cell (GO:1902186),0.3226634526963392,0.68392166996637,0.8094027954256671,1.0,1.0,3/21,8.17%,VPS37B;PML;TRIM28
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.2936133337581798,0.6838437041816314,0.837108953613808,1.0,1.0,13/61,18.42%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,vesicle coating (GO:0006901),0.2936133337581798,0.6838437041816314,0.837108953613808,1.0,1.0,13/61,18.42%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,COPII vesicle coating (GO:0048208),0.2936133337581798,0.6838437041816314,0.837108953613808,1.0,1.0,13/61,18.42%,F5;CUL3;TRAPPC6B;RAB1A;F8;SCFD1;SEC24D;TRAPPC10;ANKRD28;BET1;TRAPPC9;USO1;TMED10
prerank,regulation of cell death (GO:0010941),0.2868861953406571,0.6838027156613079,0.8645294725956567,1.0,1.0,15/94,14.34%,RAD18;TXNDC12;SPEF1;FAF1;RILPL1;CCN1;RAB29;LRRK2;AXIN2;NCK1;SRGAP2;CCN3;PRKD1;CDKN1B;RAMP3
prerank,miRNA mediated inhibition of translation (GO:0035278),0.35139911975602867,0.683415467895592,0.7869822485207101,1.0,1.0,3/11,15.48%,AGO2;RBM4;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.35139911975602867,0.683415467895592,0.7869822485207101,1.0,1.0,3/11,15.48%,AGO2;RBM4;TNRC6C
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.3235918983198177,0.6827641843894329,0.8184176394293126,1.0,1.0,3/19,6.53%,OBSL1;CUX1;CAPRIN1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.1628437542853719,-0.6826690185664303,1.0,0.9639304192212463,1.0,11/73,13.69%,STAT3;PSEN1;TLR4;EPHB2;LBP;APP;ARHGEF2;ARFGEF2;THBS1;PTPN11;IFNGR1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.2969328565359795,0.682629982081315,0.8177874186550976,1.0,1.0,8/55,10.80%,FADD;WWOX;BMF;PML;BCLAF1;AGT;TGFBR1;BOK
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.3209503047274159,0.6821223404992789,0.7823303457106274,1.0,1.0,5/20,13.42%,TGFBR3;TGFBR1;BMP2;RBPJ;HEY2
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.22502300921269597,-0.6813840620923406,0.9163346613545816,0.9643878755663423,1.0,6/19,21.57%,TLR4;LBP;RAB11FIP2;LGALS9;TIRAP;PIK3AP1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.3417533063359822,0.6812870895913601,0.7767988252569751,1.0,1.0,2/12,8.53%,STX11;STX2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.21853060751927605,-0.6811839514432318,0.9292035398230089,0.963742109034589,1.0,9/21,23.46%,COX16;OXA1L;COX19;PET100;COX20;SMIM20;COX17;COX14;COA8
prerank,regulation of acute inflammatory response (GO:0002673),-0.23607360422031023,-0.6810774777168906,0.896414342629482,0.9630433172487787,1.0,18/18,76.43%,OSMR;ADAM8;KLKB1;NLRP3;IL4;GSTP1;CREB3L3;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B;DNASE1L3;F12;C2CD4A;PTGES;IL6ST
prerank,cellular response to BMP stimulus (GO:0071773),0.29239581948031035,0.6808682412231524,0.8622502628811777,1.0,1.0,12/66,14.33%,BMPR1A;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;BMP2;SMAD4;USP9X;SMAD3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.31102931069649836,0.6805877363031577,0.8166047087980174,1.0,1.0,6/26,15.59%,NEDD4;AKAP9;DLG1;CAB39;ITGB1;STK39
prerank,regulation of protein phosphorylation (GO:0001932),0.28367315250251784,0.6804136700565194,0.955,1.0,1.0,41/256,16.13%,ECT2;PHIP;FNIP1;ROCK2;PRKDC;PRNP;XDH;LEPR;MUSK;RAP2A;ARRB1;PML;EFNA1;FMR1;CCN1;WWTR1;LRRK2;AXIN2;ANGPT1;RB1CC1;P2RY1;PPP2R5C;PLXNB2;EIF2AK3;TWF1;CRKL;BMP2;RAC1;ADAM17;BRD4;PLAUR;SLCO3A1;PPP1R15B;WDFY2;PTPN13;PIN1;FXR1;PPP2R5B;PPIL4;SESN2;PTEN
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.31901966508194274,0.6798133814279241,0.8107769423558897,1.0,1.0,1/23,1.27%,GLI3
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.2686559545338981,-0.6793459987299753,0.8780487804878049,0.9639052182147023,1.0,9/12,33.44%,GRN;PPT1;ATP6AP2;TMEM9;CLN5;VPS33A;TMEM199;CLN3;CLN6
prerank,response to interleukin-6 (GO:0070741),-0.2822958553219499,-0.6790447995256811,0.8932584269662921,0.9633797950005922,1.0,3/10,20.16%,ST3GAL6;SBNO2;PTPRT
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2884092433243712,0.678585632450595,0.8721413721413721,1.0,1.0,7/85,8.29%,PLK1;GSK3B;PSMC2;DDRGK1;FBXW7;FMR1;LRRK2
prerank,ceramide biosynthetic process (GO:0046513),0.3022925856086632,0.6784361659557459,0.8205128205128205,1.0,1.0,9/40,18.67%,CERS6;CERS5;ST8SIA2;ST3GAL5;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.2616618676774587,-0.6781735950758124,0.8640776699029126,0.9634097207475799,1.0,4/12,20.56%,ABCA5;NR1H3;NR1H2;ITGB3
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.345449907611069,0.6777419108926062,0.8157142857142857,1.0,1.0,3/13,12.35%,GJC1;CACNA1C;GJA1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2849857999701683,0.6777181831423382,0.8927477017364658,1.0,1.0,25/112,17.82%,TGFBR3L;BMPR1A;RHOA;WWOX;NLK;SOX6;TGFBR3;SMAD6;SMURF1;NR3C1;TGFBR1;LIMS1;CRKL;ARHGEF18;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;SFRP1;PTPRK;ZFYVE9;SMAD2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.3130309217945937,0.6776562161240287,0.8267716535433071,1.0,1.0,8/21,23.17%,PDZD8;MCU;MCUB;MICU1;MAIP1;RAP1GDS1;MICU2;LETM1
prerank,positive regulation of lyase activity (GO:0051349),0.34347171953934696,0.6776362046345176,0.7923186344238976,1.0,1.0,3/14,15.99%,FXN;CACNA1C;STIM1
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2833977418345189,0.6772846717725227,0.9203629032258065,1.0,1.0,26/149,15.73%,TRIM37;TRIML2;TICAM1;DDRGK1;RAB7B;DHX9;TAB1;RTKN2;IL18;UBE2N;RNF31;AGT;IKBKG;ERC1;EDA;FLOT2;PRKCB;TRIM6;BTK;ROR1;SLCO3A1;PRKD1;PRKCI;TRIM5;PRKD2;NFKB1
prerank,negative regulation of cell migration (GO:0030336),0.28726764118881937,0.6771896787600964,0.9108409321175278,1.0,1.0,33/137,18.54%,BMPR1A;ARID2;MCC;STK24;RAP2A;AFDN;HOXA7;SFRP2;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;HAS1;NKX2-1;RAC1;GJA1;CLIC4;ADIPOR1;DPYSL3;MIA3;PTPRU;NF2;SFRP1;PTEN;PTPRK;SLURP1;CLASP1;DPEP1;IGFBP3
prerank,negative regulation of cell junction assembly (GO:1901889),0.31920489396568674,0.6771553965272992,0.8169364881693649,1.0,1.0,7/25,16.13%,ROCK2;ROCK1;ARHGAP6;DMTN;SRC;RCC2;PTEN
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3605903505964405,0.6768681663464589,0.7960122699386503,1.0,1.0,4/10,22.11%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3605903505964405,0.6768681663464589,0.7960122699386503,1.0,1.0,4/10,22.11%,SMPD3;SMPD2;PRKCD;SIRT3
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.298280925286217,0.6767753130523589,0.8325740318906606,1.0,1.0,9/43,12.81%,ERFE;PTPN2;NUCKS1;ZBTB7B;NCK1;PRKCB;ENPP1;SIK2;GKAP1
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.23187328752356234,-0.6765305192047407,0.8863636363636364,0.9640985482406433,1.0,7/18,24.55%,RPS13;ESR1;KAT2B;ZC3H12A;PTBP1;RPS26;PTBP3
prerank,regulation of cellular protein localization (GO:1903827),0.3000537954905421,0.6764399225413855,0.8312849162011173,1.0,1.0,15/45,24.24%,GBF1;MAPT;GPC6;SPIDR;SETD2;PIN1;LCP1;PTPN1;CSNK1E;GPC4;PRKAA2;CCDC66;GPC3;HSP90AA1;KDM1A
prerank,regulation of epithelial cell migration (GO:0010632),0.29649356127772286,0.6763017267464437,0.8371335504885994,1.0,1.0,19/51,24.07%,MACF1;HYAL1;MCC;ENPP2;ADIPOR1;CTSH;PRKCE;DOCK1;INSL3;SRC;ARSB;CLASP1;DOCK5;RREB1;CEACAM1;DAB2IP;PTPN23;DUSP10;SASH1
prerank,cellular response to leucine starvation (GO:1990253),-0.2800112194135113,-0.676036060477816,0.8757225433526011,0.9637505485208538,1.0,3/10,10.95%,SESN3;GCN1;MTOR
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.29597145716052964,0.6759683772585137,0.8459016393442623,1.0,1.0,15/59,20.61%,SDK1;OBSL1;CDH4;ROBO1;DSCAML1;PLXNB2;DSCAM;EMB;ITGB1;AMIGO1;PLXNB3;DSG2;KIRREL3;CEACAM1;MPZL2
prerank,regulation of gluconeogenesis (GO:0006111),0.31268576471271947,0.6755324772889033,0.8168316831683168,1.0,1.0,3/27,6.19%,GCK;ERFE;PTPN2
prerank,regulation of myoblast differentiation (GO:0045661),-0.19383369651713628,-0.6749087458820996,0.9444444444444444,0.9639969375294455,1.0,7/32,20.56%,MEF2C;BOC;TBX3;BTG1;LRRC8A;SRA1;HIF1AN
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2863036940867846,0.6746710067512218,0.8855359001040582,1.0,1.0,18/86,16.56%,ANGPT4;PRNP;BMP6;EFNA1;ENPP2;SFRP2;CD80;ANGPT1;AGT;SAMSN1;DMTN;ITGA5;CD44;CNOT7;SRC;TP53;SFRP1;TNK2
prerank,postsynaptic membrane organization (GO:0001941),0.32686931802055996,0.6746139220850869,0.8010899182561307,1.0,1.0,5/17,19.53%,MUSK;NLGN3;CHRNB1;NLGN2;GPHN
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.26168907337353187,-0.6745796916471378,0.8635014836795252,0.9634969258712245,1.0,4/11,25.97%,XBP1;JAK2;TAF7;TMEM106A
prerank,positive regulation of cell death (GO:0010942),0.2925951756285177,0.6744544884609368,0.8331527627302275,1.0,1.0,10/59,14.34%,GSK3B;PRNP;MAPT;FAF1;LRRK2;AXIN2;PICALM;CDKN1B;EFNB2;RAMP3
prerank,positive regulation of axon extension (GO:0045773),0.32224335012687205,0.6740613184278014,0.8198992443324937,1.0,1.0,4/22,11.31%,MACF1;NTN1;MAPT;DSCAM
prerank,regulation of interferon-beta production (GO:0032648),0.29408507147769736,0.6740052543535546,0.8491620111731844,1.0,1.0,17/46,24.04%,DHX9;IRF1;RIOK3;POLR3D;PTPRS;YY1;MAVS;SIRPA;RELB;ISG15;POLR3C;RNF216;POLR3G;TLR7;RIPK2;HSP90AA1;REL
prerank,dephosphorylation (GO:0016311),0.28152515693078145,0.6736186325006988,0.9291497975708503,1.0,1.0,35/147,20.70%,PPM1G;PPM1D;LHPP;TAB1;PPP2R3A;SSH2;PPP3CA;DUSP12;MTMR2;PPP2R5C;PTPN21;PTPRS;FBXW11;PLPP1;PLPP5;PPP1CC;BTRC;PTPRA;STK11;PTPN13;PTPRU;MTMR3;PPP2R5B;DAPP1;PPP2R1B;PTEN;UBLCP1;PTPRK;PTPRE;DUSP7;PPM1A;PTPN1;PTPN5;PNKP;PPP4R1
prerank,ear morphogenesis (GO:0042471),0.3272084543384067,0.6736049875141742,0.8025806451612904,1.0,1.0,5/20,18.81%,FGFR2;NIPBL;TWIST1;OSR1;ZIC1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.2850685466110882,0.6733739173789794,0.8507936507936508,1.0,1.0,12/67,12.87%,USP6NL;IFT140;TBC1D13;FMR1;TBC1D2B;SDCCAG8;TRPM2;TBC1D19;TWF1;RAC1;DMTN;ATG3
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3484440038512042,0.6723445738443277,0.8378787878787879,1.0,1.0,3/11,11.10%,IPMK;PPIP5K1;IP6K2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.2861647396320107,0.6722094990637864,0.8652849740932642,1.0,1.0,17/84,15.58%,ATOH8;ANGPT4;ROCK2;GPI;ANXA3;ANGPT1;HMGB1;AGT;PIK3CB;RAC1;RRAS;PRKCA;PDPK1;ADAM17;PRKD1;AAMP;PRKD2
prerank,negative regulation of nervous system development (GO:0051961),0.3299291785971309,0.6721764243298539,0.8146143437077131,1.0,1.0,2/17,11.97%,PCM1;APPL2
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3250939396827479,0.6719809941700982,0.8189300411522634,1.0,1.0,1/15,2.79%,TICAM1
prerank,positive regulation of immune response (GO:0050778),0.2895458540506846,0.6716341112701838,0.8593073593073594,1.0,1.0,7/64,15.14%,FADD;DHX9;NMI;RIOK3;POLR3D;AKIRIN2;SLC15A4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.3056046944604606,0.6713104663368498,0.8238841978287093,1.0,1.0,10/30,22.72%,MAGT1;RPN2;STT3A;STT3B;ALG8;UBE2J1;OSTC;FUT8;DPM3;MCFD2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.3467961804573465,0.6711824993048476,0.7947530864197531,1.0,1.0,3/10,11.97%,PRKCB;ENPP1;APPL2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.30078092729121486,0.6709759589402985,0.8288888888888889,1.0,1.0,8/42,12.63%,RHOA;PDPN;NPNT;RSU1;PIK3CB;LIMS1;RAC1;DMTN
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.19722962229581098,-0.6709077279426789,0.9447852760736196,0.9660895949483267,1.0,10/30,27.65%,SELENOF;ST13;HSPA5;CCT2;DNAJC18;DNAJB12;SDF2;CHCHD4;ENTPD5;HSPA9
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.2518166539507834,-0.670830822787613,0.8934707903780069,0.9653273539108538,1.0,4/13,17.75%,ISCA1;GLRX3;CIAO1;LTO1
prerank,cellular response to interleukin-6 (GO:0071354),-0.20314971195162096,-0.6707987815802939,0.9534883720930233,0.9645373897967511,1.0,8/26,22.90%,STAT3;ST3GAL6;PTPN11;SBNO2;ST18;CBL;PTPRT;JAK2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.28436298761558393,0.6706324477036562,0.8751300728407908,1.0,1.0,12/76,13.67%,TRIP6;RHOA;ACTN4;NMI;RTKN2;LIMS1;UACA;CCN3;EZR;TRIM6;ADIPOR1;DLG1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.2850705520584368,0.6699774700976147,0.8762993762993763,1.0,1.0,8/75,9.38%,ATP2B4;THBS2;ANGPT4;ROCK2;PDE3B;PML;SULF1;ROCK1
prerank,nucleic acid-templated transcription (GO:0097659),0.29744373941508384,0.6697960930850384,0.8361970217640321,1.0,1.0,6/42,10.89%,E2F1;POLR2A;EPC1;NR4A2;MMS19;DRG1
prerank,regulation of transferase activity (GO:0051338),-0.23424266641958777,-0.6695367320102114,0.9,0.9648690319228176,1.0,8/17,30.35%,PINX1;ATM;NABP2;FEM1A;NLRC5;SPTSSB;HMBOX1;JMJD8
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2798642218813095,0.6691749494020339,0.9332659251769464,1.0,1.0,43/150,21.13%,RB1;CEP43;PRKDC;PRNP;TAB1;XDH;PMEPA1;SFRP2;WWTR1;LRRK2;SMAD6;GNAQ;NCK1;CEP85;ERRFI1;CALM2;SAMSN1;CRKL;PYDC1;ENPP1;PDPK1;NCK2;DMTN;TWIST1;SPRED1;PPP1R15B;QARS1;PTPN13;SFRP1;SPRED2;PTEN;CNKSR3;SIRPA;MVP;TERF2IP;IGFBP3;PRKCD;DNAJC10;TRIB1;CEACAM1;SNCA;FBLN1;UBASH3B
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.2559184198332515,-0.668989325944237,0.9006211180124224,0.9645644283191057,1.0,3/12,14.72%,NBL1;SLIT2;DUSP1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.31029410220586784,0.6688727030511565,0.8167848699763594,1.0,1.0,5/32,12.25%,CHAT;LPCAT1;LPIN2;CSNK2A2;ACHE
prerank,neuron projection fasciculation (GO:0106030),0.34998479767532115,0.6688374222255086,0.8043143297380585,1.0,1.0,4/10,20.01%,EPHA4;ARHGAP35;AMIGO1;SEMA5A
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2906288761570872,0.6686160369186294,0.8771186440677966,1.0,1.0,15/68,19.02%,MTHFD1L;GSTO2;BTD;MTHFR;PDXK;SLC19A1;ENPP1;DHFR;PANK2;SLC19A2;RFK;CYB5A;MMAB;SLC25A19;MTHFS
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.1742540882954865,-0.6684095480265578,0.9894736842105263,0.9642719120372458,1.0,11/57,14.10%,GRIN2A;FIS1;GRIN2B;MALT1;MAP3K5;LGMN;NOD1;CTSD;PPM1F;BCAP31;GRIN1
prerank,muscle tissue morphogenesis (GO:0060415),0.328746672736018,0.668057575742565,0.826265389876881,1.0,1.0,4/16,19.40%,TGFBR3;BMP2;HEY2;ZFPM1
prerank,histone lysine demethylation (GO:0070076),0.30236972088505915,0.6678418535799522,0.8198992443324937,1.0,1.0,9/25,25.22%,PHF2;KDM2B;KDM5C;JMJD1C;KDM4B;KDM2A;HR;KDM1A;KDM5A
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.2162825951761494,-0.6669454258326146,0.9047619047619048,0.9647923140447283,1.0,1/21,0.29%,CACNA2D1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.341683159395968,0.666931604506909,0.8113496932515337,1.0,1.0,4/10,15.58%,PRKCB;ITGA5;ARNT;PRKD2
prerank,body fluid secretion (GO:0007589),-0.2323420127110864,-0.6668705688253238,0.8936170212765957,0.96406533844541,1.0,3/15,14.55%,ERBB4;NPR1;VEGFA
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2912427258184694,0.6668199800511883,0.8484187568157033,1.0,1.0,9/54,12.73%,FADD;UBE2K;PTPN2;RNF31;SPPL2B;IKBKG;PYDC1;ADAM17;CASP8
prerank,negative regulation of lymphocyte proliferation (GO:0050672),-0.195472730535763,-0.6667781049822713,0.9518716577540107,0.9633280382617474,1.0,9/31,26.98%,TNFRSF21;LYN;ATM;CEBPB;CD274;DLG5;CD300A;CD86;SOX11
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.3336671127893054,0.6665624619469365,0.8260869565217391,1.0,1.0,2/12,14.41%,WNK1;MIA3
prerank,serine family amino acid catabolic process (GO:0009071),0.3432676509318793,0.6663529066839128,0.8305597579425114,1.0,1.0,1/10,6.76%,AMT
prerank,cellular protein localization (GO:0034613),0.2779430972851218,0.6662351502099425,0.9719719719719719,1.0,1.0,66/285,18.42%,USP6NL;CNTLN;STX11;ARFIP1;AP4M1;EVI5L;TBC1D25;SNX1;RAP2A;TBC1D13;WDR11;BICD2;VPS26C;PRPF19;TBC1D2B;RAB22A;NIPBL;RAB29;STXBP2;FBLN5;LRRK2;MFN2;SMURF1;STX2;CORO1B;AXIN2;ANGPT1;RAB1A;SNX27;VIPAS39;COPB2;HERC2;NPHP1;EPB41L3;COPZ1;PIGU;AP3B1;SCFD1;ZDHHC15;GJA1;EHD1;IFT27;HEY2;ARF4;MESD;PTPRU;ARL4A;TM9SF2;CSRP3;STX12;ARF3;TBC1D9;STXBP1;VPS26A;TMED3;UNC50;LAMTOR3;PTPRK;SH3PXD2B;ACD;RIC1;USO1;TM9SF4;CEP250;ARL5A;TMED10
prerank,protein localization to plasma membrane (GO:0072659),0.2813717992627796,0.6662177646479651,0.9093686354378818,1.0,1.0,40/129,23.58%,TSPAN33;ROCK2;RAB10;PDZK1;DENND4C;RAP2A;AFDN;ANK1;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;GORASP2;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3;ASB3;RAB3A;MAP7;ANK3;RAB8B;IKBKB;FLNA;RAPGEF6;ZDHHC2;PACS1;S100A10;RAB8A
prerank,regulation of BMP signaling pathway (GO:0030510),0.27983898291605847,0.6659827910572774,0.868421052631579,1.0,1.0,15/73,14.10%,BMPR1A;NUMA1;CRIM1;CCN1;LEMD3;SULF1;SMAD6;SMURF1;RBPMS2;SMURF2;BMP2;RBPJ;SMAD4;XIAP;HTRA3
prerank,heterocycle biosynthetic process (GO:0018130),-0.24215735408894273,-0.6654143696207117,0.8741007194244604,0.9636878648061528,1.0,4/14,15.53%,LIAS;MOCS2;MOCS1;GCH1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.33215598948278907,0.6649470083601698,0.8271428571428572,1.0,1.0,3/13,12.38%,HMGB1;PDPK1;ADAM17
prerank,axonal fasciculation (GO:0007413),0.3414425315574241,0.6649170778999075,0.8092485549132948,1.0,1.0,5/12,20.01%,EPHA4;ARHGAP35;EPHA3;AMIGO1;SEMA5A
prerank,regulation of mRNA processing (GO:0050684),0.2958764295155717,0.6647646416154381,0.828978622327791,1.0,1.0,11/32,19.49%,KHDRBS1;DHX9;SRSF10;SRSF3;SRPK1;CPSF4;IWS1;SRPK2;CWC22;LARP7;KHDRBS3
prerank,negative regulation of viral release from host cell (GO:1902187),0.3390888418917794,0.664394147893069,0.8305084745762712,1.0,1.0,3/13,14.21%,PML;TRIM28;TRIM5
prerank,mitochondrial protein processing (GO:0034982),0.3356534233755091,0.6639798589819806,0.8294460641399417,1.0,1.0,5/11,20.46%,STOML2;PMPCA;ATP23;MIPEP;SPG7
prerank,phagosome-lysosome fusion (GO:0090385),0.347043310371367,0.663383260760721,0.8188622754491018,1.0,1.0,1/10,4.45%,RAB7B
prerank,defense response to virus (GO:0051607),0.2811643722861075,0.6632928923060677,0.8839103869653768,1.0,1.0,16/100,17.14%,FADD;MOV10;MAP3K14;RNASE6;G3BP1;ATG7;TTC4;SETD2;IRF1;SKP2;RNASE1;TRIM5;CNOT7;AKAP1;IFNAR2;MAVS
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.349035771477735,0.6631574721644068,0.8215962441314554,1.0,1.0,2/10,9.27%,NCK1;VHL
prerank,regulation of osteoclast differentiation (GO:0045670),-0.19220432532363801,-0.6631249664550686,0.9724137931034482,0.9648452643842743,1.0,5/33,13.79%,TLR4;CAMK4;MTOR;CEBPB;PRXL2A
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.27630841672604833,0.6630571133847818,0.9539078156312625,1.0,1.0,35/214,17.23%,FAM83D;FGFR4;FGFR2;GAREM1;PTPN2;TGFBR3;ARRB1;FBXW7;PDGFRA;NPNT;CCN1;ANGPT1;HMGB1;APIP;P2RY1;CRKL;BMP2;EZR;RRAS;PRKCA;SMAD4;NOTCH2;ROR1;DLG1;SPRED1;RAMP3;CD44;SLC30A10;PIN1;PRKD2;SPRED2;PTEN;CNKSR3;CCN2;SIRPA
prerank,response to cAMP (GO:0051591),0.2930610812671741,0.6628596389395411,0.8346915017462165,1.0,1.0,6/37,15.58%,AQP1;AHR;EZR;AKAP9;DMTN;PKD2
prerank,positive regulation of signaling receptor activity (GO:2000273),0.29966738310433627,0.6628581913882128,0.8267898383371824,1.0,1.0,7/36,14.26%,NLGN3;FBXW7;HDAC1;ADAM17;HDAC2;ADRB2;ITGB1
prerank,cholesterol metabolic process (GO:0008203),0.2825794065317742,0.6626751672506641,0.8613445378151261,1.0,1.0,11/68,15.92%,LBR;PMVK;SOAT1;SCAP;TM7SF2;ABCA1;ACAT2;SOAT2;MVK;STARD3;DHCR7
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.28559155703852895,0.662555735434687,0.8509719222462203,1.0,1.0,7/53,9.51%,XPO1;PSMC2;DDRGK1;FBXW7;FMR1;PSMD14;PSME3IP1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.25183238571182087,-0.6623665188903805,0.8804347826086957,0.9647166513806013,1.0,2/14,4.59%,TMSB4X;SUFU
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.26626246210321497,-0.6618808871533193,0.9017857142857143,0.9642833255321298,1.0,4/10,26.98%,LRP6;BMP7;ARHGAP12;SOX11
prerank,response to UV-A (GO:0070141),-0.24243270251151988,-0.6614125322892207,0.924924924924925,0.9638895270200599,1.0,6/14,33.91%,MMP2;CERS1;CCND1;AKT1;MMP1;OPN3
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2605515358925721,-0.6611524337105036,0.9102564102564102,0.9633025350107683,1.0,4/12,21.05%,INPP5K;JUN;HMGA2;TARDBP
prerank,cellular response to gamma radiation (GO:0071480),0.3240342745161079,0.6610676808219792,0.8281461434370772,1.0,1.0,4/17,17.18%,MAP3K20;YAP1;TP53;ATR
prerank,inositol phosphate dephosphorylation (GO:0046855),0.3438333950279672,0.6608431222629765,0.8290598290598291,1.0,1.0,4/11,20.90%,OCRL;INPP5B;PTEN;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3438333950279672,0.6608431222629765,0.8290598290598291,1.0,1.0,4/11,20.90%,OCRL;INPP5B;PTEN;INPP5A
prerank,glycine metabolic process (GO:0006544),0.327583330001834,0.6608172680064351,0.8321377331420373,1.0,1.0,1/12,6.76%,AMT
prerank,protein localization to cell periphery (GO:1990778),0.2785966401994699,0.6606091757697652,0.9215086646279307,1.0,1.0,28/133,17.52%,TSPAN33;ROCK2;AP4M1;RAB10;PDZK1;DENND4C;RAP2A;ANK1;RAB29;SMURF1;ROCK1;P2RY1;EPB41L3;FLOT2;KCNIP3;EZR;GAK;EHD1;TSPAN5;DLG1;RAMP3;TTC7B;KCNB2;ZDHHC3;STXBP1;DPP6;RAB13;WNK3
prerank,plasma membrane repair (GO:0001778),0.333661500275282,0.6604922984884979,0.8226744186046512,1.0,1.0,6/13,22.87%,MYOF;SYTL4;SMPD1;DYSF;RAB3A;MYH9
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.2221550548301089,-0.6604892304086392,0.927038626609442,0.9630321653643421,1.0,6/20,23.60%,NUMB;DAB2;AP2M1;PKDCC;BCL2L1;ABI3
prerank,pentose-phosphate shunt (GO:0006098),-0.2622631270697187,-0.6603443442356549,0.8871951219512195,0.9623594215165487,1.0,4/11,21.08%,PGD;RPE;RPIA;SHPK
prerank,negative regulation of endocytosis (GO:0045806),0.3203864375506501,0.6603396697357737,0.8562421185372006,1.0,1.0,7/24,17.05%,MTMR2;PICALM;SNX33;RAC1;PRKD1;UNC119;EPHA3
prerank,mRNA catabolic process (GO:0006402),0.2878048593966756,0.6601246531158572,0.8391451068616423,1.0,1.0,12/44,18.75%,THRAP3;TUT7;MRTO4;LSM2;YTHDF2;DXO;TUT4;RC3H1;PNPT1;METTL3;EXOSC10;XRN2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.21268774114485106,-0.6601002013177811,0.916256157635468,0.9617622809522443,1.0,4/24,12.90%,TRAF3IP2;PTPN22;ZDHHC1;TOMM70
prerank,mesenchyme morphogenesis (GO:0072132),0.3199399943490282,0.6600921747204677,0.8373333333333334,1.0,1.0,3/17,11.40%,BMPR1A;MDM4;BMP2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.2270829527870356,-0.6599689092872463,0.9069767441860465,0.9610731097597255,1.0,5/19,21.58%,LARP6;RGCC;CREB3L1;TGFB3;SUCO
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.2706232493343255,-0.6590324668265553,0.9096209912536443,0.9610786176799408,1.0,2/10,6.08%,ST6GAL1;RENBP
prerank,cell differentiation in spinal cord (GO:0021515),-0.27352088111168527,-0.6587109219280856,0.9036827195467422,0.9605654710973417,1.0,4/10,22.17%,MDGA2;SOX4;SOX13;ZC4H2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2756654456628259,0.6582647055984772,0.996,1.0,1.0,74/509,15.88%,ECT2;HPSE;FADD;KSR1;ADGRV1;TRIML2;TICAM1;TRIP6;FNIP1;MAP3K14;ROCK2;MIER1;FGFR4;RHOA;FGFR2;BMF;LPAR1;IAPP;ACTN4;NEDD4;KIT;NMI;FRS2;TCF7L2;RTKN2;IL18;UBE2N;JCAD;PDGFRA;TXN;RNF31;CD80;BCLAF1;TNFRSF10B;ANGPT1;MAP3K3;PUM2;ROCK1;HMGB1;AGT;IKBKG;OSBPL8;PIK3CB;CXXC5;TGFBR1;LIMS1;BOK;GAB1;PLXNB1;PRKCB;BMP2;RAC1;PDPK1;GJA1;TRIM6;CASP8;SLC38A9;BRD4;ROR1;ADRB2;DDX21;PRKD1;PLK2;TRIM5;ITGB1;RAMP3;RPTOR;ITGAV;VAPA;SRC;RHOC;PRKD2;TP53;DDX1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.28059113291016435,0.6578360863122127,0.8769716088328076,1.0,1.0,14/75,19.01%,RGS12;ROCK2;GIT2;GRK5;RGS3;ROCK1;RIC8B;NMT2;RAMP3;SYP;ZDHHC3;METAP1;FNTB;USP20
prerank,negative regulation of DNA binding (GO:0043392),0.30658217998568205,0.6573590536639141,0.8224414303329223,1.0,1.0,5/28,18.94%,E2F1;ILRUN;HEY2;TFAP4;SP100
prerank,regulation of fibroblast migration (GO:0010762),0.31874795383183113,0.6569008191670058,0.8350515463917526,1.0,1.0,7/20,14.26%,DDR2;HAS1;RAC1;APPL2;DMTN;PRKCE;ITGB1
prerank,potassium ion transport (GO:0006813),0.2705855705931525,0.6568240531461564,0.9030612244897959,1.0,1.0,16/120,15.58%,AQP1;CCDC51;KCNN4;KCNK2;KCNH8;KCNH4;SLC9A5;KCNJ13;SLC24A3;KCNMB2;KCNMB3;KCNK12;KCNK6;KCNMB4;KCNB2;PKD2
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.33516919634448983,0.6566648078731776,0.8254437869822485,1.0,1.0,4/11,22.18%,YBX3;CASP8;RIPK1;BIRC2
prerank,regulation of secretion by cell (GO:1903530),0.28225781152692303,0.6561303230280682,0.8604143947655398,1.0,1.0,17/54,24.09%,ARFIP1;RAB10;DNAJC1;STXBP5;FMR1;LLGL2;ANXA1;P3H1;KCNMB4;RAB13;RIC1;RAB3A;RAB8B;VAMP2;CPLANE2;RAB8A;SNCAIP
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.2841684165219524,0.6561217425353622,0.8799149840595112,1.0,1.0,9/67,13.43%,TRIOBP;GSK3B;NPNT;RSU1;LIMS1;CRKL;RAC1;DMTN;DOCK1
prerank,presynaptic endocytosis (GO:0140238),0.3078509628494358,0.6560505558974784,0.8244949494949495,1.0,1.0,8/24,21.87%,STON1;STON2;NLGN3;PIP5K1C;NLGN2;SNCA;VAMP2;CDK5
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.3360022223766892,0.6558538413050174,0.8469387755102041,1.0,1.0,3/12,16.96%,IAPP;PFDN4;LDLR
prerank,positive regulation of cell growth (GO:0030307),0.27619187536782697,0.6553947069437426,0.9086242299794661,1.0,1.0,19/96,17.01%,MACF1;HYAL1;CEP43;FXN;MMP14;NTN1;MAPT;DERL2;SFRP2;SMURF1;KLHL22;TGFBR1;ADAM17;USP47;RPTOR;INO80;DBN1;SFRP1;NGF
prerank,cellular response to cytokine stimulus (GO:0071345),0.27393263304376836,0.6551757605010217,0.996,1.0,1.0,55/416,17.42%,BRCA1;BIRC5;SYNCRIP;RHOA;HYAL1;PLP2;GSK3B;ZEB1;UBE2K;MYLK3;KIT;DHX9;LEPR;PTPN2;CXCR4;IL18;TPR;WNK1;NPNT;YBX3;POU2F1;FOXO3;CD80;HTRA2;IRF1;RIPOR2;PIM1;PIK3CB;SDC1;HNRNPU;CRKL;CNTF;ANXA1;TRIM6;IL31RA;DPYSL3;RORA;TWIST1;RC3H1;CDKN1B;ITGB1;SMAD3;EPRS1;PTPN13;STK39;IL1RL2;NFKB1;TP53;SFRP1;PNPT1;IFNAR2;AXL;SIRPA;CD47;TXLNA
prerank,regulation of myeloid cell differentiation (GO:0045637),0.2814069695643979,0.6546932400415498,0.8726877040261154,1.0,1.0,9/62,12.45%,RBM15;CBFB;MOV10;NFE2;LEO1;KMT2A;PRKCB;HDAC1;KMT2D
prerank,defense response to fungus (GO:0050832),-0.2239387088671188,-0.6545233947869723,0.9108527131782945,0.9632081472091358,1.0,17/17,77.64%,GAPDH;CX3CR1;HRG;S100A9;CARD9;CLEC4D;S100A8;CLEC6A;LTF;RARRES2;CLEC4E;DEFB119;NLRP10;RNASE7;PLCG2;BCL10;FAM3A
prerank,cellular lipid catabolic process (GO:0044242),0.3026601431513283,0.6544454960390242,0.840937114673243,1.0,1.0,7/27,24.08%,LPIN2;ENPP2;ACADL;ACOT8;SMPDL3B;SIRT2;LPIN3
prerank,extracellular transport (GO:0006858),-0.2480483524333365,-0.6541358350100923,0.8571428571428571,0.9626940850776868,1.0,10/13,48.65%,TSG101;WWP2;CABYR;ROPN1L;ADCY10;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3236378462817496,0.6539088561231674,0.8170212765957446,1.0,1.0,4/13,16.96%,ABCA1;ITGB1;LPL;LDLR
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.2983882571948017,0.6534573472967303,0.8345410628019324,1.0,1.0,7/27,15.81%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.33237569402150624,0.6534250232122014,0.8218793828892006,1.0,1.0,2/14,9.89%,RHOA;MEOX2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.2850268789981067,0.6530385041614252,0.8542825361512792,1.0,1.0,11/48,15.58%,ANGPT4;JCAD;ANGPT1;MAP3K3;HMGB1;ANXA1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,aminoglycan biosynthetic process (GO:0006023),0.28618780172278213,0.6525277963111719,0.8620689655172413,1.0,1.0,16/49,23.78%,B3GNT8;GPC6;SLC35D2;B4GALT7;HAS1;SDC1;HS2ST1;HSPG2;UGDH;B3GALT2;XYLT1;SDC4;GPC4;GCNT2;EXT1;GPC3
prerank,mitochondrial RNA metabolic process (GO:0000959),0.3390335128483504,0.6522540417140092,0.8202080237741456,1.0,1.0,4/14,16.10%,FOXO3;FASTKD5;TFB1M;PNPT1
prerank,cellular response to glucose starvation (GO:0042149),0.291860420216309,0.6522474882206163,0.8459796149490374,1.0,1.0,11/41,15.98%,HNRNPA1;SH3GLB1;FOXO3;SESN1;EIF2AK3;SIK2;ITFG2;MTMR3;PRKAG1;TP53;SESN2
prerank,regulation of response to stress (GO:0080134),0.3380357274365804,0.6521055061862745,0.8069620253164557,1.0,1.0,3/10,18.41%,DYRK3;STOX1;SLC38A2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.29420887404731105,0.6520979406775693,0.8291457286432161,1.0,1.0,8/25,20.32%,PDZK1;WNK1;AKAP9;STK39;GLRX;WNK3;SLC6A9;ANK3
prerank,regulation of vacuole organization (GO:0044088),0.30681394356621106,0.6516474378049844,0.8340026773761714,1.0,1.0,5/20,18.93%,ANXA2;NPRL3;MTMR3;PIKFYVE;TBC1D12
prerank,Notch signaling involved in heart development (GO:0061314),0.3299196835516981,0.6516468634032481,0.8343023255813954,1.0,1.0,3/11,13.42%,RBPJ;NOTCH2;HEY2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.3412705012941717,0.6515918677429654,0.8377535101404057,1.0,1.0,3/10,17.55%,ERRFI1;ENPP1;MVP
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.2686896203495153,-0.6515861106508346,0.8682634730538922,0.963876888313734,1.0,1/10,5.18%,PLEK
prerank,androgen receptor signaling pathway (GO:0030521),0.33534024692373343,0.6513309622863874,0.8188512518409425,1.0,1.0,3/11,12.28%,ARID1A;PMEPA1;PLPP1
prerank,canonical glycolysis (GO:0061621),0.30089938405535666,0.650512085896267,0.8345771144278606,1.0,1.0,2/24,4.00%,GCK;GPI
prerank,glucose catabolic process to pyruvate (GO:0061718),0.30089938405535666,0.650512085896267,0.8345771144278606,1.0,1.0,2/24,4.00%,GCK;GPI
prerank,regulation of protein autophosphorylation (GO:0031952),0.2921301237151922,0.6499916054630164,0.8558139534883721,1.0,1.0,11/36,22.25%,MRE11;RAP2A;PPP2R5C;ERRFI1;CALM2;ENPP1;PPP2R5B;MVP;RAD50;TOM1L1;PDGFA
prerank,protein localization to lysosome (GO:0061462),0.29484470326603013,0.649956790000938,0.8313253012048193,1.0,1.0,4/28,12.19%,AP4M1;NEDD4;ZFYVE16;NAGPA
prerank,C-terminal protein amino acid modification (GO:0018410),0.32919359575932416,0.6497098702033373,0.8363914373088684,1.0,1.0,7/11,27.72%,ATG7;AGTPBP1;ICMT;ATG5;FOLH1;TTL;LCMT1
prerank,regulation of ossification (GO:0030278),0.29089285751012045,0.6491027474982477,0.8414918414918415,1.0,1.0,9/36,16.05%,CHSY1;SMAD6;DDR2;BMP2;ENPP1;RBPJ;TWIST1;NOTUM;SFRP1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2769771224722151,0.6489239868578872,0.8883034773445733,1.0,1.0,6/76,8.39%,PLK1;GSK3B;DDRGK1;FBXW7;LRRK2;SMURF1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.33496228640949577,0.6484125677083711,0.8490284005979073,1.0,1.0,2/11,12.06%,UAP1;GNPDA2
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.27492021148418366,-0.6481970566477329,0.9126506024096386,0.965778295931658,1.0,4/10,22.24%,CSGALNACT1;B3GAT2;XYLT2;B3GAT1
prerank,regulation of endocytic recycling (GO:2001135),-0.25822950079109364,-0.648195601844089,0.9109195402298851,0.964980233448597,1.0,5/11,30.58%,ATP9A;ARHGAP1;SORL1;EIPR1;PLA2G4E
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.29945916558277264,0.6481384755408625,0.8388683886838868,1.0,1.0,2/25,4.00%,GCK;GPI
prerank,dicarboxylic acid metabolic process (GO:0043648),0.2800657452344364,0.6480233150227652,0.8676957001102535,1.0,1.0,20/52,26.03%,MTHFD1L;MTHFR;SLC19A1;HOGA1;DGLUCY;DHFR;GCLM;MTHFS;GCLC;ME3;L2HGDH;ACOT8;ME2;SLC25A32;IDH2;SDHA;ALDH18A1;FPGS;ME1;MTHFD2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.31264335269696053,0.6472732655223985,0.8357615894039735,1.0,1.0,3/18,15.83%,NMI;ENPP3;DYSF
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.23004510586472746,-0.6470169784887794,0.9216417910447762,0.9650692005258907,1.0,2/16,7.11%,TGFB2;FOXC1
prerank,cholesterol transport (GO:0030301),0.2869924227498328,0.6470164827125452,0.8655367231638418,1.0,1.0,8/45,16.96%,TSPO2;SOAT1;ABCA1;SOAT2;STARD3;RELCH;STX12;LDLR
prerank,positive regulation of signal transduction (GO:0009967),0.271465365791861,0.6469213243780522,0.977977977977978,1.0,1.0,49/238,16.87%,LOXL3;MACF1;PHIP;DEPDC1B;FGFR2;ERFE;SULF2;ASXL1;MYO1C;TXNDC15;BMP6;NLGN3;JCAD;ZBTB7B;SULF1;TUBD1;CD80;LRRK2;AGPAT2;SMARCA4;ROBO1;YAP1;TGFBR1;LIMS1;TEDC1;CCN3;PRKCB;BMP2;PRKCA;RBPJ;RSPO3;AAK1;DMTN;GKAP1;TSPAN5;MAML1;PRKCI;ITGA5;ARNT;AGPAT1;ITGAV;SRC;PRKD2;PKD2;SFRP1;PTEN;NLGN2;SALL1;AXL
prerank,oligosaccharide metabolic process (GO:0009311),0.28209108338999794,0.6463883073600698,0.8655367231638418,1.0,1.0,10/46,20.75%,B4GALT1;ST8SIA2;MPDU1;ST3GAL3;ST3GAL4;ST3GAL2;B3GALT2;MAN1B1;NAGA;FUT8
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.22072195792716048,-0.6461984745668609,0.9454545454545454,0.9649264775152612,1.0,4/18,16.81%,ATXN3;PIK3R1;DDIT3;XBP1
prerank,focal adhesion assembly (GO:0048041),0.2989191514632396,0.6458463016086369,0.8393316195372751,1.0,1.0,7/21,20.80%,TRIP6;SRC;RCC2;PTPRK;TESK2;WHAMM;FERMT2
prerank,aminoglycan catabolic process (GO:0006026),0.2932203103017732,0.6458353999749075,0.841978287092883,1.0,1.0,3/28,10.41%,HPSE;GPC6;SDC1
prerank,myelin assembly (GO:0032288),0.33989410909364864,0.6457851837001342,0.8371040723981901,1.0,1.0,2/10,10.57%,TPPP;EPB41L3
prerank,Wnt signaling pathway (GO:0016055),0.271466592336218,0.6454217609993974,0.9053069719042663,1.0,1.0,29/92,24.25%,GSK3B;TCF7L1;WNT2B;TCF7L2;SFRP2;PORCN;LRRK2;WNT6;NR4A2;WNT9A;CSNK1G2;LRP5;BTRC;SFRP1;PTEN;VPS26A;AMER1;CSNK1A1;CSNK1G1;FRZB;WNT4;FERMT2;CSNK1E;NXN;ZRANB1;GPC4;TCF7;WLS;AXIN1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.2732380177717751,0.6451504386207646,0.9147609147609148,1.0,1.0,26/95,19.37%,TGFBR3L;PEG10;TGFBR3;PMEPA1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;DKK3;SMURF2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;STK11;PIN1;SPRED2;VEPH1;SMAD2;SKIL;SKI;PPM1A
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.27753820840056115,0.6442884777363815,0.8817891373801917,1.0,1.0,13/67,17.66%,DYRK1A;FGFR4;FGFR2;KIT;PDGFRA;EPHA4;ABI1;DDR2;BTK;EFEMP1;SRC;EPHA3;ABI2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3065412479218803,0.6441740679044371,0.8525469168900804,1.0,1.0,3/18,16.34%,PRKDC;IL4I1;METTL3
prerank,I-kappaB phosphorylation (GO:0007252),0.33719331747785813,0.6441103394954256,0.8441358024691358,1.0,1.0,4/10,23.12%,ERC1;PRDX4;TLR7;DAB2IP
prerank,regulation of sequestering of triglyceride (GO:0010889),0.3191013024801932,0.643144206974415,0.8395573997233748,1.0,1.0,3/15,15.76%,OSBPL8;PLIN2;LPL
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.28476312491098454,0.6428798570024078,0.8441410693970421,1.0,1.0,5/36,10.48%,RB1;BCL2L12;CSNK2A2;NR4A2;TGFBR1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.28345109463812057,0.6428100558193016,0.8690869086908691,1.0,1.0,3/44,4.81%,LBR;CYP39A1;PMVK
prerank,peripheral nervous system development (GO:0007422),0.29980943886944944,0.641950618127064,0.84251968503937,1.0,1.0,1/23,1.71%,ARTN
prerank,oligodendrocyte differentiation (GO:0048709),0.31176285119236574,0.6411617190406312,0.8542780748663101,1.0,1.0,6/19,21.87%,SOX6;EIF2B1;TPPP;PRDM8;EIF2B5;CDK5
prerank,lipid translocation (GO:0034204),0.3095847907764535,0.6406161478561592,0.8414948453608248,1.0,1.0,3/21,11.77%,ABCA4;ABCB4;ABCA1
prerank,magnesium ion transport (GO:0015693),-0.24712611586535232,-0.6405689430080014,0.9318181818181818,0.9684231687741648,1.0,2/12,5.21%,NIPA1;NIPA2
prerank,regulation of cytokine production (GO:0001817),0.2687987222787972,0.6405601291459162,0.9308943089430894,1.0,1.0,20/126,21.72%,POLA1;ERMAP;MAST2;AGPAT2;AGT;ATP2B1;ANXA1;CASP8;AGPAT1;PER1;SIRPA;FOXP1;CD47;MAPK14;NLRP4;LGR4;MAPKAPK2;ISG15;EIF2AK2;SOD1
prerank,cell junction assembly (GO:0034329),0.2705051572597983,0.6401094039635711,0.9328585961342828,1.0,1.0,20/100,16.40%,SDK1;CDH18;CDH24;RHOA;OBSL1;NLGN3;GRHL2;RAB29;FARP1;GJC1;TLN1;LIMS1;CAPZA1;DSCAM;ACHE;PLXND1;TLN2;PTEN;NLGN2;SHANK2
prerank,regulation of monocyte differentiation (GO:0045655),-0.2334432231142584,-0.6399913896475949,0.937037037037037,0.9680467530288326,1.0,2/14,5.29%,CDK6;ACIN1
prerank,peptidyl-asparagine modification (GO:0018196),0.28941185158396776,0.6396670655675867,0.8620689655172413,1.0,1.0,10/31,22.72%,MAGT1;RPN2;STT3A;STT3B;ALG8;UBE2J1;OSTC;FUT8;DPM3;MCFD2
prerank,homeostasis of number of cells (GO:0048872),0.3266130042435199,0.639541877063618,0.8466165413533835,1.0,1.0,3/12,15.51%,OCIAD2;CCN3;OCIAD1
prerank,myeloid leukocyte differentiation (GO:0002573),0.2731027272073259,0.6391257068058902,0.8778135048231511,1.0,1.0,7/65,12.75%,E2F1;DEK;KIT;PML;CDK2;CASP8;IL31RA
prerank,regulation of mitochondrial depolarization (GO:0051900),0.33090946311348574,0.6389516586987879,0.8260869565217391,1.0,1.0,2/10,15.31%,LRRK2;SRC
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.2686851433427423,0.6386056621095642,0.9110651499482937,1.0,1.0,30/88,23.36%,AP4M1;GBF1;RAB10;EXOC4;ACBD3;ARRB1;VPS13A;SH3D19;DNM2;CLVS2;SCFD1;TXNDC5;EXOC8;CLINT1;AP1B1;SNAP23;AP1M1;EPS15;CLTA;MON2;SCAMP2;ARF1;DNAJC6;EXOC2;VAMP2;MYO1B;SCAMP3;NAPA;HSPA8;GOLGB1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.25728241950158925,-0.6385224357463483,0.8727272727272727,0.9682831002791531,1.0,3/11,19.55%,CTNNB1;LRP6;FZD1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2885652784822705,0.637965215015799,0.852760736196319,1.0,1.0,12/34,27.33%,TICAM1;RAB7B;PTPRS;LGR4;SMPDL3B;GPR108;DAB2IP;NFKBIL1;ACOD1;NLRP2B;LY96;TLR3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.2952521157955753,0.6376468826512889,0.8468354430379746,1.0,1.0,2/22,7.79%,IL18;ZBTB7B
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.25526044854968577,-0.6369635658751016,0.9053254437869822,0.9686450669401583,1.0,2/11,12.77%,DDX5;MAP2K1
prerank,transcription by RNA polymerase I (GO:0006360),0.2878092772921288,0.6368878378069358,0.8586448598130841,1.0,1.0,6/34,13.14%,POLR1A;POLR1B;ERCC3;TAF1D;TTF1;POLR1G
prerank,positive regulation of cell adhesion (GO:0045785),0.2717899850555557,0.6361339730340841,0.8912354804646251,1.0,1.0,13/74,15.58%,HYAL1;AFDN;NPNT;SFRP2;PPP3CA;EPHA4;RSU1;LIMS1;RAC1;PRKCA;ADAM9;ITGAV;PRKD2
prerank,cation transport (GO:0006812),0.2658651612542358,0.6361300574548688,0.954864593781344,1.0,1.0,26/167,19.06%,RHAG;SLC18A2;AQP1;KCNN4;SLC38A7;KCNH4;KCNJ13;SLC8A1;KCNMB2;KCNMB3;TRPM2;PIEZO1;CHRNB1;TRPM4;KCNK6;KCNMB4;SLC22A18;KCNB2;KCNA1;SLC6A17;SLC36A4;SLC7A1;SLC6A9;SLC25A29;KCNQ4;TRPM6
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3214085775620321,0.6360213647149107,0.8634423897581792,1.0,1.0,7/13,28.17%,UAP1;GNPDA2;SLC35A3;AMDHD2;GFPT1;GFPT2;PGM3
prerank,activation of adenylate cyclase activity (GO:0007190),-0.17460259200048722,-0.6355364953462056,0.9791666666666666,0.968903167321255,1.0,5/35,14.86%,CAP1;LGR5;ADCY3;ADCY8;ADCY4
prerank,epithelial cell development (GO:0002064),0.3072300194375167,0.6353301131900218,0.8418230563002681,1.0,1.0,2/20,7.10%,GRHL2;RILPL1
prerank,autophagosome assembly (GO:0000045),0.2763644908842213,0.6352561707370221,0.8730512249443207,1.0,1.0,16/52,22.40%,ATG7;MFN2;SMURF1;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TRAPPC8;TP53INP2;AMBRA1;ATG13;ATG5
prerank,regulation of protein polymerization (GO:0032271),0.2809797644790079,0.6347852613348921,0.8652321630804077,1.0,1.0,4/35,9.18%,ARHGAP28;ARHGAP18;MAPT;TPPP
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.2703973586636073,0.6346334796271023,0.8920940170940171,1.0,1.0,24/70,24.76%,PSMC2;PSMD5;PSMB1;PSMD14;PSMD1;IKBKG;CYBB;PSMB9;PSMC6;ITGAV;SNAP23;PSMB2;PSME4;PSMB7;PSMD11;PSME3;SEC22B;IKBKB;PSMD13;PSMB8;PSMD4;PSMF1;PSMA5;PSMC3
prerank,cellular glucan metabolic process (GO:0006073),0.32231488216601867,0.6345539425910268,0.845821325648415,1.0,1.0,1/11,3.50%,GSK3B
prerank,intestinal absorption (GO:0050892),-0.2394653064046727,-0.6341008093153067,0.9381443298969072,0.9690717926747298,1.0,3/13,19.39%,F11R;ADRA2A;KCNQ1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.22154439680275895,-0.6340856971695698,0.92578125,0.9682868121804634,1.0,3/17,10.55%,FIS1;SOD2;BCL2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.29458092695952387,0.6336524085408459,0.8564231738035264,1.0,1.0,6/26,15.84%,ROCK2;ALMS1;ROCK1;RAC1;SYNPO2;FHOD1
prerank,positive regulation of actin nucleation (GO:0051127),0.32600139122374966,0.6334775535584717,0.8587731811697575,1.0,1.0,5/11,23.37%,WASF2;NCKAP1;ABI2;WHAMM;WASF1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),-0.23387154268101568,-0.6334327330539014,0.9248366013071896,0.967930707982084,1.0,7/13,36.11%,PTPRT;JAK2;EGF;MGAT5;PTPRC;CRLF2;JAK3
prerank,methylguanosine-cap decapping (GO:0110156),0.33123827112521587,0.6329551228984216,0.8448795180722891,1.0,1.0,1/10,4.27%,PATL1
prerank,negative regulation of cellular catabolic process (GO:0031330),0.2734473778415378,0.6324483926902217,0.8962566844919786,1.0,1.0,9/63,9.56%,BMF;DAP;EIF4E;LEPR;NRDE2;KLHL22;MTMR2;ROCK1;MTMR9
prerank,cellular response to estrogen stimulus (GO:0071391),-0.23318213767381987,-0.632427821041074,0.9241379310344827,0.9677740010929416,1.0,5/14,20.54%,AR;SFR1;SERPINB9;SRA1;WBP2
prerank,positive regulation of embryonic development (GO:0040019),-0.21417376102057684,-0.6322972486398646,0.9246031746031746,0.9670666845346998,1.0,6/19,28.89%,B4GALT5;NR2C2;TENM4;RACK1;ZBED3;PLCB1
prerank,glycolipid biosynthetic process (GO:0009247),0.28394699631144166,0.6322257711691466,0.8682352941176471,1.0,1.0,12/38,22.28%,LARGE1;PIGN;PIGA;ST3GAL5;PIGU;ST3GAL4;ST3GAL2;PIGM;DPM3;PIGG;A4GALT;PIGH
prerank,Fc receptor signaling pathway (GO:0038093),0.26189590109280403,0.6320357363797837,0.9237029501525941,1.0,1.0,40/110,24.76%,PSMC2;PSMD5;KIT;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;PSMB8;GAB2;PSMD4;BCL10;PSMF1;PPP3CB;PSMA5;RELA;PSMC3
prerank,calcium ion transmembrane transport (GO:0070588),0.2708142791723104,0.6319044175393306,0.9204545454545454,1.0,1.0,24/86,20.71%,ATP2B4;TRPA1;STOML2;MCU;ATP2A2;SLC24A3;SLC8A1;MCUB;CACNA1C;TRPM2;TRPC7;ATP2B1;MICU1;TRPM4;PMPCA;ITGAV;MAIP1;PKD2;GRIN2D;TRPV4;TRPM6;CACNA1G;SPG7;MICU2
prerank,synaptic vesicle endocytosis (GO:0048488),0.2857962215810247,0.6318177442745028,0.8603550295857988,1.0,1.0,13/33,21.87%,STON1;STON2;NLGN3;DNM2;PICALM;GAK;PIP5K1C;NLGN2;SNCA;DNAJC6;SNAP91;VAMP2;CDK5
prerank,negative regulation of B cell activation (GO:0050869),-0.2091266374712659,-0.6310264210772502,0.9411764705882353,0.9671572915736386,1.0,13/21,42.68%,TNFRSF21;LYN;ATM;INHBA;CD300A;LAPTM5;TNFAIP3;TYROBP;INHA;FCGR2B;ID2;BANK1;FOXJ1
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.21010160868255734,-0.6309371558944602,0.9473684210526315,0.9664235061240339,1.0,10/18,40.88%,HEATR1;WDR75;ERBB2;POLR2K;MAF1;LYAR;SIRT7;POLR2L;WDR43;RASL11A
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2903495139016643,0.6303223964287176,0.8629961587708067,1.0,1.0,6/26,19.60%,NPR3;PIK3CB;TERF2;DHFR;GDNF;TERT
prerank,photoperiodism (GO:0009648),0.28736621237128246,0.6301271430981793,0.8528347406513872,1.0,1.0,7/28,15.81%,PML;FBXL8;FBXL17;PPP1CC;RBM4;PER1;TP53
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.2883169240254828,0.6300181393937069,0.8598870056497175,1.0,1.0,5/35,12.91%,IQGAP2;PDGFRA;TRPM2;NOTCH2;BAIAP2L1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2826280322824575,0.6296636879098663,0.854916067146283,1.0,1.0,2/32,6.19%,RNASE6;HMGN2
prerank,tRNA metabolic process (GO:0006399),0.3092892778550093,0.6296630909922823,0.8569553805774278,1.0,1.0,7/17,24.77%,DARS2;RPP30;POP1;RPP21;FARS2;DTD1;SSB
prerank,toll-like receptor signaling pathway (GO:0002224),0.2671909502150211,0.6290412709536516,0.8964435146443515,1.0,1.0,11/84,13.08%,FADD;TICAM1;COLEC12;TAB1;NMI;MAP3K1;HMGB1;IKBKG;MAPKAPK3;CASP8;BTK
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.26678466882112956,0.6286083543397923,0.9103232533889468,1.0,1.0,29/86,24.76%,PSMC2;PSMD5;ELOC;CHEK1;PSMB1;PSMD14;LIMD1;VHL;PSMD1;PSMB9;STOX1;PSMC6;ARNT;INO80;TP53;PSMB2;PSME4;PSMB7;PSMD11;EGLN1;PSME3;PSMD13;EGLN3;PSMB8;PSMD4;PSMF1;PSMA5;HIF3A;PSMC3
prerank,protein secretion (GO:0009306),0.2732352615053899,0.6283919256970621,0.8916576381365113,1.0,1.0,14/56,21.50%,STEAP3;RAB10;PORCN;SVBP;ANXA1;ABCA1;NAGPA;MIA3;SNX19;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,phospholipid homeostasis (GO:0055091),-0.2542681145754211,-0.627810395259514,0.9177631578947368,0.9676388188699105,1.0,5/11,35.15%,TLCD2;RCN3;TLCD1;ANGPTL3;ABCG1
prerank,protein insertion into membrane (GO:0051205),0.28097070929937107,0.6267796854662159,0.8714285714285714,1.0,1.0,9/32,21.73%,PRNP;TRAM2;EMD;MAIP1;VAPA;CYB5A;TRAM1;CCDC47;VAMP2
prerank,response to insulin (GO:0032868),0.2686574551525492,0.6266118429054425,0.9119496855345912,1.0,1.0,28/80,24.31%,GCK;RAB10;PRKDC;PDE3B;DENND4C;LPIN2;ZBTB7B;RHOQ;CPEB2;ENPP1;PDPK1;PRKCI;EPRS1;PCK2;RAB13;INSIG2;SLC2A4;SYAP1;CEACAM1;INSIG1;FER;RAB8B;VAMP2;ZFP36L1;SLC25A33;RAB8A;LPIN3;RPS6KB1
prerank,positive regulation of phospholipase C activity (GO:0010863),0.27941132973320565,0.6266037497389191,0.887627695800227,1.0,1.0,5/40,10.40%,LPAR1;KIT;PDGFRA;GNAQ;ARHGAP6
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.20922263774072317,-0.6265633341955514,0.9395348837209302,0.9676880128117252,1.0,4/18,20.98%,BCL2;BNIP3;SLC25A4;BCL2L1
prerank,modulation by host of symbiont process (GO:0051851),0.2821297359166236,0.6265091180760161,0.8820697954271961,1.0,1.0,6/31,17.38%,AQP1;NUCKS1;SMARCA4;HDAC1;CHD1;TFAP4
prerank,amino sugar biosynthetic process (GO:0046349),0.3195698635838087,0.6258903889708337,0.8607038123167156,1.0,1.0,2/12,12.06%,UAP1;GNPDA2
prerank,lipid droplet formation (GO:0140042),-0.2581601918203839,-0.6254262993198402,0.9161849710982659,0.9676206678567308,1.0,3/10,17.83%,CDS2;CDS1;AUP1
prerank,zinc ion transmembrane transport (GO:0071577),0.2933287879549623,0.6254087449251244,0.8587223587223587,1.0,1.0,5/22,15.01%,SLC39A11;TRPM2;SLC39A8;SLC39A6;SLC30A10
prerank,actin filament network formation (GO:0051639),-0.2477942375918208,-0.6245472685971163,0.9181818181818182,0.9673922061028724,1.0,1/11,0.95%,PLS3
prerank,inflammatory response (GO:0006954),0.25849520848642626,0.624342405140484,0.9648946840521565,1.0,1.0,17/195,12.82%,LOXL3;MMP25;SCUBE1;HYAL1;KIT;CXCR4;IL18;BDKRB2;NOX4;HMGB1;IKBKG;CYBB;PXK;BMP2;ANXA1;RAC1;ITCH
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.3026325650464807,0.6242552611391058,0.8443271767810027,1.0,1.0,2/18,10.80%,GSK3B;BOK
prerank,androgen metabolic process (GO:0008209),0.298432795326829,0.624205058924509,0.8739946380697051,1.0,1.0,2/18,13.63%,SRD5A3;MED1
prerank,cellular response to lipid (GO:0071396),0.26261376317177676,0.6238329025269613,0.961,1.0,1.0,36/191,20.26%,HMGB2;AQP1;SETX;TICAM1;ROCK2;RHOA;ABCB4;LCOR;SERPINE1;CD80;HTRA2;WNT6;HMGB1;NR3C1;AHR;WNT9A;RORA;MED1;ADAM9;RUVBL2;RAMP3;ADCY6;NFKB1;LPL;SFRP1;MSN;AXL;EPHA3;SIRPA;ADCY2;MAPK14;PLAA;ADNP2;PDE4B;CD68;TRAF6
prerank,muscle cell development (GO:0055001),0.28212475007972265,0.6237370044455594,0.8771084337349397,1.0,1.0,6/30,15.83%,MYOF;SLC8A1;SDC1;CHRNB1;HEY2;DYSF
prerank,regulation of cholesterol esterification (GO:0010872),-0.25629121077049455,-0.6234181430494558,0.9121813031161473,0.9672929929486566,1.0,2/10,12.21%,APOE;AGTR1
prerank,sensory organ development (GO:0007423),0.27435178128896465,0.6226591643780207,0.8902305159165752,1.0,1.0,2/51,2.57%,PBX4;PBX3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26267571736120293,0.6226113532754908,0.934560327198364,1.0,1.0,28/104,19.72%,BMPR1A;PEG10;PMEPA1;CRIM1;LEMD3;SMAD6;SMURF1;ADAMTSL2;TGFBR1;RBPMS2;SMURF2;CCN3;BMP2;NKX2-1;PDPK1;ADAM17;SMAD4;SPRED1;HTRA3;SMAD3;PIN1;SPRED2;VEPH1;SMAD2;SKIL;SKI;PPM1A;UBE2D3
prerank,ubiquinone metabolic process (GO:0006743),0.2980284448626545,0.6215935889772803,0.8577405857740585,1.0,1.0,2/15,7.08%,AIFM2;COQ10B
prerank,iron ion homeostasis (GO:0055072),0.2714936383607864,0.6215750886706929,0.8921251348435815,1.0,1.0,16/58,21.99%,FXN;ERFE;CYB561A3;BMP6;PICALM;SMAD4;CCDC115;ACO1;ALAS2;BDH2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.2412956787801125,-0.6214153359868234,0.9102564102564102,0.9677902083043596,1.0,7/12,39.89%,BCL2;TAF9B;CD74;MIF;RPL26;TAF9;TRIAP1
prerank,platelet aggregation (GO:0070527),0.28070246230105217,0.6213291145350922,0.8617886178861789,1.0,1.0,11/33,22.87%,PDGFRA;PIK3CB;TLN1;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;VCL;MYH9
prerank,secondary alcohol metabolic process (GO:1902652),0.2698907248828133,0.6210689320776486,0.8791946308724832,1.0,1.0,6/42,15.49%,IDH3A;SOAT1;SCAP;ABCA1;SOAT2;STARD3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.2993365251064981,0.621029508713991,0.8668341708542714,1.0,1.0,3/24,8.07%,PRNP;FBXW7;FOXO3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.31381997855611504,0.6206156899898976,0.8696925329428989,1.0,1.0,3/13,13.92%,DDRGK1;NCK1;PPP1R15B
prerank,cellular response to lectin (GO:1990858),0.2605607158929253,0.6201373346477641,0.9211065573770492,1.0,1.0,35/104,24.76%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;KRAS;NRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.2605607158929253,0.6201373346477641,0.9211065573770492,1.0,1.0,35/104,24.76%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;KRAS;NRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,embryonic appendage morphogenesis (GO:0035113),0.3190929291400993,0.620103295887569,0.8444767441860465,1.0,1.0,1/12,3.24%,CYP26B1
prerank,regulation of lipase activity (GO:0060191),0.316134880953867,0.6192027274707538,0.8662790697674418,1.0,1.0,4/13,20.64%,RHOA;RHOC;LPL;SNCA
prerank,regulation of T cell migration (GO:2000404),0.3005550980109206,0.6191842846226696,0.8706199460916442,1.0,1.0,2/18,8.79%,RHOA;RIPOR2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.31812394708949704,0.6191298344406853,0.8417818740399385,1.0,1.0,4/10,24.16%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,calcineurin-mediated signaling (GO:0097720),0.31812394708949704,0.6191298344406853,0.8417818740399385,1.0,1.0,4/10,24.16%,PPP3CA;PPP3R1;NFATC3;PPP3CB
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.25936326448143937,0.6186474419378588,0.9476861167002012,1.0,1.0,21/128,14.33%,TGFBR3L;BMPR1A;RHOA;NLK;RGMA;HIVEP1;BMP6;TGFBR3;SMAD6;SMURF1;ZFYVE16;TGFBR1;SMURF2;ARHGEF18;BMP2;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.30474013990571736,0.6186464242212927,0.8647540983606558,1.0,1.0,3/15,14.03%,UST;DSE;BGN
prerank,negative regulation of leukocyte migration (GO:0002686),0.3227590109241061,0.6186247370255216,0.8662704309063893,1.0,1.0,1/10,6.51%,HOXA7
prerank,regulation of lipid catabolic process (GO:0050994),0.3003535785763085,0.6185624982559815,0.875,1.0,1.0,1/19,4.92%,PDE3B
prerank,gonad development (GO:0008406),0.27197987099326293,0.6183169610312406,0.8771526980482205,1.0,1.0,3/41,6.04%,KIT;WNT2B;MKKS
prerank,positive regulation of metabolic process (GO:0009893),0.2600972812177622,0.6182998757642172,0.9355168884339816,1.0,1.0,18/103,14.67%,MFAP2;LEPR;PIGA;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;CAMK1D;ACACA;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL;AGPAT1
prerank,positive regulation of phospholipid transport (GO:2001140),0.31655699244390856,0.6181546880496681,0.86697965571205,1.0,1.0,1/10,4.57%,ABCB4
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.25982748902032804,0.6179975284102515,0.9261538461538461,1.0,1.0,35/105,24.76%,PSMC2;PSMD5;TAB1;PSMB1;PSMD14;PSMD1;IKBKG;PSMB9;FBXW11;PDPK1;BTRC;PSMC6;SRC;NFKB1;PSMB2;KRAS;NRAS;PSME4;PSMB7;RELB;PRKCD;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;FYN;PSMD4;BCL10;PSMF1;PRKACA;PSMA5;RELA;PSMC3
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3102123245449332,0.6175251592324772,0.8656716417910447,1.0,1.0,2/12,10.55%,HNRNPU;YTHDF2
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.2862857336267049,0.6174401466210749,0.8795483061480552,1.0,1.0,4/25,12.83%,RNF168;LEO1;HNRNPU;BRD4
prerank,substantia nigra development (GO:0021762),0.2758829666791883,0.6173875856196511,0.8795749704840614,1.0,1.0,5/37,10.92%,RHOA;RAD1;CCDC14;MAPKAP1;CALM2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.25801907463733187,0.6173646843265341,0.98,1.0,1.0,35/234,14.33%,TRIM37;TRIML2;TICAM1;TFDP1;DDRGK1;RAB7B;KIT;DHX9;SRF;TAB1;STK3;ANXA3;RTKN2;IL18;UBE2N;TAF12;RNF31;SMARCA4;AGT;IKBKG;ERC1;EDA;DDR2;CAMK1D;FLOT2;PRKCB;TRIM6;BTK;ROR1;SLCO3A1;PPRC1;PRKD1;PRKCI;TRIM5;SMAD3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.2763767316966859,0.6172886589363271,0.8964326812428078,1.0,1.0,8/38,18.38%,ATP2B4;ROCK2;RAC1;SMAD3;PKD2;SIRPA;CD47;PTGIS
prerank,acyl-CoA biosynthetic process (GO:0071616),0.303027960690272,0.616795913206751,0.8781456953642384,1.0,1.0,3/16,11.72%,ACAT1;ACSS1;ACACA
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.31162932341978045,0.6166686428010544,0.8776978417266187,1.0,1.0,2/13,10.55%,GPRC5A;ERRFI1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.2908036192575025,0.6158464976304262,0.8663239074550129,1.0,1.0,3/20,16.78%,LMBRD2;ADRB2;ZDHHC21
prerank,steroid biosynthetic process (GO:0006694),0.2658054821863127,0.6154258077731996,0.9131832797427653,1.0,1.0,3/56,4.81%,LBR;CYP39A1;PMVK
prerank,synaptic membrane adhesion (GO:0099560),-0.238304488896361,-0.6152765681961357,0.9556313993174061,0.9706655459184789,1.0,4/14,15.66%,PTPRD;SLITRK1;NTNG1;LRRC4B
prerank,O-glycan processing (GO:0016266),0.2672197308352505,0.6145241018529252,0.899343544857768,1.0,1.0,8/54,15.44%,GALNT1;B3GNT8;ST3GAL3;C1GALT1;POFUT1;ST3GAL4;ST3GAL1;ST3GAL2
prerank,B cell differentiation (GO:0030183),0.2655921900099485,0.6144497947150843,0.8968166849615807,1.0,1.0,6/46,15.42%,FNIP1;KIT;PTPN2;ADAM17;ITGB1;DCAF1
prerank,response to interleukin-1 (GO:0070555),0.26079942197688843,0.6136234956465276,0.9284963196635121,1.0,1.0,19/73,23.22%,HYAL1;MYLK3;ANXA1;PRKCA;RC3H1;SMPD1;SRC;NFKB1;SFRP1;SIRPA;CD47;PTGIS;TRAF6;SNCA;TANK;RBMX;HDAC4;DAB2IP;CCL14
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.30284964470789394,0.6134442934632484,0.8698630136986302,1.0,1.0,1/16,5.54%,RAET1E
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.31237318047867624,0.6130688723068205,0.8582317073170732,1.0,1.0,2/10,13.79%,ACTN4;RARB
prerank,regulation of RNA metabolic process (GO:0051252),0.2646846427562994,0.6120779948798435,0.903470715835141,1.0,1.0,12/59,13.95%,TRA2B;MBNL3;HNRNPH1;FUS;RC3H2;YTHDF2;HNRNPL;HNRNPH2;METTL4;PTBP2;MED1;RC3H1
prerank,positive regulation of wound healing (GO:0090303),0.2782606944740566,0.6116418735653822,0.8654292343387471,1.0,1.0,8/36,14.26%,HPSE;SERPINE1;ANXA1;DMTN;PRKCE;INSL3;ST3GAL4;ITGB1
prerank,synaptic vesicle membrane organization (GO:0048499),0.29868396268572944,0.6112597319474162,0.8797202797202798,1.0,1.0,4/17,15.66%,STX11;STX2;SYP;SNAP23
prerank,T-helper cell differentiation (GO:0042093),0.3049438865169004,0.6110374837206943,0.8686730506155951,1.0,1.0,4/14,19.40%,HMGB1;TMEM98;FOXP1;ZFPM1
prerank,blood vessel endothelial cell migration (GO:0043534),0.2879693240422758,0.6109114360290052,0.8536269430051814,1.0,1.0,5/22,14.41%,SRF;ROBO1;NR4A1;EFNB2;MIA3
prerank,plasma membrane organization (GO:0007009),0.2628386043406818,0.6108862670062462,0.8942826321467098,1.0,1.0,19/61,22.87%,PLSCR2;PACSIN2;CXCR4;MYOF;STX2;SNX33;EPB41L3;SYTL4;SMPD1;DYSF;CHMP4A;FA2H;RAB3A;UGCG;ANK3;WHAMM;A4GALT;SNX9;MYH9
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.25925696530557807,0.610612544574846,0.9296794208893485,1.0,1.0,19/87,17.82%,TGFBR3L;BMPR1A;RHOA;NLK;TGFBR3;SMAD6;SMURF1;TGFBR1;ARHGEF18;APPL2;SMAD4;USP9X;ADAM9;ITGB1;SMAD3;SRC;PTPRK;ZFYVE9;SMAD2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.2880163582156263,0.610442733170704,0.8769230769230769,1.0,1.0,1/21,2.15%,NAP1L1
prerank,phagolysosome assembly (GO:0001845),0.31091687384021555,0.6102563195000499,0.8726207906295754,1.0,1.0,1/12,4.45%,RAB7B
prerank,regulation of programmed cell death (GO:0043067),0.2549175324302409,0.6102529038531109,0.9668341708542714,1.0,1.0,17/161,12.04%,BIRC5;STEAP3;ACTN4;ANP32B;AIFM2;RBM25;TMEM219;LRRK2;TNFRSF10B;KANK2;SKP2;AGT;GAS1;APAF1;NDRG1;ANP32E;CHM
prerank,negative regulation of cell motility (GO:2000146),0.2593259532368697,0.6100296996524139,0.9402061855670103,1.0,1.0,25/108,18.07%,ARID2;STK24;RAP2A;AFDN;SFRP2;EPHA4;SULF1;SERPINE1;FOXO3;TMEFF2;ROBO1;SRGAP2;SRGAP3;NKX2-1;CLIC4;DPYSL3;MIA3;PTPRU;PIN1;NF2;SFRP1;PTEN;PTPRK;SLURP1;DPEP1
prerank,axon extension (GO:0048675),0.2922010496308976,0.6098326622975202,0.8729763387297634,1.0,1.0,5/23,13.51%,ALCAM;AUTS2;NLGN3;ULK2;USP9X
prerank,negative regulation of response to external stimulus (GO:0032102),0.2580663337418394,0.609703830387939,0.9332648870636551,1.0,1.0,14/105,13.71%,RB1;RTN4R;CASK;NMI;PTPN2;EPHA4;ENPP3;SERPINE1;CCN3;PTPRS;ILRUN;ITCH;RORA;MVK
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.28657800083549834,0.6096278999039116,0.8977832512315271,1.0,1.0,4/25,9.91%,KLHL15;CUL3;LONP1;FBXL17
prerank,mitochondrial membrane organization (GO:0007006),0.2780298116063928,0.6093088702448541,0.8766310794780545,1.0,1.0,11/32,21.99%,TMEM11;MFN2;CHCHD3;APOO;MAIP1;MFN1;MICOS10;BAD;SLC25A5;SPG7;IMMT
prerank,positive regulation of filopodium assembly (GO:0051491),0.28396345486426905,0.6090425351385548,0.8674101610904585,1.0,1.0,5/24,12.80%,FMR1;RHOQ;RIPOR2;DOCK11;DPYSL3
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.2590107910710594,0.6088620521795896,0.9319148936170213,1.0,1.0,17/80,19.35%,GBF1;RAB7B;SPAG9;SNX1;DENND2A;RAB29;ERC1;DENND5A;VTI1A;GOSR1;SNX32;TRAPPC10;VPS26A;RIC1;PIKFYVE;TBC1D10A;BET1L
prerank,aerobic respiration (GO:0009060),0.29050892996380756,0.6087731734851718,0.8851174934725848,1.0,1.0,1/20,2.45%,MTFR2
prerank,NAD biosynthetic process (GO:0009435),0.2823644451079406,0.6082916273196147,0.8791946308724832,1.0,1.0,8/20,25.14%,NADSYN1;PARP9;NAPRT;NMNAT1;PTGIS;NMNAT2;QPRT;NMNAT3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.23772522638698834,-0.6082557949153117,0.9588607594936709,0.9739149067582596,1.0,4/12,33.80%,ESR1;ZC3H12A;ZC3H10;PPARG
prerank,modulation by host of viral genome replication (GO:0044827),0.3021217807863987,0.6077415553637697,0.8788300835654597,1.0,1.0,3/13,15.26%,FMR1;NUCKS1;VAPA
prerank,Golgi ribbon formation (GO:0090161),-0.22757482344250224,-0.607687647178994,0.9344827586206896,0.9734365151786595,1.0,2/13,9.91%,STX6;MYO18A
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.25708090196694655,0.6076087908594648,0.9553299492385787,1.0,1.0,18/150,12.27%,HPSE;FGFR4;FGFR2;IAPP;KIT;FRS2;TCF7L2;IL18;PDGFRA;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;TGFBR1;GAB1;RAC1;PDPK1
prerank,peptide catabolic process (GO:0043171),0.2843562128030148,0.6074277643893874,0.8647959183673469,1.0,1.0,6/23,18.07%,LVRN;CPQ;TRHDE;CTSH;NPEPPS;DPEP1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.29048585891826173,0.607367590281979,0.864321608040201,1.0,1.0,4/21,19.60%,EYA4;EYA2;GDNF;TERT
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.29048585891826173,0.607367590281979,0.864321608040201,1.0,1.0,4/21,19.60%,EYA4;EYA2;GDNF;TERT
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.29005552249874467,0.6069621128081574,0.8668478260869565,1.0,1.0,1/16,2.76%,MOV10
prerank,heart process (GO:0003015),0.30855519829070305,0.6053100384632238,0.8801711840228246,1.0,1.0,4/14,22.78%,NOX4;RAMP3;SOD1;FYN
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.28417373805370394,0.6050004884993812,0.8933500627352572,1.0,1.0,6/24,15.07%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,positive regulation of defense response (GO:0031349),0.2555472388445369,0.6040348231920034,0.934224049331963,1.0,1.0,20/89,22.98%,DHX9;NMI;IL18;SERPINE1;RIOK3;AGT;POLR3D;AKIRIN2;SLC15A4;SETD4;LPL;CD47;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;POLR3G;TLR7
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.2970126014887195,0.6039843912681685,0.8782489740082079,1.0,1.0,1/17,5.54%,RAET1E
prerank,mononuclear cell differentiation (GO:1903131),0.27842373929748754,0.6038901706520605,0.8902743142144638,1.0,1.0,8/24,23.35%,IKZF1;TRPM2;IL31RA;AXL;RELB;THOC5;MYH9;IRF8
prerank,regulation of interferon-alpha production (GO:0032647),0.2755408861668651,0.603782418239362,0.8985879332477535,1.0,1.0,7/23,23.56%,DHX9;SETD2;PTPRS;MAVS;HAVCR2;TLR7;RIPK2
prerank,response to interferon-gamma (GO:0034341),-0.14478137395157653,-0.6037029481084216,1.0,0.9749400035201082,1.0,13/67,20.22%,NUB1;TLR4;IFITM3;CX3CL1;GBP3;GBP4;GCH1;BST2;IFITM2;RPL13A;LGALS9;GAPDH;GBP6
prerank,cellular iron ion homeostasis (GO:0006879),0.2641728819388506,0.6036168289215612,0.9093886462882096,1.0,1.0,14/55,21.99%,FXN;ERFE;CYB561A3;BMP6;SMAD4;CCDC115;ACO1;ALAS2;CAND1;NUBP1;FRRS1;ATP6V0A2;SOD1;NEDD8
prerank,regulation of Notch signaling pathway (GO:0008593),0.25874947738958104,0.6034266679272738,0.9219562955254943,1.0,1.0,17/76,16.34%,MMP14;DLK1;ARRB1;FBXW7;YAP1;LLGL2;YTHDF2;POFUT1;ARRDC1;CCN3;RBPJ;AAK1;TSPAN5;MAML1;PRKCI;SRC;METTL3
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.2809539472867449,0.6033368008891901,0.8759124087591241,1.0,1.0,4/24,11.74%,MAP4K4;ROCK1;LIMS1;RAC1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.2616105187588221,0.6033229995732913,0.8918617614269788,1.0,1.0,6/46,10.81%,PRKDC;TCF7L2;IL18;MFN2;ELN;RBPMS2
prerank,regulation of cardiac conduction (GO:1903779),0.2605767145596102,0.6033037089970775,0.9255202628696605,1.0,1.0,9/54,15.99%,ATP2B4;ITPR1;ATP2A2;SLC8A1;AGT;ATP2B1;ITPR3;TMEM65;STIM1
prerank,receptor clustering (GO:0043113),0.27351754257089156,0.6028616077442241,0.8901234567901235,1.0,1.0,3/27,7.48%,ITGB7;MUSK;SCRIB
prerank,regulation of autophagy (GO:0010506),0.2529137694719468,0.6018353064769999,0.9819639278557114,1.0,1.0,43/216,16.83%,TRIML2;TICAM1;GSK3B;BMF;DEPDC5;DAP;ITPR1;EXOC4;NEDD4;EIF4E;MAPT;LEPR;TPCN1;FBXW7;SH3GLB1;FOXO3;HTRA2;LRRK2;KLHL22;ROCK1;MTMR9;HMGB1;CSNK2A2;PIK3CB;RB1CC1;BOK;DCAF12;TRIM6;SLC38A9;EXOC8;PRKD1;SNX32;PLK2;FOXK2;TRIM5;STK11;RPTOR;MTMR3;PRKAG1;CISD2;TPCN2;VPS26A;LAMTOR3
prerank,detection of mechanical stimulus (GO:0050982),0.2920762721684473,0.6017637171650414,0.8825100133511349,1.0,1.0,7/19,22.34%,PKD2L2;PIEZO1;LHFPL5;PKD2;CSRP3;PIEZO2;PKD1L2
prerank,inorganic cation transmembrane transport (GO:0098662),0.2517964345064311,0.6013997248202466,0.987987987987988,1.0,1.0,21/268,10.73%,RHD;RHAG;ATP2B4;CCDC51;KCNN4;KCNK2;SLC6A2;SLC6A5;TRPA1;SLC39A11;KCNH8;KCNH4;SLC9A5;ATP2A2;SLC24A3;SLC8A1;CACNA1C;KCNK12;TRPM2;TRPC7;SLC39A8
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.2584332557167085,0.6011917794917534,0.9233997901364114,1.0,1.0,5/76,6.67%,SETD6;TRIM37;DAP;FAF1;ARRB1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.2650941178835762,0.6011174069159623,0.9034090909090909,1.0,1.0,10/39,21.50%,STEAP3;RAB10;SVBP;ABCA1;MIA3;RAB13;TMEM167A;RAB3A;RAB8B;PPY
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.2598133058562264,0.6010692974759669,0.9231578947368421,1.0,1.0,22/70,24.96%,FADD;GSK3B;CASP8AP2;TNFRSF10B;BOK;PDPK1;CASP8;SMAD3;ITGAV;NGF;BAD;HIPK1;RIPK1;TRAF2;APPL1;DAXX;IL6R;DAB2IP;BID;BAX;TGFB1;MCL1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.2797373455138065,0.6008195739174529,0.8868613138686131,1.0,1.0,6/27,15.76%,IL18;AGT;ABCA1;ITGAV;NFKB1;LPL
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.2734180923281793,0.6003007644517585,0.8879716981132075,1.0,1.0,3/28,10.43%,ARHGAP28;ARHGAP18;ARHGAP35
prerank,positive regulation of neuron death (GO:1901216),0.26586951544257176,0.5997919882232251,0.9037610619469026,1.0,1.0,5/46,9.54%,GSK3B;PRNP;MAPT;FOXO3;PICALM
prerank,positive regulation of vascular permeability (GO:0043117),0.3035060070235236,0.599758033710099,0.883008356545961,1.0,1.0,4/12,17.59%,BMP6;ANGPT1;TJP2;TRPV4
prerank,glycoprotein catabolic process (GO:0006516),0.29139819831293057,0.5987373284838624,0.8926174496644296,1.0,1.0,4/17,14.92%,ADAMTS9;STT3B;FBXO27;FBXO17
prerank,homotypic cell-cell adhesion (GO:0034109),0.2666304096208985,0.5986240343486854,0.8923766816143498,1.0,1.0,12/39,22.87%,PDGFRA;PIK3CB;TLN1;TJP2;CLIC1;STXBP1;FERMT3;METAP1;UBASH3B;FLNA;VCL;MYH9
prerank,regulation of endothelial cell migration (GO:0010594),0.2557861413887927,0.5985349509197885,0.9241164241164241,1.0,1.0,16/85,15.58%,ATOH8;ANGPT4;ROCK2;GPI;ANXA3;ADAMTS9;ANGPT1;AGT;SVBP;PIK3CB;RAC1;RRAS;PRKCA;PRKD1;AAMP;PRKD2
prerank,positive regulation of exocytosis (GO:0045921),0.2635051116196821,0.5984036360700181,0.8882488479262672,1.0,1.0,10/35,21.87%,STXBP5;STAM;SDC1;SYTL4;SMPD3;CLASP1;RAB3A;SDC4;SNCA;PDCD6IP
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2717963366701268,0.5981932525351805,0.8957845433255269,1.0,1.0,4/32,8.29%,GSK3B;FMR1;VPS18;LRRK2
prerank,regulation of vasculogenesis (GO:2001212),0.2932234932101709,0.5979731324280102,0.8813559322033898,1.0,1.0,3/14,13.42%,XDH;RRAS;HEY2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.25131857056436235,0.5979445457928135,0.9512195121951219,1.0,1.0,21/121,16.56%,ANGPT4;KIT;PRNP;BMP6;IL18;EFNA1;ENPP2;EPHA4;CD80;ANGPT1;NOX4;AGT;PARP9;CNTF;IL31RA;ITGA5;CD44;UNC119;SRC;TP53;TNK2
prerank,response to glucose (GO:0009749),0.2634208506398227,0.5979438053449497,0.8981900452488688,1.0,1.0,5/46,9.59%,GCK;TRA2B;TCF7L2;EIF2B1;ZBTB20
prerank,negative regulation of mitochondrion organization (GO:0010823),0.26946149021543603,0.5979271831358782,0.8706998813760379,1.0,1.0,3/33,5.53%,FXN;IAPP;MAPT
prerank,regulation of lymphocyte activation (GO:0051249),0.3012116265930064,0.5975611412928851,0.8895434462444771,1.0,1.0,12/12,69.90%,KAT2A;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;PAG1
prerank,myeloid cell differentiation (GO:0030099),0.25947343739889617,0.597420550960368,0.8934977578475336,1.0,1.0,11/47,19.40%,KIT;DYRK3;IKZF1;PTPN2;TAL1;ATP5IF1;KAT6A;ALAS2;RUNX1;SLC25A5;ZFPM1
prerank,regulation of protein modification process (GO:0031399),0.26097289543590546,0.5972949381448226,0.9010011123470523,1.0,1.0,9/50,16.08%,PHIP;FNIP1;PML;ATG7;PLXNB2;SPRED1;PIN1;SESN2;SPRED2
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.27828249687681283,0.5972103736264821,0.8761651131824234,1.0,1.0,2/20,7.87%,SULF2;SULF1
prerank,regulation of ATP biosynthetic process (GO:2001169),0.2893195959050061,0.5960735480085045,0.888121546961326,1.0,1.0,1/16,2.84%,ATPSCKMT
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.25148357074596406,0.5959799393445331,0.9606854838709677,1.0,1.0,14/136,13.71%,SETD6;TRIM37;PAXIP1;RB1;DAP;TAF3;PRNP;TCF7L2;ARRB1;PIM1;PYDC1;HDAC2;ITCH;BTRC
prerank,plasma membrane tubulation (GO:0097320),0.30314409642198364,0.5956703668037029,0.8753541076487252,1.0,1.0,6/13,24.30%,PACSIN2;SNX33;CHMP4A;WHAMM;SNX9;EHD2
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2632378872481495,0.5954981589479698,0.9175824175824175,1.0,1.0,12/48,21.82%,ACAT1;PAPSS2;PPCDC;ADSL;GUCY2C;PANK4;PANK2;ADCY6;ADCY2;COASY;ADSS2;GUCY2D
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.17531866597879223,-0.5952451829111304,0.99375,0.9785306766125875,1.0,10/31,35.44%,TLR4;HSPD1;LGALS9;TIRAP;SYK;LAPTM5;PLCB1;CD40;CCL19;IRF5
prerank,positive regulation of calcium ion import (GO:0090280),-0.23184718874220003,-0.5950526800443474,0.9441176470588235,0.9778547040846207,1.0,1/12,4.17%,PDGFRB
prerank,activation of phospholipase C activity (GO:0007202),0.2712628040387928,0.5948816893512272,0.9032258064516129,1.0,1.0,3/29,10.40%,LPAR1;GNAQ;ARHGAP6
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2722172889047342,0.5947351830097877,0.8916876574307305,1.0,1.0,4/22,12.83%,DDX39B;LEO1;SCAF8;BRD4
prerank,chondroitin sulfate catabolic process (GO:0030207),0.2963460152326639,0.5944883542366024,0.8605299860529986,1.0,1.0,3/13,17.34%,HYAL1;BGN;ARSB
prerank,nitric oxide biosynthetic process (GO:0006809),0.29373144371707627,0.5942804208155519,0.8997175141242938,1.0,1.0,2/13,10.01%,NQO1;CYB5B
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.20647426975037847,-0.5941540499241847,0.9595141700404858,0.9774929709361847,1.0,4/17,24.72%,ADRA1A;ADRA2A;DRD2;ADRA1B
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2948543513838515,0.5937830468027488,0.8624113475177305,1.0,1.0,2/16,6.06%,PIGN;PIGA
prerank,negative regulation of ATPase activity (GO:0032780),0.2884512479650939,0.593298545529741,0.8794037940379403,1.0,1.0,3/16,15.81%,PXK;ATP5IF1;TP53
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.272034889215936,0.5932629881782298,0.8948655256723717,1.0,1.0,6/26,15.07%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP
prerank,actin-myosin filament sliding (GO:0033275),0.2584444199222664,0.5926337978911189,0.8910776361529548,1.0,1.0,4/38,16.48%,TPM4;MYH2;DES;TNNT3
prerank,muscle filament sliding (GO:0030049),0.2584444199222664,0.5926337978911189,0.8910776361529548,1.0,1.0,4/38,16.48%,TPM4;MYH2;DES;TNNT3
prerank,brain morphogenesis (GO:0048854),0.3015827533908425,0.5924518619342034,0.8992481203007519,1.0,1.0,3/12,16.13%,MKKS;FBXW11;PTEN
prerank,multivesicular body assembly (GO:0036258),0.2650181485586775,0.5921448680429258,0.9020310633213859,1.0,1.0,4/30,10.88%,VPS37B;VPS37A;STAM;VTA1
prerank,regulation of protein kinase B signaling (GO:0051896),0.24842592988292997,0.5921372484505089,0.9779116465863453,1.0,1.0,28/193,16.13%,HPSE;FGFR4;FGFR2;IAPP;KIT;PHLPP2;FRS2;XDH;TCF7L2;IL18;PDGFRA;TXN;CD80;ANGPT1;OSBPL8;PIK3CB;PPP2R5C;TGFBR1;GAB1;RAC1;RRAS;PDPK1;ITGB1;RAMP3;PLEKHA1;SRC;PPP2R5B;PTEN
prerank,response to peptide hormone (GO:0043434),0.2557013690190083,0.5917505856011533,0.9210822998872604,1.0,1.0,6/43,11.46%,ROCK2;EIF2B1;TGFBR3;ZBTB7B;ROCK1;ANXA1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.25637599976705094,0.5904263437000011,0.9085963003264418,1.0,1.0,7/54,10.90%,HPSE;GPC6;SLC35D2;B4GALT7;HAS1;SDC1;HS2ST1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.25863488344564906,0.5902698747647347,0.9048672566371682,1.0,1.0,9/46,15.26%,RB1;ADAMTS5;ALDH1A1;NPR3;RBPJ;ADAM17;DOCK7;STK11;TLE3
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.2583016397507397,0.5901659733939674,0.912751677852349,1.0,1.0,6/43,14.18%,BMPR1A;IL18;MFN2;RBPMS2;GJA1;ADAMTS1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.2872702770385841,0.5898254636006637,0.889487870619946,1.0,1.0,1/17,2.99%,PFKFB1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.2448154965929803,0.5896771808296056,0.9520408163265306,1.0,1.0,39/109,24.76%,PSMC2;PSMD5;TAB1;MAP3K1;VAV2;PPP3CA;PSMB1;PSMD14;PSMD1;IKBKG;PIK3CB;PSMB9;RAC1;FBXW11;PDPK1;BTK;BTRC;PSMC6;NFKB1;PPP3R1;PSMB2;PSME4;PSMB7;NFATC3;PSMD11;TRAF6;PSME3;FER;IKBKB;PSMD13;PSMB8;GAB2;PSMD4;BCL10;PSMF1;PPP3CB;PSMA5;RELA;PSMC3
prerank,melanosome transport (GO:0032402),0.28002546137608325,0.5894342320220146,0.8884462151394422,1.0,1.0,3/18,13.81%,MKKS;MLPH;BLOC1S5
prerank,pigment granule transport (GO:0051904),0.28002546137608325,0.5894342320220146,0.8884462151394422,1.0,1.0,3/18,13.81%,MKKS;MLPH;BLOC1S5
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.3055677609691797,0.5893450293683891,0.8755760368663594,1.0,1.0,10/10,69.46%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.3055677609691797,0.5893450293683891,0.8755760368663594,1.0,1.0,10/10,69.46%,CEP250;TULP1;GRM6;RPE65;CACNA1F;GNAT2;REEP6;GNAT1;CNGB1;CACNA2D4
prerank,histone H3-K4 trimethylation (GO:0080182),0.309623404682995,0.5892677224715236,0.8861313868613139,1.0,1.0,2/11,12.45%,KMT2A;KMT2D
prerank,regulation of cellular amide metabolic process (GO:0034248),0.26791722820143465,0.5885115186788,0.8926014319809069,1.0,1.0,7/32,19.52%,EIF4E;FOXO3;ROCK1;PICALM;METAP1;TMED10;PRKCD
prerank,nitric oxide metabolic process (GO:0046209),0.29002063613018697,0.5884910715541921,0.908344733242134,1.0,1.0,2/14,10.01%,NQO1;CYB5B
prerank,positive regulation of insulin secretion (GO:0032024),0.2624856539414283,0.5879327847959,0.9028901734104047,1.0,1.0,8/36,18.32%,GCK;TCF7L2;MCU;TRPM4;AACS;C2CD2L;NLGN2;BAD
prerank,protein targeting to membrane (GO:0006612),0.24852375965383672,0.5875028196487702,0.9365904365904366,1.0,1.0,25/83,22.92%,VPS37B;MYO1C;VPS37A;ARL6IP1;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;SLC25A17;PIKFYVE;CHMP4A;CHMP4B;TRAM1;PEX12;ZDHHC24;ICMT;RAB8B;PEX13;VPS37C;ZDHHC2;ZDHHC14
prerank,monocarboxylic acid metabolic process (GO:0032787),0.24803274885260687,0.5874520126238438,0.958627648839556,1.0,1.0,13/117,13.64%,ALDH8A1;ECHDC3;PTGR1;CYP26B1;MTHFD1L;ALDH1A2;BTD;SCPEP1;AGXT;ABAT;HOGA1;ACOT2;PANK2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.26736163741284547,0.5873130154110894,0.890625,1.0,1.0,3/29,11.40%,FGFR2;TGFBR3;BMP2
prerank,regulation of response to external stimulus (GO:0032101),0.24809547499019566,0.5872690433228358,0.9593082400813835,1.0,1.0,24/121,18.45%,SETD6;USP18;ADGRA2;STK24;CXCR4;AKNA;PDGFRA;IRF1;NMT2;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;XIAP;TRIM5;EFNB2;IL1RL2;FOXP1;LACC1;METAP1;USP14;FNTB
prerank,inositol phosphate catabolic process (GO:0071545),0.3038264515311474,0.5870879002876458,0.9101283880171184,1.0,1.0,4/12,20.90%,OCRL;INPP5B;PTEN;INPP5A
prerank,positive regulation of dendrite development (GO:1900006),0.30620036080889357,0.5868974114881054,0.8914027149321267,1.0,1.0,4/10,23.12%,ZDHHC15;COBL;BMP5;DAB2IP
prerank,regulation of response to biotic stimulus (GO:0002831),0.26490053145573117,0.5849883978290574,0.8883495145631068,1.0,1.0,10/28,24.20%,IRF1;APPL2;CASP8;XIAP;TRIM5;FOXP1;APPL1;BIRC2;ELMOD2;FGR
prerank,establishment of melanosome localization (GO:0032401),0.2762697821878485,0.5848957597760237,0.8868421052631579,1.0,1.0,4/19,17.49%,MKKS;MLPH;BLOC1S5;SHROOM2
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28207592330090353,0.5848228341349071,0.8974700399467377,1.0,1.0,7/18,20.21%,B4GALT7;EMD;MORC3;TP53;SFRP1;SKI;MED25
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.20897332526784856,-0.5842816541963648,0.9508196721311475,0.9813676764630075,1.0,7/16,41.01%,PTPN22;TNFRSF1B;FGF10;SOX11;TNFSF8;IL27;LST1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.22805140158684217,-0.5833557493694986,0.9444444444444444,0.9809633926423731,1.0,1/12,8.02%,PRKCQ
prerank,steroid hormone biosynthetic process (GO:0120178),0.2633185168514782,0.5832650576512902,0.89568345323741,1.0,1.0,5/29,15.92%,SRD5A3;MED1;FDXR;STARD3;DHCR7
prerank,axon guidance (GO:0007411),0.24711528961468973,0.5811624602571501,0.9839679358717435,1.0,1.0,35/201,15.47%,SPTA1;GLI2;ARTN;NCAM1;ALCAM;SPTB;NTN1;NFIB;FRS2;CXCR4;NTN3;EFNA1;EPHA4;DOK2;ROBO1;DSCAML1;PIK3CB;ARHGAP35;PLXNB2;GAB1;PLXNB1;EFNB1;DSCAM;EZR;RAC1;EMB;PRKCA;NOTCH2;PLXND1;EFNB2;PTPRA;SEMA3D;SRC;GDNF;NTN4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.27091950075192445,0.5809956998403036,0.9014267185473411,1.0,1.0,5/21,18.53%,CGNL1;MFN2;MAPKAP1;RASAL3;LZTR1
prerank,regulation of endocytosis (GO:0030100),0.2520522452786521,0.5807049328688948,0.932258064516129,1.0,1.0,12/61,17.05%,STON1;PACSIN2;STON2;ZFYVE16;MTMR2;ROCK1;PICALM;SNX33;PRKD1;SMPD1;SRC;EPHA3
prerank,ERBB signaling pathway (GO:0038127),0.24955564736882135,0.5799470203630549,0.9337606837606838,1.0,1.0,12/64,15.31%,MATK;GAREM1;CUL5;GAB1;PRKCA;PDPK1;NCK2;ADAM17;SLC30A10;AAMP;EFEMP1;SRC
prerank,protein insertion into ER membrane (GO:0045048),0.25755339926478654,0.5799302878872816,0.9156214367160775,1.0,1.0,11/37,21.73%,PRNP;EMC7;TRAM2;EMD;VAPA;CYB5A;EMC8;TRAM1;CCDC47;EMC4;VAMP2
prerank,lymphocyte differentiation (GO:0030098),0.2482100785355144,0.5794743424135353,0.9307450157397692,1.0,1.0,12/68,19.33%,KIT;NFIL3;IKZF1;LEPR;PTPN2;LMBR1L;ADAM17;ITGB1;DCAF1;AXL;RELB;SLC25A5
prerank,negative regulation of developmental growth (GO:0048640),0.261847745787789,0.5791116387872886,0.9080745341614906,1.0,1.0,11/30,25.92%,RTN4R;PTPRS;ULK2;CDKN1B;NKD1;PTEN;DIP2B;WWC2;DUSP10;SLC6A4;RTN4
prerank,negative regulation of ion transport (GO:0043271),0.2678079785557823,0.5790490205148375,0.9147582697201018,1.0,1.0,3/24,10.04%,NEDD4;WNK1;PXK
prerank,positive regulation of myelination (GO:0031643),-0.22801565775608443,-0.5780432140616769,0.9247648902821317,0.9826062363924121,1.0,3/11,15.09%,TNFRSF1B;TENM4;DICER1
prerank,modulation by symbiont of entry into host (GO:0052372),0.28903372813510625,0.5776597640469661,0.901685393258427,1.0,1.0,3/16,14.21%,TRIML2;TRIM6;TRIM5
prerank,inner ear morphogenesis (GO:0042472),0.28093338681802293,0.5775527740035816,0.8987179487179487,1.0,1.0,3/22,11.71%,FGFR2;TTC39C;TBX18
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.26680682956845975,0.5769152380318011,0.9029585798816568,1.0,1.0,6/33,13.15%,TCF7L2;SERPINE1;YAP1;ANGPT1;PDPK1;CAST
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.2865035154043225,0.5767403049344839,0.9097421203438395,1.0,1.0,5/14,24.82%,YBX3;ANGEL2;MAPK14;MAPKAPK2;HNRNPC
prerank,positive regulation of cell projection organization (GO:0031346),0.2429496727184702,0.5766335340666805,0.9674134419551935,1.0,1.0,28/115,19.65%,SETX;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;MARK2;CAMK1D;ARHGAP35;PLXNB2;PLXNB1;GRIP1;TWF1;P3H1;DPYSL3;ROR1;PLXND1;PRKD1;PRKCI;MAP6;STMN2;NGF;EPHA3;ARSB;PLXNA2;CAPRIN2;AMIGO1;PLXNB3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.25748149628678874,0.5765908269154103,0.9191090269636577,1.0,1.0,10/38,19.79%,PRNP;EFNA1;EPHA4;NOX4;AGT;NCK2;UNC119;MVP;SH3BP5;PTPN1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.297219258050342,0.5754452931694545,0.9057437407952872,1.0,1.0,10/10,70.30%,GNB1;GRK1;CNGA1;GNAT1;RHO;PDE6B;PDE6G;CNGB1;PDE6A;SAG
prerank,regulation of macroautophagy (GO:0016241),0.23994739518261518,0.5750295829027198,0.9576446280991735,1.0,1.0,21/105,17.73%,EXOC4;NEDD4;TBC1D25;QSOX1;SH3GLB1;LARP1;LRRK2;IKBKG;SESN1;RB1CC1;GNAI3;SLC38A9;EXOC8;SNX32;RPTOR;PRKAG1;CLEC16A;SESN2;VPS26A;LAMTOR3;LAMTOR5
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.19009608055072896,-0.5748979286857897,0.9745762711864406,0.9831435557511821,1.0,2/20,9.30%,AKR1B1;FDX1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.25605661843941546,0.5748123524614337,0.9147025813692481,1.0,1.0,8/40,19.46%,BMF;FXN;FAM162A;PLAUR;TP53;TNFSF10;BAD;DNM1L
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.24936252564572442,0.5738623016502653,0.9423913043478261,1.0,1.0,8/57,15.61%,KIT;PTPN2;IL18;PARP9;CNTF;IL31RA;CNOT7;NF2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.24507940568759626,0.5736009180739845,0.9282608695652174,1.0,1.0,11/54,16.93%,KCNN4;NEDD4;KCNMB2;KCNMB3;KCNIP3;DLG1;CAB39;KCNMB4;STK39;GABBR2;DPP6
prerank,carbohydrate homeostasis (GO:0033500),0.24601023606398273,0.5728717909182615,0.9361702127659575,1.0,1.0,12/67,18.52%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;MCU;APPL2;ADIPOR1;STK11;BAD;SLC2A4;HECTD4
prerank,cellular response to interleukin-1 (GO:0071347),0.23709223062701282,0.5724319298400925,0.9707661290322581,1.0,1.0,41/143,24.76%,HYAL1;PSMC2;PSMD5;MYLK3;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;BTRC;RC3H1;PSMC6;NFKB1;SFRP1;SIRPA;CD47;PSMB2;MAP3K8;PTGIS;PSME4;PSMB7;PSMD11;TRAF6;PSME3;TANK;RBMX;IKBKB;PSMD13;PSMB8;PSMD4;DAB2IP;CCL14;RIPK2;PSMF1;PSMA5;RELA;PSMC3
prerank,JNK cascade (GO:0007254),0.2517793054197697,0.5723713795244366,0.9114942528735632,1.0,1.0,6/40,11.25%,MAP4K2;SH2D3C;TAB1;UBE2N;IKBKG;CRKL
prerank,histone H3-K36 demethylation (GO:0070544),0.29522923499961384,0.5720995742896006,0.9004893964110929,1.0,1.0,3/10,21.62%,KDM2B;KDM4B;KDM2A
prerank,negative regulation of axonogenesis (GO:0050771),0.25866428008624953,0.5719618282181939,0.9080604534005038,1.0,1.0,4/27,12.23%,RHOA;RTN4R;PTPRS;ULK2
prerank,positive regulation of interferon-beta production (GO:0032728),0.25706691253413494,0.5719085297665413,0.927144535840188,1.0,1.0,11/33,23.87%,DHX9;IRF1;RIOK3;POLR3D;MAVS;ISG15;POLR3C;POLR3G;TLR7;RIPK2;HSP90AA1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.2580680267040518,0.5715584413307371,0.9115250291036089,1.0,1.0,5/32,13.14%,POLR1A;POLR1B;ERCC3;TAF1D;POLR1G
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.24129700563604015,0.571404519357174,0.9533678756476683,1.0,1.0,14/90,14.30%,MFAP2;LEPR;CXCR4;IL18;ZBTB7B;MFN2;ALMS1;APPL2;ACHE;GJA1;ADIPOR1;ADRB2;CPT2;ACADL
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.2545687338983901,0.5708217067487542,0.9116647791619479,1.0,1.0,6/39,18.32%,GCK;TCF7L2;MCU;AACS;NLGN2;BAD
prerank,positive regulation of immune system process (GO:0002684),0.2805426908378786,0.5707710337332157,0.8995929443690638,1.0,1.0,3/16,14.41%,PIK3CB;ANXA1;MIA3
prerank,multivesicular body organization (GO:0036257),0.25473118716956966,0.5705671643686798,0.921146953405018,1.0,1.0,4/31,10.88%,VPS37B;VPS37A;STAM;VTA1
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.19030161958503047,-0.5700963271855656,0.9726027397260274,0.9841734751079925,1.0,13/20,38.47%,HSP90AB1;HSPD1;CCT2;PSMG2;PSMG1;NDUFAF1;BBS12;HOPX;TMEM35A;PFDN6;HSPA1A;PTGES3L;PTGES3
prerank,regulation of mast cell degranulation (GO:0043304),-0.2099728865646259,-0.5697300625578299,0.9401993355481728,0.9835369342356486,1.0,7/14,31.59%,LYN;LGALS9;CD84;CD300A;SYK;FES;SPHK2
prerank,cellular amide metabolic process (GO:0043603),0.2414088793741774,0.5693443571398403,0.9487704918032787,1.0,1.0,21/102,21.52%,MTHFD1L;DNPEP;NLN;BTD;MTHFR;CPXM1;SLC19A1;PLPP1;DHFR;ACOT2;PANK2;SMPD1;ST3GAL1;ABHD4;SMPD3;SMPD2;MTHFS;MIPEP;ACOT8;ORMDL2;NAAA
prerank,regulation of neutrophil migration (GO:1902622),0.2986768207996425,0.5690146954314396,0.9161676646706587,1.0,1.0,2/10,22.89%,RAC1;RHOH
prerank,negative regulation of catabolic process (GO:0009895),0.2527050084726032,0.5683342784911469,0.9379084967320261,1.0,1.0,10/47,22.08%,PFKFB1;MDM4;PDE3B;SF3B3;PIN1;AZIN1;FMN2;HDAC4;SIRT2;FLNA
prerank,metal ion export (GO:0070839),0.257756812738504,0.5676835522621301,0.9334916864608076,1.0,1.0,1/31,2.10%,ATP2B4
prerank,oligodendrocyte development (GO:0014003),0.27540019708967656,0.5674544438504293,0.9151599443671766,1.0,1.0,3/15,15.17%,EIF2B1;TPPP;PRDM8
prerank,protein kinase B signaling (GO:0043491),0.2640295437501367,0.5669981945317873,0.9186046511627907,1.0,1.0,1/23,2.65%,SETX
prerank,manganese ion transport (GO:0006828),0.28524778435684744,0.5665870873915233,0.9076479076479076,1.0,1.0,5/14,23.19%,TRPC7;SLC39A8;SLC30A10;TMEM165;SLC11A2
prerank,oxoacid metabolic process (GO:0043436),0.2640162205079515,0.5661324524949238,0.9206730769230769,1.0,1.0,6/27,20.66%,PPA1;AGXT;ENPP1;THAP4;BPNT1;DDO
prerank,positive regulation of sodium ion transport (GO:0010765),-0.21246485279989707,-0.5658309143345811,0.948051948051948,0.9842770250681725,1.0,6/12,32.55%,SCN1B;NOS1;SCN4B;PKP2;GPD1L;SCN3B
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.2487850562934099,0.5657552666064402,0.9323394495412844,1.0,1.0,10/41,22.08%,KCNN4;PDZK1;KCNMB2;KCNMB3;KCNMB4;GABBR2;AMIGO1;ANK3;GNB1;FLNA
prerank,regulation of cell communication (GO:0010646),0.2513024345974218,0.5652641540785399,0.9322235434007135,1.0,1.0,12/35,23.73%,NCLN;GRK5;SLC8A1;ANXA1;TBX18;GRK3;VEPH1;PTPN1;UGCG;CDC42SE2;CXADR;CRK
prerank,negative regulation of macroautophagy (GO:0016242),0.2565574089161783,0.5651780102162153,0.933579335793358,1.0,1.0,7/26,18.51%,QSOX1;LRRK2;TMEM39A;SCFD1;CLEC16A;CHMP4A;CHMP4B
prerank,protein lipidation (GO:0006497),0.24219615182545734,0.564848376405315,0.945474372955289,1.0,1.0,18/59,22.92%,PIGN;PIGA;ATG7;PORCN;ZDHHC18;PIGU;ZDHHC15;HHAT;PIGM;ZDHHC3;ZDHHC21;UGCG;DPM3;PIGG;PIGH;ATG5;ZDHHC2;ZDHHC14
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.26719462478622963,0.5647953161207504,0.9149797570850202,1.0,1.0,2/17,9.73%,SERPINE1;HMGB1
prerank,smooth muscle cell differentiation (GO:0051145),0.27798928597312234,0.5645478323088469,0.9353383458646617,1.0,1.0,3/12,13.42%,TBX18;MRTFA;HEY2
prerank,metanephric mesenchyme development (GO:0072075),0.2964475839953021,0.5644792939764929,0.8861538461538462,1.0,1.0,3/10,19.03%,PKD2;OSR1;WNT4
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.2918924677382961,0.5640079559250375,0.8898678414096917,1.0,1.0,3/11,20.44%,AHR;IL4I1;CEACAM1
prerank,organophosphate biosynthetic process (GO:0090407),0.2531565240092684,0.5636272126005477,0.936,1.0,1.0,10/37,20.45%,LPCAT1;IPMK;PPIP5K1;TKT;IP6K2;AGPAT3;GK5;GK;GPHN;MOCOS
prerank,regulation of hormone secretion (GO:0046883),-0.20234021824109283,-0.5635824570600916,0.9671052631578947,0.9843535654305254,1.0,6/15,33.27%,VAMP3;SCG5;EDN1;SOX11;EDN3;SNX6
prerank,regulation of actin filament polymerization (GO:0030833),0.241632505953559,0.5633244410963959,0.9441517386722866,1.0,1.0,17/69,22.49%,ARHGAP28;ARHGAP18;SSH2;CDC42EP2;NCK1;TWF1;NCK2;BAIAP2L1;PRKCE;DBN1;NCKAP1;PRKCD;FER;LATS1;VASP;LMOD1;SNX9
prerank,mitochondrion morphogenesis (GO:0070584),-0.22605993314647338,-0.5632531211605548,0.9696969696969697,0.9837059796906158,1.0,7/11,42.61%,FIS1;SUPV3L1;SLIRP;MYH14;NUBPL;MFF;PID1
prerank,positive regulation of neurogenesis (GO:0050769),0.2408930738356483,0.5623445802110301,0.9595744680851064,1.0,1.0,15/68,19.65%,NAP1L1;RHOA;OBSL1;CUX1;CAPRIN1;ROBO1;PLXNB2;PLXNB1;PLXND1;MAP6;NGF;PLXNA2;CAPRIN2;AMIGO1;PLXNB3
prerank,positive regulation of interleukin-8 production (GO:0032757),0.24458174708884536,0.5618152970928354,0.9411111111111111,1.0,1.0,8/49,18.72%,FADD;SERPINE1;HMGB1;RAB1A;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,Rap protein signal transduction (GO:0032486),0.2925446662523886,0.5609677112392749,0.91324200913242,1.0,1.0,2/10,13.84%,RAP2A;PLK2
prerank,ovarian follicle development (GO:0001541),0.2757408845794752,0.560852159957399,0.922752808988764,1.0,1.0,1/13,4.54%,KIT
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.2604145689696875,0.5607766790447696,0.9236545682102628,1.0,1.0,4/23,12.71%,NMI;UACA;CCN3;ADIPOR1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.27492885780192194,0.5602659204562691,0.9022164276401564,1.0,1.0,5/18,18.59%,SMAD4;SMAD3;ITGAV;ITGB8;LTBP1
prerank,adenine nucleotide transport (GO:0051503),0.2692068020228904,0.5600622607689905,0.905608755129959,1.0,1.0,5/17,19.33%,SLC19A1;SLC25A42;LRRC8C;SLC25A17;SLC25A5
prerank,transcription preinitiation complex assembly (GO:0070897),0.2837142708902546,0.559978665090742,0.9231927710843374,1.0,1.0,4/12,21.64%,TAF12;DR1;GTF2B;GTF2A2
prerank,regulation of axon guidance (GO:1902667),0.29221147938022113,0.559168889709079,0.9113149847094801,1.0,1.0,1/10,4.59%,MYCBP2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.24194175477758956,0.5572412901685357,0.9293598233995585,1.0,1.0,3/48,7.48%,FADD;IL18;SCRIB
prerank,regulation of neuron projection development (GO:0010975),0.23471317774376854,0.5569308063897818,0.9849246231155779,1.0,1.0,38/163,18.66%,ULK4;SETX;GSK3B;RTN4R;LPAR1;EPHA4;RAB29;LRRK2;MARK2;DENND5A;CAMK1D;ARHGAP35;LZTS3;PLXNB2;TWF1;PTPRS;BAG5;GAK;P3H1;PDLIM5;ZDHHC15;HDAC2;DPYSL3;ROR1;PRKD1;PRKCI;EFNB2;ADCY6;DBN1;PTEN;STMN2;SIPA1L1;EPHA3;ARSB;TRPV4;ABI2;MYLIP;TANC2
prerank,dendrite self-avoidance (GO:0070593),0.27464211218474044,0.5566958073302573,0.9084880636604774,1.0,1.0,3/16,11.80%,DSCAML1;DSCAM;EMB
prerank,purine ribonucleotide metabolic process (GO:0009150),0.24067911376030013,0.5564466402744542,0.9538131041890441,1.0,1.0,14/68,20.61%,HPRT1;ACAT1;EFL1;LRRK2;RHOQ;HINT1;ENPP1;GNAI3;ACOT2;MFN1;BPNT1;BAD;ADSS2;ACOT8
prerank,circulatory system development (GO:0072359),0.23468764707512849,0.5563425722536,0.9676767676767677,1.0,1.0,25/118,19.40%,GLI2;FBN1;BCOR;SRF;PDLIM4;MKKS;WDR11;FBXW7;TGFBR1;CACNA1C;BMP2;PDLIM5;CASP8;HEY2;FOXL1;CDKN1B;STK11;PKD2;PTEN;HSPG2;SALL1;SH3PXD2B;OSR1;ZFPM2;ZFPM1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.2769859429848796,0.5562240013115232,0.9303977272727273,1.0,1.0,2/15,9.50%,RAB10;SRPRA
prerank,regulation of urine volume (GO:0035809),0.2917861124735799,0.556120004130513,0.9138972809667674,1.0,1.0,2/10,15.10%,NPR3;ADCY6
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.25457141209263007,0.555861382103067,0.9261992619926199,1.0,1.0,8/28,20.26%,TAB1;UBE2N;IKBKG;CASP8;ITCH;AAMP;LACC1;TRAF6
prerank,positive regulation of interferon-alpha production (GO:0032727),0.26202644553122706,0.5558276681655485,0.9183400267737617,1.0,1.0,2/19,7.48%,DHX9;SETD2
prerank,positive regulation of lipid transport (GO:0032370),0.28296704422907837,0.5557678376425013,0.9171511627906976,1.0,1.0,1/12,4.57%,ABCB4
prerank,protein polyglutamylation (GO:0018095),0.2906400206875761,0.5556707222842675,0.9204712812960235,1.0,1.0,2/11,12.25%,TTLL4;TTLL11
prerank,amino acid transmembrane transport (GO:0003333),0.2428102121469125,0.55548574515951,0.9333333333333333,1.0,1.0,11/45,21.71%,SLC38A7;TSPO2;SLC38A4;SLC16A2;SLC38A9;SLC25A22;SLC36A4;SLC7A1;SLC38A2;SLC7A11;SLC6A13
prerank,sphingolipid catabolic process (GO:0030149),0.2777591069478209,0.5554788835462627,0.9175977653631285,1.0,1.0,5/15,21.09%,ENPP2;SMPDL3A;SMPD1;SMPD2;PDXDC1
prerank,regulation of cellular pH (GO:0030641),0.2520891588790496,0.5551758241649192,0.9279711884753902,1.0,1.0,5/29,17.78%,SLC4A2;SLC9A5;CA2;TM9SF4;LACC1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.23133044949764178,0.5543896495819653,0.995995995995996,1.0,1.0,50/291,18.34%,HMGB2;AQP1;ATP2B4;SETX;TICAM1;ROCK2;RHOA;ABCB4;MAPT;LCOR;PDGFRA;CDK2;SERPINE1;CD80;AGAP3;HTRA2;WNT6;HMGB1;P2RY1;IP6K2;AHR;EZR;AKAP9;WNT9A;DMTN;SLC38A9;RORA;PRKD1;ADAM9;GLRA2;RUVBL2;RAMP3;RPTOR;ADCY6;PKD2;NFKB1;IPO5;LPL;SESN2;SFRP1;LARS1;LAMTOR3;AXL;PTPRK;EPHA3;SIRPA;LAMTOR5;DPEP1;MAPK14;PLAA
prerank,neutrophil degranulation (GO:0043312),0.2325533752120743,0.5541250267509122,0.999,1.0,1.0,69/425,17.98%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,regulation of cholesterol storage (GO:0010885),0.272021725646866,0.5538729196035049,0.9176954732510288,1.0,1.0,3/15,15.76%,ABCA1;EHD1;LPL
prerank,cell part morphogenesis (GO:0032990),0.2749071921730143,0.5538710168557132,0.912981455064194,1.0,1.0,4/13,23.37%,PACSIN2;PNPT1;DNM1L;WASF1
prerank,cellular response to lipopolysaccharide (GO:0071222),0.23339619035347806,0.5529898958016423,0.9652351738241309,1.0,1.0,17/101,20.26%,HMGB2;TICAM1;RHOA;IL18;SERPINE1;CD80;HMGB1;PRKCE;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;PDE4B;CD68;TRAF6
prerank,fatty acid metabolic process (GO:0006631),0.23348718787569378,0.5529366513279989,0.9642492339121552,1.0,1.0,11/115,15.76%,PON1;ECHDC3;LPIN2;NDUFAB1;ACACA;ADIPOR1;ACOT2;ELOVL4;CPT2;PON2;LPL
prerank,neutrophil activation involved in immune response (GO:0002283),0.23170557913825268,0.5523647088582436,1.0,1.0,1.0,69/428,17.98%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.26153311713130356,0.5515795813009879,0.9235588972431078,1.0,1.0,3/22,14.36%,WNK1;FLOT2;CD44
prerank,macrophage differentiation (GO:0030225),0.2704288673618164,0.5508328781115772,0.9310344827586207,1.0,1.0,2/13,12.75%,CASP8;IL31RA
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.26067958686911713,0.5507387593228837,0.9408740359897172,1.0,1.0,5/22,17.01%,ACAP2;MAPT;EHD1;STMN2;NGF
prerank,male gonad development (GO:0008584),0.244358422299276,0.5501941991841158,0.9371980676328503,1.0,1.0,2/34,5.16%,KIT;WNT2B
prerank,regulation of response to interferon-gamma (GO:0060330),0.27113509599802516,0.5501658883249796,0.9281609195402298,1.0,1.0,2/14,10.38%,PTPN2;PARP9
prerank,positive regulation of signaling (GO:0023056),0.24225631346718224,0.5500748872102476,0.9573732718894009,1.0,1.0,4/37,8.14%,ANXA2;SCRIB;RAB29;CD80
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.22969026423308103,0.5500501239864232,0.9660144181256437,1.0,1.0,30/94,24.76%,PSMC2;PSMD5;TAB1;UBE2N;PSMB1;PSMD14;MAP3K3;PSMD1;IKBKG;PSMB9;FBXW11;BTRC;PSMC6;NFKB1;PSMB2;MAP3K8;PSME4;PSMB7;PSMD11;TRAF6;PSME3;IKBKB;PSMD13;PSMB8;PSMD4;RIPK2;PSMF1;PSMA5;RELA;PSMC3
prerank,regulation of histone methylation (GO:0031060),0.2784263795589262,0.5499387358775145,0.9375,1.0,1.0,1/13,5.66%,MTHFR
prerank,pyruvate metabolic process (GO:0006090),0.24008281438918916,0.5497778859780379,0.9405286343612335,1.0,1.0,5/52,11.76%,PFKFB1;GCK;GPI;PGM1;HOGA1
prerank,integrated stress response signaling (GO:0140467),0.2747338035197068,0.549205890503295,0.9120111731843575,1.0,1.0,2/14,11.33%,EIF2AK3;QRICH1
prerank,Golgi to plasma membrane transport (GO:0006893),0.23583665374793192,0.5491774281944651,0.9485458612975392,1.0,1.0,3/47,4.28%,MACF1;RAB10;EXOC4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.27820346530103324,0.5490367668790119,0.9357142857142857,1.0,1.0,1/12,5.13%,B3GNT8
prerank,negative regulation of neuron differentiation (GO:0045665),0.26021398038467985,0.5488218282422174,0.9250317662007624,1.0,1.0,2/22,13.63%,GSK3B;MED1
prerank,regulation of cell differentiation (GO:0045595),0.23233227745669854,0.5486507592171271,0.9849094567404426,1.0,1.0,12/148,11.27%,CDK5RAP2;TCFL5;CBFB;SUZ12;FGFR2;ANP32B;SRF;VHL;ROCK1;TGFBR1;FLOT2;PRKCB
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.2412129783279513,0.5486135048049811,0.9534632034632035,1.0,1.0,9/54,15.58%,ATP2B4;ANGPT4;ANGPT1;HMGB1;PRKCA;PDPK1;ADAM17;PRKD1;PRKD2
prerank,regulation of ion transmembrane transport (GO:0034765),0.24325879299590672,0.5484362561212845,0.9479289940828403,1.0,1.0,4/33,11.54%,NEDD4;WNK1;KCNJ13;AKAP9
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.24074566573276457,0.548126533658513,0.9393282773564464,1.0,1.0,4/52,10.42%,DDX11;HDGF;SRPRA;TLN1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.21259868595215414,-0.54800554015323,0.9666666666666667,0.9881924136491915,1.0,2/12,9.30%,AKR1B1;FDX1
prerank,neutrophil mediated immunity (GO:0002446),0.23009595560983911,0.5479636092534333,0.999,1.0,1.0,70/432,17.98%,IQGAP2;HPSE;DSN1;MMP25;RHOA;PSMC2;ANXA2;PTGES2;B4GALT1;STK10;GPI;RAB10;DIAPH1;UBR4;LPCAT1;ANXA3;PDXK;CNN2;AGL;PYGB;ATG7;PLAU;QSOX1;STXBP2;PSMB1;AGPAT2;PGM1;MAGT1;PSMD14;CDA;ROCK1;PSMD1;HMGB1;CYBB;ARMC8;APAF1;TRPM2;PLEKHO2;RAC1;ADAM17;GYG1;ILF2;TXNDC5;NAPRT;PLAUR;CTSH;TOM1;CAB39;PRDX4;CD44;CYSTM1;GSDMD;FAF2;ITGAV;SLC15A4;VAPA;CKAP4;SNAP23;NFKB1;COMMD3;GGH;LAMTOR3;AP1M1;SIRPA;CD47;ARSB;MVP;DNAJC5;CFP;NRAS
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.24697005840163824,0.5478821879653111,0.9347079037800687,1.0,1.0,6/40,12.95%,MAPT;STOML2;PYCR1;LRRK2;STOX1;ATP5IF1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.21608036172346348,-0.5475870366402433,0.9588235294117647,0.9875331301632969,1.0,8/11,48.21%,BCL2;TAF9B;CD74;MIF;TAF9;TRIAP1;MUC1;SIRT1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.2521242292493842,0.54732921577971,0.9232643118148599,1.0,1.0,10/28,27.17%,ITPR1;TNFRSF10B;QRICH1;TMEM117;DNAJC10;TRAF2;DAB2IP;BAX;TRIB3;BAG6
prerank,macroautophagy (GO:0016236),0.22643800847231194,0.5452262114807815,0.9706477732793523,1.0,1.0,36/118,23.31%,VPS37B;MTMR14;ATG7;VPS37A;STAM;MFN2;LIX1L;ZFYVE1;CSNK2A2;VIPAS39;RB1CC1;VTA1;ILRUN;ATG3;MTMR3;UVRAG;PRKAG1;SRC;MFN1;VPS16;PLAA;CHMP4A;CHMP4B;VPS39;PRKAB1;TOMM40;LIX1;PGAM5;AMBRA1;ATG13;ATG5;VPS37C;PRKAG3;TOMM20;ATG4B;PRKAA2
prerank,positive regulation of phosphorylation (GO:0042327),0.2268240185366818,0.5449700331969934,0.9929859719438878,1.0,1.0,38/240,15.70%,FNIP1;PFKFB1;ROCK2;FGFR4;FGFR2;KIT;MRE11;LEPR;MUSK;RAP2A;ARRB1;EFNA1;FMR1;PDGFRA;CCN1;EPHA4;LRRK2;AXIN2;ANGPT1;ZBTB20;DDR2;RB1CC1;P2RY1;CRKL;DSCAM;BMP2;RAC1;KCTD20;ADAM17;PLAUR;ROR1;SLCO3A1;ARNT;BTBD10;WDFY2;PIN1;FXR1;LMO4
prerank,regulation of cellular biosynthetic process (GO:0031326),0.25595506901325427,0.5443730258826229,0.92625,1.0,1.0,6/28,17.28%,FGFR4;RAC1;ADIPOR1;MED1;SIRPA;CD47
prerank,positive regulation of chemokine production (GO:0032722),0.24096690192638262,0.544206233545873,0.9432463110102156,1.0,1.0,13/44,27.33%,IL18;HMGB1;ADAM17;TWIST1;LPL;MAVS;EIF2AK2;IL6R;TLR7;MBP;IL33;WNT5A;TLR3
prerank,negative regulation of cholesterol transport (GO:0032375),-0.22237093809033043,-0.5437612963889388,0.9451219512195121,0.987865945758641,1.0,2/10,23.08%,SREBF2;ABCA2
prerank,AMP metabolic process (GO:0046033),0.27455473019664295,0.5437408913773565,0.9525862068965517,1.0,1.0,2/13,11.44%,XDH;ADSL
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.27072433446550165,0.5435501083126145,0.9226519337016574,1.0,1.0,4/14,21.07%,TNFRSF10B;ZFP91;TRAF6;TRAF2
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.2697338299507614,0.5425881962407494,0.9320652173913043,1.0,1.0,6/15,25.16%,SMPD3;SMPD2;PRKCD;ORMDL2;SIRT3;ORMDL3
prerank,triglyceride metabolic process (GO:0006641),0.24249129497082933,0.5424005173350142,0.9551422319474836,1.0,1.0,6/48,17.78%,FABP12;LPIN2;AGMO;LPL;GK5;GK
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.26636379543648664,0.5421951685787783,0.9272486772486772,1.0,1.0,8/17,26.92%,BMP6;PRKCA;TRIM5;TRIB1;NFKBIL1;SASH1;CD55;LY96
prerank,cellular response to amino acid stimulus (GO:0071230),0.239521147992903,0.54132191245407,0.9481132075471698,1.0,1.0,10/33,17.73%,KLHL22;SESN1;SLC38A9;GLRA2;RPTOR;IPO5;SESN2;LARS1;LAMTOR3;LAMTOR5
prerank,neuronal action potential (GO:0019228),0.25435331445376175,0.540884990715063,0.9299867899603699,1.0,1.0,6/22,20.32%,KCNMB2;KCNMB3;KCNMB4;KCNA1;CACNA1G;ANK3
prerank,response to lipid (GO:0033993),0.22574422303509462,0.5403590255019973,0.9743326488706365,1.0,1.0,11/105,13.07%,HMGB2;CDKN2D;FGFR4;ASXL1;FOXO3;SMAD6;ANXA1;ADAM17;TRIM6;MAPKAPK3;CTSH
prerank,cellular protein metabolic process (GO:0044267),0.22581054427892702,0.5401699283033234,0.999,1.0,1.0,50/396,16.23%,MRPL36;TGM1;MATN3;F5;UBE2S;LOXL2;LOX;PABPC4;AGO2;GGCX;FBN1;CHEK2;LAMB1;PRKDC;SRBD1;ST8SIA2;SIAH2;MRPL18;STOML2;CCN1;PHKA2;QSOX1;B4GALT7;HTRA2;DARS1;DUSP12;RPN2;MRPL13;TTF1;MRPL55;APLP2;SEPHS1;NAGPA;ASMT;ADAM17;RPS17;ATG3;CTSH;MRPS33;MRPS18B;MIA3;ST3GAL1;UBL5;FDXR;CKAP4;LMCD1;PRSS23;ATP23;NOTUM;PLOD2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.22626540107491447,0.5400483500873502,0.9777553083923155,1.0,1.0,24/132,18.10%,COIL;SETX;DHX9;PRKDC;SRSF10;EIF4H;DDX39B;RRS1;PRPF19;CELF2;SF3A2;SRPK1;PPAN;LUC7L3;LSM4;DDX1;MCTS1;DENR;PRPF18;GEMIN7;SRPK2;LUC7L2;ABT1;MRPL20
prerank,camera-type eye morphogenesis (GO:0048593),0.27992042403289025,0.5398665881207808,0.9276923076923077,1.0,1.0,3/10,19.28%,KDM2B;SHROOM2;SKI
prerank,cellular response to heat (GO:0034605),0.2425561113998823,0.5396277050528904,0.9252873563218391,1.0,1.0,4/35,8.21%,MAPT;RBBP7;TPR;HTRA2
prerank,cranial nerve development (GO:0021545),0.27671060891399873,0.5395094835795734,0.9231905465288035,1.0,1.0,11/11,72.35%,SALL1;PAX2;ATOH7;ISL1;TIFAB;POU4F1;TFAP2A;CHRNB2;TMEM126A;ERBB3;CHD7
prerank,lipid biosynthetic process (GO:0008610),0.23097220872343552,0.5390809211982002,0.9727177334732424,1.0,1.0,10/77,15.76%,PAM;LPCAT1;NDUFAB1;AGPS;ACACA;AGPAT3;MVK;ELOVL4;FDXR;LPL
prerank,osteoclast differentiation (GO:0030316),0.24908741555985262,0.5381406456431468,0.9336734693877551,1.0,1.0,4/22,18.33%,ANXA2;SRC;FOXP1;MAPK14
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2336738008970344,0.5378960341184743,0.95,1.0,1.0,10/52,17.52%,ATP2B4;RANGRF;PDPK1;PRKCE;PRKCI;DLG1;ITGB1;RAMP3;EPHA3;WNK3
prerank,positive regulation of actin filament polymerization (GO:0030838),0.23904098345079913,0.5375971611624976,0.9480812641083521,1.0,1.0,12/44,23.97%,CDC42EP2;NCK1;NCK2;BAIAP2L1;PRKCE;NCKAP1;WHAMM;FER;VASP;LMOD1;SNX9;CDC42EP1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.16925592640256637,-0.5374401754892133,0.9896373056994818,0.9890039231803772,1.0,2/23,8.44%,CALM1;NMT1
prerank,positive chemotaxis (GO:0050918),0.2596616880478728,0.537375530437011,0.9201065246338216,1.0,1.0,4/17,20.01%,SCRIB;ANGPT1;PLXNB3;SEMA5A
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.23500863574653286,0.5373448095584151,0.9479512735326688,1.0,1.0,7/48,16.34%,USP18;PTPN2;ROBO1;YTHDF2;PYDC1;CNOT7;METTL3
prerank,positive regulation of lipid storage (GO:0010884),0.25324698175501975,0.5371397280976146,0.9329113924050633,1.0,1.0,4/21,15.76%,PLIN2;EHD1;NFKB1;LPL
prerank,cell junction organization (GO:0034330),0.2308973658687036,0.5369655817246458,0.9628482972136223,1.0,1.0,13/71,16.32%,SDK1;RHOA;MAPT;NLGN3;GRHL2;LIMS1;CAPZA1;TJP2;PPFIA4;PRKCI;SMAD3;PIN1;NLGN2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.24295507683311865,0.5366094791656004,0.9476135040745053,1.0,1.0,11/38,23.12%,TRIM59;RIOK3;CASP8;RORA;PER1;OTUD7B;RIPK1;PPM1A;TANK;RHOH;DAB2IP
prerank,cellular response to glucagon stimulus (GO:0071377),0.2585273228860777,0.5365399850334431,0.9358288770053476,1.0,1.0,7/17,24.36%,ADCY6;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;PRKACA
prerank,aminoglycan metabolic process (GO:0006022),-0.22482195601679145,-0.5360163500379492,0.9577464788732394,0.9886414466325533,1.0,7/10,36.32%,CHST9;B3GAT2;XYLT2;B3GAT1;CLN6;B3GAT3;B3GALT6
prerank,alcohol catabolic process (GO:0046164),0.2797439226791395,0.5352651861722173,0.9221183800623053,1.0,1.0,1/10,6.76%,SRD5A3
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.2588201176024112,0.5352513446525167,0.9371794871794872,1.0,1.0,4/22,17.78%,TRPM4;TRIM6;BTK;LACC1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.27170862130298234,0.5350205231696115,0.9474431818181818,1.0,1.0,5/13,19.65%,PLXNB2;PLXNB1;PLXND1;PLXNA2;PLXNB3
prerank,positive regulation of viral transcription (GO:0050434),0.24367064538532554,0.5348703809492324,0.94529262086514,1.0,1.0,2/25,7.46%,DHX9;POLR2A
prerank,hexose metabolic process (GO:0019318),0.23998599951846072,0.5346632722524071,0.9461988304093567,1.0,1.0,3/39,8.43%,CHST15;SORD;PGM1
prerank,vitamin transport (GO:0051180),0.24571571159863387,0.5346086856700191,0.9462759462759462,1.0,1.0,2/29,6.14%,PDPN;SLC19A1
prerank,protein catabolic process (GO:0030163),0.22885508867397458,0.5344952996653398,0.9597826086956521,1.0,1.0,9/59,14.92%,CHEK2;SIAH2;PRPF19;ADAMTS9;HTRA2;CUL4B;STT3B;FBXO27;FBXO17
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.27952958119733523,0.5344610434934797,0.9274074074074075,1.0,1.0,4/12,16.04%,KLF9;CTSH;MED1;BRD8
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.22319980920105642,-0.5341616186190997,0.9508196721311475,0.9884280557836531,1.0,3/10,19.77%,GAP43;PICK1;DGKD
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.2679278472155823,0.5338469287818811,0.9484240687679083,1.0,1.0,1/13,5.13%,B3GNT8
prerank,protein K63-linked deubiquitination (GO:0070536),0.24287664602947445,0.5336649874306779,0.9443127962085308,1.0,1.0,11/31,24.51%,UIMC1;PSMD14;USP16;BRCC3;OTUD1;OTUD7B;USP20;ZRANB1;USP25;BABAM2;USP13
prerank,GPI anchor biosynthetic process (GO:0006506),0.2443373216655338,0.533517598680947,0.9423312883435583,1.0,1.0,9/30,22.28%,PIGN;PIGA;PIGU;PIGT;PIGM;DPM3;PIGG;GPAA1;PIGH
prerank,cellular response to catecholamine stimulus (GO:0071870),0.24961232960891278,0.5332448936241598,0.93854033290653,1.0,1.0,7/23,22.02%,ATP2B4;LRRK2;ADCY6;PDE4B;SNCA;SIRT2;GNB1
prerank,T cell activation involved in immune response (GO:0002286),0.2718940297570468,0.532965786382542,0.9326347305389222,1.0,1.0,12/12,72.83%,LCP1;TNFSF18;IFNK;F2RL1;ITGAL;ICAM1;LILRB1;MDK;EIF2AK4;SLC11A1;FCER1G;CD74
prerank,regulation of superoxide anion generation (GO:0032928),0.2620507622598154,0.5318606313629554,0.9246088193456614,1.0,1.0,4/14,24.85%,MAPT;PRKCD;SOD1;TGFB1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2620698486198748,0.5316902064801088,0.9350828729281768,1.0,1.0,1/14,5.75%,NUDT5
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2576123669161655,0.531644269285165,0.9262187088274044,1.0,1.0,1/17,4.92%,PDE3B
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.27891044707182094,0.5316351228382322,0.9544764795144158,1.0,1.0,2/10,13.63%,NUMA1;MED1
prerank,acylglycerol homeostasis (GO:0055090),0.2601286397977639,0.5311759586670493,0.9513797634691196,1.0,1.0,3/20,15.76%,IL18;RORA;LPL
prerank,acute inflammatory response (GO:0002526),0.24559865870515055,0.5309056769436418,0.9493670886075949,1.0,1.0,1/23,4.22%,MYLK3
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.24539363864558,0.5306297670343432,0.9455445544554455,1.0,1.0,5/25,21.07%,KIT;TRIM6;LACC1;TRAF6;TRAF2
prerank,peptide hormone secretion (GO:0030072),0.24756985385699842,0.5304918846586066,0.9431818181818182,1.0,1.0,3/26,14.70%,RAB1A;ANXA1;SNX19
prerank,response to hexose (GO:0009746),0.24754598402447342,0.53001451290698,0.9378109452736318,1.0,1.0,2/25,6.44%,TCF7L2;EIF2B1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.18687644629477201,-0.5293572951448811,0.9892086330935251,0.9889074788790431,1.0,9/16,41.37%,LONP2;PRKAG2;PPARGC1A;SOX9;ACADVL;NR4A3;PDK4;PPARA;FABP3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.22411703008724593,0.529334400517471,0.9868819374369324,1.0,1.0,13/140,12.83%,LPAR3;LPAR1;IAPP;CXCR4;PDGFRA;SLC8A1;BDKRB2;HMGB1;P2RY1;CACNA1C;ITPR3;TRPM4;C1QTNF1
prerank,integrin-mediated signaling pathway (GO:0007229),0.22526947245915552,0.528661882550469,0.9548319327731093,1.0,1.0,21/73,21.48%,ITGB7;CUL3;DOCK1;PRKD1;ADAM9;ADAMTS1;ITGA5;ITGB1;PTPRA;ITGAV;SRC;RCC2;ITGB8;FERMT3;CD47;CEACAM1;FERMT2;FBLN1;ISG15;ITGBL1;ITGA11
prerank,purine ribonucleotide transport (GO:0015868),0.2560815178300862,0.5285486781556917,0.9304589707927677,1.0,1.0,4/16,17.41%,SLC19A1;SLC25A42;LRRC8C;SLC25A17
prerank,regulation of type I interferon production (GO:0032479),0.22202195715585876,0.5282346564267816,0.9620123203285421,1.0,1.0,25/84,25.34%,POLA1;DHX9;PRKDC;MRE11;G3BP1;IRF1;POLR3D;ILRUN;ITCH;PIN1;NFKB1;MAVS;NLRP4;ISG15;TAX1BP1;POLR3C;RNF216;POLR3G;PCBP2;IRF8;CRCP;GPATCH3;RELA;DHX33;ACOD1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.22095225277167158,0.5269997428018124,0.9796954314720813,1.0,1.0,13/110,16.31%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GNAQ;S1PR2;ABCA1;ADGRG2;ADRB2;RAMP3;ADCY6;ADGRD1
prerank,sphingolipid biosynthetic process (GO:0030148),0.2294469511725553,0.5269549212419201,0.9647435897435898,1.0,1.0,13/71,15.58%,CERS6;CERS5;LARGE1;ST3GAL5;PLPP1;CSNK1G2;AGK;PRKD1;ELOVL4;SMPD1;SPTLC2;VAPA;PRKD2
prerank,glycoprotein biosynthetic process (GO:0009101),0.22322198510308916,0.5255494397281426,0.979253112033195,1.0,1.0,14/79,18.76%,LARGE1;FUT10;ST8SIA2;B3GNT8;ST3GAL3;B4GALT7;ST3GAL5;FOXL1;ST3GAL4;ST3GAL2;B3GALT2;CHST10;XYLT1;GCNT1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.2240772287465719,0.5254283341178158,0.9541088580576307,1.0,1.0,20/69,24.93%,INTS7;PHAX;POLR2A;POU2F1;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;GTF2B;ELL2;INTS13;GTF2A2;SNAPC4;SP1;INTS6;SNAPC1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.256151209501364,0.5247887600926345,0.9446022727272727,1.0,1.0,4/16,17.73%,PSIP1;WBP4;PRPF39;SFSWAP
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.24523748674962204,0.524140185573023,0.9432717678100264,1.0,1.0,3/20,13.32%,LYPD1;GNAQ;LY6H
prerank,negative regulation of defense response (GO:0031348),0.2245413930138843,0.5240734233121814,0.9653725078698846,1.0,1.0,9/77,13.71%,RB1;NMI;PTPN2;ENPP3;CCN3;ILRUN;ITCH;RORA;MVK
prerank,glucose homeostasis (GO:0042593),0.22314871883907,0.5232833956627339,0.9696016771488469,1.0,1.0,11/83,14.68%,FGFR4;GCK;LEPR;PTPN2;TCF7L2;NUCKS1;MCU;APPL2;ADIPOR1;FOXK2;STK11
prerank,response to thyroid hormone (GO:0097066),0.2702810335723573,0.5232064862900929,0.9416909620991254,1.0,1.0,4/13,16.04%,KLF9;CTSH;MED1;BRD8
prerank,development of primary male sexual characteristics (GO:0046546),0.23000384613720765,0.5225417791591277,0.9631391200951248,1.0,1.0,2/34,5.16%,KIT;WNT2B
prerank,muscle organ development (GO:0007517),0.22867801983137104,0.5224038355358716,0.9596069868995634,1.0,1.0,6/54,11.32%,LARGE1;SOX6;SGCE;EMD;SMTN;CHD2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.26134210166976557,0.5219118196834025,0.9462209302325582,1.0,1.0,2/12,12.61%,TMEFF2;HDAC2
prerank,snRNA transcription (GO:0009301),0.2225627701781396,0.5209092633044239,0.9614973262032086,1.0,1.0,20/70,24.93%,INTS7;PHAX;POLR2A;POU2F1;INTS8;GTF2A1;RPRD1A;POU2F2;ZC3H8;RPRD1B;POLR2B;INTS4;GTF2B;ELL2;INTS13;GTF2A2;SNAPC4;SP1;INTS6;SNAPC1
prerank,regulation of defense response (GO:0031347),0.22065803522111824,0.5208927838488636,0.9683877766069547,1.0,1.0,14/76,17.78%,SETD6;USP18;AKNA;IRF1;NLRP6;ANXA1;APPL2;DAGLB;CASP8;BRD4;XIAP;IL1RL2;FOXP1;LACC1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.2590941224773068,0.5195082769266659,0.9529914529914529,1.0,1.0,4/15,20.92%,WDR54;RBPJ;CEACAM1;FER
prerank,positive regulation of secretion by cell (GO:1903532),0.2207105627061305,0.5194957406061546,0.9643979057591623,1.0,1.0,15/70,20.64%,FRMD4A;STXBP5;MYH10;BMP6;BMP2;EZR;SYTL4;ACHE;PPID;ADAM9;CLASP1;TMED10;DNM1L;RAB3A;SNCA
prerank,negative regulation of GTPase activity (GO:0034260),0.24444215954508486,0.5193890457071864,0.9331619537275064,1.0,1.0,3/22,9.13%,WNK1;LRRK2;CPEB2
prerank,negative regulation of reproductive process (GO:2000242),0.2561258461263481,0.5192113158706704,0.9486486486486486,1.0,1.0,2/17,12.35%,SULF1;GJA1
prerank,amyloid fibril formation (GO:1990000),0.22792211454748393,0.5185538001479485,0.9617067833698031,1.0,1.0,7/51,13.51%,TSPAN33;IAPP;SIAH2;MAPT;CALB1;TSPAN5;USP9X
prerank,regulation of interferon-gamma production (GO:0032649),0.2205712208648922,0.5181274587123528,0.964968152866242,1.0,1.0,12/71,21.08%,FADD;PRNP;IL18;SCRIB;HMGB1;AXL;SIRPA;CD47;HAVCR2;ZFPM1;PDE4B;ISG15
prerank,glutathione metabolic process (GO:0006749),0.2311978130376716,0.5163541227741524,0.9585730724971231,1.0,1.0,10/38,22.10%,GSS;HPGDS;GSTT1;DPEP1;GCLM;GSTM5;GCLC;HAGH;SOD1;GSTZ1
prerank,arachidonic acid metabolic process (GO:0019369),0.23342107522750702,0.5162926060615602,0.9634433962264151,1.0,1.0,4/35,12.44%,PTGES2;HPGDS;PTGS1;DAGLB
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.22814807949780772,0.516282101896131,0.9558823529411765,1.0,1.0,11/41,23.76%,AFDN;PIEZO1;PLAUR;ADAM19;CD44;PTPRU;CD47;ANK3;DENND6A;GCNT2;PTPN23
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.25616877001318517,0.5162529491882488,0.95,1.0,1.0,14/14,74.41%,TRAF6;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;CSF1;TYROBP;ATP6AP1
prerank,melanosome localization (GO:0032400),0.23877371411836823,0.5159877712969474,0.9412515964240102,1.0,1.0,4/21,17.49%,MKKS;MLPH;BLOC1S5;SHROOM2
prerank,positive regulation of neuron projection development (GO:0010976),0.21902392842783042,0.5153780853784837,0.977296181630547,1.0,1.0,18/85,17.34%,SETX;CAPRIN1;MARK2;CAMK1D;ARHGAP35;PLXNB2;TWF1;P3H1;ZDHHC15;DPYSL3;ROR1;PRKD1;PRKCI;DBN1;COBL;STMN2;EPHA3;ARSB
prerank,GPI anchor metabolic process (GO:0006505),0.23858503944451956,0.5150814219748038,0.9517766497461929,1.0,1.0,7/26,22.28%,PIGN;PIGA;PIGU;PIGM;DPM3;PIGG;PIGH
prerank,lysosome localization (GO:0032418),0.23137254476186497,0.5145860959730588,0.9571263035921205,1.0,1.0,7/37,19.54%,KIT;SPAG9;BORCS6;SYTL4;MAP6;KLC2;RAB3A
prerank,cellular respiration (GO:0045333),0.22516028877938268,0.5143083430996411,0.9571106094808126,1.0,1.0,3/41,7.08%,MTFR2;COX10;COQ10B
prerank,negative regulation of cartilage development (GO:0061037),0.2620981522826402,0.5138867706637077,0.9607843137254902,1.0,1.0,4/13,20.13%,TGFBR1;WNT9A;EFEMP1;CHADL
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.26981463833105485,0.5133378139235248,0.9384615384615385,1.0,1.0,2/10,14.28%,ZNHIT3;RUVBL2
prerank,regulation of interleukin-8 production (GO:0032677),0.21748482360287552,0.513312973383497,0.975583864118896,1.0,1.0,11/69,18.72%,FADD;ARRB1;SERPINE1;HMGB1;RAB1A;ANXA1;OTUD7B;PRKD2;MAVS;LAMTOR5;RIPK1
prerank,peptidyl-amino acid modification (GO:0018193),0.2721735372785664,0.5127074596537807,0.9515625,1.0,1.0,2/10,17.99%,TTLL4;METAP1
prerank,membrane protein proteolysis (GO:0033619),0.23123388965906086,0.5126494514472485,0.9480968858131488,1.0,1.0,13/37,24.98%,SPPL2B;ADAM17;CTSH;ADAM9;ADAM19;NFKB1;TRAF6;RBMX;MYH9;NAPSA;RELA;TGFB1;SPPL3
prerank,cellular response to chemokine (GO:1990869),0.2243911318797252,0.5119015080253181,0.9649717514124294,1.0,1.0,3/46,8.79%,RHOA;WNK1;RIPOR2
prerank,maturation of LSU-rRNA (GO:0000470),0.23344877057448005,0.5118125304524894,0.9546568627450981,1.0,1.0,5/26,15.68%,ZNHIT3;DDX18;MRPL1;MAK16;WDR12
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.24310114062203161,0.5114709992313626,0.9381720430107527,1.0,1.0,5/20,15.98%,CARF;BMP2;RBPJ;SMAD4;SESN2
prerank,urogenital system development (GO:0001655),-0.19991457550442593,-0.5098646604929462,0.9846153846153847,0.992863581750772,1.0,4/11,27.95%,EPHB2;PAX8;SOX9;EPHB3
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.2143773114006995,0.5097849088536525,0.9868819374369324,1.0,1.0,23/138,17.05%,STYK1;FGFR4;FGFR2;KIT;FRS2;MUSK;PDGFRA;EPHA4;ABI1;BDKRB2;DDR2;PIK3CB;CLNK;GUCY2C;IL31RA;POLR1G;ROR1;PTPRU;SRC;TNK2;AXL;NGF;EPHA3
prerank,cytosolic transport (GO:0016482),0.21314116972784675,0.5088791701680515,0.9887410440122825,1.0,1.0,21/108,19.80%,AP4M1;GBF1;SPAG9;SNX1;DENND2A;RAB29;VPS13A;ANKRD27;ERC1;DENND5A;GAK;VTI1A;GOSR1;SNX32;VPS26A;EPS15;RIC1;PIKFYVE;TBC1D10A;BET1L;MON2
prerank,melanosome organization (GO:0032438),0.23768089212066623,0.5081619721451123,0.9579207920792079,1.0,1.0,6/26,17.75%,RAB29;AP3B1;BLOC1S5;AP1M1;SHROOM2;PIKFYVE
prerank,regulation of defense response to virus by host (GO:0050691),0.2323254775113349,0.5069641597453372,0.9591346153846154,1.0,1.0,4/30,17.14%,DHX9;PARP9;TRIM6;MAVS
prerank,regulation of biosynthetic process (GO:0009889),0.26476224733187714,0.5068098336758952,0.9401197604790419,1.0,1.0,3/11,23.35%,PIKFYVE;SNCA;SLC25A33
prerank,ceramide metabolic process (GO:0006672),0.2208975934682771,0.5066200651386815,0.9655937846836848,1.0,1.0,8/49,18.67%,CERS6;CERS5;PLPP1;AGK;SMPD1;SPTLC2;SMPD2;FA2H
prerank,negative regulation of hormone secretion (GO:0046888),0.26672433408295887,0.5055920938175641,0.9476744186046512,1.0,1.0,1/10,12.35%,GJA1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.2317401144802707,0.5036716032179362,0.962640099626401,1.0,1.0,4/24,15.24%,RHOQ;PICALM;DMTN;LZTFL1
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.25777668047533736,0.5027703342578175,0.9571005917159763,1.0,1.0,4/10,21.99%,TUT7;TUT4;ISG15;NEDD8
prerank,phosphate-containing compound metabolic process (GO:0006796),0.21071494473232721,0.5025081055508694,0.996993987975952,1.0,1.0,32/198,16.59%,PFKFB1;GCK;GPI;LHPP;OCRL;NUDT5;PPP3CA;IPMK;ENPP3;INPP5B;LRRK2;AGPAT2;LIMD1;DUSP12;PPA1;PPIP5K1;PIK3CB;ACYP2;IP6K2;ENPP1;PLPP1;AGK;NUDT4;PANK2;AGPAT1;PLCB4;TAOK1;LPL;PTEN;GK5;TNK2;GDE1
prerank,regulation of B cell activation (GO:0050864),0.23151229892090935,0.4985680845774548,0.9683944374209861,1.0,1.0,3/25,13.20%,SAMSN1;AHR;IL4I1
prerank,cellular response to starvation (GO:0009267),0.20870758741207387,0.4978730704140684,0.9899091826437941,1.0,1.0,28/147,18.08%,FNIP1;DEPDC5;DAP;HNRNPA1;STK24;ATG7;SH3GLB1;FOXO3;LRRK2;ZFYVE1;NPRL3;SESN1;EIF2AK3;SIK2;SLC38A9;PRKD1;ITFG2;RPTOR;MTMR3;PRKAG1;TP53;CLEC16A;SESN2;SFRP1;LARS1;LAMTOR3;LAMTOR5;SREBF1
prerank,regulation of inflammatory response (GO:0050727),0.20869397227269804,0.4973240608293022,0.9959839357429718,1.0,1.0,30/190,19.52%,SETD6;RB1;USP18;DHX9;NMI;PTPN2;IL18;AKNA;ENPP3;SERPINE1;AGT;NLRP6;CCN3;ANXA1;DAGLB;BRD4;RORA;MVK;XIAP;SETD4;IL1RL2;LPL;SIRPA;FOXP1;CD47;LACC1;PTGIS;RIPK1;DAGLA;PRKCD
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2201488024795002,0.4967374159131946,0.9679203539823009,1.0,1.0,10/49,19.46%,BMF;RTKN2;BCLAF1;BOK;EIF2AK3;PLAUR;SRC;TP53;BAD;DNM1L
prerank,positive regulation of potassium ion transport (GO:0043268),0.2227876568320315,0.49646975726757664,0.9813519813519813,1.0,1.0,9/38,22.08%,KCNN4;KCNMB2;KCNMB3;DLG1;KCNMB4;GABBR2;AMIGO1;GNB1;FLNA
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.23876628152673612,0.49615092389189375,0.9681697612732095,1.0,1.0,3/20,14.99%,GSK3B;BOK;ITGAV
prerank,positive regulation of type I interferon production (GO:0032481),0.20885269528051706,0.49604917073524923,0.9821989528795811,1.0,1.0,8/73,10.53%,DHX9;PRKDC;MRE11;G3BP1;SETD2;IRF1;RIOK3;POLR3D
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.2059820949002422,0.49543957904046776,0.9919354838709677,1.0,1.0,19/151,15.58%,FGFR4;FGFR2;GAREM1;ARRB1;FBXW7;PDGFRA;NPNT;ANGPT1;HMGB1;P2RY1;CRKL;BMP2;PRKCA;NOTCH2;ROR1;RAMP3;CD44;SLC30A10;PRKD2
prerank,response to glucagon (GO:0033762),0.23556433846664337,0.49491745940725185,0.9670619235836627,1.0,1.0,7/19,24.36%,ADCY6;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;PRKAR1A;PRKACA
prerank,female gonad development (GO:0008585),0.23191347741314328,0.4936571101578178,0.9517601043024772,1.0,1.0,1/19,4.54%,KIT
prerank,acylglycerol biosynthetic process (GO:0046463),0.2366857427885861,0.49348814754425446,0.9669631512071156,1.0,1.0,2/23,7.14%,LPIN2;AGMO
prerank,maturation of SSU-rRNA (GO:0030490),0.22092863757283454,0.49284788867108004,0.9686746987951808,1.0,1.0,6/34,15.78%,RIOK3;UTP3;NOL11;DHX37;TSR1;HELB
prerank,metanephros development (GO:0001656),0.2288946628974476,0.49237529533164953,0.9694656488549618,1.0,1.0,5/26,18.16%,NIPBL;CTSH;GDNF;PKD2;OSR1
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.22861830097639363,0.49228860624946635,0.9650711513583441,1.0,1.0,7/22,22.92%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.22861830097639363,0.49228860624946635,0.9650711513583441,1.0,1.0,7/22,22.92%,ZDHHC18;ZDHHC15;ZDHHC3;ZDHHC21;ZDHHC24;ZDHHC2;ZDHHC14
prerank,positive regulation of leukocyte migration (GO:0002687),0.2273153661772626,0.4911867083944362,0.9662650602409638,1.0,1.0,3/27,15.30%,ADAM17;MIA3;PLVAP
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.24267780756536322,0.49026227002771366,0.9634146341463414,1.0,1.0,1/14,4.05%,DDRGK1
prerank,autophagosome organization (GO:1905037),0.2132029027078126,0.48925412027801407,0.9700665188470067,1.0,1.0,13/50,22.40%,ATG7;ATP2A2;RAB1A;RB1CC1;ULK2;ATG3;ATG2A;STX12;UBXN2B;TP53INP2;AMBRA1;ATG13;ATG5
prerank,second-messenger-mediated signaling (GO:0019932),0.20744491061370113,0.4891272056745668,0.9852941176470589,1.0,1.0,10/82,13.58%,CXCR4;LRRK2;MCU;AGT;SAMD14;EIF2AK3;PDPK1;TRPM4;BTK;NUDT4
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.23362973909450382,0.48886063426386234,0.9633507853403142,1.0,1.0,8/20,26.55%,SPPL2B;ADAM17;ADAM9;NFKB1;TRAF6;RELA;TGFB1;RHBDD1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.22666322522086227,0.4885626655703666,0.9791411042944785,1.0,1.0,3/25,11.62%,DDX39B;SCAF8;HTATSF1
prerank,negative regulation of complement activation (GO:0045916),0.25484903646977597,0.48838403767188177,0.9577677224736049,1.0,1.0,10/10,74.53%,SUSD4;CD55;C4BPA;C4BPB;CD46;VSIG4;A2M;SERPING1;CR2;CR1L
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.21994948381081905,0.48805849285029684,0.9780600461893765,1.0,1.0,4/35,14.00%,PAM;ACAT1;ACACA;AACS
prerank,negative regulation of protein kinase activity (GO:0006469),0.2054891690596529,0.48780068533044524,0.9823834196891191,1.0,1.0,20/88,21.13%,RB1;CEP43;TAB1;WWTR1;GNAQ;SLC8A1;CEP85;PYDC1;PDPK1;LRP5;SPRED1;CDKN1B;QARS1;MVP;SH3BP5;PTPN1;TRIB1;CEACAM1;SNCA;UBASH3B
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.25282798906929366,0.48682810638933194,0.9545454545454546,1.0,1.0,1/11,9.77%,AGT
prerank,positive regulation of response to external stimulus (GO:0032103),0.20403998590051237,0.48658885591855267,0.9909547738693467,1.0,1.0,25/128,22.98%,DHX9;NMI;BMP6;IL18;SERPINE1;RIOK3;PUM2;AGT;POLR3D;CNTF;PRKCA;AKIRIN2;SLC15A4;SETD4;LPL;CD47;ANKRD17;RIPK1;IL16;SNCA;POLR3C;OPTN;GPRC5B;POLR3G;TLR7
prerank,inositol phosphate-mediated signaling (GO:0048016),0.23286828768248613,0.4863947112734769,0.9687924016282226,1.0,1.0,6/19,24.16%,PPP3CA;PPP3R1;NFATC3;INPP5A;HRH1;PPP3CB
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2035219441842946,0.4860329421325636,0.9909547738693467,1.0,1.0,17/152,15.10%,LPAR3;LPAR1;IAPP;ADGRL1;GNA13;GRK5;GNAQ;S1PR2;ABCA1;GLP2R;WASF2;GNAI3;ADGRG2;ADRB2;INSL3;RAMP3;ADCY6
prerank,ion transport (GO:0006811),0.20783820094314334,0.485953072250156,0.9918533604887984,1.0,1.0,11/111,12.03%,KCNN4;PLP2;SLC20A2;TRPA1;WNK1;SLC4A2;SLC9A5;SLC24A3;SLC8A1;PIEZO1;CHRNB1
prerank,protein targeting (GO:0006605),0.20316888158331614,0.48583375312154314,0.9898167006109979,1.0,1.0,30/118,23.86%,VPS37B;TRAK1;AP4M1;FUT10;MYO1C;VPS37A;MFN2;SRPRA;ZDHHC18;CHM;ZDHHC15;ATG3;PRKCI;ZDHHC3;ZDHHC21;PIKFYVE;KIF13B;PEX12;ZDHHC24;TSPO;ICMT;TIMM23;TOMM40;SPCS3;VPS37C;ZDHHC2;ZDHHC14;TOMM20;PITRM1;TIMM10B
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.20767390221121357,0.48568988645694694,0.9796791443850268,1.0,1.0,8/62,12.60%,ERCC3;ELOF1;ELOC;POLR2A;SETD2;LEO1;ADRM1;SSRP1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.22694358498679915,0.4851974850266209,0.9766009852216748,1.0,1.0,7/26,23.18%,NMI;ILRUN;ITCH;TRIB1;SIRT2;NFKBIL1;PCBP2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.24520212743596692,0.4837397353580258,0.9641319942611191,1.0,1.0,1/12,4.71%,IDH3A
prerank,negative regulation of signaling receptor activity (GO:2000272),0.2250619129071219,0.4831852351114162,0.9558080808080808,1.0,1.0,4/25,17.82%,GPRC5A;ERRFI1;RAMP3;SLC6A9
prerank,negative regulation of bone remodeling (GO:0046851),0.2513496547394854,0.48315533272382105,0.9671641791044776,1.0,1.0,11/11,74.88%,SFRP1;UBASH3B;GPR137B;IL6;TMEM119;CARTPT;CALCA;GREM1;TNFAIP3;GPR137;P2RX7
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.22723583278741338,0.4829982472426752,0.9583333333333334,1.0,1.0,7/22,24.48%,PSMB1;PSMB9;PSMB2;PSME4;PSMB7;PSMB8;PSMA5
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.18920276208411801,-0.482430748758476,0.990990990990991,0.9971151574085751,1.0,11/11,81.10%,P3H2;P4HA1;EGLN2;P4HA3;P4HTM;P4HA2;CRTAP;P4HB;EGLN3;EGLN1;OGFOD1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.23371633503895878,0.48164377359832644,0.9699346405228758,1.0,1.0,3/17,12.51%,SLC8A1;CACNA1C;TRPM4
prerank,positive regulation of TORC1 signaling (GO:1904263),0.23442280507656182,0.48150569477648303,0.9791666666666666,1.0,1.0,6/16,25.19%,KLHL22;CLEC16A;LARS1;LAMTOR5;GPR137B;SEH1L
prerank,response to cytokine (GO:0034097),0.20258758589289866,0.481120038858993,0.9939271255060729,1.0,1.0,30/141,21.35%,RHOA;ALDH1A2;SRF;AFF3;PTPN2;CXCR4;PML;SETD2;ANXA1;PRKCA;MAPKAPK3;CASP8;DPYSL3;ADAM9;SMPD1;SMAD3;PTPN13;SRC;IL1RL2;IFNAR2;RIPK1;SP100;RELB;PTPN5;TRAF6;SNCA;MAPKAPK2;ISG15;EIF2AK2;HDAC4
prerank,carnitine shuttle (GO:0006853),0.24476069912610418,0.4800540569116556,0.9678832116788321,1.0,1.0,2/11,14.01%,ACACA;CPT2
prerank,mammary gland epithelium development (GO:0061180),-0.17070197906139958,-0.47994675466862596,0.9936102236421726,0.9966489698305585,1.0,2/14,8.69%,AKT2;ERBB4
prerank,protein localization to mitochondrion (GO:0070585),0.24161831769334013,0.47874339792890097,0.9536321483771252,1.0,1.0,5/11,26.96%,LRRK2;MAIP1;ISG15;RALA;COX18
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2016267484989264,0.47714763627037915,0.984552008238929,1.0,1.0,15/95,20.26%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;HMGB1;ADAM9;NFKB1;AXL;SIRPA;MAPK14;PLAA;PDE4B;CD68;TRAF6
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.20295875046742104,0.47684874956912626,0.9851063829787234,1.0,1.0,8/64,12.60%,ERCC3;ELOF1;ELOC;POLR2A;SETD2;LEO1;ADRM1;SSRP1
prerank,regulation of interleukin-12 production (GO:0032655),0.20822730212207222,0.474036246530034,0.984304932735426,1.0,1.0,6/47,20.31%,MAST2;HMGB1;FOXP1;CD47;MAPK14;IL16
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.2316049572318603,0.47213763695058397,0.9641319942611191,1.0,1.0,7/14,26.49%,AK7;NMNAT1;NMNAT2;PNP;NMNAT3;ME1;AK8
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.2060359654874237,0.4721015706890133,0.9844444444444445,1.0,1.0,5/49,12.75%,KIT;IL18;PARP9;CNTF;IL31RA
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.24133121177531364,0.4720373437686775,0.9701726844583988,1.0,1.0,3/11,20.32%,PRKCA;PLAUR;ANK3
prerank,superoxide metabolic process (GO:0006801),0.2140349718334619,0.47185351027785566,0.9794685990338164,1.0,1.0,5/29,17.51%,SOD3;NOX4;CYBB;CCS;SH3PXD2B
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.22364551621932882,0.4708757221902455,0.9676584734799483,1.0,1.0,4/21,14.05%,SPPL2B;ADAM17;ADAM9;ADAM19
prerank,positive regulation of integrin activation (GO:0033625),0.23914685437510524,0.4690032708757625,0.9667149059334298,1.0,1.0,3/11,20.80%,PIEZO1;SRC;FERMT2
prerank,negative chemotaxis (GO:0050919),0.2096953700936901,0.4672783350151253,0.9802325581395349,1.0,1.0,5/33,15.22%,RHOA;NTN1;ROBO1;ITGAV;SEMA3D
prerank,ncRNA catabolic process (GO:0034661),0.2144355672627401,0.4671360705518353,0.984009840098401,1.0,1.0,7/28,21.21%,POP1;EXOSC7;TUT4;ZCCHC8;EXOSC10;DIS3;TRIR
prerank,lytic vacuole organization (GO:0080171),0.2137921196559483,0.4668343566629084,0.9806060606060606,0.9997899369882065,1.0,7/32,17.34%,VPS18;LRRK2;CLVS2;ABCA1;NAGPA;TPCN2;ARSB
prerank,regulation of peptide hormone secretion (GO:0090276),0.1989941519924137,0.4650358798580508,0.9947033898305084,0.9999815545047412,1.0,8/67,15.60%,GCK;ITPR1;CACNA1C;RAPGEF4;ITPR3;PRKCA;ENSA;PASK
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.2347291104275222,0.4650116324898462,0.9698275862068966,0.9995823080982674,1.0,12/12,76.54%,CD44;GCNT2;FLOT1;FGG;IL10;IL1B;TNF;LCK;AGER;SKAP1;THY1;BMP7
prerank,histone H3-K9 demethylation (GO:0033169),-0.18464006977623285,-0.46487261959814985,1.0,0.9978215366608749,1.0,5/11,32.71%,KDM4C;KDM4D;KDM4A;KDM3B;KDM7A
prerank,positive regulation of TOR signaling (GO:0032008),0.20548630789171268,0.46420053363078256,0.9859154929577465,0.9994505270039016,1.0,8/40,17.73%,FNIP1;KLHL22;SLC38A9;RPTOR;CLEC16A;LARS1;LAMTOR3;LAMTOR5
prerank,negative regulation of immune response (GO:0050777),0.1946723377046019,0.46206633354882615,0.9979859013091642,0.999725453989607,1.0,31/154,23.18%,IAPP;NMI;ENPP3;SAMSN1;ILRUN;GLP2R;ADAM17;ITCH;ADRB2;PLK2;RC3H1;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;HAVCR2;YES1;FER;HTR7;SIRT2;GNB1;PRKAR1A;FYN;MYH9;PCBP2
prerank,negative regulation of inclusion body assembly (GO:0090084),0.23721602462021035,0.4609338855810628,0.9686567164179104,0.9996737314985201,1.0,3/10,19.65%,DNAJB2;DNAJB6;SACS
prerank,B cell activation (GO:0042113),0.19664082438937422,0.46066217250647806,0.9915074309978769,0.9993542286812565,1.0,9/68,15.42%,KIT;PTPN2;CTPS1;PRKCB;ADAM17;CASP8;BTK;ITGB1;DCAF1
prerank,cellular response to UV-A (GO:0071492),-0.18346394617311546,-0.45909587833080673,0.994535519125683,0.9976730173944244,1.0,6/11,44.84%,MMP2;CERS1;MMP1;OPN3;TIMP1;MMP3
prerank,response to lipopolysaccharide (GO:0032496),0.19140805530117233,0.4564600004526886,1.0,1.0,1.0,24/138,20.92%,HMGB2;TICAM1;RHOA;SERPINE1;CD80;SMAD6;HMGB1;ADAM17;TRIM6;MAPKAPK3;ADAM9;NFKB1;AXL;SIRPA;FOXP1;MAPK14;PLAA;PDE4B;TRIB1;CD68;TRAF6;SNCA;MAPKAPK2;FER
prerank,neutrophil chemotaxis (GO:0030593),0.1981027544522216,0.4561623179572885,0.9854748603351955,0.9999230773416198,1.0,2/53,4.99%,GBF1;CKLF
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.19470286291461347,0.4549363378887964,0.9923329682365827,0.9998864619043546,1.0,3/53,11.46%,LPAR3;AGT;ANXA1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.23001947292377928,0.4546531483712147,0.9687034277198212,0.9995653786462506,1.0,3/13,17.18%,SPRED1;SPRED2;ATR
prerank,mitochondrial transcription (GO:0006390),0.24421389522073766,0.4525294691519749,0.9692307692307692,0.999816673753192,1.0,2/10,14.96%,FOXO3;TFB1M
prerank,negative regulation of type I interferon production (GO:0032480),0.2002489411629192,0.4519970796505141,0.994343891402715,0.9995555485148452,1.0,16/40,25.34%,PTPRS;ILRUN;ITCH;YY1;PIN1;MAVS;SIRPA;HAVCR2;RELB;ISG15;TAX1BP1;RNF216;PCBP2;REL;GPATCH3;ACOD1
prerank,regulation of intracellular pH (GO:0051453),0.20042393051045493,0.45122233074296836,0.9787985865724381,0.9993696939302625,1.0,5/34,17.64%,SLC4A2;LRRK2;SLC9A5;CA2;TM9SF4
prerank,DNA catabolic process (GO:0006308),0.229504080351538,0.4504325306155238,0.9768875192604006,0.9991950433163974,1.0,11/11,77.07%,XRN2;DFFB;DNASE1L1;DNASE1L3;DNASE1;ISG20;FBH1;DNASE1L2;MUS81;SETMAR;REXO4
prerank,steroid metabolic process (GO:0008202),0.193233036244285,0.44992891029791565,0.9936507936507937,0.9989334829292764,1.0,2/72,3.24%,CYP39A1;CYP26B1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.20138914258679774,0.44585998946782274,0.9888059701492538,0.9996262988478036,1.0,5/30,16.99%,KIT;LMBR1L;TP53;SFRP1;MLLT3
prerank,regulation of T cell proliferation (GO:0042129),0.1931283028788945,0.4443163349836544,0.9914346895074947,0.9996273908165484,1.0,8/61,21.49%,CD80;NCK1;ANXA1;NCK2;IL4I1;SLC7A1;SDC4;PNP
prerank,regulation of actin filament depolymerization (GO:0030834),-0.17061488570761676,-0.44090567923890134,0.9967741935483871,0.9984518287196278,1.0,1/12,5.18%,PLEK
prerank,innate immune response (GO:0045087),0.18370229410655473,0.4398332930494951,1.0,1.0,1.0,35/217,21.68%,STYK1;TRIML2;COLEC12;RNASE6;TRIM59;PML;TTC4;SETD2;TRIM28;SKP2;HMGB1;IKBKG;CYBB;SRPK1;CAPZA1;PYDC1;TRIM6;BTK;SMPD1;TRIM5;SRC;AKAP1;TNK2;MAVS;SRPK2;CFP;ANKRD17;SP100;RELB;YES1;SNCA;FER;ISG15;CLPB;IKBKB
prerank,positive regulation of peptidase activity (GO:0010952),0.2104891161623907,0.4382456505974776,0.9724047306176085,1.0,1.0,4/20,21.07%,DDRGK1;CTSH;PSME3;TANK
prerank,lymphocyte migration (GO:0072676),0.19908007254970564,0.43706359125269717,0.98661800486618,1.0,1.0,1/32,4.99%,CKLF
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.221180731567369,0.43524027934935006,0.9734904270986745,1.0,1.0,2/12,15.37%,AGT;GDNF
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.19756466791586036,0.4306858559493606,0.9939024390243902,1.0,1.0,1/27,3.90%,LPAR1
prerank,granulocyte chemotaxis (GO:0071621),0.1857106311684538,0.43041421118499634,0.9911602209944751,1.0,1.0,8/55,23.22%,GBF1;CKLF;ANXA1;PIP5K1C;PIKFYVE;PDE4B;CXADR;CCL14
prerank,RNA methylation (GO:0001510),0.1822608304816024,0.4267268287189296,0.9936373276776246,1.0,1.0,10/60,19.74%,RBM15;METTL5;RBM15B;METTL8;TFB1M;MRM2;METTL3;NSUN3;VIRMA;TGS1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.15621304453734647,-0.4257439879253909,0.996551724137931,0.9985790389111066,1.0,9/15,44.97%,TLR4;NLRC3;DDX3X;USP50;MYD88;TREM2;CPTP;CD36;TLR6
prerank,regulation of chemokine production (GO:0032642),0.19036213542287664,0.42557239922328793,0.9896907216494846,1.0,1.0,10/36,27.33%,IL18;ADAM17;LPL;FOXP1;EIF2AK2;IL6R;TLR7;IL33;WNT5A;TLR3
prerank,regulation of phosphatase activity (GO:0010921),0.1996148877868517,0.4236467334088899,0.9922380336351876,1.0,1.0,4/24,17.45%,MTMR9;BMP2;PTPA;PPP6R2
prerank,negative regulation of dephosphorylation (GO:0035305),0.19920199202554206,0.41945176531233097,0.9906666666666667,1.0,1.0,3/18,14.64%,PPP1R8;ENSA;PTPA
prerank,cochlea morphogenesis (GO:0090103),0.22155406093323016,0.41936360861620686,0.9848484848484849,1.0,1.0,1/10,11.71%,TBX18
prerank,peptidyl-methionine modification (GO:0018206),0.21253474453417537,0.41665547796072244,0.9871060171919771,1.0,1.0,3/12,17.99%,NAA20;NAA60;METAP1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.2055682128568403,0.4157629838656829,0.976056338028169,1.0,1.0,2/15,15.37%,AGT;GDNF
prerank,rRNA modification (GO:0000154),0.19551752032019717,0.4136011589698533,0.9851752021563343,1.0,1.0,4/21,17.45%,METTL5;TFB1M;MRM2;NSUN3
prerank,mesenchymal to epithelial transition (GO:0060231),0.21649613960203384,0.41264131701090434,0.9909365558912386,1.0,1.0,10/10,78.36%,SALL1;BMP4;FZD7;SIX2;PAX2;CITED1;WT1;GATA3;PAX8;BASP1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.17338138280934354,0.4035275870652427,0.9967567567567568,1.0,1.0,8/68,17.14%,RAB7B;DHX9;HMGB1;TWIST1;POU2F2;SETD4;LPL;MAVS
prerank,N-terminal protein amino acid modification (GO:0031365),0.19799610884959826,0.40310344292428474,0.987688098495212,1.0,1.0,6/14,28.31%,NAA60;METAP1;NAA40;NAA50;NAA35;METAP2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.17630710660305832,0.40175515234807013,0.9943693693693694,1.0,1.0,8/47,19.52%,MAPT;XDH;AGT;TP53;MAPK14;RIPK1;DHRS4;PRKCD
prerank,rRNA transcription (GO:0009303),0.1969783969306642,0.40123672857316584,0.9945872801082544,1.0,1.0,5/17,24.72%,GTF3C4;POLR1G;GTF3C5;BRF1;CAVIN1
prerank,neutrophil migration (GO:1990266),0.17027965663407263,0.39376535680633123,0.9978021978021978,1.0,1.0,2/58,4.99%,GBF1;CKLF
prerank,negative regulation of hydrolase activity (GO:0051346),0.1678043943461013,0.3894443695682842,0.9988938053097345,1.0,1.0,8/49,20.26%,WNK1;LRRK2;CPEB2;TERF2;ATP5IF1;RCC2;PLXNB3;EGLN1
prerank,potassium ion export across plasma membrane (GO:0097623),0.19393520843797069,0.3852052620592293,0.9970544918998527,1.0,1.0,13/13,80.62%,KCNT2;KCNK5;KCND3;KCNA5;KCNK18;KCNE1;KCNE3;KCNE2;KCNE5;KCNH2;KCNE4;KCNIP2;KCNQ1
prerank,monosaccharide transmembrane transport (GO:0015749),0.18675039246467826,0.383521022312416,0.9958904109589041,1.0,1.0,16/16,81.34%,SLC50A1;SLC2A8;SLC2A7;SLC2A12;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC2A6;SLC23A2;SLC23A1;SLC2A2;SLC5A3;SLC2A9;SLC45A3;SLC2A10
prerank,rRNA catabolic process (GO:0016075),0.18902087704110127,0.38329416075223927,0.9958677685950413,1.0,1.0,5/16,24.53%,EXOSC7;EXOSC10;DIS3;TRIR;EXOSC8
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.18713313571740758,0.37948984360541377,0.9973154362416108,0.9999899005068601,1.0,6/18,23.59%,YAP1;SMAD4;SRC;FER;IL6R;IL6ST
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.19545301640907636,0.3754016962290461,0.9970414201183432,0.9999246240669748,1.0,1/10,8.98%,RIOK3
prerank,positive regulation of T cell activation (GO:0050870),0.16238966068359978,0.3732130962712359,1.0,0.9997015490583988,1.0,9/62,18.54%,CD80;NCK1;FLOT2;ANXA1;NCK2;SIRPA;CD47;SLC7A1;ZBTB1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.16840805799435055,0.3558337212153747,0.9962073324905183,1.0,1.0,3/23,15.37%,AGT;GJA1;GDNF
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.1604616222327807,0.35272397077551565,1.0,1.0,1.0,5/25,23.25%,DNAJB5;GAK;HSPA14;BAG1;HSPA8
prerank,cell-cell junction maintenance (GO:0045217),0.17753970739870412,0.33767849488949064,1.0,1.0,1.0,3/11,24.99%,NLGN2;FERMT2;MYADM
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.13644452902500262,0.32284603425413083,1.0,1.0,1.0,21/116,22.87%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;YES1;HTR7;GNB1;PRKAR1A;FYN;MYH9
prerank,insulin secretion (GO:0030073),0.153047690119519,0.3194406458460079,1.0,0.9999967595179553,1.0,2/19,14.70%,ANXA1;SNX19
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.134054888694008,0.3180936478856573,1.0,0.9996203494039981,1.0,21/117,22.87%,IAPP;GLP2R;ADAM17;ADRB2;PLK2;INSL3;RAMP3;ADCY6;SRC;CYSLTR2;PRKAR2B;PRKAR2A;ADCY2;DPEP1;MAPK14;YES1;HTR7;GNB1;PRKAR1A;FYN;MYH9
